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Commencement address to the Class of 1985

RESPONSIBILITY
by Howard Levitin, M.D.

A

short while ago, amid the pomp and ceremony of a marvelous
tradition. President Giamatti on behalf of Yale University,
conferred on you the degree of Doctor of Medicine and said, “I
admit you with all its rights and responsibilities.”

I would like to spend the next few minutes sharing with you my thoughts on the
need to maintain a proper balance between the rights and responsibilities of the
medical profession. It is easy to accept the rights and privileges of your profession,
and rightly so, for you have worked hard, demonstrated your competence and
commitment and deserve to enjoy the reward of your effort.
But, it is equally important to keep ever-present in your mind that the
responsibilities of your profession are a crucial part of your life and career. 1 will
dwell more on the need to meet these responsibilities, not to put things out of
balance, but because it is important to constantly remind ourselves of our
obligations.
There are four components of our responsibilities as members of the medical
profession:
1. responsibility to ourselves
2. responsibility to our patients
3. responsibility to our profession
4. responsibility to society
RESPONSIBILITY TO OURSELVES
You owe it to yourself to enjoy the fruits of your labor, to take pride in your
profession and to enjoy a very good standard of living, It is equally important that
you have time for your personal and family life. While being dedicated to your
work, you should not feel that medicine is an impediment to a good life. Rather, it
should be complementary to a full and complete realization of your goals in life.
At the present time, much criticism is being leveled against the medical
profession, to such a degree that I begin to sense a feeling of guilt among my
colleagues and young physicians like yourself. For whatever reason society has
been motivated to diminish its long standing respect, if not reverence for the
profession, we have nothing to be ashamed of. Modern medicine, through both
basic research and health care delivery, is doing remarkable things, and the future
bodes well for further rapid advances in our understanding of biologic function
and the technology required to apply this knowledge to the good of our patients.
You are well prepared to take your place in the profession and to participate in the
continuing battle against disease and human suffering. You have a responsibility
to continue your education and to keep pace with the progress medicine will make
during your professional career.
Balance is the key. Neither be obsessed with the need to be 100 percent
committed to your work with the inevitable toll it will take on your personal and
family life, nor allow the prestige and remunerative aspects of the profession to
become an overriding influence.
Enjoy the rewards and respond with a lifetime commitment to be a superb
physician.

RESPONSIBILITY TO YOUR PATIENTS
I doubt that we could generate an argument about the
fact that a good physician should be well informed,
technically competent and genuinely concerned for the
welfare of his her patients. But above and beyond this
given, is the question of the role the patient should and
can play in matters concerning their own health care and
the manner in which they approach death. 1 encourage
you to consider the doctor patient relationship, not as a
high priest dealing with a supplicant flock, but rather as a
partnership, with physician and patient working together
towards the common goal of good health. In this
partnership, each makes an important contribution in the
prevention, management and cure of disease and when,
as is inevitable, dying and death have to be reckoned
with, the wishes of the patient become an integral part of
medical management.
I am unimpressed with the argument that patients do
not want, or are ill-prepared for this degree of involvement
in their care. Nor is the argument that meaningful and
informed decisions require an extensive medical back¬
ground. The contribution that the patient can make is not
a substitute for, or competitive with the medical expertise
of the physician, but rather, a crucial supplement. Nor is
involvement in their own care an additional and unde¬
sirable emotional burden. I submit that the anxiety
associated with not knowing and not being involved is
even greater. Don't let false pride prevent you from
saying, "I don’t know,” and from sharing the truth, and
planning treatment with your patients.
All too often, this subject is placed in the context of a
crisis situation with immediate life or death decisions, as
exemplified by the Karen Quinlan case or other “should
we pull the plug?” situations. While these are important
dilemmas, I would like to focus more on the role the
patient should play in the day-to-day prevention and
management of routine medical problems, and w ill take a
minute to tell you of a personal experience that might
help explain my position.
I broke my ankle many years ago. In the emergency
room, I was given strong sedation in anticipation of
anesthesia for a closed reduction of a bad fracture. The
orthopedic surgeon arrived accompanied by a resident.
I Hiring the examination, he explained to the resident that
they could elect to put on a short leg cast or a long leg
cast He decided on a short leg cast because, he explained,
I w ould w ant to get back to w'ork as soon as possible, and
that I would be more mobile in a wheel chair and on
crutches in a short leg cast.
call marshalling all of my clouded senses and
W hich will get me on the tennis court with the
best chance of full function?”
He icsponded, “ I he long leg cast, but it will be more
inconvenient and uncomfortable.”

As I drifted off into drug-induced oblivion, I muttered,
“Put on the long leg cast.”
With the very best of intentions, the surgeon erroneously
thought that getting back to work would be my highest
priority. I am happy to report that yesterday, I played
tennis with a group of medical students and in no way
embarrassed myself. My ankle is in perfect shape and I
am forever grateful to that surgeon, and especially to the
resident.
The medical options in my case were entirely left to the
physician. But, because two options existed, and the
consequences of each carried different implications for
life style, my contribution was terribly important to me.
It was based on my needs, which could not have been
fully appreciated by anyone else.
There are many advantages to this partnership
approach. The well informed, involved patient is more
likely to comply with a jointly arrived at therapeutic
regimen. There is much evidence in the literature to
support this conclusion.
I he well informed and involved patient is more likely
to have a realistic appraisal of the likely outcome of a
particular therapeutic or surgical intervention. Anger,
frustration and disappointment will be minimized when
the patient has been an informed contributor to his/her
own care. 1 believe that the current malpractice crisis is
based more in the anger and disappointment associated
with unrealistic goals and a feeling of noninvolvement
than in a sudden upsurge in suboptimal medical care. 1
find it a paradox that in the over 35 years since 1
graduated from medical school, the profession has
acquired the knowledge and skill to do remarkable
things, but paralleling this remarkable progress, society’s
regard for the profession is somewhat less than we would
like it to be.
Informed consent, always used in the ad hoc situation
for a particular invasive procedure, should be extended
to cover the entire scope of medical practice. It begins
w ith the first contact with your patient and continues for
the duration of your contact. In this setting, the patient
will, in a nonthreatening manner, gradually become
accustomed to participation and will certainly be better
prepared to discuss difficult decisions when they present
in the future. It also sets the stage for the patient to let you
know more about the values that will apply when a crisis
develops or when decisions that affect life style have to be
made. We have accepted the idea of a last will and
testament, a declaration of our wishes concerning the
disposition of our worldly possessions after we die. Why
not have a first w ill and testament
an opportunity in a
non-crisis situation, over a period of time, to address the
issue of the control of our most precious commodity
—our own life?

M.NOYES

Dr. Howard Levitin, at the podium, addressed the 101 members of the medical Class of 1985 at
commencement ceremonies held on the Harkness Green on May 24.

RESPONSIBILITY TO THE PROFESSION
Do not, as it is claimed the ostrich does, put your head in
the sand and hope that the issues confronting the medical
profession will go away. That is the one thing I can assure
you will not happen.
Over and over again, 1 hear about all of the bad things
that are happening to medicine - new government rules
and regulations, DRG’s, change in Medicare reimburse¬
ment, impaired physicians, malpractice inequities, and so
on. These are important issues that must be addressed.
In an address given many years ago to the Association
of American Medical Colleges, Senator Edward M. Kennedy
called attention to the rising concern for these same issues
and beseeched the medical profession to get involved in
proposing solutions or, he indicated, people far less
aware of the nature of medical practice and with a vested
interest that was not always compatible with that of the
medical profession, would promulgate undesirable rules
and regulations. Indeed, his wisdom and foresight have
unfortunately come to pass. And, unless you get involved
and the current state of affairs is not allowed to follow its
present course, you might look forward to increasing
control and restrictions, leading ultimately to medicine
being declared a public utility under the control of a
regulatory agency.
Remember that, if and when you emulate the ostrich,
the unique anatomical configuation required to get your
head in the sand leaves you remarkably vulnerable. You
should be concerned w ith your own continuing education
and the education of the generation of physicians that
will follow you.
Medical schools are currently being asked to reevaluate
the process of medical education. I think it is a good idea

and, in fact, the education process should be under
constant scrutiny. However, the call for reassessment
flows from the absurd assumption that the problems now
facing medicine can in some way be attributed to
deficiencies in the method of recruiting and educating
physicians. It seems that all of the evils that have befallen
us will disappear if we reduce the amount of basic science
teaching and include a sprinkling of humanities in the
curriculum.
I have trouble accepting the concept that teaching
humanities (a wonderful idea for its own sake) will
translate into making physicians more humane. Yale
medical students and faculty can enjoy a degree of
satisfaction from the recommendations of the GPEP
report outlining new proposals that closely approximate
the curriculum of our school.
Do not be afraid of peer review when intelligently
implemented. An effective stimulus to keep up-to-date, is
in itself, an educational experience and can do much to
restore confidence in the medical profession.
You will not escape the issue of cost containment and
the many secondary issues it raises. The availability of
good and readily accessible medical care is at risk to
become more and more a function of ability to pay.
Regulations establishing fixed prices according to disease
run the risk of making some patients more desirable than
others. National Health Insurance, which may or may
not be a good thing, will be a disaster if left exclusively to
beaurocratic planning and implementation.
But, most worrisome of all and potentially destructive,
is the emergence of large corporate, stock beholden,
medical industries. “Medicine for profit” will make
cost/effective ratios, market value of stock and profit
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margins important considerations, influencing decisions
of hospital and health maintenance administrators. Even
worse, and in my opinion, unconscionable, is the physician
who has an entrepreneurial interest in the health facility
w here he she practices. This must lead, at some point, to
a conflict of interest when the decision to admit, duration
of stay, and the type of procedures undertaken, translate
into financial remuneration above and beyond fee-forservice.
Please worry about this important issue. Keep your
head above the ground.
RESPONSIBILITY TO SOCIETY
We are a well informed and concerned segment of our
society. It is our responsibility to speak out on the broad
issues that affect the health of our individual citizens and
society at large. It is appropriate to address the issues of
prevention and management of health problems. It is not
a political statement that smoking is bad for your health,
and I endorse the current practice of labeling cigarettes. 1
also suggest that nuclear weapons and warheads be
labeled, “Warning! Undoubtedly hazardous to your
health”. Similarly, we must become more involved with
the reasons behind and control of drug, alcohol and
cigarette abuse. I he deleterious effect of air pollution,
contaminated water supplies, indiscriminate use and
disposal of toxic material must command our attention.
But these are the obvious. I call on you to address the
more subtle issue of chronic stress, the inevitable conse¬
quence of uncertainty, fear, unemployment and failure to
achieve one’s ambition. We are excessively concerned
with being number one. competing in a destructive
manner for material acquisitions.
I he very fear of survival in the current political climate
is a health issue. I do not believe the call for available
cyanide pills on college campuses was a well thought out
plan that proponents felt should be implemented. It was a
statement. “We are scared,"and being sacred is not good
for your health.
Violence has not been given its proper classification as
a disease. We should reject violence as entertainment.
One should not enjoy viewing or participating in violent
actions. Child abuse, spouse abuse, rape and the assump¬
tion that \ iolence is a legitimate way to settle difference,
are all too prevalent.
Creed is an illness. I he behavior ol highly paid
. ol General Dynamics, General Electric and
I
Mutton are manifestations of disturbed behavior,
us pledge not to succumb to similar temptations,
s a partnership with your patients can be useful,
partnership w ith society lead to more effective
ol such unresolved questions as definition of
out ion ('I limited health resources, care of the

indigent and care of the aged. Again, 1 would ask you to
consider this partnership complimentary
not competi¬
tive. We have the knowledge and technical competence,
but everyone has a legitimate role to play in the moral and
ethical issues we have yet to solve.
In conclusion, let us temporarily put these issues aside
for this festive occasion. You deserve the honor and
pleasure of successful completion of your studies and
entry into the medical profession. Test and enjoy the title
“Doctor”, now permanently prefixed to your name and
share with your family and friends their justifiable pride.
I know you will all appreciate, especially your parents,
your transition from paying and indebted student to
(modest as it may be) wage earner.
However, the issues addressed today evolve, and
whatever changes come about, 1 am confident of one
thing — society will always hold good health as a top
priority and want excellent medical care. The medical
profession will continue to offer dedicated men and
women the opportunity to use their intellectual and
technical skills in the service of humanity.
You have chosen well, worked hard and achieved your
goal. History tells us that in spite of anxiety about your
forthcoming adventure as a resident, you will do well.
Congratulations and best w ishes!

Dr. Levitin, professor of medicine, was associate dean from
1966 to 19H5.

CLOSING IN
ON CANCER
Dr. Sara Rockwell, professor (adjunct)
of research in therapeutic radiology,
(above) is conducting research on the
use of perfluorochemicals — a chemical
solution with properties similar to blood
plasma —in combination with
radiotherapy to improve treatment of
solid tumors which are resistant to even
the best of current treatment.

T his article is excerpted from a
forthcoming brochure People
Conquering Cancer prepared by Marion
E. Morra, assistant director, with Paula
A. Wilson, staff assistant, of the Yale
Comprehensive Cancer Center.
Photographs are by William Carter.

E

stablished in 1974, the Yale Cancer Center is one of twenty
Comprehensive Cancer Centers in the U nited States designated
by the National Cancer Institute to bring together the best in

research, diagnosis, treatment and prevention. The Center gives
to Connecticut and its surrounding states, strong programs in
basic sciences which are translated rapidly into patient care and treatment.
Talented and caring individuals, conducting research at the Yale School
of Medicine and the Yale-New Haven Hospital, are the mainstays of our
staff and programs. World authorities in the cancer field are here, along
with patients from Connecticut as well as from cities and towns around the
nation and from many countries overseas. New national figures in the
cancer field are created here —with radiation therapists, medical oncolo¬
gists and laboratory investigators, trained at the Center, having assumed
leadership roles in major institutions around the country.
We are in a particularly exciting and hopeful time in the field of cancer
research. Discoveries in molecular and cell biology are forging the way to
an understanding of the basic mechanism by which normal cells turn into
cancerous ones, supplying new leads towards earlier diagnosis and new
approaches to therapy which ultimately will lead to a cure for all cancers.
Our scientists are actively pursuing these and many other areas. Looking
at oncogenes involved in transforming cells and using this knowledge to
find new approaches to treatment. Developing new and unique drugs to
use in combinations which will attack specific kinds of cancerous cells.
Finding drugs that will have fewer side effects on normal cells. Characterizing
new radiation treatments in combination with chemotherapy to more
effectively attack cancer. Devising precise surgical procedures for removing
tumors. Creating new ways to diagnose cancer earlier. Originating
strategies in cancer prevention.
The statistics are also reflecting our new knowledge. Cancer is no longer
a death sentence — there are more people living with cancer today than
dying from it. And over half of patients with cancer are being cured of their
disease. Here at the Cancer Center at Yale, new approaches devised by the
best talents in scientific research are combined with the compassion and
commitment of a caring team of doctors, nurses, technicians, social
workers, dieticians and other professionals.
Dr. Alan C. Sartorelli

director of the Yale Comprehensive Cancer Center
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“Cancer pharmacology . . .
it’s fertile soil for testing new
ideas.
”

—Dr. John Lazo,

associate professor of pharmacology

“Our lab is a group of scientists ... its
location in the Comprehensive Cancer
Center allows us to bridge the clinical and
basic research areas, ” said Dr. Lazo.
“There are very few institutions in this
country where clinicians can work side by
side with laboratory scientists. At the
Cancer Center, we’re physically located next
to clinical facilities. We have ready access to
human tumor cells for our studies. Our
laboratories are within easy reach of the
doctors who are working with patients and

Dr. Alan C. Sartorelli, professor of pharmacology and director of the center,
(right) reviews scientific data on new chemotherapeutic agents with
Dr. Krishnamurthy Shyam, associate research scientist.

we talk with them regularly. We listen to
their ideas and observations and try to use
this information in a novel way to
formulate new therapies, design new drugs
and test new ideas that could have
immediate or long-term benefits to
patients, it’s an exciting and dynamic
arena in which to do modern cancer
pharmacology.”
Much of the work of these research
scientists has focused on anticancer drugs
that come from natural products — fungi
or other organisms — which are very
difficult to study because they are
complicated molecules. Bleomycin and
Adriamycin are examples of
chemotherapeutic agents which are natural
products. Drugs made from natural
products have been one of the most rapidly
growing classes of compounds in the last
ten years, and they now represent some of
the most useful anticancer agents.

Dr. John S. Lazo

Some of the leaders in the world of chemotherapy research are found in
Yale’s Department of Pharmacology. Collaborating with scientists in
medical oncology, they use biochemical and molecular principles to
innovate new methods of treating cancer. Major advances in the develop¬
ment of many of the chemotherapy drugs which today are changing the
cure rates for thousands of cancer patients around the globe, have come
from the laboratories of these Cancer Center researchers.
Dr. Sartorelli’s team is seeking to devise new approaches to treat
leukemia and other cancers, specifically developing treatments to convert
cancer cells through maturation to adult non-cancerous cells which are not
capable of growth. They are using chemical agents to regulate the growth
of cells by turning a cancer cell into a cell that behaves more like a normal
one. That is, to make it stop reproducing itself. Research at Yale has
already demonstrated that this approach works in the test tube.
With scientists in the Department of Therapeutic Radiology, they are
searching for biochemical differences between hypoxic cancer cells
cells
that don’t have much oxygen
and normal cells that can be exploited with
therapeutic agents. This information is being used to develop a new group
of drugs that will preferentially attack these oxygen-deficient cancer cells.
These drugs will be administered to patients in combination with x-rays
and other chemotherapeutic agents to allow greater chances for cure.
Dr. Joseph R. Bertino, professor of medicine and pharmacology, and
his colleagues are involved in three major areas of investigation: designing
new anticancer drugs, especially some which would work against the
vitamin, folic acid, which is necessary for cell growth; trying to
understand how anticancer drugs work so they can be used more
effectively in patients; and determining what happens within a cell that
allows it to become resistant to chemotherapeutic agents.
Dr. Robert E. Handschumacher, professor of pharmacology, has
recently isolated a receptor for the drug cyclosporin A, the treatment
widely used to prevent rejection of transplanted kidneys and other organs.
He reasoned that since cyclosporin acts on a specific part of the immune
system
T -cells - it might work on patients who have T-cell leukemia or
related diseases such as mycosis fungoides. His laboratory work spawned
an unexpected finding: that colon cancers have high concentrations of the
receptor for cyclosporin. The question of whether these laboratory findings
will translate into a treatment for patients will be answered through a
clinical trial conducted by physicians in Yale’s medical oncology clinic.

“Clinical research is a bridge . . it’s taking care of patients using
the newest treatments we're discovering in our laboratories
Dr. Joseph R. Bertino, associate director for clinical research,
Yale Comprehensive Cancer Center

Being in the forefront in clinical research means applying to the bedside
what the finest minds are innovating in basic research. At Yale everyone
involved in the development of new anticancer drugs works together
—from the first experiment at the laboratory bench right through to
treating a patient in the clinic.
It was at Yale in early 1942, that pharmacologist Dr. Alfred Gilman,
working with Dr. Gus Lindskog, discovered that the chemical warfare
agent nitrogen mustard could shrink tumors, giving birth to a new cancer
science — chemotherapy.
Fifteen years ago. Dr. Bertino, associate director for clinical resarch at
the Cancer Center, and an internationally renown medical oncologist,
and Dr. Morton Kligerman, who at the time, was chairman of the
Department of Radiology, pioneered the use of x-rays and combination
chemotherapy for treating Hodgkin’s disease, after noting that many
patients in remission relapsed in the area of their original tumors. He and
Drs. James Fischer and Leonard Prosnitz in the Department of Thera¬
peutic Radiology, studying the kinetics of the disease in the laboratory,
decided to give low-dose radiation following chemotherapy treatment.
Research of this type has made a difference in the cure rate for advanced
Hodgkin’s disease, which has risen dramatically from 40 to 70 percent.
Today, clinical research continues at Yale — in designing different
combinations of drugs, in using special substances to protect normal
tissues, in developing new chemotherapy agents, and in testing monoclonial
antibodies and biological response modifiers. The collaboration of pharma¬
cologists, biochemists, toxicologists, chemists and medical oncologists,
working elbow to elbow from the test tube to the patient’s bedside is what
makes the Yale Comprehensive Cancer Center special.

In the Section of Gynecologic Oncology,
patient care is only part of the effort — the
group is recognized nationally for research
conducted on several forms of cancer.
“Tumor markers are particularly
important with ovarian cancer patients,”
said Dr. Peter E. Schwartz, director of the
Section. The markers tend to become
positive well before there is any medical
evidence of the disease.
“We started doing one of the first studies
in the world looking at the possibility that
the common cancer of the ovary might
respond to estrogen,” he explained. “We
first presented the data in 1978, which
showed that about half of the common
cancers of the ovary have estrogen
receptors. Subsequently, we demonstrated
that they also contained progesterone
receptors.” Using tamoxifen, an
antiestrogenic agent. Dr. Schwartz was
able to arrest the growth of very rapidly
growing cancers for periods of three to
seven months in patients who were not
expected to have the disease controlled at
all.
Other avenues of research include the
use of new drugs combined with radiation
therapy to treat cancer of the cervix, work
with pharmacologists on more effective
ways to use tamoxifen in advanced ovarian
cancer patients and studies on a new
category of endometrial cancer w ithin the
cell lining of the uterus that, under the
microscope, looks exactly like ovarian
cancer.

“Tumor markers — substances
in the blood that can tell us if
cancer has come back before we
can measure it in other ways —
are one of the most exciting
discoveries in the last few
years.

” —

Dr. Peter E. Schwartz,

director, Section of Gynecologic Oncology

Dr. Bertino examines a patient with lymphoma whom he has treated with new
combinations of chemotherapy drugs.

“The Department of Therapeutic Radiology includes one of the major basic science
research groups in the country, working towards improving results of radiation therapy. ”
Dr. James J. Fischer, professor and chairman, Department of Therapeutic Radiology

Below, a dosimetry package prepared for
shipment to one of the numerous hospitals
that call upon Yale's Section of
Radiological Physics to plan radiation
treatment for their patients.

Complex calculations, using a computer,
are needed to determine doses of radiation
for each patient, with x-rays often beamed

The Department of Therapeutic Radiology, one of the oldest and
largest in the country, treats more than 1,700 new patients a year at the
Robert E. Hunter Radiation Therapy Center at the Yale-New Haven
Medical Center, the Phelps Center at the Uncas-on-Thames Hospital in
Norwich, Connecticut, and the West Haven Veterans Administration
Hospital.
“The Department includes one of the major basic science research
groups in the country, working towards improving results of radiation
therapy,” said Dr. Fischer. “We have an extremely broad view of what is
relevant to radiation therapy, and have attempted to mount a research
effort which covers activities from molecular biology to clinical trials.”
One advantage of this kind of program is that discoveries made in the
laboratory may be more quickly applied to patient care.
For instance, researchers are attempting to overcome the problem of
hypoxic cancer cells —cells which do not have an adequate supply of
oxygen. These cells, known to be resistant to radiation occur in tumors
because a patient’s blood supply is not sufficient to keep up with the rapid
growth of the tumor.
Scientists in the Developmental Therapeutics Program of the Department
of Pharmacology predicted that certain chemotherapy drugs would
preferentially kill hypoxic tumor cells. They worked with members of the
Radiobiology Group to show that in animals, these drugs, combined with
radiation, destroy both tumor areas — those with and without an adequate
supply of oxygen. This concept has been used to treat patients with
advanced head and neck cancer and is showing significant improvement in
tumor control. The successful outcome is a result of cooperation among
individuals in various fields of basic and applied laboratory research and
clinical research.

from several different directions in order to
kill the tumor while sparing damage to
healthy tissues. The Department of
Therapeutic Radiology specializes in this
exact science, called dosimetry, and is
often called upon by hospitals around
Connecticut and out of state to plan this
sophisticated mapping. “A physician wires
us a diagram of the patient’s shape and the
location of the tumor,” explained Dr.
Robert J. Schulz, professor of therapeutic
radiology and chief of the Section of
Radiologic Physics. Dr. Schulz and his
colleagues make the calculations and send
back a prescription for the doctor to carry
out. “We were one of the first places in the
countn to specifically train dosimetrists,”
he said. Students with degrees in one of the
phssical sciences enter the program and
arc taught this new specialty.
Dr. Schulz also directs the Eastern
' i nter for Radiological Physics, which is
onsihle for assuring that the dosimetry
f ir radiation therapy performed at 80
Is in the northeast meets current
•r(* for accuracy and is reproducible
r vtended periods of time.

Dr. Fischer (center) and Dr. Timothy Mate, senior resident in therapeutic
radiology, discuss a procedure with their patient, who is being treated for
esophageal cancer.

“Programs in basic research
— cell biology, tumor virology,
developmental therapeutics and
immunology — are closely connected.
We think it's essential not only for
these different basic research
investigators to work together,
but also to be involved with what's
happening to human cancer. "
— Dr. Sherman M. Weissman,
associate director of basic sciences,
Yale Comprehensive Cancer Center

The National Cancer Institute recently awarded Yale a program project grant of $3.3
million for studies by members of the Section of Immunology on the regulation of
immune response. Dr. Charles A. Janeway, professor of pathology and biology
(above), is the principal investigator.
Current research in the Section of
Immunology is based on the premise that
cancer cells are distinguishable from
normal cells, according to Dr. Charles
Janeway. The immune system detects

Basement membranes. Epithelial carcinomas. Oncogenes. Receptor mole¬
cules. Antigens. Monoclonal antibodies. Tumor necrosis factor. These
are the tomorrow terms, excitedly discussed by the basic research
scientists — the group deeply engrossed in the mystery of what makes a
cell become cancerous and in studying the basic workings of the body to
solve the cancer riddle.
Dr. James D. Jamieson, chairman of the Department of Cell Biology,
and his colleagues, are interested in basement membranes — particularly
how a tumor cell is able to form a ‘hole’ in the layer of cells, escaping the
normal boundaries to move through the body and attach itself to another
layer of cells to form a new tumor.
“We are also studying epithelial cells,” Dr. Jamieson said. “These cells
form tissues that cover a surface or line a cavity of the body and act as the
first line of communication and defense between the external environment
and the interior of the organism.”
Epithelial cells are important, since nearly three-quarters of tumors that
kill — such as breast, lung and prostate cancers — are epithelial tumors.
Chemotherapy drugs have been most effective against rapidly dividing
cells, but not against these slow-growing tumors. A very basic question is
being asked: what is responsible for the growth of epithelial tumors? The
answer could make a major impact on the future of cancer treatment.
Dr. Sherman Weissman and the investigators in the Tumor Virology
Program are looking at the ways tumor viruses grow; how genes express
themselves, and how gene products affect cells to make them turn into
cancer cells. Some investigators are doing fundamental studies on the
regulation of cell proliferation. Others are doing research on cell surface
antigens — markers which can be used to detect cancer and to deliver
cancer treatment. Dr. Peter Lengyel, professor of molecular biophysics
and biochemistry, and his colleagues are investigating the mechanisms
involved in the action of interferons — protein-like biological regulators
and other lymphokines. Interferons are part of the body’s defenses
against infection of a large variety of viruses, and also control the activity
of the immune system and the growth of cells. They accomplish these
functions by activating several genes. The Virology Program, representing
seven departments, is internationally recognized for its pioneering roles in
introducing new concepts for understanding the basic behavior of cells.

infectious agents and rejects them as
foreign.
“It has been known for many years that
cancer cells are also detectably foreign to
the immune system,” said Dr. Janeway.
"However, it is also clear that the immune
system fails to respond appropriately to
transformed immune system or cancer cells
that give rise to tumors.”
The Yale group, initially directed by the
late Dr. Richard K. Gershon, has
hypothesized that some of these failures to
respond to cancer cells may reflect the
immune system’s own regulatory signals,
usually invovled in preventing the system
from destroying normal self cells. In
cancer, this regulatory apparatus may also
block the destruction of the tumor cells
themselves.
Using techniques of immunology,
protein chemistry and molecular genetics,
Dr. Janeway and his colleagues have
succeeded in showing that the body does
indeed have a specific apparatus for
regulating or suppressing the responses of
the immune system. However, the detailed
mechanics of this regulatory system are
poorly understood, and none of the
molecules that these cells produce have
been purified, nor have the genes that
encode them been identified.
In current work, the team is using an
interdisciplinary approach to
characterizing these products, in order to
learn how to control them. Effective
manipulation of the immune system by
these means could have far-reaching
implications both for cancer and for other
immune system disorders.
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“Cancer prevention at the Cancer Center at Yale has a two- pronged approach

—

basic epidemiological

research and carrying out programs for preventing or controlling cancer by early diagnosis
and by changing our lifestyles.

”

Dr. Dwight T. Janerich, associate director for cancer prevention and control

Melanoma is rising at an alarming rate,
second only to lung cancer in women. . .it’s
now one of the most common cancers in
people born after 1950.
The Cancer Center's Melanoma Unit is
among the top three in the country, seeing
patients from all over the world. Here,
individuals who are at high risk for
melanoma are screened. Doctors and
laboratory researchers map and
photograph the moles, they biopsy both
the most abnormal and the most normal in
patients with a history of melanoma to
detect and help establish differences
between normal and cancerous moles.
The Melanoma Unit, established in 1978
by Dr. Kirkwood, is a multidisciplinary
effort, involving medical oncologists,
surgeons, dermatologists, pathologists,
pharmacologists, epidemiologists and
diagnostic imagery .
The Melanoma Unit has been a pioneer
in developing new treatments for
melanoma, including a major continuing
research effort in the field of interferons,
biological molecules produced by the body
to fight against disease. It is joining seven
other institutions in the country to test the
use of chemotherapy and interferon in
combination to treat melanoma.
Immunologists and oncologists
associated with the unit are also
experimenting with biological and
chemical agents which might change
melanoma cells, making them into more
normal ones. In addition, there is ongoing
research using antibodies to detect and to
treat the disease. I)r. Kirkwood noted that
"With the use of diagnostic imaging, we
can label an antibody with radioactive
isotopes and trace its localization to the
tumor. We can perhaps find metastases
'hut are undetectable by other means in
patients who have had melanoma.

'll e re working together
closely, collaborating in a way
which is electric. ” Dr John M.
Kirku i >< id. associate professor of medicine
>r oj r/ic1 Melanoma l Hit

Dr. Dwight T. Janerich, associate director for cancer prevention and control,
collaborates with Marion Morra, assistant director of the Cancer Center, on
programs for preventing cancer in Connecticut residents who are at high risk.

Much of what is known about cancer comes not only from the laboratory,
but also from studies of people and how they live, which tell us many things
about how cancer is caused and how we can prevent it. The Cancer Center’s
new statewide program for cancer control research takes advantage of
what is known about how certain cancers occur to find ways to prevent
them altogether or diagnose them earlier, when they have a better chance of
being treated successfully.
Basic research in cancer epidemiology — the study of populations and
disease
demands painstaking accumulation of clues and bits of evidence.
“For instance,’’said Dr. Janerich, “it is becoming increasingly clear, mainly
through studying groups of people with colon cancer and those who don’t
have this disease, that a diet high in bulk and low in fat can minimize the
risk of getting it. We aren't sure why this happens, but we may be able to
learn, through major research projects, how to change our eating habits
and what to add or subtract to make a difference in colon cancer rates.”
Forecasting what the cancer rates will be in Connecticut in the next
century, through statistic modeling, is also a part of this research. “For
epidemiologists, the human population is our laboratory,” continued Dr.
Janerich. “We are fortunate that in this state we have 50 years of experience
through the Connecticut Tumor Registry. More than 400,000 cases of
cancer have been recorded and analyzed. Knowing how' cancer behaves in
our population, we can forecast the kind and number of cancer cases we
will have in the year 2000. This gives us time to prepare for these future
correlations, or to intercede, if possible.
Information in the Tumor Registry also gives the Cancer Center clues on
what groups of people in Connecticut are at high risk for the various
cancers. “With the help of institutions such as the Connecticut Department
of Health Services, the University of Connecticut Health Center and the
American Cancer Society, we can look at issues
how to get women to do
breast self-examinations each month, or why blacks have poorer survival
rates than do whites,” explained Dr. Janerich. The new thrusts will help
build a foundation for other statewide population-based studies to find
innovative ways of controlling cancer.

THE REVOLUTION
IN MEDICAL DIAGNOSTIC IMAGING

In just the last decade, the field of medical diagnostic
imaging has entered into a new era with a dazzling
spectrum of computer-based technology that has vastly
improved diagnostic capability, and at the same time,
created new roles for diagnostic radiologists.
Computed tomography (CT) scans, first used in the
1970’s to detect brain tumors, now scan the entire body,
using computers to organize thousands of x-rays taken
by a machine which rotates around the patient’s body.
Recently, quantitative computed tomography (QCT) has
been developed for a meaningful assessment of cortical
and trabecular bone mass in vivo for the first time.
In 1975, the first two grey-scale ultrasound machines
commercially produced were installed for evaluation in
San Diego and at Yale. The scans they produced required
a vivid imagination to discern any detail, and were
effectively useless in the abdomen, according to Dr.
Kenneth Taylor, professor of diagnostic radiology, a well
known leader in the field. “Real-time machines, intro¬
duced in 1980, have gradually improved to the superb
imaging devices we now have, allowing prenatal diagnosis
and numerous applications in the heart, abdomen, pelvis
and neonatal brain.”
Other modalities, including digital subtraction angio¬
graphy and Doppler and pulsed Doppler, have contri¬
buted to improved diagnosis, localization and determina¬
tion of the extent of disease.
The newest diagnostic tool — and the one causing the
most excitement — is magnetic resonance imaging
(MRI). Without the use of ionizing radiation or intra¬
venous contrast material, the new technology has opened
a whole new area of diagnostic imaging. Its unsurpassed
contrast resolution enables discrimination of the individ¬
ual tissues comprising an organ. For example, grey and
white matter can be distinguished in both the brain and
the spinal cord. The spinal cord can be directly seen, in
contrast to the mere shadow identified with myelography.
Within the uterus, the glandular and muscular layers can
be delineated.
“We are doing a great deal of research with MRI
because it is a new technique with the potential of
becoming one of our best diagnostic tools,” said Dr.
Richard H. Greenspan, professor and chairman of the
Department of Diagnostic Radiology, who is recognized

for his research in clinical MR imaging. With its MRI
center soon to be completed, Yale will be one of the
leaders in the country in MR research and patient
diagnosis.
As a result of the greatly improved imaging capabilties
of these new diagnostic tools, radiologists, have become
more involved in patient treatment. Drainage procedures,
percutaneous needle biopsies, stone extractions, angio
plasties and numerous other interventional procedures
are performed under the guidance of imaging procedures.
“Since these procedures can frequently be done on an
out-patient basis, eliminating the necessity for surgery
and long-term hospitalization in some cases, this trend
will undoubtedly continue,” said Dr. Greenspan.
“A major task which remains to be accomplished is to
increase the specificity of imaging, thus permitting the
differentiation of inflammatory disease, tumor, and so
forth. Extensive research to provide greater specificity is
being carried out at Yale,” he noted.
The comfort of the patient, as well as safety are
important considerations in this explosion of techno¬
logical advances in the field. Ultrasound and MRI have
thus far not revealed any harmful effects, and other new
techniques offer improved resolution of conventional
radiographs with smaller doses of radiation to the
patient. For patients who are unstable, portable x-ray
units, ultrasound scanners and nuclear medicine cameras
can be brought to the bedside.
To achieve maximum results from this extraordinary
progress in the field, a teaching and consultation program
for integrated imaging has been developed at Yale.
“Because of the large number of imaging procedures now
available, it is necessary to avoid duplication and to plan
a logical workup of individual patients,” explained Dr.
Greenspan. “This requires prospective consultation be¬
tween the clinician and the radiologist. The choice of
imaging procedures can no longer be delegated to
individuals who are not familiar with the advantages and
the limitations of various imaging methods,” he said.
“In an attempt to use these modalities to their best
advantage, we have initiated an innovative prospective
consultation program. The program will also help to
educate both the radiologists and the clinicians by
providing evaluation of the clinical efficacy of the various
imaging methods.”

Yale's ultrasound section is one of the country
leaders in developing blood flow ultrasound, a
new method which may be useful in detecting
cancer.

FIG. 1

Fig-1 1975 ultrasound scan reportedly shows septated, renal
cysts. A vivid imagination is required.

With improved diagnostic imaging techniques, the treatment of
the fetus at risk in utero with medical or surgical therapy has
become a reality. Surgical therapy, still under evaluation, has
included placement of catheters to resolve an obstructive process
such as hydrocephaly, and to treat the fetus with posterior
urethral valve obstruction. The use of ultrasound in these
procedures has eliminated the need for techniques involving
radiation exposure to ensure proper placement of the catheters.
One of the impressive results of improved diagnostic
radiologic techniques is the use of echo cardiology for imaging
fetal cardiac development. By first determining the structure of
the normal feta! heart, Drs. Charles Kleinman, John Hobbins
and Orvan Hess were able to discern fetal cardiac anomalies of
the gross structure of the heart and ultimately, to study heart
function and rhythvms.
After analyzing the various fetal heart arrhythmias, Dr.
Kleinman. associate professor of pediatrics and diagnostic
radiology (in photo), developed a treatment for fetal nonimmune hydrops, a condition long associated with interuterine
death. To date 19 infants with this condition have been
successfully treated at Yale. A fetal cardiovascular center was
established here last spring for diagnostic procedures for
pregnant women whose fetuses are at at cardiac risk.

FIG. 2

Fig.2 Currently, real-time ultrasound machines are available
which produce dynamic images like a movie. This scan is a
frozen frame from a real-time tape showing a section through
fetal trunk. Huge disorganized renal masses are seen (arrows)
with the aorta between them dividing into the iliac arteries
below. These appearances indicate infantile, polycystic kidney.

Fig. 4 CTscan demonstrating the intimalflap (arrow) in a
patient with aortic dissection. This study obviated the need for
arteriography, an invasive procedure.

FIG 4

Fig-3 Continuous wave Doppler and pulse Doppler have
introduced another modality to assess the presence of flow and
to quantitate hemodynamic abnormalities. In this figure,
Doppler wave forms are noted in many vessels around the liver.
This allows noninvasive detection of perfusion in deep seated
vessels, (courtesy Radiol)

Fig. 5 CT scan of the liver, demonstrating three percutaneously
placed catheters (arrows) draining intrahepatic abscesses.

FIG. 5
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FIG. 6A

FIG.6C

F1G.6D

Fig. 6. Standard radiographs can only identify the degree of
bone mass loss when it is as much as 30 to 50 percent. (Fig. 6A).
Prior to quantitative computed tomography (QCT), evaluation
of a bone biopsy was the most reliable method for measuring the
extent of bone present (Fig. 6B).
Drs. Pamela Jensen and Stylianos Orphanoudakis, associate
professors of diagnostic radiology, developed a method using
QCT to measure the bone mass of the distal radius (area
between the lines in Fig. 6A). This technique permits the
separate assessment of the thick bone on the cortex and the
spongy trabecular bone. The computer identifies the high density
CT values on the cross-sectional CT image corresponding to the
cortex circled numbers in Fig. 6C, and creates a corresponding
black line in the center of the cortex (Fig. 6D). The mean value
of these numbers re flects the cortical bone mass. The trabecular
bone mass is determined by averaging the CT values in the
cortex; trabecular bone can then be compared with the normal
values (Fig. 6E). In the example here, there is both cortical and
trabecular bone loss due to osteoporosis.

FIG. 6E

trtii le is based on material prepared by Hr. Greenspan and
I >i Stanle y Rapopon, assistant professor of diagnostic

Fig. 7 Intra-arterial digital subtraction angiography (DSA )
demonstrating fine resolution. Note the presence of a small
ulcerating plaque (arrow) near the origin of the left internal
carotoid artery.
Fig. 8A An abdominal aortogram of a 50-year old man with
hypertension revealed a significant stenosis (arrow) at the origin
of the left renal artery.
Fig. 8B Inflated balloon of angioplasy catheter at the site of the
renal artery stenosis.
Fig. 8C Abdominal aortigram post-angioplasy indicates there is
no residual stenosis, and the patient has subsequently become
normotensive.
Fig. 9 A Arteriogram demonstrates occlusion of the popliteal
artery. Fibrinolytic therapy was instituted in place of surgery.
Fig. 9B Arteriogram obtained 12 hours after local infusion of
low-dose Streptokinase was instituted. The popliteal artery,
which was thrombosed due to an aneurysm, has recanalized. The
streptokinase was infused via a small catheter, the tip of which
was initially embedded in the thrombus (arrow).

[
I
FIG. 7

FIG.8B

FIG.8A

FIG. 8C

A major task which remains to be
accomplished is to increase the specificity
of imaging. Extensive research in this area
is being carried out at Yale.

FIG. 9A

F1G.9B
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FIG II

Fig. 11 Coronal MR scan through the chest and abdomen
demonstrating right (RV) and left (LV) ventricles, right (RP)
and left (LP) pulmonary arteries, and interventricular septum
(arrow) of the heart, Also note the main portal vein (M)
branching into the right and left lobes of the liver and the right
(R) and left (L) hepatic veins.
FIG 12

Magnetic Resonance Imaging Unit enables the viewing of parts
of the body previously unexplored by other techniques.
"Magnetic resonance imaging can pick up tumors in locations
that other technology cannot reach, such as the base of the skull,
the spine and the pelvis. It's hard to see the soft tissue in these
areas with a CT scan, but M RI shows it because you can't see
the overlying bones,"explained Dr. Richard H. Greenspan
(above) "It's also useful for tumors which have metastasized. "

MRI, the newest tool in diagnosis, can examine
soft tissues more clearly than bones.

Fig. 12 Coronal MR scan of abdomen showing hepatoma (H),
high intensity area in right lobe, displacing inferior vena cava
(large arrow). Note normal left lobe (L), spleen (S), aorta (A)
and renal arteries (small arrows).
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STUDENT RESEARCH
FELLOWSHIPS
ESTABLISHED IN HONOR
OF TWO DISTINGUISHED
LATE FACULTY

SYMPOSIUM HONORS
DR. LERNER
Colleagues came from across the nation
and from overseas on June 22 to pay
tribute to Dr. Aaron B. Lerner at a
symposium celebrating his three decades
of dedication and outstanding accom¬
plishments as scientific investigator, clini¬
cian and administrator. A member of
the Yale faculty since 1955, Dr. Lerner
was appointed chairman when the De¬
partment of Dermatology was established
in 1971 — a post he will hold until he is
succeeded by Dr. Richard Edelson on
January 1.
Dean Leon E. Rosenberg gave the
opening remarks of the day-long program
presented by distinguished scientists. “His
30 years at Yale have been full ones — as
clinician, teacher, administrator and in¬
vestigator. Aaron and the colleagues he
recruited made Yale’s dermatology pro¬
gram a premier one nationally — a
model for others to praise and to compete
with,” said Dean Rosenberg.
“He interested a generation of medical
students in academic or clinical careers
in dermatology. He helped train derma¬
tology residents and fostered a collegial
relationship between full time faculty
and community practitioners without
the town/ gown tensions so characteristic
of other clinical specialties.
“But most of all professionally, Aaron
has been a scientist. He demonstrated
his investigative acumen early — during
medical school when he and Cecil Watson
discovered the first patient with cryoglob¬
ulinemia and isolated the protein from
serum. When, a few years later, he
turned his attention to the field of cu¬
taneous pigmentation, he proceeded to
make a series of major contributions
including: early definition of the mecha¬
nism of enzymatic cleavage of phenyl¬
alanine and tyrosine; isolation and char¬
acterization of melanocyte stimulating
hormone (MSH) and of melatonin; recog¬
nition of the universal nature of vitiligo
in the animal kingdom; clues to the
mechanism of action of MSH; and the
development of experimental therapies
for melanoma. This work, not surprising¬
ly, has brought Aaron considerable ac¬
claim, notably the Myron-Gordon Award
for pigment cell research in 1969, election
to the National Academy of Sciences in
1973, and the Lita Annenberg Hazen
Award for excellence in clinical research
in 1981. . .
“I’ll close by saying simply that as

The Dr. Vernon W. Lippard
Student Fellowship in Pediatrics

DR. 1 ERNER

you, Aaron, prepare to embark on yet
another phase in your remarkable life
and illustrious career — that again of
clinician/' scientist — we wish you every
success, confident that you will continue
to make lasting contributions to medi¬
cine, to science, to Yale, to your friends,
and to your family,” Dean Rosenberg
concluded.
The symposium faculty included Julius
Axelrod, Ph.D., chief. Section of Pharma¬
cology, Laboratory of Clinical Science,
NIH; Jack D. Barchas, M.D., professor
of psychiatry and behavioral sciences,
Stanford University; Dr. Edelson;
Thomas B. Fitzpatrick, M.D., professor
of dermatology, Harvard University;
Klaus Hofmann, Ph.D., University Pro¬
fessor of Experimental Medicine and
Biochemistry, University of Pittsburgh;
John A. Parrish, M.D., professor of
dermatology. Harvard University; John
A. Pawelek, Ph.D., senior research sci¬
entist, dermatology, Yale University;
Sheldon R. Pinne, M.D., professor of
medicine, Duke University; Kazuo
Shizume, M.D., professor of medicine,
Tokyo Women’s Medical College, and
Richard J. Wurtman, M.D., professor
of neuroendocrine regulation, M.I.T.
Manuscripts based on talks presented
at the symposium will be published in a
forthcoming issue of the Yale Journal of
Biology and Medicine.

The William T. Grant Foundation of
New York has made a $50,000 grant to
the School of Medicine to establish the
Dr. Vernon W. Lippard Student Fellow¬
ship in Pediatrics. The gift comes during
the school’s $125 million capital cam¬
paign to increase its endowment, meet
research and program needs and provide
new and renovated facilities.
This summer student research fellow¬
ship, one of several being established in
the school, honors Dr. Lippard, who
died in December 1984. For many years
the distinguished medical educator, who
was dean of the school from 1952 to
1967, served as chairman of the William
T. Grant Foundation’s Faculty Scholars
Selection Committee.
Dr. Robert H. Gifford, associate dean
for medical education and student affairs,
said that the new funds will support
medical student research, adding, “Yale
School of Medicine is a perfect place to
generate excitement for student research
because of the requirement that all stu¬
dents must complete a thesis in order to
graduate, and because of the outstanding
quality of our students.” Last summer,
nearly 100 students remained in New
Haven to work in various laboratories.
This summer fellowship of $2,250 will
be awarded annually to one or more
students working on children’s behavior
and development in either the Depart¬
ment of Pediatrics or the Child Study
Center. Application deadline is April 1.

The Richard K. Gershon
Student Research Fellowship
The School of Medicine has established
the Richard K. Gershon Student Re¬
search Fellowship with gifts made in
honor of the late physician-scientist.
The endowed fellowship will enable a
young man or woman to spend an extra
year at the medical school and conduct
research in the field of immunology or a
related discipline. The school will present
the first fellowship in July 1986.
“We hope that this fellowship and
others to come will stimulate medical
students to pursue biomedical research
careers and to remember Richard Gershon’s creative scholarship,” said Dean
Leon E. Rosenberg.
Dr. Gershon, who died at age 50 in
July 1983, was professor of pathology,
continued on page 22
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DR. THIER NAMED
PRESIDENT OF THE IOM

IMMUNOLOGIST
APPOINTED CHAIRMAN
OF DERMATOLOGY

Dr. Samuel O. Thier, a noted physician,
educator, and health care administrator,
has been selected to become the fifth
president of the Institute of Medicine
(IOM). Currently Sterling Professorand
chairman of the Department of Internal
Medicine at Yale, Dr. Thier was sworn
into a five-year term at an inauguration
during the IOM annual meeting in Wash¬
ington on October 16-17. Until January,
he will be president-designate and will
commute between posts at Yale and the
IOM. In January, he assumes the IOM
presidency on a full-time basis.
The 650 member Institute of Medicine
was chartered in 1970 by the National
Academy of Sciences to enlist distin¬
guished members of medical and other
professions to examine policy matters
pertaining to the public’s health. As
president. Dr. Thier will serve on the
governing board of the National Re¬
search Council, the operating arm of the
NAS and its sister organization, the
National Academy of Engineering.
Dr. Thier has been chairman of the
Department of Internal Medicine since
1975. During that time he has initiated
improvement of the training of doctors
in the field of clinical research and the
establishment of a network of affiliated
hospitals throughout southwestern Con¬
necticut for providing continuing educa¬
tion for internal medicine physicians. In
addition, he has been responsible for
initiatives to ensure that the shifting
focus of medicine from hospital-based
to more ambulatory care is reflected in
the university’s residency program.

Dr. Richard L. Edelson, a noted clinical
immunologist and teacher, has been
appointed professor and chairman of
the Department of Dermatology, effec¬
tive January 1, 1986. Dr. Edelson is
professor and director of research. De¬
partment of Dermatology, Columbia
University’s College of Physicians and
Surgeons, and associate director of the
General Clinical Research Center
(GCRC), Columbia-Presbyterian Medi¬
cal Center. He succeeds Dr. Aaron B.
Lerner, who has been chairman of the
Department of Dermatology since its
founding in 1971.
“Since Rick Edelson graduated from
the Yale School of Medicine, he has
made outstanding individual research
contributions and has skillfully directed
research programs at Columbia. His com¬
mit ment to research, combined with his
dedication to teaching and patient care
are key attributes he will bring in leading
the Department of Dermatology,” said
Dean Leon E. Rosenberg.
Dr. Edelson is recognized for his
research on cutaneous T-cell lymphomas,
a rare form of leukemia.A graduate of
Hamilton College, Clinton, New York,
he received his M.D. degree from Yale in
1970. He spent the following year as an
intern in internal medicine, University
of Chicago Hospital and Clinics, and in
1971 -72, was resident in dermatology at
Massachusetts General Hospital. From
1972 until 1975, he was research associate
in the Laboratory of Immunology, Na¬
tional Institute of Allergy and Infectious
Diseases, N1H.
Dr. Edelson joined the faculty of
Columbia University’s College of Physi¬
cians and Surgeons in 1976 as an assistant
professor of dermatology. He was pro¬
moted to associate professor in 1978,
and in 1983, was named professor and
director of research in dermatology. He
has been associate director of the GCRC
at Columbia Presbyterian Medical Cen¬
ter since 1980.
A member of the American Society
for Clinical Investigation, he has received
the Irma I Hirschl Career Investigator
Award, the McKee Research Prize, and
i he American Academy of Dermatology
Scientific Exhibit Award.

The process of finding a successor to Dr.
Thier as chairman of the Department of
Internal Medicine is underway. Applica¬
tions and nominations are invited.
Candidates must be qualified for
faculty appointment at the rank of pro¬
fessor, and must be recognized leaders in
the field with proven ability as scholars,
clinicians, teachers and administrators.
Appointment is to be effective July 1986
or as soon thereafter as possible. Applica¬
tions should be submitted prior to Janu¬
ary 15, 1986. Qualified women and
minority group members are encouraged
to apply. Curriculum vitae and biblio¬
graphy should be sent to the Chairman
of the Search Committee: Dr. Vincent
T. Marchesi, Department of Pathology,
Yale University School of Medicine, 333
Cedar Street, P.O. Box 3333, New Haven,
CT 06510

DR HE1RHOLZER

BIOSTATISTICIAN
APPOINTED
TO EPH FACULTY
Dr. Burton H. Singer has been appointed
professor of public health (biostatistics)
and head of the Biostatistics Division in
the Department of Epidemiology and
Public Health, effective July 1. Prior to
his appointment, he had been professor
of mathematical statistics and since 1983,
chairman of the Department of Statistics
at Columbia University.
Dr. Singer is recognized in academic
and industrial communities for his broad
range of statistical expertise in fields as
diverse as demography, economics, socio¬
logy and epidemiology. A graduate of
Case Institute of Technology, where he
received his B.S. in engineering science
in 1959 and his M.S. in mechanical
engineering in 1961, he received a Ph. D.
degree in statistics from Stanford Univer¬
sity in 1967.
A member of the Columbia University
faculty since 1967, Dr. Singer also has
been adjunct professor at Rockefeller
University since 1977. From 1979 to
1981, he was visiting investigator in the
Biostatistics Laboratory of Sloan-Kettering Institute for Cancer Research.
A Fellow of the American Association
for the Advancement of Science as well
as of the American Statistical Associa¬
tion, Dr. Singer is a member of the
editorial board of the Springer-Verlag
Series, “Frontiers of Primary Medicine”,
and is chairman of the Panel on Immigra¬
tion Statistics of the National Research
Council, National Academy of Sciences.
He also serves as chairman of the advisory
board of the Department of Statistics at
Princeton University.

DR, HIERHOLZER
APPOINTED
Dr. Walter J. H ierholzer, J r., a U niversity
of Iowa epidemiologist, has returned to
Yale as professor of medicine and epidem¬
iology, and to Yale-New Haven Hospital
as hospital epidemiologist. His appoint¬
ment was effective September 1.
Dr. Hierholzer, who was at Yale for
17 years as a student, resident physician
and a faculty member, has been associate
professor of medicine and preventive
medicine at the University of Iowa Col¬
lege of Medicine and attending physician,
consultant in infectious diseases and
hospital epidemiologist at the University
of Iowa’s Hospitals and Clinics since
1976. He also was a consultant and
hospital epidemiologist at the Veterans

Administration Medical Center in Iowa
City.
At Iowa, Dr. Hierholzer developed a
nationally recognized program in hospi¬
tal epidemiology. The program includes
an infection control-quality assurance
support service for which he and others
developed a computerized infection data
management system. An international
corporation now markets the system.
In addition, the program encompasses
a regional education and consultation
service that several Iowa state organiza¬
tions support. It serves all hospitals in
Iowa and some in surrounding states.
A native of Midland, Michigan, Dr.
Hierholzer received a B.A. degree from
Albion College and his M.D. degree
from Yale in 1961; this was followed by
residency training at Yale-New Haven
Hospital. He is a member of Phi Beta
Kappa and was a Fulbright Scholar to
Denmark at the Biological Institute of
the Carlsburg Foundation.
In 1967, he joined the Yale faculty as
an instructor in internal medicine and
the following year, served a postdoctoral
fellowship in pediatric infectious diseases
and virology. Between 1970 and 1976, he
held appointments at the School of
Medicine, West Haven Veterans Admini¬
stration Hospital, and Yale-New Haven
Hospital, where he served as hospital
epidemiologist from 1973 to 1976.

DR. RASTEGAR
APPOINTED CHIEF OF
MEDICINE AT VA
MEDICAL CENTER
Dr. Asghar Rastegar has been appointed
associate professor of medicine at Yale,
and chief of medicine at the West Haven
Veterans Administration Medical Center.
An outstanding teacher and administra¬
tor whose research interests are in renal
physiology, he returns to Yale from the
University of Colorado, where he was
associate professor of medicine.
Born in Shiraz, Iran, Dr. Rastegar
received both his B.A. and M.D. degrees
from the University of Wisconsin, and
served his residency at the University of
Pennsylvania, where he also served a
renal fellowship and was chief resident
in medicine. He then returned to Iran,
where he became dean for academic
affairs and a leading figure on the medical
faculty of the Shiraz University School
of Medicine (formerly Pahlavi Univer¬
sity). He spent a sabbatical year at Yale
in 1977 as visiting associate professor in
the Department of Internal Medicine.
Dr. Rastegar spent the year 1983-84 at

the West Haven VA Medical Center
prior to his appointment at the University
of Colorado, where in addition to his
academic appointment, he was director
of the residency program in the Depart¬
ment of Medicine, and chief of medical
services at Colorado General Hospital.

DR. DeCHERNEY

DR. DeCHERNEY
APPOINTED TO
ENDOWED CHAIR
Dr. Alan H. DeCherney has been desig¬
nated the John Slade Ely Professor of
Obstetrics and Gynecology. Nationally
recognized for his work in infertility and
in vitro fertilization. Dr. DeCherney is
also Chief of the Section of Reproductive
Endocrinology in the Department of
Obstetrics and Gynecology.
In addition to his research and clinical
activities. Dr. DeCherney is an outstand¬
ing teacher. He has coordinated the
residency program and resident educa¬
tion in obstetrics and gynecology at
Yale-New Haven Hospital, and directed
the Ambulatory Service Council there
since 1974.
A graduate of Muhlenberg College in
Allentown, Pennsylvania, he received
his M.D. degree from Temple University
in 1967. He came to the School of
Medicine in 1974 as assistant professor
of obstetrics and gynecology as well as
chief of the Section of Reproductive Endo¬
crinology. In 1979, he was promoted to
associate professor and in 1984, he was
appointed professor. Dr. DeCherney
will assume his new title on January 1.
The John Slade Ely Chair was estab¬
lished in 1906 to honor Dr. Ely, professor
of medical theory and practice from
1897 to 1906. The last incumbent of the
chair was Dr. John McL. Morris, who
became an emeritus professor in July.
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LCI RENAMED
TO HONOR DR. LIPPARD
The School of Medicine’s Laboratory
for Clinical Investigation has been
renamed the Lippard Laboratory for
Clinical Investigation to honor Dr.
Vernon W. Lippard, who died last Decem¬
ber. The distinguished medical educator
had been dean of the school from 1952
to 1967
a time of phenomenal growth
in its academic programs, faculty and
facilities.
Dr. Lippard considered the Laboratory'
for Clinical Investigation one of his
proudest accomplishments. Built in 1966
to provide facilities for the growing
research needs of the Departments of
Medicine and Pediatrics, the 10-story
glass and brick structure reflects his
concept of the medical school as an
“academic atmosphere where communi¬
cation between clinicians and basic
scientists is easy and natural, and a line
between the two is difficult to define.”

FIVE BECOME
PROFESSOR EMERITUS
Five distinguished members of the Yale
medical faculty retired on July 1, 1985.
Dr. Elisha Atkins, professor of medi¬
cine, is one of the leading investigators
in the world on the mechanism of fever
production, and an outstanding clinician
in the field of infectious disease. He
received his M.D. degree from the Univer¬
sity of Rochester and joined the Yale
faculty in 1955 after completing postgrad¬
uate training at Barnes Hospital and
Washington University in St. Louis. Dr.
Atkins also served as master of Saybrook
College at Yale from 1975 until his
retirement this year.
Dean of the School of Medicine from
1973 to 1984, Dr. Robert Berliner, pro¬
fessor of physiology and medicine, has
been a member of the Yale faculty for 1i
years. He is a graduate of Yale College
and Columbia University College of
Physicians and Surgeons. A world re¬
nowned authority on renal physiology,
Dr Berliner, from 1950 until his appoint¬
ment as dean, was at the National Insti¬
tutes of Health and was its deputy
director from 1969 to 1973.
Dr. VV.W.L. Glenn, the Charles W.
Ohse Professor of Surgery, has been a
member of the faculty for 37 years.
Appointed as an assistant professor in
1948. He became Yale’s first cardiac
surgeon; he developed and perfected
mans early techniques for repair of
congenital and valvular heart disease.
More recently he has received interna¬
tional recognition for his innovative

work on radiofrequency pacemakers to
regulate the heart rate and also respira¬
tion. He is a graduate of Jefferson
Medical College and completed his surgi¬
cal residency training at the Massachu¬
setts General Hospital.
Former chief of the Section of Otolar¬
yngology, Dr. John A. Kirchner, profes¬
sor of surgery (otolaryngology) came to
Yale in 1951 as an assistant professor
and the first full-time chief of that
section. He received his M.D. degree
from the University of Virginia and
completed his residency training at the
Johns Hopkins Hospital. Dr. Kirchner
soon became widely known in this coun¬
try and abroad for his research, which
has focused especially on the larynx and
laryngeal cancer.
Dr. John McLean Morris, the John
Slade Ely Professor of Gynecology, re¬
ceived his M.D. degree from Harvard,
completed his residency training at the
Massachusetts General Hospital, and
was a Damon Runyon clinical research
fellow at the Radiumhemmet in Stock¬
holm, Sweden prior to joining the Yale
faculty as an associate professor in 1952.
The gynecologic service here was devel¬
oped under Dr. Morris’ leadership. In
addition to his contributions as an out¬
standing clinician, he has also received
world-wide recognition for research in
two distinct areas — treatment of gyneco¬
logic neoplasms and conception control.
Dr. Morris has long been concerned
about the hazards of unlimited popula¬
tion growth and the problems of popula¬
tion control.

AWARDS TO FACUTTY
AND HOUSE STAFF 1985
The Francis Gilman Blake Award, pre¬
sented each year by the graduating class
to the outstanding teacher of the medical
sciences was awarded to Dr. Kenneth
W. Barwick, associate professor of path¬
ology.
Dr. James S. Grober, ’83, a resident in
internal medicine, was selected by the
senior class to receive the Betsy Winters
House Staff Award, presented annually
to the member of the house staff of YaleNew Haven Hospital who has made the
most significant contribution toward
the education of medical students.
The Benedict Harris Award, estab¬
lished in 1967 to recognize the private
physician who has contributed the most
to the teaching of house staff, was pre¬
sented this year to Dr. Steven J. Mason,
assistant clinical professor of medicine
(cardiology).
In addition. Dr. Mason was the recipi¬

ent of the first Meyer Etkind Prize,
awarded to the community physician
who, in the opinion of the house staff,
provides the best clinical expertise and
compassionate care to his or her patients.
Dr. Mark Marieb, an intern in internal
medicine, and Dr. Eric Winer, junior
assistant resident in medicine received
the Samuel D. Kushlan Awards, recog¬
nizing the intern and second-year resident
who have contributed the most to patient
care during rotation through the Memor¬
ial Unit Medical Service. Selection of
recipients is made in consultation with
the clinical faculty and nursing service.

PROMOTIONS
AND APPOINTMENTS
The following members of the medical
faculty were promoted to professorships
effective July 1, 1985: Robert S. Adams,
M.D., clinical professor in the Child
Study Center; Leonard R. Farber, M.D.,
clinical professor of medicine; John N.
Forrest, M.D., professor of medicine;
Thomas W. Hansen, M.D., clinical pro¬
fessor of dermatology; Ravinder Nath,
Ph.D., professor of therapeutic radiology
(radiologicalphysics); Peter E. Schwartz,
M.D., professor of obstetrics and gyne¬
cology; Dennis D. Spencer, M.D., pro¬
fessor of surgery; Robert K-J. Yu, Ph.D.,
professor of neurology; Joseph H.
Zelson, M.D., clinical professor of
pediatrics.
New appointments at the rank of
clinical professor, effective July 1985
include Gerald W. Peskin, M.D., clinical
professor of surgery, and Jack L. Westcott, M.D., clinical professor of diag¬
nostic radiology.
The following associate professors
have been awarded tenure appointments:
Roland Baron, D.D.S., associate pro¬
fessor of surgery (orthopedic); Priscilla
Dannies, Ph.D., associate professor of
pharmacology; Ralph I. Horwitz, M.D.,
associate professor of medicine; Laura
K. Manuelidis, M.D., associate professor
of neuropathology; Nancy H. Ruddle,
PhD., associate professor of epidemio¬
logy (microbiology), Allen C. Steere,
Jr., M.D., associate professor of medi¬
cine, and Robert B. Tesh, M.D., associate
professor of epidemiology.

YALE AWARDED
$3.5 MILLION TO
ESTABLISH CENTER IN
NEUROSCIENCE
The National Institute of Neurological
and Communicative Disorders and
Stroke has awarded $3.5 million to Yale
University to establish a Javits Center of
Excellence in Neuroscience in the Section
of Neuroanatomy. It is one of four
centers to be established by NINCDS in
honor of former U.S. Senator Jacob K.
Javits.
Dr. Pasko Rakic, chairman of the
section and Dorys McConnell Duberg
Professor of Neuroscience is principal
investigator, and Dr. Patricia S. Goldman-Rakic, professor of neuroscience,
is co-principal investigator of the center.
Selected from among 55 institutions,
the Javits Centers of Excellence in Neuro¬
science will be devoted to fundamental
biological issues of the nervous system
structure and function. The center at
Yale will focus on the development,
plasticity and organization of the neo¬
cortex at the molecular, structural and
functional levels.
In man, the cerebral cortex constitutes
by far the largest portion of the brain
and is the key structure subserving human
mentation and intellect. Dysfunction of
the cortex is responsible for numerous
neurological and psychiatric diseases.
The N1H Javits Center Award, which is
for five years, will allow application of
the most advanced neurobiological tech¬
niques to the study of the neocortex.

STUDY TO FOCUS ON
INFECTION IN ELDERLY
IN NURSING HOMES
The Center for Disease Control has
awarded two Yale School of Medicine
professors a contract to conduct an 18month collaborative study of the cause
and complex nature of infections ac¬
quired by elderly residents of nursing
homes. It is the first study of its kind in
the country, according to CDC officials.
Dr. David A. Pearson, associate dean
and research scientist in public health,
and Dr. Walter J. Hierholzer, professor
of medicine and epidemiology and public
health, plan to define the risks, determine
who are vulnerable to the infections and
identify infections which may be pre¬
vented in residents of the nation's 18,900
skilled nursing homes. In addition, they
intend to develop guidelines for preven¬
tion of infections acquired as a result of
hospitalization or institutionalization (no¬

socomial infections.
By the year 2000, 12 percent of the
nation’s population will be 65 years or
older, and life expectancy continues to
increase. “More and more individuals
will require temporary and long-term
care in our nation’s extended care facil¬
ities,” said Dr. Pearson. “As a result,
infection prevention and control are
viewed as essential requirements for an
acceptable standard of living for these
residents.”
Several known risk factors contribute
to the infections that elderly persons
acquire in nursing homes, where residents
are predominantly female, white, wid¬
owed and over age 75. The risk for
nosocomial infections include decline in
immune response as people age, the
burden of chronic underlying diseases,
nutrition, physiologic changes, alteration
in mental status and age-related changes
in various diseases from which they may
suffer.
Drs. Pearson and Hierholzer believe
that specific infection control procedures
need to be developed for extended care
facilities which differ from hospitals.
For example, if nursing home residents
need to be isolated, then reasonable and
realistic procedures are needed which
must represent a balance between risk of
transmission and the need to maintain
patients’ psychological and social inte¬
grity in the facility’s community.
Within the past 15 years, hospitals
with acutely ill patients have started
programs to reduce infections that their
patients acquire. However, few studies
have been done on infections that may
be acquired by those receiving chronic
care in nursing homes.
The Yale study, scheduled to be com¬
pleted in December 1986, will involve a
random survey of 20 percent of the
licensed, skilled nursing facilities in Con¬
necticut.

SCHOOL RECEIVES
$400,000 FOR TRAINING IN
CHILDHOOD
NEUROPSYCHIATRIC
DISORDERS
Long recognized for its leadership in
child psychiatry, the School of Medicine
has received a grant of $400,000 from
the National Institute of Mental Health
for a five-year training program in child¬
hood neuropsychiatric disorders. Dr.
James F. Leckman, associate professor
of psychiatry and pediatrics is director
of the program based in the Child Study
Center.

“A training program devoted exclu¬
sively to the education and training of
clinical investigators in child psychiatry
is urgently needed,” said Dr. Leckman.
“While biomedical knowledge is expand¬
ing at an increasingly rapid rate, there
are only a handful of active clinical
investigators in child psychiatry who are
able to translate new findings of basic
research into relevant advances in clini¬
cal practice.”
Three fellows will participate in the
program during the first year, and in
subsequent years there will be four, each
of whom will remain in the program for
two years. It is anticipated that one or
two fellows will be physicians in child
psychiatry or pediatrics; the remaining
two or three will be postdoctoral fellows
in developmental psychology, analytic
neurochemistry or human genetics.
The program will emphasize interdisci¬
plinary approaches to childhood neuro¬
psychiatric disorders such as infantile
autism, Tourette’s syndrome, fragile X
syndrome and attention deficit disorder
with hypertension. “By focusing on these
disorders, researchers in the Child Study
Center have developed a range of clinical
instruments and neuropharmacological
and genetic strategies applicable across
disorders,’’explained Dr. Leckman. “We
also believe that understanding the mech¬
anisms underlying a particular set of
behaviors as they occur in one syndrome
hyperactivity, for instance — will
increase our understanding of similar
behavior in other disorders.”

THE CLASS OF ’89
Sixty-two men and 40 women entered
the first year medical class in September.
They are among the 2,619 students repre¬
senting 50 colleges who applied for
admission, and the 199 who were ac¬
cepted for the class of 1989.
Typically, the class is highly qualified
academically, based on GPA and MCAT
scores. Ivy League and West Coast
colleges supplied the most students, and
while almost all of them are entering
after four years of college, 11 have
masters degrees. Five of the new students
are enrolled in the M.D./Ph.D. program.
As in all previous classes, the majority
of the class of 1989 majored in science as
undergraduates, but 15 concentrated on
the social sciences while others majored
in the humanities. In addition to being
excellent in their academic endeavors,
they participated extensively in extra¬
curricular activities, especially in indepen¬
dent study or research.
continued on page 22
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PHYSICIAN ASSOCIATES
HOLD 14th GRADUATION
Twenty-three students graduated August
19 from the Physician Associate Program
at the School of Medicine. They were
members of the 14th class to complete
the 24-month program.
Dr. Alan C. Mermann, chaplain of
the school and clinical professor of
pediatrics, delivered the commencement
address “The lmpasto Experience”, based
on the life of Vincent Van Gogh, during
ceremonies held in Mary S. Harkness
Auditorium. Dr. Mermann developed
and taught the medical ethics course for
the 1985 class.
During the ceremony, several awards
were presented. Dr. Richard D’Aquila,
a fellow in the Section of Infectious
Diseases, and a research fellow in the
Departments of Therapeutic Radiology,
Human Genetics, and Molecular Bio¬
physics and Biochemistry, received the
Student Didactic Instructor Award.
The Student Clinical Instruction
Award was presented to the Department
of Obstetrics and Gynecology at Bridge¬
port Hospital, a clinical site for Yale PA
students for more than a decade.
John Dailinger, a physician associate
at the Yale Health Plan’s urgent visit
area, received the Jack Cole Society
Award, which is presented to an indivi¬
dual whom the class believes has made a
significant contribution to their educa¬
tional program, as well as to their
profession.

Class of 1989, continued from page 21
The geographical representation of
this class, whose average age is 23 and a
half, is wide ranging from Puerto Rico
to Oregon. Sixty-two come from the
East Coast, including 27 from New York
state and nine from Connecticut; 17 are
from the West Coast (14 from California).
Eight students are foreign nationals, and
there are I I black students and four
Hispanic Americans.
! he Department of Epidemiology and
Public Health, which is an accredited
school ol public health, registered 105
students in its first year class — 79
>men and 26 men. They come from 22
is well as from Bangladesh, Brazil,
(ihana, Iran, Spain, Switzerland and the
of China. As undergraduates,
:d in the sciences. Seventys and universities are represented by this class of luture public

AN OPPORTUNITY TO
ASSIST IN
UNDERGRADUATE
MEDICAL EDUCATION IN
CHINA
There have been increasing contacts
between medical schools in this country
and The People’s Republic of China in
the six years since the normalization of
diplomatic relations between the two
nations. One recent program involving
the Yale School of Medicine, under the
auspices of Yale-China Association’s
Medical Exchange Program, provides
medical school instruction in the English
language to a group of selected medical
students at Hunan Medical College in
Changsha.
With a firm background in the lan¬
guage, these students have received all of
their medical classes in English. This
“English Stream” program is a result of
the success of the Association’s “Bachelor
Program” of English instruction which
was recently revived at the school,
founded in 1914 as Xing-ya, with the
help of the Yale School of Medicine and
alumni. A goal of the program is to
enable the next generation of Chinese
physicians to have full access to medical
advances, foreign training and collegial
interactions on a global scale.
The response of the Chinese medical
students has been enthusiastic. Not only
have they worked hard on their course
material, but they have also responded
warmly to new teaching styles of their
American teachers.
Opportunities exist for qualified physi¬
cians and basic scientists to offer units to
undergraduate medical school students
at Hunan Medical Collge. Periods of
appointment are flexible, varying from
four weeks to one semester. Travel is
paid for by the Yale-China Association
and living expenses are covered by Hunan
Medical College. A small stipend for
domestic travel in China is offered to
those who teach a full semester, but no
salary is provided.
For further information, write or call
Dr. William C. Summers, Department
of Therapeutic Radiology, Yale School
of Medicine, P.O.Box 3333, New Haven,
CT 06510, (203/785-2980).

MEDICAL STUDENTS
RECEIVE AWARDS
Terry Yee, a second year medical student,
received the Richard K. Gershon Memo¬
rial Summer Student Fellowship of Re¬
search in Immunology. As the Gershon
Fellow, he spent last summer working
on B-Cell Differentiating Factor Recep¬
tor in the laboratory of Dr. Kim Bottomly, assistant professor of pathology.
Douglas Black, a fourth year graduate
student working toward a Ph.D. degree
in molecular biophysics and biochemis¬
try, received a $22,100 Graduate Fellow¬
ship Grant from the General Electric
Foundation. Working in the laboratory
of Dr. Joan Steitz, professor of molecular
biophysics and biochemistry, Mr. Black’s
research is in the structure and function
of small nuclear ribonucleoproteins in¬
volved in gene expression.

Student Fellowships
continued from page 17
immunology and biology at Yale and a
leader in the exploration of the immune
system. In his original scientific research,
he showed that the introduction of an
antigen into the body produced not only
the immunological attack on the antigen
but also the participation of cells that try
to prevent or suppress the immune re¬
sponse. His early work concentrated on
tumor biology and research into the
spread of cancer.
“We deeply appreciate the generous
contributions that Murray Gershon,
Dick's father, and many other individuals
have made to support this student re¬
search fellowship,” the dean added.
Contributions came from more than
300 donors, including Mr. Gershon of
New York City, and Dr. Gershon's
widow, Robyn Gershon, who is director
of Yale Health Services’ Department of
Biological Safety. Other gifts were made
by Dr. Gershon’s family, former students,
alumni, faculty, fellow research scientists
and friends.
The endowed fellowship carries a sti¬
pend of $ 10,000, plus a $ 1,000 allowance
for research support. Any full-time med¬
ical student may apply after matricula¬
tion, and a special awards committee
will select the recipient by March 1.
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Faculty News
Dr. Joseph E. Craft, assistant professor
of medicine in the Section of Rheumatol¬
ogy, is one of 20 outstanding young
scientists to be named the first Pew
Scholars in the Biomedical Sciences by
the Pew Memorial Trust of Philadelphia.
The scholars were selected because of
their outstanding promise in basic science
or clinical research that will help advance
human health.
“These awards, presented for the first
time, will enable accomplished scientists
to develop their research further,” said
Dr. Robert W. Berliner, director of the
Pew Scholars program and professor
emeritus of physiology and medicine at
the School of Medicine, where the pro¬
gram is administered. In addition to the
Pew Scholars Award, Dr. Craft received
a grant from the Lupus Foundation of
America, Inc. for his research on “Auto¬
antigens in Drug-induced Lupus.”
For research to improve treatment for
newborns and infants critically ill with
cardiac or pulmonary disease. Dr. George
Lister, associate professor of pediatrics
and anesthesiology, has received a fiveyear Established Investigator Award
from the American Heart Association.
The American Heart Association, South
Central Connecticut Chapter, has named
Dr. William W.L. Glenn “Man of the
Year,” recognizing his outstanding con¬
tributions to the AHA and to cardiology
and cardiovascular surgery during the
past 40 years. Dr. Glenn, Charles W.
Ohse Professor Emeritus and senior
research scientist in the Department of
Surgery, was honored at a dinner on
September 11.
Angela R. Holder has been named presi¬
dent-elect of the American Society of
Law and Medicine, a 5,000-member
organization of lawyers, physicians,
nurses and hospital administrators. Ms.
Holder, who is counsel for medicolegal
affairs at Yale-New Haven Hospital and
clinical professor of pediatrics (law) in
the School of Medicine, will become the
society’s president in July 1986. A noted
attorney and educator, she is the author
of several books, including “Legal Issues
in Pediatrics and Medicine” recently
published in the second edition by Yale
University Press.
The International Society for Optical
Engineering has presented its 1984 Kingslake Award to Drs. Gene R. Gindi and
Arthur F. Gmitro, assistant professors
of diagnostic radiology, for their paper

“Optical Feature Extraction Via the
Radon Transform”. The paper, which
was published in the September-October
1984 issue of Optical Engineering”, was
selected from over 141 highly qualified
technical papers.
Dr. Gilbert H. Glaser, professor and
chairman of the Department of Neuro¬
logy, was elected an honorary member
of The Academy of Medicine of Y ugoslavia (Croatia) last November, at which
time he gave an inaugural address in
Zagreb on “Modern Dynamic Neurology:
the Search fo Brain Mechanisms”.
Last fall, Dr. Glaser was visiting professor
of neurology at Oxford University, con¬
ducting neurophysiological research at
the Department of Experimental Psycho¬
logy and The Park Hospital (The Na¬
tional Center for Epilepsy in Children).
For research leading to an understanding
of how the cerebral cortex processes
information. Dr. Mriganka Sur has re¬
ceived a grant of $100,000 from the
National Science Foundation. In addi¬
tion, Dr. Sur, who is assistant professor
of neuroanatomy, has been named a
Sloan Research Fellow. The Alfred P.
Sloan Foundation identifies and supports
young scientists who have demonstrated
special creative ability in the physical
sciences, neuroscience and economics.
Dr. Frank H. Ruddle, professor of bio¬
logy and human genetics, has been elected
to the Institute of Medicine. He is known
throughout the world for his pioneering
research in mapping specific genes on
chromosomes and more recently, for his
work in transplanting foreign genes into
animal embryos, which opened a broad
range of possibilities for future studies
of the chemistry of genetics. Dr. Ruddle
is a member of the National Academy of
Sciences and president of the American
Society of Human Genetics.

The American Association of Clinical
Chemists presented the Award for Out¬
standing Contributions to Clinical Chem¬
istry in a Selected Area to Dr. Peter
Jatlow, professor and chairman of the
Department of Laboratory Medicine, in
recognition of his research on the mea¬
surement and clinical pharmacology of
psychotropic and psychotherapeutic
drugs, including cocaine and the tricyclic
antidepressants. Dr. Jatlow's laboratory
was among the first to describe plasma
cocaine concentrations after various
routes of administration, and the relation¬
ship of various concentrations to beha¬
vioral changes.

In celebration of the dedication of the
Seoul National University Children’s
Hospital October 17 and 18, Dr. Donald
Cohen delivered the inaugural lecture,
“The Contributions of Clinical Research
to the Understanding and Treatment of
Childhood Psychopathology”. While in
Korea, Dr. Cohen, director of the Child
Study Center and professor of pediatrics,
psychiatry and psychology, gave special
lectures at the annual meetings of the
Korean Neuropsychiatric Association
and the Korean Psychoanalytic Associa¬
tion.
Dr. Perry L. Miller, assistant professor
of anesthesiology, was a co-recipient of
the Honeywell-Universita degli Studi di
Pavia per l’Informatica(HUSPI) Award
for research published between 1980 and
1985 in Artificial Intelligence in Medi¬
cine. The award, presented at the Inter¬
national Symposium on. Artificial Intelli¬
gence in Medicine in Pavia, Italy in
September, recognizes Dr. Miller’s re¬
search in developing expert computer
systems which critique a physician’s plan
for patient care.

BOOKS BY FACULTY
“House Officer Guide to ICU Care
The Cardiothoracic Surgical Patient”,
by John A. Elefteriades, M.D., assistant
professor of surgery (cardiothoracic),
and Alexander S. Geha, M.Dprofessor
of surgery and chief of the Section of
Cardiothoracic Surgery. Aspen Systems
Corporation (Rockville, MD), 1985. 207
pp, illus.
“Surgeons at the Bailey. English Forensic
Medicine to 1878", by Thomas R. Forbes,
E.K. Hunt Professor Emeritus of Ana¬
tomy and senior research scholar in the
history of medicine. Yale University
Press (New Haven)1985. 352 pp.
“The Kidney: Physiology and Patho¬
physiology”, Volumes 1 and 2, edited by
Donald W. Seldin M.D. and Gerhard
Giebisch, M.D., Sterling Professor of
Physiology. Raven Press (New York)
1985. 2,650 pp, illus.
“The Patient: Biological, Psychological,
and Social Dimensions of Medical Prac¬
tice”, second edition, edited by Hoyle
Leigh, M.D., professor of psychiatry,
and Morton F. Reiser, M.D. professor
and chairman, Department of Psychiatry.
Plenum Publishing Corporation (New
York) 1985, 457 pp.
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WOODROW WILSON
LINDENMUTH, M.D.
Dr. Woodrow W. Lindenmuth, clinical
professor of surgery, died on August 2,
1985. He had been a member of the Yale
School of Medicine faculty since 1956.
Dr. Lindenmuth’s work on treatment
of bleeding esophageal varices, especially
prophylactic portacaval anastomosis,
was a major contribution in this complex
surgical field.
A graduate of Pennsylvania State
University and Jefferson Medical Col¬
lege, Dr. Lindenmuth was a surgical
intern at Pennsylvania Hospital and had
residency training at Boston City Hospi¬
tal, Bryn Mawr Hospital and at the E.J.
Meyer Memorial Hospital in Buffalo,
New York. From 1945 to 1956, he
practiced surgery and held appointments
at Pennsylvania Hospital and Jefferson
Medical College in Philadelphia.
In 1956, he was appointed the first
full-time chief of surgery at the Veterans
Administration Hospital in West Haven,
and as an associate clinical professor of
surgery at Yale. He held this post until
1968, and during this time developed an
outstanding teaching service. From 1968
to 1973, he served as associate chief of
surgery at Yale-New Haven Hospital
and director of surgery in the Memorial
Unit. He was promoted to clinical pro¬
fessor in 1971.
Dr. Lindenmuth was a member of the
American College of Surgeons, the East¬
ern Surgical Society, the New England
Surgical Society and a past member of
the Society of Alimentary Surgeons.
Affectionately known by his many
friends and associates as “Lindy”, he
was described by a colleague as “the
epitome of the compassionate physician,
the thoughtful surgeon, the admired and
emulated teacher, the steadfast, honest
triend, and the loving, devoted husband
and father.”
Dr. Lindenmuth is survived by his
wife, Virginia, and his two daughters
and two grandchildren.

JAMES D. HARDY, Ph.D.
James Daniel Hardy, professor emeritus
of physiology and epidemiology and
public health, and director emeritus of
the John B. Pierce Foundation Labora¬
tory. died at his home in Woodbridge on
September 6 at the age of 81.
Dr. Hardy was best known for his
work on body temperature and its regula¬
tion. Trained as an astrophysicist at
John Hopkins University, heapplied his
knowledge of infrared spectroscopy to
the measurement of heat radiation from
the skin at the Russell Sage Institute of
Pathology at Cornell Medical School.
Foreseeing the imminence of war, he
enlisted in the U.S. Navy prior to World
War 11 and because of his knowledge of
physics, was assigned to the M ine Sweep¬
ing School in England. He swept mines
from the landing area of Normandy in
front of the Allied invasion, and later
retired from the Naval Reserve as a Rear
Admiral.
Meanwhile, in 1953 he moved to
Philadelphia where he simultaneously
was research director of the U.S. Naval
Air Development Center's Aviation Med¬
ical Acceleration Laboratory (human
centrifuge) at Johnsville, Pennsylvania,
and was in charge of graduate studies in
physiology at the University of Pennsyl¬
vania until 1961. By simulation of the
forces of exit and reentry. Dr. Hardy
trained the Apollo astronauts to fly the
spacecratt using the human centrifuge.
In 1961, Dr. Hardy assumed director¬
ship of the John B. Pierce Foundation
Laboratory in New Haven, and was
appointed professor of physiology and
epidemiology and public health at Yale,
posts he held until I974and 1973, respec¬
tively. During that time, he developed
an active program of environmental
physiology and health science, supported
by the Pierce Foundation and govern¬
ment agencies.
A native of Georgetown, Texas, Dr.
Hardy received an A.B. degree, magna
cum laiule in 1924, and an M.A. degree
in 1925. both from the University of
Mississippi at Oxford, and a Ph.D.
degree in 1930 from the Johns Hopkins
University. A member of Phi Beta Kappa
and Sigma Xi. he was elected to the
National Academy of Sciences in 1970.
A lellow ol the American Academy of
Arts and Sciences, he had been awarded
honorary doctor of science degrees by
the Kansas City College of Osteopathy
and Surgery and from Southwestern
University, and a donor honoris causa
by the University ol Lyon's Faculty of
Medicine and Pharmacy. A.B.D.B.

NEA MAE NORTON, M.S.S.
Nea Mae Norton, clinical professor
emeritus of psychiatry (social work),
died on April 27. 1985 at the age of 78.
She had joined the faculty of the Depart¬
ment of Psychiatry in 1947 at the invi¬
tation of Dr. Eugen Kahn and rose
through the academic ranks from assis¬
tant professor to professor, the onlysuch appointment and honor awarded a
social worker at Yale.
During her more than 20 years of full¬
time activity. Ms. Norton contributed to
the development and expansion of the
department from a handful of full-time
faculty members to well over 100. This
development entailed the inauguation of
three major services in addition to an
intensive reorganization of the Yale Psy¬
chiatric Institute, the original clinical
base of the department. Ms. Norton was
involved in all of these innovative enter¬
prises, recruiting the staff and teaching,
monitoring and supervising them through¬
out their tenures, in addition to teaching
medical students, residents and other
graduate trainees in psychiatric social
work and psychology. She was a highly
valued colleague who participated not
only critically in these developments and
the day-to-day services, but also in many
research projects, initially w ith Drs. F.C.
Redlich and Richard Newman on interview'ing, and later in family research and
then, in various service analyses.
In recognition of her final promotion
an array of accolades was obtained from
many leaders in psychiatry and social
w'ork throughout the country; this dos¬
sier reads like a “Who's Who" of Yale
graduates who have become leaders in
academic psychiatry and mental health
services. After her retirement, she main¬
tained an important presence in the
academic and personal lives of members
of the department until the past two
years, when she was incapacitated by
severe arthritis and complications. Her
impact will also be felt by future genera¬
tions because her leadership and concepts
of social work participation and contribu¬
tion to the care of the mentally ill remain
guideposts for the future. S.F.
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ALUM%ws
ASSOCIATION OF YALE
ALUMNI IN MEDICINE
HOLDS ANNUAL
BUSINESS MEETING
As part of an outstanding Alumni
Weekend, the annual business meeting
of the Association was held on Saturday,
June 8, with Dr. Nicholas Spinelli, presi¬
dent, as chairman.
Following introductory remarks by
Dr. Spinelli, Dr. Lawrence Pickett read
obituary citations from the Association
for two distinguished alumni: Dr. Vernon
W. Lippard (’29), who served as dean of
the school from 1952 to 1967, and Dr.
Courtney C. Bishop (’30), who was chief
of staff at Yale-New Haven Hospital
from 1960 to 1973.
After recognition of a number of
senior alumni present from classes of
1921 through 1929 and members of the
55th reunion class of 1930, Dr. Spinelli
presented special recognition awards to
members of the 50th reunion class of
1935 and welcomed the other five-year
reunion classes of 1940 through 1980.
Dean Leon E. Rosenberg reported on
new appointments to the faculty and to
the administration of the school. It was
with special pleasure that he noted Dr.
Spinelli had been appointed Director of
Alumni Affairs. He also mentioned that
search committees are looking for chair¬
men for the Departments of Dermato¬
logy, Neurology, Psychiatry and Surgery.
The dean then briefly described new
construction currently underway or
planned. These projects include the Mag¬
netic Resonance Imaging Center, a new
building for faculty ambulatory practice,
expansion of the Medical Library, a new
Yale Psychiatric Institute, the Eye Center
for the Department of Ophthalmology
and Visual Science, and a proposed

building for the Center for Molecular
Medicine.
Following the dean’s report, the Nomi¬
nating Committee recommendations
were presented by Dr. Gilbert Hogan
and the following were elected by vote of
the members present: President, Dwight
Miller (’56); Vice President, Thomas
Kugelman (’60); Executive Committee
(each for a term of two years), Joseph
F.J. Curi (’64), James Q. Haralambie
(’35), Marie-Louise Johnson (’56), Patri¬
cia E. Wanning (’40), Muriel D. Wolf
(’59). In addition, the following were
elected as representatives to the Associa¬
tion of Yale Alumni (AYA), each for a
three-year term: Edith M. Jurka (’44),
Mohandas M. Kini (’65), and Warren D.
Widmann (’61).
Following the elections. Dr. Spinelli
congratulated and cordially welcomed
those newly elected. He also expressed
appreciation and thanks to those who
were leaving the Executive Committee;
Susan S. Addiss(M.P.H. ’69), J. Roswell
Gallagher (’30), Thomas P. Kugelman
(’60), and Richard D. Otis(’49). Apprecia¬
tion was also expressed to Marie-Louise
Johnson and Frederick North, Jr.,(’56)
for their service as representatives to the
AYA during the past three years.
Dr. Dwight Miller, chairman of the
Association’s Awards Committee pre¬
sented Distinguished Alumni Awards Yale chairs with inscribed plaques — to
Dr. Samuel Kushlanand Dr. J. Roswell
Gallagher. Dr. Lowell Goodman, chair¬
man of the Yale Medical School Alumni
Fund, then gave a most encouraging
report which noted that over $300,000
had been contributed to the Fund , and
that the 1984-85 goal of $325,000 would
be reached by June 30.
At the conclusion of the meeting.
Dean Rosenberg presented Dr. Spinelli
with a Distinguished Service Recognition
Award for his four years as president of
the Association.

1986
ALUMNI WEEKEND
JUNE 6 and 7
For entertainment, education and a bit of nostalgia,
plan now to attend!

REUNION NOTES
1925
60th Reunion
by Alice A.S. Whittier
The 60th reunion of the class of 1925 was
unfortunately represented by only one
member, Alice A.S. Whittier, class agent
and class secretary.
Waldo Desmond and his wife had
planned to attend, but changed their
plans. He expected to have an operation
the following week.
Howard Wood was honored recently
at his 90th birthday and limits his tra¬
velling. Two members are in Florida and
one is in Georgia. The other members
did not supply news.

1930
55th Reunion
by Paul Lavietes
Of 23 survivors of our class, five came to
New Haven with their spouses for Re¬
union Weekend and remained for dinner
at the Graduates Club on Saturday.
There were witty and informative talks
by the new dean and the president of the
Alumni Association during the annual
meeting and also at the dinner.
Seminars by distinguished faculty mem¬
bers in the forenoon Saturday were well
received. There was much stimulating
interchange between speakers and alumni
at the annual meeting.
Knox Finley and his wife Mary Lee
came farthest from San Francisco, where
he is still active as a neurologist and
teacher. Ros Gallagher, who has served
as chairperson of the committee for
alumni bequests and endowments for
years, has a home in New Haven and a
vacation home in Nova Scotia, where he
and his wife, Connie, are going for the
summer.
Jim Hart and I are almost completely
retired in New Haven and Moe Lischner
— in Bloomfield Connecticut. We are all
fairly fit for our years, as are our wives,
Peggy, Ruth and Frieda, respectively. It
was good to join with them and chat
about old times and recent changes.
Leonard Greenberg, who taught us
bacteriology in our preclinical years and
then went on to get an M.D. degree with
us, is retired in Long Boat Key, Florida.
He informed me that he was 92 and his
wife, 91, and that they could not travel
to the reunion, much as he would like to
do so.
The family of the late Morris Krosnick,
who was an associate clinical professor
of pediatrics at Yale, has established an
annual award to be given to the member
of the Yale-New Haven Hospital Pedia25

tries House Staff who exemplifies the
“caring, compassionate, and dedicated
pediatrician.” This year’s recipient was
Dr. Donald Schwarz.

1935
50th Reunion
by Samuel Kushlan
Eight members of the class returned for
our 50th reunion. All were accompanied
by their lovely wives except for James
tiaralambie, whose devoted wife died
recently after a long illness. We appreci¬
ated his coming so that we could express
our appreciation for his decades of de¬
voted service as our class agent. Jim
retired in 1978 to Southbury, Connecti¬
cut, after a notable career in pediatrics,
retiring as clinical professor emeritus at
Cornell, where he established the first
pediatric neurology clinic.
Walt Barney retired in 1982 after
years of important service in and to
Milford (Connecticut) Hospital, where
he played a major role in its development
and growth as chief of staff for ten years
and chief of anesthesia for 20 years.
Sawnie Gaston retired this year after
an outstanding career in orthopedic and
trauma surgery, fields in which he re¬
ceived national recognition, with most
of his professional life spent at ColumbiaPresbyterian in New York, retiring as
associate professor of clinical ortho¬
pedics. More recently, he was actively
involved in the development of electro¬
magnetic stimulation treatment of frac¬
ture non-union
Howard “Jack” Horner retired in 1975
after an unusual and rewarding career,
first as a medical missionary in Zaire
(then the Belgian Congo) from 1939 to
1954; w hile there he became a fellow of
the American College of Surgeons in
1949, fulfilling the requirements under
difficult conditions. He then returned to
California to practice and to retire.
Sam Kushlan retired in 1982 as associ¬
ate physician-in-chief of Yale-New Haven
Hospital, where he continues to be active
as consultant to the chief-of-staff and as
clinical professor of medicine, he con¬
tinues to serve Yale Alumni in Medicine
as co-chairman of the Bequests and
Endowment Program, chairman of the
former House Staff Alumni Fund Pro¬
gram, and alumni representative on the
Medical School Council.
Norman Rindge retired after an out¬
standing liletime of service to the popu¬
lace ot the Clinton-Madison (CT) area
as family doctor par excellence in the
best tradition of that great calling. When
retired, I was present at the heartirming testimonial to him by towns¬

people who turned out in the hundreds
to honor him; it was common for several
generations of a family to have been his
devoted patients and to pay tribute to
him on that memorable day.
Clark Searle is about to retire after an
eminent career in pediatrics. In addition
to having been pediatrician-in-chief of
the Maple Knoll Hospital in Wyoming,
Ohio, he was also president for 40 years
of the Wyoming Medical Center, which
he organized.
Walter Thompson retired in 1975 to
summer in Old Lyme, Connecticut, and
winter in Grenada, after a long and
distinguished career in orthopedics in
New York City. He had been chairman
of orthopedics at New York University
and Bellevue Hospital from 1950 to
1975, having previously been chief-oforthopedics at Walter Reed Hospital in
Washington, D.C.
We were the guests of honor at a
beautiful and sumptuous banquet at the
Graduates Club, tendered us by the
School of Medicine. Present also w'ere
several members of the Class of 1930,
representatives of other classes, and mem¬
bers of the Executive Committee of the
Alumni Association. Former Dean Rob¬
ert Berliner and his wife were present, as
was Deputy Dean Arthur Ebbert, Jr.
Larry Pickett ’44, former associate dean,
was a great toastmaster. Dean Leon
Rosenberg and his wife were present and
he spoke graciously about our class.
Nick Spinelli, ’44, retiring president of
our Alumni Association and now director
of alumni affairs, greeted us officially
and warmly. Sawnie Gaston and I remi¬
nisced briefly about our class, as I
presented each of them to the assembly.
All in all, a very nice and heartwarming
evening.
Several members of the class, unable
to attend, sent warm greetings: George
Carden, Edward Carvey, Edward Falsey,
Howard Groskloss, Mildred Hartshorn
January, Dana Howe, Bascom Johnson,
Graham Newbury, John Preece, Edmond
Sinclair, and Samuel Zelman. Don
Morris, also unable to attend, was joined
by his wife in making a most generous
endowment gift to our Alumni Fund as
an expression of their devotion to and
happy memories of our School and our
Class.

1940
45th Reunion
by Donald Johnson
The 45th reunion was a thoroughly
enjoyable time. T his report is concerned
only with those in the Class of 1940 who
returned for this event. Ron and Betty

Beckett came down from Bloomfield,
CT; both look exceedingly well. Betty
says Ron is retired, and she is sure of this
since he gets home at 8 o’clock rather
than later. What a pleasant surprise to
see Phil Breznia after 45 years; both he
and his wife are revelling in diminished
medical activity. Wy and Biddy Dean
stayed with Jim and Izzy Ferguson. Wy
looks the same as he did five years ago,
and Jim is still running, playing tennis
and generally enjoying retirement. Gene
Fitzpatrick and his wife came to the
class dinner at the Quinnipiack Club. He
has retired from active practice and only
sees patients on a limited consultation
basis. Jack and Rosemary Haley came
to the festivities. Jack had a coronary
by-pass last year, following a “mild”
cardiac episode and seems to have toler¬
ated it well. Other by-pass recipients
present were Champ and Mary Louise
Taylor and Joe and Nancy Sokol. Champ
is completely retired and spends a good
part of the year in Virginia where they
have a retreat. Joe Sokol is still very
active at Duke with his international
chronic myeloid leukemia project. Joe
and Nancy have one son back in West
Africa and the second in Dallas, both in
medicine. Hank and Ellen Humphrey
were down from Ithaca; Hank is about
ready for retirement in December. Eddy
and Marty Martin, Jack and Eunie Ells,
Joe and Eileen Zigarelli were all there
and all looking so very well.
Helen (Haury) Woods and husband
Dick, came all the way from Corpus
Christi, Texas, having visited along the
way with friends and children. Pat (Emer¬
son) Wanning, still busy with her biofeed¬
back interests, was present as was Lee
Sannella, who came from far-off Cali¬
fornia. Lee is still active with his projects,
particularly those related to ecologic
matters. Your obedient secretary, still
very busy with the Red Cross as volunteer
chairman of the board of directors.
Blood Services, Northeast Region, can
report that everyone seemed to enjoy
returning to New Haven after these
many years. All expressed the hope that
at the next reunion — our 50th — we
will have an extraordinary class turnout
and a gala program planned. So you
scientists in the class, you historians, get
ready for a class of 1940 seminar program
and write the trip off your taxes!
1 cannot close this column with out a
plea for information for future and more
meaty columns, and a word of regret
that many, if not all, members of the
class of 1940 are painfully modest about
speaking of themselves, their accomplish¬
ments, their families, and their lives in
general.

1945
40th Reunion
by Frederic Blodgett
The members of the class of 1945 held a
most successful 40th reunion, thanks to
the preplanning of Dick Breck, Al At¬
wood, and the assistance of the School
of Medicine’s Alumni Office, Nick Spinelli (’44) and Connie Tolliver.
The program included scientific and
not so scientific experiences and recollec¬
tions. Dick Breck reviewed the war years
at 333 Cedar Street in a most comprehen¬
sive manner with many warm recollec¬
tions of our relation to the war effort.
James Mason (Reeves) told us of medical
care in Sumatra, while George Naum berg
described wine makingalongthe Hudson
River and told us that he has developed
a top-notch line of choice wines. Ed
Daniels told us of some highly amusing
and inspiring experiences during his
four decades of psychiatry. Though many
of the class are ready to consider and
have even made the big step into retire¬
ment, Ed is convinced that we all have
too much to teach the next generation
and that retirement is not yet justifiable.
Dick Peters shared with us his insights
and concerns regarding the rapid changes
in delivery of medical care.
The class has produced a wide range
of investigators, clinicians, directors,
deans, chairmen, administrators in all
medical specialties, now widely spread
over the United States and the rest of the
world. Not only have we been successful
professionally, but of the 34 classmates
who responded to our cards, we now
know that 34 of the class have produced
134 children, 92 grandchildren and look
forward to increasing the latter figure.
For a supposedly “forgotten wartime
class”, it looks as though a great deal has
been accomplished with more to come.
The development of the School has
been impressive and gives us confidence
in the future of the institution and her
graduates, and merits our continued
support.

1950
35th Reunion
by Lyal Asay and William Bucher
“I’m sold! Sign me up for the 40th right
now!” That’s what Margaret Lyman
said at the end of the 35th reunion of the
class of 1950 Yale School of Medicine.
She’s attended five schools and never
attended a reunion before!
All who didn’t make it missed a great
affair, but you were all sorely missed.
After a day of lectures and meetings
sponsored by the School of Medicine
and interspersed with a marvelous compli¬

mentary festive luncheon, 1950 gathered
for cocktails and dinner at Mory’s. Eigh¬
teen class members made it (34, including
widows, sons and spouses). Tom F'erraro
couldn’t make it but he sent his hand¬
some, charming son to take notes on us
all. His son is an American history
graduate student at Yale. Ruth Quinn
Stewart, Bob's widow, brought Jeoffrey
Quinn, their son, a charming young man
who has been with Associated Press in
Hartford, but is about to take a breather
and write a book on the great conserva¬
tionists of America. He must have grown
tired of us telling him how much he
resembled the Bob we knew “in the good
old days”, but he maintained that same
warm, open interest in people that so
characterized his father.
After a fabulous dinner, class secretary
Lyal Asay (ageless, handsome and witty!)
conducted the class meeting. We elected
Bill Delia to hold us all together for the
next five years. So expect to hear from
him and send him all news, complaints
and inspired ideas!
We talked lovingly of our members
who are deceased. Jean Smith, Martin’s
widow, read us a wonderful memorial
tribute which had been read at the
service for him in Gloversville, N.Y.,
and told us of a new hospital wing
named in his honor. Kent told us of his
last visit with Pat Dowling — a beloved
general doctor in the waterfront area of
Seattle; and Dave Frucht told us about
the great dedication of Marina in her
work as an ophthalmologist. He attri¬
butes the tremendous success of his own
daughter in overcoming a congenital eye
problem to the great skill and dedication
of Marina. This daughter, against the
early predictions of all other physicians,
recently graduated from Yale College.
Bill Delia spoke lovingly of his friend
Fred “Bones" Vultee, and C.G. Gunn
told of the death of Bill Newton, who
was a very respected and beloved surgeon
and teacher at George Washington Uni¬
versity Medical School
We read letters sent by Milton and
Betty Lesser, still practicing cardiology
in Miami Beach; Butch and Peg Felmly,
who were attending the graduation of
their son at Jefferson Medical College;
Bob Sturman, who has given up neurosur¬
gery in Waterbury for a more relaxed
insurance consultant job in Detroit.
Cynia Shirnm is still in psychiatry in
Durham, N.C. —affiliated with Duke.
One son is in radiation therapy at Univer¬
sity of Arizona Medical School; the
other is an architect.
O.J. Miller writes that he has no
thought of retiring. He’s just started a
whole new career as head of Molecular

Biology at Wayne State University. Dan¬
ny and Anita Fine are going to retire to
half-time medicine, but true to a lifelong
commitment to making the world a
better place for us all, they are planning
to work the other half of their time on
advancing world nuclear disarmament!
Jan Lindner and John Strauss couldn’t
make it either, but they sent best wishes
and completed the retirement question¬
naire (the results of which were included
in the newsletter which has already been
sent to all members of the class). Personal
greetings were brought to us by the
Buchers from Al Davis — still in internal
medicine at Long Beach-VA Hospital
and University of California at Irvine
Medical School; Charlie and Peg Nugent
(’51), still at University of Arizona and
Tucson VA Hospital, and Larry Freed¬
man (’51), who has returned from Switzer¬
land, lives five houses away from the
Buchers, and is at UCLA and West Los
Angeles VA Hospital. Russ Anderson
had to drop out at the last minute. He
has remarried since the death of his wife,
Louise. Many of you may bump into
him as he travels around the country
with Joan for the Joint Commission on
Accreditation of Hospitals.
Then the highlight of the evening was
the panel on retirement arranged by Bill
Bucher. To capture the hysterical report
of Bob McSherry would be impossible!
You had to be there or get Jane Baldwin’s
taped copy. He is retired and he mingled
computer jargonese with philosophical
observations which kept us laughing so
hard I forgot to take notes! Bill Delia on
the other end of the spectrum, plans
never to retire, but “to die in the saddle”,
because he loves money too much, and
he, too, was his usual witty self. By the
way, he looks like the same young
happy-go-lucky kid he did 35 years ago.
Archie Golden and Naomi have sold
their home in Wethersfield, closed out
the family practice (30 years of service)
and have built a new home on the Cape
where they were to move this summer.
He’ll work summers in an outpatient
clinic there. He told us of a wonderful
goodbye party where patients of 30
years came to pay tribute to his many
years of service as their family doctor.
Ida Bucher reports that she’s upset that
Bill’s cutting back to half-time in July
because she never got the opportunity to
play that mythical role, created in the
minds of the lay American public, “the
rich doctor’s wife”, that person of ele¬
gance, style and unending partying!
The class was honored to have as its
guests. Dr. Thomas Forbes and his wife.
He spoke warmly of the early days as
our anatomy teacher and of his assistant
27

deanship. He surprised and flattered
some by remembering all kinds of indivi¬
dual things about them. He looks wonder¬
ful, still has an office at the medical
school and writes extensively on the
history of forensic medicine. Subsequent
to the reunion we received a warm note
of appreciation for the evening and
recalling many happy memories. He
stated Yale can be proud of the doctors
she graduates and the spouses they choose.
Prizes for the youngest looking went to
svelte Marilyn Sugarman Kritchman,
director of anesthesiology residents at
NYU, and Yvette Francis McBarnette,
mother of six, who is involved in sickle
cell anemia. Starting out as a pediatrician,
she’s moved to internal medicine as her
patient population aged.
The evening ended with a pitch by Sid
Lee for the upcoming endowment drive
for the medical school. It is important
that all of us help in the drive to keep
Yale School of Medicine on the cutting
edge of research, both pure and clinical,
and to maintain the excellence of the
private university, where freedom of
inquiry is a prized value. Remember,
many large corporate donors give in
proportion to the contribution of the
alumni ae. So give a little —give a lot
whatever your pocketbook allows —
but do give when you’re asked to partici¬
pate in the drive. Sid is now', by the way,
in a new job as executive director of the
Milbank Fund in New York City. (At¬
tention —all grant applicants!!) He is
also a member of the Yale Development
Fund Committee seeking to increase the
medical school endowment.
Present at the reunion, which included
Friday night dancing and a hilarious
Sunday brunch were: John LeRoy, Bill
Delia, Mrs. Martin Smith (Jean), Tony
Tyler, Lyal and Bonnie Asay, Kent and
Barbara Ellis, Marilyn Sugarman Kritch¬
man, Archie and Naomi Golden, Ida
and Bill Bucher, Sylvia Levine Axelrod
and Bob Axelrod, Jane Baldwin Shumway, Ruth Quinn and Jeoffrey Quinn,
Dave and Claire Frucht, Gloria Sturman, Sid Lee, Yvette Francis McBarnette
and Mac, Mag Lyman, CG and Doris
Gunn, Sheila and Harry McClelland.
Harry McClelland thinks we should
plan a mini-interim reunion medical
meeting (tax deductible you know!) at
e wonderful resort in two or three
I he Buchers always attend “Yale
1 V " wmite” in first of May at Yosemite
Lodge It' run by Yale Western Office
and the Natural Science Experts from
'lose lite 11 anyone would like to come
with us
(quite inexpensive) do let us
know’ Hikes are arranged to fit each
i\ capabilities and there’s square

dancing and barbeques. Any other sug¬
gestions? Mag Lyman volunteered her
farm for a picnic symposium too, and
some suggested an Elder hostel program.
Send Bill Delia your ideas.
Love and best wishes for five years of
health, wealth and happiness from the
Buchers and Asays.

1955
30th Reunion
by William Lattanzi
Twenty-five of our classmates returned
to New Haven for this reunion. 1 have
been told by the director of Alumni
Affairs, Dr. Nicholas Spinelli (’44), that
the class of '55 once again has gathered
more returning alumni than any other
class. From the comments of those who
returned, it seemed to have been a
worthwhile experience and one that gave
all of us great enjoyment.
Attending all or part of the weekend’s
activities were the following: Milt Corn,
Kahler Hench, Dorothy Leib, Alan
Stone, John Hodge, and Frank Kenney.
The following alumni returned with their
wives (or in Gregg Peterson’s case, with
his daughter): Joe McGuire, Jack Lan¬
dau, Nick Coassin, Jim Nolan, Joe
Camilleri, Greg Peterson, Russ Miller,
Shep Nuland, Bob Kramer, Jerry Bobruff, Bill Lattanzi, Padraic Burns, Paul
Gonick, Bob Reich, Irwin Braverman,
Bob Peters, Phil Smith, Ed Brennan,
Paul Calabresi.
Activities began on Friday afternoon
with a talk by Dr. Arnold Reiman,
editor of the New England Journal of
Medicine. His topic concerned the impact
of for-profit hospitals on our present
medical system. After his talk, we spent
an evening at the home of the Lattanzi’s
with cocktails and dinner. This was the
first meeting of some of our classmates
in the past 30 years. As you can imagine,
it was an exciting evening. Some of our
classmates had not been to any reunion
since we graduated and it became ex¬
tremely pleasurable for those of us who
have attended all of these to be able to
see them again. We caught up on every¬
one’s activities and what has taken place
in their lives since graduation. A sad
note was the demise of Ed Coppola
during the past five years.
After the activities at Yale on Saturday,
June 8th, we all gathered at the Oak
Lane Country Club for dinner. During
the course of the dinner. Bob Fekety
called from Michigan and spoke to
everyone w ho was in attendance. We all
felt that was a very warm and welcome
addition to the evening’s entertainment.
At the dinner, a number of our class rose

to the occasion and talked about their
lives and remembrances of things past.
On Sunday, Jack Landau had invited
those who could stay in town to a
brunch at his home. Although few were
able to attend, it was again, most
enjoyable.
The reunion, I think, ended on a very
high note of good spirits, and genuine
fondness for one another.
We had sent a questionnaire to our
classmates concerning their attitudes and
feelings towards medicine and the view
of the Yale School of Medicine. Although
not enough questionnaires were returned
for a reliable sample, practically unani¬
mous opinions were that:
1. The Yale system was thought of as
positive and worthy of support.
2. Most of the class felt that their lives
were very satisfying, but at the same
time, did not feel that the future physi¬
cians will find that to be so. This was
reflected in the fact that most would not
like to see their children enter medicine
at this time.
3. Most of the class engage in sports
activity of some sort, but do not feel they
have enough time for relaxation.
4. Many of the class have received
distinguished awards and have very im¬
pressive bibliographies.
If energy remains, perhaps in the next
five years a more extensive questionnaire
with followup could be done to achieve a
large enough sample that could be viewed
upon as reliable
I would like to thank the committee
for its efforts and especially Jack Landau
for arranging the evening at the Oak
Lane Country Club.
We all look forward to the 35th.

Milton Corn has been appointed dean at
the Georgetowm University School of
Medicine, effective August 1.

1960
25th Reunion
by Jerrold Post
The 25th reunion of the class of 1960 was
a very special occasion for all — awash
with warm memories and good humor.
The class sponsored a reunion seminar
on "The Brain, The Mind, and Behavior.”
Two of the class’ outstanding neurobio¬
logists, Chuck Stevens and Alan Finkelstein, presented fascinating discussions
of the advances in understanding the
biological basis of mind. Setting the
stage for the rest of the weekend, special
attention was given to the neurochemical
basis of the seven deadly sins, particularly
gluttony, lust and sloth. At a more

microscopic level, this was followed by a
talk on the social psychology of terrorism
by Jerry Post. Rick Kindwall wrapped
up with a fascinating discussion of his
own esoteric specialty — hyperbaric
medicine.
Having made a ritual bow to education,
the serious concerns of the weekend
began. After a pleasant reception for all
returning alumni, hosted by Dean Rosen¬
berg, the class repaired to a delightful
informal evening at Vic and Laura Altshul’s splendid rambling home in New
Haven, for a buffet hosted by Vic, Tom
Kugelman and Jerry Post. The next
morning brought a series of stimulating
roundtables, including a very provocative
discussion of the ethical challenges facing
contemporary medicine. Forty-four
strong descended on Mory’s that evening
for a class dinner, straining both the
capacity and the patience of that vener¬
able institution. One of the highlights
was a raucous photo session observed
with bemusement by one of New Haven’s
street people. After a fine dinner of
prime rib and stuffed shrimp, we shared
personal and professional experiences,
read the letters of classmates unable to
attend, and caught up on news of other
members of the class. During this portion
of the evening, the droll humor of Bob
Wallach and A1 Ross had the class in a
state of hilarity. The evening ended with
the maitre d’ asking us to leave.
The rich collection of news and scurri¬
lous gossip collected during the evening
and from class letters will be collated in a
newsletter which will be sent to all this
summer.
In attendance were: Festus Adebonojo,
Vic and Laura Altshul, Ormond Brody,
Don and Nancy Buebendorf, Gerry and
Donna Cimino, Frank and Ann Cogliano, Jon and Carol Courtney, Jim and
Kitty Eusterman, Alan and Joan Finkelstein, Jim Gilman, Roland and Mar¬
guerite Ingram, Dan and Carolyn Jones,
Rick and Marilyn Kindwall, Sue Kleeman, Tom and Alice Kugelman, Ed and
Jean Lang, Bob Marcus, Don and Pat
Miller, A1 and Barbara Newcomb, Nick
and Veda Nichols and their daughter,
Carol, Fred and Ruth Palace, Jerry and
Carolyn Post, Nancy Rolick Powell and
her husband. Bill, Buzz and Pat Robin¬
son, Al Ross, Chuck Stevens, Bob Wal¬
lach, and May Woo Wang and her
husband, George.

On May 31, Jack Barchas presented the
John P. Flynn Memorial Lecture at
Yale. Dr. Barchas, who is Nancy Friend
Pritzker Professor and Associate Chair¬
man of Psychiatry at Stanford University,

spoke on “The Search for Neuroregula¬
tors: Neuropeptides and Behavior.”

1965
20th Reunion
No report received

1970
15th Reunion
by Robert Rosa
The class of 1970 gathered for its reunion
at the fashionable Quinnipiack Club in
New Haven where dinner arrangements
were made by Scott Peterson. The
evening was very enjoyable and there
was ample opportunity for everyone to
talk and describe their recent activities.
Those present, in most cases accom¬
panied by their spouses, included Bruce
Reitz, who recently moved from the
rolling hills of Palo Alto to become
professor of surgery and chief of cardio¬
vascular surgery at Johns Hopkins. By
moving, Bruce has brought heart-lung
transplantation to the East Coast. Ray
Tripp is still in Massachusetts and is
chief of pediatrics at the Emerson Hos¬
pital in Concord. Lenny Milstone re¬
mains at Yale on the full-time staff in
dermatology, while Ann Curtis, just
back from sabbatical in England with
her husband Jim Fischer, is now head of
chest radiology at Yale. Also present
and still in Connecticut, but now on the
anesthesia staff at St. Vincent’s Hospital
in Bridgeport, was Jonathan Katz. John
Blanton is still in New Haven and remains
a great pediatrician and knitter. Phil
Steeves journeyed down from Back Bay
for the evening and revealed that he
remains active in radiology on the North
Shore of Masschusetts. Farther up the
North Shore in Newburyport, Joel
Rubenstein is practicing psychiatry while
west of Boston Bruce Wenger is engaged
in research in thermal physiology. Paul
Hessler has an active practice in radiology
in Rhode Island. Gerry Kennealey, who
finally shaved his moustache because, “1
no longer need to try to look older,” is
busily engaged in the practice of oncology
in the Waterbury area, while Scott Peter¬
son remains very busy in the practice of
ophthalmology in Waterbury, where he
has established a regional eye center.
Your class secretary. Bob Rosa, remains
in Boston, where he directs the Clinical
Research Center at Beth Israel Hospital
and dabbles in nephrology.
Letters were received from classmates
who could not attend and they reveal
that Joellen Werne is actively practicing
psychiatry half-time and raising a family
full-time; Dan Dederick is on the full¬

time anesthesia staff at Brigham and
Women’s Hospital; Tom Singer (writing
on stationary from Marrakech) is associ¬
ate professor of surgery at Bellevue in
New York; Ken Khoury is at UCSDand
recently has taken up jazz dancing and
ballet (if you can believe that!); Bob
Litman is in family practice and is also
an allergist in Ogdensburg, N.Y., where
he runs a TV program and has recently
published a novel; and Jonathan Ecker
got a haircut and is now practicing
psychiatry in the Syracuse area.

1975
I0th Reunion
by Mary Jane Minkin
To summarize our reunion
we had a
great time — what else? Our two major
events were a get-together at my house
Friday evening, and a more formal
dinner at the Colony Inn restaurant on
Saturday. It was a terrific occasion for
the large local contingent to meet — as
we never do — and see many out-oftowners. We also got lots of letters from
classmates to read (and make nasty
comments) — well, you can’t defend
yourself if not there.
Local attendees included: Andy Pachner and wife, Dan Passeri and wife, Sal
Romano and wife, Henry Cabin and
wife, Florence Comite (’76) and sisterin-law, Harriet Comite (’77), Stan Gale
and wife, and honorary classmate, Mark
Ruchman (officially ’76) and wife. Long¬
est distance guests were: Haig Donabedian, still voted class’funniest member,
Jim Grabman, Hank Willner and Fred
Sherman, who did manage a few rounds
of golf. Bob Sandler and wife, Jamie
Robertson, Rob Malacoff (or should
Boston be considered local?) and of
course, your local arranger, me.
We all decided none of us has changed
—and we really hadn’t — and enjoyed
sharing our practice experiences, and
also reflected how medicine has changed
so much in ten brief years. Let’s see how
much more it will change in the next 15,
and plan even better attendance at our
25th.
A gossip sheet is in the printing stage,
so if you have any class news, please
send it. Thanks.

1980
5th Reunion
No report received
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Other Class Notes

1936
George Hahn has received the Sigma
Chi Fraternity’s highest honor for out¬
standing achievements in his professional
field. The 1984-85 Significant Sig Award
was presented to Dr. Hahn at a Washing¬
ton, D.C., Sigma Chi Alumni Chapter
meeting on June 13, for his medical
research including carbon dioxide laser
beam surgery and other cancer treatments
as professor of gynecology and obstetrics
at Thomas Jefferson University in Phila¬
delphia; and for his outstanding achieve¬
ments in the control of cancer for which
he received the National Division Gold
Medal Award of the American Cancer
Society. Dr. Hahn was recognized for
his leadership in the field; as an active
member of the Medical Board of Project
HOPE; as governor of the American
College of Surgeons; as vice president of
the American Gynecological and Obstet¬
rical Society; and as an officer of many
other medical societies and associations.

1952
New s of Willard and Siegried Centerwall
has been received. In March, while in
India during a five-nation lecture tour
through Asia, Dr. Centerwall was pre¬
sented the first J.B.S. Haldane Oration
Medal from the Society of Bionaturalists
at Bhopal University. The medal honors
John Burden Sanderson Haldane (18921964), one of the world’s pioneers in the
field of human genetics, who emigrated
from England in 1957 to spend the rest
of his life in India. The followingcitation
accompanied the aw'ard: “The President
and Fife Servers of the Society record
with privilege, the outstanding contribu¬
tions of Professor Willard R. Centerwall
in human genetics and animal cytogene¬
tics extending over three decades. His
work on phenylketonuria and extension
of genetic services for the prevention of
mental retardation are more than
exemplary.”
In New Delhi, Dr. Centerwall was
chairman of one of the scientific sessions
if the Seventh World Congress of the
International Association for the ScientiStudy of Mental Deficiency. At VelSouth India, he lectured at Christian
College, where he and his wife
spent live years as medical missionaries.

During this time, he started his genetic
studies in India and has continued them
during periodic return visits. Dr. Centerwall retired in February as professor of
pediatrics and genetics and director of
Medical Genetic Services at the Univer¬
sity of California, Davis.
In May, Dr. Siegrid Centerwall was
awarded an honorary Doctor of Humane
Letters degree from her alma mater,
Mount Holyoke College, for a lifetime
of outstanding professional and humani¬
tarian achievements.
From 1961 through 1966 in India,
where she went with her husband and six
young children to work as a missionary,
she engaged in public health work. On
her return to this country, her community
service included developing a program
for tutoring disadvantaged college stu¬
dents. and she has taken active interest
in affirmative action, women's rights,
world hunger relief and peace between
nations. Professionally, she has worked
in public health clinics, headed maternal
and child health services in San Ber¬
nardino County in Southern California
and has served on the faculty of the
Loma Linda U niversity School of Health.
Dr. Centerwall retired this year from
the Claifornia Department of Health
Services, where she was chief of the
Child Health and Disability Prevention
Branch. During the last eight and a half
years, she has headed maternal, adoles¬
cent and child health services and under
her leadership, coordinated child health
care systems were developed in all the
counties in California.
In June, Drs. Centerwall, on personal
invitation from Norway, participated in
the dedication of a memorial to the
Norwegian physician and biochemist.
Dr. Asbjorn Foiling, who 50 years ago
discovered phenylketonuria, the heredi¬
tary disease known in the U.S. as PKU.
The Centerwalls were honored for their
achievements in the I950’s in the U.S.
with the dietary treatment and the first
early infancy testing programs for PKU.
In retirement, the Centerwalls plan to
write, lecture and consult as well as to
expand the program of the non-profit
organization. Light for the Way, Inc.,
which they founded to help families
whose children have serious medical and
developmental problems.

IN MEMORIAM
Leo J. Hahn
August 14, 1985
Daniel M. Thron, M.D.
February 19, 1985
Morris Slater
July 2,1985

’18 M.D.
’20 ex med
’24 M.D.

Stanley K. Livingston, M.D . ’25 ex med
April 25, 1984
Eugene C. Beck
June 13,1985
Sheldon A. Payne
May 29, 1985

’26 M.D.

Rebecca L. Proctor
April 10, 1985

’31 M.D.

’31 M.D.

Herbert F. Hirsche
September 20, 1985
Thomas E. Farthing
May 7, 1985

’31 M.P.H.

Edward T. O’Donnell
June 23, 1985

’34 M.D.

Thomas F. Hersey, M.D.
July 9. 1985
Thomas H. Burford
May 17, 1977

’32 M.D.

’34 ex med
’36 M.D.

Lloyd R. Studebaker, M.D. ’39 ex P.H.
May 12, 1984
Robert A. Hettig
’40 HS
August 8, 1984
’40 M.P.H.
Meyer J. Plishner
date unknown
’42 M.D.
Francis P. Vose
June 5, 1985
'44 HS
Nicholas A. Tierney
November 12, 1984
47 HS
Mathew W. Kobak
January 16,1985
'53 M.P.H.
Naomi Bitz Markthaler
March 31, 1985
William A. O’Shea
'55 HS
June 25, 1984
’57 HS
Jane A. Wilkinson
April 9, 1985
’59 M.D.
Lois W. Tice
August 2, 1985
'61 M.P.H.
Herbert Rubenstein
February 24, 1984
Sister Mary Lucina Wierzbicki
July 23, 1985
’71 M.P.H.
Jacques Lagier
December 25, 1984

’76 HS

ERRATUM
Based on incorrect information received
by the Editorial Office of Yale Medicine,
the “In Memoriam” listing which ap¬
peared in the Spring issue included the
name of Dr. Joseph H. Zelson, ’69 HS.
It has since been learned that it was Dr.
Zelson’s father, Carl, also a pediatrician,
and not Dr. Joseph Zelson, who died in
December. We apologize for the error.

1984 - 1985 ALUMNI FUND REPORT
A MESSAGE FROM THE MEDICAL SCHOOL ALUMNI
FUND CHAIRMAN

FUND OFFICERS 1984 - 85
Medical School Alumni Fund
Lowell 1. Goodman, '51, Chairman
J. Roswell Gallagher, ’30, Bequest
and Endowment Co-Chairman
Samuel D. Kushlan, ’35, Bequest
and Endowment Co-Chairman and
Chairman, Former House Staff
Public Health Alumni Fund
Kathleen H. Howe, ’56, Chairman

1984-85 was another banner year for the
Medical School Alumni Fund. Four
years ago this summer, 1 began my term
in office by recruiting a number of
additional Class Agents and announcing
a goal of $ 190,000 for the 1981-82 cam¬
paign year.Each year since then the goal
has been a little higher and everyone
responded admirably. In 1983-84 we fell
a little short, but this year we really came
through
$380,818 and that’s $55,818
over our goal! The Reunioning Classes
did their winning bit, as usual, by contri¬
buting well over $ 1 10,000. Jim Haralambie’s group of generous givers from the
Class of 1935 led the parade with $54,090
in honor of their 50th, while the Class of
1960 celebrated their 25th with an impres¬
sive total of $ I 1,1 13 under the guidance
of agents Roland Ingram and Tom
Kugelman.
Special notes of thanks to Nick Spin¬
elli, who continues to be helpful in
maintaining contact with the Reunion
Classes; to that inimitable team of Ros
Gallagher and Sam Kushlan for their

YALE MEDICAL SCHOOL
ALUMNI FUND BOARD
Lowell I. Goodman, M.D., ’51,
Chairman
J. Roswell Gallagher, M.D., ’30
Harry Sherman, M.D., '34
Samuel D. Kushlan, M.D., ’35
Malvin White, M.D., ’39
R. Leonard Kemler, M.D., '43
Nicholas P.R. Spinelli, M.D., ’44
William McClelland, M.D., ’47
Harvey L. Young, M.D.,’52
Harold Bornstein, Jr., M.D., ’53
Robert Kramer, M.D., ’55
William Kissick, M.D., '57
William Waskowitz, M.D., '57
Nicholas Passarelli, M.D., '59
Earl Baker, M.D., ’61
David Hill, M.D., ’65
Douglas Berv, M.D., '74
O’Dell Owens, M.D., ’76

efforts on behalf of the Bequest and
Endowment and Former House Staff
Programs; and to Bill Waskowitz and all
the alumni and student phonathon volun¬
teers who helped so much to make this
another memorable and rewarding year
for the Fund.
Not all the good news is to be seen just
in the numbers of dollars given during
the past year. We now have a Medical
School Alumni Fund Board of Directors
responsible for the overall guidance and
management of the Fund. Four members
will be immediately active by functioning
as Vice Chairmen of Agents to help
maintain bettercommunication with the
agents; their respective classes are:
Mai White, ’39 — 1923-1945
Bill McClelland, ’47 — 1946-1960
David Hill,’65
1961-1973
Doug Berv, 74 — 1974-1985
Our fund could not exist without the
loyal support of the School’s alumni,
alumnae, former house officers, parents
and friends, and I wish to thank everyone
for their thoughtful contributions.
Lowell I. Goodman

A MESSAGE FROM THE DEAN
Since becoming the dean of our School
of Medicine last July, I have become
increasingly aware of the importance of
the Medical School Alumni Fund in
providing a source of unrestricted in¬
come. For many years, this money has
been used to provide additional student
loans. Today, student financial aid contin¬
ues to be one of the School’s top priori¬
ties. I want to assure you that your
Medical School Alumni Fund contribu¬
tions will continue to be added to the
Student Revolving Loan Fund.
In reviewing the report of the Fund
for 1984-85, I was extremely gratified
and encouraged to note that the total
contributions have continued to increase
and that the goal set for this year has
been surpassed. I want to thank each of
you who contributed to the Fund this
year and to encourage your future sup¬
port. I also hope that those graduates
who did not contribute this year will do
so in the coming year.
The success of the Fund’s annual
giving campaign is due mainly to hard
work and persistence on the part of the

class agents and the various officers of
the Fund. Their contributions of time
and effort on behalf of the School are
greatly appreciated. I want especially to
congratulate Lowell Goodman on the
tremendous job that he has done as
chairman, a job which he has held since
1981.
At the Alumni weekend in June, I met
with Lowell, other officers, and a number
of class agents. We had a very frank
discussion of how the School might be
more responsive to some of the alumni
expectations, especially in regard to ad¬
missions. I also had an opportunity on
that occasion to express my personal
appreciation to those who have worked
so loyally on behalf of the Fund.
In conclusion, I wish to emphasize
that your support of the School through
the Alumni Fund is very important and
that contributions to the Fund will be
added to the School’s Student Revolving
Loan Fund to provide financial assistance
for our students now and for years to
come. This is certainly worthy of your
support.
Leon E. Rosenberg
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MESSAGE
TO PUBLIC HEALTH
GRADUATES AND FRIENDS
The Department is extremely grateful to
the 651 alumni, alumnae and friends
who contributed to the success of the
1984-85 Public Health Alumni Fund
Campaign.
The proceeds of the drive are desig¬
nated for student loans, a high priority
of need, as the cost of graduate education
continues to escalate.
The total of $44,986 exceeded the goal
by 112 percent and includes over $4,000
raised by an enthusiastic group of volun¬
teers from the New Haven area during a
phonathon in June.
Kathleen H. Howe
Chairman

- AND A MESSAGE

FROM THE CHAIRMAN
OF E.P.H.
That the 1984-85 Alumni Fund Camp¬
aign for the Department of E.P.H. ex¬
ceeded its goal is due in large part to
Kaye Howe and her cohort of hard¬
working volunteers. It is continually
evident that the Alumni Fund is an
important asset to the School, providing
much needed financial assistance to
highly qualified graduate students.
Ourthanksto Kaye Howe and all who
participated and contributed to this very
successful campaign.
Jan A.J. Stolwijk

MEMORIALS
Deceased medical alumni (and friends)
may be memorialized by a gift at any
time to the Medical School Alumni
Fund Endowment in the name and class
of the person so honored. The next-ofkin of a deceased medical alumnus/a is
advised about this In Memoriam Pro¬
gram by mailing from New Haven some
weeks after the School of Medicine
receives notification of the death. The
letter of information includes a copy of
The Testament of Remembrance in which
the names of all persons so memorialized
are listed in the medical section by class,
thus establishing a lasting memorial.
Donors receive a personal penned note
of appreciation from me. Your inquiries
and interest are welcome at any time.
Deceased alumni and friends so hon¬
ored for the first time in 1984-85 were:
Ernest Russell, '16 and David P. Dunn,
'60.
Richard G. Jordan
Director, In Memoriam Program

MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION
FINAL REPORT-1984-85

YEAR

AGENT

1423
1424
1425
1426
1427
1928
1424
1430
1431
1432
1433
1434
1435
1436
1437
1438
1434
1440
1441
1442
144 3 A
1443 B
1444
1445
1446 A
1446B
1447
1448
144 V
1450

William Cohen
Myron Sallick
Alice Whittier
Maxwell Bogin
Harry Zimmerman
Max Alpert
Paul McAlenney
J. Edward Flynn
Michael D'Amico
Henry Brill
Franklin Foote
John Ogilvie
James Haralambie
George Hahn
David Dolowitz
Nelson Ordway
Rebecca Solomon
James Ferguson
Charles Cheney
Walter Burdette
Dorothea Peck
S Brownlee Brinkley
Nicholas Spinelli
Richard Breck
Charles Judd
Thomas Whelan
William Roy Brcg
Paul Koehler
Daniel Elliott
David Frucht
Lowell Goodman
Harvey Young
Vincent Gott
John Rose
Robert Kramer
John Gardner
Ronald 1 ishbein
Howard Minners
Charles Hall

1454

1983-84
TOTAL

1983-84
% PART.

1984-85
TOTAL

1984-85
% PART.

608
3,652
960
546
975
3.216
1,612
2,446
1,90!
1.366
2.107
14.929*
3,736
4,333
1,671
1,100
3,231*
3,750
2.287
2,356
2.915
2.686
17.394*
3.350
4,438
2.583
4.918
5.251
5.829*
5.230
5.075
5.035
3.865
6.248*
4.712
6.275
3.195
3,205
1.715

67
86
77
67
56
73
90
52
68
50
74
61
58
47
48
63
57
65
64
61
66
47
74
60
56
73
66
51
52
58
45
46
56
65
62
49
56
73
54

541
5.081
875
551
1,048
3.555
1.192
15.984
1.663
1.725
1.537
4.071
54,090*
5.850
753
1,215
3.371
10.793*
2,856
1.973
2.995
3,164
8,393
24,854*
4.675
3,084
4.700
5,407
3,785
6,781*
5.271
4.310
3,095
5.323
8,841*
4.600
3.620
4.055
1.570

60
71
67
71
53
77
72
60
83
44
63
65
70
47
53
74
62
67
64
54
69
52
61
65
56
62
59
56
47
71
49
43
45
67
62
36
59
68
51

MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION —continued

YEAR

AGENT

1958 B
I959A
1959 B
I960 A
1960 B
1961A
1961 B
I962A
I962B
1963
1964A
I964B
1965
I966A
I966B
1967 A
I967B
1968 A
I968B
1969
1970
1971A
1971B
1972
1973 A
I973B
I973C
1974
I974A
I974B
I975A
I975B
1976
I977A
I977B
I978A
I978B
I978C
1979 A

Paul Rudnick
Asa Barnes
Muriel Wolf
Roland Ingram
Thomas Kugelman
Earl Baker
Anoush Miridjanian
A. Richard Pschirrer
Frank Hartman
Craig Llewellyn
William Houghton
William Pratt
David Hill
Mary-Alice Houghton
Henry Mann
James Dowaliby
Anthony Lovell
Frank Lucente
Donald Lyman
Lee Jampol
James Missett
John Cieply
Barbara Kinder
Paul l.ucky
David Bailey
David Johnson
Jerrold Rosenbaum
Peter Buchin
Amv Schecter
Robert Schecter
Daniel Passeri
Mary Jane Minkin
Robert Taylor
David Kreis
Ronald Vender
Duke Cameron
Seth Powsner
Thomas Smith
Michael Hausman
Jeffrey Kaine
Laurie Smaldone
F.duardo Alfonso
Mark Bernhardt
Anthony Urbano
Muriel Cyrus
Jed Gorlin
Lynn Tanoue
Stephanie WolfRosenbaum
Michael Tom
David Schwartz
David Astrachan
Jay Kostman

I979B
1980 A
I980B
1981
I982A
I982B
I982C

1983 A
I983B
1984A
1984B

1983-84
TOTAL

1983-84
% PART.

1984-85
TOTAL

1984-85
% PART.

3,350
4,185"
5,930*
4,480
3,800
2,430
3,406
2,680
1,367
5,715
3,620*
5,050*
3,905
2,770
1,355
2,596
4.000
2,801
1,865
7,948*
3,909
2,486
3,545
3,048
955
1,415
1,145
1,970*

71
58
66
63
69
47
50
59
35
54
63
71
38
80
50
69
83
56
51
62
49
44
58
44
42
46
54
37

4,010
3,376
4,679
7,400*
11,113*
2,625
2,310
2,865
1,475
10,685
2,100
5,145
8,840*
2,580
1,975
1,691
3,605
2,701
1,800
5,872
3,796*
1,942
3,690
4,143
1,050
1,135
1,120
—
1,000
850
1,450*
1,135*
2,116
600
820
1,360
105
110

56
64
46
67
71
52
44
54
32
56
47
76
53
66
63
47
77
47
51
52
42
40
63
46
39
36
45
—
38
26
35
19
30
21
38
26
14
20

—
—

25
18
30
36
37
26
21
31
21

625
795
1,982
1,200
715
1.340
215
580
365*
—

465*
415
415
530
110
90
75

18
29
22
19
12
19
12

145
1 10

9
1 1
—

—

—

—

—

266
445
610*
655*
575
65
135

23
21
36
33
17
9
27

1 15
170
197
140
121

17
10
23
12
17

* Reunion

MEDICAL SCHOOL ALUMNI LUND
1983-84
NUMBER
SOLI¬
CITED

NUMBER
CONTRI¬
BUTORS

3480

1674

Former
House Staff

945

148

Parents;
Friends

345

63

Alumni

1984-85
NEW/
INCREASED
GIFTS

48

PERCENT
PARTICI¬
PATION

TOTAL

NUMBER
SOLI¬
CITED

NUMBER
CONTRI¬
BUTORS

PERCENT
PARTICI¬
PATION

TOTAL

$55,217

$254,710

3509

1613

46

$359,470.50

16

1,785

7,095

1004

168

17

9,560.00

18

1.625

1 1.652

366

60

16

11.787.00

Interest
Miscellaneous
Gifts

1 1,319

Baumgartner
Match

13,464.42

19,542*

4770

1885

40

$58,627

$304,319

4879

1841

38

$380,817.50

■"Balance of $50,000 earned along with Public Health Alumni Fund.
"Includes $67,372.75 for 3 life income gifts.
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PUBLIC HEALTH ALUMNI FUND CLASS PARTICIPATION
FINAL REPORT-1984-85

YEAR
1923-1941
1942
1943
1944
1945
1946
1947
1948
1949
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
I960
1961
1962
1963
1964
1965
1966
1967
I96X
1969
1970
1971
1972
1973
1974 A
1974 li
1975
1976
1977
1978
1979
1980
19X1A
19X1 B
19X2 A
I9X2B
19X3 A
1983 B
1984A
I9X4B

AGENT

Eric Mood
Eric Mood
Eric Mood
_
_
_

Elizabeth Robinton
Elizabeth Robinton
Eric Mood
Norton Chaucer
Yolande Lvon
Milton Sisselman
Ruth Taber
Eric Mood
Frances Ogasawara
David Boyd
Edward DeLouise
Thomas Flynn
Dorothy Wilson
Else Schulze
William Slivka
A. Kay Reiser
David Dolins
Estelle Siker
H Patterson Harris
Allen Cohen
James Mallov
Arnold Saslow
Samuel Korper
Susan Balter
John Bihldorff
Dorothy Lewis
Judith Beatrice
Elizabeth Helming
Thomas Benoit
Karen I indfors
Linda Broker
Elaine Anderson
Dorothy Rice
Ann Freedman
Ralph Tartaglione
Christina Quinn
Diane Goren
Barbara Gaugler
Michele Visconti
Amy Wilson
Jeffrey Hughes
Mary Beth McNernev
Anthony Alberg
Leslie A. Balch

1983-84
TOTAL

1983-84
% PART.

1984-85
TOTAL

1984-85
% PART.

1.791
265
275
270
130
65
265
7X5
440
790
565
840
860
70

58
33
31
56
33
22
39
39
22
50
37
39
42
13

5,770
460
460
260
1 10
80
220
1.115
495
975
645
870
730

50
80
45
33
43
33
35
50
36
62
38
33
39

535
555
470
765
945
1.050
1,300
60
520
895
5X0
305
2.445
1,475
1,450
1.650
2,221
830
820
170

50
36
48
29
48
54
43
10
33
29
29
24
36
43
27
35
53
34
20
22

45
655
545
525
700
605
195
655
75
850
1,220
1.885
220
1.525
1.805
1.035
1.345
2,025
485
1.495

13
50
29
57
29
40
25
50
20
43
42
50
18
41
45
36
31
49
30
29

525
1.391
1,560
1.390
1.318
2.420
1,020
805
165
385
475
505
300

33
35
34
29
38
51
31
36
24
22
32
39
32

320
535
1,667
1,690
1.380
1.759
1.505
1.155
6156
240
265
445
1.260
175
110
80

35
44
41
35
33
39
32
37
26
32
14
39
24
16
17
10

42,590
2.396

—

44,986

35%

ALUMNI AE TOTALS
Interest misc. gifts
Baumgartner Match

38.761
1.755
3.162

TOTAL

43.678

—
36%

Contributors to the Medical School Alumni Fund 1984-85
Alumni
1906
Charles R. Mitchell *
1908
Michael A Parlato *
1912
Walter C. Tilden *
1913
Ralph E. Taylor *
1916
Ernest Russell *
1919
Willys M. Monroe *
1920
Oscar Brenner *
1921
Ella W. Calhoun
1922
Maurice Grozin *
Benedict R Harris
Chester E. Hurwitz *
Helen P. Langner
Reginald T. Lombard
1923
William Cohen
Joseph Epstein
Jacob Mellion
Julius Olean
Hyman Weinstein *
1924
John J. Batchelor
D. Anthony D’Esopo
David M. Raskind
Myron A. Sallick
Harold T. Vogel
1925
Dorence S. Cowles
Waldo F. Desmond
Henry W Ferris *
William E. Hall
Samuel Reback
Welles A. Standish
Alice A.S. Whittier
Howard A. Wood
1926
Stanton T. Allison *
Maxwell Bogin
William H. Hahn *
Joseph L. Hetzel *
Morris Hinenburg
Ben Klotz
Milton Malev
1927
Milton B. Berman
Wallace R. Bostwick *
John M. Freiheit *
Albert Jablonsky
Nathan Levy
William C. Meredith
Moses Rothberg
Alfred F. Seibert
M. Dawson Tyson
Harry M. Zimmerman
1928
Max Alpert
Berthold R. Comeau *
Sheldon A. Jacobson
Raymond A. Johnson
Edward P.J. Kearney
Ralph E Knutti
R. Harold Lockhart
Edward W. Ludwig *
Nathan E. Ross
Robert I. Rubinstein
John M. Russell *
Alvin A. Schaye *
Lewis A. Scheuer
* Deceased

1929
James Rae Arneill, Jr.
John W. Cass, Jr.
Charles J. Epstein
Robert A. Frisch
Olive Gates
George S. Goldman
Alexander O. Haff *
John A Hangen
Harold J. Harris
Paul F. McAlenney
Tony L. Rakieten *
William F. Roth, Jr. *
Russell B Scobie
Robert Tennant
Newell Raymond Washburn *
Julius G. Weiner *
Mabel Wilson
Herman Yannet
1930
Daniel N. Beers *
Frederick Fitzherbert Boyce
Charles A Breck *
Vincent A. Doroszka
Knox H. Finley
J. Edward Flynn
J Roswell Gallagher
Leonard Greenburg
James C. Hart
Edmund L. Kitzmeyer
Paul H. Lavietes
Moses D. Lischner
James M. Lynch *
Paul Watson *
Amy H. Wilson
Charles L. Wood
1931
Henry H Briggs, Jr.
Benjamin Castleman *
Michael D’Amico
Richard L. Frank
Helen R. Gilmore
Paul A. Harper
Harold E. Harrison
Morris Freund Heller *
Thomas Jaleski
A. Philip LaFrance
Rhoda M. Mickey
Nelson Newmark
Sheldon Payne
Morris L. Rakieten
James W Reed
Abraham J. Schechter
James A. Stringham
1932
Louis K. Alpert
Henry Brill
Frank Carroll
Clement C. Clarke
Joseph P. Donnelly
Lee E. Farr
Lewis F. Foster
Conrad R. Lam
Arthur J. Present
Elizabeth M Ramsey
Benjamin N. Tager
Myron E. Wegman
Ronald J. Wehger *
1933
Myron J. Adams *
Fred W. Buse
Warren P. Cordes
Franklin M Foote
Jack Greenberg
Daniel F. Harvey *
George K. Hirst
Raymond E. Miller
Ashley Pond ill
Paul L. Saffo
Sidney Stringer *
John J. Wolfe
Francis M. Woods

1934
Leona Baumgartner
Frederick Beck
James F. Blades
Joseph Budnitz
Derick A. January
Theodore P. Merrick
Herbert C. Miller
John B. Ogilvie
Lucien M. Pascucci
Harry Sherman
William R. Willard
George Zalkan *
1935
Walter E. Barney
George A Carden, Jr
Edgar S. Childs
Edward F. Falsey
Sawnie R Gaston
H. Hoffman Groskloss
James Quintin Haralambie
W Howard Horner
Mildred Hartshorn January
Samuel D Kushlan
Donald P. Morris
Norman E. Peatfield
Norman P Rindge
Milton Rose *
Clark P Searle
Walter A.L. Thompson
Samuel Zelman
1936
Daniel Bergsma
George Henderson Brown
Lester W. Burket
Albert W. Diddle
Franklin F. Ferguson
Margaret C.L. Gildea
George D. Gross
George A. Hahn
Louise G. Hutchins
Philip M. Le Compte
Donald F. Marshall
Stephen F. Nagyfy
Frederick A Post
Margaret Sommers
Morris Tager
Edgar W. Warren
1937
Edmund R Blower
Guido A. Deblasio
David A. Dolowitz
D. Crosby Greene
Joseph B. Hollinshead
Wilbur D. Johnston
Alfred E. King
Dunham Kirkham
Julia Mehlman
James P Morrill
Charles W. Neuhardt
Morgan Sargent
Edward J. Shaw
Albert D. Spicer
John M. Thomas
Jean Wells
1938
Roy N. Barnett
Agnes Vernon Bartlett
Henry L. Carideo
S. Charles Kasdon
Benjamin E. Lyons
Edward Nichols
Nelson K. Ordway
Charles J. Petrillo
Edward W. Pinkham
James Radcliffe
Arthur S. Reynolds
George E. Roberge
Lester J. Wallman
J. Richard Zahn

1939
Harold H. Coppersmith
Norman L. Cressy
William H Druckemiller
Robert G. Ernst
John P. Ferguson, Jr.
Joseph B Forman
S. Jerome Greenfield
Margaret A. Lennox
Ward J. McFarland
James Peter Murphy
Russell Nahigian
Douglas S. Riggs
Ernest L. Sarason
Bradford Simmons
Rebecca Z. Solomon
Stuart S. Stevenson
John D. Tobin
Arthur S. Tucker
Darrell G. Voorhees
Douglass W. Walker
John H. Wentworth
Malvin F. White
1940
Theodore E. Allen
Joseph V. Baldwin
Ronald S. Beckett
Jack S. Blaisdell
Philip S. Brezina
Thaddeus S. Danowski
Richard E. Dormont
Robert M. Dunlap
James F. Ferguson, Jr
Eugene J. Fitzpatrick, Jr.
Henry D. Humphrey
H. Stuart Irons, Jr.
Donald G. Johnson
Ira D. LeFevre, Jr.
Paul D. MacLean
Edward Martin
William R. Oakes
Maurice Ross
Lee S. Sannella
W. Norman Sears *
Joseph E. Sokal
J. Champneys Taylor
Patricia E. Wanning
John B. Wells
Helen H. Woods
1941
Sophia Chamberlain Alway
Robert H Areson
W. Randal Bell
Knute E Berger
William A. Carey
Joseph P. Carson, Jr.
Charles B. Cheney
Herbert W. Diefendorf
Robert Dine *
Lloyd D. Flint
John Franklin
Frederick P. Glike
Sidney L. Lasell
Bjorn Lih
F. Eugene Martin
Willys M. Monroe
Malcolm C. Murfitt
Edward B O’Connell
Robert W. Ollayos
Gioacchino S. Parrella
David V Pecora
Edwin D. Rogers
Leslie Simmonds
Irving Waltman
1942
Eugene M. de Hostos
William E. Bloomer
James M. Bunce
Walter J. Burdette
Robert E. Carroll
Vincent J Collins
Hendrick DeKruif
Davitt Felder
Elihu Friedmann

Allan V.N. Goodyer
William Harrison, Jr.
Leo Kellerman
John R Lincoln
Patrick S. Mullins
Dean Nichols *
Samuel Ritvo
Lois Knight Rogers
Richmond W. Smith, Jr.
Edgar B. Taft
Maurice Tulin
Irving Norman Wolfson
1943 (March)
Ralph D Alley
John R Brobeck
Lycurgus M. Davey
Donal L. Dunphy
Gerard Fountain
R. Leonard Kemler
Joseph P. Kriss
Jonathan T. Lanman
Douglas Lindsey
J. Philip Loge
Henry E. Markley
Walter J. J. Nero
Dorothea R. Peck
Edward F Rabe
Earl J. Rhoades
Henry A Riedel
Bernard R. Rowen
Marcus E. Sanford
Edward Hersey Soule
Hilliard Spitz
Nicholas M Stahl
Sophie Trent Stevens
Oliver G. Stonington
Robert Lee Taylor
Frederick A. Waldron
John J. Weber
Robert H Wyatt
1943 (December)
Richard N. Abbott
John R Almklov
David G. Borden
S. Brownlee Brinkley
Henry B. Bruyn, Jr
Thomas L. Bucky
Jane B. Cadbury
Philip B. Chase
Hunter H. Comly
Norman I Condit
Thomas D. Cook
Ronald W. Cooke
Jean P. Davis
Joseph I. Epstein
Robert H Furman
Victor C. Hackney
Henry H. Jones
Joseph Kell
Sawyer E. Medbury
Ira A. Rashkoff
Donald W. Seldin
Francis A. Spellman
1944
Carl E. Andrews
Edward J. Conway
George B. Corcoran, Jr
Frank W. Countryman
Charles H. Crothers
Lawrence G. Crowley
John H. Doherty
Robert W. Frelick
Carol Goldenthal
Charles A. Hall
Robert 1 Hinkley
Edith M. Jurka
John Weaver King
Frederick F. Krauskopf
Elias J. Marsh
Katherine Hawley Martin
Joseph Massaro
A. Reese Matteson
Paul E. Molumphy
Lawrence K. Pickett

35

Haynes W. Sheppard
Sarah P. Sherwood
Eugene Smith
Nicholas P R. Spinelli
Priscilla Dienes Taft
Anthony Varjabedian
Calvin W. Woodruff
Rueben Zucker
1945
George Howard Allison
A. John Anlyan
Albert S. Atwood
Frederic M. Blodgett
Richard W Breck
Louise H. Burr
Alice Shepard Cary
Sanford F. Cockerell
Jay B Cohn
Thomas P. Cotter
Edward M. Daniels
Robert S. Easton
Sidney S. Feuerstein
Alice Dershimer Friedman
Raymond A. Gagliardi
James D. Gardam
James R. Mason
Philip S. Good
Gove Hambidge, Jr.
Herbert S. Harned, Jr.
Paul W. Hoffert
O Roger Hollan
Hans R. Huessy
Inland W. Jones
William E. Laupus
Raymond E. Lesser
Mark McD Lindsey
Charles E. McLean
George W. Naumburg, Jr.
Fitzhugh C. Pannill
Richard M Peters
Elliot R Reiner
Charles E. Sherwood
Joseph R. Stanton
Kenneth C. Steele
1946
Margaret J. Albrink
Aaron T. Beck
Franklin C. Behrle
Frederick C. Biehusen
Sanfurd G Bluestein
Linus W. Cave
Thomas J. Coleman
Thomas A. Doe
Edward F. Edinger
Geogory E. Flynn
Martin E Gordon
Charles S. Judd, Jr.
Harold King
Benjamin F. Kitchen, Jr.
Vincent J. Longo
Richard H Mann
Thomas J Mathieu
Hugh J. McLane
John H. Morton
John F. Neville, Jr.
Laura W. Neville
Harry Dickson Patton
Vincent Pepe
Francis Reilly *
David H Riege
Julian A. Sachs
Donald P. Shcdd
Richard G. Sisson
Robert R Wagner
William J Wcdemeycr, Jr.
rhomas J. Whelan, Jr.
Flihu S. Wing
George R Barnes, Jr.
M r \ Blansficld
Albert W. Bostrom, Jr.
William Roy Brcg, Jr.
Rocco A. Calandruccio
John I Cannon
M Richard Carlin

Charles R. Cavanagh, Jr.
Robert A. Chase
Amoz I. Chemoff
William F. Collins, Jr.
Robert P Darrow
Owen W. Doyle
Franklin Harold Epstein
Richard K. Friedlander
Frank H. Horton
Robert J. Kerin
Don F. Kimmerling
Richard P. Levy
Brock Lynch
Victor A. Machcinski
Robert F. Newton
Myron K. Nobil
Lawrence C. Perry
Philip H. Philbin
Edgar B. Phillips II
Olive E. Pitkin
Irving Rudman
Alvin Somberg
Igor Tamm
Patricia B Tudbury
Ellis J. Van Slyck
M Henry Williams, Jr.
1948
Russell J Barrnett
George F. Batten
Allyn G. Bridge
Ruth E. Cortell
G Robert Downie
Elizabeth Fuller Eisner
Boy Frame
Emil Frei III
Julian Frieden
B. Herold Griffith
Sylvia Preston Griffiths
Richard M Hannah
Ross R Harcus
W Rayner Johnson
Paul B Koehler
Patrick J. McLaughlin, Jr.
C. Arden Miller
John P. Morris
John B Morrison
David E Morton
George P. Rostel
Benjamin F. Rush, Jr.
Jerome H Shapiro
William A. Sibley
Jessie Parkinson Spear
Anne G. St. Goar
Paul Talalay
Wallace W. Turner
Paul Woodbury Weld
1949
William G. Anlyan
Henry W. Baird 111
William D. Bevis
Jonathan S. Bishop
Mary Pucci Couchman
Phillip G. Couchman
N Joel Ehrenkranz
Daniel W. Elliott
Albert A. Fisk
Paul S. Goldstein
Eleanora C. Gordon
Frederic W. Gray
Daniel K. Halvorsen
Jackson Harris
Gordon D. Jensen
Timothy F. Nolan, Jr.
Richard D. Otis
Julian I. Pichel
Edmund L. Piper
Charles L. Rennell, Jr.
Daniel Rudman
William H. Sewell
Raymond D. Sudarsky
Mary-Agncs Pratt Wine
1950
Russell N. Anderson
Lyal D. Asay
Sylvia L. Axelrod
Malcolm A. Bagshaw
John E. Borowy
Deceased

William H. Bucher
Alvin Davis
Claude W. Delia
Kent Ellis
Thomas J. Ferraro, Jr.
Daniel Fine
David A. Frucht
Carl A. Gagliardi
Archie J. Golden
Marilyn M. Kritchman
Lucian S. Lapinski
Sidney S. Lee
Janus C. Lindner
Margaret S. Lyman
Harold March
Harry L. McClelland
John H Meyers
Orlando J. Miller
Robert T. Sceery
Cynia B. Shimm
Jane B Shumway
Martin Smith *
Myra D. Tyler
1951
Karel Bedrich Absolon
W Robert Adams
Thomas T. Amatruda, Jr.
Stanley D Ardell
Muriel H Bagshaw
Eleanor Clay Bigley
John J. Egan
Daniel X. Freedman
Sidney S. Furst
Joseph M. Garland
Ralph M. Gofstein
Lowell J. Goodman
John T. Groel
Robert N. Hamburger
John V. Haxo
Carrold K. Iverson
Paul D. Millikin
Walter S. Morgan
Albert R. Mowlem
Richard S. Munford
Charles A. Nugent, Jr.
Gerard B. Odell
Jose Felix Patino
Arthur A. Pava
Majic S. Potsaid
William F. Stephenson
Harold M. Sterling
William Taylor *
1952
John W. Arnold
Frank R. Coughlin. Jr.
Philip Gardner Deane
Raymond S. Duff
James R Durham
Richard D. Floyd
William Joseph Johnson
Thomas S. Kelly
James Kent Luce
Robert F. Owen
Robert G. Petersdorf
Leon A. Phillips
John Macklin Roberts
Leonard Rush
Mary Wheatland Schley
Donald H. Schultz
Robert B. Schultz
Virginia Lee Swanson
John H Wagner, Jr.
Doris L. Wethers
John L. Wolff
Harvey L. Young
Robert Zeppa
1953
Claude Bloch
Harold D. Bornstein, Jr.
William R. Chaffee
Allen Chetrick
Rex B. Conn
Louis R.M. Del Guercio
James P. Dunn
Donnell Dencil Etzwiler
Robert Emanuel Hamlisch
A. Daniel Hauser

George L. Hoffmann
David Purdy Holman
Peter Biggs Hukill
Richard Robert Knowles III
Robert N. Melnick
Harvey Martin Peck
Warwick Potter, Jr.
Paul G. Quie
Jose Ramirez-Rivera
Barbara F. Rosenburg
Irwin K. Rosenburg
Virginia C. Saft
Ora K. Smith
Lynn Cortland Stoker
William Junior Vandervort
William August Wilson
1954
Frank P. Berg
Richard J Bouchard
George N. Bowers, Jr.
Ralph K. Campbell
John R Cole
Arthur C. Crovatto
Donald D Davis
Walter J. Freeman
John A. Gariepy
Edward J. Gerety
Frank L. Gruskay
Nicholas A. Halasz
Walker R Heap. Jr.
Eva H Henriksen
Samuel J. Hunter
Herbert S. Hurwitz
Robert J T Joy
Donald S. Kornfeld
Lowell A. Kristensen
Richard Lamb
Harry C. Miller, Jr.
Paul N. Newfeld
James .1. Nora
Lowell E. Olson
William J. Paule
Anthony V. Piccirillo
Richard D. Pullen
Jacques M. Quen
Edwin R. Ranzenhofer
Earl D Rees
David M. Robinson
John Keith Rose
Elihu M. Schimmel
Leonard M. Silverman
Robert L. Stein
John W. Vosskuhler
1955
John B. Atwater
John C. Bailar III
George E. Becker
E. Edward Bittar
Jerome Bobruff
Douglas G. Boyden
Irwin M, Braverman
Edward Noel Brennan
Padraic Burns
Leo R Cardillo
Nicholas A. Coassin
Edward D. Coppola *
Milton Corn
Pasquale James Costa
Robert G. Crounse
John G. Daley
Fred Wendell Doyle
William O. Edward
Leroy Engel
F. Robert Fekety. Jr.
Mahlon V.R. Freeman
Barbara W. Gibson
Rudolph J. Goerke III
Paul Gonick
Ion Gresser
John H. Hodge
D. Franklin Johnson, Jr.
Harry O. Kendall
David R Kessler
Robert A. Kramer
William E. Lattanzi
Roger Lester
Alexander Maitland III
Joseph S. McGuire, Jr.

Guy M. McKhann
Russell Miller, Jr.
David Joseph Nelligan
Robert C. Nodine
James P. Nolan, Jr.
Sherwin B. Nuland
Gloria C. Onque
John C. Pace, Jr.
Robert H Peters, Jr.
Gregory Peterson, Jr.
F. Brantley Scott, Jr.
Phillip W 'Smith
Alan A. Stone
1956
Levon Z Boyajian
Thomas M. Brown
Rosalie A Burns
Chandler Dawson
S. Evans Downing
Gilbert M. Eisner
Thomas F. Ferris
Armen Charles Haig
John Herd Hart
William H Hindle
Marie-Louise T. Johnson
George T. Kammerer
Jerome O. Klein
William V. Lewit
Leo Lutwak
Preston C. Manning
Dwight F. Miller
Norman F. Moon
Donald J Nalebuff
A. Frederick North, Jr.
David A Page
Stewart E. Purse]
Edward C. Senay
Benjamin A. Shaver, Jr.
Daniel R Silbert
1957
Donald Agostinelli
Joseph S. Amenta
Louis V. Avioli
Jack Norman Blechner
Richard I. Breuer
Harry C. Briggs
Carl A. Brinkman
John P Carey
Albert K. Chun-Hoon
Harold Dick Cross
John D’Agostino. Jr.
Thomas H. Danaher
James R Dorr
Edward Louis Eyerman, Jr.
Harold J. Fallon, Jr.
Robert E. Fishbein
Ronald H. Fishbein
Anthony L. Fons Ill
Elizabeth H. Forsyth
Robert H Glass
Anne H Good
Jack Peter Green
Gilbert F. Hogan
Warren R Johnson
Richard Lee Kahler
Stanley E. Kilty
William L. Kissick
George C. Knovick
Jack Levin
Mark D. Marshall
David E. Martin III
Howard A. Minners
Robert K Modlin
Hugh Lamson Moffet
George Albert Nelson, Jr.
Herbert A. Newman
Thomas Francis O'Brien. Jr
Joseph S. Pagano
Raymond E. Phillips
Clifford B Reifler
Arnold Schoolman
Kenneth A. Simon
Gilbert B Solitare
Robert W. Southworth
Donald C. Stahl
Arthur Taub
William J. Waskowitz
James G. Zimmer

1958
George K. Aghajanian
Don P. Amren
Joseph E. Angelo
John P Arnot
Gerard N. Burrow
David A. Carlson
John A. Carlston
John A. Creatura
Lawrence Dubin
Donald A. Duncan
Joel C. Eberlin
Michael E. Fishman
Peter A. Flynn
Raymond A Gaito
John C. Gallagher
James Greenwald
Charles A. Hall, Jr.
Michael Kashgarian
Jay Ward Kislak
Theodore W. Lieberman
Myron Lotz
Thomas J. Mauro, Jr.
Michael J. McCabe
Andrew Joseph McGowan, Jr.
John A. Merritt, Jr.
David W. O’Keeffe
Carol F. Phillips
David M. Pugh
William B. Radcliffe
Paul A. Rudnick
William W. Schlaepfer
Thomas R. Shea
Edward Lloyd Socolow
Raymond W. Turner
Margaret Smith Wenzel
Joseph P. Wierzbinski III
John Patrick Wood
1959
Scott Ingram Allen
Carol J. Amick
Robert M. Amick
Asa Barnes, Jr.
Francis A. Beer
William C. Butterfield
Edward Call, Jr.
Sidney M. Cohen
Ronald C. De Conti
Gerald Fenichel
Robert L. Fisher
Paul Jay Friedman
Robert J. Gonyea
Gerald B Gordon
W. Keith Hadley
James H Halsey, Jr.
William H Heydorn Me
C. Richard Hinckley
Leonard Inker
John J. Jasaitis
Edvardas Kaminskas
Herbert J. Kaufmann, Jr.
David W. Kingsbury
Myron S. S. Lee
Kathryn Huxtable Lewis
Daniel L. Macken
John C. Marsh
James A. O’Neill, Jr.
Robert H. Ostberg
Nicholas M. Passarelli
Charles A. Phillips
James R. Ralph
David Pardee Reed
Joseph Douglass Robinson, Jr.
Joseph D. Saccio
Marvin L. Schulman
David B. Skinner
Sanford P. Solomon
Lisa A. Steiner
Leo H Von Euler
Muriel D. Wolf
1960
Festus O. Adebonojo
Victor Altshul
Jack D. Barchas
Colin Mercer Bioor
Ormond V. Brody
* Deceased

Donald P. Buebendorf
Stanley M. K. Chung
Gerald N. Cimmino
Jon E. Courtney
Louis A. D’Avanzo
Malm Dollinger
David P. Dunn *
Caldwell B. Esselstyn, Jr.
Warren H. Fisher
Paul Jay Friedman
Alvin E. Friedman-Kien
Eugene C. Gaenslen, Jr.
James I. Gilman
Maxwell E. Gottesman
Sylvia D. Grant
Roland H. Ingram, Jr.
Daniel M. Jones
William S. Kaden
Eric P. Kindwall
Susan T. Kleeman
Thomas P. Kugelman
Edward R. Lang
Thomas Lau
Edward Longo
Robert Marcus
Eugene G. McCarthy, Jr.
Donald L. Miller
Richard G. Morrill
Michael J. Moynihan
Allan W. Newcomb
Buford L. Nichols, Jr.
J. Thomas Okin
Jerrold M. Post
Nancy Rolick Powell
Albert Matthew Ross
Daniel J Rubin
John J. Schrogie
Fred Stargardter
Charles F. Stevens
Robert C. Wallach
May Yung-Fun Woo Wang
Ronald A. Yankee
1961
Kenneth A. Arndt
Earl L. Baker
Frank H. Baker
Albert A. Bechtoldt, Jr
Robert S. Briggs
David William Brook
Paul David Deiter
Ralph J. DePonte
Ronald A. Dierwechter
Jon Dudley Dorman
T. Wayne Downey
John E. Fenn
Norbert Fleisig
Edward C. Gilbert
Louis D. Hunt
Richard L. Keefe
Thomas Kirsch
Robert lssac Levy
Hugh James Lurie
Anoush Miridjanian
Richard Allen Moore
Norman 1. Moss
John Curtis Parker
John Pearce, Jr.
Elaine Pitt
Roy E. Ronke, Jr.
Stanley G. Schade
Robert N. Taub
Hugh C. Thompson 111
Franklin H. Top, Jr.
David E. Weaver
Warren D. Widmann
1962
Michael H. Alderman
Charles B. Anderson
Frederic P. Anderson
Dean E. Burget, Jr.
Fredric K. Cantor
Ray Allen Carlsen
Thomas Newell Chase
Oliver Townsend Dann
Arnold Joel Eisenfeld
I. Bruce Elfenbein
Roderick C. Haff

Patricia C. Hassakis
Victor W. Hurst 111
Walter Watson Karney
Glenn L. Kelly
David E. Knoop
Manual J Lipson
John P. Lynch
Malcolm A. Martin
Allan L. Mattern
Stanley E. Matyszewski
William G. Meffert
George Stuart Miller
William A. Miller
Malcolm S. Mitchell
David D. Nicholas
Joseph Ross
James A. E. Spencer
H. Oliver Stoutland
Seth Thaler
Sherwood Waldron, Jr.
Stewart R. Wright
1963
Arthur Howard Ackerman
Miguel R. Alonso
V. Richard Back
Charles W. Carl, Jr.
Theodore J. Chu
Gordon S. Cohen
John E. Conte, Jr.
David F. Cross
Dudley Seth Danoff
Judith Malm Davis
Andrew Edin
David H. Fram
William T. Friedewald
David H. Fulmer
Alexander R Gaudio
Lee D. Goldberg
Peter B. Gregory
Benjamin Keith Harris
Harold P. Kaplan
Constantine D. Kyropoulos
William B. Lehmann
Craig H. Llewellyn
Edward G. Lund, Jr.
Sally Lockwood Marchesi
Vincent T. Marchesi
Robert H Margulis
Herbert Meltzer
Robert E. Mueller
Sheldon R. Pinnell
Jay M. Pomerantz
Gene R Profant
Lee Bland Talner
Thomas W. Tillack
Peter V. Tishler
Lawrence Tremonti
Peter G. Weiner
Jerome Allen Winer
Alfred J. Wise
1964
Berton W. Ashman
Leland S. Berger
Philip Blume
Anthony J. Bravo
Robert M Briggs
Thomas A. Cardella
Joseph F. J. Curi
Alfonso Esguerra
Norman C. Fost
Peter A. Gross
John F. B, Haney
Gene 1. Higashi
Lawrence Horwitz
William J. Houghton
William E. Knight
Lewis Landsberg
Richard V. Lee
Thomas L. Lentz
James S. Levine
Paul R. Lightfoot, Jr.
Richard Murray Linburg
Andrew E. MacMahon
William F. Matchett
Thomas O. McCann
Robert L. Mitchell
James J. Murphy

Donald A. O'Kieffe
William B Pratt
Stanley J. Rosenberg
Jonathan J. Russ
Richard P. Saik
Stephen A. Schacher
Norman Scher
Robert L. Shelton
Donald G. Skinner
A. Thomas Snoke
Richard C. Stillman
Lyall C. Stilp II
Charles Vogel
Stephen Waltman
Oscar Wand
1965
Susan A. Aoki
John H M. Austin
Paul Balter
Victor J Burner
Thomas B. Caldwell III
David G. Campbell
Dewey A. Christmas, Jr.
Robert M. Cohn
Michael J. Cummings
Phyllis Hurwitz Duvdevani
David S. Fedson
Robert I. Finkel
Frank J. Grady
Gary Lawrence Gross
Robert Andre Gryboski
James K. Gude
Reid R. Heffner, Jr.
David A. Hill
Carl E. Hunt
Robert H. Koehl
Richard J Kozera
David J. Kupfer
David B. Leof
Sandra Chook Levine
Mark W. Lischner
Philip D. Manfredi
Walter W. Noll
A. Lawrence Ossais
John A. Parrish
Robert L. Pickens
Alan N. Rachleff
William A. Renert
George B. Rowland
John H Seashore
Margretta Ann Reed Seashore
Charles J. Semonsky
David M. Shames
David P. Simmons
Robert T. Solis
Alan William Stone
Robert G. Weiner
Bert Yuan-Shu Wong
1966
Benjamin F. Balme
John D. Baxter
Frank C, Bell
Philip Bernstein
James Edward Brown
Eugene Patrick Cassidy
Joseph A, Donadio
Robert E. Dragon
Marvin A. Eisengart
Jared M. Emery
Robert N. Frank
Robert C. George
Peter D. Gibbons
Stanley I. Greenspan
J. McLeod Griffiss
Robert A. Gunn
Stuart T Hauser
Jay G. Hayden
Mary Alice Houghton
Richard J. Howard
Bruce W. Jackson
Gordon R. Kelly
Neal Koss
Stuart M. Kotler
Wilbur L. Kukes
David C. Law
Lynne L. Levitsky
Henry B. Mann

Robert L. McRoberts
John Stephens Melish
Marian Matheke Melish
Harold Mellin
Eli H. Newberger
Neil J. Peterson
William D. Peterson
Joel Singer
James D. Slavin, Jr.
Gary L. Townsend
Lee Van Lenten
Joan T. Wayland
Jon S. Wayland
John W. Wickenden
William B. Yeagley
Arne S. Youngberg
Richard B. Yules
1967
Daniel L Arons
Arthur L. Beaudet
Daniel J. Booser
Gary C. Burget
William T. Cave, Jr.
Marian C. Davidson
James J. Dineen
James M. Dowaliby, Jr.
John A. Drews
Peter R Egbert
Herbert W. Felsenfeld
Melvin Victor Goldblat
Richard J Hart
Richard L. Heppner
Peter N. Herbert
George P Herr
David L. Ingram
Anthony P. Lovell
Stephen W. Miller
William J. Mitchell
Joseph L. Morris
Jennifer Robinson Niebyl
John O. Pastore
William E. Perkins
Brian F. Rigney
Robert I Roy
Jonathan L. Saveli
Alfred Q. Scheuer
Stephen C. Schimpff
Sidney C. Smith, Jr.
Helen L. Smits
Lewis S. Solomon
Robert S. Steinberg
Richard B. Swett
M. David Tilson III
Karen H. Toker
George Tyler
Robert A. Vogel
Joseph F. Walter
Martin Wand
Robert J. Winer
Robert S. K. Young
Ihor George Zachary
Peter M. Zeman
1968
Philip L. Barry
Daniel I. Becker
Grace Jordison Boxer
William Catalona
Donald R. Coustan
Edward M. Druy
Barbara M. Egbert
Alan G. Finesilver
Richard A. Getnick
Mark Gilbert Grand
Leonard Grauer
Ralph S. Greco
Kevin N, Hennessey
John R. Hill, Jr.
Harry S. Holcomb III
Thomas R. Johnson
Jeffrey S. Lee
Frank E. Lucente
Donald O. Lyman
Rodrigo Martinez
HaTmon Michelson
David P. Millett
Richard P Mills
Peter Nicholas, Jr.
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John A Ogden
Margot Onek
Jackson B E. Pickett 111
Charles T. Post, Jr.
Joseph L. Renda
Gordon H. Sasaki
Frederick C. Sherman
Elizabeth M. Short
Howard W. Siegel
Gerald L. Springer
Lee H. Strohl
James L Weiss
Per Henrik Wickstrom
1969
Charles S. Angell
David G. Ansel
David W. Barry
Robert E. Belliveau
N. Roger Cooke
Richard J. Daly
Charles A. Dinarello
Ralph J. Falkenstein
Gary S. Farnham
William H. Frazier
Royal J. Gay
David A. Geer
Sander G. Censer
Robert O Gordon
Steven M Herzberg
Thomas C. Howard
Lee M. Jampol
Joel Mark Kaufman
Paul H. Kelker
John J. Kelly, Jr.
Stephen Krant
Elliot M. Livstone
Robert L. Marier
Arnold F. Mazur
Ellen B Milstone
Thomas F. Minehan
Bruce K. Nagle
Lionel M. Nelson
Nancy Olmsted
Deborah A Putnam
N Burgess Record, Jr.
Joseph D. Robinson
Joseph M Rochford
Dennis J Rudzinski
David J Sahn
Adrian M. Schnall
David J Schulak
Gerald J. Smallberg
Michael S. Toren
Robert J. Walat
Steven C. White
1970
William Romney Burke
Henry Chessin
Michael J. Chusid
C. Norman Coleman
Michael D. Danzig
Jonathan Ecker
Robert Alan Epstein
Bruce A. Fabric
Thomas H. Gouge
Paul C. Hesslcr
Jay H Hoofnagle
Jonathan D. Katz
Gerard T Kennealey
Ely A Kirschncr
William G Koehnc
Mark A Korsten
IJiomas L Lewis
Robert B Litman
Anne W. Lucky
Leonard M Milstone
lames R Missclt
Bruce A Reitz
Robert M Rosa
Joel 1- Rubinstein
Dennis E. Shield
Stuart S. Shorr
Richard A St. Ongc
Ray W l ripp III
Brian Weiss
C Bruce Wenger
Jodlcn Wcrnc
Daniel Wucnsch

1971
Judith L. Bader
Laurie J Bleicher
Willard Cates, Jr.
John L. Cieply
Frederick L. Cohn
Andrew D. Cook
Edward C. Cottle
Michael Cynamon
John S. Ebersole
Leonard 1. Eisenfeld
Harvey Fernbach
Fred Finkelman
Jared J Gardner
Richard Gloor
Michael J. Hart
William W Hay, Jr.
Barbara K Kinder
Michael E. Klein
William L. Krinsky
David H. Lippman
Samuel S. Masters
Wallace J Matthews, Jr.
John C. Mills
Patrick T. Minihan
Steven H Moffic
Richard Albert Moggio
Richard R Neufeld
Martin Paris
John A. Patti
Barry Bruce Perlman
Michael C. Piercey
Anthony V. Proto, Jr.
Barry S. Rand
David M Rinzler
Douglas R. Schmidt
John Smiarowski
James P. Southwick
Jonathan W. Stewart
Daniel R Synkowski
Richard D. Travers
Yvonne E. Vaucher
Paul A. Vignola
Robert B Vranian
Albert Carl Weihl
Daniel G. Wright
1972
Robert D. Arbeit
R Michael Buckley, Jr.
Michael A. Catalano
Leonard H. Cohen
Philip L. Cohen
Gloria Cummings *
Norman M Dinerman
William H. Druckemiller, Jr.
William F. Duke
John W. Foster, Jr.
M Fleix Freshwater
John P. Fulkerson
Dorothy M. Gohdes
Bruce B Haak
Andrew E. Hoover
Thomas L. Horn
Vernon H Humbert, Jr.
Fred Hyde
Anthony H. Jackson
Jesse B Jupiter
Roy A. Kaplan
Donald L. Kent
David L Kneapler
Paul A. Lucky
Harry L. Malech
Jeffrey S. Menkes
Jerome H. Meyer
Jorge A Motta
Thomas H. Ogden
Edward J. Olinger
John N. Posch
William L. Risser
Philip M. Rothfeld
John S. Smolowe
Frederick D. Stockwell
Philip J. Wcyman
Michael W. Yogman
Steven M. Zcldis

1973
David Nelson Bailey
Mary Ann Brunstetter-Shafer
Marvin M. Chassin
Joseph M. Connors
David L. Coulter
Christopher M. Doran
Joseph W Eichenbaum
Jane H Ferguson
Richard J. Fingeroth
Robert A. Florin
Robert E. Galloway
Lee Goldman
Gary T. Grimes
Neal Handel
David C. Johnson
Andrew G. Kadar
Lynne M. Liptay
George Lister, Jr.
Harold R Mancusi-Ungaro, Jr.
Mark G.F. McCormick
David E. Peach
Charles F. Reynolds III
James S. Robertson
Harry S Romanowitz
Jerrold F Rosenbaum
Robert A. Sirota
John R. Stratton
James F. Sullivan
Thomas F. Sweeney
Robert J. Ursano
Christine A. Walsh
Marc A. Weinberg
Richard S K. Young
Randall M. Zusman
1974
Irving M. Asher
Douglas A. Berv
Bruce David Blumberg
Neil Blumberg
Peter J. Buchin
Bert D Collier, Jr.
Paul David
Vincent A. Di Maria
Michael K. Eshelman
Irl L. Extein
Allan B. Friedland
Michael A. Gerber
David Grant
Robert C. Jimerson
Ancil A. Jones
Saul Lande
Edward L. Marut
Richard C. Pasternak
Andrew L Ries
David Z Ritvo
Daniel 1 Rosenthal
Amy S. Schechter
Robert J Schechter
Carol C Teitz
John Jones Thompson
1975
Ralph E Binder
Neil Blumberg
William S Bush
Carl C. Chi
Stanley W Gale
Elizabeth R Gawron
Carol L. Kandall
Richard J. Loewenstein
Bruce B. McLucas
Hyman J Milstein
Mary Jane Minkin
Robert G. Nankin
Andrew B. Newman
Edwin G. Olson
Vivian Reznik
James F. Robertson III
Salvatore V. Romano, Jr.
Fred P. Rosenfelt
Richard L. Roth
Robert S. Sandler
Steven A. Schwartz
George H. Talbot
Mark F. Wheeler
Henry S. Willner
David W. Wiltse
Douglas R. Zusman

1976
Sarah S. Auchincloss
Alfredo L Axtmayer
John C. Bartlett
Peter B Bitterman
Sharon L. Bonney
Roger A Boshes
Randall D. Cebul
John D. Clemens
Geoffrey Etherington
Leonard Firestone
Rose Hannah Goldman
Glenn A. Gorlitsky
Avi J. Hettena
Norman V. Kohn
William J. Lederer
William K. Levy
George W. Luedke
Douglas G Mann
Paul R Ramirez
Mark C. Ruchman
Lawrence E. Samelson
John T. Sladky
Bonita F. Stanton
Peter M. Ting
Frank B Watkins
John C. Wiles
Carol M. Ziminski
1977
John J. Boronow
Stuart Brian Dubin
Sybil E. Duchin
Susan Firestone
James A. Fox
Julia B Frank
Steven R Hahn
Robert W. Hand
Jeffrey Neal Hausfeld
Karen G Kelly
David J Kreis, Jr
Alice Y. Matoba
Margaret S. McKenna
Robert J. Mitchell
Alan S. Penziner
Steven J. Scheinman
Ricky M. Schneider
Simeon A. Schwartz
Mark S. Smith
Gail M. Sullivan
Ronald J. Vender
Steven L. Warsof
John E. Whitcomb
J. Douglas White
1978
Thomas T Amatruda
Richard J. Baron
Booker T Bush, Jr.
Duke E. Cameron
Emily A. Fine
Stuart M Forman
Arthur M. Gershkoff
Nancy E. Good
Linda J Hall
Jerald D Hansing
Robert Hershfield
Robert L. Kraft
Cynthia S. Kretschmar
Kendrick E. Lee
Kenneth L. Marek
Steven M. Shoum
Donald C. Simonson
Caroline R. Taylor
Marcia J. Wade
Jonathan D. Weinberg
Sharon R. Weinstein
David L Wessel
Susan Wong
1979
Nancy Berliner
David A Brenner
Ken Burkus
Orlando Fernandez
Joel I. Franck
John Jay Gargus
David E. Golan
Bruce Halperin

Edward C. Halperin
Jeffrey L. Kaine
Leslie Jay Katz
Michael K. Lindsay
Westley Reeves
Jean Rosenthal
Gary L. Schaer
Eric A. Schwartz
Cynthia Anne Sherman
Jill A. Silverman
John T. Woo
Jeffrey Work
1980
David E. Adelberg
Eduardo Alfonso
Seth Leo Alper
Frederick R Aronson
Alan B Astrow
David Allen August
Jay M. Baraban
Mark S. Bernhardt
Patricia Church Brown
Daryl Fraser Browne
Stuart L. Bursten
Michael M. Chang
Thomas F. Deering
Forrest John Doud
Todd J Garvin
Marc F. Glickstein
David Jay Goldberg
Gary 1. Greenwald
Maria White Greenwald
Barry M. Kacinski
David Kass
Mary C Kornei
Theodore W. Marcy
Cesar R. Molina
Steven Ira Rosenfeld
Alan E. Schlesinger
John A. Selling
Hillel D. Skoff
Marcia R. Taylor
Nancy T. Taylor
Mary Hill Wise
Lawrence H Young
1981
Cynthia B. Aten
Alicia Barela
Susan Burdette
Patricia A Burke
Christine M Duranceau
Louis Essandoh
Paula M. Fracasso
Ramona Q. Fung
Judy E. Garber
Robert S. Goldman
Laurie J. Gordon
Scott A. Hundahl
Barton N. Milestone
Robert M. Milstein
David A. Paly
Barbara A Roach
Sheryl A. Ryan
John C. Wong
1982
Thomas J. Brennan
Muriel Cyrus
Liba E. Goldblum
Jed B Gorlin
Daphne Hsu
Kathleen Anne Nolan
Joyce A O'Shaughnessy
Dan B Odenheimer
Christopher N. Otis
Carrie A Redlich
Paula C. Schlesinger
William M. Sikov
Albert L. Ungricht
Stephanie Wolf-Rosenblui
Charles D. Wright

1983
George Bartzokis
Elena Citkowitz
Nancy Kraemer Crocker
James S. Grober
Ana Maria Lamas
Laurie Margolies
Dan A. Oren
Augusta S. Roth
David E. Schwartz
Michael Silverberg
Daniel M Sosin
Philip M. Spiro
Kenichi Takeshita
Nancy K Terrell
1984
Charles S. Abrams
John F. Babich
Leonard O Bell
Barbara Ann Coda
Jeffrey N. Katz
Michel Kliot
Jay R Kostman
Richard L Leff
Paul B. Rothman
Mark Stein
Andrew L. Sternlicht
Susan P. Tredwell

Contributors to the
Public Health Alumni
Fund 1984-85
1923
Leonard Greenburg
1926
John J. Batchelor
1927
Alice S. Baldwin
1929
Mitchell B Stock
1930
Ruth E. Grout
1932
Leona Baumgartner
1933
Edward B Bosworth
Evelyn H. Halpin
Elizabeth Murphy
1934
Ival A. Merchant
Iwao M. Moriyama
Amy H. Wilson
1935
Franklin M. Foote
Almeda King
1936
M. Allen Pond
1937
Lidie V. Dyer
William R. Willard
1938
Willard H. Boynton
Richard K.C. Lee
Katharine Hawley Martin
1939
Carl I. Cohen
James C. Hart
Frances S. Miller
1940
Elizabeth H. Pitney
Meyer J. Plishner
Ruth G. Taylor
1941
Roslyn L. MacNish
A. Helen Martikainen
Marion Redmond
Alexander Witkow

1942
Henry F. Canby
Leonard Parente
Arthur B Robins
Charles D. Spangler
1943
Julius Elston
Carolyn S. Koffler
Eric W Mood
Miriam H Rohde
Jane L. White
1944
Massimo Calabresi
Jean F. Heston
Jane Y. Parker
1945
Roslyn R Bilford
Mary B. Dale
Naomi Barer Golden
Joe B. Graber
Lois M. Jund
Naomi Helen Kalajan
1946
Dorothy B. Hamilton
Dorothy Y. Kirk
D Patricia Nelson
1947
Sidney S. Chipman
Anne E. Fulton
Lillian L. Konick
Raymond W. Leonard
JoAnn S. Lewis
Rosa Frances Montgomery
Jean M. Pinder
Samuel Zibit
1948
Chester S. Bowers
John B. Dibeler
Mary L. Ellis
Mary Margaret Fitzgerald
Samuel S. Herman
Richard E Johnson
Beatrice H. Kaasch
Dorothea S. LaBelle
Hiram Sibley
1949
Eleanor C. Connolly
M. Otis Flanary
Edgar L. Geibel
Eleanor P. Kostant
Hilda H. Kroeger
Christine R. Owre
William B. Parsons
Elizabeth D Robinton
1950
Wyntha T. Boothe
Henry G Brickman
Ida M Bucher
Helen P. Cleary
Austin J. Evans
Jerome M. Glassman
Dorothy R Granoff
Eugene K. Harris
Martha P. Jayne
Everette D Reese
Frances K. Reynolds
Nathan M. Simon
John D. Thompson
1951
Joseph Axelrod
Clarissa E. Boyd
Norton G. Chaucer
Homer P. Hopkins, Jr.
Robert L. Johnson
George Kraus
Leonard F. Menczer
Elizabeth Ulrich Throm
Virginia E. Torres
Alexander J. Tutles
Walter Wenkert

1952
Cahil H. Corbacioglu
Mary M. Del Piero
Howard Dunphy
Malcolm C. Hope
Charles Holway Lawrence
Sidney S. Lee
Helen Kardys Loria
Yolande F. Lyon
Anne Barlow Ramsay
Brena B. Wolff

1961
Gordon R Beem
Mary S Blackburn
Benjamin L. Capili
Alfred E. Fletcher
Helen M. O’Connell
Margaret R. Parker
Joseph T. Prekup
Angela M Russo
William R. Slivka
Harold W. Wicks

1953
Jeanette Averill
Harold Robert Bernshock
Graydon Dorsch
William H Hermann
Barbara J. Lee
Laurence K Rainsford
Milton H Sisselman
Constance B. Thomas
Donald N. Zehl

1962
A. Kay Keiser
Thomas R Mayhugh

1954
Donald R Cowan
Alvin Hamburg
1955
Constance T. Beemer
Lester M Borstein
Charline S. Buck
Amy L. Cawley
Israel Gitlitz
Morris London
Mary Me C. Mogan
Frances R. Ogasawara
Ann Peverley
Gerald Rosenblatt
Daniel E. Ross
1956
David D Boyd
Kathleen H. Howe
Paul C. Kaufman
Mary K. Ochiai
Floyd D Parrish
Alice M. Wagner
1957
Anne Anzola
Janet Beach
Lee De Cady, Jr.
William A. Clermont
Edward R. DeLouise
Sheldon Selig King
Edna May Klutas
William R. Metzger
Jerome R. Sapolsky
Shirley T. Steidel
Paul W. Sternlof
Patricia A. Viscosi
1958
Josephine Blanchett
Helen H Davenport
Thomas T. Flynn
Normand E. Girard
Edward H. Noroian
Joseph A. Scorpion
Mary K. Spiker
Thomas P. Weil
1959
Joshua I. Cohen
Raymond S. Duff
Bennett I Enowitch
John T. Foster
Marvin A. Lavenhar
Hugh J. Maher
Feme G. Moore
Lee J. Podolin
John S. Pullman
Ellwyn D Spiker
Mattie Lee D. Wade
Dorothy M. Wilson
1960
Kathryn L. D’Amico
Wouter Ekker
Maxine Geeslin
Rose A. lannotta
Hannah Clark Russell
Else Niebuhr Schulze

1963
Dorothy Weichert Brockway
Hantp Coley
Raul R. Cuadrado
David Dolins
Frank M. Isbell
Edward M Kenney
Jean M. Maynard
David R. Sheehan
Samuel B Webb, Jr.
1964
Maria S. Baisier
Elizabeth C. Beilis
James J. Culhane
Katherine Maria Detre
Linda F. George
Neal L. Maslan
Theodore Rosenberg
Estelle Siker
Monroe W. Spero
Claudewell Sidney Thomas
1965
Robert M. Edwards
Edgar W Francisco, III
Monte Nelson Frazier
H. Patterson Harris, Jr
William C. Harvey
James F. Jekel
Michael E. Kove
Peter J Levin
Elliot A. Segal
Wallace W. Smith
Viola J. Spinelh
Matagiese G. Tunoa
Sarah I.. Turner
David S Weiner
1966
Allen Cohen
Amalia P Crago
Diana B Fischer
Norman M Gervais
Jennifer L. Kelsey
Nancy Alfred Persily
1967
Carlos E. Alvarez Herrera
Peter T. Elliot-Wotton
Caroline Fong-Cheng
Richard W. Gerry
Ann Gomez
Alberta S. Jacoby
Steven Jonas
Joel Kavet
Lawrence J. Krone
Joseph F. Kukla
Dennis J. Magid
Patricia D Mail
James M. Malloy
Brigitte Prusoff
Beth M. Whelan
Irma Willner
Robert L. Woodward

1968
Doris Storms Brenner
Philip D. Cobb
Sonia M. Colon
Joseph L. Dorsey
Robert R. Everett
L. Carol Fernow
Carl R Fischer
Michael J. Geaney
Francis J. Greaney, Jr.
Harold C. Lovely
Jean C. MacCorison
John M Patton
Richard L. Petrelli
Bobby G. Rowe
Arnold R. Saslow
Elizabeth A. Small
Martha F. Steel
Sheila W. Wellington
Elizabeth C. Wright
1969
Susan S. Addiss
Jean Parker Cobb
Victor Crown
James M Dawson, Jr.
Sharon A. Garcia
Gerald R Harpel
Sylvia N. Holtzberg
Charles C. Jeffrey
Samuel P. Korper
Judith B. Nichipor
Samuel D Rowley
Marva Serotkin
Wanda Vierthaler
Robert L. Young
Chester W. Zarnoch, Jr.
1970
Susan W Balter
Robert T. Beeman
Arthur A. Berarducci
Michael B. Bracken
Hamilton B Brown, Jr.
Shan Cretin
Walter M. Gawlak
Robert S. Gureasko
C.P.Noel McCarthy
Anthony M. Orlando
Nancy Norton Reitz
Charlotte F. Schwartz
Stephen Skorcz
Donald S. Wilkinson
Joseph A. Zaccagnino
1971
Evarists Berzins
John Bihldorff
Evelyn J Bromet
William F. Carey, Jr.
Willard Cates, Jr.
Katrina H Clark
John A. Daeley
Harvey Fernback
William P. Ferretti
Anne-Marie A. Foltz
Sara P. Hartman
Wanda J. Hatmaker
William P. Koughan
Bernard G Koval
Mark J. Magenheim
Eugene S. Mayer
Joseph S. McManus
Nancy P. Mogielnicki
Wan Hin Ooi
David A. Osgood
Caro] L. Paul
Marcia Russell
Jane Silver
Walter O. Spitzer
Robert E. Steele
Barbara R. Stoloff
Claudia J. Svara
Judith Whitcomb
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1972
David P. Barone
Steven H. Beloff
Catherine A. Connolly
Thomas F. Frist
Daphne Dej Gemmill
Jean T. Harrison
Dorothy N. Lewis
Gerald Miller
Sergio Ruschel
Jo Ann K. Silverstein
Laurence A. Tanner
Frederick A. Vago
Joyce R. Waksman
Owen L. Wood
1973
Emily M. Barclay
Karen D. Brabill
Eva Danielsson Cohen
Bernice E. Coleman
Marie L. Dargan
Ellen B Dolt
Schula Russell Hobbs
Chang S. Lao
Dennis P May
Marjorie E. Nelson
Gary Dean Sax
Janet B. Schoenberg
Alice S. Stark
Thomas J. Stranova
Irene Trowell-Harris
Larry S. Webber
Bonnie C. Yankaskas
Carl J. Zack
1974
1 Willard Abrahams
Rose Salisbury Beer
Gregory Belok
Thomas A. Benoit
Olga M. Brown
Carl A Cappello
J Breckenridge Eagle
Elizabeth M. Helming
Roberta Lawerence
Karen K Lindfors
Nancy F Meneelv
Nils R Richardson
Deborah Rose
Carole T. Schreiber
Shelly S. Shanok
Donald R Showalter
Abigail L. Smith
J Lawrence Tanenbaum
Myrna M. Weissman
Bienvenido G. Yangco
1975
Clayton A. Ajello
Edith N Baum
Ralph E Binder
Gerald F. Bisbee, Jr.
Linda K Broker
Hillary Demby
Linda K. Demlo
William J. Grego, Jr.
Anne H Hall
Edward J. Halloran
Kenneth G Hill
Elizabeth T. Hunter
Rosemary M. Johnson
Barbara R. Untcrman Jones
Susan M Kaetz
Philip D Kennedy
James E Knoben
Kathy S Kohn
Patrick W Uskey
Stuart 1 Lcfkowich
Sheldon M. Levy
l ots S. Michaels
I ilccn M O'Gara
Mary W. Palshaw
William P. Quinn
I dward V Sargent
Nancy F Stroup
R i . in d ' hiu-Ping fang

Franziska U. Ulrich
Vera B. Walline
Audrey S. Weiner
Marion Lee Wu
1976
Peter B. Aaronson
William F. Appicelli
Agueda N. Deans
Joanna M Erikson
Paul H. Etkind
Robert H. Frazier
Gail lies Genvert
Linda J. Goodhart
Karen A. Gordon
Raymond E. Grier
Janet Heinrich
Robert T. Kauer
Robert A. Knauf
Janina Levy
Robert C. Marquardt
Lawrence V Meagher, Jr.
Gino A. Nalli
Ruth Fitch Quah
James B Rokos
Robert Risdon Schwarz
Mary Jo Shepard
Robert Silten
Marcia A Testa
Gladys A. Williams
Thomas S. Wingardner, Jr.
1977
Richard B Burford, Jr.
Patrick F. Carone
Jeffrey Allen Cassis
Dennis K. Dang
Annette T. Eichenbaum
Gerard J Foley
Barbara L. Gervis
Henry C. Gift
Ellen D. Jaslow
Rhona Kantor Kershnar
Teri J Klein
Ronald F. LaPensee
Wendy K. Lefkowich
Polly W, Marvin
Sharon A Mulgrew
James M O'Connor
Kristin K. O'Connor
Harris Pastides
Linda Mendelsohn Pottern
Dorothy A. Rice
William T. Richards
Lynne E. Rosenwald
Abby Rothschild
Anthony V. Sardinas
Carroll Schilling
Gail M. Sullivan
Rose M. Truax
Thomas H. Ulfelder
Leon F. Vinci
1978
David S. Abernethy
Vijaya V. Bapat
Kathleen M Berman
William Harvey Blitz
Alan B Bloch
Maura Carley
Robert J Fensterheim
Robert H. Frazier
Ann T. Freedman
Janice F. Gold
James Gonzalez
Cynthia R. Gross
Patricia S. Harfst
Nancy G. Hildreth
Stephen W Hildreth
David W. Houck
William A. Howard
Margaret Long Karis
Roslyn I. Liss
Christopher M Maylhan
Marguerite Nelligan
Michael H. Owens
Trudec Parentcau
Ellen J. ReiOcr

Irene Schapiro
Michelle D. Schoenberger
Robert E. Schwartz
Roberta Jo Shapiro
Gloria Shappy-Meickle
Karen Wolchuck Sher
Roberta Nancy Silbert
Alan J. Siniscalchi
Martyn R. Smith
Marie Stoeckel
Sydney S. Tang
Rolando Antonio Thorne
R Bradford Walker
Lucy Ellen Weiger
1979
Bruce S Anderson
Virginia P. Bainbridge
Gertrud S Berkowitz.
Marianne Berwick
Marna P Borgstrom
Russell J. Bramlage
Elizabeth S. Carter
Ralph J. Coburn
Terry Edelstein
Nurit Erger
Lynn Fielden-Smith
Kathe P. Fox
Judith B Gancher
Lucinda H Gerson
Debra Haffner
Bruce H Heckman
Shelley Helfer-Amira
Karen Kmetzo
Benjamin Krevsky
Renee S. Leary
Mary Elizabeth Lorenzi
Osvaldo Marrero
Laure C. Nichols
Betty J Reid
Marcia C. Richardson
George B Rowland
Ralph Tartaglione, Jr.
Elizabeth Tedder
Mary Jane A. Teta
llene B Wachs
Louise Wise
1980
Gary J Aboff
Frederick R Aronson
Curtis S. Breslin
Antoinette M Brooke
Richard L Buck
Gary L. Busack
Deborah J. Carr
Sheila Conneen
Diane L. Denis
Audrey L. Fetter
Beth M. Finkelstein
Barbara H. Granger
Susan Greenberg
Ellen B Greif
Samuel S. Hamilton
James P Harisiades
Virginia S. Humphrey
Helen E Kelly
Yee-Lean Lee
Robert V. Levine
Kathleen A. Lewis
Paul A. Locke
Leroy F. Ludwig
James S. Marks
Linda L. Moraga
Anne E. Morrison
Steven Morrow
Ann L. Prestipino
Christina P. Quinn
Jeri Ann Rose
Susan L. Schwartz
Lydia A. Selling
Jane T. Siegal
Marsha L. Silverman
Judith Stavisky
Richard Gerard Stracqualursi
Thomas A. Tobin
Tal Ben-Dashan Widdes
Philip A. Witman
Marie L. Zanotti

1981
Jean Adnopoz
Patricia J. Checko
Rollin C. Chew
Ann M. Dunbar
Julia Eisenstein
Brian J. Foley
Kristen H. Forrest
Robert Fox
Judy E. Garber
Barbara A Gaugler
Marie F. Gavula
Louis M. Gonzalez
Joan Urauhart Goodman
Susan A Hart
Susan E. Jennings
Thomas J. Krause
Jill L. Lapides
Katherine M. McCormack
Blackford Middleton
Marlee D. Mooney
Charles W. Nelson
Mary E. Papke
Maureen T. Power
Elizabeth N. Shapiro
Karin Swanson
Nancy Schlesinger Weiss
1982
Jamie L. Amaral
Jenny I. Andrus
Francis L. Crowley
James L Hadler
Denise Heinemann
Constance M. Jarowey
Charles A. Klivans
Linda F. Me Caig
William F. McKeon
David L Mork
Jill A. Okrent
Carolyn Xavier Orcutt
Marie Zullo Rice
Sally R Rinaldi
Christopher J. Rogers
Dale Allan Rublee
Lisa E. Stone
Yukiko Tomabechi
Michele T. Visconti
Sandra Michaelson Warren
Daniel Wartenberg
Alvin C. White
Amy B Wilson
1983
Gail Alexander
Patricia Charnas
Eileen Conlon
Mark L. Dembert
Robert A Duncan
Susan Faris
James N. Gaito
Ellen M. Ginzler
Daniel A. Graybill
Cindy Lou Jajich
Nancy R. Kellett
Allen F. Levy
Wendy L. McGill
Beverly Y. Nipper
Jeannee M Parker
Barbra G. Rabson
William Sabella
Marilyn F. Vine
Nancy K. Wright
1984
Leslie A. Balch
Linda Balzano
V. Deborah C. Carroll
Carolyn H. Grantham-Millman
Penny H Hausser
Cynthia A. Hymes
Jean G. Larson
John S. LaBella
Theresa Marie O'Connor
Julie A. Russem
Gerald L. Springer
Carey Vames

Contributors to the
Public Health Alumni
Fund 1984-85
Friends
Thomas H.G. Aitken
Edward M. Cohart
Wilbur G. Downs
Adolf Pharo Gagge
Edward M. Opton

Contributors to the
Medical School Alumni
Fund 1984-85
Former House Staff
Robert A. Achtel
Frederick W. Ackroyd
N. Erick Albert
John L. Albrigo
Neil S. Alex
Adel H. Ayoub
Robert G. Bachand
Ronald J. Bailey
David B Baldwin
Carl Bennett Bean
Robert Berger
Gregory Kent Bergey
Larry Berte
Kenneth R. Berv
Mary C. Bibro
Ralph Daniel Bien
Robert M Black
William K. Boss
Laurence A. Boxer
Alan L. Breed
Steven A. Brody
Marvin B Brooks
Thomas N. Byrne
Dennis J. Card
Victor Carpiniello
J. Richard Casuccio
Joseph B. Chandler
Whei C. Chang
Richard Allen Chase
Chang Song Choi
Michael Chun
David L. Copen
Robert E. Crootof
Jeffrey P. Cullen
F. Mitchell Cummins
Harvey Davis
Richard K. Donabedian
William R. Drucker
Tom W. Duke
Marlene R. Eckstein
Stephen A. Edelstein
Daniel S. Egbert
David E Eibling
Lawrence B Eisenberg
Malcolm Mitchell Ellison
Walter Ettinger
Alvan R. Feinstein
Richard Webster Finner
Daniel J. Friedenson
Gary E. Friedlaender
Norman H Gahm
Henry B Garrison
David M. Gershenson
V. Philip Glassman
Barry Goldberg
Nelson H Goldberg
Isaac Goodrich
Paul Ned Graffagnino
Willard F. Greenwald
Robert J. Gross
Gordon W. Grundy
Joseph Guaraldo
William R Haas
Hedda Ann Litowitz Haning
Stanley Hersh
Douglas P. Hobson
Melvin Horwitz
David Smith Hubbell

Eric A Hyson
Robert Orville Jensen
Rollin M. Johnson
Robert M. Johnston
Wayne Julian
Norman Kaplan
Jill P. Karpel
Michael W. Keith
David J. Keller
Stephen King
Samuel C. Klagsbrun
Lawrence E. Klein
Thomas J. Koontz
Eugene Kuchner
Joel C. Labow
Sheri J. Lagin
Emmanuel Landau
Joan L. Lasser
John T. Latham
Douglas M. Levin
Stanley B. Levine
Peter G. Levinson
Arthur L. Levy
John D. Lewis
John A. Libertir.o
John Loeffler
Phillip Luchini
Steven Macht
Mark Maltzer
Edward J. Manwell
Stephen Mariani
Frank Masino
Richard J. Maunder
Pamela M. McBogg
John P. McGovern
Thalia Mesologites
Patrick E. Moriarty
Hans C. Muechler
Seymour Cy Nash
Richard A. Norton
Joseph Manuel Ortiz
Raymond L. Osborne
Robert L. Paltzik
Elaine Beguin Panitz
Pradip M. Pathare
Gordon K. Phillips
Edward L. Racek
Donald C. Rankin
Gilbert A. Ratcliff
Ranjit Rath
Stephen Rawe
Thomas Rock
Claude Roge
Mark Rubenstein
Julia Sabetta
Michael Saruk
Ronald Scarpinato
Susan Lynn Schley
Robert Schnurr
James Thomas Sehn
Richard Alan Selzer
Thomas E. Shaffer
Daniel W. Shapiro
Ezra A. Sharp
Joel Silidker
Frederic N. Silverman
Ethan A H. Sims
Richard I. Staiman
Sally K. Stansfield
John G. Steciw
Sturla Stefansson
Elsa L. Stone
Fred Leslie Strieker
Craig Summers
Herbert Tabor
Imad F. Tabry
Theodore Tyberg
Daniel W. VanHeeckeren
Douglas Viets
Romulo L. Villar
Milton Virshup
E. Maurice Wakeman
Thomas A. Warthin
Alan Weinberg
Ssu I. Weng
Herbert Allan Wenner
George Wharton

Robert R. White
Robert J. Williamson
Suna Woods
Eiji Yanagisawa
Michael Yaros
Robert P. Yoo
Robert C. Young
Andrew Zaruski
Richard Walter Zimmerman
Lawrence H. Zingesser
Louis Zinterhofer

The help of medical school alumni is
crucial to enhance teaching and research.
But it is also essential for another reason
and that is to maintain what l call the
freedom to educate as we at Yale think
best. We face the all too real possibility
that our autonomy to teach the students
we select, to hire the faculty we wish, to
engage in the research we design, to
practice medicine when, where, and how
it must be practiced will gradually
deteriorate without adequate resources.
“Essentially and ultimately, our
autonomy is at stake. Universities have as
their challenge for the next generation
the definition and defense of their lawful
independence as institutions. We must
preserve this spiritual and intellectual
independence because it promotes
teaching, learning, research, and because
it protects minority opinion, dissent, and
criticism as well as all those other values
we share as a whole with the country at
its very best.
“And that is why unrestricted
endowment is so important. There are no
funds more vital for preserving the
intangible, essential value of the medical
school, that freedom of choice so
necessary to a great academic
institution. ”

*
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Carl Hirshfield
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Carolyn Leehy
Boris Kliot
Joseph Litchman
Shizuo Matsui
Pedro Miro
Mr. & Mrs. Lewis Nankin
Mr. & Mrs. Victor M. Newman
William G. O’Donnell
Mary M. Olson
Dr Gideon A. Oren
Dr. Richard D. Otis
Dr. & Mrs. Levi V. Perry
Patricia H. Powell
R Donald Reich
Barry D. Reznik
Yolanda Rivero
Joel G. Roth
Dr. & Mrs. Carl E. Rothschild
Mr. & Mrs. Jack Saltz
Harold & Frances Sampson
Joseph Schlesinger
Mohan N. Shrestha
Melvin L. Schwartz
Arthur A. Shachner
Mr. & Mrs. Philip Soskis
Mrs. Leo Teitz
Thomas M. Tierney
Mrs. Albina K. Vazquez
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Tony Y. Wong
Paul M. Zabetakis
* Deceased

President A. Bartlett Giamatti
in his address to Yale medical alumni, June 8, 1985
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LAW
& MEDICINE
IN CONFRONTATION

a deans dialogue
’

Deans Leon E. Rosenberg of the School of Medicine and
Guido Calabresi of the Law School spoke to standing room
only audiences as they discussed such medicolegal issues as
malpractice law, bioethics and third party payors in a twopart series billed as “A Deans’ Dialogue: Law and Medicine
in Confrontation.” On December 2, Dean Rosenberg ad¬
dressed medical and law students and faculty in the Law
School Auditorium; and on the following Monday, Dean
Calabresi spoke before a similar audience in the medical
school’s Harkness Auditorium. Each dean responded to the
other’s remarks following the talks.
Dean Rosenberg set the tone of the dialogue when he
expressed deep concern about the future of the medical
profession, predicated on the “pervasive, unwelcome,
crushing embrace of medicine by law.
“Every participant in the health care system
doctors,
nurses, hospital administrators, paramedical personnel - is
beset by an onslaught of new laws and regulations affecting
every phase of medicine - from care of the critically ill
newborn to that of the terminally ill aged; from the decision
to terminate a pregnancy to that concerned with termination
of life-support systems; from criteria for hospital admission
to those involved with Medicare reimbursement; from ‘Baby
Doe’ regulations to ‘squeal’ laws,” he said.
“And worst of all, because it is the most personal,
physicians are forced to live with the spector of malpractice
litigation constantly in their minds’ eye. This legal assault
has occurred so swif tly and has been implemented so harshly
that it has begun to erase some of the very attractions long
associated with pursuing a medical career
autonomy.

independence, approbation, inquiry,” Dean Rosenberg
added.
“The issue, in my view, is not whether law has a legitimate
claim to a greater scrutiny of and control over medicine, for
clearly it does. Rather, the question is whether the legal
means being used to control medicine and the conduct of
some of the lawyers implementing the laws are moving our
society in a direction such that the largest number of people
have available the highest quality health care,” he said.
“Sadly, my answer to this question is ‘NO’ ”,
Dean Rosenberg cited two examples to support this
response. The first had to do with attempts to decrease the
enormous cost of hospitalizing patients, such as the Diagnostic Related Group system of hospital reimbursement and
other strategies which are aimed at keeping people out of the
hospital who don’t need to be there, such as the recently
implemented program of the federal Healthcare Financing
Administration (HCFA) which manages Medicare regula¬
tions.
This program mandates that all Medicare patients sched¬
uled for elective surgery or emergency admission to any
hospital in Connecticut will be required to have pre¬
admission screening and certification from the state’s HCFA
delegate - the Connecticut Peer Review Organization
(CPRO). If the admitting physician fails to comply, either
by not seeking certification or by admitting the patient
despite denial of the request for certification by the CPRO,
neither theTiospital nor the physician will receive reimburse¬
ment from Medicare. Private insurance carriers, according
to the dean, are establishing similar pre-admissioin approval

T. Charles Erickson

Dean Rosenberg

systems with perhaps even tighter controls.
“The message is clear,” he said. “In the name of cost
containment, it has been determined that the judgement of
CPRO or insurance company personnel based on no patient
contact is superior to that of the physician caring for the
patient . . . This is health care by a bureaucracy out of
contact with the patient and out of touch with the physician.
It tends to mock the age-old ethical precepts that each
patient is unique, that the physician’s first obligation is to his
or her patient, and that clinical skill, knowledge and
judgement are gained by experience. How can the many
subtle determinants leading to the decision to hospitalize an
elderly person be reduced to the simplicity of ‘yes/no’
certification by telephone? Who will be held culpable if a
patient deemed uncertifiable for admission dies at home for
want of hospital attention? When does the life of one person
count for more than the dollars of many?” he asked.
1 he other issue is medical malpractice litigation — an
incendiary topic that is front page news.
“Professional rivalry between physicians and lawyers is
understandable, perhaps inevitable. The hostility, misunder¬
standing, and antagonism which now characterize the
dialogue between members of the two disciplines in the area
of malpractice, however, has reached unacceptable pro¬
portions. It poses a threat to the two warring professions
who may soon hear from the public something like ‘a pox on
both your houses.’ More importantly, it places at risk the
very quality of health care physicians are committed to
provide and lawyers are bound to protect. If, for example, a
ignilicant fraction of obstetricians stop delivering babies
i \ »ung M.D.’s follow suit by going into other less
ion-liable specialties, then one day maternal and
ml.mt mortality rates will begin to climb. Clearly, wisdom
dictates changing course before such dire consequences

occur,” advised Dean Rosenberg.
To underscore the magnitude of the malpractice crisis.
Dean Rosenberg cited a few statistics including that fact that
in 1983, one of every five practicing physicians in the United
States was sued for malpractice with a total of 42,000
malpractice claims lodged in that one year; for all physicians,
premiums for malpractice insurance increased by 238 percent
between 1975 and 1984 and in that same interval, mean
physician income increased by 92 percent; in 1975, the
average malpractice judgement was $95,000 and in 1984, it
was $338,000, and in 1984, the national cost for the practice
of “defensive medicine” was estimated at $15 billion.
The legal definition of medical malpractice is straightfor¬
ward and originated under the law of torts, noted Dean
Rosenberg. According to the law, once a physician-patient
relationship has been established, the physician is obligated
to diagnose and treat that patient with “due care”. Failure to
do so constitutes negligence for which the injured patient
may sue and recover monetary damages.
“It is this claim of negligence which lies at the heart of the
medical malpractice problem,” he contended. “All physicians
know that medicine is an imperfect science, that maloccurrences take place, and that some maloccurrences result from
negligence and incompetence.”

“The issue, in my view, is not whether law has a
legitimate claim to a greater scrutiny of and
control over medicine, for clearly it does.
Rather, the question is whether the legal means
being used to control medicine and the conduct
of some of the lawyers implementing the laws
are moving our society in a direction such that
the largest number of people have available the
highest quality of health care. ”
Dean Rosenberg

As to why the issue of medical malpractice is so explosive.
Dean Rosenberg maintains this is largely a function ot the
vast ignorance of physicians about law, and the equally
cavernous ignorance of lawyers about medicine. “II physi¬
cians understood that the law doesn’t believe in absolute
truth but rather employs an adversary system to resolve
conflicts by coming as close to the truth as possible, they
might not see a claim of professional negligence as such a
mortal threat to their self esteem.
“If lawyers understood that medicine has no adversary
other than illness, injury, or death and that the practice ol
medicine depends on the willingness of patients to believe in
their physician’s expertise, they might understand why a
charge of professional negligence tends to undermine the
very authority and trust so crucial to the doctor-patient

relationship,” he said. “Because the vast majority of law
students are not required to take a course in ‘biomedical law’
and most medical students learn little if any ‘legal medicine’,
both groups are socialized into their respective professions
without any positive endorsement of the other. Thus, the
bright, aggressive, ambitious people who become our doctors
and lawyers substitute professional chauvinism for mutual
understanding and learn only too well how to use words like
‘shyster’, ‘quack’, ‘ambulance chaser’ or ‘butcher’.

“ . . This legal assault has occurred so swiftly
and has been implemented so harshly that it has

begun to erase some of the very attractions long
associated with pursuing a medical career —
autonomy, independence, approbation, inquiry. ”
— Dean Rosenberg

“Can it surprise us then, that when members of these two
professions, who have had so little contact with each other
during their formative years, confront each other in the
charged, complex and visible cauldron of medical malprac¬
tice litigation, that physicians scream that our society must
do something to keep rapacious lawyers from destroying
our system of health care, and lawyers yell back that society
must do something to keep incompetent doctors from
killing and maiming people?”
Since what we as a society are doing about medical
malpractice obviously isn’t working, we must do something
else, according to the medical school dean. First and
foremost, we must begin to educate the public to the fact
that medical care can sometimes be “hazardous to your
health” and that “physicians cannot always solve patients’
problems and may even make them worse; that there are
inherent contradictions in the demands for medical care of
high quality and equally affordable cost; and that this
country has among the best health care systems in the world
because the great majority of its practicing physicians are
well trained, skillful and caring.”
Lawyers, he said, must learn that there is a real and critical
difference between maloccurrence and malpractice; that
physicians speak truthfully when they say that being sued
for malpractice is among the most devastating and disfiguring
catastrophies that can happen to them, and that demanding
a standard of professional responsibility from physicians
more rigorous than that expected for themselves is the
ultimate hypocrisy.
In turn, the dean said that physicians must learn that the
venerable contract between doctor and patient must be
rewritten so that the physician is viewed as a partner in the
transaction rather than as an infallible, unchallengable
authority, and that “failure to discipline and weed out
incompetent or impaired physicians has so eroded the
public’s confidence that they, the patients, not we, the
doctors, are the primary focus of our ethical concerns; and
that the single most effective safeguard against malpractice
suits is the bond established between doctor and patient
through informed consent and thoughtful communication.”
This educational agenda is long and challenging. It will be
achieved only if it is addressed in the classrooms of our

medical and law schools, in the workrooms of our news
media, in the board rooms of our insurance companies, and
in the living room of our citizens. While all this is going on, 1
believe we must modify — perhaps even overhaul
the
legal system which adjudicates professional liability claims...
“Broader reform measures, aimed at lawyers and physi¬
cians, must be considered to put some limit on damages for
pain and suffering, to subject contingency fees to a sliding
scale by which the attorney for the plaintiff’s fraction of
monetary damages falls as the size of the judgement rises; to
require periodic rather than lump sum payments for large
awards; to mandate risk-management programs for physi¬
cians and hospitals; to insist that insurance companies make
data concerning malpractice awards available to state
agencies responsible for discipling physicians, and to fund
expanded state disciplinary agencies by increasing fees for
licensure from physicians and allocating the additional
revenue to the disciplinary authority. Such reforms will not
do away with medical injury, negligence or incompetence.
They will, however, demonstrate to physicians and lawyers
alike that the threat to the public’s health posed by the
current malpractice litigation nightmare must be contained
until something better comes along,” predicted the dean.
The way out of the malpractice dilemma, he contends, is
through educating the public as well as physicians and
lawyers, and by modifying the legal system which adjudicates
professional liability claims. A possible solution, he sug¬
gested, would be a “no-fault”-based national compensation
system for medical injury along the general lines of work¬
men's compensation or automobile accident liability.
In conclusion he said, “The constraints, contradictions,
and contumely currently being heaped on physicians are not
justified by any errors physicians have committed in meeting
their professional and social responsibilities. The medical
profession must be given back a central role in the develop¬
ment of national health care strategies because it is among
the few groups with the expertise to help make some of the
difficult choices which lie ahead. The public, through the
law, and lawyers, through their professional behavior, must
show restraint in the demands they make of Medicine
because, in the final analysis, the public stands to lose the
most if the profession of Medicine is diminished and, by
being diminished, attracts to its ranks a less capable and
dedicated breed of physician. Surely, that is not the way to
ensure one of our citizens’ unalienable rights — to life.”
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“One of the troubling things about the whole
discussion of malpractice is how often doctors
on the one side and lawyers on the other, seem
to be primarily concerned with what malpractice
law means for them rather than what it means
for patients. ” — Dean Calabresi

In his talk on December 9, Dean Calabresi responded,
“One of the troubling things about the whole discussion of
malpractice is how often doctors on the one side and lawyers
on the other, seem to be primarily concerned with what
malpractice law means for them rather than what it means
for patients.” Malpractice law' fails to induce better medical
care and to efficiently compensate patients who sutler severe
medical ill effects, because instead it produces “outrageously
wasteful defensive medicine,” observed the Law School
dean, whose father and brother are physicians.
Wh\ do we stay with malpractice? Because other methods
of inducing better medical care are equally flawed, according
to Dean Calabresi.
In response to Dean Rosenberg’s proposal for implementa¬
tion of a no-fault-based national compensation system, the
law school dean advised, “We still can, and should, decide
w hat medical maloccurrences are sufficiently dire to justify
such a compensation system. I here may be differences on
this question, but how ever resolved the cost of the approach
is likely to be small compared to the disaster of our current
malpractice law. To do it today, however, we would have to
make such a fund take the place of the malpractice suit, for
we cannot roll things back and return to the pious fraud
malpractice was,” he said. “We have all eaten the fruit ol the
Tree of Knowledge and can no longer successfully pretend
that we are seeking medical perfection through a do-nothing
malpractice law, while compensating injured parties through
another system . . .
“We can only get out of our mess by admitting what is
hard to admit, that lots of errors and maloccurrences will
occur, that as to all but the grossest (which self-regulation or
patient choice may control), there isn’t anything we can do,
and that the best we can do is alleviate the suffering of those
most severely injured."
Leaving the subject of malpractice, he turned to two areas
that concern him about how physicians behave today, both
involving failure on the part of physicians to take responsi¬
bility. “They both will lead, are leading, to precisely the kind
of crushing embrace of medicine by law that Dean Rosenberg
suggested was disastrous,” he cautioned.
I he first is the area of payments and insurance for medical
care, which he contends is not viewed by most doctors as
nothing they should become involved in, except when

“somehow the insurance system ends up asking them to fill
out outrageous forms or paying them less than they think
they should get.” And yet, he believes, it is one of the factors
that most destroys a decent patient-physician relationship.
“How can a patient believe that a doctor or hospital cares
for her or his w'ell being when entrance to a hospital or to a
doctor’s office — often however dire the emergency awaits proof of insurance or other form of capacity to
pay? How can the patient believe the doctor cares, when
after treatment or discharge, in many, many cases the
patient is left unaided to fill out forms that
believe me
—strain the capacity of highly trained lawyers or accountants?”,
asked Dean Calabresi.
“How can any semblance of relationship persist when
after the ’third-party-carrier’ has inevitably returned the
forms as inadequately filled, or sent to the w rong carrier, or
with a reimbursement that bears no relationship to the
doctor’s or hospital’s bill, the patient is faced by a dunning
letter from doctor or hospital threatening interest or far
worse penalties, if no payment is made at once?” he asked.
“It is there that 1 and many lawyers would find the medical
profession wanting,” he said.
“Why are doctors and their associations not lobbying,
shouting, writing letters, and as important, joining lawyers
in drafting bills to create a system of health care insurance
that is speedy, efficient, and easily understood by the
ordinary patient?”
When he raises this question with doctors as well as with
lawyers. Dean Calabresi said, he is usually told that there
isn’t time for such lobbying and thinking and bill writing.
“But there is time (on both sides) to lobby and fuss about
malpractice... No. it is not a matter of time, but a matter of
interest, of caring.”
The second issue of physician responsibility is harder and
more deeply important in that it deals with doctors being
willing to take responsibility for desperately ill patients.
“There are. I think, few things more scandalous than doctors
who, when a patient and that patient’s family have said that
extraordinary medical treatment should be avoided, neverthe¬
less insist on such treatment, or worse, ask that a court
decide for them whether treatment must take place, or
whether the plug should be pulled.”
“In the past, doctors made analogous decisions routinely,
and admittedly were criticized for being high-handed and
not communicating with patient and family,” said Dean
Calabresi. “They were told they were playing God and
shouldn’t. There is plenty of room, however, between
playing God and trying to duck the responsibility that being
a member of a profession has to entail. It is for being
unwilling to act in this middle zone of uncertainty that
doctors have been most severely criticized by legal scholars.

Why are doctors and their associations not
lobbying, shouting, writing letters, and as
important, joining lawyers in drafting bills to
create a system of health care insurance that is
speedy, efficient, and easily understood by the
ordinary patient?”
Dean Calabresi
“

"Here, as in so many things between law and medicine,
there is a fundamental lack of understanding by each
profession of what the other is about,” he pointed out. "The
doctor who seeks legal assurance that a tragic choice should
be made in one way (while keeping the patient and family in
limbo), believes that the law is set of clear rules that can give
‘yes’and ‘no’answers to conduct, and can do it publicly. The
law knows that this cannot be so, that often the law will
declare one thing and permit the opposite precisely because
it is the only way to allow a society to cleave to conflicting
ideals,” he added, citing an example of euthanasia to explain
his point.
“When a doctor invokes the law in such a situation, that
doctor not only fails to give the patient and family the care
they have a right to — which means immediate care
but
also starts a process that goes a long way toward establishing
the crushing embrace the doctor will later, properly, complain
about,” said Dean Calabresi.". . .to people outside of
medicine, a doctor’s role is not just to keep people alive at all
costs; it is to care for them, to treat them according to their
best interest. That, as 1 said earlier, involves a decent
medical payment system, but it also involves allowing
people to die with dignity and without having to go to court
to do so. . . ”

.. .a doctor's role is not just to keep people alive
at all costs, it is to care for them, to treat them
according to their best interest. That involves a
decent medical payment system, but it also
involves allowing people to die with dignity and
without having to go to court to do so. . . ”

Dean Calabresi

Dean Calabresi

Dean Calabresi noted that one person's death with dignity
is another person’s premature abandonment, which is just
one reason why yes or no legal rules wont’work. “It requires
exquisite sensitivity to the particular situation of the particu¬
lar patient and that patient’s family,” he explained.
. . .“Most doctors fear the crushing embrace of the law.
Most thoughtful lawyers fear being called in to regulate
medicine. They fear the same embrace just as strongly,” he
said in conclusion. “If the embrace comes, then, it is because
the professions have not worked together to find ways of
accomplishing what the public desires of us. There are things
the public wants that cannot be given to it
perfection in
medicine and simple rules in law.
“But there are things the public wants that can be given it
the capacity to cope financially with catastrophic medical
maloccurrences, the possibility of having decent medical
care without being badgered by bureaucrats armed with
unintelligible financial forms and requirements before and
after treatment, and the chance to live without the fear of
either being discarded prematurely or being kept alive in
intolerable conditions. If lawyers and doctors, both, focus
more on these things that the public wants from us in our
interactions, and less on what benefits ns or frightens ns
most in those interactions, we will be able to respond to the
public, be true to our calling, and, in the long run, also
remain the professions we would wish to be.”
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TRACKING THE EPSTEIN-BARR VIRUS
Dr. /. George Miller won't let up until he pinpoints the mechanism which allows EBV to persist.
Thus far, his research team has found a rearranged piece of viral DNA which seems to control
latency, perhaps causing the virus to replicate.

by Grace Breitstein
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or more than 15 years. Dr. I. George Miller has
relentlessly pursued a scoundrel
the EpsteinBarr virus (EBV).
EBV, a member of the herpes virus family first discovered
in 1964, has been associated with infectious mononucleosis,
several cancers and, most recently, with Acquired Immune
Deficiency Syndrome (AIDS) in infants and children.
The direction of his research and the key challenge before
Dr. Miller, the 48-year old John F. Enders Professor of
Pediatric Infectious Diseases at Yale, has been to acquire
clues as to how EBV persists.
“I'm interested in figuring out the basic mechanism of
how the virus interacts with the lymphocyte, its usual
target,” said Dr. Miller. “How does it change the behavior of
the cell, so that a normal cell takes on the direction of
becoming a cancer cell?”
The \ irus, when added to a normal cell in a culture, causes
the cell to grow continuously, a process Dr. Miller has
termed immortalization. It is unknown which particular
EBV gene immortalizes the cell, causing the virus to persist
in a latent, or dormant form inside the cell.
“If the virus were to start to replicate, it would kill the
cell,” said Dr. Miller. “So a very important problem to
resolve is what keeps the virus from replicating and what
controls the process of latency.”
An exciting finding of his research team here has been a
rearranged piece of viral DNA which seems to control
latency. When put into the cell, it causes the latent virus to
replicate.
Working with Dr. Miller on that study were Jill Country¬
man, a graduate student in biochemistry, and Dr. Hal
Jenson, a postdoctoral fellow in pediatrics and epidemiology,
and recipient of an N1H Physician Scientist Award for the
study of basic science related to clinical problems.
Dr. Miller’s accomplishments thus far earn him warm
praise from his colleagues. Dr. Dorothy M. Horstmann,
John R. Paul Professor Emeritus of Epidemiology, describes
Dr. Miller as a “remarkably able and imaginative in¬
vestigator.
“He knows how to ask the right questions and he gets
around to answering them,’’she said. Dr. Horstmann noted
Dr Miller’s early work in which, using information derived
from studies on the Marmoset monkey, he devised a tissue
ulture system that subsequently allowed for the study of
I BV around the world.
i BV was first isolated in tissues of patients with Burkitt’s
nphoma, a form of cancer prevalent in parts of East
and later in a nose cancer common among Chinese
Hnally, EBV has been associated with cancer in
suffering from immune deficiencies that resulted
I tccts ol drugs used in organ transplants. This led
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Dr. Miller to pursue a hypothesis of EBV’s association with
AIDS in children.
The largest and most complicated of viruses, EBV
contains as many as 75 different genes, most of which are
involved in replicating the virus. A subset of no more than
ten and no fewer than three genes has been implicated as the
primary culprits, said Dr. Miller. Much of his work focuses
on finding out how those genes function. Answers to such
questions could lead to ideas on how to cure the cells by
destroying the virus, perhaps with drugs developed to have a
crucial point of attack.
Meanwhile, Dr. Miller and his colleagues have called
attention to the association between EBV and AIDS and the
complications the virus causes in infected infants and
children. He and other AIDS researchers in his laboratory
have detected EBV in tissue extracts from the lungs of nine
children and from the brain of one child after examining
specimens from 18 infants and children w'ith AIDS.
In some cases. Dr. Miller has found EBV to be pervasive
in children with A1DS. The virus was readily recovered from
the blood and saliva of a seven-month old boy born heroinaddicted to a 27-year-old prostitute. The infant’s lung

Dr. Miller's mentor, the late Nobel Prize-winning
virologist John F. Enders, conducted research which led
to vaccines that fight against childhood diseases, including
polio and German measles. His message to Dr. Miller
conveys a sense of the warm relationship that existed
between the two scientists.

biopsy showed normal air spaces in the lung being replaced
by EBV-infected tissue.
The findings, reported in a December issue of The Lancet,
underscore the importance of EBV as the cause of various
complications, including cancer of the brain and a form of
chronic pneumonia, in children with AIDS.
“It may be that cells in the lung support replication of the
virus, especially in patients with immune deficiencies,” Dr.
Miller said during a January medical oncology conference
he conducted on AIDS in children.
Children, according to Dr. Miller, appear to be more
susceptible to EBV-related complications than adults,
possibly because of the sequence of events surrounding the
time in which they contact AIDS. The HTLV virus which
causes AIDS may somehow predispose children to acquiring
complications after being EBV-infected.
“One reason may be that adults probably contract the
AIDS virus after they’ve been infected with EBV,” Dr.
Miller said. “So they’ve already developed a certain amount
of immunity to the virus and have brought it under control.”
Children, on the other hand, may develop EBV while they
are already infected with the AIDS virus. “It’s more
simultaneous,” he said.
Most recently. Dr. Miller and a Yale medical research
team have begun studying how children with AIDS become
infected with HTLV III, the causative agent of AIDS. They
hope to identify the risks of transmission, particularly
among siblings.
Those participating in the study include: Dr. Warren A.
Andiman, associate professor of pediatrics and epidemio¬
logy; Dr. Ben Katz, a Pfizer postdoctoral fellow; Dr. Karen
Dahl, an N1H postdoctoral fellow; and Kelsey Martin, a
first-year medical student.
“We know they are born into a family with high-risk
members,” said Dr. Miller. “The mother and father are
usually drug abusers. Sometimes the father may be bisexual
or occasionally, he may be hemophiliac.
“We’re working on the question of why some people get
sick and others don’t, and exploring the possibility that
there might be a difference in the viruses, some of which are
killer viruses and some of which aren’t.”
In these and other areas of research. Dr. Miller has
employed the quiet precision and conviction of his mentor,
the late Nobel Prize-winning virologist and Yale College
alumnus, John F. Enders, whose chair Dr. Miller has held at
Yale since it was created in 1976.
Dr. Enders’ work advanced the fight against cancer and
led to vaccines that fight against many childhood diseases,
including polio and the German measles. Dr. Miller worked
under his instruction from 1966 to 1969 as a fellow at
Harvard Medical School, where together they studied the
ways viruses infect normal lymphocytes.
Dr. Miller said he hopes that he emulates the style and
techniques of Dr. Enders, who “was interested in straddling
the line between medicine, its practical problems and basic
research.”
Dr. Miller’s background and career do indeed reflect his
mentor’s influence. Born in Chicago, Dr. Miller graduated
cum laude from Harvard College and from Harvard Medical
School in 1962. He wrote his medical school thesis on
techniques developed to measure the production of inter¬
feron, a protein produced in the cell to fight viral replication.
Aftera residency at the University Hospitals of Cleveland,
Dr. Miller served as Epidemic Intelligence Service Officer

Exercising patience and persistence, Dr. I. George Miller,
the John F. Enders Professor of Pediatric Infectious
Diseases, has studied the Epstein-Barr virus and its
association with several cancers, mononucleosis and with
AIDS in children. Pictured above in his laboratory, Dr.
Miller examines recombinant DNA clones.

for the Communicable Disease Center in Atlanta, and later
as chief of the center’s virus unit.
Following his work with Dr. Enders at Harvard, Dr.
Miller joined the Yale medical faculty in 1969 as assistant
professor of pediatrics and epidemiology, and in 1972 he
became an associate professor. In 1982, Dr. Miller received
the Squibb Award from the Infectious Disease Society for
his work regarding the growth of EBV.
His wish-list includes seeing greater research efforts
aimed at linking a number of viruses and cancer.
“There are four or five viruses where the evidence is good
that they cause cancer in humans,” Dr. Miller said. “The
time is very much ripe for studying these viruses.” One such
virus, hepatitis B, is believed to cause cancer of the liver.
Another, the papilloma virus, may cause cervical cancer.
For pleasure, good health and mostly as relief from the
stress of his day-to-day research. Dr. Miller jogs 20 miles
each week, plays the piano, and retreats to a country home
in Vermont where he keeps plenty of wood to chop.
His wife, Arlette, a real estate agent and avid potter, is no
stranger to Yale either. From 1974 - 84, she taught pottery to
hospitalized children at the Yale Psychiatric Institute.
1 he Millers have three children: Liza, 23, an editor for the
Harvard Business Review, John, 20, a junior at Swarthmore
College; and David, 16, an 11 th grader at Hopkins Grammar
School.

Grace Breitstein, is staff writer to the School o f
Medicine’s Office of Public Relations.
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DIGESTIVE DISEASES RESEARCH:

continuing the Yale legacy

With basic scientists and clinicians working side by side, recent advances in treatment for some of
man’s most troubling diseases are more rapidly delivered from the research bench to the bedside.

T

by Marje Noyes

he prognosis lor an infant born with biliary
atresia is devastating. Almost as somber are
prospects for children diagnosed as having cystic
fibrosis or adults with inflammatory bowel disease
oreirrhosis of the liver. According to the National Digestive
Diseases Educational Program, an estimated 20 million
persons in the United States are chronically ill, and more
Americans are hospitalized with digestive diseases than with
any other group of disorders.
Research being done in the Digestive Diseases Division at
Yale may significantly change the outlook for many of these
patients. Established in 19X2 under the direction of Dr.
James Boyer, professor of medicine, the division combines
the interests and expertise of the Gastroenterology Unit (GI)
and the Liver Study Unit in a wide range of studies of the
digestive system. Recognized for its pioneering research into
the causes and treatment of these diseases, and for its
outstanding postdoctoral training program, it is as well, a
major referral center for patients with digestive disorders of
all kinds.
The achievements of the Digestive Diseases Division area
result, in part, of the legacy of Dr. Howard Spiro, professor
of medicine, one of Yale’s most distinguished gastroenterolo¬
gists, w ho for 27 years as its founder and director, shaped the
development of the G1 Unit; and of Dr. Gerald Klatskin, the
David Paige Smith Professor Emeritus of Medicine, who
founded the first liver study unit in the country at Yale in
194X.
The GI Unit and Liver Study Unit have changed a great
deal in the last decade. With the formation of the division,
there are more researchers and clinicians working side by
side whose interests cover a much broader range than before
in keeping with the expanding disciplines in this field.

In 19X4, following nearly Jour decades of
pioneering work on liver function and disease,
Yale received a $2.4 million Digestive Diseases
Research Center grant from the National
Institutes of Health to establish one of the first
three federally funded liver centers in the
country. Directed by Dr. Royer, it integrates the
rk of 19 principal investigators and IS
nporting full-time faculty from eight
rtments, in a broad based program ranging
a sic research on the cellular and
tar levels to therapeutic trials in patients
triplications of chronic liver disease.

William Carter

A video-enhanced image of a liver cell couplet appears on
the screen behind Dr. James Boyer.

The list of almost 50 postdoctoral fellows who trained with
Dr. Klatskin from 1958 until his retirement reads like a
“Who’s Who in Liver Disease Research.” One of these
fellows was Dr. Boyer, who assumed leadership of the Liver
Study Unit on Dr. Klatskin's retirement in 1978. A graduate
of Johns Hopkins School of Medicine intent on a career in
infectious diseases, he changed course while on duty with the
Public Health Service in Calcutta in the ’60s, where he
worked wath patients with liver disease.
Then as now, Yale was one of three or four major centers
for training in this field, and the only one with strong clinical
as well as research orientation.
“I came here in 1965 to interveiw for a fellowship
appointment,” recalls Dr. Boyer. “I had hardly explained
the purpose of my visit w hen Dr. Klatskin spied the box of
liver biopsies I had brought from India. He’d been to India
as well, and after examining my slides under the microscope
in minute detail without saying a word, he launched into a
full discussion of the subject, complete with background
literature, as though he’d just prepared the most comprehen¬
sive review!”
Since the time of his fellowship. Dr. Boyer’s main research
interest has been the mechanism of the hepatic bile secretory
and transport process.
“I saw an isolated perfused liver preparation make golden
bile one day while I w'as a fellow, and have been fascinated
ever since with how that process works in this cell system.”
Recently, Dr. Boyer and his colleagues achieved a major
advance in liver disease research by isolating a liver cell
couplet
two liver cells joined together at the bile
canaliculus, the site on the cell where bile is made. In
collaboration w ith Drs. Anil Gautam, assistant professor of

medicine, and Dr. Jurig Graf, a physiologist from the
University of Vienna, they have been able to obtain a
definition of the electrophysiological events occuring at the
site. This enables for the first time, the measurement of the
secretory volume and an accurate determination of the
driving forces for the movement of water and solutes from
the liver cell.
Because of the complex anatomy of the liver, it previously
was impossible to sample primary bile secretion at the level
at which it is made.
“By the time we were able to collect the secretion, it had
passed over several different cell types. It was like trying to
understand the source of spring water from the Adirondacks
by collecting the effluent of the Hudson River at Battery
Park,’’explained Dr. Boyer. “The cell couplet system allows
us to get directly to the source.”
Production of bile is one of the liver’s most important
functions, and when it is injured by disease, this process is
almost always impaired. With the cell couplet system,
researchers now can determine whether or not an agent
stimulates or inhibits the primary secretion. This should
eventually lead to the development of more effective agents
for stimulating bile secretion and modulating this important
excretory function.
“The more we know about the normal process of the
system, the better we will be able to understand and then
correct the pathological physiology of the disease,’’explained
Dr. Boyer.

William Carter

William Carter

The focus of postdoctoral training is an acquisition of
scientific skills and the application of these skills to
important basic science or clinical problems related to
digestive diseases. Dr. John Helzberg. above, also
working with Dr. Gordon, is using the new technique of
nuclear magnetic resonance spectrometry to assess the
effects of alcohol on oxygen consumption by the liver.

The postdoctoral training program in the
Digestive Diseases Division is one of the largest
in the country, and attracts highly qualified
individuals from the U.S. and abroad. In
addition, Yale medical students and house staff
receive training from faculty in the division.

Dr. Ellen Gordon, pro fessor (adjunct) of research in
medicine, and an internationally recognized biochemist
(right) is conducting studies on hepatic bilirubin
metabolism to identify the chemical nature and source of
a recently discovered bilirubin metabolite to better
understand liver metabolic abnormalities. Working in her
laboratory as a postdoctoral fellow is Dr. Neil Sitiith
(left), one of nine postdoctoral fellows in the Digestive
Diseases Division supported by N/H training grants.
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Five years ago, the World Health Organization
established the investigation and control of
diarrheal diseases as one of the major goals for
the next decade. Investigation into the causes
and treatment of these diseases by Dr. Binder
and Dr. Dobbins constitutes a significant
portion of research interests in the GI Unit.

Dr. Henry Binder

Studies of the pathogenesis of liver cirrhosis by Dr.
Bernard Davis, a postdoctoral fellow in the Liver Study
l nit working in the laboratory of Dr. Joseph Madri,
assistant professor of pathology, is an example of the
< ali her as well as interdisciplinary nature of training in
'ioth the Gl and l iver Study Units. In an effort to
understand the mechanisms of fibrogenesis, Drs. Madri
/ Davis have focused on a recently isolated cell, the ho
i d. which produces connective tissue and stores vitamin
I In particular, they are investigating the role of vitamin
I in controlling the cirrhotic process.

In 1982, Dr. Howard Spiro decided to devote a greater
portion of his time to caring for his patients as well as
directing the Humanities in Medicine Lecture Series, which
he founded; Dr. Boyer had been appointed chief of the
division that combined the liver and Gl units, and Dr. Henry
Binder, professor of medicine and director of the General
Clinical Research Center at Yale, was named head of
gastroenterology research in the division.
Dr. Binder, who had planned a career in Gl diseases from
the day he entered the New York University School of
Medicine, came to Yale as a fellow in 1963. and with the
exception of three years (two in military service), has been
here ever since.
“Yale is a very stimulating place to be in terms of digestive
diseases,” he said, citing such colleagues as Dr. Spiro and
Dr. Robert Donaldson, the David Paige Smith Professor of
Medicine and acting chairman of the Department of
Internal Medicine, who is a former president of the American
Gastroenterology Association and editor for seven years of
the journal Gastroenterology.
Dr. Donaldson and Dr. Cyrus Kapadia, associate profes¬
sor of medicine, are conducting research to better understand
the mechanism of transport of vitamin B12 and other
essential nutrients made available to the body through the
intrinsic factor — a substance produced by normal gastro¬
intestinal mucosa. This research, with implications for
understanding peptic ulcer disease, is being done in labora¬
tories in the Veterans Administration Medical Center at
W est Haven with support of a VA Merit Review Grant.
Dr. Binder’s own research interest for many years has
been mechanisms of diarrheal diseases and in particular, the
role of the colon as a transporting organ in health and
disease
especially diarrheal diseases. The thrust of his
w ork has been to identify the regulation of colonic electro¬
lyte transport to determine which agents stimulate absorption
and w'hich ones are associated with secretion.
In an investigation of the effects of corticoid steroids on
the intestines, he demonstrated that glucocorticoids, previ¬
ously thought not to affect electrolyte transport, have a very
decided effect, and in fact, stimulate active cellular absorp¬
tion. This research has led to the development of new7
treatment regimens w ith glucocorticoids, such as prednisone,
for a variety of serious intestinal disorders including Crohn's
disease and ulcerative colitis.

Research in the Division covers a wide range from
basic research at the cellular and molecular levels
to clinical trials at the bedside. . .
LIVER
Research into the pathophysiology
and pharmacologic control of
portal hypertension in patients as
well as animal models is being done
in the liver bloodflow laboratory at
the VA Medical Center in West
Haven. Directed by Dr. Roberto
Groszmann, associate professor of
medicine, this laboratory is a major
research and training resource.
Also at the VAMC, Dr. Harold O.
Conn, professor of medicine and
chief of the Liver Disease Unit, Dr.
Grozsmann and Dr. Colin Atterbury,
associate professor of medicine, are
conducting therapeutic trials in
patients with complications of
chronic liver disease. They have
demonstrated that drug and
hormone therapy reduces portal
hypertension.
Comprehensive interdisciplinary
studies of the mechanisms of bile
secretion and jaundice in the
laboratory of Dr. James Boyer,
professor of medicine and director
of the l.iver Center, led to the
important discovery of the liver cell
couplet culture system, enabling for
the first time the sampling of
primary bile secretion. This
research is being done in
collaboration with Drs. Anil
Gautam, assistant professor of
medicine and Dr. Jurig Graf, a
physiologist from the University of
Vienna.
Hepatic metabolic abnormalities
are being investigated by Dr. Ellen
Gordon, professor (adjunct) of
research in medicine, and her
colleagues in studies to measure the
effects of alcohol on the energy
level of the liver, and the
differential effect of hepatic
metabolism of alcohol in different
areas of the liver lobule — an
important problem relating to the
development of alcohol tolerance.
In addition. Dr. Gordon has
developed a research program to
study mechanisms of hepatic
bilirubin metabolism.
A special program in pediatric
hepatology, organized by Dr.
Caroline Riely, associate professor
of medicine, includes clinical studies
of the effects of intravenous feeding
on hepatic function, the natural
history of hepatic arterial dysplasia
and the evaluation of non-invasive
methods of assessing hepatic
structure. The program also
evaluates the incidence and causes
of liver disease in pregnancy.

CLINICAL NUTRITION
Dr. Rosemarie Fisher, associate
professor of medicine and director
of the GI Unit at the VAMC, heads
the recently established clinical
nutrition consultative service of the
G1 Unit, and is responsible for
promoting protocols for
intravenous nutritional support for
patients with digestive diseases in
Yale-New Haven Hospital and the
VA Medical Center.

esophagus
GALL BLADDER
Dr. Adrian Reuben, assistant
professor of medicine, is
investigating the mechanisms of bile
lipid excretion in animals and man,
an important problem in
understanding how gallstones are
formed and how they might be
dissolved with medication.

GITRACT
ESOPHAGUS
Dr. Morris Traube, assistant
professor of medicine, is studying
the mechanisms of swallowing and
reflux to gain a better
understanding of motility disorders
such as swallowing difficulties and
heartburn, which affect many
people.

STOMACH
Research by Dr. Cyrus Kapadia,
associate professor of medicine, and
Dr. Robert Donaldson, David
Paige Smith Professor of Medicine,
is directed toward increasing
knowledge about the intestinal
transport of cobalamin (vitamin
Bo) and the control of intestinal
secretory function in the stomach
that relate to peptic ulcer disease.

PANCREAS
In studies to learn more about the
mechanisms of the pancreas, one of
the least understood components of
the GI system. Dr. Fred Gorelick,
associate professor of medicine, in
collaboration with Dr. James
Jamieson, professor and chairman
ot the Department of Cell Biology,
has undertaken a comprehensive
study of the pancreatic acinar cell
for a better understanding of the
mechanisms involved in the release
of secretory protein in the pancreas.

INTESTINES
Dr. Henry Binder, professor of
medicine and director of research in
the GI Unit, and Dr. John
Dobbins, associate professor of
medicine, direct a comprehensive
program to study the mechanisms
of absorption and secretion of fluid
in diarrheal diseases in human
patients and animal models. Dr.
Dobbins’ research is directed at the
mechanisms and hormonal effects
of electrolyte transport in the
intestine; Dr Binder has focused his
work on intestinal peptide and
corticosteroid receptors, and the
mechanism of colonic potassium
transport.

In addition to its important programs in
research and training, the Digestive Diseases
Division is a major tertiary care resource for
digestive disorders in Connecticut and the
northeast, from Boston to New York. The
combined GI and liver outpatient clinics average
over 2,000 patient visits each year.

Marje Noyes

This service will soon be greatly enhanced with the comple¬
tion of a new, considerably enlarged clinical endoscopic
center on the third floor of the Boardman Building. Directed
by Dr. John Dobbins, associate professor of medicine, this
Yale-New Haven Hospital facility serving physicians at Yale
as well as from the community, will provide endoscopic
procedures for biopsy, removal of stones by non-invasive
techniques, canulation and other procedures, such as liver
biopsy, on an inpatient as well as outpatient basis.
When the Liver Research Center was established here a
little over a year ago, Joyce Willig, co-chairman of the
Connecticut Chapter of the American Liver Foundation,
commented, “It is extremely heartening to know that a
major center to find out what causes liver failure and how to
prevent its consequences, has been established at a place like
Yale.”
M rs. Willig, w ho is a liver transplant recipient, has been a
patient in the Liver Study Unit for a number of years. She
was referring to the fact that “bench” scientists doing the
most basic research on digestive disorders work side by side
with clinicians who care for patients. As a result, the most
up-to-date information about the causes and treatment of
diseases of the digestive system can rapidly be applied at the
bedside.
For years, these scientists and clinicians have been
working in incredibly cramped and outmoded facilities. The
hospital’s new endoscopic service is the first step in expanding
and improving these conditions. Soon to be started are
projects for a centrally located conference room to be named
in honor of Dr. Spiro, and a library to house Dr. Klatskin’s
remarkable collection of more than 50,000 kodachromes
from nearly 10,000 liver specimens — considered the most
comprehensive and useful resource in the world for investi¬
gating the natural history of liver disease.
Further plans, awaiting funding, include enlarging and
renovating offices and laboratories of both units.
“We look forward,” said Dr. Boyer, “to the next few
years, when, finally, space renovations will provide new
facilities commensurate with the excellence of our faculty,
staff and programs.”

Dr. Fred Gorelick, associate pro fessor of medicine, (left)
combines basic research in the mechanism of the pancreas
with patient care.

HERE AND ABOUT

Center for Molecular Medicine to be Built at School
A New Research Matrix:
Yale and Howard Hughes Medical Institute join to create new Center
The School of Medicine, in cooperation
with the Howard Hughes Medical Insti¬
tute (HHM1), plans to create a $25
million Center for Molecular Medicine
that will provide a new facility in which
basic and clinical researchers will work
together to advance biomedical science
and improve health.
The project represents an innovative
approach to biomedical research and a
major extension of the scientific collabora¬
tion between the School of Medicine and
the HHMI. At the new center, Yale and
H H M1 researchers will work to discover
how human cells function in isolation
and in the context of whole tissues and
intact organisms.
“This Center for Molecular Medicine
will enhance the future of biomedical
sciences at Yale and strengthen applica¬
tions in health care,” said Dr. Leon E.
Rosenberg, the dean of the School of
Medicine who has focused his own re¬
search on inherited metabolic disorders
in children.
“We plan to create a new research
matrix at Yale’s Center for Molecular
Medicine by organizing scientific research
along programmatic rather than depart¬
mental lines,”the dean said. “By bringing
the laboratories of basic scientists and
clinical investigators together, we hope to
accelerate the translation of fundamental
information about human biology into
new preventive, diagnostic and therapeu¬
tic strategies.”
To understand human biology at the
molecular level and foster information
flow between basic scientists and physi¬
cians, researchers will likely concentrate
in these major areas: organization, regula¬
tion and expression of genes; cellular and
molecular basis of the nervous system’s
function; carcinogenesis, or causes of
cancer, with special emphasis on regula¬
tion of the cell cycle and the role of
oncogenes; neuroendocrine modulation
of homeostasis and behavior, and the
study of the body’s disease-fighting im¬
mune system.
“These endeavors share a common
conceptual basis in modern advance cellu¬
lar and molecular biology and depend in
large measure on such powerful methodo¬
logies as recombinant DNA technology,
characterization of protein structure and
monoclonal antibody production,” Dr.
Rosenberg said.

In an agreement between Yale Univer¬
sity and the Howard Hughes Medical
Institute of Bethesda, Md., Yale will plan
and construct the new I 10,000 grosssquare-foot medical research facility for
Yale and HHMI to use.
Yale scientists and HHMI scientists,
who will also be Yale faculty members,
will conduct research in the building and
will share core laboratories. These core
laboratories, which will be available to
the entire Yale medical school faculty,
will generate state-of-the-art data on nucle¬
ic acid and protein chemistry. A hybridoma facility will produce monoclonal
antibodies.

Dr. Fredrickson

“This project exemplifies the Howard
Hughes Medical Institute’s purpose of
promoting basic scientific knowledge in
molecular genetics, immunology, metabo¬
lism and neuroscience,” said Dr. Donald
S. Fredrickson, HHMI president and
chief executive officer of the Hughes
medical research organization, a not-forprofit-entity. He also is former director
of the National Institutes of Health.
The Howard Hughes Medical Institute
has earmarked $15 million toward con¬
struction of the Center for Molecular
Medicine. The construction funds com¬
prise only a portion of the more than $50
million which institute officials have al¬
located for medical research operations
at Yale.
Yale is one of 22 academic medical
centers where the institute conducts affilia¬
ted research programs, and these collabor¬
ations often involve the most advanced
research. Yale and HHMI have been
affiliated formally since 1977, just 24
years after H ughes, an aviator and indus¬
trialist, founded the institute (1953). Its
funding and endowment comes from
proceeds of the Hughes Aircraft Corpor¬
ation sale.
The molecular medicine building will
be constructed on University-owned land
on the medical school campus and will
connect with the Sterling Hall of Medi¬
cine. Yale officials estimate that the facility
will be completed in 1989.
Yale University President A. Bartlett
Giamatti has selected the New Haven
architectural firm of Cesar Pelli & Associ¬
ates to design the new center. Mr. Pelli
wasdean of Yale’s School of Architecture
between 1977 and 1984 and now is profes¬
sor of architecture.

Dean Rosenberg

Coordinating the Yale project is Wil¬
liam C. Brainard, provost of the Univer¬
sity and professor of economics. At the
School of Medicine, Dean Rosenberg
has appointed a special advisory commit¬
tee to assist in planning the proposed
Center for Molecular Medicine. Commit¬
tee members include: Drs. Emile Boulpaep, chairman. Department of Physio¬
logy; William konigsberg, chairman.
Department of Molecular Biophysics and
Biochemistry; George Palade, Sterling
Professor Emeritus and Senior Research
Scientist, Department of Cell Biology
and special advisor to the dean; Robert
M. Donaldson, acting chairman. Depart¬
ment of Internal Medicine and David
Paige Smith Professor of Medicine.
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Dr. Collins Appointed
Chairman of Surgery

Neurosurgery. In 1970, he was named the
Harvey and Kate Cushing Professor.
The editor of the Journal of Neurosur¬
gery, he is as well a member of a number
of scientific societies including: American
Surgical Association. American Academy
of Neurological Surgery, American As¬
sociation of Neurological Surgeons (mem¬
ber of the Board ot Directors 1974-77),
American College of Surgeons, American
Physiological Society. AOA, Association
for Research in Nervous and Mental
Disease. Neurosurgical Society for
America (president 1973-74), Research
Society of Neurological Surgeons and
the Society of Neurological Surgeons
(president 1984-85)

New Psychiatric Service
for Children Opens

I)r. William F. Collins, Jr., a renowned
neurosurgeon, has been appointed chair¬
man of the Department of Surgery, effec¬
tive immediately. Dr. Collins, the Harvey
and Kate Cushing Professor of Surgery,
has been acting chairman of the depart¬
ment since September 1984 and head of
the Section of Neurosurgery since 1967.
“We are pleased that Bill Collins will
continue to lead the Department of Sur¬
gery.” said Dr. Leon E. Rosenberg, dean
of the School of Medicine. “Not only is
he a consummate neurosurgeon whose
research into the understanding and treat¬
ment of pain is recognized worldwide, he
is also an extremely capable administrator
and loyal alumnus of this university and
its medical school.”
A native of New Haven, Dr. Collins
received a B.S. degree in 1944 and an
M.D. degree in 1947 from Yale. In addi¬
tion to his studies on pain, he has focused
his research interests on pituitary tumors
and acute spinal cord injury, and has
contributed over 100 papers on these
topics to the scientific literature.
Following internship in surgery, then
residency in neurosurgery at Barnes Hos¬
pital in St. Louis, Dr. Collins served two
years as captain in the U.S. Army Medical
Corps and was a fellow in neurophysio¬
logy at Washington University in St.
1 ouis. before beginning his career in
academic medicine as an instructor in
n urosurgery at Case Western Reserve
University in 1954. He was associate
sor there, when in 1963 he was
cd professor and chairman of
it eery at The Medical College of
5 iigima in Richmond.
ns returned to Yale in 1967 as
i and head of the Section of

A Children's Psychiatric Inpatient Service
opened in November on Winchester 1, is
expected to serve as a national resource
forchildren with serious psychiatric, beha¬
vioral or developmental disorders. Dr.
Joseph Woolston, associate clinical pro¬
fessor in the Child Study Center and
psychiatry is the director.
The result of long collaborative effort
between the Child Study Center and
Yale-New Haven Hospital, the 12-bed
unit will offer diagnostic evaluation, crisis
intervention and short-term treatment
for pre-school through adolescent children
with mental health problems such as
severe eating disorders, depression, au¬
tism, psychosomatic illnesses, attention
deficiency disorders, schizophrenia and
Tourette’s syndrome. Family involvement,
as well as a school program are important
elements in the treatment program devel¬
oped for pediatric-psychiatric patients in
the new unit.

New Yale President
Committed to Scholarship
and Professionalism
Benno C. Schmidt, Jr., the Columbia
University Law School dean who was
named Yale University's 20th president,
has strong commitments to academics
and scholarship, expressing the belief
"that scholarly striving is the predicate of
vigor in teaching.”
At a December 10 press conference to
announce his appointment, Mr.
Schmidt reaffirmed his commitment to
scholarship and said that “a great center
of learning, such as Yale, must be strong
in the sciences.
“One of Bart’s (President A. Bartlett
Giamatti) great contributions has been to
strengthen Yale’s commitment to the
sciences, and that is a commitment that I
will strive to maintain.

In his prepared statement, the 43-year
old legal scholar said, “Yale is one of the
signal achievements that is America;. . .
As a place where knowledge is advanced,
where scientific investigation and human¬
istic inquiry are nourished, where artistic
creation is stimulated, Yale stands almost
alone in importance in the world ....
"Yale’s greatness carries an urgent need
to guard against the fall of excellence into
exclusivity, of refinement into precious¬
ness, of elegance into class and con¬
vention.”
Mr. Schmidt, who also is the Harlan
Fiske Stone Professor of Constitutional
Law, will return July I to Yale, where he
graduated from the College in 1963 and
the Law School in 1966.
A member of the Columbia Law School
faculty since 1969, he is an internationally
recognized authority on constitutional
law, the history ol the Supreme Court
and mass communications law in the
United States.
The president designate said that he
will continue to speak out on scholarship
and professionalism in Constitutional
law, including freedom of the press, race
relations, and problems of secrecy in
national security. To those concerns, he
said he would add speaking out on issues
in higher education.

Library Acquires
Cushing Letter
More insight on the late Dr. Harvey
Cushing’s pursuit of rare medical books
may be gleaned from one of his letters
that an anonymous donor has given to
the Yale Medical Library.
Dr. Cushing, a neurosurgeon who
helped shape the library collection, wrote
the two-and-a-half-page letter to Jens
Christian Bay, librarian of the John
Crerer Library in Chicago, telling Bay
that he collects books by Dr. Daniel
Drake. "1 don’t possess a copy of the
Discourses of the Interior Valley. I shall
have to do (some scouring until) 1 find
one in the original covers. If you ever run
across one do let me know. I shall have
your address bound and put along-side
my Drake volume,” Dr. Cushing writes
encouragingly in his own hand.
About the letter, Ferenc A. Gyorgyey,
historical librarian, said. “While Yale has
the most complete collection of correspon¬
dence addressed to Dr. Cushing, letters in
his own hand to his correspondents are
scarce, and this one is in fine condition.”
The two Drake volumes were purchased
in 1936, just three years before Dr. Cush¬
ing’s death. They are among the library’s
30 some volumes by Dr. Drake, a scientist,
physician and leader in medical education.

FACULTY NEWS
Dr. Albert J. Solnit. the Sterling Profes¬
sor in the Child Study Center, Pediatrics
and Psychiatry, was named the Sigmund
Freud Visiting Professor at Hebrew Uni¬
versity’s Sigmund Freud Center in Jerusa¬
lem lor the academic year 1985-86. He is
one of the conveners of an International
Symposium on "A Psychoanalytical View
of Play and Trauma” being given at the
center March 16 - 20.
At its annual meeting in November, the
American Public Health Association pre¬
sented Dr. Mvrna Weissnian, with the
1985 Rema Lapouse Mental Health Epi¬
demiology Award for her “significant
contributions to the scientific understand¬
ing of the epidemiology and control of
mental disorders."The award established
in 1972, is the only major award in the
world for outstanding contributions to
the field of mental health epidemiology.
Dr. Weissman, professor of psychiatry
and epidemiology, is director of the De¬
pression Research Unit, a joint program
of the Department of Psychiatry and the
Connecticut Mental Health Center.
Dr. Dorothy Horstmann presented Part
I of the Second Annual K.F.Meyer Lec¬
ture, “Can Poliovirus be Eradicated?”
The lecture was held in December by the
George Williams Hooper Foundation at
the University of Southern California.
Dr. Horstmann, John Rodman Paul Pro¬
fessor Emeritus of Epidemiology and
Pediatrics, is known throughout the world
for her pioneering research on poliomye¬
litis which led to the discovery of a
vaccine for the disease. The title of her
lecture was, “The Present: Epidemio¬
logical Realities and Challenges.”
The 1985 Graham Eddy Endoscopic
Award was presented to Dr. Fiji Yanagisawa for his videotape “Videolaryngo¬
scopy
a Comparison of Fiberscopic
and Telescopic Documentation.’’The tape
demonstrates the physiology and patho¬
logy of the larynx using a flexible fiberscope and a rigid telescope. He also
organized and presented two of his video¬
tapes in the academic program of the
Movie Session in Otolaryngology at the
1985 Clinical Congress of the American
College of Surgeons, held in Chicago in
October. In addition. Dr. Yanagisawa
and Dr. Martin Gordon, associate clinical
professor of medicine, served on the jury
of the International Film Festival at the
XIII World Congress of Otorhinolaryngo¬
logy, held in Miami last May.
Shanghai First Medical College has
named Dr. Robert K. Yu, as Honorary
Professor, the highest honor of that uni¬
versity. Dr. Y u is professor of neurology.

The American Gastroenterology Associa¬
tion has presented the 1986 Morton Grossman Research Fellowship Award to Dr.
Fred Corelick. This prestigious award,
which carries a stipend of $30,000, sup¬
ports junior faculty during sabbatical
years and enables them to pursue research
goals. Dr. Gorelick, associate professor
of medicine, is investigating the mechan¬
isms of the pancreas at the cellular level.
Dr. Bruce R. Pitt, associate professor of
anesthesiology, has received an Estab¬
lished lnvestigatorship award from the
American Heart Association. For a five
year period. Dr. Pitt will be studying
biochemical actions as they relate to high
blood pressure and pulmonary vascular
disease. The focus of the project is to
develop a diagnostic test of pulmonary
vascular pathology to be used in newborns
and aid in understanding congenital heart
disease.
The F. Paul Anderson Award for Scienti¬
fic Achievement, the highest honor of the
American Society of Heating, Refriger¬
ating and Air-Conditioning Engineers
(ASHRAE), was presented to Dr. A.
Pharo Gagge, professor emeritus of epi¬
demiology, at a meeting of the society in
San Francisco on January 20. A well
known author, researcher and educator
in the field of environmental physiology.
Dr. Gagge has made numerous contribu¬
tions during the past 50 years to know¬
ledge of the effects of indoor environment
on human comfort and health. He is a
fellow emeritus and consultant to the
John B. Pierce Foundation Laboratory.
At the annual meeting of the American
Epilepsy Society in December, Dr. Rich¬
ard H. Mattson was elected president of
the 1,250-member society of physicians,
scientists and other professionals. Dr.
Mattson, professor of neurology and
chief of the neurology service at the West
Haven Veterans Administration Medical
Center, and Ins colleagues recently re¬
ceived a $2.5 million, five-year multi¬
center grant from the VA Cooperative
Studies group to investigate the treatment
of epilepsy.
Dr. Peter S. Aronson was the first recip¬
ient of the Young Investigator’s Award
given annually by the American Heart
Association and the American Society of
Nephrology for outstanding nephrologic
research. The award which includes a
$5,000 prize, was presented to Dr. Aron¬
son, associate professor of medicine and
physiology, at the annual meeting of the
American Society of Nephrology, held in
New Orleans on December 18th.

The 28th Murray S. Danforth Oration
was delivered by Dr. Wayne (). Southwick, professor of surgery (orthopaedics)
on November 14. The oration is presented
each year by a distinguished orthopaedic
surgeon during a three-day tenure as
surgeon-in-chief pro tempore of the De¬
partment of Orthopaedics and Rehabilita¬
tion, Rhode Island Hospital, and Brown
University. The title of Dr. Southwick’s
talk was “Cervical Spondylosis.”
The American Public Health Association
presented its 1985 Distinguished Service
and Professional Achievements Award
in Environmental Health to Dr. Eric
Mood, associate clinical professor of
public health (environmental health), for
his research and teaching in environmental
health and his contributions in interna¬
tional health programs over several de¬
cades. Dr. Mood, who recently retired
after 25 years as a member of the Expert
Advisory Committee on Environmental
Health, WHO, is editor of Housing and
Health soon to be released by the A PH A.
It includes a revised version of the APH A’s
and CDC’s recommended minimum
housing standards developed in 1952
under the leadership of the late professor
C.-E.A. Winslow, the first chairman of
the Department of Epidemiology and
Public Health.
Dr. Kurt Stenn, professor of dermatology
and pathology, was elected president of
the American Society for Dermatopathology for a one-year term beginning De¬
cember I, 1985.
In November, Dr. David Seligson, pro¬
fessor of laboratory medicine, was visiting
professor in the Department of Labora¬
tory Medicine and Pathology at the Uni¬
versity of Minnesota, and in December,
in the Department of Laboratory Medi¬
cine at the University of California, San
Francisco. The topic of his talks was
bilirubin covalently bound to albumin,
issues concerning laboratory medicine
and resident training.
As the newly elected chairperson of the
National Coalition of Arts Therapy. Dr.
David R. Johnson, in November presided
over the first conference of the six national
arts therapy organziations respresenting
over 12,000 art, music, dance, drama and
psychodrama therapists in the country.
Dr. Johnson is assistant clinical professor
of psychiatry.
Dr. Clarence Sasaki, professor of surgery
and head of the Section of Otolaryn¬
gology. has been appointed to the National
Institutes of Health Study Section on
“Sensory disorders and language.” He is
also president-elect of the New England
Otolaryngological Society.
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IN PROGRESS
March of Dimes Awards
Yale Researchers a
Half-Million Dollars in Grants
The March of Dimes Birth Defects Foun¬
dation has awarded $463,000 in grants to
support projects by 21 Yale researchers
designed to better understand the cause
and improve methods for preventing and
treating birth defects.
Statistics indicate that approximately
one child in fourteen is born with a birth
defect, ranging from prematurity and low
birth weight to spina bifida. "Research is
the key." said William Carey, president
of the New Haven County March of
Dimes, in announcing the grants, “and it
is encouraging to see the March of Dimes
Birth Defects Foundation backing so
substantially the research being conducted
at Yale.”
1 he research includes a study of central
nervous system maldevelopment by Dr.
Karl Herrup, associate professor of hu¬
man genetics; investigation into causes
and treatments of brain hemorrhage in
premature newborns by Dr. Laura Ment.
associate professor of pediatrics and neuro¬
logy. and basic research by Dr. Kay
Tanaka, professor of human genetics, in
isovaleric acidemia, a cause of infant
death and retardation.
Other projects to receive funding from
the March of Dimes include basic research
on embryo development by Dr. Elizabeth
Dolci, associate research scientist in cell
biology; continuing letal heart research
by Dr. Charles Kleinman. associate profes¬
sor of pediatrics and diagnostic radiology;
and basic studies of damaged visual nerve
pathways being done by Dr. Douglas
hrost, assistant professor of neuroanato¬
my Dr. Albert Reece, assistant professor
of obstetrics and gynecology received a
grant for his work on disruption of
embryo development by various metabolic
abnormalities of maternal diabetes, and
Dr. Mark Mooseker, associate professor
ot biology and cell biology, was awarded
funding for his research on cellular protein
production.
Other Yale researchers to receive March
ol Dimes grants include: Dr. Michael
Bracken, associate professor (adjunct) of
research in epidemiology and obstetrics
and gynecology; Dr. Mark Cullen, associ¬
ate professor of medicine and epidemiolo. Dr. John Ilobbins, professor of obsteand gynecology and diagnostic radiDr. ( Tiarles Greer, assistant profes>1 surgery and neuroanatomy; Dr.
t l.evenson, assistant professor of
biology: 1 )r Maurice Mahoney, pro¬
em.m genetics, pediatrics and
a and gynecology, and Dr. Jon
assistant professor ol pathology,
r l iank Ruddle, professor of
human genetics; Dr. Mrinal

Sanyal, research scientist in obstetrics
and gynecology; Dr. David Scott, assis¬
tant professor of pediatrics; Dr. Margretta
Seashore, associate professor of human
genetics and pediatrics, and Dr. Sara
Sparrow, associate professor in the Child
Study Center.

New Procedure Extends
in vitro Fertilization
Physicians at the School ol Medicine will
begin performing a rare procedure that
they predict will increase pregnancy rates
for infertile couples and decrease the
chance of multiple pregnancies.
The new procedure combines cryopreservation, or freezing, of human embryos
with earlier work in in vitro fertilization,
now an accepted method to treat infertil¬
ity, and embryo transfer.
Nationally, one in five couples is infer¬
tile, and the cause of the infertility is
evenly divided between men and women,
according to Dr. Alan H. DeCherney, the
John Slade Ely Professor of Obstetrics
and Gynecology, who will lead the medical
team.
“Cryopreservation, potentially, could
increase the universal pregnancy rate
with in vitro fertilization and provide
additional hope tor those couples who
desperately want to become parents," he
said. This infrequently performed proce¬
dure. he believes, will benefit patients
with tubal diseases, unexplained infertili¬
ty, sperm antibodies and diseases of the
membrane lining the womb or uterus.
Dr. DeCherney describes the procedure
as “very technical. . . The principle is
simple, but technically it is difficult to
lreeze the embryos.”
Basically, a woman’s eggs are collected
during a laparoscopy, an exam using an
illuminated tubular instrument. In a petri
dish, the eggs are fertilized with her
husband's sperm as part of the in vitro
fertilization process.
It is at this point that cryopreservation,
the procedure's new dimension, occurs.
The fertilized embryos are rapidly frozen
and stored. “If embryos will withstand
freezing and remain viable, the hardy
embryos will survive,” according to Dr.
DeCherney. Later, an embryo may be
thawed and transferred to the woman’s
uterus when it is most prepared to receive
one. If the first attempt doesn’t result in
pregnancy, then the remaining embryos
may be reimplanted.
Dr. DeCherney cites several advan¬
tages ol the procedure. First, physicians
will transfer no more than four embryos
at a time to the woman’s uterus, decreasing
the chance of multiple pregnancies. “By
saving some embryos through cryopreser¬
vation. additional embryo transfers may

occur without repeating the laparoscopy
or ultrasound egg collection,” he said.
This procedure also prov ides physicians
and patients with opportunities for more
flexible timing. “We can return embryos
to a woman in 'unstimulated cycles’, or at
a time when she is not taking hormone
medication that may prevent pregnancy,”
explained Dr. DeCherney. “We also may
transfer the embryos at the normal devel¬
opmental stage in the menstrual cycle
and hopefully, increase the chance for
pregnancy.”
The Yale team plans to initiate this
procedure because of previous success
with in vitro fertilization, improvements
in cryopreservation techniques and the
adaptation or transfer of successful animal
research to human beings, according to
the gynecologist.
Since May 1983. Dr. DeCherney and
the health care team have performed in
vitro fertilization for couples, a prelude
to this new procedure. More than 80
pregnancies have resulted, and the labora¬
tory’s fertilization rate has reached 80
percent of all eggs.
At present, cryopreservation of embry¬
os and reimplantations are being per¬
formed in Australia, England, Holland
and in the United States at the University
of Southern California. Forapproximately ten years, reproductive and endocrine
studies involving animals have been con¬
ducted to develop safe and effective proced ures and to determine vvhether embryos will remain viable, and if so, tor how
long. In the U.S., this research has been
extended so that embryo freezing has
become the norm for breeding purebred
livestock.
“What we have learned from animal
studies, we now are ready to apply to
humans to increase pregnancy rates," Dr.
DeCherney said. “This gives us an op¬
portunity to better understand human
reproduction.”
During the past seven months, the Yale
team, coordinated by Dr. Jeffrey B. Rus¬
sell, a fellow in reproductive endocrinol¬
ogy, has prepared to perform this pro¬
cedure by familiarizing themselves with
new equipment and techniques. 1 hey
also have conducted extensive research
with mouse embryos, testing freezing
solutions and techniques of freezing and
thawing embryos.
After card ul consideration, the School
of Medicine’s 26-member Human Investi¬
gation Committee of medical and non¬
medical professionals, students and com¬
munity representatives approved the
procedure. The committee, chaired by
Dr. Robert .1. Levine, professor of medi¬
cine, developed specific guidelines, in
conjunction with the gynecologists, to
assure safety for both the women and the
frozen embryos.
According to the guidelines, women
will receive only their own frozen embryos,
and only those couples in which the

husband has an adequate sperm count
will be considered for the procedure.
Frozen human embryos will be stored at
Yale-New Haven Hospital for no longer
than two years because there is not
enough experience with long-term storage.
Although federal law permits research
on embryos, no research will be conducted
at Yale, according to Dr. L.evine.

Revised Procedure May
Prove a Major Step in Heart
Attack Treatment
Yale researchers have been given the go
ahead by the National Institutes of Health
to streamline clinical trials that might
yield significant results in the treatment
of acute heart attack.
The crux of the revised procedure to
rapidly dissolve blood clots in acute heart
attack patients is the elimination of prelim¬
inary diagnosis by angiogram and immedi¬
ate intravenous injection into the coronary
artery of a new, more effective clot¬
dissolving drug. The drug, tissue plasmino¬
gen activator, (t-PA), acts to dissolve
clots within 30 to 60 minutes after
administration.
Previous studies demonstrated that the
sooner after onset of heart attack symp¬
toms clots were dissolved the better the
prognosis for recovery. “We view this as a
major step forward in the treatment of
acute myocardial infarction,” said Dr.
Tawrence S. Cohen, the Ebenezer K.
Hunt Professor of Medicine who is co¬
principal investigator of the trial with Dr.
Charles K. Francis, associate professor
of medicine. “Our studies have shown
that it is important to dissolve clots
within the shortest possible time after the
onset of the attack. By eliminating the
angiogram, we can save up to two hours.”
Dr. Cohen stressed that the first four
hours after onset of heart attack are the
most critical. After that, the heart muscle
is irreparably damaged.
The procedure is part of a major multi¬
center study of thrombolysis in myocardi¬
al infarction (T1M1) sponsored by the
N1H for collaborative clinical trials of
new treatment for acute heart attack. In
1983, the NIH awarded more than $1.5
million to Yale to establish one of three
core laboratories and a clinical unit for
the TIM I study. Dr. Barry Zaret, the
Robert W. Berliner Professor of Internal
Medicine, is director of the core labora¬
tory for radionucleotide evaluation, and
Dr. Francis is principal investigator of
the clinical unit of Yale’s portion of the
12-center TIM 1 study.
Until recently, there was no drugavailable to dissolve blood clots in coronary
arteries. The first such anticoagulant,
streptokinase, proved effective when ad¬
ministered by catheter into the heart

muscle, but this procedure requires tech¬
nology not available in many hospitals,
thus limiting the use ot the drug.
In the first phase of the TIM1 study,
the Yale research team observed clot
dissolving properties of streptokinase
administered intravenously. When t-PA
became available for research purposes a
little over a year ago, they compared it to
streptokinase and found the new drug
almost twice as effective in rapidly dis¬
solving clots in coronary arteries. More¬
over, because it acts specifically on clots
with minimum effects on other clotting
factors, t-PA reduces the risk of excessive
bleeding.
The recent NIH decision to eliminate
preliminary diagnosis by angiogram was
based on results of treatment of 50 patients
in Yale-New H aven Hospital and a total
of almost 600 patients treated in the
twelve medical institutions participating
in the TIM I study. As yet, there is not
sufficient data to demonstrate whether or
not t-PA is superior to streptokinase in
reducing mortality or improving the qual¬
ity of recovery from acute heart attack.
The new anticoagulent is a synthetic
agent produced by recombinant DNA
technology. Still classified as an investiga¬
tional drug, t-PA is available only to
studies such as TIMI.
Because research to date underscores
the importance of dissolving blood clots
in the coronary artery early in the episode.
Dr. Francis and his colleagues are optimis¬
tic about the potential for the revised
procedure to greatly improve treatment
of heart attack. The next step in their
research will be to administer t-PA in
combination with balloon angiography.
To be eligible for the treatment, patients
must arrive at Yale New Haven Hospital
within the first four hours after onset of
heart attack symptoms, be under age 75,
have no other life threatening disease or
bleeding disorder, and their electrocardio¬
graph reading must suggest they are
having heart attack.
In addition to Drs. Francis, Cohen and
Zaret. members of the research team
include Dr. Frans Wackers, associate
professor of diagnositc radiology and
medicine, who is associate director of
Yale’s TIM1 core laboratory, Caroline
Piscelli, associate in research in medicine,
and Joan Girard Amatruda. nurse
specialist.

Menopause Study to
Determine Hormone Impact
The effects of the ovarian hormones on
women’s functions, particularly upon sen¬
sory perception, during and after meno¬
pause, are being studied by researchers in
the Department of Obstetrics and Gyne¬
cology.
Hormonal changes may markedly alter
a woman’s sense of touch, taste and
smell, affecting her life at work and at
home, the researcher say. The three-year
study’s ultimate goal would be to restore
women to their normal functioning, accordingto Dr. Philip M. Sarrel,associate
professor of obstetrics and gynecology
and psychiatry.
“We hope to sort out the symptoms
women experience, and to identify those
which require estrogen replacement,” said
Dr. Sarrel, principal investigator of the
$700,000 multidisciplinary study funded
by the National Institute on Aging.
Between 100 and 120 women will be
evaluated for 22-week periods each, during
which they will undergo a series of psycho¬
logical. dermatological, neurological and
physiological studies.
The team of investigators includes: Dr.
Tawrence E. Marks, professor of epidemio¬
logy and psychology; Dr. William M.
Glazer, associate professor of psychiatry
and Dr. Irwin M. Braverman, professor
of dermatology. Dr. Hal Morgenstern,
associate professor of epidemiology and
public health, is the program’s statistical
analyses consultant. Research assistants
include: Mary Ellen Rousseau, a nurse
practitioner; Valerie Abbott, assistant
for psychological studies and Dr. Jean
Bolognia, postdoctoral fellow in derma¬
tology.

Hypothesis for New AIDS
Treatment Evaluated
To halt the progression of Acquired
Immune Deficiency Syndrome (AIDS).
Dr. Nancy H. Ruddle has proposed inter¬
fering with the virus-infected cell’s produc¬
tion of a protein called lymphotoxin.
Lymphotoxins are proteins with de¬
structive characteristics normally pro¬
duced by white blood cells to fight tumor
cells. When produced in very high quanti¬
ties, as they may be in AIDS, lymphotoxins cause the cell to self destruct,
accordingto Dr. Ruddle, associate profes¬
sor of epidemiology.
Should her hypothesis prove correct.
Dr. Ruddle has proposed treatment that
differs from the conventional therapy for
AIDS, which is to try to restore T cells,
the virus-infected white blood cells, after
they are killed. Her approach focuses on
interfering with the mechanisms that de¬
stroys the cells in the first place.
“If the lymphotoxins are responsible
17

f or the pathogenesis, — inhibit the patho¬
genesis. allow the system to recover for
awhile and then try to deal with the
v irus," said Dr. Ruddle. Her hypothesis
and proposals for possible treatment of
AIDS appear in the January issue of
Immunology Today, a British journal.
A protein of HTLV-III, the A1DScausing v irus, activates the host T cells,
the white blood cells which HTLV-III
infects, to produce the destructive lymphotoxins, according to Dr. Ruddle. “T cells
can in fact be killed by a product they are
making,” she said.
Dr. Ruddle believes that lymphotoxins
may cause several characteristics of AIDS,
such as reduced body weight and a.smaller
number of circulating T cells. Lympho¬
toxins inhibit an enzyme essential for
lipid metabolism, thus disturbing the
digestion of certain foods, especially fats.
II her hypothesis proves correct. Dr.
Ruddle proposes several ways to reverse
the fatal course of the disease:
Inhibit lymphotoxin activity either by
addingan antibody to it or binding it so it
doesn't feed back on the T cells and kill
them.
Block the receptor, or the site of attach¬
ment. for lymphotoxin in the T cell.
"11 you understand what components
make up the receptor, then you can
actually present the patient with those
components in a high enough quantity to
compete with the receptor for lympho¬
toxin," Dr. Ruddle explained.
The receptors have already been shown
to contain certain sugars to w hich lympho¬
toxins will bind, she added. With an
understanding of the protein structure of
the receptor, agents could be introduced
to stop the lymphotoxin from binding to
the receptor and killing the cell.
Dr. Ruddle applied for a patent and
has prepared a proposal for a grant to
develop research at Vale that would test
her hypothesis regarding lymphotoxin
production in AIDS. The T cells, it
seems, may be producing lymphotoxins
in an “inappropriate fashion.”
I hus lar. Dr. Ruddle has tested the
serum of 12 AIDS patients for lympho¬
toxin content. The serum of some 100
AIDS patients will be tested by the
study’s end. Of the 12 tested, eight have
contained the destructive protein. Further¬
more, Dr. Ruddle obtained growth media
of HTLV-III infected lymphocytes and
non-infected lymphocytes from nonAIDS patients. She found that the cells
infected with the virus produced lym¬
photoxins.
Dr. Ruddle obtained the growth media
Irom Dr. Lee Rainer, an M l). Ph D.
jraduate from Yale, who is assistant
po 'lessor ol hematology and oncology at
shinglon University in St. Louis. I he
lest i suits, although preliminary, support
hei hypothesis, according to Dr. Ruddle.

IK

WILLIAM M. LESSER. Ph.D.

BENEDICT R. HARRIS, M.D.

William M. Lesser, Ph.D., director of
psychological training at Waterbury Hos¬
pital Health Center, died suddenly on
June 28. 1985 at age 53. Dr. Lesser
graduated from the Bronx High School
of Science, received his bachelor’s and
master’s degrees from the City College of
New York, and his doctorate from Michi¬
gan State University.
An assistant clinical professor of psychi¬
atry and a member of the executive
committee of the Section of Psychology
at the Yale School of Medicine, he was a
Diplomate in Clinical Psychology of the
American Board of Professional Psycho¬
logy, and a member of the American
Psychological Association. He was active
on various committees and served two
terms on the Board of Directors of CPA.
In private practice in Torrington, Connect¬
icut, he was a consultant to the Connecti¬
cut Junior Republic, the Northwest Child
and Family Services and Lark Institute.
Dr. Lesser’s civic interests included
volunteer services to Litchfield Hospice
and the American Cancer Society. He
was actively involved in the American
Field Service of Litchfield, and for many
years, headed a committee to locate host
families there for foreign students. He
was a member, trustee and past-president
of the Litchfield B’nai B’rith in Torring¬
ton.
SB.

Dr. Benedict Harris, clinical professor
emeritus of medicine and public health
died on November 3, at the age of 86.
Ben Harris had a long and distinguished
medical career. Following two older
brothers who also received their M.D.’s
from Yale, he had his house staff training
at New Haven Hospital from 1922-24. He
did postgraduate work in cardiology at
Johns Hopkins and at the Herzstation in
Vienna, after hav ing been an instructor in
medicine at Yale from 1924 to 1927.
Dr. Harris returned to New Haven to
practice internal medicine and cardiology
from 1929 to 1967. during w hich time he
developed a reputation as a superb clini¬
cian and teacher and rose to clinical
professor medicine in 1961. From 1959 to
1967, he was associate chief of medicine
at the Grace-New' Haven Community
Hospital. In charge of the Community
Medicine Division, he molded this into
an integral part of the Department of
Medicine and began the difficult task of
bringing together the community physi¬
cians, the hospital and the medical school
by his effective and trustworthy leader¬
ship.
In 1964, he was appointed clinical
professor of medicine and public health
(medical care) w hen he became associated
with Dr. Isidore Falk in the project
“Performance of a Study to Develop
Standards for Audit of Medical Services”
w hich became the basis for what we know
today as Diagnostic Related Groups
(DRGs). In 1965. he became the first
medical director of the Sound View Re¬
habilitation Center, an expression of his
interest in care for patients still needing
professional attention after hospital
discharge.
At the time of his retirement as associate
chief of medicine in 1967, the first year
assistant residents in medicine, a percep¬
tive and critical group, honored him by
establishing the Benedict R. Harris Award. It is given annually to the commun¬
ity physician w ho contributed the most to
the education of the medical house staff.
However, Dr. Harris was far from
ready to retire from medicine. From 1967
to 1969. he was chief of medicine at the
Atomic Bomb Casualty Commission in
Hiroshima, Japan, as well as principal
investigator of the Department of Collab¬
orative Studies of the National Heart
Institute -NIH for Japan. As a Navy
lieutenant commander in 1945, he had
been among the first medical personnel
to enter Nagasaki to offer medical care
following the atomic bomb explosion
there. On his return from Hiroshima, he
resumed his private practice in New Haven
and did not retire completely from medi¬
cine until 1983.
He is survived by his wife. Pearl, his
tw'o daughters, his five grandchildren and
his great-grandchild. S.D.K.

ERNST M. MYLON, M.D.

Dr. Ernst M. Mylon, associate professor
emeritus of pathology, died at his home
in New Haven on October 15 following a
long illness. He was 90 years old.
Born in Schneidemuehl, Germany, he
received his doctor of medicine degree
from Friedrich Wilhelm University in
Berlin in 1920. Prior to coming to the
United States, he held faculty posts in
Berlin and subsequently, at the Univer¬
sity of Belgrade, Yugoslavia.
Dr. Mvlon came to New Haven in
1938, when he was appointed a special
research fellow in pathology at Yale. The
following year, he became a research
assistant in pathology, with the rank of
assistant professor. He was elected to the
Yale chapter of Sigma Xi in 1940, and in
1944, he was promoted to research associate
with the rank of associate professor.
From 1951 until his retirement in 1963,
he was an associate professor on the
regular academic faculty.
Dr. Mylon was appointed Director of
Laboratories at the Lawrence and Memo¬
rial Hospitals in New London in 1951
under a contract with Yale, and developed
a residency training program there. Al¬
though he held his post at New London
until his retirement, he continued to
teach medical students in the pathology
course at Yale. Dr. Mylon was the author
of numerous scientific publications, parti¬
cularly in the field of vascular pathology.
The husband of the late Hildegard
Joseph Mylon, he is survived bv a
daughter, Inge Yaffe of Thomaston; a
son, Peter Mylon of Syracuse, New York;
six grandchildren and a great-grandchild.
Memorial contributions may be made
to the Professor Ernst Mylon and Hildegarde Mylon Scholarship Fund at the
Yale School of Medicine.
A.E.

CECIL J.HODSON, M.B..B.S.

Cecil John Hodson, professor emeritus
of diagnostic radiology, died at his home
in Sussex, England on December 2, after
several months of illness.
Born in England, John Hodson received
his medical training in London. During
World War II, he served in Britain’s
armed services in North Africa and Italy
as an officer of the Royal Army Medical
Corps and was cited for outstanding
performance.
He began his academic career in 1946,
and as a chest radiologist, made several
original and important observations, pri¬
marily concerned with pediatric thoracic
disease. At the end of 1949, he became
deputy director of the X-ray Diagnostic
Department at University College Hospi¬
tal, London and became director of that
department in 1961. He left London in
1970 to become professor of radiology at
Memorial University of Newfoundland
in St. Johns.
Dr. Hodson joined the Yale faculty in
October 1975 as professor of radiology
and head of the Renal Section. He became
professor emeritus in July 1984.
During his distinguished career Dr.
Hodson served as secretary and diagnostic
vice president to The Faculty of Radiolo¬
gists in England. As chairman of the
museum board of The Faculty, he was
personally responsible for initiation of
one of the largest X-ray museums in the
world. He also was advisor in radiology
to the M inister of Health for three years,
and in 1981, was awarded an honorary
fellowship in the American College of
Radiology.
Dr. Hodson had an extremely produc¬
tive career which is reflected in the ap¬
proximately 100 original publications and
chapters in books, and many speaking
engagements at national and international
meetings. Although in his brief term as a
chest radiologist he made several original
and innovative contributions to the field,
his major research interest — spanning a
period of 25 years - - was concerned with
the kidney. These endeavors led to his
defining a new entity, reflux nephropathy
- a classical model of what a long-term
investigation should be.
With imagination, background know¬
ledge, persistence, hard work and novel
experimental design. Dr. Hodson defined
and revolutionized medical perception of
the entity, despite considerable resistance

from those holding to established doctrine.
This work will probably save many chil¬
dren from irreversible kidney disease,
provides a firm basis for therapy and
represents a real and valuable contribution
to medicine
one that will have lasting
effects.
His quiet determination, high stan¬
dards, excellence as a radiologist and
physician and absolute honesty were in¬
spirational to those who knew and worked
with Dr. Hodson. His interests were not
only in medicine and kidney disease. He
was an excellent sailor, an enthusiastic
climber and a member of the Alpine Ski
Club. An avid rugby player. Dr. Hodson
was coach to the Yale rugby team before
his illness. He was also an amateur singer
of some repute.
John Hodson could best be classified
as a giant of a man in all ways. Those who
knew him well, personally feel an intense
loss at his death. The Yale Department of
Diagnostic Radiology is in the process of
establishing a yearly lecture in his memory.
R.H.G.
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FACULTY-STUDENT TEAS

A pleasant tradition of the past is revived

A

then. . .

long table set with a fresh
cloth and magnificent brass
candlesticks was laden with
plates of sweets and sand¬
wiches. Tea from handsome
samovars at either end was
graciously served in china cups and
saucers by medical school faculty
wives and their friends.
Small groups of professors and
students and their guests were
gathered in amiable conversation.
Everyone in the Yale medical
community was welcomed.
The faculty-student teas held
every weekday from October to
March, were started in the AOs by
Dean Milton Winternitz, reportedly
to provide medical students with at
least one good meal a day and to
teach them “the social graces.”
Most students then lived in three
shabby apartment buildings on
Howard Avenue or in boarding
houses scattered throughout the
city. There were only a couple of
inexpensive restaurants in the
neighborhood, and opportunities
for students to get together socially
were few and far between.
“1 suspect the refreshments served
at the teas were almost the only
supper some students had many
days,” observed Dr. Thomas R.
Forbes, the Ebenezer K. Hunt
Professor Emeritus of Anatomy.
Dr. Forbes’wife Helen, and Mrs.
Vernon Lippard, the wife of Dean
Lippard, managed the teas

—

informally

for more than a decade.
The students were in luck, recalls
Dr. Forbes, who was assistant, then
associate dean for students from
1948 to 1968. “There was the
atmosphere of an informal tea
party. Faculty ladies from the
various departments in the medical
school and their friends arranged an
attractive table, welcomed the
guests and poured countless cups of
tea. They all seemed to enjoy
themselves.”
In a letter written to Mrs. Forbes
in 1954, Mrs. Lippard noted that
tea was served on 99 days that year
to 15,933 persons — with an
average attendance of 161 each day,
at a cost of five-and-a-half cents per
person! “Judging from the numbers
who come and from what
individual students have said, the
teas are very much appreciated
indeed,” she said.
Times and attitudes change, and
seven years later, the wives of the
Board of Permanent Officers
reluctantly decided to discontinue
the daily teas, at least temporarily,
because attendance had dwindled
away. The Edward S. Harkness
Hall, completed in 1956, with its
spacious dining room and
comfortable lounge replete with
w'ood panelling, fireplace and a
grand piano, provided students with
nourishment and social amenities
the teas had so graciously given
them over the years.

William Carter

and now
William Carter

Marje Noyes

In the 20 years since, faculty and
student numbers have almost
doubled; many students again live
off campus and feel the need for
more “interaction, understanding,
knowledge and friendship between
faculty and students.” In January
1983, at the request of a committee
of first- and second-years students.
Dean Robert Berliner revived the
teas.
What they lack in grace and
elegance, the department-sponsored
gatherings held in the Beaumont
Room on the first Thursday each
academic month, make up for in
imagination. Once the Beaumont
Room was marvelously
transformed into a disco - complete
with Bashing lights and music. But
mostly the entertainment is, as in
days past, gathering together in
pleasant conversation.
Jugs of wine and cider and cans
of soda have replaced tea served in
stately samovars. Refreshments
prepared by students may include
cookies and sandwiches, but are
just as likely to be scoops of
homemade ice cream or baskets of
fresh strawberries (in December!)
with pots of hot fudge sauce to dip
them in. Guests help themselves,
and dress is decidedly informal.
As in teas of the ’40s and ’50s.
though, the mood is warm and
friendly and everyone has a good
time.

Dr. Thomas Forbes, right, enjoyed the earlier teas, and appears
also to enjoy the recent versions.
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ALUMNI NEWS
A New Policy for Alumni Children Applying for Admission
What is the School's policy with regard to
applications for admission from children
of medical school alumni? The question
is frequently asked, and this policy has
been under careful review during the past
year by Dean Rosenbergand members of
his stall.
Dr. Robert Gifford, associate dean for
medical education and student affairs,
has discussed the current policy with
various alumni groups during the past
tall He feels that all alumni should be

medical school alumni who apply for
admission will be granted an interview.
The interview w ill be given by members
of the Admissions Committee or by the
Associate Dean for Medical Education
and Student Affairs. The associate dean
also serves as an ex-officio member of the
Admissions Committee and can bring all
of the necessary information to the atten¬
tion of that body.
Since there are close to 3000 applica¬
tions each year, only five or six hundred
of the most qualified regular applicants
can be interviewed. From this pool, the
Admissions Committee usually accepts
about 200 of the top candidates in order
to fill the class of 102 students. Thus, only
one out of every 15 is accepted,
and one out of every 30 applicants is
eventually enrolled. As you can see, this

is an extremely competitive business and
many well qualified candidates will have
to be turned down.
However, all children of medical school
alumni will now be automatically inter¬
viewed, bypassing the usual screening
procedure. Of course, all final decisions
regarding admission will remain with the
Admissions Committee.
We hope that the school's new policy
regarding alumni children, and Dr. Gif¬
ford's personal contacts with these appli¬
cants and their families will help soothe
some of the unhappiness and disappoint¬
ment of those alumni whose children are
not accepted.
Letters commenting on this report are
most welcome. They should be sent to the
Editor, and will be shared with Dr.
Gifford and the alumni leadership.

1929

1946

1948

On October 6. Kay and Russell Scobie
celebrated their fiftieth wedding anniver¬
sary. The event was marked by an organ
recital and reception at Calvary Presby¬
terian Church in Newburgh. New' York.
Just prior to this event, a planting honor¬
ing the Scobies for their loyalty and
service to the community was dedicated
in the local historic park.

Donald Shedd, at Roswell Park Memorial
Institute in Buffalo, New' York, writes
that he was a guest speaker at a meeting
on head and neck surgery held in Goiania,
Brazil, near Brasilia, last May. He is co¬
editor of a new book concerned with
recent results of basic research and treat¬
ment of head and neck cancer, “Proceed¬
ings of the First International Conference
of the Society of Head and Neck Surgeons
and the American Society for Head and
Neck Surgery”. It was published in August
by B.C.Decker. Inc.

A profile of Boy Frame. w hich appeared
in the American College of Physicians’
Observer in September, summarized Dr.
Frame's career, noting him as one of the
top specialists in bone and mineral metabo¬
lism in the country. A few months previ¬
ously, he had been named chairman of
the Department of Medicine at Henry
Ford Hospital in Detroit; he is also
clinical professor of medicine at the Uni¬
versity of Michigan Medical School.
Dr. Frame’s civic support is evidenced
by his work with the Detroit Lions. From
1965 to 1975 he conducted all physical
examinations of the players, coaches and
management and for about eight years,
traveled with the team.
Dr. and Mrs. Frame have three children,
the oldest of whom is also a physician.
"One of the most pleasant experiences of
my life,” he says, “was working with Rick
in the hospital, doing rounds together.”
He has also been very actively working
with other young physicians — first as
ACP Governor for Michigan (he was
named Governor of the Year in 1981),
and now as Regent, he has been a prime
mover in the Associates’ program which
has become fairly W'ell integrated into the
College, both at the local and the national
level. This development is, in his opinion.

acquainted with the current policy. Our
alumni leaders concur, and that is the
reason for this report.
Dr. Gifford has said that he will person¬
ally follow up on the application of
anyone identified as the child of an
alumnus or alumna of the medical school.
As of the current year, all children of Yale

CLASS NOTES

1944
Robert Cooke has been appointed chair¬
man of the Department of Pediatrics at
the State University of New York at
Buffalo. He is also pediatrician-in-chief
at Children’s Hospital of Buffalo.
Dr. Cooke is a board member for the
International Special Olympics, the As¬
sociation of Retarded Children in Erie
Counts and the Encylcopedia of Bioethics
<ind is chairman of the Scientific Advisory
Board of the Joseph P. Kennedy, Jr.
I undation. He is a past president of the
Society for Pediatric Research.
lie has held the positions of president
I ili Medical College of Pennsylvania,
chancellor for health affairs at the
a \ of Wisconsin and pediatricianai the Johns Hopkins Hospital.
Dr. ( • kc is the father of six children; he
! his familv li\c in Orchard Park, N.Y.

1947
At recent inaugural ceremonies of an
International Conference on Thalassemia
held in Bangkok, Amoz Chernoff was
honored as a founder of thalassemia
research in Thailand. A “Citation of
Recognition” was presented to him by
H.R.H. Princess MahaChakri Sirindhorn
on behalf of her father. His Majesty
Bhumidol Adulyade. King of Thailand.
Dr. Chernoff, a resident of Potomac,
Maryland, is currently director. Division
of Blood Diseases and Resources, Na¬
tional Heart, Fung and Blood Institute,
National Institutes of Health.

necessary for the continued growth of the
College.
Although he claims not to have made
any outstanding contributions, he notes,
"1 have been interested in metabolic bone
disease, particularly some of the more
unusual and rare forms, and I have had
the opportunity to see patients with certain
diseases that were so rare that they had,
up to that time, not been recognized. My
associates and 1 were able to carry out
certain investigations and studies, particu¬
larly bone biopspy interpretation, in order
to understand the nature of underlying
bone disease.”

1959
In the November 1985 issue of Surfer
magazine, Malcolm Ing was one of several
Honolulu residents who were featured as
having an avid interest in the sport of
surfing outside of their professional ca¬
reers. Dr. Ing, who is chief of Ophthal¬
mology at the University of Hawaii and

at Queen’s Medical Center as well as
president of the Hawaii Ophthalmological Association, has been a surfing enthusiast since he was 15 and recalls his most
memorable surfing experience which was
in 1967, when he rode alone at Honolua
Bay in double overhead waves. His interest
has not waivered over the years and in
addition to the pleasure of the sport itself,
he considers surfing to be “one of the best
ways of dealing with the stresses of daily
professional life. When I’m sitting on my
board late in the day, 1 get to watch the
moon come up over Diamond Head, a
rainbow in Manoa Valley and a beautiful
sun setting over the Waianae mountain
range
the effect of this activity is
indescribable except to say that it stabil¬
izes my mind and body after a day in the
operating room.” Dr. Ing advises young
surfers “to remind themselves that the
body is the temple of the soul and that if
they keep it in good shape, they ought to
be able to go on surfing well into their
seventies and eighties
just as I plan to
do.”

1961
Roland Paegle and his wife, Grazina,
were in New Haven last spring for the
30th reunion of Roland’s Yale College
class. A recent letter notes that he thought
the co-ed arrangement at his alma mater
was a marked improvement over the
males only policy during his college years.
During his reunion visit, he also had an
opportunity to visit the School of Medi¬
cine. The Paegles have been located in
Marion, Indiana for the past two years.

1963
Jon FesseI,who has been in private prac¬
tice in the New Haven area for 15 years
and is assistant clinical professor of medi¬
cine at Yale, has been appointed chief of
internal medicine at the Yale Health
Plan.

1952

A class note in the fall issue told of recent activities of Willard
and Siegried Centerwall and of various honors they have
received. The photograph (left) received subsequently shows the
Centerwalls at the memorial to Dr. Asbjorn Foiling, the
Norwegian physician and biochemist who discovered
phenylketonuria 50 years ago. The Centerwalls participated in
the dedication of this memorial in Norway last June and were
honored for their work in the 1950's with dietary treatment of
PKU and the first early infancy testing programs for this
disorder.

NOTE: The Yale School of Medicine
Office of Alumni Affairs has relocated to
the Suite 3D, Sterling Apartment
Building, 350 Congress Avenue. The
mailing address remains: Office of Alumni
Affairs, 333 Cedar St., P.O.Box 3333,
New Haven, CT 06510; phone (203) 7854674.
Constance Q. Tolliver has been named
assistant to the director of the Office of
Alumni Affairs.
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1968

1974

1984

Grace Jordison Boxer, who is associate
chief of staff for education at the Ann
Arhor Veterans Administration Medical
Center, was one of 60 participants selected
to attend the prestigious Leadership VA
training program. Leadership VA is de¬
signed to identify gifted leaders in the
Veterans Administration and to enrich
their career development through an in¬

Frank Brown is director of Medical Af¬
fairs at Neema Emergency Medical, a
primary care physician group and manage¬
ment services firm based in Philadelphia.
He wrote that he has been appointed
chairman of The American College of
Emergency Physicians’national Member¬
ship Constitution and By-Laws Commit¬
tee. For the past two years. Dr. Brown
has served as the College's project director
for International Membership Affairs.

Dan Oren is the author of “Joining The
Club: A History of Jews and Yale.” This
book, the product often years of research,
was published in February by the Yale
University Press. The study began as a
term paper when he was a sophomore in
Yale College in 1976 and in his senior
year was expanded to a history thesis.
With encouragement from his professors
and help of the American Jewish Archive,
he decided to write the book while he was
a medical student and finished it about
thetime he received his M.D. degree. T he
book documents the dark history of antiSemitism and discrimination at Yale
which, along with Harvard. Princeton
and other prestigious educational institu¬
tions, was considered to be “the club” in
American social hierarchy. There is com¬
ment about the School of Medicine admis¬
sions policies instituted under the aegis of
Dean Winternit/.
Dr. Oren is currently a postdoctoral
fellow in the Yale Department ot Psy¬
chiatry.

tense year-long leadership training period.
She and her husband, Laurence Boxer
(’68 HS), who is director of Pediatric
Hematology-Oncology at Mott Children's
Hospital and professor of pediatrics at
the University of Michigan School of
Medicine, live in Ann Arbor with their
nine-year-old son, David.

1969
Charles Dinarello was the Elisha Atkins
Visiting Professor at Yale School of
Medicine in February and lectured on
“Changing Concepts of the Pathogenesis
of Fever.” Dr. Dinarello is professor of
medicine and pediatrics at Tults Univer¬
sity School of Medicine in Boston.
Elliot Livstone, who was associate profes¬
sor at Yale before leaving to practice
gastroenterology in Sarasota, Florida,
was the major guest lecturer at the First
Norbert Schnog lecture at the Yale Com¬
prehensive Cancer Center in September.
He spoke on “Pancreatic Cancer: Current
Status and Prospects lor the Future.”
Dr. Livstone noted that because pancre¬
atic cancer produces only vague symptoms
and there is no adequate screening test
for it, the disease is usually discovered in
an advanced state. Reporting on clinical
trials now underway for this disease, he
discussed the different kinds of chemother¬
apy being used and stated that the com¬
bined therapies have prolonged survival
for many people.
“The future,” Dr. Livstone said, "is in
using monoclonal antibodies both for
finding the tumors and for treating the
disease. New imaging technology should
also help us find pancreatic cancer earlier.
Norbert and Sue Schnog of Westport,
Connecticut, sponsored the lectureship
at Yale Comprehensive Cancer Center,
where Mr. Schnog has been under treat¬
ment for pancreatic cancer. They have
established the lectureship to help foster
an attitude of positive thinking in the
medical community so that physicians
v. ill focus on ways to treat the disease and
to help stimulate additional research by
increasing communication among those
who are already working in this area.

!4

1977
Ricky Schneider of Bryn Mawr, Pennsyl¬
vania has been elected to fellowship in the
American College of Cardiology. Dr.
Schneider is director of nuclear cardiology
and assistant professor of clinical medicine
at Presbyerian-U niversity of Pennsylvania
Medical Center in Philadelphia.
Harvey Berger wrote that on February I
he became Senior Vice President of Medi¬
cal Affairs and Director of the diagnostic
imaging and immunotherapy programs
at Centocor, Incorporated. He noted that
Centocor has, since its founding in 1979,
been committed to the development of
unique radiopharmaceuticals and thera¬
peutic products based on monclonal anti¬
bodies and to strong collaborations with
academic institutions. Dr. Berger also
will be a member of the Nuclear Medicine
faculty at the University of Pennsylvania.

1982
Craig Lewis wrote recently: "1 am now
completing my first six months of a threeyear commitment with the National
Health Service Corps in Yap State of the
Federated States of Micronesia, where I
am practicing internal medicine. Yap
hopes that an internist on island may
decrease the need for costly referrals. 1
am discovering with some surprise, that
quite good medicine can often be practiced
without knowledge of anion and osmolar
gaps. Of greatest excitement to me have
been seafaring excursions to the dispen¬
saries of the little known outer island
atolls for both emergency care and routine
support. 1 would strongly encourage a
Third World experience for anyone in
medicine so inclined.”

PUBLIC HEALTH

1973
As of October 21. Thomas Stranova of
North Easton, Massachusetts became
dean for administration at the Tufts
University School of Medicine in Boston.
He has been associate director and chief
executive officer in hospitals in Wisconsin,
California and Indianaand most recently,
chief executive officer at the Veteran’s
Administration Medical Center in Brock¬
ton West Roxbury. A lecturer at Harvard
Medical School, he was also on the
clinical faculty of the Harvard University
School of Public Health.
Mr. Stranova is a board member of the
Association of American Medical Col¬
leges’Council of Teaching Hospitals and
is a member of the Governor’s Health
Coordinating Council for Massachusetts.
Within the VA system, he had been on
the VA Management Information Systems
Task Force, and the VA Strategic Manage¬
ment Task Force.
Mr. Stranova and his wife, Mary, have
three children
Thomas .1. Jr., 14;
Nichole, 8; and Dana, 5.

HAVE WE HEARD
FROM YOU?
We’d like to. Please send news of awards,
recent publications, professional appoint¬
ment or other items of interest to the
Editor, Yale Medicine, P.O. Box 3333,
333 Cedar Street, New Haven, CT06510

A TIME OF CHANGE
IN MEMORIAM
Ella Wakeman Calhoun
November 27, 1985

’2IM.D.

Benedict R. Harris
November 3, 1985

’22 M.D.

Julius A. Olean
November 18, 1985

'23 M.D.

Saul Schapiro
December, 1985

'23 M.D.

William .1. Logan
November 15, 1985

’25 M.D.

Rebecca Proctor
April 10, 1985

’31 M.D.

Russel] A. Anthony

In his "State of Our School”address to the faculty in September 1984, Dean Leon
E. Rosenberg said, “II you join me in aspiring to be vibrant as well as vital, and to
soar as well as be sound, then we must strive even harder for excellence and be
prepared for change. It is this challenge of change which I see as the major agenda
item ot my deanship and it will take many forms.”
In fact, in the ensuing two years, there have been many changes, and some of the
most visible are quickly noted by alumni when they return to the School to find an
old building finely renovated for a new use, or a building under construction on a
parking lot. The pounding of jack hammers and screech of skill saws that has
become part of the environment here, will go on as our school continues to improve
and expand its facilities to remain at the forefront of medicine of the future. Some
of the projects begun in 1984 are nearing completion; others, such as the new
Center for Molecular Medicine and expansion of the Medical Library, are still on
the draw ing board.
It is a time of change and a time of excitement.

'42 MS

August 23, 1985
Mrs. Edith M. Blakeley
June 15. 1985

’46 M.P.H.

M. Otis Flanary
September 27, 1985

'49 M.P.H.

John P. Lamb, Jr.
1981 (?)

’49 M.P.H.

David Yakouhian

Katie Krauss

On a chilly day in February, the new nine-ton magnet for the
Magnetic Resonance Center was hoisted into the mostly under¬
ground addition to the LCI building at the corner of Davenport
and Howard Avenues. The MR Center, a joint project of the
medical school and Yale-New Haven Hospital, will bring together
)ale’s research and clinical activities in magnetic resonance
technology — considered one of the most important developments
in medicine in this decade. The building including offices, labora¬
tories and patient care rooms, will be equipped with two whole
body scanners, a small animal instrument and a high field
spectrometer. The four magnets will have a combined strength of
almost 450,000 times that of the earth's magnetic field.

On April 10 and II, a major symposium
on “Perspectives in the Management of
Eye Diseases" will celebrate the opening
of the Yale Eye Center for Clinical Re¬
search in the completely renovated Boardman Building. The $2.5 million project is
the culmination of 23 years of planning
by Dr. Marvin Sears, right in photo, who
has been chairman of the Department of
Ophthalmology and Visual Science since
it was founded in 1971. A regional,
national and international referral re¬
source, the Eye Center will be the only
facility of its kind between Boston and
New York for persons requiring diagnosis
and treatment of eye disease.

Marie Noyes

Across Howard Avenue from the MR Center, the Yale Center for
Ambulatory Medicine is becoming a reality. The facility, which
will consolidate clinics and offices of the Yale Faculty Practice
Plan currently scattered in 17 locations throughout the medical
center, is expected to attract individuals on an outpatient basis
f rom a wide geographic area for specialty and consultative services.
The estimated completion date for this project is February 1987.
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ALUMNI WEEKEND 1986
HIGHLIGHTS
subject to change
FRIDAY, JUNE 6

8:30
1:00 -3:00

Medical Alumni/ae Registration
Yale School of Medicine Class of 1961 Reunion Seminar
"Retrospective and Prospective Views. Twenty-five Years after Graduation." Speakers to include Kenneth
Arndt: David Brook; Philip Felig; Marguerite Stein Lederberg; Robert Levy; Vincent Marchesi; Charles
Sachatello; Robert daub; John Weil; Warren Widmann; John Woodward

1:15-2:30

Yale Child Study Center Grand Rounds

2:30-3:30

V ale C hild Study Center Open House

3:00

Special Alumni/ae Presentation
"Physicians and the Nuclear Arms Race”, John O. Pastore. M.D. ’67, Associate Professor of Medicine, Tufts
University; Secretary, International Physicians for the Prevention of Nuclear War.

4:00

Yale School of Medicine Special Address
" The Challenge of Yale Medicine: Protecting Excellence in an Unpredictable Environment”, Samuel O.Thier,
M.D., President, Institute of Medicine, National Academy of Sciences

5:00

Dean’s Reception
(Medical School, Public Health and Nursing Alumni/ae, Faculty, Students and Guests are invited)

7:30-9:00
9:00-1:00

Medical Alumni/ae Reunion Dinner*
V ale School of Medicine Reunion Dance**
Co-sponsored by the Yale School of Medicine 1986 Reunion Class. (All Yale-New Haven Medical Community
and Guests are invited)

PUBLIC HEALTH
Association of Vale Alumni ae in Public Health (AYAPH) and Yale University Hospital Administration
Alumni Association (YUHAAA)
"The Urban Public Health Crisis”
8:30-9:30

Registration and Coffee

9:30-10:00

Welcome and Opening Remarks

10:15-12:00

Concurrent Sessions****
AYAPH Workshop 1
“Critical Urban Public Health, Environmental Health and Mental Health Issues”.
YUHAAA Workshop 1
“Impact of the Prospective Payment System on City Hospitals”.
Speakers for both workshops to be announced

12:15 - 2:00

Luncheon***
Special Presentation to be announced

2:15-4:00

Concurrent Sessions****
AYAPH Workshop II
"Minority Health Issues of the Eighties”.
Yl IIAAA Workshop II
“Fighting the High Cost of Care with Alternative Payment Systems”.
Speakers lor both workshops to be announced

4:15-5:00

Annual Meetings — AYAPH and YUHAAA

SATURDAY, JUNE 7
8:30

Medical Alunini/ae Registration

9:15-9:45

Remarks: A.Bartlett Giamatti, President, Yale University

10:00-11:30

Seminars
I. “Seventy-five Years of Child Development at Yale”. Moderator: Donald Cohen, M.D., director, Child Stud)
Center. Participants: David Musto M.D.; Melvin Lewis, M.D.; James Leckman, M.D.
II. “Medical Education and Student Affairs”. Participants: Robert Gifford, M.D., associate dean. Medical
Education and Student Affairs; Thomas Lentz, M.D.; Pamela Nyiri
III. “New Directions in Geriatrics at Yale”. Participants: Leo Cooney, Jr., M.D., director, Continuing Care
Unit, Y-NHH; Ronald Miller, M.D.; Mary Tinetti, M.D.
IV. “Recent Advances in the Understanding and Treatment of Affective Illness” Participants: George R.
Heninger, M.D. director, Abraham Ribicoff Research Facilities; Dennis S. Charney, M.D., chief, Clinical
Research Unit; Lawrence Price, M.D.

9:45-12:00

Guided Tours: Yale Art Gallery; Yale Center for British Art; Historic Sections of New Haven

11:45-12:30

Annual Meeting of the Association of Yale Alumni in Medicine

12:30-1:00

Sherry

1:00-2:00

Buffet Luncheon

2:00-4:30

Yale School of Medicine Class of 1961 Dialogues

2:30

School of Medicine Alumni Fund Class Agents Meeting

2:45

Guided Tour: New Facilities of the Yale Eye Center for Clinical Research

Individual class parties and dinners for the five year reunion classes (’26, ’31, ’36, '41, ’46, ’51, ’56, '61, ’66, ’71, ’76, ’81).
Information will be available at Alumni registration Desk.

^Prepaid advanced reservations required. Reservations limited
**Prepaid advanced reservations required. For additional information, contact Connie Q. Tolliver, Assistant to the Director, Otlice ol Alumni
Affairs, Yale School of Medicine, P.O. Box 3333, New Haven, CT 06510, (203) 785-4674
***Prepaid advanced reservations required (luncheon cost to be announced)
****Program fee $30 per person. For additional information contact Elizabeth Lorenzi, M.P.H. 79, Alumni/ae Activities Coordinator,
Epidemiology and Public Health, Yale School of Medicine, P O.Box 3333, New Haven, CT 06510, (203) 785-4845
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CAMPAIGN UPDATE
Nearly $70 million received to date

Dr. and Mrs. A. John Anlyan

Mr. and Mrs. Adrian C. Israel with Dean Rosenberg

By mid-January, the School of Medi¬
cine had received gifts and pledges
amounting to $69,054,556 toward its
$125 million capital campaign.
“We have received gifts from foun¬
dations, corporations and individuals,
including alumni of Yale College as
well as of the medical school,” said
Sue B. Dorn, associate vice president
and director of medical school develop¬
ment. “The dollars recognize the
School's past and attest to the enthusi¬
asm for the direction it is taking.”
Highlights of the campaign so far
include a gift of $1 million for renova¬
tion of research space in the Section
of Molecular Neurobiology from one
of the School’s distinguished alumni.
Dr. A. John Anlyan, '42 S, '45 M.D.,
and his wife, Betty Jane Renneckar
Anlyan, of San Francisco, California.
A prominent surgeon, recently re¬
tired, Dr. Anlyan has been a consistent
supporter of the medical school over
the years. In addition to serving on
the Yale Development Board, he is a
member of the National Volunteer
Committee for the Campaign for the
Yale School of Medicine. Dr. and
Mrs. Anlyan’s contribution will fur¬
ther important research being done
at Yale to determine the structure
and function of the brain at the
molecular level.
Two major gifts have been received
toward construction of the Magnetic
Resonance Center. The Pew Memor¬
ial Trust of Philadelphia has given
$ 1.5 million, and Mr. and Mrs. Adrian
C. Israel of Stamford, Connecticut,
and their family have contributed
$1,250,000 toward the project.
Mr. Israel, who received a B.S.
degree in 1936 from Yale’s Sheffield
Scientific School, directs his family
business in White Plains, New York.
Active in alumni and fund raising
activities for many years, he has
served on the Yale Development
Board since 1946.

The Israel family gift completes
the school’s drive for construction of
the Magnetic Resonance Center, ac¬
cording to Mrs. Dorn. The center,
which represents an important ad¬
vance in research and patient care, is
scheduled for completion this year.
Pledges have been received of
$500,000 from the Charles E. Culpep¬
er Foundation to establish the Charles
E. Culpeper Fund in honor of Dr.
William W. E. Glenn, and of $ 125,000
from International Playtex Corpora¬
tion toward research in clinical epidem¬
iology. Inaddition, agift of $100,000
from the Surdna Foundation of New
York will endow a research venture
fund in human genetics.
The Charles E. Culpeper Fund in
honor of Dr. William W.F.Glenn
recognizes the Charles W. Ohse Pro¬
fessor Emeritus of Surgery, who is
well known to alumni as an out¬
standing teacher and surgeon, and is
recognized throughout the world for
his pioneering work on radiofre¬
quency pacemakers to regulate heart¬
beat and respiration.
By providing financial support,
the endowed permanent research ven¬
ture fund will permit the school’s
most promising young physicians to
pursue personal research interests
early in their career, allowing them to
become eligible for support from
traditional funding sources several
years sooner than is normally the
case.
In addition, Mr. H. P.J.Duberg of
Hobe Sound, Florida has given
$100,000 to establish a research fund
in neurosurgery. A graduate of the
Yale College Class of 1930, Mr. Duberg has had a strong interest in the
School of Medicine for a number of
years, contributing to student finan¬
cial aid as well as supporting young
faculty research. In 1978, he estab¬
lished the Dorys McConnell Duberg
Professorship in Neuroscience in
honor of his late wife.

Dr. William W.L. Glenn
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Yale School of Medicine - Community Hospital Affiliations

A TWO WAY STREET
THAT IS WIDE OPEN
by James D. Kenney, M.D.
Just over twenty years ago, during the era of “The Great
Society,” Congress passed public law 89-239 (The Heart
Disease, Cancer and Stroke Amendments of 1965), which
enabled regional planning for the establishment and linkage
of health services. Those who drew up the legislation might
now be seen as having built better than they knew for,
although they expected significant technical advances in
health care, they could not have predicted the “imaging
revolution” which was to occur in the next two decades, nor
the extraordinary advances which were to occur in microsur¬
gery, transplantation, manipulation of the immune response,
antibiotic therapy and the technology of intensive care.
Certain early sophistication, such as arterial blood gas
determinations and cardiac monitoring, had begun to be
widely available, however, and the architects of regional
medical planning (not yet called “health care delivery”)
sought to develop relationships which would enable easy
dissemination of new knowledge and technology. Although
they sought to involve the consumer public in this planning,
they aimed, as specified in the law, “to accomplish these ends
without interfering with the patterns or the methods of

Dr. Kenney, clinical professor of medicine, is associate dean for graduate
and continuing education.

financing of patient care or professional practice, or with the
administration of hospitals, and in cooperation with prac¬
ticing physicians, medical center officials, hospital admini¬
strators and representatives for appropriate voluntary
health agencies.” The focal points for this sought-for unity
were to be the major medical centers. Professional leadership
at the various institutions in the scheme was to enable its
coherence.
The situation in Connecticut which preexisted this plan¬
ning effort was already developed. Standards of care were
generally good and all hospitals were JCAH approved.
There were no proprietary hospitals. I he geographic area
was small, transportation was good and there were no
specific geographic barriers. Many institutional linkages
already existed, and the schools of medicine were already a
recognized “presence.” Regional teaching and consulting by
Yale faculty had been provided for many years, sometimes
through the Dean’s Office and sometimes on an individual
basis. To use the schools of medicine as focal points for
planning was perceived as reasonable and proper. The
Connecticut Regional Medical Program (CRMP) was
established.

STRUCTURE
The key feature of the new pattern was to be the installation
of fulltime chiefs of service in regional hospitals. These
physicians were to relate to schools of medicine in two ways:
first by virtue of their having faculty appointments and
second, by having the initial funding of their salaries come to
their parent institutions through affiliated schools of medi¬
cine. Their loyalties and interests would be directed to the
institutions in which they worked, to their colleagues in the
profession and to the schools of medicine in which they had
appointments.
Public influence on the scheme was to be exerted through
the appropriation of funds fora number of “field demonstra¬
tions” which were to influence the conduct of events within
the affiliation. The traditional counter-position of physicians
and hospitals was to be modified by introduction of the
consumer “third force” and key personnel.
ACCOUNTANCY
In the five years 1968 through 1973, under the terms of
formal affiliation agreements, positions were created and
most of them filled for 75 hospital-based physicians at
various Connecticut hospitals. In Yale’s case, the affiliation
agreements have been continued in all instances but one and
have been refined and renegotiated over succeeding years.
The School of Medicine now has affiliation agreements with
ten hospitals (Bridgeport, Danbury, Greenwich, Griffin
Hospital in Derby, Hospital of St. Raphael in New Haven,
Lawrence and Memorial Hospitals in New London, Norwalk
Hospital, St. Mary’s Hospital in Waterbury, St. Vincent’s
Hospital in Bridgeport and Waterbury Hospital).
A number of efforts are enabled in this way, including
contracts for teaching by Yale faculty, rotation of house
officers from Yale-New Haven Hospital to some six regional
hospitals, and from eight regional hospitals to Yale-New
Haven Medical Center. Physicians in fellowship training
rotate to five regional institutions from the School of
Medicine, and fellows from two — sometimes three regional hospitals have come to Yale to expand their
training.
Yale’s influence on scholarly events at regional institutions
has been magnified in several ways. One worth special
mention is that of contracts for didactic services, first
developed under Dr. Samuel Thier, until recently, chairman
of the Department of Internal Medicine. Such contracts not
only provide Yale faculty teaching, but also include adver¬
tising by the school of residency training at the affiliated
institutions and enabling of rotations for fellows and
housestaff, thus improving the fabric of internal medicine
education. At present, some 40 contracts exist between
several Yale departments and their regional hospital
counterparts.

In the final analysis, however, it is the fulltime chiefs at
regional hospitals who are the strong points in the linkage.
They have become “prudent buyers” of academic substance
from Yale while, at the same time, they serve as leaders in
organizing graduate and continuing education at their own
institutions. During the academic year, the regional chiefs of
medicine meet monthly at one of the affiliated institutions
for dinner and a review of common concerns and opportun¬
ities. The Yale chairman attends these meetings. Less
frequent, but regular meetings of their surgical colleagues
occur as well.
UNIQUENESS
As this scheme has matured, a very large number of
successful enterprises have blossomed. The excellent Depart¬
ment of Pediatrics at Bridgeport Hospital, where Yale
residents go for regular training, and which enables out¬
patient care for a nearby underprivileged area, is one
example. The faculty at Danbury Hospital is not only
notable for skills in nuclear medicine and cardiology, but is
in a general way, strong enough to enable the hospital to
present its first “Research Day” this year.
Lawrence and Memorial Hospitals have no house staff
but provide for continuing education for the attending staff
under the terms of several contracts. That hospital, located
near nuclear power generators on the Thames River, the
submarine base at Groton, and a number of industrial
enterprises which carry with them some possibility of
occupational hazard, has drawn upon the expertise of Yale's
Section of Occupational medicine and has set up an
occupational medicine clinic. In May, 1985, after Three
Mile Island but before Chernobyl, the hospital sponsored a
state-of-the-art program on “Medical Aspects of Radiation
Emergencies.” Dr. Paul Hoffer, Yale radiologist, was a
principal in planning this program.
St. Raphael’s Hospital, nearby in New Haven and an easy
site for the extension of Yale programs is closely involved in
several important ways. The school’s Department of Pedia¬
trics joins the hospital departments at both Yale-New Haven
Hospital and St. Raphael’s Hospital in common purpose.
No less than four fellowship programs in internal medicine
include a rotation to St. Raphael’s Hospital, thus enriching
internal medicine training at that institution, while working
with an experienced group of senior physicians. Because of
the existence of the Yale Comprehensive Cancer Center, an
outpatient cancer chemotherapy facility was enabled at St.
Raphael’s Hospital through an NIH grant. The grant linked
programs at St. Raphael’s to Yale, which provided protocols,
biostatistical aid and an academic base. All of these
developments have been enabled by perceptive leadership
on the part of St. Raphael-based physicians.
Excellent overall programs at Waterbury and St. Mary’s
Hospitals, to both of which Yale-New Haven medical

residents have rotated, deserve mention. Both have been
popular with the housestaff; the present chief resident in
medicine at Waterbury Hospital moved there from the YaleNew Haven training program. As the School of Medicine’s
program in human genetics has matured, its outreach to
regional hospitals has been extended. Substantial programs
in human genetics are now in place at Bridgeport, Danbury
and Norwalk Hospitals. At this last hospital, the Yale
presence has been so substantial that its now retired
director, Norman Brady, referred to it some years ago as
“Yale’s campus in Norwalk.” Programs at Greenwich,
Griffin and St. Vincent’s hospitals also have special qualities.
A LARGER CAMPUS?
The observation about “Yale’s campus” at a regional
hospital was in some measure prescient. At the Office of
Graduate and Continuing Education, records are kept of the
weekly education programs at all regional hospitals. The
School’s presence at these institutions is unmistakable. Yale
faculty participate in lectures, seminars, ward rounds and
even clinic work. Their impact upon the general standard of
medical practice at these institutions is inevitable.
At the same time, however, the capacity of regional
hospitals to do for themselves has grown as well. A good
example is the recent establishment of a Liaison Committee
for Surgical Education, which has a strong Yale base but has
equally strong leadership from chairmen of the four regional
hospitals with free-standing residencies. Their programs are
reinforced by the provision of solid teaching from Yale
faculty in basic sciences, essential for any surgical residency
program. At the same time, the four chiefs have themselves
arranged to be active participants in a quality control
mechanism at each other’s institutions, not depending upon
Yale for the provision of all academic leadership but
working with the Yale department. The bridge between
Yale-New Haven Hospital and St. Raphael’s Hospital in
pediatrics is a sound one; it not only provides an excellent
base for the training of house officers, but it enhances the
practicing community of pediatricians in New Haven.
Recently, at a meeting of the Medical School Council to
which representatives from all affiliated hospitals were
invited. Dr. Robert Gifford, associate dean for medical
education and student affairs, set forth an invitation and a
challenge to them to participate even more fully in the work
of the medical school. The now common perception that
inpatient care needs to be associated with an ever stronger
component of outpatient practice and a broader institutional
base, is as true at Yale as it is anywhere else.
Opportunity has thus emerged for even closer ties between
the School of Medicine and affiliated hospitals in time to
come. First class clerkships and intensive teaching at
regional institutions can find a place in the curriculum. A
director of medical education at one regional hospital

recently speculated that in the future we might not only have
“one campus”, but even a disappearance of the notion of
“town and gown.” As he put it, “everybody would be gown.”
THE FUTURE
It is conceivable that the affiliations instituted in the late
1960s, which have clearly become a functioning and success¬
ful part of the larger pattern of health care in the state of
Connecticut will continue to evolve successfully. When one
reviews early documents pertaining to our present establish¬
ment, a comment by Dr. Arthur Ebbert, Jr., deputy dean of
the medical school, at the first Conference on Yale University
School of Medicine - Community Hospital Relations in
September 1969, stands out. At that time. Dr. Ebbert said,
“Let me emphasize that to be effective and to be lasting, the
medical school-community hospital relationship must be a
two-way street. Each party must see definite benefits. A
one-way relationship will eventually lead to a dead end and
ultimate failure.”
It is pleasant to report that the two-way street remains
wide open. The relationships are healthy ones, with the
collegiality of physicians perhaps the most important among
them. Just as the profession in Connecticut was strong at the
time of the establishment of regional medical planning, it
has remained strong and, in significant ways, truly a
profession. In these days, when medical practice and the
provision of health care are increasingly viewed as businesses
and as physicians become anxious about a dominant role for
payors in health care, the facts of intellectual progress and
collegiality which have been significantly aided by the
regional hospital affiliations are pleasant to contemplate.
We hope to see them grow stronger.

an innovative education development program

by Marje Noyes
The Martin Luther King, Jr. Elementary School in New
Haven has become a model for scholastic and social
achievement for inner city schools throughout the country.
Located in a deteriorating neighborhood, with 99 percent of
its pupils minority children of mostly welfare dependent
parents, and a teaching staff that is 50 percent black and 50
percent white, this school was the first to participate in a
school development plan designed to raise the expectations
and achievements of inner city children.
The program, begun in 1968 as a joint project of the Yale
Child Study Center and the New Haven school system, is
focused on the school’s psychological makeup and the
triangular relationship between students, teachers and
parents. So successful have been the results in the King
School, that it is being introduced throughout the New
Haven school system as well as in schools in Stamford,
Connecticut, Benton Harbor, Michigan and Prince George’s
County, Maryland.
The mastermind of this innovative approach to education
is Dr. James P. Comer, Maurice Falk Professor in the Child
Study Center and Psychiatry at Yale and author of School
Power (1980), who has received wide recognition for his
w ork in promoting a better understanding of the problems
as well as the potentials in educating minority children of
low income lamilies. In developing the program. Dr. Comer
harked back to the days before large scale technology and
science had eroded some of the basic tenets of the social
structure of the nation.
Before the proliferation of cars and TV, children learned
how to deal with life through examples set by their parents
and teachers and other important authority figures and
behavioral models, according to Dr. Comer. Schools were
an important part of the social fabric of the community,
whether they were inner city or rural, and there was a feeling
ot mutual respect and trust between school and home.
"When 1 went to the grocery store with my mother and
father in the 1940s, it was a rare day that we did not
counter someone from my elementary school
the
ustodian, the principal, the secretary or a teacher. There
add always bean exchange of pleasantries and sometimes.

an exchange about my school behavior or achievement. The
knowledge that my parents knew and appeared to like and
respect the people at my school had a profound impact on
my behavior,” recalled Dr. Comer. “The authority my
parents held by virtue of the care and guidance they gave me
was transferred directly to the people who ran the school.
My parents were physically present at school only on
visiting days and other special occasions, but their involve¬
ment with the school, though indirect, was meaningful and
constant.”
The aim of the school development program at King
Elementary School, and subsequently the other schools that
have participated in the project, was to restore a reasonable
degree of trust, mutual respect and consensus about objec¬
tives and methods of education among the school staff,
pupils and their parents, while at the same time being
responsive to contemporary needs and social concerns.

“Given the complexity of the modern
world, today ’v students need more adult
help than children did in the past.
Programs that involve parents effectively
in the schools can provide a desirable
context for teaching and learning. ”
Dr. Comer
“A disproportionate number of children of low income
families are academically and socially underdeveloped,”
explained Dr. Comer. “They require assistance in developing
skills needed for school success, but because most staff
members are not trained to provide such assistance, they
tend almost automatically to label the behavior of these
pupils as ‘bad’, and they view them as less able than other
students. The teachers punish the children or hold low
expectations of them, which in turn, results in inadequate

Dr. Comer

teaching efforts,” he continued. “This adds to distrust,
alienation and conflict between home and school, further
eroding the relationships among all involved in the education
experience. Adequate learning is then not possible.”
Based largely on principles of mental health, the School
Development Program applies techniques of intervention
and primary prevention to basic problems oi inner city
schools. The strategy is to coordinate school management,
curriculum and staff development with the teaching and
learning process.
The assumption is that the vast majority of children can
acquire the psychological, social and academic competencies
required to function sufficiently in and after school when the
school environment is adequate, according to Dr. Comer.
The hypothesis is that, as the organization and management
system of a school successfully provides all participants in
the education process — students, school staff and parents
- with sufficient educational and interactional skills and
support, the academic achievement and social performance
of students will improve and provide residual academic,
social and psychological benefits to students.
The rationale for this hypothesis is drawn from an
ecological perspective, which suggests that underlying and
major causes of dysfunction in human systems or institutions
is more on an interactional than a largely interpersonal or
individual basis, and is due to organizational and manage¬
ment limitations as much, or more than, individual short¬
comings. Dr. Comer describes the case of a young transfer
student to the King School as a case in point.
The eight-year old boy was dropped off at the King
School, which is in a neighborhood that couldn’t be in
further contrast to the small rural town in North Carolina
that he had come from. He was taken almost at once to his
classroom. The teacher, who had received three transfer
students only the week before, had the exasperated look ot
“all I need is another one.”
The little boy had just come from a warm family, school,
church and community setting in which he had felt secure. A
well-meaning relative had brought him north to get “a better
education.” Here he was, alone in a strange city, living with a

relative he barely knew, and in a school totally different
from the one he had been attending.
“He took one look around the classroom full of strangers,
kicked the teacher in the leg and ran out. It was a classic fight
and llight reaction to separation anxiety and fear,” observed
Dr. Comer.
In many schools, the child would have been punished.
Instead, the psychosocial dynamics of his behavior were
discussed. The teachers planned ways to welcome him and
help him adjust to his new environment. The incident also
pointed up some deficiencies in the school system’s transfer
process, which have since been modified.
“Intervention is a process, not a package of materials,
instruetional methods, behavior modification techniques or
personnel,” explained Dr. Comer. There are four key
elements to the program: a representative governance and
management group; a parent participation group; a mental
health program and team, and a curriculum and staff
development program.
Teachers, parents and aides select their representatives to
the 12-member representative governance and management
group, which is headed by the school principal. This
important body identifies problems and opportunities within
the school, matches resources with school needs, develops
and implements programs to address the problems and
opportunities, and evaluates programs and modifies them
appropriately. All of the adults in the school feel represented
in the decision-making process as a result of the activities of
this group.
In addition to selecting a representative to serve on the
governance and management body, the parent’s group
participates in the parent-aide program, in which a parent
serves as an aide in each classroom for approximately 15
hours a week, receiving a minimum wage. Parent aides are
the core of the parent group, which also sponsors a variety of
programs in support of enhancing the school climate and
achievement goals. Their presence and participation with
the staff ensures a culturally consistent social and academic
program, so that children do not feel the social distance
between home, primary social network and school. In turn.
5

“Frequently, efforts at instituting major
change fail because too little attention is
paid to personal relationships and to
bureaucracy issues that are common to
all organizations, but are potentially
more problematic in schools because
children are developing and thus
vulnerable, their parents though able, are
underdeveloped, and most school
personnel lack preparation to address
these Conditions." - Dr. Comer

involvement of parents promotes a good feeling about the
school to other parents and to the community in general.
I he mental health team - psychiatrist, social worker,
psychologist-program evaluator and helping teacher — is
organized in a way that enables staff and parents to apply
principles of the social and behavioral sciences to every
aspect of the school practice. For instance, the team has
helped teachers understand and apply child-development
theory and practice in ways that assist a child in trouble to
leave the classroom gracefully; that promote adjustment of a
transfer student; that teach children in conflict to learn to
negotiate rather than to fight it out; that help teachers grasp
why many parents are reluctant to participate in school
programs; that help the president of the parent group to
develop programs that keep members interested and in¬
volved, and that help the school principal appreciate the
value of parent and teacher participation in what had long
been considered the school administration’s territory.
Have Dr. Comer's strategies worked? If progress in the
Martin Luther King, Jr. Elementary School and two other
New Haven elementary schools that have been participating
in the School Development Program since the 1970s, is any
indication, the answer is a resounding yes. These interven¬
tions have reduced distrust, alienation and conflict and have
led to increased staff energies and expectations of each other
and of their students. As the social climate improved, the
level of learning gradually increased.
In 1969, when the program began, fourth grade students
in King Elementary School trailed the national average in
reading and mathematics by 19 and 18 months respectively.
Pupil and staff attendance was poor, classroom behavior
often resembled bedlam, and staff-parent relationships were
poor at best.
After some tribulations in the beginning, testing the
resolve ol the most determined educators, the school began
to make measurable progress. By 1984, the fourth graders
were one year above grade level in reading and math. They
were tied for third out of 26 New Haven schools. King third
aders ranked fifth in mastery of skills, and the school has
:ed lirst or second in attendance four of the last five
\ 1982 study showed that seventh grade students who
tided King scored higher in all academic areas than
n w ith similar socio-economic backgrounds who had
i I
other New Haven public elementary schools. And,

not a single teacher has voluntarily left the school since 1975.
The School Development Program is one of the longest
running public school-university cooperative school improve¬
ment efforts in the country. Although the intervention
methods have been modified slightly for cost effectiveness
during the eighteen years since it began, their intent remains
essentially the same. A program designed to train educators
to serve as intervenors and to use the intervention process
model was initiated in 1980 and continues. Evaluation of the
program has been ongoing and is currently a major focus.
The original approach of carrying out general evaluations
has moved toward more detailed research to study the long¬
term effects of the intervention and to pursue other research
questions.
“Our program, and others like it in other cities, clearly
show that inner city children can learn at significantly higher
levels than is common,” said Dr. Comer. “It is the obligation
of each school and school system to make this possible.”

“The poor education low income
minority children receive in inner city
schools contributes heavily to our social
problems: unemployment and
underemployment, welfare dependency,
troubled race relations, delinquency,
crime. Inner city children can achieve at a
much higher level. ”
Dr. Comer

“The blood is the Life” — Deuteronomy, 12:23
“Blood is the originating cause of all men's diseases” —
Baba Bathra, 111.58a

researchers and clinicians in the Section of Hematology join in a concerted effort to discover causes

of

DISORDERS OF BLOOD
by Marje Noyes
From the earliest times, philosophers and scientists have
theorized about the origin and meaning of blood. The
unprecendented advances in medical technology during the
past quarter century have done much to unravel the
mysteries of this “vitaI ingredient ”, but many questions
remain unanswered, and more importantly, cure and preven¬
tion of disorders of blood remain elusive.

R

esearchers in the Section of Hematology at Yale
including Drs. Bernard Forget, Sally Marchesi,
Edward Benz and Paul Lebowitz, are working to
answer some very basic questions for a better
understanding of the causes of inherited disorders and
cancers of blood. Using techniques of molecular and cellular
biology and molecular genetics to study normal and ab¬
normal blood cells, their work is mainly directed at genes for
hemoglobin, the principal protein of red blood cells, and at
oncogenes of blood cells.
“Red blood cells have served as a key to experimental
medicine throughout the history of modern biology,” said
Dr. Benz. “They form the most accessible tissue in the
human body, and are much simpler than most cells. You can
easily get an idea about which substances are the key
ingredients — which are the most important molecules, and
then develop antibody or DNA or RNA probes to look at
other tissues for similar proteins in order to understand how
they function.”
“The things we have learned about normal hemoglobin
gene structure, as well as about defects of these genes, have,
in fact, been found to be true in other gene systems as well,”
observed Dr. Forget, professor of medicine and human
genetics, and head of the Section of Hematology.
Dr. Forget’s research is concerned with the molecular
genetics of globin gene expression and genes for the red cell
membrane protein called spectrin. Dr. Marchesi is studying
the spectrin, the major protein of the red cel! cytoskeleton.
Dr. Benz is conducting research to increase knowledge
about the genetic regulation of blood cell differentiation and
the molecular genetics of inherited blood disorders. Dr.
Lebowitz has focused his work on the mechanisms of
malignancy in hematological tumors. Much of their work is
done in collaboration with investigators in cell biology,
human genetics, physiology and pathology.

n outstanding example of this collaboration is
research to determine the cause of beta thalassemia
/ Y by Dr. Forget and Dr. Sherman Weissman, profes
JL jk.sor of human genetics, medicine and molecular
biophysics and biochemistry. The work began 20 years ago
when the two were at the National Institutes of Health in
Bethesda, studying the biochemical defect involved in
thalassemia. Later at Yale, using the then newly developed
recombinant DNA techniques for cloning globin genes, they
discovered the precise genetic cause of this devastating
anemia in a child of Greek ancestry. Thirty-seven different
mutations of the hemoglobin gene that can cause beta
thalassemia have since been identified by various investi¬
gators and the research continues.
Drs. Lorget, Weissman and Benz subsequently were able
to demonstrate how the initial gene mutation causes deficien¬
cy in hemoglobin synthesis by altering the precursor messen¬
ger RNA molecules. The studies have this far provided a
means for precise diagnosis in utero for thalassemia and for
sickle cell disease. Studies on thalassemia here, and at
several other medical centers, provided the first opportunity
to study a human disease at the level of DNA and RNA
sequences of specific genes.
“The lessons we have learned from studying hemoglobin
genes in thalassemia can be applied to a whole gamut of
inherited diseases,” said Dr. Forget.
In normal persons, hemoglobin present during fetal life is
different in structure from that of hemoglobin shortly after
birth. Both of these hemoglobins have two pairs of subunits
or chains — the alpha chains and the beta-like chains.
“The difference between fetal and adult hemoglobin lies in
the beta-like chain,"explained Dr. Forget. Fetal hemoglobin
contains a pair of gamma chains; adult hemoglobin, a pair
of beta chains. The switch from fetal to adult hemoglobin
—the turning off of the gamma chain gene and turning on of
the beta chain gene — takes place during the first six months
of life.
Beta thalassemia and sickle cell disease are the result of a
defect in the beta chain. In sickle cell disease, the defect is
characterized by an abnormal amino acid in the structure of
the beta chain. In beta thalassemia, it results in little or no
production of beta chains.
“If it were possible to suppress the switch from fetal to
adult hemoglobin in individuals diagnosed as having one of
these disorders, we could prevent the deleterious conse¬
quences of these diseases,” said Dr. Forget.
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Dr. Forget
In research to discover the genetic mechanism that
regulates the switch from the gamma chain to the beta chain,
he and his colleagues are studying individuals with hereditary
persistence of fetal hemoglobin (HPFH), found predomin¬
antly in persons of African and Mediterranean ancestry,
where the gamma chain is not switched off and the beta
chain is suppressed. Persons with HPFH present no clinical
symptoms and are able to lead perfectly normal lives,
according to Dr. Forget.
“With the use of recombinant DNA technology, we have
been able to isolate the gamma genes of H PFH individuals
and to determine where the abnormality is located," said
Dr. Forget. “Now' our work is to identify the negative and
positive factors that may be involved in the failure to sw itch;
to purify them and to find the genes responsible for them.”
And how would these discoveries be applied therapeutical¬
ly? One way might be to modify the genes for these factors by
genetic engineering so that factors which normally recognize
the beta gene would instead, recognize the gamma gene and
turn it on. Another approach might be to introduce a
normal beta globin gene into bone marrow cells which have
only abnormal beta genes. “But we are many years away
from that type of gene therapy,” said Dr. Forget.
In another study, he is investigating the genes for the red
blood cell membrane protein called spectrin. In broad
terms, this study is directed at understanding tissue specificity
of gene expression.
"By studying the red cell spectrin gene and comparing its
regulatory regions to those of the brain spectrin gene, we
ought to find out what signals are present that specify a
certain program of gene expression in certain types of cells,”
commented Dr. Forget.
Hemoglobin genes are present in all cells, but only
i unction in red cells. Why are certain genes turned on only in
. rtain cells and not in others? “The determining feature
ast reside in the DNA structure of the genes. By comparing
structure of globin and red cell spectrin genes it should
ssible to identify common features that might be the
n s for tissue specificity,” he explained.

hile Dr. Forget is investigating gene specificity in
red cell spectrin. Dr. Sally Marchesi, associate
professor of medicine, is studying the structure
of spectrin itself. Analyzing blood samples from
the same patients, the two laboratories are working in
concert
Dr. Forget and his colleagues are hoping to
determine specific abnormalities of a gene which will
confirm what Dr. Marchesi and investigators in her labora¬
tory find out about spectrin protein.
A graduate of the School of Medicine, Dr. Marchesi’s
interest in hematology began when she was an N1H fellow in
the laboratory of Dr. Christian Anfinsen, a well known
protein chemist. After further training, specifically in hema¬
tology, she returned to Yale as an assistant professor of
medicine and pathology, doing research, teaching and
caring for patients.
At the time when knowledge of the structure of cell
proteins had advanced to the point where it could be applied
to studies of blood disorders, her clinical activity and ability
to recognize patients with specific hematologic abnormalities
were important assets in the laboratory. Earlier, working
with platelet membranes. Dr. Marchesi was able to identify
specific platelet surface glycoproteins and make antibodies
to these membrane components which were subsequently
used to study megakaryocyte growth in bone marrow tissue.
In 1978, she turned her attention to studies of spectrin
protein, in collaboration with Dr. Vincent Marchesi, chair¬
man of the Department of Pathology, who is recognized
worldwide for his research on cell membranes. Membrane
proteins are important to the shape of the red blood cell,
which is normally discoid, but which has remarkable
properties of deformability which allow it to pass through
tiny capillaries during its 120-day life span.
There is a group of anemias, characterized by abnormal
red cell shapes, the most common of w hich are elliptocytosis
and spherocytosis. These cells are poorly deformable and
are damaged as they pass through tiny capillaries and
sinusoids in the spleen. However, the hemoglobin and
enzymes within the cells appear to be normal.
“By process of elimination, it was thought that these
abnormalities in cell shape were due to inherited abnormali¬
ties in the red cell membrane itself,” commented Dr.
Marchesi.
There are spectrin-like proteins in most tissues in humans
and other species which are quite similar even across species
barriers. Red cell spectrin is a specialized version of this class
of structural protein, engineered in concert with other
membrane proteins to allow the deformability characteristics
of red cell membrane necessary for normal life span. “For
that reason, we believe a mutation of spectrin (or of other
membrane proteins) might be the culprit determining the
unusual shapes of cells found in spherocytosis and ellipto¬
cytosis.”
Dr. Marchesi is studying blood from patients and their
families with these anemias, both of which are inherited as
autosomal dominant disorders. She has found that a high
percentage of black families with elliptocytosis have a
mutation in spectrin near the amino terminal end of the
alpha chain, which causes that section of the molecule to be
more easily broken down by certain enzymes.
“We have analyzed fragments of spectrin to get the actual
amino acid sequence near unstable regions of the molecule
and have found that, in tw o types of elliptocytosis, a single
amino acid substitution causes the change of shape and

Dr. Marchesi
shortens the life span of the cell,” she said. “This is similar to
sickle cell hemoglobin, in which a single amino acid
substitution produces devastating changes in the physical
properties of the beta globin chain.
Studies of recessive spherocytosis, a rare form of anemia
in which both parents show no evidence of the disorder, but
one or more children have severe, life threatening anemias,
have indicated an abnormality in the alpha chain of spectrin,
distinct from the mutation found in elliptocytosis.
“We assume that the gene present in the bone marrow
stem cells, which is eventually expressed in the mature red
cells, is the specific gene for that hematopoetic cell line,”
explained Dr. Marchesi.
Research on protein membranes is complicated, and as in
much of hematology research, considerable time elapses
between findings. Persistence and dedication are key words.
“We are studying the chemistry of spectrin and other
membrane proteins which have been characterized well
enough to allow us to screen large numbers of people with
anemia and abnormally shaped red cells to try to determine
if abnormal proteins are the cause,” said Dr. Marchesi.
“Once an abnormality is found by these ‘screening tests’, we
continue our studies of the apparently abnormal protein, in
so far as we can, to identify the mutation.

his lab are about equally divided between continuing studies
on hemoglobin RNA and research on cell differentiation in
leukemia.
Based on previous studies of the role of globin gene
mutations in messenger RNA (mRNA) in thalassemia, and
subsequent characterization of these mutations. Dr. Benz,
associate professor of medicine, has been doing research to
discover how they disrupt RNA metabolism.
“We have found some surprising effects of those mutations
on mRNA that are revealing some previously unknown
facts about the way RNA molecules are metabolized in
normal cells,” said Dr. Benz.
For example, there are some changes in a gene that cause
the messenger RNA to be untranslatable. The mRNA is
synthesized, but a mutation in one base will prevent it from
being translated to a protein.
“It’s obvious that you can’t make hemoglobin if you can't
make one of its protein components,” he explained. “What’s
not obvious is that mRNA doesn’t accumulate in normal
amounts, indicating that not only is it not functioning, it’s
not being produced in adequate amounts as well.”
These findings indicate that many steps are necessary for
the RNA molecule to be synthesized, to be processed from
the precursor to the mature form in the nucleus, to get out
into the cytoplasm and to function
in other words, to be
translated into globin protein.
“You have to be able to study the physiology of the
message as well as to know its anatomy,” said Dr. Benz.
“This information may give us a way to look at some basic
mechanisms that might he involved in RNA production in
all cells.
In another direction. Dr. Benz and his colleagues have
cloned the gene for the protein, lactoferrin, and are using it
as a marker for studies on leukemia. Feukemia is the result
of failure of white cells to mature. Factoferrin is present only
in the most mature of white cells.

D

r. Edward Benz and Dr. Forget began their
research association at Harvard Medical School
several years before either came to Yale. Dr. Benz
was a medical student working in the laboratory
with Dr. Forget, who was a fellow in hematology there.
Following postgraduate training at N1H, Dr. Benz came to
Yale in 1978 as a fellow in hematology. Current activities in

Dr. Benz

All photographs for this article are by William Carter.

9

distinct phases and current evidence suggests that there are

Dr Lebowitz

“Analyzing these genes allows us to search for the
components necessary for white cells to mature,” explained
Dr. Benz. “By comparing what we learn about normal
processes of cell differentiation with processes in leukemic
cells, we hope to discover the molecular basis for failure of
leukemic cells to mature. With the DNA probe for lactoferrin, we can study the expression of it, and ask why it
doesn’t appear in leukemia.
“Lactoferrin is one of the targets for what goes wrong in a
leukemia cell. If we can get our hands onto whatever is
happening to lactoferrin in leukemia, it could give us a
preview of what is happening to the entire cell in the
leukemic process,” explained Dr. Benz.

E

arly in the 1980s, oncogenes became one of the
hottest subjects in cancer research. These genes are
derived from normal precursors called proto-oncogenes
which all animals, including man, carry. There is
evidence that proto-oncogenes become activated to form
oncogenes by several mechanisms including chemical
changes
mutations, combination with other genes or an
increase in their number - amplification. Scientists have
become increasingly interested in the possibility that onco¬
genes play an important role in the development of many
human malignancies.
One such scientist is Dr. Paul Lebowitz, who also came to
Yale from Harvard Medical School via fellowship training
at the N1H Until 1980, his major research efforts had been
directed at simian virus 40
a virus which has served as a
model for malignant cellular transformation. Then, in 1981,
w hile on sabbatical leave in the labortory of Dr. Edward
Scolnick at N1H, he became interested in human oncogenic
genes. "I was in the right place at the right time.”
I he primary focus in Dr. Lebowitz’s current research is
elucidating mechanisms by which human leukemias
lop and progress. To do this, he is studying chronic
logcnous leukemia, an extremely favorable type of
mia for study, since the disease can be divided into two

three distinct steps involved in its development and pro¬
gression.
The disease starts with a very indolent, chronic phase that
can be fairly well controlled with chemotherapy. This stage
typically lasts for three or four years, when it transforms into
an acute leukemic phase called blast-crisis, either myeloid or
lymphoid. This phase can only be put into remission with
successful bone marrow transplantation.
“There appear to be three oncogenic events involved in
the development and progression of this disease,” commented
Dr. Lebowitz. “It’s important to work on each of them
because, when we identify an oncogenic event, it provides a
potential target for chemotherapy or other therapeutic
approaches in the future.”
There is reason to believe there is an initial step which
affects one hematological stem cell and causes all its
daughter cells to grow very rapidly. According to Dr.
Lebowitz, this step has received little attention from
scientists.
The second step, well known to most investigators, is
marked by a chromosomal abnormality caused by transloca¬
tion of chromosome 9 and chromosome 22. The resulting
abnormal chromosome 22 is known as the “Philadelphia”
chromosome. It is found in most patients with CML and is
the best means for diagnosing the disease. As a result of this
translocation, a proto-oncogenic gene in chromosome 9,
called the ABL gene, comes under the control of a new gene
on chromosome 22, called the BCR gene. This results in the
production of a hybrid BCR-ABL messenger RNA and a
hybrid protein, which appears to be oncogenic. Thus, this
step fixes the malignant state in CML cells.
“The third event is the one which converts the chronic
phase to the aggressive phase,” said Dr. Lebow itz. It could
be two separate steps: one which leads to a lymphoid blast
crisis in some patients or an alternative one which leads to a
myeloid blast crisis.
Little is known about the first or third events, according
to Dr. Lebowitz, who is interested in the mechanisms of the
disease as well as in approaches to changing their course.
“We are trying to develop methods by which we can take
leukemic cells from CML patients and convert them back to
normal cells,” he explained. “For example, since acute
leukemia is the result of failure of cells to differentiate, we
would like to get these cells to start differentiating again,
thereby reversing the leukemic state.”
To accomplish this, he and his colleagues are studying the
possibility of introducing certain genes which play an
important role in normal cell differentiation, into leukemic
cells. They are doing this by means of transfection now, but
eventually hope to introduce genes into the malignant cells
by means of a virus.
In this research, they are now focusing on a specific gene
the FOS gene. “We introduce the gene into the cell under
control of an inducible promotor, which is like an on-off
sw itch. When we turn the switch on, does the cell begin to
differentiate? When we turn it off, will the cell reverse back
to a non-differentiating cell?”
In related studies, the laboratory is attempting to force
leukemic cells to make antisense messenger RNA by intro¬
ducing antisense genes. There is evidence, according to Dr.
Lebowitz, that antisense RNA w ill neutralize the sense RNA
for a specific gene.
“With CML, we are anxious to get the leukemic cells to
make antisense RNA specifically directed against the villain

BCR gene,” he explained.
All of this work has implications for other leukemias as
well as for CM L. “We are working on a model system,” said
Dr. Lebowitz. “If a FOS gene differentiates CM1. cells, can
it cause differentiation in other leukemic cell types? If the
FOS gene doesn’t work, might not some other differentiationinducing gene? But that is a long way in the future,” he
added.
In addition to doing basic research on disorders of blood,
Drs. Lebowitz, Benz, Marchesi and Forget care for patients
in the hematology clinic. “Hematology is an ideal field for
combining basic science with clinical activities. The tissue of
interest is readily available and so basic studies of blood
cells, both structural and functional, can be done on human
cells,” explained Dr. Marchesi. “Hypotheses concerning
disease states derived from these studies may also be readily
tested on patients with the disorder. A call from another
hematologist concerning a patient he or she has seen, has
frequently led to additional blood samples for our study,
expanding our data base on a particular problem and in
some instances, producing entirely new information.”
This is very important to progress in discovering ways to
prevent and treat hematologic disorders, according to Dr.
Thomas Duffy, professor of medicine in the Section of
Hematology. “This interaction between basic scientists and
clinicians makes the significant difference between places
like Yale and institutions where they do only basic research.”

R

egarded as an outstanding hematologist and teacher.
Dr. Duffy came to Yale as an associate professor
from the Johns Hopkins School of Medicine in
1976. In addition to caring for patients with
hematologic diseases, he is involved in clinical research in
several areas.
Recently, he and his colleagues participated in a nationwide
clinical trial to test the efficacy of the drug, interferon, in
treating hairy cell leukemia, a rare form of cancer of the
blood. “The trial resulted in a remarkable success in the
palliation, if not the cure, of this life-threatening disease,”
commented Dr. Duffy. As a result, the federal government
has approved the commercial use of alpha-interferon against
hairy cell leukemia, the first time the genetically produced
antiviral drug has been made available by prescription.
With the demonstrated effectiveness of interferon on one
type of leukemia. Dr. Duffy has just begun a clinical trial to
test its use in treatment of agnogenic myeloid metaplasia.
This is a proliferative chronic form of cancer of the blood for
which there is no current therapy, other than symptomatic
support.
Clinical studies in hematology are not only directed at
leukemias. For instance, in collaboration with researchers in
the Department of Obstetrics and Gynecology, Dr. Duffy is
studying the causes of toxemia in pregnancy, which typically
occurs only in the third trimester, and in many cases is
manifested in thrombocytopenia. In observations of a large
number of pregnant women, they have found that hemato¬
logic lesions occurring in the first or second trimesters were
predictors of toxemia in the third trimester.
“This suggests that, although it presents only in the third
trimester, toxemia represents the final stage of a pathologi¬
cal process that begins earlier in pregnancy,” explained Dr.
Duffy. “With this information, we can focus on the symptoms
throughout pregnancy, before they result in the acute phase.

O

ne of the dilemmas for physicians and medical
school teachers is the wide gap between new
knowledge acquired in the laboratory and current
treatment available at the bedside. The problem
has been aggravated by the news media which has greatly
increased coverage of medicine in recent years.
“The patient population and the public in general, are
being led to believe that the scientific breakthroughs they
read about in newspapers and magazines and see on TV are
immediately applicable,’’said Dr. Duffy. “Take forexample,
the widely reported work of Dr. Steven Rosenberg with
leukocyte activated killer cells and interleuken 2. I didn’t see
one patient over the following several weeks after it was
reported in the popular press, who didn’t want immediate
access to that therapeutic breakthrough, which, of course,
isn’t available.
“So many of the problems of hematology have not lent
themselves to easy solution,” he commented. “For instance,
management of patients with sickle cell disease is much the
same as it was thirty years ago. The work by Dr. Forget and
his group has been responsible for revolutionizing our
knowledge about gene control of hemoglobin synthesis.
Once the code has been broken, the implications for clinical
management will be staggering.
“The media is creating extraordinary expectations on the
part of the patient that cannot yet be met,” Dr. Duffy
continued. “We as physicians have to be honest and say ‘yes,
we seem very close to some extraordinary breakthroughs in
treatment of leukemias and anemias, but not today, maybe
tomorrow’. ”
I here is much to be learned, researchers in the Section of
Hematology agree. But a great deal has been accomplished
in a very short while, and they are optimistic that the
research being done here and elsew here will eventually lead
to prevention or cure of blood disorders which have plagued
mankind for centuries.

Dr. Duffy

CWBS

—

a forum for discussion, an ombudsman for student complaints
and central clearing-house for improving student life

by Ian A. Cook
Numerous authors, both from within the medical community
and from without, have commented extensively on the
demanding tasks a medical student faces in the process of
becoming a physician. Beyond the obvious academic chal¬
lenges of medical school, students at Yale and other schools
encounter stressful situations which arise from the multitude
of intellectual, social, economic and personal demands
placed upon them. This spring marked the second anniversary
of a bold experiment in medical education at Yale, which
addresses these concerns through a Committee on the Well
Being of Students (CWBS).
Each year, the Medical School Council (MSC) has
devoted a meeting entirely to a discussion of “Student
Initiated Issues.” Two years ago, a group of students
reviewed the minutes of the previous decade’s Student
Initiated Issue meetings; this revealed that a handful of
issues appeared again and again as those viewed by the
students as important. It was noted as well, that the issues
they had identified were precisely the ones for which no
on-going administrative structure existed.
This being the case, the president of the Student Council
and the student MSC representative appealed to the Medical
School Council to establish a standing committee and thus
provide the tool needed by students, faculty and administra¬
tion alike to work together to solve these problems.
Unanimous approval of the students’ proposal led to the
formation of a Committee on the Well Being of Students,
charged with the broad task of coordinating and promoting
“activities and resources related to student life and well
being." To work toward this goal, the membership of the
committee was established as five students and five faculty
representatives, including the associate dean of Medical
Education and Student Affairs and the chaplain as members
ex officiis.

Through student survey and discussion at that time, the
committtee identified six areas of concern. They were:
facilities, advising, administration, activities, parking and
academics.
In its two years of operation, the CWBS has been involved
in a number of these matters, especially the Edward S.
Harkness Hall dormitory, the advising program, parking
and safety and issues surrounding how' the academic
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environment influences student well being. The CWBS has
sought to define its role in the medical school as being a
forum for discussion, an ombudsman for student complaints,
and a central clearing-house for improving student life. The
CWBS was originally envisioned as an entity through which
interested and motivated students, faculty and administrators
could meet and pool resources to solve cooperatively the
problems they perceived. It had not been the students’
intention that this committee would solve all the myriad
problems itself, but rather, that it would serve a vital role by
connecting those w ith needs to those w ith resources. To this
end, the CWBS has often provided the initiative to study
problems faced by Yale medical students and to involve
those who may influence the situation in discussion of the
pertinent issues. The breadth and depth of the involvement
of the CWBS in the medical center is best appreciated by
examining its efforts.
FACILITIES
Last year, presentations were made bv students about the
Hark ness Hall dormitory, which was built in 1955 and is
presently the only university housing facility open to
medical students. It was reported that Harkness Hall was in
a state of disrepair, with conditions vividly described by
students and shown to administrators with a tour of
Harkness that the CWBS arranged. Acting in a “watch-dog”
capacity, the committee helped to motivate some striking
changes, some of w hich have been accomplished, others of
which are still promised. New beds and mattresses, room
furnishings, re-papered hallways and retiled floors have
contributed much to the ambiance of the dormitory.
ADVISING
Two sorts of advising programs have attracted the attention
of the CWBS; there are programs of faculty advising the
students, and of students helping each other. The chaplain
of the school. Dr. Alan Mermann, has taken the leadership
role in overseeing the Faculty-Student Program. At present,
small groups of first-year students are assigned to faculty
members in the fall, and these groups may meet more or less
regularly throughout the year.
Topics of discussion range from concrete suggestions for
good textbooks and the recreational activities in New
Haven, to more philosophical issues of what it means to be a
good physician, and how best to be prepared for the
continual self-education which is demanded of physicians
throughout their careers. Many aspects of the program are
being reviewed and guidelines will be formulated to help
make this an integral part of medical student life.
Also of note in the area of advising are the student-tostudent programs. This past year, in which there was a

The “bold experiment” undertaken by the
CWBS is working. But rather than resting on its
laurels, the CWBS has sought to turn attention
to the intertwined issues of parking and safety
and to matters of educational philosophy.

re-birth of the Third Year - First Year Program, in which a
third-year student takes a group of first-year students under
his or her wing, helps them to ad just to the many demands of
being a medical student at Yale, and demystifies the process
of learning to be a physician.
Another program of advising takes place when fourthyear students help the third-year students make their
transition to the wards. In the past, this successful program
consisted of one meeting in the first week of the clinical
experience to discuss the transition itself, and another
meeting in January to discuss what challenges the fourth
year presents. This has been run by student coordinators
since its inception, and the CWBS has elected to help
perpetuate this program by coordinating the resources
which a fourth-year student must draw upon to run the
events.
ADMINISTRATION
At times, the students have felt distant from the administra¬
tion of the School of Medicine. The students’ sense of well
being depends in a large part on the belief that those in
power are actively interested in the issues which concern
students. To help promote informed discussion, the CWBS
developed a vehicle known as a “Town Meeting,” through
which the student body could have an opportunity to meet
with members of the faculty or administration for open
discussion. In this preliminary series of meetings, Dean
Rosenberg and Associate Dean Gifford were able to discuss
openly issues of mutual concern with the student body as a
whole, such as the student parking situation, the medical
school’s committment to minority students and to the Office
for Women in Medicine and the trends in the educational
mission of the school.
ACTIVITIES
One of the original charges of the CWBS was to “coordinate
and promote resources.’’The students here are both creative
and energetic, as the breadth and quality of their many
academic and extracurricular activities well illustrate. Each
year, certain types of projects are devised and carried out:
lecture series, social functions, athletic events, doing electives
away and others. Yet each year, these projects often had to
be started from scratch, as there were no effective ways to
help perpetuate this practical information.
I he CWBS has undertaken the creation and maintenance
of such a collection of information by establishing a set of
open files to which all students may refer. This information,
not surprisingly, comes from the narrative reports by
students who have undertaken projects and who describe
what was done, how it was done and how one might do
things differently.

SOME ISSUES MERIT
CONTINUED VIGOROUS ATTENTION
With all these things happening, one can safely say that the
“bold experiment” undertaken by the CWBS is working.
But rather than resting on its collective laurels, the CWBS
has sought to turn the school’s attention to a number of
issues where significant concern still needs to be focused.
The intertwined issues of parking and safety have been
under much discussion, as have matters of educational
philosophy by a newly-established Student Ad Hoc Commit¬
tee on Educational Issues.
PARKING
Parking is one of the chronic problems which had been
discussed before the MSC for about a decade. Before the Air
Rights Garage was opened two years ago, the students had
been led to believe that they would be able to park there.
This, sadly, did not come to be, and the students who
commuted to school and had been parking in other lots
suddenly lost all parking privileges. The priorities list for
available lots did not list students at the bottom of the list;
students weren’t on the list at all.
The complex political issues which involve the university,
the medical center and the city have left students to park
where ever they might. This has all too often meant on the
street in dangerous areas in unsafe neighborhoods sur¬
rounding the medical school. Thankfully, violent assaults
have been the exception rather than the rule, though thousands
of dollars worth of vandalism has also occurred. Drs.
Gifford and Rosenberg have worked to find ways which
would allow students to come to classes with a minimal risk
to property and personal safety, and discussions are on-going.
ACADEMICS AND THE STUDENT AD HOC
COMMITTEE ON EDUCATIONAE ISSUES
In this past year, students became more active discussants of
the educational mission of the School ot Medicine. A group
of students formed a working group known as the Student
Ad Hoc Committee on Educational Issues. These were
elected student leaders who serve on the Medical School
Council, on the Curriculum Committee, as class and
Student Council presidents, on CWBS, and as student
representatives to the AAMC.
Why, it was asked, had these active students formed yet
another committee? They were students who have worked
hard toward improving the quality of education and liie at
this school, and were keenly aware that medical education is
under careful scrutiny and re-evaluation by medical educa¬
tors throughout the country. The AAMC’s “GPEP Report"
is the most well known of these, for example, and recom13

For an effective educational partnership to
function at Yale, we must all be committed to
improving the interactions between faculty,
administration and students.
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mended ideas which sound very much like the original
philosophy that motivated the educational structure known
as the Yale System: an emphasis on independent learning
skills rather than memorizing facts, minimizing class time in
favor ol seminars and labs, and reinforcing study options
compatible with continued, independent learning.
As students who participate on various administrative
and educational committees, they were also keenly aware
that the new administration has fostered a re-examination
of parts of the Yale System and has proposed changes,
especially regardingevaluation and the place of the National
Board examinations in the medical school curriculum.
At first, student concerns centered on how instituting
exams might affect the education and experience at Yale. It
was felt that to examine this issue, a dialogue was needed
between students who had worked on curriculum commit¬
tees, those who had worked on administrative organs, for
example the Medical School Council, and those who
worked on issues of student well being, for example the
CWBS. Such a dialogue, it seemed, was unfortunately not
consistently present among faculty members of these same
groups. After numerous meetings, heated debate and much
soul searching, it was recognized that exams were not the
issue; rather, that what was needed was a comprehensive,
bjective look at the Yale System, its strong points and its
relative weaknesses.

To help identify the school’s underlying strengths and
problems, the Ad Hoc Committee has surveyed the students
on numerous occasions. The committee and CWBS were
responsible for planning and conducting the “Town
Meetings” with the deans. After many months of study and
discussion, a number of core concerns emerged and were
shared with the faculty and the administration. Students
have raised the question of how Yale can best offer medical
education which prepares one for a career in medical
practice, research or teaching given the rapidly changing
nature of medicine itself. Many of the nation’s brightest
medical educators are studing how best to train physicians
in the face of an “information explosion” in the basic and
clinical sciences.
A fundamental finding which has come forth from the
discussions is that it is more demanding to be successful in
running an open educational system, whose end goal is
students who have mastered the skill of educating themselves
and taking responsibility for their own continuing education,
than in running a regimented one. It requires considerable
individual interaction between the students and faculty, the
kind of interaction that doctoral students enjoy at Yale.
The CWBS and students at large, realize that for an
effective educational partnership to function at Yale, we
must all be committed to improving the interactions between
faculty, administration and students.

DR. BARBARA BACHMANN
her work affects literally thousands of research projects around the world

Although the exact nature of Dr. Bar¬
bara Bachmann’s work is known to
only a few people in the medical school,
thousands of scientists from the world
over refer to her laboratory. Dr. Bachmann, senior research scientist in the
Department of Human Genetics, is
curator of the Escherichia coli Genetic
Stock Center located in the Sterling
Hall of Medicine. Last month, the
United States Federation for Culture
Collections honored her with the J.
Roger Porter Award in recognition of
her efforts in developing and preserving
this important international resource
for biomedical research.
“The award is well deserved,” com¬
mented Dr. Edward A. Adelberg, profes¬
sor of human genetics, whose own
extensive collection of genetically
marked strains of E. coli was the nucleus
of the stock center’s collection.
“Barbara Bachmann’s research and
the data she has compiled have systema¬
tized the genetics of this complex bacter¬
ium to a degree unequalled for any
other organism,” he said. “Her publications on E.coli are recognzied as mile¬
stones in the literature, and the genetic
map and charts of various pedigrees of
the bacteria she has prepared are the
referral base for all scientists who do
molecular genetics.”
The E.coli Genetic Stock Center con¬
tains more that 5,000 mutant strains of
this bacterium, which for many years
has been the most convenient and
widely used organism for elucidating
fundamental biochemical and genetic
mechanisms common to most living
things. The strains are stored in a freeze
dried state and also as glyceriolized
liquid cultures in Dr. Bachmann’s com¬
pact laboratory, along with meticulous
records and files on each of the 5,000
strains.
Last year, more than 6,000 requests
were received and filled by Dr. Bachmann and her assistants, Cynthia DelVecchio and Ann Hayden. The stock
center is far more than a repository for
genetically marked strains of E. coli
and the service that sends them out on
request, however. Each request filled is
accompanied by papers listing the name.

Dr. Bachmann

designation, sex and chromosome
markers of the particular strain and a
note, “Please return the second sheet
with your comments on it. We need this
feedback.”
Dr. Bachmann takes these comments
into account, according to Dr. K.
Brooks Low, professor (adjunct) of
research in therapeutic radiology and a
long-time user of the collection. “Scien¬
tists frequently consult her about the
appropriateness of a particular strain
to their research,” explained Dr. Low.
“Her knowledge of every facet of this
immense collection and her ability to
interpret the experiences of the scientists
who use it, make her unique in the field
of organism collections.”
The E. coli Genetic Stock Center
began in the 1960’s in Dr. Adelberg’s
laboratory. A pioneer in the field of E.
coli bacterial genetics, he had built up
one of the largest collections at the time
of genetically marked strains of E. coli
anywhere. “Defacto, my lab had become
the center for their distribution to
scientists in this country and abroad,”

recalled Dr. Adelberg. “The requests
became so numerous that responding
to them became a burden.”
Dr. Bachmann came to the labora¬
tory as a research associate in 1968
from the Department of Microbiology
at New York University Medical Center.
“Not only did she reorganize my entire
collection, she began acquiring hun¬
dreds of key strains from well-known
collections in France and England as
well. By painstakingly researching the
notebooks of the scientists, she was
able to trace the pedigree of each of the
strains, which she then published."The
E. coli Genetic Stock Center has re¬
ceived funding from the National Sci¬
ence Foundation since 1971.
A graduate of Baker U niversity, Bald¬
win City, Kansas, Barbara J. Bachmann
received a M.S. degree in bacteriology
from the University of Kentucky in
1947, and a Ph.D. degree in microbio¬
logy in 1954 from Stanford University,
where she worked under the preceptorship of the eminent microbiologist, the
late C.B. van Niel. She first came to
Yale in 1958 as a lecturer in microbio¬
logy, and returned in 1968 after four
years at N.Y.U. Medical Center.
In addition to her curatorial postition,
she is a lecturer in the Department of
Biology and has taught microbiology
there for 23 years. “Her students are
fortunate,” said Dr. Adelberg. “She is
an excellent and dedicated teacher who
teaches in the ecological tradition of
enrichment culture taught by her men¬
tor, Dr. van Niel.”
A quiet, unassuming and intensely
private person. Dr. Bachmann sets
very high standards for everything she
does, including her hobbies, according
to Dr. Low. She was overheard a few
years ago telling a friend that she had
just purchased a garden with a house.
"That is a typical reflection of her love
for gardening,” said Dr. Low. “She is
as well, an enthusiastic bird watcher
and keyboard musician.”
“Barbara Bachmann is an unusual
person,”said Dr. Adelberg. “Everything
she does is meticulously and intelligently
done — examples of how things should
be done.”
— Marje Noyes
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PERCEPTIONS OF RISK
The importance of the public's perceptions of risks lies in the impact they have on decisions of lawmakers.
by Grace Breitstein
A mother and infant are blown out ot an
airliner in a terrorist attack in Europe.
Swedish Prime Minister Olot Palme is
gunned down and his assailant remains
unknown. A nuclear power meltdown in
Russia leaves some dead, many hospitali/ed and surrounding countries in a panic
over radiation levels.
Although isolated incidences, each front
page report scares and moves the public
to exercise greater caution and perhaps
to take action to improve the safety of a
particular technology. They shape the
general public's perceptions of such techno¬
logies as air travel, hand guns and nuclear
power.
The most important effect is the in¬
security and fear generated in the public,
but another important consequence of
these perceptions, one researcher notes,
lies in the ultimate effect they have on the
decisions reached by state and federal
lawmakers.
“Political actions by individuals in
power are more likely to be taken based
on the perceptions people have rather
than on the actual risks." says Dr. Jan
A..I. Stolwijk, Susan Dwight Bliss Profes¬
sor and chairman of the Department of
Epidemiology and Public Health.
With that in mind. Dr. Stolwijk and
several colleagues set out to analyze
"people” perceptions. They evaluated the
general public’s perceptions of the risks,
benefits and the current strictness of
safety standards in six controversial areas
handguns, nuclear power, nuclear
weapons, industrial chemicals, automo¬
bile travel and air travel.
Their findings provide insights into the
psycho-social factors that influence how
perceptions form.
“People live with a presumption of
safety. It allows us not to worry constantly
about what might go wrong. When some¬
thing happens to change that presump¬
tion, such as what happened at Love
Canal, restoring it may be almost impos¬
sible."says Dr. Stolwijk, one of a team of
consultants investigating the habitability
ol New York’s I ove Canal, from where
239 families were relocated in 1978 and
1979 due to chemical spills.
Often, individuals exaggerate the risks
>1 a technology to further environmental
goals, according to Dr. Stolwijk, causing
unnecessary anxiety. At I.ove Canal, for
sample, the risks have not proved high
nit fear runs high because of mis¬
information.
1 hese days, it seems like the ‘in’ thing
■s to make people aware of the terrible
at might lurk around the corner,”

“Familiar risks are more
likely to be ignored. You feel
you are not going to get into
an automobile accident. But
if chemicals are spilled by
some large, impersonal
corporation, and moreover,
those chemicals could cause
an incurable disease, you’re
going to perceive the risk of
that technology as higher,
even if more people die from
automobile accidents than
from chemical spills.”

Findings of the two-year, $500,000
study, funded by the National Science
Foundation, will be published by the
Russell Sage Foundation Press in New
York City. The report, in book form, is
being written by Dr. Leroy C. Gould,
professor of criminology at the University
of Florida in Tallahassee, who was a
coinvestigator of the study.
The general public’s perceptions were
compared with those of two other groups:
technology and environmental advocates.
Each group reported the level of strictness
they desired for regulations in each area,
so that their desire for safety could be
compared with their perceptions of cur¬
rent safety standards. To analyze the
relationship between perceived risks and
actions taken, the researchers assessed
the number of political actions members
of each group reported taking in each
category.
Highlights of the findings show the
general public:
Perceives an even greater need for
stricter safety standards for using indus¬
trial chemicals than the environmental
advocates. “We're now dealing with strong
political pressure from the public for
further regulation on industrial chemicals
when strict standards may already be in
place,” says Dr. Stolwijk,
Takes more frequent action, from
signing petitions to suing, than previously
believed, according to Dr. Stolwijk,
Perceives handguns, automobile travel

and air travel as a “very great" risk more
often than either advocacy group.
— Perceives a relatively low risk for auto¬
mobile travel and a very high risk for
being exposed to industrial chemicals.
The perception of lack of control over a
particular technology can cause its risk to
be perceived as high, he explains.
“Familiar risks are more likely to be
ignored,” he says. “You feel, after all, that
you are not going to get into an automo¬
bile accident. But if chemicals are spilled
by some large, impersonal corporation,
and moreover, those chemicals could
cause an incurable disease, you’re going
to perceive the risk of that technology as
higher, even if more people die from
automobile accidents than from chemical
spills.”
Demographic factors, such as age, sex,
education or income, didn’t seem to
influence the perceived risks and benefits
of a technology, according to the study.
The Yale Roper Center, a survey re¬
search resource for faculty members
throughout the university, conducted in¬
terviews in Connecticut. The National
Opinion Research Center, a non-profit
organization associated w ith the Univer¬
sity of Chicago, did the field work in
Arizona.
Some 400 questions were asked of
1,320 people, 1,021 of whom were sampled
from the general public, with the remain¬
der making up the advocacy group
samples.
Coinvestigators included Drs. Donald
R. DeLucaand Wendy Horow itz, associ¬
ate research scientists at the Institution
for Social and Policy Studies; Dr. Leonard
W. Doob. Sterling Professor Emeritus of
Psychology; Dr. Gerald T. Gardner, pro¬
fessor of psychology at the University of
Michigan in Dearborn and Dr. Adrian
Tiemann, of Digital Interface Inc., a
Manhattan consulting firm.
Post script: The Russian reactor failure
at Chernobyl indicates that in a more
closed society in which news and informa¬
tion is tightly controlled, the public percep¬
tions are quite different. Dr. Stolwijk
observed. “It is likely that the level of
concern in neighboring countries down¬
wind from the stricken reactor was greater
than in nearby Kiev, the third largest city
in the U.S.S.R. It is clear that the risk to
the immediate surroundings beyond the
evacuation zone was much greater than
the risk to Poland or Sweden," he says.
“The public perceptions which were
studied in the U.S. clearly rely on a free
flow of information and effective news
coverage by the media.”

HERE AND ABOUT
MR Center Open
For Patient Care
On May 15, after months of careful
planning to the last detail, the patient
care facilities of the Magnetic Resonance
Center were opened. The research compo¬
nent of the center is expected to be
completed later this summer, and a dedica¬
tion ceremony is being planned for early
fall.
A joint project of the School of Medi¬
cine and Yale-New Haven Hospital, the
M R Center will bring together the institu¬
tions’ research and clinical activities in
magnetic resonance technology — con¬
sidered one of the most important develop¬
ments in medicine in this decade. When
completed, the building including offices,
laboratories and patient care rooms, will
be equipped with two whole body scan¬
ners, a small animal instrument and a
high-field spectrometer. The four magnets
will have a combined strength of almost
450,000 times that of the earth's magnetic
field
a factor that was key to the
planning of the building.
Eunding for construction of the new
facility was provided in part by two
major gifts to the School of Medicine and
by generous donations to the hospital’s
Annual Appeal.
The Pew Memorial Trust of Philadel¬
phia gave $1.5 million toward construc¬
tion of research space, and M r. and M rs.
Adrian C. Israel of Stamford, Con¬
necticut, and their family contributed
$1,250,000 toward building projects in
the center. Both gifts were contributed as
part of the school’s $125 million capital
campaign, announced a year ago.
In addition. General Electric Company,
manufacturer of the magnetic resonance
imagers, lent philanthropic support
through a significant discount toward the
clinical care unit. In addition, GE pre¬
sented a major donation for the building,
furnishing and equipping of the MR
Center conference room. The company
also has a research agreement with the
School of Medicine to contribute on¬
going funds to support MR research.

Yale Eye Center Opens
A clinical symposium of distinguished
ophthalmologists followed by a gala
dinner dance celebrated the opening of
the Yale Eye Center for Clinical Reseach
on April 10-11. The events, which also
included a special program for ophthalmic
nurses and technicians, were typical of
the scholarship, dedication and creativity
that have marked the development of the
center all along.

Sponsored by the Department of Oph¬
thalmology and Visual Science, the clini¬
cal symposium, “Perspectives in the Man¬
agement of Eye Disease,” brought to¬
gether a group of 40 internationally prom¬
inent professionals to present and discuss
critical issues in the study and treatment
of eye diseases.
“Our goal in sponsoring this event was
to share knowledge about scientific ad¬
vancements, and debate new methods of
intervention and correction of eye disease
to develop perspectives in management,”
said Dr. Marvin Sears, chairman of the
Department of Ophthalmology and Visual
Science since its establishment in 1971,
and a recognized leader in research on
diseases of the eye. Under Dr. Sears’
leadership, the department has earned a
world-wide reputation for its significant
contributions to thedevelopment of treat¬
ments for blinding eye diseases.
The $2.5 million project, the culmina¬
tion of 23 years of planning by Dr. Sears,
is a regional, national and international
referral resource for persons requiring
diagnosis and treatment of eye diseases.
Housed in the extensively renovated
Boardman Building, which is centrally
located in the Medical Center and adjacent
to the Department of Ophthalmology
and Visual Science’s research laboratories,
the new Eye Center will integrate patient
care with basic research and teaching
activities. With an entrance off Cedar
Street, the center includes a general eye
clinic, and treatment centers for retinal
and corneal diseases, strabismus and
glaucoma.

Cancer Control Research
Unit Established at Yale
With a $6.5 Million Grant
Connecticut will become a national labora¬
tory for research in controlling cancer
with the establishment of the Cancer
Control Research Unit for Connecticut
at Yale. Announcement of the new pro¬
gram, which was awarded $6.5 million
for the first three years by the National
Cancer Institute, was made at a press
conference on April 8.
“Connecticut’s longstanding light against cancer takes yet another important
step forward today,” said Connecticut’s
Governor William O’Neill at the press
conference. “The fact that our state has
been singled out by the National Cancer
Institute for this grant speaks volumes
about our state. The $6.5 million grant
says, or perhaps reaffirms, that Con¬
necticut is at the forefront of medical
inquiry and consequently, medical treat¬
ment.”

Dr. Dwight T. Janerich, professor of
epidemiology anti public health and medi¬
cal director of the State of Connecticut
Tumor Registry, will direct the program,
with Marion E. Morra, assistant director
of the Yale Comprehensive Cancer Center,
responsible for the outreach components.
In addition to the Cancer Center, participatingagencies will include the Yale Depart¬
ment of Epidemiology and Public Health,
the State of Connecticut Department of
Health Services and the University of
Connecticut Health Center.
Program is only the second federally
funded program of its kind
The program, which was awarded fol¬
lowing intensive national competition,
and is one of only two such programs in
the nation, will have seven major projects:
improving early detection of cervical can¬
cer; decreasing adolescent use of smoke¬
less tobacco; effects of race and social
factors on stage at diagnosis; interventions
to improve use of breast cancer screening;
case-control study of lethal melanoma
and skin examinations; microbial and
biochemical predictors of colorectal carci¬
noma, and a paired-community approach
to colorectal cancer control being con¬
ducted in collaboration with the School
of Medicine, State University of New
York at Stony Brook.
“We believe that with the help of the
many agencies in Connecticut involved in
the fight against cancer, this major effort
in cancer control can find new means to
detect and prevent some of the most
serious forms of cancer, making our
Connecticut-based program a national
model for cancer control,” said Dr. Alan
C. Sartorelli, director of the Yale Compre¬
hensive Cancer Center.
Advisory committees will monitor and
review the Cancer Control Research
Elnit's Program
Two committees have been formed to
advise the program. The first, the Connect¬
icut Advisory Committee, has been estab¬
lished to ensure that the major organiza¬
tions are kept informed and participate
actively in the project. This committee
has been structured to allow maximum
participation at a decision making level
by major health agencies and institutions
in the state.
The second group, the Scientific Ad¬
visory Committee, includes people inter¬
nationally known in the field of cancer
research who review the work accom¬
plished and advise on luture research
directions. T his committee is composed
of experts in the fields of cancer epidemio¬
logy, cancer control, behavioral science
and health policy management.
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Community Mental
Health Leader Appointed
Chairman of Psychiatry

Dr. Tischler
Dr. Gary L. Tischler, professor of psychi¬
atry and director of the Yale Psychiatric
Institute, has been appointed chairman
of the School of Medicine's Department
of Psychiatry and chief of the psychiatry
service at Yale-New Haven Hospital,
effective July 1.
He succeeds Dr. Morton F. Reiser, the
Charles B.G. Murphy Professor of Psychi¬
atry, who has been chairman of the
medical school's department for 16 years,
and Dr. Malcolm B. Bowers, Jr., the
hospital’s chief of psychiatry since 1973.
In addition. Dr. Tischler will continue as
director of Y.P.I., a position he has held
since 1979.
On his appointment. Dean Teon E.
Rosenberg said, “Gary Tischler possesses
the experience and vision to lead one of
this country’s truly premier psychiatry
departments - a department which spans
the broad spectrum of biological, psycho¬
logical and social dimensions of mental
health and illness in human life. He has
demonstrated outstanding skills as an
administrator, educator and researcher
and is dedicated to quality clinical services
for mentally ill people.”
Dr. Tischler, who also directs Yale’s
Mental Health Services Research Training
Program, has focused his career on com¬
munity mental health issues. He also has
a strong interest in social psychiatry and
psychiatric epidemiology.
He joined the Yale medical faculty in
1967 as assistant professor, and from
1967 to 1978, concurrently was associated
with the Connecticut Mental Health Cen¬
ter, serving as associate director for six
years. Dr. Tischler chairs a National
Institute of Mental Health’s study section
on epidemiology and mental health ser¬
vices research. In 1978-79, he was the
tudy director of President Jimmy Carter’s

Commission on Mental Health which led
to recommendations regarding future
directions for community mental health
services and mental health evaluation
and research.
A native of Newark, New Jersey, Dr.
Tischler received an A.B. degree in 1957
from Hamilton College and an M.D.
degree in 1961 from the University of
Pennsylvania. He completed an internship
at Kings County Hospital in Brooklyn,
New York, and a residency training in
psychiatry at Yale. He served in the U.S.
Army Medical Corps from 1965 to 1967.
He has written more than 70 publica¬
tions in areas of psychiatric epidemiology,
health services research and social psychia¬
try. Active in numerous professional or¬
ganizations. Dr. Tischler is a fellow of the
American Psychiatric Association, Ameri¬
can College of Mental Health Administra¬
tion and the American Association for
Social Psychiatry.

Four Members of
Faculty are Honored

Dr. Reiser

Dr. Tamborlane Named
Program Director of
Children s CRC
Dr. William V. Tamborlane Jr., professor
of pediatrics, has been named program
director of the Children’s Clinical Re¬
search Center and head of the Division of
Endocrinology and Diabetes. In these
appointments, he succeeds Dr. Myron
Genel, associate dean for government
and community relations.
The school’s five-bed Children’s Clinical
Research Center provides a clinical setting
for physicians to study medical and neuro¬
psychiatric disorders. Opened in 1963, it
is among 78 such centers at major medical
institutions in the U.S., supported by
grants from the U.S. Public Health Ser¬
vices, National Institutes of Health’s Di¬
vision of Research Resources.
Dr. Tamborlane, who has focused his
research on insulin-dependent diabetes in
children and young adults, was one of the
first to introduce constant infusion insulin
therapy using a portable pump. At pre¬
sent. he is conducting metabolic studies
in diabetes to prevent long-term degenera¬
tive complications, such as blindness and
vascular problems.
Dr. Tamborlane received a B.S. degree
in 1968, and an M.D. degree in 1972 from
Georgetown University and completed
his residency training at Georgetown
University Hospital. Following a post¬
doctoral fellowship at the Yale School of
Medicine, he joined the Yale faculty in
1977 as an assistant professor of pedia¬
trics. Last year, the Juvenile Diabetes
Foundation presented him the Mary Jane
Kugel Award in recognition of his contri¬
butions while serving a three-year term
on its Medical Science Advisory Board.

Dr. Glaser

Dr. Morris

Dr. Downs

Dr. Reiser, Chairman of
Psychiatry for 17 Years
A “Mind, Brain and Body”symposium in
May brought together leading neurobiolo¬
gists and psychoanalysts to share knowlege of brain mechanisms underlying
human behaviorand mental phenomenon,
and to honor Dr. Morton F. Reiser, the
Charles B.G. Murphy Professor of Psychi¬
atry, who retires as chairman of the
Department of Psychiatry on July I.
Past president of the American Psycho¬
analytical Association, Dr. Reiser has
helped chart national directions for neurobiological research and, as an educator,
invented ways of combining teaching
about neuroscience and psychological
theory in order to enhance the practice of
the disciplines. A graduate of the Univer¬
sity of Cincinnati, where he received B.S.
and M.D. degrees, he has been a member
of the Yale medical faculty since 1969.
“In much of his work over the years.
Dr. Reiser has been trying to connect the
psychology and social psychology of beha¬
vior with the biology of behavior and
understand how they interrelate,” said
Dr. Boris M. Astrachan. professor of
psychiatry and director of the symposium.
“The goal of the symposium was to get
various disciplines talking together in
what is now considered one of the hottest
areas of science,” said Dr. Astrachan.
“We’re learning that this elegant ner¬
vous system which mediates in our feelings
and sensations is very similar to the
nervous system of lower animals and gets
elaborated in this thinking brain, a re¬
markable organism that is able to remem¬
ber and build upon memory.”
Dr. Reiser is the author of “Mind,
Brain, Body: Toward a Convergence of
Psychoanalysis and Neurobiology” (1984)
and co-author of “The Patient: Biological,
Psychological and Social Dimensions of
Medical Practice”(1980). A fellow of the
American Association for the Advance¬
ment of Science and of the American
College of Psychiatrists, he also serves on
the editorial boards of publications, includmg “Psychoanalysis and Contempor¬
ary Science," “Psychiatry in Medicine”
and the “International Journal of Psycho¬
analytic Psychotherapy.”

Dr. Glaser, First Chairman of
the Department of Neurology
Some 25 neurologists, present and former
colleagues of Dr. Gilbert H. Glaser, dis¬
cussed advances in understanding and
treating diseases of the nervous system at
a May 17 symposium honoring the first
chairman and founder 34 years ago of the
Yale Department of Neurology. Dr.
Glaser is retiring as chairman as of July I.
“Everything that has occurred in the
department is directly or indirectly a
result of Dr. Glaser’s efforts,” said Dr.

Jonathan H. Pincus, professor of neuro¬
logy, who was director of the all-day
symposium. “His contribution to neuro¬
logy has been tremendous.”
Dr. Glaser joined the medical school in
1952 after positions that included chief
resident in neurology, senior research
scientist and ehief in neurology, senior
research scientist and chief of the neuro¬
logy clinic at Columbia-Presbyterian Med¬
ical Center in New York. Dr. Glaser
graduated in 1943 with honors from
Columbia University’s College of Physi¬
cians and Surgeons.
In the last 20 years. Dr. Glaser focused
the department’s research effort on epi¬
lepsy. In addition, under his leadership,
Yale physicians were among the first to
participate in clinical trials of 1-dopa, the
most effective treatment for Parkinson’s
disease.
“His contribution to neurology has
been tremendous,” said Dr. Pincus.
“There is literally not’a subject he hasn’t
written about,” he added, referring to Dr.
Glaser’s more than 200 published articles
addressing the subjects of epilepsy, move¬
ment disorders, demyelinating disease,
muscle disease, the complications of inter¬
nal diseases and the borderline between
neurology and psychiatry.
Participants in the symposium dis¬
cussed these topics and others in tribute
to Dr. Glaser’s accomplishments.

Dr. Morris,
Distinguished Gynecologist
Friends and colleagues paid tribute to
Dr. John McL. Morris with a symposium
and dinner dance on April 19. The oc¬
casion celebrated the noted gynecologist’s
34 years as a dedicated teacher, physician
and researcher.
Dr. Morris, the John Slade Ely Profes¬
sor Emeritus of Gynecology, is a graduate
of Harvard Medical School. Following
residency training at the Massachusetts
General Hospital, he was a Damon Run¬
yon clinical research fellow at the Radiumhemmet in Stockholm, Sweden, before
joining the Yale medical faculty in 1952
as an associate professor.
The gynecologic service at Yale was
developed under the leadership of Dr.
Morris, who is widely recognized as an
outstanding clinician. In addition, he is
recognized worldwide for research in the
treatment of gynecologic neoplasms, and
for his contributions to conception
control.
Among the participants in the symposi¬
um honoring Dr. Morris were four mem¬
bers of the Yale medical faculty: Drs.
Virginia Stuermer, associate clinical pro¬

fessor of obstetrics and gynecology; James
J. Fischer, professor and chairman of the
Department of Therapeutic Radiology;
Peter E. Schwartz, professor of obstetrics
and gynecology, and Frederick Naftolin,
professor and chairman of the Depart¬
ment of Obstetrics and Gynecology.

Dr. Downs, Founder of the
International Health Travel
Fellowship Program
The School of Medicine’s international
health travel fellowship program has been
named in honor of its founder. Dr.
Wilbur G. Downs, clinical professor of
epidemiology.
“The travel program is now a cherished
tradition here at Yale and the envy of
other institutions,” said Dr. Curtis L.
Patton, professor of epidemiology (micro¬
biology) and chairman of the school’s
Committee on International Health. He
outlined the program’s history at a May
15 dinner, honoring Dr. Downs and
announcing that the fellowships have
been designated the Wilbur G. Downs
International Health Travel Fellowships.
While Dr. Downs was associate director
of The Rockefeller Foundation, he con¬
ceived the idea for the international travel
program. It started in 1965 with three
students traveling to Brazil and in 1986,
14 students will visit 13 countries.
During the intervening years, more
than 180 students have participated in the
program that Dr. Downs initated to give
students the experience of working for at
least two months and sometimes as long
as a year on a specific project in a
research laboratory or in the field in a
foreign country. The students selected,
receive travel expenses and a minimal
stipend. In turn, they report on their
research and travel experiences — experi¬
ences which have influenced many career
choices.
Dr.Downs, who received A.B. and
M.D. degrees from Cornell University
and an M.P.H. degree from The Johns
Hopkins School of Medicine, was associ¬
ate director of The Rockefeller Founda¬
tion from 1963 to 1971. For 22 previous
years, he was a foundation field staff
member, responsible for malaria field
programs in Trinidad and Mexico. In
1963, he was appointed professor of
epidemiology at Yale, and from 1965
until 1971, hedirected the Yale Arbovirus
Research Unit.
Dr. Downs is a member of the Expert
Committee on Viruses, World Health
Organization. He has been the principal
investigator of the Senegal River Pilot
Health Program, a Yale project sponsored
by the U.S. Agency for International
Development.
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FACULTY NEWS
Dr. William Prusoff, a distinguished re¬
search scientist in antiviral therapy, visited
Meharry School of Medicine in April as
the college’s first Sterling Drug Visiting
Professor. During his visit. Dr. Prusoff,
professor of pharmacology, delivered the
first Ralph Cazort Lecture on "The Pres¬
ent and Future Status of Viral Chemother¬
apy.” The Sterling Drug Company has
established the visiting professor program
to promote the interchange of knowledge
among colleges in the field of pharma¬
cology.
Dr. Michael J. Bannon, assistant profes¬
sor of psychiatry and pharmacology. Dr.
Robert B. Innis, assistant professor of
psychiatry (neuroscience), and Dr. Rod¬
rigo O. Kuljis. instructor in neuroanatomy, have been awarded $25,000 Sloan
Research Fellowships. The award pro¬
gram established by the Alfred P Sloan
Foundation of New York, aids young
scientists w ho teach at American colleges
and universities.
Dr. Alan C. Sartorelli, director of the
Comprehensive Cancer Center, began a
one-year term as president of the Ameri¬
can Association for Cancer Research Inc.
on May 7, at the association’s annual
meeting in Los Angeles. I he association
brings together cancer researchers to dis¬
cuss new or significant observations and
to foster research on cancer.
Earlier this spring. Dr Sartorelli re¬
ceived the bronze medal award for experi¬
mental therapeutics from the American
Society for Pharmacology and Experimen¬
tal Therapeutics during the society’s an¬
nual meeting held in St. Louis.
Eleven young scientists in the Yale Com¬
prehensive Cancer Center have received
the New Haven Foundation’s Argali L.
and Anna (i. Hull Cancer Research
Awards They are Drs. Paula Kavathas,
assistant professor of laboratory medicine;
Richard Anderson, postdoctoral fellow
in pathology ; John Woods, postdoctoral
fellow in cell biology ; Susan Keyes, associ¬
ate research scientist in pharmacology;
Susan Kelley, postdoctoral tellow in onco¬
logy: John Flory. research associate in
human genetics; Bruce Littlefield, assis¬
tant professor of obstetrics and gyneco¬
logy. Jeffrey Radding. postdoctoral fellow
in internal medicine; Basil Rigas, post¬
doctoral fellow in human genetics; Grace
Vitkauskas.associate research scientist in
pharmacology . Also, Dr. Alfons Bonde.
research associate in internal medicine,
ind Mary Kay Knobf, R.N., M.S.N.,
use specialist and lecturer in surgery
(oncology).

Dr. George E. Palade, professor emeritus
of cell biology, special advisor to the dean
of the School of Medicine and senior
research scientist in cell biology, has been
named to a four-year term on the Adv isory
Committee to the director of the National
Institutes ol Health.
In addition. Dr. Palade received honor¬
ary' degrees from two distinguished univer¬
sities this spring. Columbia University
awarded him an honorary doctor of
science degree for the "isolation and
characterization of subcellular compo¬
nents as a major research tool,” and for
solving "the major problem of fixation of
tissues for electron microscopy, enabling
that technique to become a critical tool
for research in biology and diagnosis in
medicine.” At commencement exercises
in June, New York University awarded
Dr. Palade a doctor of science degree for
“bringing the light of understanding to
the microcosmos of the living cell.”
The American Cancer Society has awarded a two-year grant of $151,000 to
Dr. Kenneth Taylor for the study of
tumor vascularity by means of the use of
Doppler Ultrasound. Dr. Taylor, pro¬
fessor of diagnostic radiology, is well
known for developing the use of ultra¬
sound for diagnostic procedures.
The honor of Fellow of the Institute was
conferred on Dr. Robert Shope by the
Queensland Institute of Medical Research
in recognition of his distinguished contri¬
butions to the furtherance of medical
science. Dr. Shope is professor of epidemi¬
ology and director of the Yale Arbovirus
Research Unit.
Dr. Joseph McGuire, professor of derma¬
tology, who was recently appointed presi¬
dent-elect of the Society of Investigative
Dermatology, was visiting professor of
dermatology at Hunan Medical College
during April and May.
The YaleScienceand Engineering Associa¬
tion has presented its 1986 Award for the
Advancement of Basic and Applied Sci¬
ence to Dr. Alvan R. Feinstein. professor
of medicine and epidemiology, and co¬
director of the Robert Wood Johnson
Clinical Scholars Program at Yale. The
association, which includes some 1.000
Yale science and engineering alumni,
honored Dr. Feinstein for his work to
advance quantitative research in epidemiol¬
ogy and for his efforts in establishing
clinical epidemiology as a new scientific
discipline in medical research.
Dr. Norman Talner. professor ol pedia¬
trics, is one of four cardiologists appointed
as Fulbright v isiting professors in a teach¬
ing program in Hong Kong. Kuala Lum¬
pur. Malaysia and Rangoon. Burma trom
March 27 to April II. The good-will
medical science mission, conducted at the

request of medical societies of those
countries, was jointly sponsored by the
American College of Cardiology and the
Fulbright Commissions.
Dr. Pasko Rakic. Dorvs McConnell Duberg Professor of Neuroscience and chair¬
man of the Section of Neuroanatomy,
organized a conference entitled "Brain
Beyond Genes: Epigenetic Regulation of
Synaptic Circuits and their Function”,
held in New York City on June 2-4.
Dr. Rakic was one of 15 scientists to
present data and ideas about the mole¬
cular, cellular, physiological and psycho¬
logical mechanisms underlying cellular
interactions in the brain and their biomedi¬
cal and social implications. The confer¬
ence was sponsored by the Institute for
Child Development Research.

The New Haven Foundation presented
an Elm-Ivy Award to Kay D. Codish,
citing her as a force in "creating, implementingand monitoring policies on affirm¬
ative action, sexual harassment and day
care.” In addition to directing the School
of Medicine’s Office for Women in Medi¬
cine, Ms. Codish has been active in the
AIDS Project in New Haven, the Wo¬
men’s Self-Defense Alliance. Arts Coun¬
cil of New Haven and Handicapped
Artists. Inc.

BOOKS BY FACULTY
“Legal Issues in Pediatrics and Adolescent
Medicine”, Second Edition. Revised and
Enlarged, by Angela R. Holder, clinical
professor of pediatrics (law). Yale Univer¬
sity Press (New Haven, CT) 1985.
“The Psychoanalytic Study of the Child,”
Vol. 40, by Albert J. Solnit, Sterling
Professor in the Child Study Center,
Pediatrics and Psychiatry, RuthS. Eissler,
and Peter B. Neubauer. Yale University
Press (New Haven. CT) 1985.
“The Biochemical Basis of Neuropharma¬
cology”, Fifth Edition, by Jack R. Cooper.
professor of pharmacology, Floyd E.
Bloom and Robert H. Roth .professor of
psychiatry and pharmacology. Oxford
University Press (New York) 1986.
"Reproductive Failure”, edited by Alan
H. DeCherney, M.D., John Slade Ely
Professor of Obstetrics and Gynecology.
Churchill Livingstone (New York) 1986.

“Understanding Your Immune System”,
by Marion E. Morra, assistant director,
Yale Comprehensive Cancer Center, and
Eve Potts. Avon Books (New York)
1986.

Animal Care Program
Receives Full
Reaccreditation
The American Association for Accred¬
itation of Laboratory Animal Care
(AAALAC) hasapproved full reaccredita¬
tion for three years for the School of
Medicine’s animal care program.
In addition, the National Institutes of
Health’s Division of Research Resources
has awarded the medical school a
$771,000 grant to help renovate laboratory
animal facilities in Sterling Hall of
Medicine.
“Reaccreditation and the N1H renova¬
tion grant are major acknowledgements
of the school’s comprehensive program
for the care of laboratory animals used in
more than 300 biomedical research pro¬
jects,"according to Dr. Robert O. Jacoby,
associate professor of comparative medi¬
cine and head of the Division of Animal
Care.
AAALAC, a national nonprofit organi¬
zation, inspects and accredits laboratory
animal programs. The medical school’s
participation in the program, which began
in 1967, is voluntary.
“Accreditation by AAALAC is viewed
by the N1H as the best means to demon¬
strate compliance with regulations and
policies that govern the care and use of
animals in federally sponsored research,”
explained Dr. Jacoby. Yale’s Animal
Care and Use Committee, chaired by Dr.
Martine Y.K. Armstrong, intensified re¬
views of research that involves animals
before new federal regulations governing
animal use became effective January 1,
according to Dr. Jacoby.

ERRATUM

Two members of the School of Medicine
faculty. Dr.George E. Palade and Dr.
Joan A. Steitz, were awarded the National
Medal of Science by President Ronald
Reagan. They were among 20 scientists
nationwide to receive the awards at the
ceremony held at the White House on
March 12.
Dr. Palade, Sterling Professor Emeritus
of Cell Biology, special advisor to the
dean, and senior research scientist in cell
biology, was recognized for his pioneering
discoveries of fundamental structures in
living cells through studies combining
electron microscopy and biochemistry.
"These contributions stimulated the
growth in the field of cell biology, which
he continues to inspire through his own
research and leadership and active col¬

laboration and the training of new investi¬
gators,"said the White House in awarding
the prize.
Dr. Steitz, professor of molecular bio¬
physics and biochemistry, received the
national award for her discovery of at
least six new components of cells which
are significant in understanding the mole¬
cular biology of autoimmune diseases,
such as lupus and rheumatoid arthritis.
“Her discovery of at least six new compo¬
nents of cellular machinery is an accom¬
plishment of great distinction in both
basic molecular biology and in the clinical
treatment of autoimmune disease,” said
the White House. Receiving the award
from President Reagan, said Dr. Steitz,
“was a great honor."

An item in the fall 1985 issue (Here and
About, page 20) states that Dr. John A.
Kirchner came to Yale in 1951 as the first
full-time chief of the Section of Otolaryn¬
gology. It has been brought to our atten¬
tion that Dr. Norton Canfield was the
first full-time chief of that section from
1933 to 1951. Dr. Canfield is currently
living in M iami, Florida, and recently has
been consultant in audiology at the M iami
Hearing and Speech Center working on
the cochlear implant project.

IN PROGRESS
New Drug Combination
to Treat Brain Tumors
A new , investigational treatment for malig¬
nant glioma, the most common of adult
brain tumors, has been developed at the
at the Yale School of Medicine.
Combininga known chemotherapeutic
agent with a class of anti-psychotic drugs
appears to markedly increase the killing
of tumor cells, according to researchers
in the Brain Tumor Study Group at the
Yale Comprehensive Cancer Center. They
have studied the safety of this treatment
in the past year, during the first phase of a
clinical trial that involved 18 patients.
“We are encouraged by our preliminary
results in the laboratory and are optimistic
that the combination will be well toler¬
ated,"said Dr. William N. Hait, assistant
professor of medicine, in whose laboratory
the project began in collaboration with
Dr. John S. Lazo, associate professor of
pharmacology.
The anti-psychotic drugs, known as
phenothiazines, concentrate in the brain
and may overcome a major problem in
treating malignant glioma —the inability
of most cancer-fighting drugs to get from
the blood into the brain. Phenothiazines
appear to inhibit the protein calmodulin
that is involved in cellular division, thus
helping the chemotherapeutic agent bleo¬
mycin to attack cancer cells and halt the
tumor’s growth, the researchers report.
I he high-grade brain tumor, glioblasto¬
ma multiforme, is usually incurable and
fatal. The most common treatment in¬
volves surgery, in which part of the tumor
is removed. Radiation and chemotherapy
treatments follow.
“Because of the tumor’s nature, it’s
difficult to remove it entirely, without
removing a small portion of the normal
brain, sometimes leaving the person with
impaired function,” said Dr. Hait.
In the newly developed treatment, labor¬
atory studies demonstrated that the ability
of the chemotherapeutic agent, bleomycin,
to kill cancer cells increased.
“Our studies showed that when calmodu¬
lin inhibitors were combined with bleomy¬
cin, almost 500 times more cancer cells
were killed than when either drug was
given independently,” said Dr. Hait. He
and Dr. Lazo first conducted animal
studies and then a study in patients to
assure the safety of the combination.
I he 18 patients treated had no longer
responded to traditional chemotherapy,
said Dr. Hait. The clinical trial, approved
by the medical school’s Human Investigai ion ('ommittec, was designed to help the
archers determine the tolerable doses
ol phenothiazines with bleomycin and

the side effects resulting from the new
drug combination.
Preliminary results have proved “prom¬
ising,” according to Dr. Hait. Most pa¬
tients tolerated the drug combination
very well compared to patient responses
to most chemotherapies, although the
expected side effects of chemotherapy oc¬
curred. These preliminary results are sum¬
marized in the current proceedings of the
American Society of Clinical Oncology.
A full report has been submitted to
Cancer Treat mem Reports.
Side effects, all related to the anti¬
psychotic drug, included sleepiness and
some anxiety that discontinued as soon
as the treatment was stopped. Some lung
toxicity resulted from the bleomycin, but
not greater than expected from this drug
used alone, the researchers reported.
They chose to focus on brain tumors,
rather than on another form of cancer,
because of phenothiazines’action in the
brain. "The striking thing about phenothia¬
zines is that they accumulate in the brain,
thereby concentrating in the area that
they are needed in concentration,” com¬
mented Dr. Hait.
Most drugs don't reach as high concen¬
trations in the central nervous system as
they do peripherally because of a pheno¬
menon known as the “blood brain bar¬
rier,” which keeps things out of the brain.
Phenothiazines can pass through that
barrier, explained Dr. Hait, and poten¬
tially augment the effects of bleomycin.
Coinvestigators in the multidisciplinary
Brain Tumor Study Group include Drs.
Joseph Piepmeier, assistant professor of
surgery (neurosurgery); Thomas N. Byrne,
assistant clinical professor of neurology;
Henry J. Durivage, associate research
scientist in medicine, and Douglas Reed,
assistant professor of diagnostic radio¬
logy. The American Cancer Society, the
National Institutes of Health and BristolMyers Company in Wallingford, funded
the study with basic research grants to¬
taling $162,500.

Yale Researchers Achieve
Breakthrough in
Treatment of Severe Burns
A new chapter in the annals of transplanta¬
tion was written recently by a team of
Yale-New Haven Medical Center physi¬
cians who successfully treated a critically
injured burn patient by transplanting
skin donor dermis and the patient’s own
laboratory-cultured epidermis to the
wound site.
J he procedure, announced at a hospital
news conference on April 4, marks the
first time human skin has been permanent¬
ly transplanted from donor to host with¬
out the use of immunosuppressives. The
breakthrough was made by three Yale
School of Medicine physicians: Drs.
Charles Cuono, associate professor of
surgery (plastic and reconstructive),
Robert Langdon, assistant professor of
dermatology and Joseph McGuire, profes¬
sor of dermatology.
Over the last decade, skin transplanta¬
tion has been used widely to treat burn
victims, but because of the rejectionphenomenon, the use of full-thickness
donor skin (dermal and epidermal layers)
can be be applied only as a stopgap
measure. Through the Yale team's work,
however, it appears dermal transplants
can be permanently accepted by the host
if the donor epidermis is removed.
It was November of last year when a
white, middle-aged male was brought to
Yale-New Haven Hospital with third
degree burns to 55 percent of his body
from his chest to his ankles. Placed under
the care of Dr. Cuono and the nurses in
the Surgical Intensive Care Unit, the
patient’s injured skin was debrided and
cryopreserved cadaver allograft skin from
the Yale Skin Bank was placed on the
wound bed.
Keratinocyte cultures were initiated
with cells from the patient’s uninjured
skin and these cultures were expanded in
vivo. Techniques similar to those used by
Dr. Langdon to expand the cultures had
been used elsewhere in the United States
but through his refinements in the process,
he was able to expand the cultures more
rapidly.
On the patient’s 32nd day in the hospi¬
tal, a cylindrical air-driven carborundum
wheel was used to literally sand off the
epidermal layer of the allograft on his
torso, leaving only the less antigenic
dermal bed. The patient’s own epidermal
cultures, grown in 35 six-centimeter
dishes, were used to resurface this exposed
dermal bed. Each disc of epidermis was
approximately two-cells thick at the time
of application.
The epidermal discs were covered for
seven days, and then re-examined. The
physicians were excited to find the cultures
had adapted to their dermal bed and

grown. The procedure was repeated on
the abdomen beginning on the 42nd day,
and the results were equally positive. By
the 52nd day, the patient was walking
and he was discharged from Yale-New
Haven Hospital on the 71st day. To date,
the patient has displayed no signs of
rejecting the foreign dermis.
Drs. Cuono, McGuire and Langdon
emphasized their achievement was built
on the work of other scientists. “None of
the techniques, taken individually, were
developed here,” Dr. Cuono said. “We’ve
just put them together and exploited
certain aspects of the biology of the skin.”
The procedure demonstrated several
advantages over previously applied forms
of treatment. A rule of thumb is that a
burn patient will require three days in the
hospital for each percent of the body
burned
150 to 175 days in the case of
this patient. Though given only a 20
percent chance of survival on admission,
he was discharged after only 71 days.
Scarring is the most visible consequence
of severe burns, but the Yale team's
approach helps reduce scarring by adding
dermis which provides flexibility and
durability to skin. It is the lack of dermis
which results in the lumpy scars and
contractions which commonly afflict re¬
covered burn victims. The addition of
dermis not only gives the injured flesh a
more natural texture, but also makes it
more resistant to injury.
Infection, the leading cause of death
for burn victims, tends to set in during the
weeks of recovery when skin grafts are
being harvested to cover the patient’s
wounds. By using cryopreserved skin
from a skin bank, surgeons are able to
completely cover the wound site within
days of the accident, effectively protect¬
ing the patient from infection and theoreti¬
cally improving morbidity rates.
- Tom Urtz

Enzyme Understanding
First Step in Aiding
Heart Disease Patients
To design better drugs and improve a
current drug used to treat patients with
heart disorders, Yale researchers have
been studying the structure and functions
of a life-sustaining enzyme. The enzyme
or protein, sodium potassium ATPase,
affects the sensitivity and resistance in
different organisms to digitalis, a drug
used to treat heart disease patients.
“We think that by understanding as¬
pects of structure/ function organization,
we can begin to think of better ways to
design drugs to treat people with heart
disease,’’said Dr. Robert Levenson, assis¬
tant professor of cell biology, the principal
investigator of the study.
The enzyme is the cellular receptor of a
family of compounds including digitalis,
which stimulate the heart muscle. But,
digitalis presents complications to some
people, including nausea, vomiting, loss
of appetite and abnormal heart activity.
“The dose that is therapeutic and the
one that is toxic are not very different,”
said Dr. Levenson.
Information derived from an under¬
standing of the enzyme’s structure, such
as pinpointing important sites for drug
binding and drug interaction, could pave
the way for a more effective drug treat¬
ment, according to Dr. Levenson. The
researchers isolated the DNA sequence
coding for the sodium potassium ATPase
using recombinant DNA techniques.
Patients can get sick from digitalis,
according to Dr. Levenson, because the
drug is non-specific. It can affect the
enzymes in many tissues and not only the
enzyme in heart muscle.
“We could possibly design a better
drug that would be safer, if we knew
exactly where the drug bound and how it
interacts with the protein,” he said. “There
may be something different about this
enzyme in the heart that we can take
advantage of, so that the drug designed
will only or preferentially act with the
heart form of the enzyme.”
Finally, this enzyme, which helps to
sustain life by regulating ion transport
into and out of cells, may also prove
important toward developing diagnostic
tests for several genetic diseases, including
hypertension, cystic fibrosis and muscular
dystrophy. The defects leading to these

diseases may lie in the gene coding for
systems which transport ions, said Dr.
Levenson.
The ongoing research, which began
two years ago, has been funded through
grants totalling $420,000 from the Ameri¬
can Heart Association, the National Can¬
cer Institute, the Cystic Fibrosis Founda¬
tion and the March of Dimes. Coinvestiga¬
tors include Drs. Janet Emanuel, associate
research scientist in cell biology and Dr.
Edward J. Benz, associate professor of
medicine and human genetics.

Antiviral Drugs Tested
in Army-funded Study
Numerous anti-viral drugs are being tested
by Yale investigators who hope to develop
those that could treat a wide range of
virus-caused diseases, from yellow fever
to AIDS. Approximately 500 drugs will
be tested over the next five years during a
$1.5 million study funded by the U.S.
Army.
“This study involves private industry,
defense and academia working together
to develop specific anti-viral drugs,” said
Dr. Gregory H. Tignor, associate pro¬
fessor of epidemiology, the study’s princi¬
pal investigator. “It gives us access to
hundreds of anti-viral drugs that would
otherwise go untested.”
Each drug is first evaluated in tissue
culture to determine its worthiness for
further study, according to Dr. Tignor.
Researchers test for toxicity before fur¬
ther testing to determine an estimate of
the drug’s potential efficacy in humans.
If an important anti-viral drug is pin¬
pointed, Dr. Tignor and his coinvestiga¬
tors would collaborate with the drug’s
manufacturers in completing the necessary
preliminary tests leading to preliminary
trials in humans and ultimate governmen¬
tal approval for marketing the drug.
Coinvestigators in the study include:
Dr. Robert E. Shope, professor of epi¬
demiology and director of the Yale Arbo¬
virus Research Unit; Dr. Abigail Smith,
associate professor of comparative medi¬
cine and epidemiology, and Dr. Thomas
G. Burrage, associate research scientist
and lecturer in epidemiology.
“We’re looking for a drug that has a
high safety index,” said Dr. Shope. “It
should have minimal toxicity and be
effective at low concentrations.”
The drugs will be evaluated primarily
with the yellow fever virus. The Yale
Arbovirus Research Unit has a long
association with studies on yellow fever
virus. A vaccine was developed 45 years
ago at Yale by the late Max Theiler, who
received the Nobel Prize for his work on
the vaccine. Later, Dr. Theiler worked
with Drs. Shope and Tignor.
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Yale Surgeons Analyze
Heart Valve Replacements
In studies to determine which valve type
is better for heart valve replacement
surgery. Yale surgeons have analyzed
two main types of valves. After review ing
more than 1.100 biological and mechani¬
cal valves inserted in adults during an
11-year period, they have concluded that
little direct evidence exists to strongly
support one type of valve over another.
"All ot the valves have problems, and
the problems cancel each other out. If
you look at failure rates, there is no clear
advantage of one type over another,” said
Dr. Graeme L. Hammond, professor of
surgery.
Basically , patients who received mechan¬
ical heart valves experienced a higher
incidence of blood clotting, while those
who were given hiological, or pig heart,
valves registered a higher incidence of
valve failure, according to Dr. Hammond,
who co-authored the study with Dr.
Alexander S. Geha, professor of surgery.
Dr. Gary S. Kopf. associate professor of
surgery, and Dr. Sabet W. Hashim, assis¬
tant professor of surgery.
After assessing problems of biological
and mechanical valves and addressing
questions about which may be better the
researchers concluded that the final valve
selection is relative. "As physicians and
patients discuss risks and benefits of the
respective valves before deciding which
to use, they must take into account the
individual’s age, reliability to self-medicate, activity level and anticipated life
expectancy.” said Dr. Hammond.
In their study the research team ana¬
lyzed I. I 16 valves inserted in 1,012 adults,
aged 18 to 88 from January 1974 through
January 1985 at Yale-New Haven Hospi¬
tal. Six-hundred-and-six biological valves
were implanted in 533 patients, and 479
individuals received 510 mechanical
valves. ITie Yale surgeons examined the
valves for such complications as blood
clotting, anticoagulation-related hemor¬
rhage. valve susceptibility to infection,
valve leaks, valve failure and the need for
reoperation.
" I here is no artificial valve that is as
good as the normal God-given valve,”
Dr. Hammond said. Human heart valves
are flexible, openingand closing easily as
the human heart beats 40 million times a
year. No man-made material similarly
Ilexes as often w ithout wearing out.
Biological valves and the three w idely
used mechanical valves that the Yale
team evaluated eventually fail. Dr. Ham¬
mond noted. Complications generally
begin to appear two or three years after
valve replacement surgery.

The pig valves that surgeons sew into
their patients, can’t regenerate themselves
like human valves do. In addition, calcium
may build up in the porcine valves; fatty
acids and cholesterol can infiltrate them.
“Our data showed that biological valves
deteriorate more than mechanical valves,”
commented Dr. Hammond. A total of
11.4 percent of the patients with biological
valves experienced valve failure, com¬
pared with 4.5 percent of those with
mechanical valves. J orn leaflets and calci¬
fication caused most, or 69 of the 606,
biological valve failures, with a sharp
increase occurring six years after replace¬
ment surgery.
At the same time, patients who received
mechanical valves experienced other com¬
plications which were equally serious.
For example, clotting, leaflet jamming,
tissue ingrowth and material degradation
occurred in 26 of the 510 mechanical
valves.
"We found that blood clots occurred in
2.3 percent of all the mechanical valves,
compared with 0.7 percent in the biologi¬
cal valves,” Dr. Hammond reported.
Heart valve disease is most common
among adults W'ho had rheumatic or
scarlet feveras children. Work on refining
replacement heart valves and in devel¬
oping new ones to eliminate problems
has been progressing since the early 1960s.

Foundation Gift
Supports Clinical
Scholarship
1 he Robert Wood Johnson Foundation
has granted the School of Medicine
$1,017,000 to support the Foundation's
clinical Scholars Program for three addi¬
tional years. The gift was made as part of
the school’s S125 million capital campaign.
Since its beginning in 1974. the Clinical
Scholars Program at Yale has provided a
fellowship period of training for post¬
graduate physicians working in clinical
epidemiology, health care delivery or
health policy. More than 40 American
physicians and various foreign visitors
have attended the program.
Dr. Alvan R. Feinstein. professor of
medicine and epidemiology, and Dr.
Ralph I. Horowitz, associate professor of
medicine and epidemiology, areco-directors of the program. Four new scholars
are selected each year from about 30
applicants. They study quantitative clini¬
cal epidemiology, attend seminars in
health policy, delivery and the social
sciences and conduct research projects
during the two-year fellowship period.

OBITUARIES
Robert Reese Berneike, M.D.
Dr. Robert R. Berneike, associate clinical
professor of surgery (urology), died at
Yale-New Haven Hospital on March 15,
1986 following a lengthy illness.
Born in Cleveland, Ohio, on October
23, 1915, he received a bachelor’s degree
in 1937 and his medical degree in 1941
from Case Western Reserve University in
Cleveland, where he was elected to AOA
prior to graduation. Dr. Berneike received
postdoctoral training in surgery and urolo¬
gy at the New Haven Hospital and was
certified by the American Board of Urolo¬
gy in 1948. He served on the full-time
faculty at Yale under Dr. Clyde Deming
from 1946 to 1949. He then entered the
private practice of urology which he
maintained in New Haven from 1949
until 1983, when he retired.
He was very active in the clinical
teaching program at Yale, as well as on
the staff at both hospitals in New Haven.
He served as president of the medical
staff at Yale-New Haven Hospital in
1968-1969, president of the New Haven
Medical Association in 1973-1974, and
president of The New England Section of
The American Urologic Association in
1974-1975. He was associate chief of the
Section Urology at Yale-New Haven Hos¬
pital from 1946 to 1963 and was chief of
chief of the Urologic Service at The
Hospital of Saint Raphael from 1963 to
1980. He also was involved in many
community activities and had been chair¬
man of the Board of Education in Woodbridge from 1965 to 1971.

Gerald Klatskin, M.D.
Dr. Gerald Klatskin, an internationally
known liver specialist who was the David
Paige Smith Professor Emeritus of Medi¬
cine, died on Thursday, March 27 at his
home in Hamden following a lengthy
illness. He was 75.
He is survived hy his wife, the former
Ethelyn Elmer Henry, professor emeritus
of psychology and pediatrics in the Yale
Child Study Center; two daughters, Jane
K. Herner of Santa Barbara, California,
and Ann Klatskin of New Haven; a son,
Robert of Los Angeles, California, and
three grandchildren.
He was born May 14, 1910 in New
York City, the son of Archy and Cecelia
Golub Klatskin. He completed a bache¬
lor’s degree in 1929 at Cornell University,
where he was elected a member of Phi
Beta Kappa, and received his M.D. degree
from Cornell Medical College in 1933,
graduating first in his class. He took his
internship and residency in medicine at
New Haven Hospital between 1933 and
1935 and then went to Rochester, N.Y.,
where he was an intern in surgery and an
associate resident in medicine at Strong
Memorial Hospital from 1935-37. He
was an instructor in medicine at the
University of Rochester for a year before
joining the Yale medical faculty in 1937.
His academic career at Yale was inter¬
rupted by World War II, and he served in
the U.S. Army Medical Corps between
1942 and 1946, achieving the rank of
lieutenant colonel.
When he returned to Yale in 1946, he
was appointed assistant professor of medi¬
cine, a post he held for two years. He was
then named associate professor of medi¬
cine in 1948 and professor in 1957. A year
later, he became the David Paige Smith
Professor of Medicine, and then professor
emeritus in July 1978.
A member of numerous professional
organizations. Dr. Klatskin helped found
the American Association for the Study
of Liver Diseases in 1948 and served as its
president in 1957-1958. He served as a
member of several National Institutes of
Health committees, including the Gastro¬
intestinal Nutrition and Liver Disease
Training Committee between 1959 and
1964, and also as a consultant to the
Surgeon-General’s U.S. Army Medical
Research and Development Command
from 1965 to 1975.
In May 1983, the American Gastroenter¬
ological Association awarded Dr. Klat¬
skin the Julius Friedenwald Medal, honor¬
ing him on the 50th anniversary of his
distinguished medical career. Among his
other honors. Dr. Klatskin was presented

the American College of Physicians’ Mas¬
tership and Distinguished Teacher Awards in 1974and 1979, respectively. He
was a member of Alpha Omega Alpha,
the national medical honor society, and
Sigma Xi, the national scientific society.
At Yale, he was the first recipient of the
Francis Gilman Blake Award for out¬
standing medical student teaching in 1952.
Dr. Klatskin is best known for his
contributions to the correlations between
biochemical and biological abnormalities
and the clinical features of the diseased
liver. He was a pioneer in the development
of liver biopsy techniques and their histo¬
logical interpretation, techniques devel¬
oped in 1947 that are still used today. He
and his colleagues accumulated more
than 50,000 microscopic slides and cor¬
related clinical data from nearly 10,000
liver biopsy specimens.
His scholarship also encompassed the
entire spectrum of clinical liver diseases,
ranging from chronic hepatitis to alcoholic
liver injury. Dr. Klatskin’s scientific and
scholarly accomplishments include the
first demonstration that viral hepatitis
and the Australian antigen are associated
with chronic hepatitis.
He documented the beneficial effects
of alcohol withdrawal on the natural
history of alcoholic liver disease. He
described the prognostic significance of
acute liver cell injury in hepatitis, devel¬
oped evidence for an association between
the general anesthesic halothan and hepa¬
titis, and identified the clinical significance
of granuloma in liver biopsies. He also
recognized that certain cancers present as
a bile duct bifurcation tumor, the socalled Klatskin’s tumor, and recognized
the common association of fever with
Laennec’s cirrhosis.
Undoubtedly the greatest beneficiaries
of Dr. Klatskin’s skills were the 47 postdoc¬
toral fellows who came to Yale to train
with him during the years from 1951 to
1978. Of these, 34 hold positions in
academic medicine, 19 are full professors,
seven have become chairmen of depart¬
ments and one is a dean.
A memorial service was held for Dr.
Klatskin on June 6, in the Yale Medical
Historical Library. Contributions in his
memory may be made to the Yale Liver
Study Unit, 333 Cedar Street, New Haven,
CT 06510, or to the charity of one’s
choice.

Ira Vaughan Hiscock, M.P.H.
Dr. Ira V. Hiscock, for many years a
leader in public health in the United
States, died April 4, 1986, in Doylestown,
Pennsylvania. Dr. Hiscock was a member
of the faculty at Yale University from
1920 to 1960, retiring as Anna M. Lauder
Professor of Public Health and chairman
of the Department of Public Health.
Dr. Hiscock was born in Farmington,
Maine in 1892. He received B.A. and
M.A. degrees from Wesleyan University
(Connecticut) and the M.P.H. degree
from Yale University.
During his career. Dr. Hiscock con¬
ducted comprehensive health surveys
throughout the United States and in
American Samoa. For many years, he
was chairman or secretary of expert
panels of the World Health Organization
in Geneva, Switzerland. On his retirement
from Yale, he was awarded a Carnegie
Visiting Professorship in Public Health
at the University of Hawaii.
Dr. Hiscock’s many honors and awards
included an honorary Doctor of Science
degree from Wesleyan University and an
Honorary Doctor of Medicine from the
Connecticut State Medical Society. The
American Public Health Association pre¬
sented him with the Sedgwick Memorial
Medal in 1962. His other honors include
the Public Service Award of the Connecti¬
cut Bar Association, the C.-E.A. Winslow
Award of the Connecticut Public Health
Association and the Lemuel Shattuck
Award of the Massachusetts Public
Health Association. Yale honored him in
1978 with the dedication of the Ira V.
Hiscock Library in the Laboratory of
Epidemiology and Public Health.
Dr. Hiscock served as president of the
American Public Health Association, the
National Health Council, the Associa¬
tion of Schools of Public Health and the
National Society for the Prevention of
Blindness. He was a veteran of both
World Wars. In WW II, as a colonel, he
was chief of Public Health, Civil Affairs
Division, War Department and was awarded the Legion of Merit. He served 31
years, with eight years of active duty.
His published books include: Commun¬
ity Health Organization; Public Health
in Hawaii; District Health Administra¬
tion, and Ways to Community Health
Education.
Dr. Hiscock is survived by his son,
William McC. Hiscock, of Baltimore,
Maryland; his daughter, Margaret H.
Weatherly, of Mt. Laurel, New Jersey;
seven grandchildren and onegreatgranddaughter.
The Ira V. Hiscock Memorial Scholar¬
ship Fund has been established in the
Department of Epidemiology and Public
Health. Gifts may be made to the fund,
care of the Yale Public Health Alumnae
Fund, P.O.Box 1890, New Haven, Cl
06508.
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Dr. Petersdorf, ’52, to Head AAMC
ly qualified for this role.”

As of September 1986, Robert Peters¬
dorf, M.D., ’52, who is vice-chancellor

Dr. Richard Janeway, vice president
for health affairs and executive dean of
Bowman Gray School of Medicine and
AAMC Presidential Search Committee

for health sciences and dean of the
University of California, San Diego,
School of Medicine, will be president
and chief executive officer of the Associ¬
ation of American Medical Colleges in
Washington, D.C. The AAMC, formed
in 1876, represents 127 U.S. medical
schools, more than 400 teaching hospi¬

chairman, commented, “The nation’s
medical school and teaching hospitals
respect Dr. Petersdorfs record of accom¬
plishment and his wide ranging experi¬
ence and wisdom. He worked his way
through the medical school academic
ranks, having been chairman of the

tals, over 70 medical professional socie¬
ties, and the U.S. medical students.
Dr. Petersdorf succeeds Dr. John A.

Department of Medicine at the Univer¬
sity of Washington School of Medicine
at Seattle, a spot he held with distinction

Cooper, who is retiring from the posi¬
tion he has held since 1969. In com¬
menting on the appointment. Dr.

for 15 years; serving as president of
Brigham and Women’s Hospital in
Boston from 1979 to 1981 when he then

Cooper praised the selection of Dr.
Petersdorf, calling him “a longtime
friend who has an outstanding national
reputation forstrongand effective lead¬

assumed his present responsibilities at
the University of California, San Di¬
ego,” said Dr. Janeway.
“He is one of the few people in the
country with outstanding qualifications

ership in academic medicine.
“He is a distinguished scientist, a
superb clinician, who is deeply inter¬
ested in medical education and the
nation's teaching hospitals,” said Dr.
Cooper. “Dr. Petersdorf is recognized
as one of the outstanding investigators
and clinicians in internal medicine and
infectious diseases in the United States.”
The newly appointed AAMC presi¬
dent has served with a wide variety of
national organizations. As a member
of the Accreditation Council for Gradu¬
ate Medical Education, he has fought
for high standards for the residency
training programs in U.S. hospitals, a
subject on which he has frequently
written, and in 1977 -78, he was chair¬
man of the AAMC Assembly. He has
served as president of the American

Dr. Petersdorf

in academics, medical college adminis¬

College of Physicians, of the Associa¬
tion of American Physicians, of the

tration and hospital direction, thus
touching the three major constituent
parts of the association. This wide
ranging experience equips Dr. Peters¬

Association of Professors of Medicine,
and as chairman of the Board of Gover¬

dorf well as he assumes the leadership
of the association.”

nors of the American Board oflnternal
Medicine. He is also a member of the
Institute of Medicine of the National

Dr. Petersdorf has been an editor of
Harrison’s Principles oflnternal Medi¬
cine since 1968. He has published over
300 papers, his chief areas of interest

Academy of Sciences.
Of Dr. Petersdorfs appointment.
Dr. Virginia Weldon, AAMC chairman
and deputy vice chancellor for medical
affairs at Washington University School
of Medicine, said that “he assumes the
leadership of the Association at a time
of great uncertainty for the medical
profession and for academic medical
centers in particular. He brings to the
association a depth of experience in
medical education, biomedical research
and patient care that makes him unique¬

having been the pathogenesis, epidemi¬
ology, diagnosis and treatment of bacter¬
ial infections, including urinary tract
infections, meningitis, bacterial endocar¬
ditis and gram negative bacteremia,
along with an in-depth study of fever.

DUKE - YALE
Conference
Facing an Era of Upheaval: the
C hanging Environment of Medical
Education and Medical Practice
More than 100 alumni from the Yale and
Duke classes of 1948, 1949 and 1950
gathered in April to discuss the profound
changes in medical care and education
that have occurred during the last three
decades. The three-day conference in
Durham, North Carolina, brought togethera diverse group of physicians, each
with 30 to 35 years of practice, research,
education and administrative experience.
“It allowed an interesting group of
leaders in American medicine to assemble
and provide one another with insights
into some of the problems we face in
academic institutions and in society,”
said Dr. Nicholas P.R. Spinelli, director
of medical alumni affairs and associate
clinical professor of medicine, who
served on the planning committee for the
conference.

Dr. An!van

The meeting, the first of its kind for the
two institutions, was hosted by Dr. Leon
E. Rosenberg, dean of the Yale School of
Medicine, and by Dr. William G. Anlyan
(Yale med ’49), chancellor for health
affairs at Duke. Topics ranged from the
changing criteria for admission to medical
school to a keynote address focusing on
the impact of regulation, health main¬

tenance organizations and the corporatiza¬
tion of medicine.
The goal, according to Dr. Spinelli,
was to bring together classmates from a
mid-20th century era, who now hold a
variety of positions of authority and
responsibility. Most of the alumni
gathered were between the ages of 59 and
62 and will probably pursue theircurrent
activities for another five to ten years.
“Generally speaking, it was a means of
exchanging information among people
with the expertise to direct change in the
future,” said Dr. Spinelli.
In addition to Dr. Anlyan, Yale medical
school alumni participating in the confer¬
ence included: Drs. Robert G. Petersdorf,
Paul Talalay, Lewis P. Rowland, Paul
Goldstein, A|bert Fisk, C. Arden Miller,
William F. Collins, Jr., Sidney S. Lee,
Ben Rush and Lyal Asay. Dr. Petersdorf
delivered the keynote address
In summing up the conference. Dr.
Rosenberg noted the enormous opportun¬
ities which accompany the dramatic
changes in medicine today.

Dr. Rosenberg

“It is time tor a reaffirmation of the
responsibility of physicians to serve the
public, to care for people, and to place
our clients’needs above our own self-interest,”
said the dean, who echoed several
speakers’ comments. “If we are going to
recover the place that physicians once
had in our society and that we believe it
deserves, we must convey to our citizens
the feeling that when we speak out, we are
speaking out for them, not for ourselves.”

CLASS NOTES
194.1
A reception to celebrate Rocko Fasanella’s career in ophthalmology was held
at the New Haven Lawn Club on May 30.
Dr. Fasanella noted that he was not
retiring and that his future activities
would include consultations, second opin¬
ions and office surgery. He also plans to
do research on blepharospasm in hope of
finding a more lasting cure and to conduct
a re-evaluation of Dr. Leon Stone’s classic
studies on regeneration of the optic nerve.

1944
Fulfilling a dream to return to the United
States and to the Yale School of Medicine,
Nora Harnden Mason of Cumbria, Eng¬
land, did return during the week of
November 23rd, 1985. Noracameto Yale
during World War 11 and the blitz, when
many students in England were transterred to American schools.
For her first visit back, she was hosted
by her classmate, Nick Spinelli, who is
now director of Alumni Affairs. Nora
was accompanied by her son. Dr. Robert
Mason, who is on the junior faculty of
Guy’s Hospital in London in the Depart¬
ment of Surgery, where he is active in
research involving gastric and pancreatic
carcinoma. Robert had visited New Haven
ten years ago as a medical student.
Three exciting days in New York fol¬
lowed, where, beyond revisiting the con¬
ventional tourist haunts, visits to the
United Nations and the Metropolitan
Opera were much enjoyed. They were
also guests of Edith Jurka. The group
then spent three days at the Yale-New
Haven Medical Center where Barbara
Kinder (71), associate professor of sur¬
gery, provided Robert and Nora with
inside views of surgery at Yale at the
present time. Paul Molumphy and his
wife Ann, assisted in revealing the “new”

Dr. Mason
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New Haven to Nora, who found both the
city and the medical school entirely
changed.
The Masons left for Boston, where for
one week, Robert was the guest of Dr.
Rob Skillman, of Massachusetts General
Hospital, whom he assisted in gastrointes¬
tinal surgery. Nora sends her best wishes
to all of her classmates whom she regretted
not seeing.

1945
Raymond Gagliardi of Pontiac, M ichigan
was elected president-elect of the Ameri¬
can Roentgen Ray Society at its 86th
annual meeting in Washington, D.C. in
April. He has served as the ARRS secre¬
tary since 1980 and is an active member
of the American College of Radiology
and the Radiological Society of North
America. Dr. Gagliardi is chief radiologist
at St. Joseph Mercy Hospital in Pontiac
and associate professor of clinical radio¬
logy at Wayne State University School of
Medicine.
The Medical College of Wisconsin pre¬
sented its distinguished service award to
Frederic Blodgett for his contributions to
the development of rapid protoporphyrin
quantitation, considered the most accur¬
ate method for detecting lead-poisoning.
In 1984. Dr. Blodgett, professorof pedia¬
trics at WCM, received the Job Lewis
Smith Award from the American Acad¬
emy of Pediatrics in recognition of his
outstanding services to children.

1946
Friends and colleagues honored Gerald
Shattuck on May 1 on the occasion of his
retirement from his pediatric practice in
Portsmouth, New Hampshire. It was
noted that “during his 35 years of practice.
Dr. Shattuck exemplified the medical
profession w ith his dedication and profes¬
sional commitment to the health and
welfare of our community.”

1947
Franklin Epstein wrote in March: “As
you know, I left Yale in 1972 to head up
the Harvard Department of Medicine at
Boston City Hospital and to become
director of Harvard's JTiorndike Memori¬
al Laboratory at that institution. From
1973- 1980.1 directed Harvard’s Depart¬
ment of Medicine at Beth Israel Hospital
as the Herrman Blumgart Professor of
Medicine. Since 1980, I have headed that
institution’s Division of Nephrology, as
the William Applebaum Professor of
Medicine.”
In December 1985, Dr. Epstein reved the John P. Peters Award of the
American Society of Nephrology for "dis¬
tinguished contributions to the mechanii' i'i disease." I he award was presented
lo him by Thomas Ferris (’56).
! n addition. Dr Epstein is an associate
tv: of the Yen England Journal of

Medicine. “I have just been named presi¬
dent of the Mount Desert Island Biologi¬
cal Laboratory in Salisbury Cove. Maine,”
he wrote, “where many Yale people have
visited and worked."

1949
In a recent letter to class agent Dan
Elliott. George Anderson wrote that he is
"fully retired after 30 years' of active
military service (five years WW II and 25
years USAF), also I I years with the
Texas Department of Health. Lots of
travel and activity in such a career — the
medals and war stories are only the up¬
front part of a life of hard work, dedication
and early retirement. At 53, I started a
new and second career in public health.”
He says that his oldest son has followed
in his footsteps: University of Michigan
School of Medicine, Tulane School of
Public Health. USAF training in aero¬
space medicine. He is now in the Surgeon
General’s office in Washington, D.C., a
colonel with 19 years of active service.
Dr. Anderson sends his regards to all.
Dan Elliott has been named president
elect of the Central Surgical Association,
an organization whose members are sur¬
geons from 16 eastern and midwestern
states and four Canadian provinces. He
will take office as president in 1987.
Dr. Elliott has served as professor and
chairman of surgery at Wright State
University School of Medicine since 1976
and also serves on the active medical
staffs of Kettering Memorial Hospital
and Miami Valley Hospital in Dayton. In
addition to being on the courtesy staffs of
six other hospitals in Dayton, he is a
consultant to the Dayton Veterans Admin¬
istration Medical Center and the USAF
Medical Center at Wright-Patterson Air
Force Base. He lives in Kettering, Ohio.
Lawrence Shulman has been appointed
acting director of the new National Insti¬
tute of Arthritis and Musculoskeletal and
Skin Diseases at the National Institutes
of Health in Bethesda, Maryland. This
institute has recently been established
under provisions of the Health Research
Extension Act of 1985. Dr. Shulman
joined the staff of the NIH in 1976; he
previously was on the faculty of The
Johns Hopkins University School of Med¬
icine, where he served as director of the
Connective Tissue Division in the Depart¬
ment of Medicine.

1950
Lloyd Felmy has provided some addition¬
al information about faculty-student teas
(Yale Medicine, winter 1986 issue). “1
enjoyed reading your article on ‘FacultyStudent Teas’ very much. Brought back
memories: both pre-and post- WW1I. I
was originally a member of the Class of

'44. However, I dropped out of school to
enter the Navy; and returned after the
war to graduate with the Class of ’50.
“When I came back to school in 1946, 1
found that the teas had been discontinued.
Having made the contacts previously, I
got in touch w ith M rs. Gardner and a few
of the faculty wives and discussed the
restarting of the afternoon teas. To finance
the teas, the Class of ’50 also re-estab¬
lished the Aesculapian Frolics: same hav¬
ing paid the expenses of the teas before
the war. We continued the Frolics during
our tenure at the school. Sorry you
missed those facts when writing your
article. Anyway, just thought you'd like
to know.”

1966
Reynold Spector. who is a professor of
internal medicine and pharmacology at
the University of Iowa, has been appointed
the director of the General Clinical Re¬
search Center at that institution. Dr.
Spector joined the Iowa faculty in 1968.
In 1983-84, he was visiting professor of
biochemistry at Stanford U niversity where
he worked in molecular biology. He is a
member of numerous scientific societies,
including the American Society for Clini¬
cal Investigation and the Association of
American Physicians.

1973
As of March 1. Da\ id Coulter is associate
professor of pediatrics and neurology
and director of pediatric neurology at
Boston University School of Medicine.
He is also director of pediatric neurology
at Boston City Hospital. “I came to
Boston from the University of Texas
Medical Branch at Galveston, where I
w'as associate professor of neurology and
pediatrics. I am primarily interested in
epilepsy and mental retardation, and as
of June 1. w ill be president of the Ameri¬
can Academy of Mental Retardation. At
Boston University, 1 will be establishing
and directing the pediatric epilepsy pro¬
gram to provide services to children w ith
epilepsy and their families.
"My wife. Mary C. Cetteto. Ph D., is
executive director of the Accreditation
Council for Serv ices to Mentally Retarded
and Developmental^ Disabled Persons.
The Council’s executive offices are also
moving to Boston, bringing a national
perspective on quality assurance in
MR DD programs to the New England
area. Mary and I will be living in an old
Victorian house in Natick."

1983
Tufts University’s Alumni Association,
presented its distinguished service citation
for faculty excellence to Theoharis C.
Theoharides. He is assistant professor of
biochemistry, pharmacology and clinical
pharmacology, and director of medical
pharmacology at Tufts.

Elizabeth Nolan, now working in the
Emergency Department at Coronado Hos¬
pital in Coronado, California, returned
to Yale for a visit in April, in addition to
her medical activities in California, she is
writing fiction and children’s stories.
Abby Van Voorheesand Jeffrey Chodakewitz (’81), were married on April 20 in
Woodbridge, Connecticut. Both are at
Yale; Dr. Van Voorhees is a resident in
dermatology, and Dr. Chodakewitz is a
fellow in infectious diseases.

PUBLIC HEALTH
1983
William Sabella has recently been ap¬
pointed AIDS Education Coordinator
for the State of Connecticut.

HOUSE STAFF
1962
At a ceremony in May at the Cathedral of
the Sacred Heart in Newark, New Jersey,
Dr. Leon G. Smith received papal honors
and was inducted as a Knight of St.
Gregory in the Order of St. Gregory the
Great. Pope Gregory XVI instituted the
award to honor his subjects for their
loyalty, piety and virtue in defending the
Holy See. Director of medicine and chief
of infectious diseases at St. Michael’s
Medical Center in Newark, Dr. Smith is
co-founder with his wife, Margaret, of
Queen of Angels Family Health Service,
a voluntary organization that gives medi¬
cal aid to indigent residents of Newark.

Dr. Beeson's Chief Residents Hold Reunion

IN MEMORIAM
Louis M. Shapiro, M.D.
November 6, 1985

’21 ex med

Ira V. Hiscock
April 3, 1986

’21 M.P.H.

F. Erwin Tracy,

’29 M.D.

April 26, 1985
A. Philip La France
April 18, 1985
Ival A. Merchant
December 16, 1985
Graham C. Newbury
December 22, 1985
Prof. William W. Walcott
February 23, 1986

’31 M.D.

’34 M.P.H.

’35 M.D.

’38 ex med

John A. Murtagh, M.D.
January 15, 1986

’38 H.S.

Roderick Macdonald, M.D.
July 27, 1985

’42 H.S.

Ashley Pond 111
March 17, 1986

’33 M.D.

Robert Lee Taylor
November 13, 1985

’43 M.D.

Robert R. Berneike, M.D.
March 15, 1986
John P. Dowling
September 29, 1985

’46 H.S.

’56 M.P.H.

Hugo Saenz Noguerol, M.D .’59 M.P.H.
March 29, 1986
Bernhard H. Lisker
April 8, 1986

’75 M.D.

Dr. Thomas Ferris, class of ’56 and house staff ’63, sent the above photo with the
following information: “I am enclosing a picture of the reunion of Paul Beeson’s
Chief Residents, held in Washington at the time of the clinical meetings. Seated
from left to right: Phil Bondy, chief of staff. West Haven VAH and professor of
medicine, Yale; Larry Freedman, professor of medicine, UCLA and chief of
medicine at Wadsworth VA Hospital; Paul Beeson; Bob Petersdorf, vice chancellor
of medicine. University of California, San Diego and president-elect of the AAMC;
Gerry Burrow, professor and chairman of medicine. University of Toronto.
“Standing: Tom Amatruda, director of medicine, Waterbury Hospital; Sylvester
Ryan, staff physician, St. Mary’s Hospital, Waterbury; Eli Schimmel, professor of
medicine, Boston University School of Medicine and chief of medicine, Boston VA
Hospital; Ken Johnson, staff physician, Benedictine Hospital, Kingston, N.Y.; Jim
Nolan, professor and chairman of medicine, State University of New York,
Buffalo; Dick Kahler, staff cardiologist, Scripps Clinic, La Jolla, CA.; Tom Ferris,
professor and chairman of medicine. University of Minnesota; Herb Lubs,
professor of genetics, University of Miami Medical School; Hal Conn, professor ot
of medicine, Yale.
“I think this picture will bring back memories to many former students and
housestaff at Yale. It was a memorable occasion for those of us present.”
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CAMPAIGN UPDATE
In May, 1985 The Campaign for the Yale School of Medicine
was formally launched. A t that time, S32 million in gifts and
pledges had been raised toward the $125 million campaign goal.
School officials are exceptionally pleased to announce that the
campaign total now stands at more than $84 million — a $52
million increase in the past year (see progress report summary).
This progress is encouraging, but the task that remains is
formidable. Only 23 percent of the endowment goal of $59
million has been achieved, and an even smaller percentage of the
funds needed for the renovation of laboratories is in hand.
During the coming year, campaign volunteers will focus more of
their efforts upon contacting medical alumni and parents for
major gifts to the campaign.

Kingsley Fellowship Endowment Announced
The Francis G. Kingsley Memorial Fellow¬
ship Fund has been established in the
School of Medicine to honor a longtime
friend of the school. The fellowship is the
result of gifts from family and friends of
Mr. Kingsley, including 5500,000 each
from Milliken and Company, and Mercan¬
tile Stores Company. At the time of his
death in January, Mr. Kingsley was an
officer and director of each company.
A graduate of Syracuse University and
the Tondon School of Economics, Mr.
Kingsley was first employed by Mercantile
in 1932, and became president of the
department store chain two years later.
In 1941, he joined Milliken and Com¬
pany, textile manufacturers, and was
named chairman of Mercantile. In addi¬
tion to these major corporate duties, he
served as financial advisor to the Manhat¬
tan Project, which was responsible for
the design and assembly of the first
atomic bomb.
H is special interest in the school began
when his daughter. Ora Kingsley Smith,
M.D. '53, enrolled in the School of
The late Francis G. Kingsley

Medicine. She is an associate fellow of
the John B. Pierce Foundation, an affiliate
of Yale University.
The Kingsley Fellowship will be
awarded to young investigators at Yale
whose research shows great promise.
Awards will be for one to three years, and
are not restricted to a specific department
or discipline.
Dean Leon E. Rosenberg, who will be
responsible for the final selection of Kings¬
ley Fellows, stressed the Fellowship's
potential to advance medical knowledge.
"Since most funding is based on a physi¬
cian's record of achievement, junior facul¬
ty members rarely have adequate support
for their own research. Often, the most
talented young scientists are relegated to
an assistant’s role in projects directed by
more senior faculty members. This is
unfortunate, because it delays the pursuit
of personal research interests at a time
when the outstanding young physician is
especially energetic, creative and enthusi¬
astic. The Kingsley Fellowship addresses
this problem head-on.”

Lionel .I.M.Delevingne

Tax Reform and the
Campaign for the Yale
School of Medicine
The U.S. Senate’s passage ot a taxreform bill is intended to reduce the tax
rates for most Americans, while elimin¬
ating many deductions. Both House and
Senate versions of the bill preserve the
deduction for charitable contributions
but, if enacted, the bill should create
additional incentives to make charitable
gifts before December 31, 1986. This is
because the reduction in tax rates increases
the after-tax costs of making gifts.
For example, a $10,000 donor in the
50 percent bracket has an after-tax cost
of $5,000 for that gift ($10,000 minus
$5,000 credit for deduction). If that
donor’s tax bracket is reduced to 30
percent, a likely compromise between the
two bills, the after tax cost of the same
gift rises to $7,000 ($10,000 minus $3,000
credit for deduction).
The Campaign for the School oi Medi¬
cine is a five-year effort because it will
take that long to reach all alumni and
friends in a personal and effective way. If
you wish to give to the campaign this year
due to tax considerations and have not
yet been contacted, please write or call
the Office of Medical Development for
more information.

Frank A. Sprole, Y.C. '42, of New York
has been named co-chairman of The
Campaign for the Yale School of Medi¬
cine Volunteer Committee. Mr. Sprole,
who is also chairman of Special Gifts for
the 45th Reunion of the Class of ’42, has
recently retired as vice-chairman of the
board of Bristol-Myers company, where
he spent most of his professional career.
He currently serves as a director of The
Bristol-Myers Fund, Inc.

PROGRESS REPORT SUMMARY
As of May 31, 1986

Received
Building
Endowment
Equipment
Loan Funds
Research
Various
Operations

Outstanding
Pledges

Total

$ 5,874,812
$ 6,789,109
$
616,963
$
479,793
$ 23,433,155
$ 1,024,320
$
706,062

$ 24,476,007
$ 7,358.376
$
0
$
0
$ 13,456,298
$
0
$
0

$ 30,350,819
$ 14,147,485
$
616,963
$
479,793
$ 36,889,453
$ 1,024,320
$
706,062

TOTAL

$ 38,924,214

$ 45,290,681

$ 84,214,895

SOURCES

Received

Outstanding
Pledges

Total

Corporations
Foundations
Individuals
Other

$ 7,379,523
$ 13,723,051
$ 9,343,655
$ 8,477,985

$ 5,669,192
$ 8,392,951
$ 13,900,945
$ 17,327,593

$
$
$
$

$38,924,214

$ 45,290,681

$ 84,214,895

TOTAL

As the School of Medicine moves to
expand its fund-raising capabilities, a
new addition to the Office of Development
staff is Will Melton. A graduate of the
University of Virginia, Mr. Melton comes
to Yale from Northfield Mount Hermon
School, where he served as development
director for six years and had oversight of
that school's successful $10 million capital
campaign.
His duties will include organizing the
solicitation of medical alumni for the
Campaign for the Yale School of Medi¬
cine, and making alumni more aware of
creative ways to help the school through
life income trusts and gifts of real estate
or other highly appreciated property.
The Office of Medical Development
solicits gifts and grants for endowment,
facilities and non-governmental research
funds for the School of Medicine. The
Medical School Alumni Fund, a separate
entity, conducts the annual giving pro¬
gram to provide funds for student aid.
The address of the Office of Medical
Development is: 350 Congress Avenue,
3C, New Haven, CT 06519; telephone
(203) 785-4420.

13,048,715
22,116,002
23,244,600
25,805,578
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CLASS OF 1986 Residency Positions
CALIFORNIA
Harbor-UCLA Medical Center, Torrance
Cynthia Dyess, Surgery
Joe Kurosu, Transitional
Stanford University Hospital
Richard Gates, General Surgery
UCLA Neuropsychiatric Institute,
Los Angeles
Kimberli McCallum, Psychiatry
University of California Hospitals,
San Francisco
Sophie Cole, Internal Medicine
Gerard Doherty, General Surgery
Liangge Hsu, Medicine
Bruce Jacobson, Surgery
David Kaku, Internal Medicine
Clinton Lindo, Internal Medicine
Mary Nakamura, Internal Medicine
Louise Sanematsu, Pediatrics
Chris Takimoto, Internal Medicine
University of California San Diego
Affiliated Hospitals
Daniel Fierer, Internal Medicine
COLORADO
University of Colorado Affiliated
Hospitals, Denver
Gail Mizner, Medicine
llena Norton, Psychiatry
Andrew Steele, Internal Medicine
CONNECTICUT
Danbury Hospital
Amanda Dill, Internal Medicine
Mount Sinai Hospital, Hartford
Dae Song, Medicine
St. Vincent’s Medical Center, Bridgeport
Eric Bernstein, Transitional
Vale-New Haven Medii
Center
Catharine Arnold, In
nal Medicine
William Esterline, General Surgery
David Frank, Internal Medicine
James Goldenring, General Surgery
Cynthia Hall, Obstetrics & Gynecology
Jacqueline Hodge, Pediatrics
Stacey Mandelbaum, Obstetrics
Gynecology
Timothy McGowen, Orthopedic Surgery
Lynne Perry, Internal Medicine
Steven Peterec, Pediatrics
Paula Rackoff, Internal Medicine
Donald Reich, Psychiatry
Ernesto Roederer, Psychiatry
Marcus Walker, Psychiatry
Julia Whiteside, Medicine
FLORIDA
Jackson Memorial Hospital, Miami
Richard Bridgewater, General Surgery
ILLINOIS
McGaw Medical CenterNorthwestern University, Chicago
Richard Lewis, Medicine
Benjamin Li, General Surgery
MAINE
Maine Medical Center, Portland
Barbara Harvey, Internal Medicine
1 wrence Sampson, General Surgery

MARYLAND
Francis Scott Key Medical Center,
Baltimore
Robert Study, Internal Medicine
Johns Hopkins Hospital, Baltimore
Raymond Chung, Internal Medicine
Mary Greene, Pediatrics
Univeristy of Maryland Hospital,
Baltimore
Young Kim, Internal Medicine
MASSACHUSETTS
Boston I niversity Affdiated Hospitals,
Boston
Danilo Castro, General Surgery
Brigham and Women's Hospital, Boston
Laird Madison, Internal Medicine
Matthew Moore, Surgery
Gregory Orloff, Internal Medicine
Kimberlee, Sorem, Obstetrics
& Gyneology
Cambridge Hospital
Roberto Lewis-Fernandez, Transitional
Children's Hospital, Boston
Jonathan Alpert, Pediatrics
Stephen Roth, Pediatrics
Massachusetts General Hospital, Boston
Michael Grossbard, Internal Medicine
Thomas Lynch, Internal Medicine
Mount Auburn Hospital, Cambridge
George Sachs, Medicine
New England Deaconess Hospital, Boston
Samir Bhatt, Surgery
New England Medical Center Hospital,
Boston
Dory Altmann, Internal Medicine
John Wysolmerski, Internal Medicine
MICHIGAN
University of Michigan Affiliated Hospital,
Ann Arbor
Paul Wang, Pediatrics
MINNESOTA
University of Minnesota Hospitals,
Minneapolis
Jeremy Holtzman, Internal Medicine
Robert Kinney, Internal Medicine
Brian Lombardo, Family Practice
Steven Waisbren, General Surgery
MISSOURI
Barnes Hospital, St. Louis
Gary Shapira, Pathology
NEW JERSEY
St. Barnabas Medical Center, Livingston
Betty Klein, Transitional
Maxine Spicer, Obstetrics & Gynecology

NEW YORK
Beth Israel Hospital, New York
Gary Hirshfield, Medicine
Columbia-Presbyterian Hospital, New York
Margaret Alexander, Surgery
Long Island Jewish Medical Center,
New Hyde Park
Glenn Faust, General Surgery
Nassau Hospital, Mineola
Young Kang, Medicine
New York University Medical Center,
New York
Paul DeRenzi, Internal Medicine
Mark Lipian, Pediatrics
Jeffrey Schneider, Internal Medicine
Roosevelt Hospital, New York
Michael Sherman, General Surgery
State University Of New YorkKings County Hospital, Brooklyn
Alfred Harrington, Pediatrics
The New York Hospital, New York
W. Lee Bailey, Internal Medicine
Paul Chang. Internal Medicine
Andrew Costin, Internal Medicine
Manuel Litchman, Internal Medicine
University of Rochester Associated
Hospital Programs, Rochester
Miriam Tatum, Pediatrics
W ilson Hospital, Johnson City
Reginald Windom, Transitional
NORTH CAROLINA
Duke University Medical Center, Durham
Raymond Cuevo, Internal Medicine
Ronald Weigel, General Surgery
OREGON
Oregon Health Sciences University, Portland
Sean Jones, Medicine
Lisa Yee, General Surgery
PENNSYLVANIA
Abington Memorial Hospital, Abington
Bethanne Moore-Sanders, Medicine
Bryn Mawr Hospital
Eric Suan, Medicine
Hospital of the I’niversity of Pennsylvania,
Philadelphia
Jeffrey Carpenter, General Surgery
Hospitals of the University Health Center
of Pittsburgh
David Atkins. Internal Medicine
John Detre, Internal Medicine
Temple University Hospital, Philadelphia
Andrew Conn, Internal Medicine
RHODE ISLAND
Miriam Hospital, Providence
Andrea Stone, Medicine
Rhode Island Hospital, Providence
Antoinette Lloyd, Internal Medicine

TENNESSEE
Vanderbilt University Hospital, Nashville
Allen Ries, Internal Medicine
TEXAS
Baylor College of Medicine
Affiliated Hospitals, Houston
Duncan Fischer, Surgery
University of Texas Southwestern
Affiliated Hospitals, Dallas
Mahesh Shrestha, Internal Medicine
VERMONT
Medical Center Hospital of Vermont,
Burlington
Michael Miller, General Surgery
WASHINGTON
University of Washington
Affiliated Hospitals, Seattle
Richard Gibbs, Family Practice
Elizabeth Plotkin, Medicine
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YJB&M OBSERVES
60 YEARS OF PUBLICATION
What makes the Yale School of Medicine special? The Yale Sys¬
tem? The thesis requirement? An outstanding study body work¬
ing with a superior faculty?
All of these exceptional features characterize Yale, says Dr.
Philip K. Bondy, associate dean for the Veterans Administra¬
tion Medical Center. To them he adds another: The Yale Journal
of Biology and Medicine.
Yale is the only American school that offers students an op¬
portunity to edit and publish an internationally recognized jour¬
nal of medical science, says Dr. Bondy, the Journal’s editor-inchief.
In 1987, the Journal will celebrate its 60th year of publica¬
tion, and yet another group of first-year medical and graduate
students will join the board of editors to be introduced to the
medical publishing world.
Over the years, the Journal’s contents have reflected the con¬
tinuity of medical investigation. The first issue, which appeared
in October 1928, included a paper by Dr. James D. Trask,
professor of pediatrics, on “Comparative Immunology in
Pediatrics.”
Sixty years later, the Journal will publish the American Col¬
lege of Epidemiology’s tribute to Dr. Alfreds. Evans, the John
Rodman Paul Professor of Epidemiology who also served as a
Journal editor-in-chief. The issue will once again discuss recent
advances in pediatric immunology.
In its first year of publication, the Journal presented papers
on infectious diseases, embryology, nutritional deficiency dis¬
eases, community health, trauma, medical history and cancer.
The material published today continues to cover the breadth of
the past, although the level of sophistication has changed.
MANUSCRIPT REVIEW
The Journal’s long life can be attributed, in part, to the continu¬
ing dedication of successive generations of Yale medical stu¬
dents and faculty, according to Dr. Bondy. The task of review¬
ing manuscripts and readying them for publication is handled
by the editorial board of 30 student editors and nine faculty as¬
sociate editors. Each December, eight to 14 apprentice student
editors are chosen through a competition. At the end of the
spring semester, if they have fulfilled the requirements of re¬
viewing assigned manuscripts and submitting one or two writ¬
ten book reviews, most usually become full-fledged board
members.
Although this seems simple enough, a strict adherence to
deadlines and meeting attendance is required. According to Dr.
Bondy, the selection process is unquestionably elitist, which is
appropriate, because it recruits outstanding students. Proof of
this is the unusually high proportion of prizes garnered by the
Journal’s student editors each year at commencement. In 1986,
for example, 14 awards were presented to seven of the nine
graduating members of the Journal board. Two weeks earlier,
at student research day, three of these same students were
awarded prizes from only five presented.

The Yale Journal of
'Biology and YMedicine
The Yale Journal
of Biology & Medicine

The Yale Journal of
Biology & Medicine

ACADEMIC PRESS
New York and London

Through the years, Yale Journal readers have seen graphic design
changes. Early volumes featured a silhouette of Dr. Nathan Smith,
professor of the theory and practice of physic, surgery and obstetrics
when the Medical Institution of Yale College opened in 1813. Recent
covers use different typographical elements to present the scholarly
articles and book reviews.

What advantage does a student on the editorial board have be¬
sides seeing his or her name on the masthead six times a year?
Although the majority of the student editors are candidates for
the medical degree, some are enrolled in the combined M.D.Ph.D. program and others are working toward the Ph.D. in
epidemiology or one of the basic sciences. They quickly learn
to sharpen their critical skills as they evaluate submitted manu¬
scripts.
Every paper is reviewed jointly by a student editor and a fac¬
ulty member recommended by the entire board. This can be one
of the faculty associate editors, but more often than not it is
someone selected from the medical school at large. It occasion¬
ally becomes necessary for the faculty reviewer to temper the
tone of the student’s review, although most of the time they
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agree. This close collaboration between the student and faculty
expert is one of the major benefits of editorial board member¬
ship. It often results in a newfound friendship.
After the student editor and faculty reviewer have met and
thoroughly evaluated each manuscript, the student presents his
or her findings to the board, which meets twice a month over
lunch in the Beaumont Room. After the presentation, the papers
are openly discussed, and the entire board decides whether or
not to publish the article. Although this first such session can
be a traumatic experience for the neophyte reviewer, it soon be¬
comes second nature.
Approximately four years ago, the board of editors formed
an executive committee. This began as the brainchild of student
editors Mariano Garcia-Bianco and Duncan Fischer, and now
it meets a few times a year to discuss and resolve Journal affairs
and editorial problems. Three students meet with the managing
editor and three faculty editors, and through this experience all
learn about publishing stages—from author to reviewer to copy
editor to press to final product. They also get a taste of market¬
ing, promotion and sales. Thus, the Yale Journal of Biology and
Medicine, in addition to teaching the students good scientific
writing and editing skills, acquaints them with the business side
of journal publishing.
Currently, the Journal’s board of editors includes these stu¬
dents: Craig Basson, Jennifer F. Bock, Jonathan A. Borden,
Maureen E. Brady, Robert K. Brown, David Chelmow, ChiehMin Fan, James M. Ford, Louis Glazer, Subba Rao Gollamudi,
Laurence A. Greenbaum, Andrew Griffith, Stephen B. Gruber,
Sunil Hingorani, Paul A. Khavari, Marc Levesque, Peggy M.
Liao, Lewis Lipsey, Elan D. Louis, Michael Mockovak, John
W. Mott, Sina Nasri-Chenijani, Kenneth E. Newhouse, Lisa
Ragen, Tarik M. Ramahi, Henry Rice, Seth Rosenthal, Sally
Wade, Greg M. Yarrington and Hedayatollah Zaghi.
Dr. Emile L. Boulpaep, professor and chairman of the De¬
partment of Physiology, is deputy editor-in-chief. Other faculty
members who serve as associate editors are: Robert S. Balti¬
more, Priscilla S. Dannies, Stephen C. Edberg, James F. Jekel,
G.J. Walker Smith, JohnT. Stitt and Arthur J. Viseltear.
Suzanne Lande is the publisher/managing editor; Rose
Jacobowitz is copy/production editor.

TOPICS
During the past eight years, the Journal has concentrated on
publishing proceedings of international symposia. Some of the
more recent topics covered are schizophrenia, Lyme disease,
mycopiasmology and pediatric critical care.
For the first time in its history, the Journal, in co-operation
with the Section of Rheumatology, co-sponsored “The First In¬
ternational Symposium on Lyme Disease.” Two of the student
editors were among the five guest co-editors of the resulting
July-August 1984 issue, which subsequently was republished in
hardback and is still selling briskly. In 1983, the Journal pub¬
lished “Current Insights in Mycopiasmology,” which resulted
in a tome of more than 600 pages—an entire year’s pages in one
issue. Other symposium issues have been redone in book form
and sold worldwide.
For years, the Journal has celebrated the careers of notable
Yale medical faculty with festschrift issues in their honor. Dr.
Bondy says. Recent issues include tributes to Drs. Dorothy
Horstmann, Elisha Atkins, Aaron Lemer and the late Gerald
Klatskin. In preparation for spring 1987 is a symposium issue
to honor Dr. Gilbert H. Glaser.
All of these activities have kept the Journal active and
healthy. In recognizing its contributions to Yale medical educa¬
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tion. Dr. Robert H. Gifford, associate dean for medical educa¬
tion and student affairs, has agreed to consider membership on
the Journal’s editorial board as an elective in the medical school
curriculum.
The Journal welcomes this formal recognition of excellence
and the high caliber of its contribution to a Yale medical educa¬
tion. It accepts the additional responsibilities associated with
becoming a recognized element of the course of study. Dr.
Bondy says. “We have every confidence that the basic nature
of this unique Yale enterprise will not wilt under the academic
burden. It will continue to be a collegial and congenial group.
Its special nature will survive.”
But the proof of any publication is in the reading. The Jour¬
nal’s success is reflected in its widely distributed readership,
mostly to medical libraries scattered throughout 40 countries on
six continents. Libraries in 13 Third World countries subscribe,
as well as seven in the Eastern Block, including the People’s
Republic of China, the USSR and Czechoslovakia. The Yale
medical word reaches the entire globe.
The Journal welcomes additional support from Yale medical
alumni and invites individual subscriptions. Thus, future gener¬
ations of Yale medical students will be able to benefit from the
special medical publishing opportunities the Journal offers the
Yale community.

STUDENT EDITORS LAUD
JOURNAL EXPERIENCES
My student editor experience precipitated valuable interactions
with some of Yale’s preeminent medical scholars. More
often than not, what started as a meeting to discuss a
manuscript with an esteemed professor developed into a
valuable dialogue on topics sometimes scientific, sometimes
philosophical and sometimes just interesting.

Harris Pastides, Ph.D. ’80
Epidemiology and Public Health
Seeing my own work in print, in the form of published book
reviews, and seeing the impact of my work in revised
manuscripts was a source of enormous pride to me. The
experience of critically analyzing research design and
presentation formed an emerging desire to pursue a career
in research and academics....My memories, then, are grateful
ones—among the unique educational opportunities offered
at Yale, the Journal is one of the best!

Kathleen A. Nolan, M.D. ’82
Working on the Journal allowed meaningful contact with
clinical and research faculty in diverse disciplines. My
involvement with symposia and serving on the executive
committee provided some problem-solving challenges that
were unlike most of my medical school responsibilities.

Robert W. Arnold, M.D. '84
Not only was my experience as a student editor one of my
most rewarding experiences as a medical student, in terms
of learning scientific material and interacting with very
knowledgeable faculty members, but it was also a considerable
amount of fun.

Duncan K. Fischer, M.D., Ph.D. ’86

THE YALE SYSTEM
THE EARLY YEARS
by Arthur J. Viseltear, Ph.D.

“Time dissipates into shining ether the solid angularity of
facts”.
Ralph Waldo Emerson, 1841

The Yale System—or plan, or philosophy, or program—is
most closely associated with Milton Wintemitz, dean of the
school from 1920 to 1935. Wintemitz's portrait is displayed
next to the dean’s office. I invite you to see it, for it was Winternitz and his predecessor, George Blumer, who began the pro¬
cess that brought Yale to the front rank of medical schools in
the United States.
Many changes have occurred at Yale since the School of
Medicine opened in 1813 as the Medical Institution of Yale Col¬
lege. Throughout the 19th century, distinguished faculty taught
here and much was accomplished, but money was scarce, and
the single building housing the school was “uninspired and
obsolete.”
In the 19th and early 20th centuries, medical education was
primarily lectures and demonstrations. Medical schools, with
rare exceptions, were only steps above grammar schools. By the
early 20th century not much had changed, except that entrance
requirements at Yale were stiffened to include at least two years
in college and not just a high school or preparatory school
diploma.
Blumer and Wintemitz looked at the state of affairs—as had
Lewellys Barker at Hopkins, William Pepper at Pennsylvania,
Charles Eliot at Harvard and James Angell Sr. at Michigan—
and said it was all wrong. Medical schools, including Yale,
needed more science, fewer didactic lectures, better students,
additional laboratories and more money.
Abraham Flexner studied early Yale in 1909 and concluded
that its medical school was at a crossroad. To bring the medical
school into the front rank of schools, he wrote, Yale needed en¬
dowment, closer ties to a hospital, additional basic science and
clinical laboratories and a full-time faculty. Thanks to George
Blumer, the support of Yale’s president and corporation, and
gifts from the Rockefeller Foundation and private donors, Yale
achieved these goals; but, although standing at the threshold,
something else was needed, and that something else had to do
with the curriculum.
PEDAGOGIC EXPERIMENTS
Wintemitz thought about a modern Yale and initiated discus¬
sions that led to “pedagogic experiments”—experiments that
ultimately formed the basis of the Yale Plan—each designed to
Dr. Viseltear, associate professor of the history of medicine and
public health, presented this report to the Medical School Council
on Oct. 2. “The Yale Plan of Medical Education: The Early Years”
will appear in its entirety in the November-December 1986 issue of
the Yale Journal of Biology and Medicine.

give Yale’s medical school “personality,” “individuality,”
something that would make medical educators sit up and “take
notice.”
The basic and clinical sciences had advanced in the late 19th
and early 20th centuries with great speed, and the temptation
was for professors to continue to add to their courses without
discarding older parts and without periodically reorganizing
each course to correspond to the new developments in each
science.
Professor F.P Underhill, chairman of Yale’s Curriculum
Committee, reported in 1922 that the student had become “the
defenseless recipient of an overwhelming mass of facts which
he may or may not be able to correlate.” Regarding professors,
Underhill wrote, “In their enthusiasm for teaching [their own
subjects] there is the decided tendency [for each professor] to
over-teach—to expect the students to become in turn a finished
anatomist, physiologist or pathologist. ”
Underhill believed that a curriculum so arranged discouraged
initiative and independence and filled the students with required
work, leaving no free time for electives, independent research,
reading in the library or contemplation. Wintemitz accepted
Underhill’s conclusions and, in the early 1920s, recommended
that the number of course hours be reduced by more than 1,200
hours—one full year. Electives were substituted for required
courses, a change that Wintemitz believed would “permit stu¬
dents to exercise their individuality,” to pace themselves and
to try things out.
A second pedagogic experiment, the M.D. thesis, in exis¬
tence at Yale since the mid-19th century, was reaffirmed. With
more time available, more opportunities for basic and clinical
science, Wintemitz reasoned that there would be a “premium
on research” and, with proper faculty supervision, student
theses would become truly valuable educational experiences.
A third principle of the plan was a belief that the Yale medical
school should be a graduate school and that students need not
be “spoon-fed.” The memorization of “a mass of facts,” said
Yale System advocates, was far less important than a wellrounded education in fundamental principles, training in
methods of investigation, and above all, the acquisition of the
scientific habit of mind, all of which could be achieved if the
medical school were a graduate school.
Students would no longer be regimented, but instead would
attend lectures, enroll in electives, prepare their M.D. theses,
and when ready, sit for two comprehensive examinations. As
students were to advance at their own paces, it mattered not to
the faculty if students took their qualifying examinations after
one year or after three years. All that mattered was that students,
treated now as adults, would make their own decisions.
The examinations, designed and administered by a Yale com¬
mittee of basic scientists and clinicians, were comprehensive
and difficult, having been based on examinations for member¬
ship in the Royal College of Physicians and the tripos given at
Oxford and Cambridge. Indeed, it was even recommended that
examiners be selected from schools other than Yale, to assure
that the examinations would be truly extramural.
The comprehensive examinations were given three or four
times during the year and were in four parts: short and long an3

swer questions, an essay (which lasted only a year as it proved
too difficult for the faculty to grade), a practical (substituted for
the essay) and an oral. The examinations introduced in 1927 and
evaluated in 1929 revealed that, of the 160 students sitting for
the exams in this two-year period, 120 (or 75 percent) had
passed and 40 failed. Of the 40 failing, 10 passed the second
time around and 12 flunked out. Seventeen took the exam yet
a third time, but the Board of Permanent Officers’ records are
fuzzy regarding the fates of these students.
CONTROVERSY
The Yale System was studied and restudied in the early years.
Special committees of the faculty looked at the plan throughout
the 1930s and in the years during and immediately following
World War II. There was much discussion, similar in many
ways to the discussions that took place in 1985-86. As may well
be expected, some believed in the plan, others wished to modify
it, and another group regarded it with disdain or indifference.
Samuel Harvey, chairman of Yale’s Department of Surgery
for almost two decades, strongly supported the plan. In a 1941
paper, Harvey presented his ideas on medical education in gen¬
eral and the Yale Plan in particular. Harvey believed that the im¬
portant qualities for student physicians were integrity, intelli¬
gence, capacity for work, and judgment and skill in using the
scientific method, none of which, he believed, could be taught
in lectures.
Give students examinations in courses and check attendance,
and you defeat the purposes of graduate education, he said. Stu¬
dents learned on their own; they learned in the lab; they learned
from each other; they learned in small groups. Students also
learned by being led to the literature, which they would absorb
themselves. This was a better idea than having it “eructated by
the teacher whose ruminative assistance [would] not be avail¬
able for them in [their] future life. ”
"Medical education,’’ Harvey concluded, “was a continuing
process of growth..., a sensitive process, for the most part autocatalytic, which responded most favorably to a proper environ¬
ment,” an environment that Harvey and like-minded colleagues
believed should be based on small group teaching and indepen¬
dent research, the absence of course examinations (“which dis¬
couraged the proper type of study”), an emphasis on electives,
and the close relationship of students with faculty who pos¬
sessed uncommon capacity for initiating and sustaining firstrate work.
The Yale System also had opponents. The common, recur¬
ring complaint was that the system was faculty intensive. Small
group teaching and the M.D. thesis were considered valuable,
but took faculty away from their own research. The comprehen¬
sive examinations also were considered inappropriate. Winternitz wanted the examinations to be written by Yale faculty from
both the basic science and the clinical departments, but agreed
to accept the external National Board Examinations in 1932
when his faculty complained that preparing and administering
the internal exam was difficult and intruded into their primary
responsibilities for teaching, service and research.
Five years later, after the faculty found that almost all (99.4
percent) of the students sitting for the external National Board
Examination had passed, they voted to restore to the faculty the
responsibility for preparing internal exams. If there were a com¬
prehensive exam, they argued, Yale should be responsible for
evaluating its own students. This policy remained in effect until
1942, when, owing to the exigencies of World War II, the exams
of the National Board were once again substituted for Yale’s
comprehensives.
Other faculty evaluators reviewed the original objectives of
4

the exam and concluded that both the Yale and National Board
exams were less than optimum. Both tested only discrete sub¬
jects and cognate disciplines and, as such, did not permit stu¬
dents to “correlate their knowledge”; nor were the exams de¬
signed to be “integrative,” as they were intended, serving the
important purpose of revealing to students “the essential unity”
or synergy of basic science courses with each other and with the
clinical years.
Equally distressing was the fate of those students who did not
pass Yale’s comprehensive exam. Did Yale have a continuing
responsibility for such students? Some said “yes”; others said
“no.”
REAFFIRMATION OF PLAN
Despite the ambiguous conclusions of the evaluation commit¬
tees and the occasional faculty polarization regarding the com¬
prehensive exams, each element comprising the Yale System—
small-group teaching, electives, comprehensive examinations
prepared and administered either by a committee composed of
Yale faculty or by the National Board, the absence of individual
course examinations, the M.D. thesis, the spirit of a graduate
school, the acceptance of the principle that Yale medical stu¬
dents were adults—remained intact, was institutionalized,
legitimized, and in the early years, reaffirmed by both the facul¬
ty and Wintemitz’s successors. Stanhope Bayne-Jones, Francis
Gilman Blake andC.N.H. Long.
The basic elements of the Yale Plan did not change in the
early years because the social contract between faculty and stu¬
dents had not changed. As originally set forth in the Curriculum
Committee report of 1928:
“Fundamental to [the Yale Plan] is the concept that the
medical student is a mature individual, is strongly moti¬
vated to learn and requires guidance and stimulation
rather than compulsion or competition for relative standing
in his group. Equally basic is the concept that if [students
are] given unusual privileges [they] must assume more
than usual responsibility for [their] education.”
And, as Francis Gilman Blake wrote in 1941, the principal
element in the Yale Plan was:
“the too often overlooked fact that [medical students
are adults] already embarked upon [their] own life’s
work and the obvious corollary that [students] must
learn both to pilot [their] own boat and assure to a large
extent the responsibility for acquiring that content of
knowledge which is necessary for [them] in charting
[their] future professional course.”
I submit that it is this social contract—which, in the early
years, was and remains now in part responsible for Yale’s essen¬
tial character—that is the ethos of the Yale Plan.
As we review our past traditions and legacies in the light of
present needs and concerns, it is important to remember that the
Yale System, which has evolved for more that 60 years, been
modified and fine-tuned but never abandoned, remains the dis¬
tinguishing feature of Yale medicine.
Pedagogic experiments, faculty and administrators, curricula
revisions, courses, departments, sections and institutes have
come and gone; but the Yale System remains the essential ele¬
ment in the mix of ingredients that has made the Yale School
of Medicine the truly exceptional institution it has been these
many years.

CURRICULUM CHANGES.
DURING THE LAST
THREE DECADES
by Arthur Ebbert Jr., M.D.

In 1952 and 1953, the Yale plan of medical education underwent
a comprehensive review and reappraisal. This was precipitated
by three concurrent phenomena: the appointment of a new dean
in 1952, the growth of the faculty and some skepticism toward
the plan by faculty who had been recruited from other schools.
Although the new dean. Dr. Vernon Lippard, had received
his M.D. from Yale in 1929 and was a strong supporter of the
plan, the November 1952 minutes of the school’s executive
committee, composed of the department chairmen, noted, “It
was the consensus of opinion that there exists a real need for
clarification of what is meant by the Yale Plan and what are its
underlying principles. ”
The following March, a Curriculum Committee was ap¬
pointed “to define the Yale system of medical education and
make recommendations for such changes in this system as
seemed to be in order.” The executive committee also recom¬
mended studying the place of the National Board Examinations
in the Yale System.
CURRICULUM REPORT
The report of the Curriculum Committee was presented to the
school’s Board of Permanent Officers in May 1953. I would like
to quote from the introductory paragraphs of that report.
“The purpose of this statement is to reaffirm the confidence
of the faculty of the School of Medicine in the methods
of instruction which, over the past 30 years, have become
known as the 'Yale System’ and to define the program
so that faculty and students may begin the next academic
year with a common understanding of its objectives and
procedures and with freedom from confusion arising
from misinterpretation. After a periodic review, minor
revisions of current practices have been adopted and it
is expected that, with further experience, other revisions
will be recommended but the basic philosophy underlying
the program is believed to be sound.
“The program is distinguished by the following charac¬
teristics: (1) the required thesis, (2) lack of fixed course
requirements for qualified students, (3) emphasis on
elective courses, (4) absence of required course
examinations.”
The report goes on to discuss these characteristics of the Yale
System. In the section describing evaluation, the report notes
that during pre-clinical years, examinations were to be offered
but were neither required nor graded for record. At the end of
each basic course, the department concerned was to submit a
composite narrative opinion of the student’s achievement, sum¬
marized as “satisfactory” or “unsatisfactory.” Progress com¬
mittees were to be appointed to evaluate the achievement of stu¬
dents in each year and certify to the dean’s office that students
were eligible to take the National Board Examinations.
Dr. Ebbert, deputy dean, presented this report to the Medical
School Council on Oct. 2.

According to this report, the committees were expected to
reach their decisions by using all information at their disposal
and were privileged to give special examinations when neces¬
sary. Completion of the National Board Examinations was re¬
quired for advancement from the pre-clinical to clinical years
and for graduation; however, responsibility for a student’s ad¬
vancement rested in the progress committees and, finally, in the
Board of Permanent Officers.
Dean Lippard published an article entitled “The Yale Plan of
Medical Education After 30 Years” in the Journal of Medical
Education in September 1954. 1 recommend this to those who
want more detailed information about the plan as it existed at
that time. I would like to note that, in the article. Dean Lippard
made the following statement: “No educational program worth
its salt ever has or ever will be in final form. To be effective,
it must be subjected to constant evaluation and improvement. ”
To my knowledge there was very little change in the program
of medical education over the next 10 or 12 years. The Curricu¬
lum Committee, concerned primarily with scheduling problems
resulting from expanding knowledge, strove to protect elective
time and to improve elective courses. The question of whether
or not the school should continue to require the National Board
Examinations recurred periodically.
THE NEW CURRICULUM
In February 1965, appointing the Committee to Re-evaluate the
Goals of Medical Education and their Implementation at Yale,
Dean Lippard commented: “The traditional curriculum of
American medical schools, adopted 60 years ago, was designed
to prepare physicians to enter practice on graduation. Although
methods of instruction and course content have changed, the
courses offered and the time allotted to them have remained rel¬
atively constant, despite the ever-increasing mass of knowl¬
edge, the variety of careers open to medical school graduates,
the extension of postdoctoral educational experience, and the
changing role of medicine in society.”
This committee, chaired by Dr. Byron Waksman, labored for
more than a year. In April 1966, its recommendations were ap¬
proved by the school’s Board of Permanent Officers. Although
these recommendations established what subsequently became
known as “the new curriculum,” they did not change the basic
principles or characteristics of the Yale Plan.
Among the recommendations was that an Office of Associate
Dean for Curriculum be established to provide, for the first
time, an administrative mechanism for the year-to-year supervi¬
sion of the curriculum by an officer of the school. Dr. Howard
Levitin was appointed to that post in the fall of 1966. The Curri¬
culum Committee worked hard for two years to develop the new
curriculum for the class entering in September 1968.
Time does not permit a detailed description of the new curri¬
culum; however, the key features were as follows:
1. Some reduction in the initial time devoted to the
study of basic sciences, with considerable reduction in
time for the gross anatomy course.
2. Early introduction of the students to clinical medicine,
requiring that students spend six weeks of the first summer
in a clinical setting.
3. The opportunity to study advanced basic science
following clinical clerkships.
4. A flexible program during the last one-and-one-half
years, allowing students to plan their own curricula in
consultation with their advisers. This became known as
the multiple track system. Each available track was to
include graduate level science courses, appropriate
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clinical experience, and courses correlating clinical
medicine and fundamental science. The tracks were
"biology in medicine,” "behavioral medicine,” “com¬
munity medicine” and "growth and development.”
Each third-year student was expected to select one of
these tracks.
5. An extended outpatient clinic experience.
REAPPRAISAL
The introduction of the new curriculum and the increase in class
size to 102 in 1971 put added strain on the evaluation system.
Because most faculty did not have enough protracted contact
with students to evaluate their progress, the Medical School
Council appointed a committee to look at the pre-clinical
courses and the evaluation of students.
The report of this group was adopted by the council in the
spring of 1973. The major recommendation of that committee,
chaired by Dr. Michael Kashgarian, was that each pre-clinical
course would be required to offer students three evaluation op¬
tions, including an oral or written examination; a report on the
student’s performance in conferences, seminars or laboratory
exercises; and the presentation of papers. However, no grades
as such were to be recorded.
About this same time, in 1973, the Medical School Council
directed the Curriculum Committee to redesign the pre-clinical
curriculum with changes in content, sequence and time alloca¬
tion. Two major changes became effective in the fall of 1975.
The summer clinical experience following the first year was
made optional instead of required, and the multiple track system
in the last three semesters was eliminated. Thus, in 1975 the
curriculum returned to the general format that existed prior to
the introduction of the so-called new curriculum in 1968; how¬
ever, the clinical correlation lectures and tutorials in the first
year were retained.
Two additional changes dealing with evaluation should be
mentioned. Beginning with the class entering in September
1977, students were required, in addition to receiving a passing
total score on the Part I National Board Examination, to receive
passing grades in each of the component subjects of the exami¬
nation. In December 1977, the Curriculum Committee recom¬
mended mandatory anonymous course examinations in the preclinical courses. Before this was implemented, though, the
word “mandatory” was deleted and replaced with a statement
indicating that students were expected to participate.
To this brief summary of events, I would like to add a com¬
ment about the accreditation of the school in 1983. Accredita¬
tion is the responsibility of a group called the Liaison Commit¬
tee on Medical Education (LCME), which represents the Amer¬
ican Medical Association (AMA) Council on Medical Educa¬
tion and the Association of American Medical Colleges
(AAMC).
Although the school received a highly complimentary report
and was accredited for the maximum period of 10 years, the vis¬
iting survey team expressed concern regarding curriculum and
evaluation. The report states: "The Curriculum Committee ap¬
pears to be more occupied with minor adjustments to the opera¬
tion of the academic programs and less with fundamental educa¬
tional philosophy and its implementation,” and “Aside from
student performance on the National Boards, the existing evalu¬
ation system is unconventional and evidence of its effectiveness
is largely anecdotal.”

EVALUATION OF STUDENTS
by Robert H. Gifford, M.D.

The Yale System has been an important part of life at Yale Uni¬
versity School of Medicine since 1931. Although it has under¬
gone minor modifications in the intervening years, its essential
spirit has remained intact and it is a major reason why students
elect to come to New Haven for their medical education. Inter¬
estingly, no firm agreement exists on how to evaluate students
under the Yale System.
Although the system uses neither letter grades nor class rank¬
ings, the faculty always has attempted to recognize excellence
and, conversely, to identify students in academic difficulty so
they can receive special help. When students apply to residency
programs, letters to hospitals must indicate each candidate’s
specific strengths. Obviously, not all students can make superb
laboratory investigators nor can everyone become a skillful
neurosurgeon. However, all students must prove to the faculty
that they have attained minimal proficiency in each required
course or clerkship.
The evaluation of performance and the proof of minimal
proficiency require two very different scales of measurement
that are frequently blurred in students’ minds. Thus, the ques¬
tion is not whether there will be evaluations or whether there
will be minimal proficiency hurdles to overcome, but rather
how will these be done and how will they be kept separate from
each other.
In the past year, the Curriculum Committees and Medical
School Council have considered changes in the traditional
method of determining minimum competence. Some of the
reasons behind the changes are as follows:
1. To provide an alternative to the National Board
Examination, which will discontinue providing individual
subject scores after 1988. Yale will need a new method
of ensuring that students have learned the basic principles
of each course before moving into the clinical years.
2. To provide a means for students in academic difficulty
to become aware of their deficiencies during the course
in question, rather than after the second year has been
completed and students already have started their clinical
training.
3. To encourage more students to participate in and take
advantage of course offerings as they are given, rather
than leaving the bulk of study to the weeks before the
National Board Examination.
4. To stimulate the development of a well-established
and easily accessible system of remedial help for students
who might want it.
5. To provide the faculty with a better yardstick of its
teaching.
6. To dissociate the evaluation of performance from the
evaluation of minimum competence.
7. To preserve the spirit of the “Yale System” of medical
education.

During the past year, students, faculty and administrators in the
School of Medicine reviewed the student evaluation system. Earlier
this fall, Yale Medicine asked Dr. Gifford, associate dean for
medical education and student affairs, to comment on the Yale
System. His article complements the preceding historical
presentations to the Medical School Council.

PERFORMANCE AND PROFICIENCY
The methods used to evaluate performance have not changed.
The faculty of each required basic science course and each re¬
quired clinical clerkship must submit a descriptive evaluation
of every student to the associate dean for medical education and
student affairs. No letter grades are assigned, although relative
terms such as “outstanding,” “excellent” or “very good” may
be used occasionally. No attempt is made to establish a grading
“curve” or to rank the class in any order.
In the basic sciences, students are given evaluation options
at the beginning of each course. Although most evaluations re¬
sult from students' participation in seminars, labs and tutorials,
alternative methods include a special written or oral examina¬
tion or presentation of a paper or other project. In their evalua¬
tions, the basic science faculty generally comment on partici¬
pation, level of knowledge, preparation and quality of a paper
presented.
The clinical faculty generally base their comments on daily
observations of each student’s clinical and interpersonal skills,
knowledge base, problem-solving ability and adherence to as¬
signed responsibilities.
The students have access to their evaluations at any time. One
copy of each is retained by the department, second copies go
in students’ permanent records, and third copies are available
for students to keep.
Each basic science department that teaches a major course
must offer all students one written, minimum competency,
anonymous examination. Although all students have been
expected to participate anonymously in these exams, only
about 60 percent actually have done so. Following extensive
discussions during the past academic year, the Medical School
Council approved a resolution that all students must take an
anonymous minimum competency examination in each course,
beginning with the class entering in September 1986.
The concept of minimum competency implies that all stu¬
dents should be able to pass an examination on fundamental
facts and principles of each discipline taught.
Although current teaching should not necessarily change to
dwell on these facts and principles, the faculty will be responsi¬
ble for informing students in advance of the areas considered
important for medical students to know particularly well. The
anonymous minimum competency examination should test only
these areas. The examination should be written in such a way
that each student who has participated in the coursework should
be able to pass with a score of at least 6590.
There should be one required anonymous minimum compe¬
tency examination per course. However, course directors are
encouraged to offer their customary examinations throughout
the course. Students will be expected to take these examinations
as well, but with no requirement to pass or to identify them¬
selves in any way. The regular examinations will merely serve
as guides to the students as to their overall competence in each
discipline. However, students wishing to choose an examina¬
tion for evaluation and students who must take a course for
graded credit (for example, M.D./Ph.D. students) could use the
regular examinations for credit.

DMS that the deficiency has been corrected either by taking
another minimum proficiency exam or by some other method
agreed upon by the DMS and student (e.g. oral exam, extended
conversations during study).
The deficiency must be corrected before clinical rotations
begin. Students who fail the make-up examinations must iden¬
tify themselves to the associate dean for medical education and
student affairs for counseling. Failure a third time will lead to
a review by the progress committee to determine appropriate
dispositions.
Under this new system, students still will be required to take
Part I of the National Board Examination but will be required
to pass only the overall test. Several weeks of review are allotted
following the fourth semester for preparation and study for the
boards.
All departments will provide easily accessible tutorial pro¬
grams for any students who wish extra help, special tutoring,
or re-testing. An individual in each department whom students
can easily approach will fulfill this function. Students will have
access to practical examinations and computer programs for re¬
view and self-teaching. A special computer room and learning
center for students is being developed adjacent to the teaching
laboratories in Lauder Hall and should be in place during the
coming academic year. This tutorial system will be developed
in more detail.

REMEDIATION
Students who fail the minimum competence section of the
examination are on their honor to contact the director of medical
studies (DMS) in the appropriate department, to receive addi¬
tional help. Each of these students must eventually show the
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COMMENCEMENT 1986PROFESSIONAL RESPONSIBILITY
by Samuel O. Thier, M.D.

KNOWLEDGE

I want to add my congratulations to the graduating class and to
talk about what’s ahead as medicine moves into an almost un¬
precedented period of change. When you move into a rapidly
changing system, it becomes important to have guiding princi¬
ples clearly in mind so that pressing financial and organizational
changes won’t distort what you’ve been taught.
As you leave Yale, you will learn as I did in the last few
months, that the name Yale stays with you, and it means quite
a bit. You carry with you 300 years of credibility, excellence
and the responsibility to continue that tradition.
As you move into the medical profession, you also inherit
millenia of tradition. It has been exciting most of the time, re¬
sulting in a remarkable social contract of which you are now'
part. You will have a lifetime of learning ahead. You will have
the opportunity to share with people their times of crisis, to
guide them, to heal them and perhaps to prevent their illness.
You will have their trust and respect and you will have security.
To maintain that contract you have to meet your professional
responsibilities.
I would like to talk with you about professional responsibili¬
ties, to put some of them in perspective and to discuss how the
traditions of medicine and of Yale ultimately may come to¬
gether. Justice Louis Brandeis provided most of my definition
of a profession: a profession is the keeper of a body of knowl¬
edge learned more from experience than memory. It is responsi¬
ble for maintaining and advancing that knowledge and passing
it on to the next generation. It has a code of ethics with a signifi¬
cant component of service to others. It sets and enforces its own
standards, and it values performance above reward. I’d like to
examine where your profession is today as you become full
members.
z
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What about knowledge? We have the greatest knowledge base
applied to the practice of medicine in the history' of mankind,
and the practice of medicine has been more firmly based on sci¬
entific principles.
What about passing that knowledge on to the next genera¬
tion? As students look to you as house officers, it will be a little
scary but fun. We don’t do a bad job at medical education. For
the last hundred years, we have operated with a simple set of
principles. Our educational process is founded on the connec¬
tion between basic sciences and clinical medicine. It rejected
apprenticeship for the more rigorous bedside teaching of the
clinical clerkship. It is based on problem solving, not memory.
In the next few years, many suggestions will be made to
change our educational principles because the way medicine is
practiced is changing. But those simple principles have taken
us from general practice in horse-and-buggy times through the
development of hospitals to academic medical centers, HMOs
and other providers. The principles have served us well. We
may require some reorganization, but the principles are firm.
Don’t allow them to be abandoned lightly.
Reading about medical education from the Journal of the
American Medical Association: “The most common criticism
made at present by older practitioners is that young graduates
have been taught a great deal about the mechanism of disease
but very little about the practice of medicine, or to put it more
bluntly, they are too scientific and do not know how to take care
of patients. When one considers the amazing progress of sci¬
ence and its relation to medicine during the last 30 years, and
the enormous mass of scientific material which must be made
available to the modem physician, it is not surprising that the
schools have tended to concern themselves more and more with
this phase of the educational problem.”
The article continues to talk about the art of medicine, con¬
cluding, “The art of medicine and the science of medicine are
not antagonistic but supplementary to each other. ”
That was written in 1927 by Francis Peabody. Things have
not changed as much as we sometimes like to think. Do keep
your perspective. The criticism of medicine that I just presented
should always exist. When you do not hear that criticism any¬
more, then medicine has ceased to advance.
If you are not better educated in the science of medicine than
I was when I graduated, we have not advanced, and the educa¬
tional system has not functioned. If I, after 30 years of experi¬
ence caring for patients, have not learned something more about
how to interact with patients, then I have been something of a
stone during that time.
Dr. Shimon Glick notes that the words “patient” and “com¬
passion” have a common root. Don’t forget that root. It’s hard
to construct a common root with client or consumer. You’re still
taking care of patients.

What about advancing knowledge? We have done spectacu¬
larly well in advancing knowledge in what is, probably, the
most exciting time in the history of medical science. People
have told you all your lives that the way in which medicine ad¬
vances is to have a basic observation applied through clinical
research and eventually have it translated into clinical practice.
It almost never happens that way. In fact, it has been very much
the opposite.
People at the bedside have always asked questions and sought
answers: ultimately explaining empiric observations on the
basis of science. Trying to explain sickle cell anemia led to our
understanding of the tertiary structure of proteins and trying to
sort out thalassemia led to an understanding of advances in
molecular genetics. It was not virology and immunology that
taught us about immunization, but immunization that made us
understand what virology and immunology had to contribute.
Do not forget the importance of trained clinical observation. It
leads to very important questions, and it is an inseparable part¬
ner in the science of medicine.
As we move to gene therapy and new areas of medically as¬
sisted conception, for example, we will introduce therapies that
will have predictable and unpredictable effects. The rate at
which these new technologies and approaches are introduced is
occurring rapidly, we desperately need people who can make
the observations that will provide the insights into biology that
unexpected clinical events offer. We must also examine the
legal and ethical foundations of our new technologies because
the public will require careful and understandable answers to the
complex questions that are going to be raised.
This brings me to the question of ethics. Does medicine have
a code of ethics, and is it committed to a component of service
to others? It has, but it could do a lot better in expressing it.
The original code of ethics that guided medicine was a code
of interaction between physicians. It didn’t get to where we
should be today: our primary responsibility and commitment to
our patients overriding virtually everything else we do. This
simple ethical principle becomes critical to keep in mind be¬
cause it is threatened dramatically as we are asked to restrict
access to care and to new technology.

RESPONSIBILITIES
You have two responsibilities. Remember George Bernard
Shaw’s Doctor's Dilemma when thinking about them. Shaw
didn’t think highly of physicians. He wrote of a physician who
was in love with the wife of a man with a treatable disease. That
physician was faced with the challenge of whether to treat the
patient and lose this woman he coveted, or whether to not treat
the patient, let him die and potentially have the woman as his
wife. As you might guess, Shaw allows the physician to allow
the patient to die; the woman runs off with somebody else, so
there is some equity in the system, but there is a conflict of inter¬
est in the system.
Remember that you may be asked to take on a conflict of in¬
terest that other professionals are not. No sane lawyer would be
advocate and judge in the same case. You cannot simultane¬
ously be advocate for your patient and the judge of the patient’s
right to scarce resources. When patients come to you, they have
every right to expect that you will be their advocate, care for
them and defend them. When you are separate from patients,
you may deal, as an informed professional, with decisions
based on cost-benefit analysis of various technologies or treat¬
ments. But you must never allow yourselves to be forced to do
both simultaneously, or you will find yourself in an untenable
position.

You may face restricted resources for medical care, just when
we have the greatest opportunity for care. It will require some
balancing of values that will go beyond consideration of re¬
sources and require you to put idealism above pragmatism in
certain circumstances. And remember, as Dr. Rosenberg said,
that this is an idealistic profession and that you should not feel
uncomfortable for putting your idealism ahead of pragmatism
in the care of your patients.
What about the other requirements for being a profession? Do
we set and enforce our standards? Yes, we do. We set fairly high
standards. We may not always police our own profession the
way I hope we would, and I’m particularly sad that we don’t
always comfort our own professionals when they’re impaired
as well as we should. In the future, more openness will be im¬
portant in setting and enforcing standards. With some compas¬
sion in the system, enforcement becomes more humane.
We must avoid allowing our standards to become those of a
trade. We must avoid allowing those who structure the organiza¬
tion of medicine to tell us what physicians should be trained to
do and what standards they should meet. Physicians may have
to meet standards of those organizations, but they must meet the
profession’s standards first. We ought to be willing to press for
higher standards and mechanisms of reevaluation so that pa¬
tients will know whether you are as good 10 to 20 years from
now as when you started in practice.

PERFORMANCE
What about valuing performance above reward? The greatest
criticism is now leveled at that area of the medical profession,
and I think not unfairly. The question is, do we perform only
if we’re reimbursed? We have a long tradition that says we care
for those who need it, regardless of the ability to pay. In the last
20 years, through well-intended mechanisms of insurance,
Medicare and Medicaid, we have provided coverage for pa¬
tients, but we also have allowed a generation of physicians to
grow up thinking that they didn’t have a responsibility to care
for those patients for whom there was no reimbursement. That
is a very dangerous position for our profession.
For example, should a colonoscopy, reimbursed at $500, be
done when one that is reimbursed at $100 and is equally medi¬
cally indicated is not? Is that what we’re actually saying? Do
we really think that technical skills are so important that we
value them more than we value cognitive skills or principles?
If we mean that, then we ought to say that. We ought to say if
reimbursement is reduced, patients will not be served. Then we
have to answer ’’Who will not serve?” If the answer is “the
medical profession,” then we have forfeited our professional
social contract.
As you go forward, then you will find a lot of rhetoric, self-in¬
terest and difficulty in defining when one is dealing with princi¬
ple or self-interest. Your professional responsibility is to argue
from any vantage point you wish, but to be honest in identifying
the motives from which you’re operating.
As a group from Yale, you should be responsible for introduc¬
ing light and truth to the argument. I am confident that this class
of students, with the value systems that I have seen over the
years at this institution, with the qualities of excellence, can
meet these challenges. If you do, the change should be an enor¬
mous opportunity to set right those things we haven’t quite got¬
ten right and to protect those things we have.
Let me wish you again the very best of luck, and congratula¬
tions again.
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HERE AND
ABOUT
Dr. Stephen Waxman
to Head Neurology
Dr. Stephen G. Waxman, professor and as¬
sociate chairman of the Stanford University
School of Medicine Department of Neurol¬
ogy, became chairman of the School of
Medicine’s Department of Neurology and
chief of neurology at Yale-New Haven Hos¬
pital on July 15.
Dr. Waxman succeeds Dr. Gilbert H.
Glaser, who relinquished the medical
school chairmanship he held for 34 years.
“At Stanford, Stephen Waxman has con¬
ducted elegant research on nerve cell
growth aimed, ultimately, at advancing the
treatment of neurological diseases such as
multiple sclerosis, spinal cord injury and
stroke," said Dr. Leon E. Rosenberg,
Dean. “We are delighted that, while con¬
tinuing his outstanding work in New
Haven, he will lead our educational, re¬
search and patient care programs in the criti¬
cal discipline of neurology. ”
Dr. Waxman, who is internationally
known for his research on regeneration of
nerve cells and adaptive response of the ner¬
vous system to illness and injury, led a Stan¬
ford research group that delineated the
molecular changes of the nerve fiber during
clinical remissions of multiple sclerosis.
A native of Newark, N.J., Dr. Waxman
received an A.B. degree cum laude in 1967
from Harvard College and Ph.D. and M.D.
degrees in 1970 and 1972, respectively,
from Albert Einstein College of Medicine in
New York City. He completed his residency
training in neurology at Boston City Hospi¬
tal and was a visiting research fellow at
Massachusetts Institute of Technology.

In 1978, Dr. Waxman joined the Stanford
medical school faculty as professor and
concurrently served as chief of the
neurological unit at the Palo Alto Veterans
Administration Medical Center. In 1981,
he was named associate chairman of the
department.
Dr. Waxman, who has co-authored more
than 165 scientific articles based on his re¬
search, is associate editor of the Journal of
Neurological Sciences and the Journal of
Neurocytology. He also serves on the edito¬
rial boards of five other journals and as a reviewerformorethan lOotherpublications.
The National Institute for Advanced Edu¬
cation in the Sciences presented him the
First Annual Trygve Tuve Memorial Award
for Outstanding Contributions in the
Biomedical Sciences in 1973. Two years
later, he received a research career develop¬
ment award from the National Institute of
Neurological and Communicative Disor¬
ders and Stroke.

professional standing and personal lives of
women in medicine and the biomedical sci¬
ences. The office provides advisory and ad¬
vocacy services and helps women counter
prejudice, discrimination and sex-role
stereotyping.
Ms. Waxman also will serve as a liaison
with the University administration and as an
advocate for local and national women’s
medical issues.
A native of Newark, N.J., Ms. Waxman
received a B.S. degree in 1968 from Boston
University and an M A. degree in 1972
from the City University of New York. Her
professional experiences range from work¬
ing as a research assistant in neurology to
serving as a speech consultant and therapist.
Between 1983 and August 1986, Ms.
Waxman was assistant ombudsman at Stan¬
ford University Medical Center where she
specialized in conflict resolution and formu¬
lated policies and procedures to facilitate
non-litigious dispute resolution.

Merle Waxman to Head
Women in Medicine

Dr. Gary Friedlaender
to Lead New
Department of
Orthopaedics and
Rehabilitation

Merle Waxman, who previously served as
assistant ombudsman at Stanford Univer¬
sity Medical Center, has been named direc¬
tor of the Office for Women in Medicine.
She succeeds Kay D. Codish.
In announcing the appointment. Dr.
Leon E. Rosenberg, Dean, said "Merle
Waxman possesses outstanding leadership
and communication skills which will enable
her to carry out the office’s diverse respon¬
sibilities. Ms. Waxman’s experience in
non-litigious conflict resolution and advo¬
cacy will be of great value to our women
students and faculty members who are con¬
cerned with affirmative action, recruitment,
advancement and counseling. ”
At Yale, Ms. Waxman will direct the
office established in 1975 to advance the
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Merle Waxman

The Yale School of Medicine and Yale-New
Haven Hospital have established a new De¬
partment of Orthopaedics and Rehabilita¬
tion, and Dr. Gary E. Friedlaender has been
named the first chairman of the school’s de¬
partment and chief of the hospital’s service.
Dr. Friedlaender, a member of the
School of Medicine faculty and an attending
surgeon at Y-NHH since 1976, will expand
the existing orthopaedics program that pre¬
viously was a section within the Department
of Surgery.
The new Department of Orthopaedics
and Rehabilitation combines surgical and
medical approaches to disorders of the mus¬
culoskeletal system, along with a program
in rehabilitation, as reflected in the depart¬
ment's name. The opportunities and chal¬
lenges presented by the scope of activities
will be met by sections of clinical or¬
thopaedics, rehabilitation and research. The
full-time faculty includes eight clinicians
with interest and nationally recognized ex¬
pertise in the spine, joint reconstruction,
trauma, arthritis, pediatrics, oncology,
bone transplantation and complex surgery
of the hand and foot. The department also
includes five basic scientists highly re¬
spected for their continuing contributions to
the biology, biochemistry, immunology
and biomechanics of the skeleton.
Dr. Friedlaender looks forward to adding
and expanding expertise in sports medicine
and rehabilitation and more fully utilizing
the teaching and clinical skills of the 40-50
members of the community-based or¬
thopaedic faculty. Five residents are ac-

tissue donation and transplantation. He is a
fellow of the American College of Surgeons
and the American Academy of Orthopaedic
Surgeons.
At Yale, Dr. Friedlaender has directed
the orthopaedic oncology and transplanta¬
tion immunobiology laboratory since 1977
and the orthopaedic research program since
1981. He was named professor of surgery
(orthopaedics) in 1984 and concurrently
served as chief of Y-NHH’s orthopaedic
service.
In 1982, Dr. Friedlaender received the
Kappa Delta Award for Outstanding Or¬
thopaedic Research from the American
Academy of Orthopaedic Surgeons and the
Orthopaedic Research Society. He has writ¬
ten extensively on tissue banking, fracture
healing and bone allografts and coedited
three textbooks on these subjects.
Dr. Richard H. Greenspan

Dr. Gary E. Friedlaender

cepted annually in the four-year residency
training program.
“In establishing the new department, the
School of Medicine is making a greater in¬
stitutional commitment to enhancing the
teaching, research and patient care pertain¬
ing to the musculoskeletal system,” said
Dr. Leon E. Rosenberg. “Gary Friedlaender’s fine research on bone transplantation
and his superb leadership will significantly
advance orthopaedics at Yale. ”
A native of Detroit, Mich., Dr. Fried¬
laender received a B.S. degree with distinc¬
tion from the University of Michigan in
1967 and an M.D. degree from Michigan’s
School of Medicine in 1969. He was an in¬
tern and surgical assistant resident at the
University of Michigan Medical Center and
completed his orthopaedic residency train¬
ing at Newington Children’s Hospital and
Y-NHHin 1974.
Dr. Friedlaender first came to Yale in
1971 as a National Institutes of Health post¬
doctoral research fellow in surgery, oncol¬
ogy and immunology, during which he de¬
veloped his interests in bone transplanta¬
tion.
In his clinical work and research. Dr.
Friedlaender has specialized in oncology re¬
construction. He has been particularly inter¬
ested in limb-sparing tumor resection fol¬
lowed by skeleton repair using bone trans¬
plants, and has developed many aspects of
this innovative surgery.
His contributions include assessment of
the influence of chemotherapy and radiation
therapy on intact bone, fracture repair and
graft incorporation, an understanding of im¬
mune responses to bone transplants and
methods for safely and efficiently banking
bone. As part of this work, he founded and
directs the Yale Bone Bank.
Dr. Friedlaender has served as president
of the American Association of Tissue
Banks and the American Council on Trans¬
plantation (ACT). He founded ACT, a cen¬
tralized resource for information, educa¬
tion, program support and coordination of
national activities pertaining to organ and

Dr. Richard Greenspan
Named Associate Dean
Dr. Richard H. Greenspan, professor and
chairman of the Yale School of Medicine’s
Department of Diagnostic Radiology, has
been appointed to the newly created posi¬
tion of associate dean for clinical affairs.
“Dick Greenspan brings strong experi¬
ence in clinical medicine to this new post.
He has demonstrated his medical and ad¬
ministrative abilities in leading Diagnostic
Radiology, a department which provides
the highest quality patient care and offers
superb clinical training programs. He also
possesses a record of excellence in teaching
and research and a broad knowledge of
health care financing,” said Dr. Leon E.
Rosenberg, Dean.
“As associate dean for clinical affairs,
Dick Greenspan will provide the leadership
to establish an office that will further devel¬
op and coordinate clinical care by our full¬
time faculty physicians,” the dean said.
“He also will encourage the development of
new and innovative clinical programs by
working in cooperation with the school’s
clinical department chairmen and with col¬
leagues at Yale-New Haven Hospital. ”
In his new position. Dr. Greenspan will
chair the executive committee of the Facul¬
ty Practice Plan, established in 1981 to
bring together administrative, management
and financial activities of the full-time fac¬
ulty physicians.
Dr. Greenspan, who has served as de¬
partment chairman and chief of diagnostic
imaging at Y-NHH since 1973, is known in¬
ternationally for his research in clinical
magnetic resonance imaging. He was one of
the medical faculty members instrumental
in planning the Magnetic Resonance Cen¬
ter, a joint school-hospital project that
opened in May.
He first came to Yale in 1960 as assistant
professor of radiology and was named pro¬
fessor in 1964. Between 1968 and 1973, he
served on the medical faculty at the Univer¬
sity of California at San Francisco.

When Dr. Greenspan returned to become
the first chairman of the Department of
Diagnostic Radiology, he focused on the
study and techniques of diagnosing illnes¬
ses using radiologic methods. His research
has encompassed a major project to
evaluate the accuracy of current diagnostic
techniques for patients suspected of having
pulmonary embolism.
A native of New York City, Dr.
Greenspan received a B.A. degree in 1944
from Columbia University, and four years
later was awarded an M.D. degree, magna
cum laude, from Syracuse University Col¬
lege of Medicine.
Dr. Greenspan interned at Michael Reese
Hospital in Chicago and then worked in the
hospital’s gastrointestinal research depart¬
ment. Between 1950 and 1952, he took resi¬
dency training in internal medicine at the
University of Minnesota Hospitals and,
after a two-year stint in the U.S. Air Force,
returned to Minnesota for radiology train¬
ing. In 1957 he became an instructor and
later an assistant professor in the radiology
department there.
He has written more than 100 articles for
scientific publications and for eight years
served as editor-in-chief of the journal
Investigative Radiology.
A member of numerous national profes¬
sional committees. Dr. Greenspan is a past
president of the Fleischner Society and the
Association of University Radiologists
(AUR). He received the gold medal from
the AUR in 1984.
A fellow of the American College of
Radiology and a member of Sigma Xi and
Alpha Omega Alpha, Dr. Greenspan was a
National Science Foundation Senior Post¬
doctoral Fellow in 1966 and a Josiah Macy
Jr. Foundation Faculty Scholar in 1980.
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Class of 1990
Brings Diversity

Minority Students
Conduct Research

Women comprise 35 percent of the firstyear class that enrolled this fall at the Yale
School of Medicine. The 36 women were
among the 102 students selected for the
Class of 1990 from 2,326 applicants. Ac¬
cording to Dr. Robert H. Gifford, associate
dean for medical education and student af¬
fairs, the enrollment of women has doubled
in the last 20 years.
The increased enrollment of women at
the school has made Yale “a better place,”
says Dr. Gifford. Speaking at the mid-Sep¬
tember opening of a Yale Medical Library
exhibit on the school’s early women
graduates, Dr. Gifford said: “There has
been a new life and a new sensitivity in¬
stilled in all of us. Some of our rough edges
have been smoothed. We have learned for
certain that gender has absolutely nothing to
do with one’s ability to be a physician. We
owe a great debt to those who led the way
The Class of 1990 includes one student
accepted through the early decision plan,
seven students enrolled in the M.D./Ph.D.
program and six children of Yale University
alumni (four of the parents are medical
alumni). Eight of the first-year students
hold master’s degrees: one has a Ph. D.
Black Americans and other minority stu¬
dents comprise 26 percent of the Class of
1990. Three of the first-year students are
foreign nationals. Students in the Class of
1990 range in age from 19 to 39, with a
mean age of 23.5.
The majority of the Class of 1990 were
science majors as undergraduates, with
biology, biochemistry and chemistry being
the dominant areas of concentration.
Twenty-seven percent of the class majored
in the humanities and social sciences. As an
undergraduate group, the Class of 1990
earned a mean cumulative grade-point aver¬
age of 3.69.
The first-year students now enrolled
earned their undergraduate degrees at 54
colleges throughout the United States and
one in England. Fourteen are Yale alumni,
10 came from Stanford, six each graduated
from Harvard and Brown. Although New
England college degrees are heavily rep¬
resented (41), more than half of the Class of
1990 hold degrees from colleges in the
Southeastern, West Coast and Mid-Atlantic
states.
In the Department of Epidemiology and
Public Health, 99 students are enrolled in
the first-year class. The EPH Class of 1990
includes 64 women; 22 Black, Hispanic and
Asian Americans; and 15 foreign nationals.
The first-year students come from 26 states
and 12 countries. Thirty hold M.D. de¬
grees, 10 are nurses; the remainder earned
undergraduate degrees in the sciences and
liberal arts. The Department of Epidemiol¬
ogy and Public Health, in addition to being
a department of the medical school, is an
accredited school of public health.

Eight students from the Greater New Haven
area participated in the School of Medicine
Summer Research Apprenticeship Program
for Minority High School Students.
The eight-week, federally funded pro¬
gram provided the minority students with
meaningful experiences in various aspects
of biomedical science and health care to
stimulate their interest in careers in science.
The students were introduced to various
settings in the medical school and the John
B. Pierce Foundation Laboratory. They at¬
tended a weekly lecture series and spent 30
hours a week in laboratory research with
Yale faculty members who helped them un¬
derstand biomedical research and learn
technical skills involved in conducting
research.
Since the program started in 1980, 57 stu¬
dents, including those in 1986, have partici¬
pated at Yale. It is designed for minority stu¬
dents who identify themselves as being
Black, Hispanic, American Indian, Alas¬
kan native or Pacific Islander/Asian. The
Yale program is one of 74 that the National
Institutes of Health, Division of Research
Resources funds at medical schools in 33
states, Washington, DC., and Puerto Rico.
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IN PROGRESS
NIDA Funds Research
Center on Cocaine
and Opioid Abuse
A new Clinical Research Center to develop
improved ways to treat people with opioid
and cocaine abuse problems has been estabI ished at the School of Medicine.
Dr. Herbert D. Kleber, professor of psy¬
chiatry, will direct the new center for which
the National Institute on Drug Abuse
(NIDA) has granted Yale University
$1,491,000 during the next five years. This
is one of two centers NIDA has funded na¬
tionally.
“The center, which arises out of research
that medical school faculty members have
conducted during the past 17 years in the
Connecticut Mental Health Center and APT
Foundation’s Substance Abuse Treatment
Unit, will lend a new coherence and breadth
toourwork,” Dr. Kleber says.
“We will undertake several major new
projects, including the first comprehensive
study in humans of the transition from
methadone treatment to naltrexone via a
new agent, buprenorphine,” Dr. Kleber
says.
“By
switching
patients
from
methadone to buprenorphine before nal¬
trexone, we hope to alleviate withdrawal

problems and improve the success rate for
treatment.”
Methadone, an agonist, has been widely
used to treat opioid addicts; these patients
generally stay in treatment programs but re¬
main opioid dependent. Naltrexone, an an¬
tagonist, does not produce opioid depen¬
dence, but it can be difficult for patients to
begin and remain in treatment programs.
Besides Dr. Kleber, the new Clinical Re¬
search Center leaders include Dr. Bruce J.
Rounsaville, associate professor of psychi¬
atry, as scientific director, and Dr. Thomas
R. Kosten, assistant professor of psychi¬
atry, as associate scientific director.
Dr. Kosten will head the treatment re¬
search division that will develop and test in¬
novative treatment approaches.
Dr. Frank H. Gawin, assistant professor
of psychiatry, and Dr. Robert Byck, profes¬
sor of psychiatry and pharmacology, will
study the clinical interaction of cocaine with
three commonly used treatment drugs
that may affect either cocaine treatment or
toxicity.
Dr. Dennis S. Charney, associate profes¬
sor of psychiatry, will head the neurobiol¬
ogy division to investigate the neurochemi¬
cal, neuroendocrine and neuropharmacological correlates of opioid and cocaine
use and withdrawal in humans.
In the project. Dr. Charney will investi¬
gate whether hormonal changes that result
from long-term drug use are related to
the development of drug withdrawal syn¬
dromes and the response to specific treat¬
ment.
“At the new Clinical Research Center,
we also will coordinate Yale’s rich training
programs and research resources on sub¬
stance abuse disorders," Dr. Kleber adds.
Seminars on drug abuse treatment and
training opportunities at the Substance
Abuse Unit and other sites will increase the
number of health professionals skilled in
treating opioid and cocaine abusers from all
walks of life.

Pediatricians to Assist
Children at Camp
Some physicians and staff in the School of
Medicine Department of Pediatrics may go
to camp in Northeastern Connecticut next
summer as part of actor Paul Newman’s
dream to open the Hole-in-the-Wall Gang
Camp.
Boys and girls who have cancer, blood
diseases or other life-threatening diseases
will enjoy camp experiences, much as
healthy youngsters do, under safe and rela¬
tively unobtrusive medical supervision.
The camp is to be constructed on a 267-acre
site, with a 47-acre lake, that overlaps the
town boundaries of Ashford and Eastford.
The camp will be closely associated with
the Department of Pediatrics and Yale-New
Haven Hospital, both of which will cooper¬
ate to provide medical services and co-

ordinate medical care with other camp
activities.
Dr. Howard A. Pearson, professor and
chairman of pediatrics, said that the chil¬
dren with chronic illnesses will be assured
of having fun, as well as the proper medical
supervision. “We will provide first-class
quality medical backup on the site so the
children and their parents will have no
concerns.”
Dr. Pearson will provide medical super¬
vision for the camp. Among the seven phy¬
sicians serving on the medical advisory
board are Yale's Dr. Peter Beardsley, as¬
sociate professor of pediatrics, and Dr.
Diane Komp, professor of pediatrics. In ad¬
dition, Dr. Arnold Altman, Y-NHH House
Staff 1965-66, serves on the advisory
board. He is head of the University of
Connecticut Health Center Division of
Hematology/Oncology.
At a mid-September press conference an¬
nouncing the camp. Dr. Myron Genel, as¬
sociate dean for government and communi¬
ty affairs, said, “The need for a camp for
seriously ill children has been created by the
success of basic and clinical biomedical re¬
search which enables a majority of children
to survive, but often with major disabilities.
Yale faculty have made and continue to
make major contributions to this effort. ”
The camp will accommodate the special
needs of children aged 7 to 17 years with
multiple diagnoses, and at the same time
will provide them with outdoor experiences
in an “Old West” spirit. Campers will live
in log cabins, visit a corral filled with ani¬
mals, sing in an old-fashioned music hall,
swim, canoe, hike and camp out overnight.
Actor Newman, who lives in Westport,
Conn., hopes the camp will open next sum¬
mer for two, two-week sessions for approx¬
imately 50 children. In the future, enroll¬
ment is anticipated to increase to some 150
children for eight, two-week sessions. Chil¬
dren will attend the camp at no cost.
The estimated cost to build and endow
the camp is $8 million and Paul Newman’s
food companies, which make popcorn,
salad dressing and spaghetti sauce, will pro¬
vide half the funds.

FACULTY NEWS
Dr. Donald J. Cohen, director of the Child
Study Center and professor of pediatrics,
psychiatry and psychology, was elected
vice president of the International Associa¬
tion of Child and Adolescent Psychiatry and
Allied Professions at its international con¬
gress in Paris in July.

Lisa F. Berkman, associate professor of
epidemiology, is the principal investigator
for one of four core studies in the MacArthur Foundation Research Program on Suc¬
cessful Aging. While previous studies have
concentrated solely on changes that occur

with age, this investigation focuses on iden¬
tifying factors that account for the variabil¬
ity in functioning found among people of
the same age. A better understanding of the
psychosocial, environmental and biomedi¬
cal influences in aging processes and of how
these processes influence physical and men¬
tal health is expected.

Dr. Steven D. Helgerson and Dr. James
F. Jekel were named co-recipients of the
1986 Distinguished Teaching Award that
the Epidemiology and Public Health Stu¬
dent Organization presented this spring.
They were recognized for their teaching
ability, excellence in and contribution to
their field, concern for students and dedica¬
tion to the department’s educational pro¬
gram. Dr. Helgerson is assistant clinical
professor of epidemiology and public
health, while Dr. Jekel is the Charles E-A.
Winslow Professor of Public Health.
The American Public Health Association
and its Maternal and Child Health Section
presented the 1986 Martha May Eliot
Award to Dr. George A. Silver, professor
emeritus of public health, at its annual
meeting in Las Vegas, Nev. The award,
which honors its namesake, the former head
of the federal Children’s Bureau, recog¬
nized Dr. Silver as “the nation’s foremost
exponent of public policies which give spe¬
cial priority to the needs of children.”

Three Become Emeritus
Three members of the Yale faculty retired
July 1, 1986.
Dr. Jack W. Cole, Ensign Professor of
Surgery and vice chairman of the Depart¬
ment of Surgery, is considered an authority
on intestinal cancer. He has done extensive
research on the physiological and structural
changes that occur in tissue and blood cells
as a result of surgical stress. He was chair¬
man of the Department of Surgery from
1966 to 1975 and director of the Com¬
prehensive Cancer Center from 1976 to
1984.
William R. Goff, Ph.D., professor of
neurology and psychology, held joint ap¬
pointments at the medical school and the
Veterans Administration Medical Center,
where he served as chief of the Neuro¬
psychology Laboratory since 1964. There,
he developed and established innovative re¬
search methods and instrumentation, which
were applied to basic problems of sensory
neurophysiology and to clinical problems in
epilepsy and brain-damaged individuals.
Dr. Martha F. Leonard, professor in the
Child Study Center and professor of pediat¬
rics, has been a faculty member for 24
years. Her work on youngsters has covered
a range of interests, from studies of infants
who refuse to eat to research on first-born
infants from disadvantaged families, to de¬
velopmental evaluations of children with
congenital hypothyroidism.

International Prize
Honors Researchers
Studying Depression
Myma M. Weissman, Ph D., professor of
psychiatry and epidemiology and director
of the Depression Research Unit at Yale,
and Gerald L. Klerman, M.D., formerly
professor of psychiatry .and director of the
Connecticut Mental Health Center at Yale
School of Medicine, have been awarded the
prestigious Anna-Monika Prize for their re¬
search on testing the effectiveness of
psychotherapy and drugs in treating clinical
depression.
The Anna-Monika Foundation presented
the international award at a ceremony at the
University of Basel. The prize, presented
every two years, recognizes recent ad¬
vances in knowledge in understanding the
causes and treatment for depression.
Since 1967, Drs. Weissman and Klerman
and their colleagues have developed new
treatment approaches and have evaluated
their effectiveness in treating clinically de¬
pressed patients. Results of two major
studies indicate that drugs and interpersonal
psychotherapy, used together, are most ef¬
fective to treat acute depression.
During the research, the group developed
interpersonal psychotherapy (IPT), a brief
treatment focusing on the reduction of de¬
pressive symptoms and interpersonal prob¬
lems often associated with clinical depres¬
sion. These problems include: grief, inter¬
personal disputes, role transitions or inter¬
personal deficits.
Interpersonal psychotherapy, which they
have described in a book Interpersonal
Psychotherapy of Depression, published by
Basic Books in 1984, was selected by the
National Institute of Mental Health (NIMH)
as one of the treatments in a multi-centered
clinical trial of drugs and psychotherapy
conducted in three university centers.
Shortly before Drs. Weissman and Kler¬
man received the Anna-Monika Prize, the
NIMH announced the study’s results and re¬
ported that IPT was as effective as drugs in
reducing the symptoms of depression over
a 12-week period. Dr. Klerman currently is
professor of psychiatry at Cornell Univer¬
sity Medical College.
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ALUMNI NEWS
Dr. Martin E. Gordon ’46, associate clini¬
cal professor of medicine at the Yale School
of Medicine, continues to consult in gas¬
troenterology and lecture nationally on the
new medical specialty, emporiatrics (medi¬
cal problems of travel). He delivered the an¬
nual lecture of the Southern California En¬
doscopy Society, “Rudolf Schindler Glimpses of the Endoscopic Pioneer,” and
presented a paper on “The Gastroen¬
terologist Becomes Emporiatrist - A Short
Step in Resolving Diagnostic Dilemmas of
the Traveler” at the American College of
Gastroenterology’s annual meeting in At¬
lanta, Ga.
Dr. Gordon has developed the "POCK¬
ET DOC,” a medical aid for travelers, a
sequel
to
the
“GLOBAL DISEASE
GUIDE,” which was designed as a pre- and
post-travel diagnostic device for physicians
and hospitals.
Dr. Joseph S. Pagano 57, has been ap¬
pointed to the Lineberger Professorship in
Cancer Research at the University of North
Carolina at Chapel Hill. The professorship
was established with part of a gift from the
Lineberger family, pioneers in the textile
industry in North Carolina. Dr. Pagano is a
professor in the departments of medicine,
microbiology and immunology in the
school of medicine and director of the
Lineberger Cancer Research Center.

Dr. George W. Namburg Jr., a 1945 graduate of Yale medical school who
practices psychiatry in Manhattan and serves as an associate clinical professor
of psychiatry at the Mount Sinai School of Medicine, has combined his working
knowledge of chemistry, physics and bacteriology with his love of farming
and wine to develop the North Salem Vineyard. Approximately 60 medical
alumni and their guests from Westchester and Fairfield counties gathered Oct.
11 for a cookout and winery tour at the vineyard Dr. Namburg planted in
1965 with 36 grapevine varieties. Dean Leon E. Rosenberg met informally
with medical and FPH alumni at North Salem, N.Y., just as he has done this
year with alumni in Durham, N.C.; Hartford, New Haven and San Francisco,
Calif. Talking on the winery balcony, from left to right, are: Dr. Namburg,
Dr. Dwight F. Miller, president of the Association of Yale Alumni in Medicine,
Diane Rosenberg and Dean Rosenberg.

Dr. Mohandas M. Kini ’65, of
Wakefield, Mass., met with Prime Minister
Rajiv Gandhi in New Delhi, India in March.
Mr. Gandhi was the honored guest at a func¬
tion held by the Medical Research Founda¬
tion, a non-profit institution providing med¬
ical and surgical eye care in Madras, India.
Dr. Kini has been an honorary consultant to
the Medical Research Foundation since its
inception in 1978. He has taught and trained
Medical Research Foundation consultants
at the Massachusetts Eye & Ear Infirmary
and Boston University Medical Center. Dr.
Kini is on the staff of the Massachusetts
Eye & Ear Infirmary, University Hospital,
Melrose-Wakefield and Malden Hospitals.
Dr. Anthony Proto ’71, of Midlothian,
Va., was named a fellow of the American
College of Radiology at its annual meeting
in Baltimore, Md
Dr. Allan L. Naarden, HS '71, was pro¬
moted to clinical professor of neurology at
the University of Texas Health Science
Center at Dallas on July I.
Dr. Louis V. Kirchhoff ’77, has re¬
ceived the prestigious Syntex Scholars Pro¬
gram Award. One of two researchers
selected nationally, he was awarded a threeyear, $150,000 grant to study Chagas’ dis¬
ease, aD illness caused by the parasite
Trypanosoma cruzi. Dr. Kirchhoff is an as-

sistant professor in the infectious diseases
division of the University of Iowa College
of Medicine, department of internal
medicine.
The annual Maxwell Bogin Pediatric Lec¬
ture at Bridgeport Hospital in Connecticut
featured four speakers, including Dr.
Robert S. Baltimore, associate professor of
pediatrics and epidemiology. Dr. Bogin at¬
tended the day-long event. In spite of lim¬
ited activities, he helped with the North
Salem Vineyard event for Dean Rosenberg
and continues his long service as Fund Class
Agent for the Class of 1926.
Dr. Michael B. Mayor '65, was appointed
chairman of the orthopaedics division at
Dartmouth-Hitchcock Medical Center in
July. Since 1971, he has been associated
with the Hitchcock Clinic as an orthopaedic
staff surgeon and has achieved the rank of
associate professor of clinical surgery.
At the 130th annual meeting of the Hawaii
Medical Association’s House of Delegates,
Dr. William H. Hindle 56 of Honolulu
was presented a Presidential Medal. The
Hawaii Medical Political Action Commit¬
tee also presented him an award for out¬
standing contributions as chairman of the
Task Force on Tort Reform.

IOM Elects New Members
Three of the 30 new members elected to the
Institute of Medicine are affiliated with the
Yale School of Medicine. The new mem¬
bers, who began their terms July 1, are
Frederick C. Battaglia, M.D. '57,
Paul G. Quie, M.D. '53, and Robert G.
Shulman, Ph.D., professor of molecular
biophysics and biochemistry.

NEW BOOKS
The Scientific Basis of Clinical Pharmacol¬
ogy: Principles and Examples, by Reynold
Spector, M.D. '66, professor of internal
medicine and pharmacology. University of
Iowa College of Medicine. Little, Brown
and Company, (Boston, Mass.) 1986, 538
PP
The Physiology and Biochemistry of the
Uterus in Pregnancy and Labor, edited by
Gabor Huszar, M. D., associate professor of
obstetrics and gynecology and pediatrics.
CRC Press, Inc., (Boca Raton, Fla.) 1986,
328 pp.
Automated Visual Field Testing: Techniques
of Examination and Interpretation, by
David E. Silverstone, M.D., assistant clini¬
cal professor of ophthalmology and visual
science, and Joy Hirsch, Ph.D., associate
professor of ophthalmology and visual sci¬
ence. Appleton-Century-Crofts, (Norwalk,
Conn.) 1986, 384pp.
Ethics & Regulation of Clinical Research,
second edition, by Robert J. Levine, M.D.,
professor of medicine. Urban & Schwarzenberg, (Baltimore, Md.) 1986, 370 pp.
Methods in Observational Epidemiology,
by Jennifer L. Kelsey, Columbia University
School of Public Health; W. Douglas
Thompson,
assistant
professor
of
epidemiology, and Alfred S. Evans, M.D.,
John Rodman Paul Professor of Epidemiol¬
ogy and director of the World Serum Bank.
Monographs in Epidemiology & Biostatis¬
tics series, 1986,384 pp.
Expert Critiquing Systems: Practice-Based
Medical Consultation by Computer, by
Perry L. Miller, M.D., assistant professor
of anesthesiology. Springer-Verlag, (New
York) 1986, 182 pp.
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When A Doctor Hates A Patient: And Other
Chapters in a Young Physician’s Life, by
Richard E. Peschel, M.D., Ph D. 'll, as¬
sociate professor of therapeutic radiology
and director of the residency program in
therapeutic radiology, and Enid Rhodes
Peschel, co-director of the Program for
Humanities in Medicine. University of
California Press, (Berkeley, Calif.) 1986.

OBITUARIES
Seymour Lipsky, M.D.
Dr. Seymour “Sandy” Lipsky, professor
emeritus of laboratory medicine, died on
Sept. 20, 1986 at Yale-New Haven Hospital
after a long illness. He had been director
and professor of physical sciences and pro¬
fessor in the Department of Laboratory
Medicine until his retirement in July 1985.
He was 62.
He received a B.A. degree from Univer¬
sity Heights College in 1944 and an M.D.
degree from the State University of New
York College of Medicine in 1949. After
completing his residency training in
medicine at the University of California in
1952, he began his career at Yale as a post¬
doctoral research fellow in the Department
of Medicine. He was named instructor in
1955, assistant professor in 1956, associate
professor in 1966 and promoted to full pro¬
fessor in 1968.
Dr. Lipsky trained as a physician in inter¬
nal medicine but established himself in
physical biochemistry. He made many orig¬
inal contributions to the development of
gas chromatography and its use in bio¬
chemistry.
He received many honors and awards, in¬
cluding an honorary M. A. degree from Yale
University in 1968, the M. Tswett Award of
the Academy of Sciences by the USSR in
1978, an unusual distinction for an Ameri¬
can scientist, and the Tswett Medal of the
International Symposium on Advances in
Chromatography in 1982.
Dr. Lipsky served as vice chairman to a
special advisory committee of the National
Heart Institute from 1960 to 1963. He was
involved with the National Aeronautics and
Space Administration from 1961 to 1970.
He served as consultant to the Lunar Sci¬
ences Subcommittee and Lunar and Plane¬
tary Program Committee, and was the prin¬
cipal experimenter for the Surveyor Lunar
Soft Landing Mission and for the detection
of organic compounds and gases on the sur¬
face of Mars. He also was a member of the
National Academy of Sciences Postdoctoral
Fellowship Committee.
Dr. Lipsky is survived by his wife. Pearl
Reitman Lipsky; a daughter, Jan Lipsky of
Lincoln, Mass.; two sons, John Lipsky of
Hamden, Conn, and James Lipsky of Bos¬
ton, Mass.; and one grandchild.

Robert S. Adams, M.D.
Dr. Robert S. Adams, clinical professor in
the Yale Child Study Center and Depart¬
ment of Psychiatry, died on Sept. 29, 1986
at his home in Woodbridge, after a two-year
battle with amyotrophic lateral sclerosis.
He was 62.
Dr. Adams had a distinguished medical
career. He received his B.A. degree from

15

Columbia College in 1945 and his M.D. de¬
gree from Columbia College of Physicians
and Surgeons in 1948. He completed his in¬
ternship and residence in medicine at Bos¬
ton City Hospital in 1950 and subsequently
trained in psychiatry at the Boston VA Hos¬
pital and in child psychiatry at Mas¬
sachusetts General Hospital and the James
Jackson Putnam Children's Center in Bos¬
ton, Mass. He finished his training in adult
and child psychoanalysis at the Western
New England Psychoanalytic Institute.
Dr. Adams was director of the Waterbury
Child Guidance Clinic from 1957 to 1986
and consultant to the Taft School from 1963
to 1968. He also was president of the Con¬
necticut Council of Psychiatrists, and from
1980 to 1982 was president of the American
Association of Psychiatric Services for
Children.
In addition. Dr. Adams served on several
national committees, and was chairman of
the Committee on Early Periodic Screening
of both the American Academy of Child
Psychiatry and the American Association of
Psychiatric Services for Children. He also
was a member of the editorial board of
the Journal of the American Academy of
Child Psychiatry and published papers on
consultation.
He received many awards and citations
for his contributions to national, state and
community mental health programs for
children and their families. Dr. Adams was
given the Outstanding Practitioner Award
from the American Association of Psychiat¬
ric Services for Children in 1986, a certifi¬
cate of appreciation from the State of Con¬
necticut Department of Children and Youth
Services in 1985, and the Phoebe Bennet
Award from the Connecticut Association of
Mental Health Clinics forChildren in 1986.
He is survived by his wife, Irene, and his
children, Lisa, Jeffrey and Jonathan.

Louis R. Mattie, M.D.
Dr. Louis R. Mattie, assistant clinical pro¬
fessor of medicine, died June 22, 1986 at
Yale-New Haven Hospital. Dr. Mattie, a
native of New Haven, received his M.D.
degree from the Yale School of Medicine in
1952 and was a postdoctoral fellow in car¬
diology from 1955 to 1956, when he began
his private practice. He was a past president
of the New Haven Heart Association.
He is survived by his wife, Camile
Panico Mattie; his mother, Lucy Ragozzino
Mattie; a daughter, Michelle Mattie
Geremia; a son, David P. Mattie; two sis¬
ters, Mary Elpi and Anne Ferguson; and a
brother. Dr. Edward Mattie.
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IN MEMORIAM
Fu-Chun Yen
November 29, 1970
William Wyatt Strange, M.D.
April 27, 1985

'27 M.D.

'25 M.D.

Lewis Dickar
August 20, 1986

'30 M.D.

Edwin R. Ranzenhofer
July 7, 1986

'54 M.D.

Col. David M. Robinson
April 28, 1986

'54 M.D.

Dr. Israel Gitlitz
March 17, 1986

'55 D PH

Marvin L. Schulman
August 18, 1986

’59 M.D.

Edward Call Jr.
December 16, 1985

'59 M.D.

Charles R. Carrington, M.D.
September 1985

'64 HS

'32 HS

Carl Hendricks Wies
April 22, 1986

'32 M.D.

Ashley Pond III
March 17, 1986

'33 M.D.

Donald P. Morris
July 1986

'35 M.D.

Fernald C. Fitts
June 13, 1986

'36 M.D.

Franklin F. Ferguson
March 8, 1986

'36 M.D.

Bernhard H. Lisker
April 8, 1986

'75 M.D.

Charles T. Davisson
June 20, 1986

'78 M.D.

Terry Newlove, M.D.
May 18, 1985

'36 HS

'39 M.D.

John A. Murtagh, M.D.
January 15, 1986

'38 HS

William R. Haas, M.D.
June 25, 1986

'40 HS

Nina Toll
May 22, 1986

'53 M.P.H.

'22 HS

Gonsalvo C. Williams Jr.
April 26, 1986

Albert W. Dautrich
May 3, 1986

'52 M.D.

'19 HS

Edward E. Harkavy
July 25, 1986

George A. Hahn, M.D.
May 2, 1986

Charles W. Chace
June 16, 1986
Dorothea Abt
June 9, 1986

'27 M.D.

Vernon P. Williams, M.D.
April 6, 1986

'50 M.D.

'09 M.D.

Milton B. Berman
July 11, 1986

Edgar I. Boggs, M.D.
1984

Archie J. Golden
May 9, 1986

41 M.P.H.

William Astrom Ahroon, M.D
October 1983

'43 HS

Robert R. Bemeike, M.D.
March 15, 1986

'46 HS

Charles W. Karpinski
January 9, 1986

'47 M.D.

Louis R. Mattie
June 22, 1986

'52 M.D.

'79 HS

THE CAMPAIGN FOR THE
YALE SCHOOL OF MEDICINE
Campaign Update
The new Magnetic Resonance Center was
dedicated on November 19. This first com¬
pleted project of The Campaign for the Yale
School of Medicine symbolizes the cam¬
paign's goal to insure the school’s leader¬
ship in the advancement of medical science.
Many challenges remain for the cam¬
paign’s leaders. More than $40 million in
endowment gifts is required, and the search
continues for gifts to support laboratory
renovations and to construct the Center for
Molecular Medicine.

Corporations Endorse
the Campaign
A number of significant developments have
occurred in recent months regarding corpo¬
rate gifts for The Campaign for the Yale
School of Medicine.
The Corporate Consortium for Clinical
Epidemiology is well on its way to comple¬
tion. This project seeks $1.25 million from
10 corporate members over a five-year
period. It is intended to improve the capa¬
bility of Yale’s Clinical Epidemiology Unit
to evaluate the safety and efficacy of health
care products. This funding will help the
unit develop alternatives to the randomized
clinical trial method of research. Presently,
five corporate members have been enlisted:
Proctor and Gamble Co., Pfizer Inc., Scher¬
ing-Plough Corp., Boehringer Ingelheim
Ltd. and International Playtex Inc. Mem¬
bers of the consortium will hold their first
meeting in January 1987.
The School of Medicine will receive
more than $400,000 of computer equipment
for instruction and research during the next
12 months. This equipment is from Project
Eli, which is to support the use of instruc¬
tional computer workstations throughout
the campus. The core of Project Eli is
formed by a $6.5 million grant from Inter¬
national Business Machines Corp.
The Merck Company Foundation will
participate in the campaign with a $ 150,000
gift to renovate one of the main gastroen¬
terological laboratories in the Division of
Digestive Diseases. This gift was generated
by the long-standing relationship between
Merck and Yale in life sciences research.
Recent campaign gifts have been made
by GTE—$75,000 for minority scholar¬
ships in medicine and by Harvey Hubbell
Incorporated—$75,000
for
geriatric

medicine. These and other Connecticut
companies seem well aware that the Yale
School of Medicine, one of two medical
schools in the state, maintains and improves
the high quality of health care that Connec¬
ticut citizens have come to expect.

Tax Reform and Gifts
in 1986
The sweeping tax reform that Congress ap¬
proved in September raised many questions
about the law’s impact on higher education,
particularly charitable giving. Leaders of
The Campaign for the Yale School of
Medicine have followed the new tax mea¬
sure throughout the past year.
"Once people understand the new rules
on giving, contributions to Yale will con¬
tinue to grow,” says Frank A. Sprole, cochairman of the campaign. "However,
1986 holds some special advantages for
donors who have already made up their
minds to help the campaign.” Mr. Sprole,
a 1942 graduate of Yale College who
studied law at Columbia, says he wants
people to understand the new rules on giv¬
ing because “the tax benefits make it possi¬
ble to give a little more. ”
Although he believes people should be
aware of the tax aspects of their contribu¬
tions, Mr. Sprole emphasized other motiva¬
tions for giving. "Our gifts are intellectual
and spiritual expressions of ourselves rather
than just a line on one’s tax return. To many
people, their time is even more precious
than money, and yet those same busy
people volunteer their time to help univer¬
sities, hospitals, churches or synagogues
without any prospect of a tax benefit. That
desire to help others is the primary reason
most people give to the campaign. ”

Profiles of Donors Who Benefit
by Giving Before December 31, 1986
Non-itemizer: He rents his apartment and
has no major medical expenses, so it makes
sense to file a short form (1040A). Each
year he gives to financial aid for medical
students. In 1986 for the first time, the nonitemizer can deduct 100 percent of the total
amount contributed to Yale and other qual¬
ified charitable organizations. Tax reform
will eliminate this new “above the line” de¬
duction in 1987.
Donor in the 50 percent tax bracket: Her
high income is taxed heavily, forcing her to
plan each deduction carefully. Since her top

tax rate will fall to 38.5 percent in 1987, she
calculates that she can actually give more to
Yale by making a major contribution in
1986. For example, a $100,000 gift with
her 50 percent bracket saves $50,000 in
taxes, while the same gift in 1987 saves
only $38,500.
Donor with appreciated property: He is
concerned about the alternative minimum
tax, yet he wants to help the campaign by
giving Yale a building lot he bought three
years ago for $5,000. Today it is worth
$25,000. He can donate that land in 1986,
eliminate the capita! gains tax and take a tax
deduction for the full value of the property.
In 1987, appreciation of the donated prop¬
erty ($20,000) would be included in cal¬
culating any alternative minimum tax
(AMT) liability. The AMT was designed to
ensure that taxpayers who claim large de¬
ductions do not escape tax altogether.
If you are considering a gift in 1986 and
have questions about the campaign or the
impact of tax reform on your giving, contact
the Office of Development, Yale School of
Medicine, 350 Congress Avenue, 3-C,
New Haven, Conn. 06519, or call Will
Melton (203) 785-4420 or Sue Dorn (212)
759-1356 of the medical development staff.

Progress Report Summary
As of September 30, 1986
PROJECTS
General Endowment
Professorships
Fellowships
Total Endowment
Center for Molecular
Medicine
Magnetic Resonance Center
Modernization of Labs
Medical Library
Other

6,350,120
8,299,012
3,385,816
$18,034,948
20,100,000
2,775,000
2,884,500
8,000,000
5,161,192

Total Facilities and
Equipment

$38,920,692

Total Programs and
Research

$39,927,105

TOTAL

$96,882,745

SOURCES
Corporations
Foundations
Individuals
Other
TOTAL

14,221,086
36,740,214
34,473,336
11,448,109
$96,882,745
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REUNION 1986
by Nicholas P R. Spinelli, M.D.
The June rains did not dampen alumni/ae
spirits at one of our largest and warmest
reunions. The weekend began with a semi¬
nar planned by the 25th reunion class at
which 11 members of the Class of 1961
summarized their clinical and research ca¬
reers. Papers were presented by Drs. Ken¬
neth D. Arndt, David W. Brook, Philip
Felig, Margurite Stein Lederberg, Robert 1.
Levy, VincentT. Marchesi, Charles R. Sachateilo, Robert N. Taub, John V. Weil, John
R. Woodward and Warren D. Widmann.
Dr. Widmann moderated the seminar.
Dr. Samuel O. Thier, president of the
Institute of Medicine, delivered the key¬
note address on “The Challenge to Yale
Medicine: Protecting Excellence in an
Unpredictable Environment.” Before his
speech. Dr. John D. Pastore ’67, associate
professor of medicine at Tufts University
and secretary of the International Physi¬
cians for the Prevention of Nuclear War,
spoke on “Physicians and the Nuclear Arms
Race.” The organization was awarded the
1985 Nobel Peace Prize.
A new feature for any returning alumni/
ae was the Medical Reunion Dinner on Fri¬
day in the Presidents’ Room at Woolsey
Hall. A dance followed in Commons, and
the entire Yale medical family, including
the Yale-New Haven Hospital staff, was in¬
vited. Despite the rain, the attendees en¬
joyed dancing in this unusual environment.
Both entertaining events may become tradi¬
tions of future reunions.
Outgoing Yale President A. Bartlett
Giamatti greeted a standing-room-only
crowd of alumni and guests on Saturday
morning. Then, at the Association of Yale
Alumni in Medicine annual business meet¬
ing, President Dwight F. Miller ’56 pre¬
sided, and Dean Leon E. Rosenberg pre¬
sented the traditional “State of the School”
message. The appointment of department
chairmen was announced, and details of six
major construction projects were presented.
Dr. Lawrence Pickett ’44 and Dr. Russell
Scobie ’29 were presented Distinguished
Service Alumni Awards for 1986.
Dr. Lowell Goodman ’51, chairman of
the Medical School Alumni Fund, reported
that $418,816 had been collected. (The final
figure was to reach a record $512,145).
Kathleen Howe reported that $30,000 had
been collected for the Department of
Epidemiology and Public Health.

Dean Rosenberg presented a citation to
Dr. Goodman as outgoing chairman and an¬
nounced that Dr. Leonard Kemler ’43
would become the new chairman in July.
Dr. Miller greeted each reunion class,
from the 50th led by Philip LeCompte to the
fifth by Barbara Ross. Special citations
were presented to each member of the 50th
reunion class. Special recognition to senior
alumni present included Arthur Griswold
’21, Helen Langner ’22, David Raskind
’24, Maxwell Bogin ’26 (60th reunion), and
Michael D’Amico and Ben Klotz, both ’31
(55th reunion).
The traditional sherry hour and sumptu¬
ous Alumni Day luncheon followed in
Harkness Hall.
On Saturday afternoon, the Class of 1961
held an unstructured dialogue with three
generations of physicians. Two faculty
members who taught them. Dr. Tom Forbes
in anatomy and Dr. Samuel Kushlan '35 in
internal medicine, were guests. Also par¬
ticipating were members of the Class of
1989: Valerie Asher, Steven Bharucha,
Howard Kesselman, Greg Koshkarian,
John Mott, Marjorie Scharoun and Jonathan
Shifren. The discussion—truly a genera¬
tional dialogue—provided an interesting
orientation for the young students whose
time to come promises so much wrenching
change. The 1986 reunion also celebrated
the 75th anniversary of child development
and child psychiatry at Yale with lectures in
the Yale Child Study Center. Other educa¬
tional seminars focused on geriatrics, treat¬
ment of affective illnesses and medical edu¬
cation, including admissions.
Individual class dinners were held on
Saturday evening. The fourth annual
“Friends of the 50th" dinner, sponsored by
the medical school to honor alumni at their
50th reunion, was held at the Graduates
Club. Approximately 100, mostly older or
non-reunion alumni, enjoyed a gala eve¬
ning, with nine returning graduates from the
Class of 1936 recounting personal experi¬
ences.
A special feature was the presence of
Class of 1981 members who returned for
their first reunion as guests of the school. A
record 21 returnees, one fifth of the class,
came with 15 guests. These happy young
people added a note of pleasant celebration
and enjoyed the dialogue with the older
physicians. This successful gesture prom¬
ises to become a tradition of Yale medical
reunions.

REUNION
REPORTS
1936
50th Reunion
by Philip M. LeCompte
Ours was a bang-up reunion which took
place in almost constant rain (our spirits un¬
dampened). Friday afternoon events were
followed by the Dean’s reception where
there was plenty to drink and lots of shrimp.
Dinner at Woolsey Hall was attended by Ed
Sullivan and sister Pat Kober, Fritz Post
and yours truly with wife Jean.
After a farewell address by retiring Presi¬
dent A Bartlett Giamatti, our class was pre¬
sented special greetings from the President
and Secretary of the University, complete
with Yale Seal and a blue ribbon, believe it
or not! Individual citations were given to
each member of the class.
On Saturday evening, we attended a deli¬
cious dinner at the Graduates Club spon¬
sored by the Yale Alumni Association. The
first reunion of the Class of 1981 was simi¬
larly feted, and the combination of 21 of
their number with us and about 30 other
guests was delightful! Hosted by Larry
Pickett and Nick Spinelli, introductions of
our class followed. Each delivered brief
autobiographical sketches.
Our group included: Bill Barry with wife
Ceil; Lester Burket with wife Grace; Nick
D’Esopo with wife Rose; AI Diddle; Phil
LeCompte with wife Jean; Dan McGillicuddy; Steven Nagfy with wife Alla;
Fritz Post; Ed Sullivan with sister Pat
Kober.
The evening's sad note was the an¬
nouncement of the death of George Hahn,
our class agent, whom we had expected to
be with us. George had an illustrious career
in gynecology at Temple School of
Medicine. A George Hahn Memorial has
been established, and checks may be sent
to: Yale Medical School Alumni Fund,
George Hahn Memorial, P.O. Box 1890,
New Haven, Conn. 06507.
Our reunion was a memorable event, and
we all look forward to a reprise for our 55th.

1941
45th Reunion

Dr. Nicholas PR. Spinelli is associate dean
for medical alumni affairs.
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by Robert W. Ollayos
Thirteen class members attended the reun¬
ion that was hosted, as usual, by Charles

W

Cheney. Attending, with their wives, were
David Pecora (and daughter Ann), Bjorn
Lih, Bob Gilbert, Pete Duncan, Bill Ken¬
ney, Jack Parella, Willys Monroe (with
news of John Franklin and Lloyd Flint),
Bill Carey, Fred Glike, Bill Diefendorf
and BobOllayos.
Sending greetings were Sophie Cham¬
berlin Alway, Ed Connell, Bob Areson,
Knute Berger and Randy Bell.
Under the hospitable eye of Charlie
Cheney, the group enjoyed the informative
and entertaining weekend program that the
medical school sponsored. The class dinner
at the Graduates Club was crowded and
convivial, as all were joined by the Classes
of 1936 and 1981 for cocktails.
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Dean Leon Rosenberg
(left), William Kissick
'57 M.D., ’61 Ph D.
with reunion guests

1946
40th Reunion
by Gregory E. Flynn
Members of the Class of 1946 who attended
their reunion thoroughly enjoyed them¬
selves. They were Molly Joralemon AlTrink and husband Will, Bill Banfield,
Tim and Phyllis Beck, Frank and Peg
Behrle, Fred and Evette Biehusen, Sandy
Bluestein, Jim Cooney, Bob and Linda
Cooper, Greg and Peggy Flynn, Marty
and Evelyn Gordon, Charlie and Mary
Judd, Ben and Ava Kitchen, the
Kleemans, Vinnie and Rosina Longo,
Dick and Jerry Mann, Tom and Coli
Mathieu, Joe Morris, the John Mortons,
the Tom Murphys, Jack and Laura
Neville, Vinnie and June Pepe, Julie
Sachs, Don and Charlotte Shedd, Dick and
Mitzi Sisson, Colby Stearns, Bruce
Thayer, the Bob Wagners, Bill and
Madori Wedemeyer, Hugh Williams, Eli
and Emma Sue Wing and Tom and Norma
Whelan.
The formal program was interesting.
Physical changes in the medical center were
impressive. The Friday night dinner-dance
was delightful.
On Saturday afternoon we visited the
Gordons’ beautiful home at Lindsay Lake
where we spent a laughter-filled afternoon.
Saturday dinner in the Captain’s Room at
Mory’s was a magic evening emceed by
Don (Dorian Gray) Shedd - only Hugh
Williams changed less. Everyone was stir¬
red by a vintage rendition of “McNamara’s
Band" by the talented General Tom
Whelan.
Don limited all to three minutes to sum¬
marize their past 40 years. Charming us
with stories were Joe Morris, Julie Sachs,
Bill Banfield on glider flying, Don Shedd
on surf sailing, Bruce Thayer and yours
truly on scuba diving.
More seriously, we remembered all who
did not attend and hope you’ll be with us the
next time. We want more time together.
Never will we find companions whose iden¬
tities are so similar: depression-bom, with
mutual goals, ethics, dedications and
philosophical values. How fortunate we
were to practice in these “Golden Years of

Lawrence Pickett '44 M.D., recipient of
1986 Alumni in Medicine Distinguished
Service Award

Dwight Miller '56 M.D., president.
Association of Yale Alumni in Medicine,
congratulates Russell Scobie ’29 M.D.,
the 1986 Alumni in Medicine Distinguished
Service Award recipient.

American Medicine." Our patient relation¬
ships were based on affection and personal
interest. I hope Yale’s new physicians will
experience the same fulfillment we have.
The class’s professional accomplish¬
ments are most impressive and would take
a book to enumerate. We can all take pride
in Yale Med. ’46.

Woodmont. It was the ideal spot for our
group. We had the Tom Amatrudas, the
Lowell Goodmans, the John Haxos, the
Carrold Iversons, the Frank Allens, the
Paul Bruchs, the Walter Morgans, Jocylin Malkin, the John Sullivans and the Sid
Fursts. Much, much, much talk of the good
old days, pictures of families.
It was a pleasant place to be with dear old
friends!

1951
35th Reunion
by John Sullivan
The reunion was modest this time. Most of
the people we talked to are gung ho for the
40th and were taking a raincheck on the
35th. So be it, we enjoyed it. The academic
program was as it should be: thoughtful and
stimulating.
Friday night was a fun night with the
Dean’s reception, cocktails and a dinnerdance at Woolsey for all Yale medical fam¬
ily and guests. As 1 understand it, the medi¬
cal alumni dinner-dance was Lowell Good¬
man’s idea. This guy gets better with time.
Saturday night was a seafood luau at Ina
and Sid Furst’s wonderful beach home in

1956
30th Reunion
by Dwight F. Miller
Twenty-four classmates convened in New
Haven for a congenial reunion to celebrate
our 30 years out. The reunion found every¬
one in good health and good spirits with
youthful vigor. Between cocktails hosted
by the Gardners, dinner hosted by the
Downings and a New England clambake
dinner at the Amarante Seacliff Inn, a spirit
of kinship prevailed. All of the school ac¬
tivities were greatly enjoyed.
Present were Alan Apfel, Alfred Berend, Leo Boyajian, Thomas Brown,
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John Carroll, Edwin Child, Chandler
Dawson, Steven Downing, Mitchell
Edson, Gilbert Eisner, Tom Ferris, John
Gardner, Bill Gryboski, Al Gurwitt,
John Hart, Bill Hindle, Marie-Louise
Johnson, Jerome Klein, Dwight Miller,
A. Frederick North, Bill O’Brien, David
Page, Robert Scheig and James Scheuer.

1961
25th Reunion
by Anoush Miridjanian
On Friday, the first day of our reunion, 31
classmates and guests gathered to hear 11
colleagues summarize their academic and
clinical activities. The following afternoon,
they assembled as three generations of Yale
medicine, with Drs. Tom Forbes and Sam
Kushlan as special guests, and seven stu¬
dents from the Class of 1989.
The dialogue was intensely interesting.
Each classmate summarized his 25 years of
medical experience and perspectives of the
rapid changes in medicine, as well as
changing expectations of a society. Present
conflicts and confusion in medicine fueled
the dialogue.
The first-year medical students presented
their concerns about the future character of
medical practice, and a lively discourse
emerged. The “old grads” felt that student
participation should be part of future reun¬
ions.
A heartwarming dinner at Mory’s wound
up the event, which was our most entertain¬
ing and delightful reunion.
Attending the reunion were Kenneth
Arndt, Earl Baker, Robert Briggs, David
Brook, Lawrence Chiaramonte, Paul
Deiter, Wayne Downey, Philip Felig,
John Fenn, Norbert Fleisig, Royal Hud¬
son, Joseph Jasaitis, Marguerite Lederberg, Robert Levy, Robert Livingston,
George Lordi, Hugh Lurie, Sally Marchesi, David Matloff, Anoush Miridja¬
nian, Richard Moore, Norman Moss,
John Pearce, Elaine Pitt, Roy Ronke,
Charles Sachatello, Franklin Top, John
Weil, Warren Widmann, Murray Wittner and John Woodward.

1966
20th Reunion
by Donald J. Cohen
The Class of 1966 gathered for dinner at
the New Haven Lawn Club. Dr. Alvan
Feinstein, our instructor in physical diag¬
nosis and now a famous epidemiologist/
methodologist, was invited as a special
guest. He discussed where Yale medicine
has been and where it is now going. There
was broad agreement that our era was ex¬
ceptionally fine for clinical education at
Yale.
At dinner one highlight was an open dis¬
cussion in which each member described
his life and work, in and out of medicine.

20

The range of careers and achievements is
extraordinary. We also shared information
about other classmates, accounting for 34 of
them.
Clarence Sasaki and Donald Cohen
have joined David Melchinger as class sec¬
retaries. Anyone with information to share
or ideas for future reunions should com¬
municate with them.
Seventeen returnees (with spouses and
guests) who registered were Donald
Cohen, Joseph Donadio, Anthony Fappiano, Peter Gibbons, J. McLeod
Griffiss,
Stuart
Hauser,
William
Houghton, John Howard, Neal Koss,
Harvey Mann, Caroline McCagg, Wil¬
liam Peterson, James Sansing, Clarence
Sasaki, Joel Singer, Lawrence Toder and
Arne Youngberg.

1971

ence coming from the opposite direction.
Soon to be a New Yorker again, Sid Mandelbaum nearly accepted Peter Ting’s
offer for a high-performance driving lesson,
leaving former mechanics Chris Golles and
John Elefteriades to wonder what hap¬
pened to Sid's judgment. By the end of the
evening however, these and other critical is¬
sues had been resolved, and it was unani¬
mously agreed to give it a go for another
10 years.
Twenty-five members of the class at¬
tended. They were Sarah Auchincloss, Al¬
fredo Axtmayer, Sharon Bonney, Roger
Boshes, Florence Comite, Mark Cullen,
Kenneth Dobuler, John Elefteriades,
Todd
Estroff,
Ira
Gewolb,
Rose
Goldman, Glenn Gorlitsky, Randall
Hawkins, Christopher Jolles, Richard
Kayne, William Levy, Sid Mandelbaum,
Larry Markowitz, Richard Pelker,
Daniel Rahn, Daniel Schuster, Peter
Swanson,
Charlie
Swenson,
Jack
Tauber, Robert Taylor and Peter Ting.

15th Reunion
by Barbara Kinder
The class reunion dinner was elegantly pro¬
vided at the home of John and Ellen Ebersole. Everyone enjoyed the nostalgia, re¬
miniscences and the hilarity. All felt that
maturity was progressing satisfactorily for
the '7 lers.
Attending the reunion were Ward Cates,
John Cieply, Frederick Cohn, David
Cossman, John Ebersole, Leonard
Eisenfeld, John Foster, Richard Kauf¬
man, Barbara Kinder, William Krinsky,
David Lippman, William Mangione,
John Mills, Richard Moggio, John Patti,
Barry Perlman, Michael Piercey, Irving
Raphael,
David
Rinzler,
Douglas
Schmidt, Richard TYavers, Paul Vignola
and Albert Weihl.

1976
10th Reunion
by Robert Taylor
Despite “typical” New Haven weather, the
showers did not dampen the festivities as
the Class of 1976 gathered for its 10th reun¬
ion dinner. Alfred Axtmeyer was even
forgiven for his photo-finish planning.
Mileage Plus awards went to Jack Tauber
and Glenn Gorlitsky, both of whom de¬
serted Los Angeles for the weekend.
Helping make quick work of acres of
steamers and gallons of clam chowder were
Florence Comite and husband, Henry
Cabin ’75, Todd Estroff, Mark Cullen,
Roger Boshes and Dan Schuster. Bill
Levy came up from Pennsylvania and
was joined by Dan Rahn and Charlie
Swenson.
The weather may have thwarted Rich
Pelker and Ken Dobuler in their attempts
to recruit a crew for an America’s Cup chal¬
lenge. Challenging the freeway was strenu¬
ous enough for most, including Sarah Auchincloss, who arrived from New York, and
Peter Swanson, who had the same experi¬

1981
5th Reunion
by Barbara Ross and Anthony Urbano
The Class of 1981 held its first medical class
reunion, and according to the Alumni
Office records was numerically and in spirit
the most successful 5th reunion ever.
Twenty-one classmates, and a total of 32
guests, convened as guests of the School of
Medicine for the traditional "Friends of the
50th” dinner. Class officers Barbara Ross,
secretary, and Anthony Urbano, class
agent, handled the arrangements.
One fourth of the group assembled for the
Friday program, while three-fourths of
the group, still involved in graduate train¬
ing, were able to attend only the dinner
Saturday.
It was a wonderful party. We suggest that
the Medical Alumni Association mix the
old classes with the young next year. It was
pleasant and easy to share medical school
experiences with graduates 50 years out.
We had a wonderful evening seeing one
another again. It was great to see everyone
happy and, especially, so successful and
fulfilled. We hope to see everyone again for
our 10th reunion. In reminiscing, those of
us who have been away from Yale for some
time were surprised to see how much the
medical center and New Haven have
changed.
After the party, we were guests of Bob
Goldman and his wife. Bob is at Yale-New
Haven Hospital in the section of molecular
neurobiology. Present were Ada Adimora,
Peter Arvan, Cynthia Aten, Joan
Bengtson, Louann Brizendine, Jeff
Chodakewitz, Mariano Garcia, Robert
Goldman, Mark Kasper, Robert Kenet,
Thomas Kievan, David Lebwohl, Yvette
Matory, Rose McCann, Donald Moore,
David Paly, Robert Portney, Patrice
Rehm, Barbara Ross, Dovelet Shashou
and Anthony Urbano.

1985-1986 ALUMNI FUND REPORT
A Message from the Dean
The men and women who have graduated
from the Yale School of Medicine are to be
commended for their generous contribu¬
tions to the Medical School Alumni Fund.
As you may know, the contributions sur¬
passed the half-million dollar mark—an
impressive and record-breaking feat.
As dean of the School of Medicine, I
greatly value these contributions and wish
to tell you that I have continued to direct all
of these unrestricted gifts toward student as¬
sistance and the Student Revolving Loan
Fund. By offering students this financial as¬
sistance we are assured of accepting and

educating the brightest young people—re¬
gardless of their economic background—
who will become tomorrow’s leaders in sci¬
entific research and medical care.
In addition, more of our students are
electing to take a fifth year to pursue
independent research. The alumni’s strong
support encourages students to expand
their educational program and avail them¬
selves of Yale's distinguished educational
resources.
Drs. Lowell I. Goodman, Nicholas PR.
Spinelli and other alumni fund-raising lead¬
ers have done a superb job in generating

gifts to enlarge the Medical School Alumni
Fund. I am extremely pleased and proud of
the strong support the medical alumni offer
their school.
In the months ahead, I look forward to
talking with you about our students, faculty
and the many exciting developments within
the Yale School of Medicine. Your con¬
tinued support and generosity make it possi¬
ble for me to fulfill my role as dean.
Leon E. Rosenberg
Dean

Message from the Medical School Alumni Fund Chairman

YALE MEDICAL SCHOOL
ALUMNI FUND BOARD

Christmas in July!

Lowell I. Goodman, M.D. '51 chairman
J. Roswell Gallagher, M.D. ’30
Harry Sherman, M.D. ’34
Samuel D. Kushlan, M.D. ’35
Malvin White, M.D. ’39
R. Leonard Kemler, M.D. ’43
Nicholas RR. Spinelli, M.D. '44
William McClelland, M.D. '47
Harvey L. Young, M.D. ’52
Harold Bomstein Jr., M.D. ’53
Robert A. Kramer, M.D. ’55
William Kissick, M.D. ’57
William Waskowitz, M.D. ’57
Nicholas Passarelli, M.D. ’59
Earl Baker, M.D. ’61
David Hill, M.D. ’65
Douglas Berv, M.D. ’74
O’Dell Owens, M.D. ’76

Ever since I heard the news in July that the 1985-86 total gifts had topped the $500,000
mark. I’ve been virtually speechless.
The campaign got off to a good start last fall, and each month seemed to pick up a little
more steam. Shortly after Christmas we began to hear rumors about a couple of large
gifts and by spring-time everybody knew that we were really on a roll!
Reunion weekend came and went in a blur and a whirl and a kind of numb anticipation.
Once or twice I was heard to mumble “wouldn’t it really be great if...” Without being
able to put my dare-to-dream—big wish into words.
And then the word came through—the generous alumni and friends of the Yale School of
Medicine had done themselves proud by assembling the largest largess ever. It will give
my successor, Len Kemler, a suitable challenge for the next few years and should provide
everyone who participated in the 1985-86 campaign a real warm glow of satisfaction.
Hats off to the Class of 1936 for its bell ringing gift of $108,906 in celebration of its
50 years of Yale doctorhood.
Hallelujah to the Class of 1946 for the establishment of the Sanfurd G. Bluestein and
Class of 1946 Scholarship Fund. Kudos to the entire crew of class agents who worked
their magic ways with suasive and gentle entreaty.
A paean of praise to the entire cast of contributors for their history-making response.
I know that I shall be forever thankful to Yale for taking me under her wing way back in
1946. I am even more grateful for the opportunity I have had as chairman these past five
years to express my appreciation.
By the time you read this, another campaign year will be under way. My closing comment
will be a hopeful one: let’s keep the Medical School Alumni Fund growing and see if we
can reach the million dollar mark by 1991.

FUND OFFICERS 1985-86
Medical School Alumni Fund
Lowell I. Goodman, M.D. ’51, chairman
J. Roswell Gallagher, M.D. ’30
Bequest and endowment co-chairman
Samuel D. Kushlan, M.D. ’35
Bequest and endowment co-chairman,
and chairman, former house staff

Public Health Alumni Fund
Kathleen H. Howe, M.P.H. ’56,
chairman

Lowell I. Goodman
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Messages to Graduates and Friends of Epidemiology
and Public Health
The Department of Epidemiology and Pub¬
lic Health and its students are very grateful
to the 618 alumni who contributed a total of
$37,450 to the Yale Public Health Alumni
Fund. The contributions of Kay Howe, the
class agents and the telephone squads have
been very important in inspiring our alumni
in theircontinuing generosity.
These funds, used for student support,
have become increasingly necessary as the
support of public health education by the
federal government keeps diminishing.
Many of our alumni recognize their good
fortune in having graduated during times of
much more adequate federal support and
give so that current students can be spared
some of the ever-increasing educational
debt burdens. Compared with 10 years ago,
the cost of education has more than dou¬
bled, and the level of federal support has
been reduced to one third.

There is little I can add to Dr. Stolwijk's
message except an expression of my warm
gratitude to everyone who participated in
this year’s Public Health Fund drive. To all
those who supported the drive financially;
to those who, in addition, gave unselfishly
of their time as class agents; to those who
joined in camaraderie for two phonathons in
the spring, 1 extend my heartfelt thanks.
Kathleen H. Howe
Chairman
Public Health Alumni Fund

Each year, thousands of School of Medicine
alumni and friends give to the Alumni Fund
to provide support essential to the school’s
educational strength. Each gift is important,
helping to underwrite operating costs while
eloquently expressing the generosity of the
many individuals who believe in the
school’s mission. Each has been gratefully
received. These three examples represent
the commitment and generosity of those
who continue to offer that support.

Giving Life Insurance
to Yale
Earlier this year, an alumna in her early 70s
who wishes to remain anonymous made a
gift of a fully paid-up $50,000 life insurance
policy to Yale. She made the gift after hav¬
ing made a single policy premium payment
of $15,000. Proceeds from the policy will
be used to establish a scholarship in the
name of her late husband, who also
graduated from the Yale School of
Medicine.
The gift of a life insurance policy enabled
her to make a much larger gift to Yale than
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Recognizing the importance of an adequate
source of financial support for medical stu¬
dents, Sanfurd G. Bluestein established a
special challenge fund on the occasion of
the 40th reunion of the Class of 1946.
Dr. Bluestein of Montclair, N.J., pro¬
vided matching gifts—at nearly two-forone—for all contributions made to the
Medical School Alumni Fund by members
of the Class of 1946. This spring, the school
established a scholarship fund named to
honor this principal donor and the class,
with whose generous assistance the new
fund was created. The fund will remain a
challenge, since members of the Class of
1946 and friends may add to it in the future.

Memorials

Jan A.J. Stolwijk
Chairman and Susan Dwight Bliss Profes¬
sor of Epidemiology and Public Health

Recent Gifts to the Medical
School Alumni Fund

Sanfurd G. Blue stein and
the Class of 1946
Scholarship Fund

she might otherwise have made. It also en¬
abled her to endow a permanent memorial
to her husband while providing scholarship
assistance so vital to many students who
pursue medical education at Yale.
These gifts, and more than 2,000 other
gifts to the Medical School Alumni Fund
during the past campaign year, help to
ensure the distinction of the School
of Medicine’s teaching and research
programs.

A Gift to Honor the
Memory of Parents
During the past fiscal year, on the occasion
of this 50th reunion, a donor who prefers to
remain anonymous established a charitable
gift annuity in memory of his parents, both
of whom also were physicians. The
$100,000 gift will endow a special fund that
the School of Medicine will use to provide
financial assistance to students in the form
of scholarships or loans.
Because the annual proceeds from the
Medical School Alumni Fund will enable
the school to address student needs as they
develop, the gift provides important flexi¬
bility to the school’s financial aid program.
That helps balance the operating budget. It
is also essential to the quality of the educa¬
tional process because it provides encour¬
agement and support to new generations of
physicians and medical scientists as they
prepare for careers in medicine.

Deceased medical alumni and friends may
be memorialized by a gift at any time to the
Medical School Alumni Fund Endowment
in the name and class of the person so hon¬
ored. The next-of-kin of a deceased medical
alumnus/a is advised about this In
Memoriam Program by a mailing from
New Haven some weeks after the School of
Medicine receives notification of the death.
The letter of information includes a copy of
The Testament of Remembrance in which
the names of all persons so memorialized
are listed in the medical section by class,
thus establishing a lasting memorial.
Donors receive a personal penned note of
appreciation from me. Your inquiries and
interest are welcome at any time.
Deceased alumni and friends so honored
for the first time in 1985-86 were; Eli Rubin
'25, Thomas Farthing ’32, Francis Guida
'34, George Hahn ’36, Francis Vose ’42,
Allan Green '48, Lois Tice ’59, Gertrude
Spinelli andT. Beers Townsend.
Richard G. Jordan
Director, In Memoriam Program

Medical School Alumni Fund Class Participation
Final Report - 1985-86
YEAR
1922 and prior
1923
1924

AGENT

1984-5
TOTAL

1984-5
% PART.

1,995
541
5,081

—

—

—

875
551
1,048
3,555
1,192
15,984
1,663
1,725
1,537
4,071
54,090*
5,850
753
1,215
3,371
10,793*
2,856
1,973
2,995
3,164
8,393
24,854*
4,675
3,084

67
71
53
77
72
60
83
44
63
65
70
47
53
74
62
67
64
54
69
52
61
65
56
62

1,873
755
2,927
1,025
3,569
1,341
6,072
2,923
2,066
1,944
3,898
12,837
108,906*
1,540
1,065
18,441
8,453
3,692*
2,519
2,908
2,171
6,014
4,025
38,826
19,274

67
70
83
60
77
67
70
79
54
73
50
57
53
53
53
67
54
69
53
70
55
76
60
70
81

60
71

1985-6
TOTAL
2,180
553

1985-6
% PART.
—

1925
1926
1927
1928
1929
1930
1931
1932
1933
1934
1935
1936
1937
1938
1939
1940
1941
1942
1943A
1943B
1944
1945
1946A
1946B

William Cohen
Myron Sallick
David M. Raskind
Alice Whittier
Maxwell Bogin
Harry Zimmerman
Max Alpert
Paul McAlenney
J. Edward Flynn
Michael D’Amico
Henry Brill
Franklin Foote
John Ogilvie
James Haralambie
George Hahn
David Dolowitz
Nelson Ordway
Rebecca Solomon
James Ferguson
Charles Cheney
Walter Burdette
Dorothea Peck
S. Brownlee Brinkley
Nicholas Spinelli
Richard Breck
Charles Judd
Thomas Whelan

1947
1948
1949
1950
1951
1952
1953
1954
1955
1956
1957A
1957B

William Roy Breg
Paul Koehler
Daniel Elliott
David Frucht
Lowell Goodman
Harvey Young
Vincent Gott
John Rose
Robert Kramer
John Gardner
Ronald Fishbein
Howard Minners

7,759
4,700
5,407
3,785
6,781*
5,271
4,310
3,095
5,323
8,841*
4,600
3,620
4,055

58
59
56
47
71
49
43
45
67
62
36
59
68

58,100*
4,925
6,067
3,970
4,486
6,884*
8,432
3,665
5,088
6,370
15,300*
4,576
3,545

75
59
62
55
76
52
57
52
68
60
57
61
68

1958A
1958B

Charles Hall
Paul Rudnick

7,675
1,570
4,010

48
51
56

8,121
2,660
4,135

64
60
65

1959A
1959B

Asa Barnes
Muriel Wolf

5,580
3,376
4,679

54
64
46

6,795
9,542
4,355

62
64
66

55
67

—

—

1960B

Roland Ingram
Victor Altshul
Thomas Kugelman

8,054
7,400

13,898

1960A

11,113

71

4,399
4,420

58
58

1961A
196 IB

Earl Baker
Anoush Miridjanian

18,213*
2,625
2,310

69
52
44

8,819
3,625
9,375

58
45
56

1962A
1962B

A. Richard Pschirrer
Frank Hartman

4,935
2,865
1,475

48
54
32

13,000*
2,300
1,800

51
54
25

1963
1964A
1964B

Craig Llewellyn
William Houghton
William Pratt

4,340
10,685
2,100
5,145

43
56
47
76

4,100
7,395
3,285
5,845

40
58
61
82

1965
1966A
1966B

David Hill
Mary-Alice Houghton
Henry Mann

7,245
8,840*
2,580
1,975

62
53
66
63

9,130
5,455
3,500
1,945

72
47
69
49

1967A
1967B

James Dowaliby
Anthony Lovell

4,555
1,691
3,605

64
47
77

5,445*
2,587
4,290

59
64
77

1968A
I968B

Frank Lucente
Donald Lyman

5,296
2,701
1,800

72
47
51

6,877
3,077
2,490

70
45
49

1969
1970
1971A
1971B

Lee Jampol
James Missett
John Cieply
Barbara Kinder

4,501
5,872
3,796*
1,942
3,690

49
52
42
40
63

5,567
6,516
3,526
4,691
5,720

47
60
45
61
60

5,632

54

10,411*

61

—

—

67
—

65
—
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MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION —continued

YEAR

AGENT

1972
I973A

1973C

Paul Lucky
David Bailey
Lee Goldman
David Johnson
John McQuade
Jerrold Rosenbaum

19 74A
I974B

1973B

1984-5
TOTAL

1984-5
% PART.

4,143
1,050

46
39

4,983
1,170

—

—

1,135

36

1985-6
TOTAL

1985-6
% PART.
41

—

—

42

_

—

—

—

1,120

45

848
970

32
38

Amy Schecter
Robert Schecter

3,305
1,000
850

40
38
26

2.988
1,645
725

38
50
23

I975A
I975B

Daniel Passeri
Mary Jane Minkin

1,850
1,450
1,135

22
35
19

2,370
850
865

37
29
16

1976
1977A

2,585
2,116
600

27
30
21

1,715
3,370*

—

—

I977B

Robert Taylor
David Kreis
Attilio Granata
Ronald Vender

1978A
1978B

Duke Cameron
Seth Powsner

I978C

Thomas Smith

1979A
1979B

1980A
I980B

23
39

_

820

38

760
590

29
33

1,420
1.360
105

29
26
14

1,350
1,105
150

31
26
21

110

20

265

47

1,575
266
445

23
23
21

1,520
391

-

—

490

19

Eduardo Alfonso
Mark Bernhardt

711
610
655

22
36
33

881
525

23
33

Cesar Molina

—

—

345

19

1,265*
575
65
135
115

34
17
9
27
17

870
1,310*
335
110
235

26
24
13
23
36

315
170
197

16
10
23

680
175
360

21
11
24

367
140

76
12

Jeffrey Kaine
Laurie Smaldone
Cynthia Sherman

1981
1982A
I982B
I982C

Anthony Urbano
Muriel Cyrus
Jed Gorlin
Stephanie Wolf-Rosenbaum

1983A
I983B

Michael Tom
David Schwartz

I984A
I984B

David Astrachan
Hingge Hsu
Jay Kostman

1985A
I985B
I985C

Robert Higgins
Fred Santoro
Javier Vizoso

*

—

—

—

535

17

261

14

—

—

—

—

—

—

—

16

—

—

121

29
28

_

—

—

210
115

14
9

325
1,355
585
359

11
83
100
100

2,299

97

Reunion

Medical School Alumni Fund
1985-86

1984-85

CITED

BUTORS

PATION

TOTAL

NUMBER
SOLI¬
CITED

Alumni

3.509

1,613

46

$346,006*

3,583

1,773

50

Former
House Staff

1,004

168

17

9,560

1,002

181

18

11,821

366

60

16

11,787

432

79

18

8.558

Parents/ Friends

NUMBER

NUMBER

SOLI-

CONTRI-

PERCENT
PARTICI-

NUMBER
CONTRI¬
BUTORS

PERCENT
PARTICI¬
PATION

TOTAL
$467,234°

Interest and
Miscellaneous
Gifts
TOTAL

4,879

•Includes $67,373 for 3 life income gifts,
" Includes $113,975 in life income gifts.

24

14,532

13,464
1.841

38

$380,818

5,017

2,035

41

$502,145

Public Health Alumni Fund Class Participation
Final Report - 1985-86
YEAR

AGENT

1923-1941
1942
1943
1944
1945
1946
1947
1948
1949
1950
1951
1952
1953
1954
1955
1956
1957
1958

_ _ _ _

1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974A
1974B
1975
1976
1977
1978
1979A
1979B
1980
1981A
1981 B
1982A
1982B
1983A
1983B
1984A
1984B
1985A
1985B

Eric Mood
Eric Mood
Eric Mood
—
—
—

Elizabeth Robinton
Elizabeth Robinton
Eric Mood
Norton Chaucer
Yolande Lyon
Milton Sisselman
Eric Mood
Frances Ogasawara
David Boyd
Edward DeLouise
Thomas Flynn
Philip Hallen
Dorothy Wilson
Else Schulze
R. John C. Pearson
William Slivka
A. Kay Keiser
Thomas R. Mayhugh
David Dolins
Estelle Siker
H. Patterson Harris
Allen Cohen
James Malloy
Arnold Saslow
Samuel Korper
Susan Balter
John Bihldorff
Dorothy Lewis
Judith Beatrice
Thomas Benoit
Karen Lindfors
Linda Broker
Elaine Anderson
Dorothy Rice
Ann Freedman
Catherine H. Norton
Ralph Tartaglione
Christina Quinn
Diane Goren
Angelo DeVita
Barbara Gaugler
Michele Visconti
Constance M. Jarowey
Amy Wilson
Jean L. Milton
Jeffrey Hughes
Mary Beth McNerney
Anthony Alberg
Leslie A. Balch
Joan M. Cleary
Katherine Santella

1984-5
TOTAL
5,770
460
460
260
110
80
220
1,115
495
975
645
870
730
45
655
545
525
700

—
605
195

—
655
75

—
850
1,220
1,885
220
1,525
1,805
1,035
1,345
2,025
485
1,495
320
535
1,667
1,690
1,380
1,759
—

1,505
1,155
615

—
240
265

—
445

—
1,260
175
110
80

—
—

1984-5
% PART.
—

80
45
33
43
33
35
50
36
62
38
33
39
13
50
29
57
29

—
40
25

—
50
20

—
43
42
50
18
41
45
36
31
49
30
29
35
44
41
35
33
39

—
32
37
26

—
32
14

—
39

—
24
16
17
10

ALUMNI/AE TOTALS
Interest/misc. gifts
Baumgartner Match

42,590
2,396

—

—
—
—
—
-

TOTAL

44,986

35%

1985-6
TOTAL
2,159
420
90
275
135
75
330
675
465
685
600
695
810
85
485
672
705

—
1,175
430

—
1,159
1,075

—

1985-6
% PART.
—

60
27
22
50
29
48
44
33
43
50
41
52
21
44
50
52

—
29
38
—

43
40

—

175
785
640
600
280
1,185
1,705
955
1,533
1,803
385
1,160
290
475
1,602
1,140
918
1,123
535
460
1,050

30
38
33
31
27
32
51
32
31
53
17
31
26
40
35
30
29
29
25
38
27

745
490

27
36

—
460

—
290
315
190
215
50
268
180
35,201
2,339

—
18
—

30
25
22
22
5
19
11

_

—

—
—

37,540

32%
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Contributors to the Medical School Alumni Fund 1985-86
Alumni

1906
Charles R. Mitchell*

Lucien M. Pascucci

John D. Tobin

Harold J. Harris

Harry Sherman

Darrell G. Voorhees

Henry E. Markley

Paul F. McAlenney

George Zalkan*

Douglass W. Walker

Walter J. J. Nero

John H. Wentworth

Dorothea R Peck

Malvin F. White

Edward F. Rabe

Tony L. Rakieten*

1908

William F. Roth*

Michael A. Parlato*

Russell B. Scobie
Robert Tennant

1912
Walter C. Tilden*

Newell R. Washburn*
Julius G. Weiner*

1935
George A. Carden, Jr

Earl J Rhodes

Edgar S. Childs

1940

Sawnie R. Gaston

Theodore E. Allen

H Hoffman Groskloss

Joseph V. Baldwin

Henry A. Riedel

James Quintin Haralambie

Ronald S. Beckett

W. Howard Horner

Jack S. Blaisdell

1913

Mrs. Mabel Wilson

Ralph E. Taylor*

Herman Yannet

Mildred Hartshorn January

Philip S. Brezina

1916

1930

Samuel D. Kushlan

Thaddeus S. Danowski

Ernest Russell*

Samuel Alpert

Donald P Morris*

Robert M. Dunlap

Daniel N. Beers*

Norman E. Peatfield

James F. Ferguson, Jr.

Ignacio Bird-Acosta

Norman P. Rindge

Eugene J. Fitzpatrick, Jr.

1919
Willys M. Monroe*

1920
Oscar Brenner*

Frederick Fitzherbert Boyce

Milton Rose*

H. Stuart Irons, Jr.

Charles A. Breck*

Clark P Searle

Donald G. Johnson

Lewis Dickar

Samuel Zelman

Ira D LeFevre, Jr.

Vincent A. Doroszka

1922
Maurice Grozin*
Chester E. Hurwitz*
Helen P. Langner

Knox H. Finley
J. Edward Flynn
J Roswell Gallagher
James C. Hart

1923

Edmund L. Kitzmeyer

William Cohen

Paul H Lavietes

Jacob Mellion

Moses D. Lischner

Julius A. Olean*

James M. Lynch*

Hyman W. Weinstein*

Paul Watson*
Amy H. Wilson

1924
John J. Batchelor

Charles L. Wood

Edward Martin

1936
Daniel Bergsma
George Henderson Brown
Dean Lester W Burket
Albert W. Diddle
Margaret C. L. Gildea
George Hahn*
Louise G. Hutchins

Robert F. Bradley
S. Brownlee Brinkley

John B Wells

Henry H Bruyn, Jr.

Helen H. Woods

Thomas L. Bucky
Jane B. Cadbury

E. Robbins Kimball

1941

Philip M. LeCompte

Sophia C. Alway

E. James Mulligan

Robert H. Areson

Stephen F. Nagyfy

W Randal Bell

Philip B. Chase

Benjamin Castleman*

Margaret Sommers

Joseph P. Carson, Jr.

Michael D’Amico

Morris Tager

Charles B. Cheney

Morris F. Heller*

Rafael Arrillaga Torrens

Herbert W. Diefendorf

Helen R. Gilmore

Edgar W. Warren

Robert Dine*

Eli H. Rubin*
Welles A. Standish
Alice A. S. Whittier
Howard A Wood

Thomas C. Jaleski
Rhoda M. Mickey
Nelson Newmark
James W Reed

1926
Stanton T. Allison*
Maxwell Bogin
William H. Hahn*
Joseph L. Hetzel*
Morris Hinenburg
Ben Klotz
Milton Malev
Joseph T. Matteis

Abraham J. Schechter
Max Taffel

Peter A. Duncan

1937
David A. Dolowitz
D. Crosby Greene
Joseph B. Hollingshead
Wilbur D Johnston
Alfred E. King
Dunham Kirkham
Julia Mehlman

1932

James P Morrill

Louis K Alpert

Charles W. Neuhardt

Henry Bnll

Alan A. Rozen

Frank Carroll

Morgan Sargent

Clement C. Clarke

Edward J Shaw

Joseph P Donnelly

Albert D. Spicer

Lee E. Farr

John M. TTiomas

Thomas E. Farthing*

Jean Wells

Milton B. Berman

Lewis F. Foster

Mrs. Lucille R. Wiepert

Wallace R Bostwick*

Conrad R Lam

Lorande M. Woodruff

1927

John M, Freiheit*

Mario L. Palmieri

Meyer Friedenson

Arthur J. Present

Albert Jablonsky

Elizabeth M. Ramsey

Nathan Levy

Benjamin N. Tager

William C. Meredith

Rudolph E. Vandeveer

Moses Rothberg

Myron E. Wegman

Theodore H Sills

Roland J. Wehger*

M. Dawson Tyson
Harry M. Zimmerman

Roy N. Barnett
Henry L. Carideo
S. Charles Kasdon
Edward Nichols
Nelson K Ordway
Edward E. Pinkham, Jr.

1933

James Radcliffe, Jr.

Myron J. Adams*

George E. Roberge

1928

Fred W. Buse

Lester J. Wallman

Max Alpert

Warren P Cordes

J. Richard Zahn

Louis M. D’Esopo

Franklin M. Foote

Sheldon A. Jacobson

Jack Greenberg

Raymond A. Johnson

Daniel F. Harvey*

Edward P J. Kearney

George K Hirst

Ralph E. Knutti

John G. Martin

R. Harold Lockhart

Raymond E. Miller

Edward W. Ludwig*

Ashley Pond III*

Nathan E. Ross

Paul L. Saffo

Robert I. Rubinstein

Sidney Stringer*

John M. Russell*

John

Alvin A. Schaye*

Francis M. Woods

Lewis A. Scheuer

j.

Wolfe

1934

Lloyd D. Flint
John Franklin
Robert L. Gilbert

Ronald W. Cooke
Joseph I. Epstein
Robert H. Furman
Victor C. Hackney
Paul W. Hughes
Frank R Hurlbutt, Jr.
Henry H. Jones
Sawyer E. Medbury
Ira A. Rashkoff
Donald W. Seldin
Francis A. Spellman

William Lee

1944

Bjorn Lih

Carl Andrews

F. Eugene Martin

Edward J. Conway

John R McDermott

John C. Coolidge

Willys M. Monroe

George B Corcoran, Jr

Edward B O'Connell

Frank W Countryman

Robert W. Ollayos

Charles H. Crothers

Gioacchino S. Parrella

Lawrence G. Crowley

David V. Pec ora

John H

Edwin D Rogers

Robert W Frelick

Leslie Simmonds

Carol Goldenthal

Irving Waltman

Charles A. Hall

Doherty

Howard B. Hamilton

1942

Ward S. Jenkins

James M. Bunce
Walter J Burdette
Robert E. Carroll
Vincent J. Collins
David G. Decker
Hendrik DeKruif
Davitt Felder
Elihu Friedmann
Allan V. N. Goodyer
William Harrison, Jr.
John R Lincoln

1939

Patrick S. Mullins

Harold H Coppersmith

Dean Nichols*

Norman L. Cressy

Michael A. Puzak

William H. Druckemiller

Samuel Ritvo

Robert G. Ernst*

Richmond W. Smith, Jr.

John P Ferguson, Jr.

Edgar B. Taft

Joseph B. Forman

Maurice Tulin

S. Jerome Greenfield

Francis P Voss*

Paul E

Irving Norman Wolfson

Huston

Hunter H Comly
Norman 1. Condit

William Edmund Kenney

Eugene M. de Hostos

1938

1943 December

Patricia E. Wanning

Harold T. Vogel

Harold E. Harrison

Robert H. Wyatt

David G. Borden

Knute E. Berger

Paul A. Harper

Frederick A. Waldron
John J. Weber

J. Champneys Taylor

William A. Carey

William E. Hall

Sophie Trent Stevens
Oliver G. Stonington

Joseph E. Sokal

Hugh Allan Smith

Samuel Reback

Hilliard Spitz
Nicholas M. Stahl

Richard N. Abbott

Frederick A. Post

1925

Edward Hersey Soule

John R Almklov

1931

Waldo F. Desmond

Marcus E. Sanford
Robert A. Sears

W. Norman Sears*

Henry H Briggs, Jr

Raskind

Bernard R Rowen

William R. Oakes

Myron A. Sallick

David M

J Philip Loge

Mr. John A. Hangen

Edith M. Jurka
Jerome J. Kaye
John Weaver King
Frederick F. Krauskopf
Elias J. Marsh
Katharine Hawley Martin
Mrs. Nora Harnden Mason
Joseph Massaro
A. Reese Matteson
Paul E. Molumphy
Russell R

Monroe

Lawrence K. Pickett
Laurence G. Roth
Haynes W. Sheppard
Sarah P. Sherwood
Eugene Smith
Nicholas P R. Spinelli
Priscilla Dienes Taft
Anthony Varjabedian
Calvin W. Woodruff
Reuben Zucker

Nathaniel Kerugsberg
Arthur E. Laidlaw

1943 March

1945

Margaret A. Lennox

Ralph D Alley

George Howard Allison

John R

A. John Anlyan

1929

Leona Baumgartner

Ward J

James Rae Arncill, Jr.

Frederick Beck

James Peter Murphy

Lycurgus M. Davey

Albert S. Atwood

Charles J. Epstein

James F. Blades

Russell Nahigian

Gerard Fountain

Frederic M Blodgett

Robert A. Frisch

Francis P. Guida *

Douglas S. Riggs

R. Leonard Kemler

Richard W. Breck

Olive Gates

Derick A. January

Ernest L. Sarason

Joseph P Kriss

Louise H Burr

George S. Goldman

Herbert C. Miller

Bradford Simmons

Jonathan T. Lanman

Alice Shepard Cary

Alexander O. Haff*

John B. Ogilvie

Rebecca Z. Solomon

Douglas Lindsey

Jay B Cohn

•Deceased

• Deceased
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McFarland

Brobeck

Thomas P. Cotter

William K. McClelland

Daniel Fine

Vincent Lynn Gott

Robert A. Kramer

Edward M. Daniels

Robert F. Newton

David A. Frucht

Robert Emanuel Hamlisch

James Lum

Richard R. Dyer

Myron K. Nobil

Chesterfield G. Gunr, Jr.

George L. Hoffmann

Alexander Maitland III

Robert S. Easton

Lawrence C. Perry

Melvin H. Kaplan

David Purdy Holman

Joseph S. McGuire, Jr.

Alice Dershimer Friedman

Philip H. Philbin

Lucian S. Lapinski

Peter Biggs Hukill

Robert C. Nodine

Raymond A. Gagliardi

Olive E. Pitkin

Sidney S. Lee

Richard Robert Knowles, 3d

Gloria C. Onque
John C. Pace, Jr.

Philip S. Good

Irving Rudman

John B LeRoy

Hildegard Mueller Leslie

Gove Hambidge, Jr

Alvin Somberg

Janus C. Lindner

Preston Lee Leslie

Robert H. Peters, Jr

Herbert S. Harned, Jr.

Igor Tamm

Margaret S. Lyman

John Dutch Lord

Gregory Peterson, Jr.

O. Roger Hollan

Patricia B Tudbury

Harold March

Robert N. Melnick

Robert A. Reich

Hans R Huessy

Ellis J. Van Slyck

Harry McClelland*

Warwick Potter, Jr.

Paul J. Robinson

Leland W Jones

M. Henry Williams, Jr.

John H. Meyers

Paul G. Quie

F. Brantley Scott, Jr.

William E. Laupus

Sumner Root Ziegra

Orlando J. Miller

Jose Ramirez-Rivera

Clement B. Sledge

Raymond E. Lesser
Garner L. Lewis
Mark McD Lindsey
Charles E McLean
George W. Naumburg
Richard M. Peters
Elliot R

Reiner

Charles E. Sherwood
Joseph R. Stanton
Kenneth C. Steele

1948
Russell J. Barrnett
George F. Batten
Edith M. Beck
Allyn G. Bridge
Lee Buckingham Brown

Robert T. Sceery

John C Roberts

Phillip W Smith

Cynia B. Shimm

Barbara F. Rosenberg

Alan A. Stone

Jane B. Shumway

Irwin K. Rosenberg

Martin Smith*

Virginia C. Saft

John S. Strauss

Howard Willis Smith

Robert H. Sturman

Ora K. Smith

Richard Steele Buker, Jr.

1951

Arthur L. Coleman, Jr.

Karel Bedrich Absolon

Ruth E. Cortell

W. Robert Adams

Lynn Cortland Stoker
William Junior Vandervort
William August Wilson

Alexander Zuckerbraum
1956
Alan E. Apfel
Levon Z. Boyajian
Thomas M. Brown
Dr. Rosalie A. Burns
John F. Carroll
Joseph C. Cerny

G. Robert Downie

Thomas T. Amatruda, Jr.

1954

1946

Marie C. Duncan

Stanley D. Ardell

Frank P Berg

Edwin L. Child

Margaret J. Albnnk

Elizabeth Fuller Eisner

Muriel H. Bagshaw

Richard J. Bouchard

James C. Collias

William G. Banfield, Jr.

Boy Frame

Eleanor Clay Bigley

George N. Bowers, Jr

Donald J Dalessio

Franklin C. Behrle

Emil Frei 3d

John J. Egan

Ralph K. Campbell

S. Evans Downing

Frederick C. Biehusen

Julian Frieden

Daniel X. Freedman

John R Cole

Mitchell Edson

Sanfurd G Bluestein

Allan Green*

Sidney S. Furst

Alan H. Covey

Gilbert M. Eisner

Linus W. Cave

B. Herold Griffith

Joseph M. Garland

Arthur C. Crovatto

Thomas F. Ferris

Thomas J. Coleman

Sylvia Preston Griffiths

Ralph M. Gofstein

Donald D Davis

John H Gardner III
Sumner Gochberg

Fred C. Collier

Richard M. Hannah

Lowell I. Goodman

Frederick J. Fiederlein

James F. Cooney

Ross R Harcus

John T. Groel

Walter J. Freeman

Robert H Groves

George C. Cusick

W. Rayner Johnson

Robert N. Hamburger

John A. Gariepy

Arne G. Haavik

Thomas A. Doe

Paul B Koehler

Carrold K. Iverson

Edward J. Gerety

Armen Charles Haig

Edward F. Edinger

Robert E. Lempke

William Kiekhofer

Frank L. Gruskay

William H

Gregory E. Flynn

C. Arden Miller

Jocelyn S. Malkin

Nicholas A. Halasz

Marie-Louise T. Johnson

Hindle

Martin E. Gordon

John P. Morris

John J. McGarry

Robert P. Hatch

George T. Kammerer

Charles S. Judd, Jr.

Richard C. Peterson

Paul D Millikin

Walker R Heap, Jr.

Jerome O. Klein

Harold King

George P. Rostel

Walter S. Morgan

Herbert S. Hurwitz

William V. Lewit

Benjamin F. Kitchen, Jr

Benjamin F. Rush, Jr.

Albert R. Mowlem

Robert F. Hustead

Leo Lutwak

James A. Kleeman

Gabriel A. Saviano*

Richard S. Munford

Robert J. T. Joy

Preston C. Manning

Vincent J. Longo

Jerome H. Shapiro

Charles A. Nugent, Jr.

Donald S. Kornfeld

Robert McDivitt

Richard H. Mann

Jessie Parkinson Spear

Gerard B. Odell

Lowell A. Kristensen

Dwight F. Miller

Thomas J

Mathieu

Anne G. St. Goar

Arthur A. Pava

Richard Lamb

Elmer T. Mitchell, Jr.

Hugh J. McLane

Paul Talalay

Majic S. Potsaid

Harry C. Miller, Jr

Donald J. Nalebuff

Joe D Morris

Wallace W. Turner

William F. Stephenson

Paul N. Neufeld

RADM William M. Narva

John H. Morton

Paul Woodbury Weld

William Taylor*

James J. Nora

A. Frederick North, Jr.

William J. Paule

David A Page

Anthony V. Piccirillo

George W. Paulson

Richard D Pullen

Stewart E. Pursel

Thomas J

Murphy

John F. Neville, Jr.
Laura W. Neville

1952

1949
George R. Anderson

Vincent Pepe

William G. Anlyan

David H

Alfred E. Bacon, Jr.

Riege

Francis G. Reilly*

Henry W Baird III

Phillips E. Roth

Jonathan S. Bishop

Julian A. Sachs

Thomas L. Chiffele

Donald P Shedd

Mary Pucci Couchman

Richard G. Sisson

Phillip G. Couchman

Colby S. Stearns

N. Joel Ehrenkranz

R Bruce Thayer

Daniel W. Elliott

Robert H. Wagner

Gunnar O. Eng

William J. Wedemeyer, Jr.

Albert A. Fisk

Thomas J Whelan, Jr.

Paul S. Goldstein

Hugh R Williams

Eleanora C. Gordon

Elihu S. Wing, Jr.

Frederic W. Gray
Jackson Harris

1947
George R Barnes, Jr.
Albert W. Bostrom, Jr
John E. Bowers
William Roy Breg, Jr.
Rocco A. Calandruccio
John L. Cannon
M. Richard Carlin
Charles R. Cavanagh, Jr.
Roland G. Chambers
Amoz I Chernoff
William F. Collins, Jr.
Robert P Darrow

Robert C. Howard
Benjamin A. Johnson
Orval I

McKay

Timothy F. Nolan, Jr.
Julian I

Pichel

Edmund L. Piper
Charles L. Rennell, Jr.
Murray Z. Rosenberg
Daniel Rudman
R. David Sudarsky
Martha Vaughan
Mary-Agnes P Wine

Richard N. deNiord, Jr.
Frank A. Carone
Siegried A. Centerwall
Willard R. Centerwall
Philip Gardner Deane
Raymond S. Duff
James R Durham
John P. Filley
Richard D. Floyd

Jacques M. Quen

Robert Lee Scheig

Earl D. Rees

James Scheuer

John Keith Rose

Edward C. Senay

Elihu M. Schimmel

Benjamin A. Shaver, Jr.

Leonard M. Silverman

Donald William Sherrick

Robert L. Stein

Daniel R Silbert

John W. Vosskuhler

1957

Robert P Gerety

1955

Donald Agostinelli

Thomas S. Kelly

John B. Atwater

Joseph S. Amenta

James Kent Luce

John C. Bailar III

Jack Norman Blechner
Richard I Breuer

Wilbur P. McNulty, Jr.

George E. Becker

N. Karle Mottet

E. Edward Bittar

Harry C. Briggs

Robert F. Owen

Douglas G. Boyden

Carl A. Brinkman

Sidney Nathan Paly

Joseph I. Boylan, Jr.

John P. Carey

Robert G. Petersdorf

Irwin M. Braverman

Albert K. Chun-Hoon

Leon A. Phillips

Edward Noel Brennan

Louis Z. Cooper

John Macklin Roberts

Padraic Burns

John D'Agostino, Jr.

Leonard Rush

Leo R. Cardillo

Thomas H. Danaher

Mary Wheatland Schley

Nicholas A. Coassin

James R. Dorr

Donald H. Schultz

Edward D. Coppola*

Salvatore Falbo

Robert B. Schultz

Milton Corn

Harold J. Fallon, Jr.

Virginia Lee Swanson

Pasquale James Costa

Robert E. Fishbein

John H Wagner, Jr.

Robert G. Crounse

Ronald H Fishbein

Doris L. Wethers

John G. Daley

Anthony L. Fons 3d

John L. Wolff

Fred Wendell Doyle

Elizabeth H. Forsyth

Harvey L. Young

William O. Edward

Gary A. Fry

Robert Zeppa

Leroy Engel

Robert H. Glass

F Robert Fekety, Jr.

Anne H. Good

Archie L. Dean, Jr.

1950

Owen W. Doyle

Russell N. Anderson

1953

Mahlon V. R. Freeman

Jack Peter Green

Franklin Harold Epstein

Lyal D. Asay

Claude Bloch

James Conway Garlington

Gilbert F. Hogan

Richard K. Friedlander

Malcolm A. Bagshaw

Harold D Bornstein, Jr

Barbara W. Gibson

Warren R. Johnson

Frank H

John E. Borowy

William R. Chaffee

Paul Gonick

Stanley E. Kilty

William H. Bucher

Allen Chetrick

Ion Gresser

William L. Kissick

Don F. Kimmerling

Alvin Davis

Rex B. Conn

John H. Hodge

Edgar H. Levin

Richard P Levy

Claude W. Delia

James P. Dunn

D. Franklin Johnson, Jr

Jack Levin

Brock Lynch

Kent Ellis

Donnell Dencil Etzwiler

Harry O. Kendall

Mark D. Marshall

Victor A. Machcinski

Thomas J. Ferraro, Jr.

Thomas O. Gentsch

David R Kessler

David E. Martin III

Horton

Robert J. Kerin

♦Deceased
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Howard A. Minners

Myron S. S. Lee

John Curtis Parker

Sidney M. Baker

Robert K. Modlin

Kathryn Huxtable Lewis

Elaine Pitt

Leland S. Berger

Eugene Patrick Cassidy

Hugh Lamson Moffet

Raymond Mark

William M. Rogoway

Philip Blume

Jospeh A. Donadio

George Albert Nelson, Jr.

John C. Marsh

Roy E. Ronke, Jr.

Anthony J. Bravo

Robert E. Dragon

Herbert A. Newman

Brian J

Thomas H, Sakoda

Robert M Briggs

Marvin A. Eisengart

McGrath

James Edward Brown

Thomas Francis O’Brien, Jr.

D. Kent Morest

Stanley G. Schade

Joseph F J. Curi

Jared M. Emery

Joseph S. Pagano

James A. O’Neill, Jr.

Robert N. Taub

Mary V. Digangi

Peter M. Fitzer

Raymond E. Phillips

Robert H. Ostberg

Hugh C. Thompson III

Alfonso Esguerra

Robert N. Frank

Clifford B. Reifler

Nicholas M. Passarelli

Franklin H. Top, Jr.

Anthony Ferrante

Robert C. George

Arnold Schoolman

Charles A. Phillips

David E. Weaver

Norman C. Fost

Peter D. Gibbons

Stanley Simbonis

Lincoln T. Potter

Warren D. Widmann

Peter A. Gross

Stanley I. Greenspan

Kenneth A. Simon

James D. Prokop

Murray Wittner

John F B. Haney

J. McLead Griffiss

Charles A. Slanetz, Jr.

James R Ralph

John R. Woodward

Gene I. Higashi

Robert A. Gunn

Gilbert B Solitare

David Pardee Reed

Richard Hockman

Henry G. Hanley

Joseph D. Saccio

1962

Robert W. South worth

Michael H. Alderman

Lawrence Horwitz

Jay G. Hayden

Donald C. Stahl

Marc D. Schwartz

Charles B. Anderson

William J. Houghton

Mary Alice Houghton

Frederic P. Anderson

Sue Kimm

Richard J. Howard

Dean E. Burget, Jr.

Lewis Landsberg

Bruce W. Jackson

Frederic K Cantor

Richard V. Lee

Gordon R Kelly

Arthur Taub
William J Waskowitz
1958
George K. Aghajanian
Don P. Amren
Joseph E. Angelo
Dr. John P. Arnot
Peter Alfred Benson
Gerard N. Burrow

Sanford P. Solomon
.Gene W. Spector
James J. Stagnone
Lisa A. Steiner
John S. Strauss
Lois Tice*
Leo H. Von Euler
Robert E. Waugh
Muriel D. Wolf

Ray Allen Carlsen

Thomas L. Lentz

Neal Koss

Oliver Townsend Dann

James S. Levine

Stuart M. Kotler

Arnold Joel Eisenfeld

Paul R. Lightfoot, Jr

Wilbur L. Kukes

I Bruce Elfenbein

Richard Murray Linburg

David C. Law

John W. Foreman

Robert W. Lyons

Lynne L. Levitsky

Stephen John Flicker

William F. Matchett

John Stephens Melish
Marian Matheke Melish

Benjamtn Bursten

1960

Roger P. Friedenthal

Thomas O McCann

David A. Carlson

Victor Altshul

John N. German

Alan H. Morris

Harold Mellin

John A. Carlston

Alan W. Ames

John T. Harrington

James J. Murphy

William D. Peterson

Robert V. Diserens

Jack D Barchas

Patricia C. Hassakis

Donald A. O’Kieffe

Joel Singer

Donald A. Duncan

Colin Mercer Bloor

J. Dale Howe

William B. Pratt

James D. Slavin, Jr.

Joel C. Eberlin

Ormond V. Brody

Victor W. Hurst III

Jack S. Rice, Jr.

Mark Snider

Philip R. Fazzone

Donald P. Buebendorf

Gary Jacobson

Stanley Rosenberg

Gary Love Townsend

Michael E. Fishman

Stanley M. K. Chung

Glenn L. Kelly

Jonathan J. Russ

Lee Van Lenten

Raymond A. Gaito

Louis A. D'Avanzo

David E. Knoop

Saul M. Schanberg

Joan T. Wayland

John C. Gallagher

David Dunn*

John P. Lynch

Robert L. Shelton

Jon S. Wayland

Marcia Kraft Goin

March Enders

Stanley E. Matyszewski

Major Tadashi Shimada

John W. Wickenden

William M. Gould

Caldwell B. Esselstyn, Jr.

William A. Miller

Diane Shrier

Arne S. Youngberg

James Greenwald

Warren H. Fisher

Malcolm S. Mitchell

Donald G. Skinner

Michael Kashgarian

Paul Jay Friedman

A. Richard Pschirrer

A. Thomas Snoke
Richard C. Stillman

Haskins K Kashima

Eugene C. Gaenslen, Jr.

James A. E. Spencer

Jay Ward Kislak

James I. Gilman

H Oliver Stoutland

Lyall C. Stilp II

Seth Thaler

Sigrid L. Tishler

Sherwood Waldron Jr.

Charles Vogel

1963

Oscar Wand

Theodore W. Lieberman

Maxwell E. Gottesman

Myron Lotz

Sylvia D. Grant

Michael J. McCabe

Roland H. Ingram, Jr.

Leo T. McCallum

Daniel M. Jones

Andrew Joseph McGowan, Jr.

William S. Kaden

Robert S. Neuwirth

Eric P Kindwall

David W O’Keeffe

Susan T. Kleeman

Carol F. Phillips

Thomas P. Kugelman

David M. Pugh

Edward R. Lang

William B. Radcliffe

Thomas Lau

Paul A. Rudnick

Thomas L. Lincoln

William W. Schlaepfer

Edward Longo

Thomas R. Shea

Eugene G. McCarthy

Bruce H. Sklarew

Donald L. Miller

Richard E. Sledden

Richard G Morrill

Edward Lloyd Socolow

Allan W. Newcomb

Raymond W. Turner

Buford L. Nichols, Jr.

Margaret Smith Wenzel

Fred Palace

Joseph P. Wierzbinski 3d

Albert Matthew Ross

John Patrick Wood

John J. Schrogie

Pauline B Wood

Fred Stargardter

1959
Scott Ingram Allen
Carol J Amick
Robert M. Amick

Constantine M. Voyagis
Robert C. Wallach
May Yung-Fun Woo Wang
Ronald A. Yankee

Stephen Waltman
Arthur Howard Ackerman
Miguel R. Alonso
V Richard Back
Charles W. Carl, Jr.
Theodore J. Chu
Gordon S. Cohen
John E. Conte, Jr.
David F. Cross
James S. Dalsimer
Dudley Seth Danoff
Andrew Edin
B. Allen Flaxman
David H. Fram
William T. Friedewald
David H. Fulmer
Alexander R. Gaudio
Vincent F. Geremia, Jr.
Lee D. Goldberg
Peter B Gregory
Benjamin Keith Harris
Brian C. Judd
Constantine D. Kyropoulos

1961

William B Lehmann

Jack F. Bowers

Kenneth A. Ardt

Craig H. Llewellyn

William C. Butterfield

Earl L. Baker

Edward G. Lund, Jr.

Edwin M. Clayton

Albert A. Bechtoldt, Jr.

Sally Lockwood Marchesi

Sicney M. Cohen

Robert S. Briggs

Vincent T. Marchesi

Lyall S. Crary, Jr.

David William Brook

Robert H

Ronald C. De Conti

Paul David Deiter

Herbert Meltzer

Asa Barnes, Jr.

Margulis

William L. Donegan

Ralph J. DePonte

Robert E. Mueller

Gerald Fenichel

Ronald A. Dierwechter

Sheldon R. Pinnell

Robert L. Fisher

Jon Dudley Dorman

Jay M. Pomerantz

Paul Jay Friedman

John E. Fenn

Gene R Profant

Robert L. Fisher

Norbert Fleisig

Berkely L. Rich

Paul Jay Friedman

Edward C. Gilbert

Lee Bland Talner

1965

Mary Williams Clark
Cynthia Rapp Curry

John H. M. Austin

Timothy J. Dondero. Jr.

Paul Balter

James M. Dowaliby II

Victor J Burner

John A. Drews

Thomas B. Caldwell III

Peter R. Egbert

David G. Campbell

Herbert W. Felsenfeld

Robert M. Cohn

Melvin Victor Goldblat

Michael J. Cummings

Richard J, Hart

Phyllis Hurwitz Duvdevani

Richard L. Heppner

David S. Fedson

Peter N. Herbert

Robert I. Finkel

George P Herr

Gary Lawrence Gross

Melvyn Ko rob kin

Robert Andre Gryboski

Carl E. Lane

Reid R Heffner, Jr.

Anthony P Lovell

David A Hill

Ralph G. Maurer

Carl E. Hunt

Stephen W. Miller

Ronald J Karpick

William J. Mitchell

Mohandas M. Kini

Joseph L. Morris

Richard J. Kozera

Jennifer Robinson Niebyl

David J Kupfer

John O. Pastore

David B. Leof

William E. Perkins

Sandra Chook Levine

Brian F. Rigney

Mark W. Lischner

Robert I. Roy

Walter W. Noll

Jonathan L. Saveli

A. Lawrence Ossias

Stephen C. Schimpff

John A. Parrish

Sidney C. Smith, Jr.

Robert L. Pickens

Helen L. Smits

Alan N. Rachleff

Lewis S. Solomon

John H Seashore

Robert S. Steinberg

Margaretta Ann Reed Seashore

Richard B. Swett

Charles J. Semonsky

M. David Tilson 111

David M. Shames

Karen H. Toker

David P. Simmons

George Tyler

Harlan Spitz

Robert A. Vogel

Peter V. Tishler
Lawrence Tremonti

W. Keith Hadley

Richard L. Keefe

Gary Van Galder

William H. Heydorn

Robert Isaac Levy

Peter G. Weiner

C Richard Hinckley

Hugh James Lurie

Jerome Allen Winer

1966

Leonard Inker

David B. Matloff

Alfred J. Wise

Benjamin F. Balme

John J. Jasaitis

Anoush Miridjanian

Edvardas Kaminskas

Richard Allen Moore

David W. Kingsbury

Norman 1. Moss

28

William H. Cave, Jr.

Marian C. Davidson

Louis D. Hunt

•Deceased

Gary C Burget

James J. Dineen

Joseph E. Jasaitis

Berton W, Ashman

Richard S. Bockman
Daniel Booser

Thomas T. Aoki

Robert J. Gonyea

William A. Alonso

Arthur L. Beaudet

Susan A. Aoki

Gerald B. Gordon

1964

1967
Daniel L. Arons

Alan William Stone

Robert A. Vollero

Bert Yuan-Shu Wong

Joseph F. Walter

John D. Baxter
Frank C. Bell
Philip Bernstein

Martin Wand
Redford B. Williams, Jr.
Robert J. Winer
Robert S. K. Young
Peter M. Zeman

1968

Michael D. Danzig

Michael A. Catalano

Andrew L. Ries

Donald R Coustan

Daniel Frizell Dedrick

Philip L. Cohen

David Z. Ritvo

Phyllis A. Taufield

Robert G. Dillard

Margaret W. DeLano

Gloria Cummings*

Amy S. Schechter

Steven L. Warsof

Edward M Drury

Jonathan Ecker

Robert F. Deblasi

Robert J. Schechter

John E. Whitcomb

Barbara Mayer Egbert

Richard L. Edelson

Norman M. Dinerman

James A. Strom

J

Alan G. Finesilver

Robert Alan Epstein

William H. Druckmiller, Jr.

George H. Talbot

Daniel Wohlgelernter

William F. Flynn

Bruce A. Fabric

M. Felix Freshwater

Carol C. Teitz

Richard A. Getnick

Thomas H. Gouge

Dorothy M. Gohdes

John Jones Thompson

Mark Gilbert Grand

Marcus W. Hedgcock, Jr

Andrew E. Hoover

Leonard Grauer

Paul Hessler

Thomas L. Horn

Ralph S. Greco

Jay H. Hoofnagle

Vernon H. Humbert, Jr.

Kevin N. Hennessey

Mark A. Korsten

Anthony H. Jackson

John R Hill II

Thomas L. Lewis

Jesse B. Jupiter

Harry Holcomb III

Robert B. Litman

Roy A. Kaplan

Jeffrey S. Lee

Anne W. Lucky

Donald L. Kent

Ellen Marks Lippman

Jay W. Marks

David L. Kneapler

Frank E. Lucente

Leonard M. Milstone

Philip L. Lebowitz

Donald O. Lyman

James R. Missett

Theodore M. Levin

Rodrigo Martinez

William K. Mueller

Paul A. Lucky

David P. Millett

W. Scott Peterson

Jeffrey S. Menkes

Richard P Mills

Robert M. Rosa

Jerome H. Meyer

Richard M. Morehead, Jr.

Joel F. Rubinstein

David B. Moyer, Jr.

John A. Ogden

Dennis E. Shield

John P. O’Grady

Stuart S. Shorr

Thomas H. Ogden

Richard A. St. Onge

Edward J. Olinger

Joseph L. Renda

Philip E. Steeves

William L. Risser

Gordon H. Sasaki

Daniel A. Symonds

Philip M. Rothfeld

Jacob .1 Schlesinger

Ray W. Tripp III

John S. Smolowe

Frederick C. Sherman

Brian Weiss

Frederick D. Stockwell

Elizabeth M. Short

Joellen Werne

Lawrence P Temkin

Howard W. Siegel

Daniel Wuensch

Philip J. Weyman

James W. Ogilvie
Jackson B E. Pickett

111

Gerald L. Springer
Lee H. Strohl
Per Henrik Wickstrom
Creed W. Wood
1969

1971
Judith L. Bader

Michael W. Yogman
Steven M. Zeldis
1973

Michael .1 Beierle

David Nelson Bailey

Laurie J Bleicher

Richard P Bozof

Charles S. Angell

Bruce Block

Mary Ann Brunstetter-Shafer

David G

Marian H. Block

James N. Campbell

David W. Barry

Williard Cates, Jr

Marvin M. Chassin

Robert E. Belliveau

John L. Cieply

Joseph M. Connors

David A. Berkowitz

Frederick L. Cohn

Carolyn G. Dedrick

William F. Bynum

Andrew D. Cook

Christopher M. Doran

N

David Cossman

Joseph W. Eichenbaum

Leo M. Cooney, Jr.

Edward C. Cottle

Jane H. Ferguson

Richard J

Michael Cynamon

Richard J. Fingeroth

Michael W. Dennis

John S. Ebersole

Robert A. Florin

Charles A. Dinarello

Leonard I. Eisenfeld

Lee Goldman

Douglass T. Domoto

Harvey Fernbach

Gary T Grimes

Ansel

Roger Cooke
Daly

Ralph J. Falkenstein

Fred Finkelm-tn

Andrew G. Kadar

Gary S. Farnham

John W. Foster, Jr.

Michael S. Kramer

Lesley Forman Fishelman

Jared J, Gardner

Mark G. F. McCormick

Steven A. Frankel

Richard Gloor

John F. McQuade III

Anna S. Gail

Jerold Alan Haber

Jerry Nagler

Royal J. Gay

Michael J. Hart

Claes M. Nilsson

Sander G. Genser

William W. Hay, Jr.

David E. Peach

Robert O. Gordon

Richard Katzman

David Pickar

Thomas C. Howard

Richard E. Kaufman

Charles F. Reynolds III

Lee M. Jampol

Barbara K. Kinder

James S. Robertson

Joel Mark Kaufman

Stuart R. Kleeman

Harry S. Romanowitz

Paul H. Kelker

William L. Krinsky

Jerrold F. Rosenbaum

John J. Kelly, Jr.

David H. Lippman

Robert A Sirota

Rowena Korobkin

William J. Mangione

James F. Sullivan

Lynn G. Lagerquist, Jr.

Samuel S. Masters

Robert J. Ursano

Michael R. Liebowitz

John C. Mills

Christine A. Walsh

Elliot M. Livstone

Patrick T. Minihan

Marc A. Weinberg
Richard S. K. Young

Robert Marier

Steven H. Moffic

Arnold F. Mazur

Richard Albert Moggio

Ellen B, Milstone

Martin Paris

Thomas F. Minehan

Robert Park

Bruce K. Nagle

John A. Patti

Lionel M. Nelson

Barry Bruce Perlman

Nancy Olmsted

Stuart B Phillips

Deborah A. Putnam

Michael C. Piercey

Joseph M, Rochford

Anthony V. Proto

Joseph D. Robinson

Barry S. Rand

Dennis J. Rudzinski

Irving G Raphael

David J. Sahn

David M. RinzJer

Adrian M. Schnall

Douglas R, Schmidt

David J. Schulak

James P. Southwick

Gerald J. Smallberg

Jonathan W. Stewart

Michael S. Toren

Richard D. Travers

Robert J Walat

Yvonne E. Vaucher

Stephen R. Webb

Paul A. Vignola

1970
Elissa B. Arons
William Romney Burke

Robert B. Vranian
Ray C. Walker
Burns Woodward

1974
Irving M. Asher
Leonard I

Banco

Douglas A. Berv
Bruce David Blumberg
Neil Blumberg
Peter J. Buchin
Bert D. Collier, Jr.
Paul David
Vincent A. Di Maria
Irl L. Extein
Reginald K. Franklin
Allan B Friedland
Michael A. Gerber
Ary Louis Goldberger
David Grant
Robert F. Hempton
Ancil A. Jones
Saul Lande

Michael J. Chusid

1972

Olusegun O. Lawoyin

C. Norman Coleman

Robert D. Arbeit

Richard C. Pasternak

1978
Thomas T. Amatruda
Michael J. Anderson

Ralph E Binder

Richard J. Baron

William S. Bush

Joann N. Bodurtha

Rodney J. Butch

Booker T. Bush, Jr.

Brendan Clifford

Duke E. Cameron

Carol L. Kandall

Emilio L. Cruz III

Kevin Kane

Emily A. Fine

Robert F. Malacoff

Eugene Glenn Fong

Hyman J. Milstein

Stuart M. Forman

Mary Jane Minkin

Arthur M. Gershkoff

Robert G. Nankin

Linda J. Hall

Andrew B. Newman

Jerald D. Hansing

Edwin G. Olson

Robert Hershfield

Vivian Reznik

Elizabeth S. Hodgson

Philip J. Rich

Robert L. Kraft

Fred P. Rosenfelt

Cynthia S. Kretschmar

Robert S. Sandler

Michael R. Lerner

Steven A. Schwartz

Kenneth L. Marek

Sydney Z. Spiesel

Noreen F. Rossi

Barbara J Stoll

Sally Rudicel

Mark F. Wheeler

Steven M. Shoum

Henry S. Willner

Donald C. Simonson

David M. Zwerdling

Thomas Joseph Smith

1976
Alfredo L. Axtmayer
John C. Bartlett

Stanley J. Tillinghast
Sharon R. Weinstein
David L. Wessel
Susan Wong

Peter B Bitterman

1979

Alan B. Bloch

Nancy Berliner

Sharon L. Bonney

David A. Brenner

Roger A. Boshes

Ken Burkus

Randall D. Cebul

Stuart L. Bursten

Joseph Ciabattoni

Isabel Cunningham

John D. Clemens

Orlando Fernandez

Mark R. Cullen

Joel I. Franck

Geoffrey Etherington

John Jay Gargus

Leonard Firestone

David E. Golan

Ira H. Gewolb

Bruce Halpenn

Rose Hannah Goldman

Edward C. Halperin

Glenn A. Gorlitsky

Jeffrey L. Kaine

Joel Kabak

Helen H. Kay

Norman V. Kohn

Michael K. Lindsay

William J. Lederer

David E. Ness

William K. Levy

Jean Rosenthal

George W. Luedke

Gary L. Schaer

Douglas G. Mann

Cynthia Anne Sherman

James L. Rosenzweig

Thomas Trumble

Mark C. Ruchman

John T Woo

Susan H. K. Ryu

Jeffrey Work

Lawrence E. Samelson
Richard S. Schottenfeld
John T. Sladky
Bonita F. Stanton
F. Peter Swanson, Jr.
Jacob E. Tauber
Robert F Taylor
Peter M. Ting
John C. Wiles
Carol M. Ziminski

Stephen B. Arnold

Douglas White

1975

Sarah S. Auchincloss

Gregory W. Bartha

Susan Bromberg Schneider

1980
David E. Adelberg
Eduardo Alfonso
Seth Leo Alper
Frederick R. Aronson
David Allen August
Jay M. Baraban
Patricia Church Brown
Michael W. Champeau
Michael M. Chang

1977

Thomas F. Deering

John J Boronow

Jeffrey Neil Dornbusch

Christopher S. Clark

Forrest John Doud

Stuart Brian Dubin

Todd J Garvin

Marybeth Ezaki

Marc F, Glickstein

Susan Firestone

David Jay Goldberg

James A. Fox

Gary I. Greenwald

Julia B. Frank

Mr. George B. Holmes, Jr.

Attilio V. Granata

Jonathan L. Jacobs

Steven R. Hahn

Theodore W. Marcy

Robert W. Hand

Suzanne M. Matsui

Jeffrey Neal Hausfeld

Cesar R. Molina

Bruce L. Innis

Jane G. Schweitzer

Joseph J. Jacobs

John A. Selling

Howard K. Koh

Marcia R. Taylor

Margaret S. McKenna

Walter H. Williams

Robert J. Mitchell
Alan S. Penzinger
Theordore M. Pitts
Leonard A. Rappaport

1981
Cynthia B. Aten
Alicia Barela
Susan Burdette

* Deceased
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Stephen Wilson Burgos
Patricia A. Burke
Marc D. Coltrera
Christine M. Duranceau
Louis Essandoh
Johnathan M. Fine
Paula M. Fracasso
Ramona Q. Fung
Judy E. Garber
Robert S. Goldman
Sol Hamburg
Alan Heimann
Scott A. Hundahl
Robert M. Milstein
Robert B Portney
Barbara A. Roach
Dovelet Shashau
Bernard H P. Shen
Martin H. Teicher
Anthony M. Urbano
Nancy E. Vinton
Aizik L. Wolf
John C. Wong
1982
Sylvia R. Beck
Rise Maura Chait
Richard J. Doan
Keith L. Gladstien
Liba E. Goldblum
Jed B Gorlin
Jessica Herzstein
Daphne Hsu
Henry Jampel
Kathleen Anne Nolan
Joyce A. O'Shaughnessy
Came A. Redlich
Robert J. Rizzo
Robert M. Rohrbaugh
William M. Sikov
Henry J. Stern
Lynn T. Tanoue
Albert L. Ungricht
David A. White
Stephanie Wolf-Rosenblum
1983
John Taylor Adams*
Amos Bodner
Robert E. Bookstein
Elena Citkowitz
Ana Maria Lamas
Adam Lerner
John H. Neal
Dan A. Oren
Augusta S. Roth
Leonard B. Saltz
David E. Schwartz
Michael Silverberg
Daniel M. Sosin
Philip M. Spiro
Kenichi Takeshita
Pamela Leslie Zeitlin
1984
Charles S. Abrams
David 1. Astrachan
John F. Babich
Leonard O. Bell
Barbara Ann Coda
Donald Ingber
Michel Kliot
Jay R. Kostman
Steven A. Porcelli
Paul B Rothman
Andrew L. Sternlicht
1985
David M. A]win
Brian H, Annex
Robert A. Aronowitz
Jaime I. Arroyo
Michael Behrman
Barry D Bergquist
J Alexander Bodkin
Stafford R Broumand
Vance Brown
JoAnne Burger
Jennifer L. Calagan
Jane E. Carter
Peter Chang Sing
•Deceased
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Alice S. Y. Chi
Terri L. Cornelison
Julie Ann Danaherson
Bryan DeSouza
Calixto E. Dimas
Carol F. Farver
Guy Fried
William D. Gaillard
Richard Bruce Garber
Michael W Gilbert
Samuel Goos
Peter S. Greene
Daniel Greenwald
Barbara Guillette
Jacqueline Gutmann
Robert S. D Higgins
Marie Hobart
Victor W. Hsu
Virginia S. Huang
Stuart Neal Isaacs
Darlyne A. Johnson
Michael A. Johnson
Robert Klitzman
Susan Korrick
Shirley J. Lee
Jonathan Lewin
Ronald M. Lisan
Ted W. Love
Jeffrey A. Lowell
Anthony Marks
Elizabeth Mason
Jane Mathisen
Gail Mattson
Kathleen F. Maurer
John Jerome Merendino
Marnin A. Merrick
Brent Moelleken
Susan E. Moore
Jeffrey Morton
Elizabeth G. Moy
Jon Nakamoto
Robert D. Needlman
Lisa Nelson-Robinson
Thomas Newton
Richard George Parker
Leslye C. Pennypacker
Samuel Richard Pesin
Eric Murname Poeschia
Anne Regenstein
Ellen C. Rieur
David J. Roberts
John R Roberts
Paul Roberts
Peter A. Rubin
Richard A Ruiz
Greg A. Sachs
Reginald J. Sanders
Fred Santoro
Edward B. Savage
Joshua D Schor
Sara A. Schutzman
Mark Shachner
Timothy Alan Shapiro
Peter Shile
Collin Smikle
Robert C. Smith
Joshua David Sparrow
Aaron Stone
Timothy H. Tanner
Louis J. Tesoro
Tina N. Tillis
Mark Topazian
Edward S. Tyau
Pablo Vazquez-Seoane
Javier Vizoso
Steven B. Warren
Kimball Woodward
Janet K. Young
1986
Jay Gates

Contributors to the
Public Health Alumni
Fund 1985-86
1921
Ira V. Hiscock*

1922
Alice G. Laanes
1926
John J. Batchelor
1927
Alice S. Baldwin
1930
Ruth E. Grout
Katherine Marden
1932
Leona Baumgartner
1933
Edward B Bosworth
Eunice Nickerson Tyler
1934
Amy H Hunter-Wilson
Iwao M. Moriyama
1935
Franklin M. Foote
Almeda King
1936
M. Allen Pond
1937
Lidie V. Dyer
1938
Willard H Boynton
Richard K. C. Lee
Katharine Hawley Martin
Lucy S. Morgan
Jean H. Nelbach
1939
Carl I. Cohen
James C. Hart
1940
Elizabeth H. Pitney
Ruth G. Taylor
1941
Rosyln L. MacNish
A. Helen Martikainen
Margaret Hyde Moore
Marion Redmond
1942
Leonard Parente
Arthur B. Robins
Charles D. Spangler
1943
Carolyn S. Koffler
Adele P Schlosser
Jane L. White
1944
Jean F. Heston
Jane Y. Parker
1945
Roslyn R. Bilford
Mary B Dale
Naomi Barer Golden
Joe B Graber
Lois M Jund
John C. Potkay
Maxine B Sandison
1946
Dorothy B Hamilton
D. Patricia Nelson
1947
Sidney S. Chipman
Anne E. Fulton
Lillian L. Konick
Raymond W. Leonard
JoAnn S. Lewis
Rosa Frances Montgomery
Paul A. Pamplona
Jean M. Pinder
Cecil G. Sheps
Samuel Zibit
1948
Chester S. Bowers
Mary L. Ellis
Mary Margaret Fitzgerald
Samuel S. Herman

Richard E. Johnson
Beatrice H. Kaasch
Dorothea S. La Belle
Hiram Sibley
1949
Eleanor C. Connolly
Edgar L. Geibel
Hilda H Kroeger
Christine R Owre
William B Parsons
Elizabeth D. Robinton
Mary C. Springer
1950
Henry G. Bnckman
Helen P. Cleary
Austin J. Evans
Jerome M. Glassman
Dorothy R. Granoff
Eugene K. Harris
Dorothy E Reese
Frances K Reynolds
Nathan M. Simon
1951
Joseph Alexrod
Clarissa E. Boyd
Clarence William Bushnell
Norton G. Chaucer
Joanne E. Finley
Florencia M. Herrera
Robert L. Johnson
Leonard S. Krassner
Leonard F. Menczer
Emi T. Rausch
Jessie Parkinson Spear
Angelica Z. Syseskey
Elizabeth Ulrich Throm
Walter Wenkert
1952
Cahit H. Corbacioglu
Howard Dunphy
Joanna Adele Henry
Malcolm C. Hope
Charles Holway Lawrance
Sidney S. Lee
Helen Kardys Loria
Yolande F. Lyon
Richard B. Ogrean
Jeanne Ellen Paty
Anne Barlow Ramsay
Brena B Wolff
1953
Jeannette Averill
Harold Robert Bernshock
Abraham Robert Cutcher
Cecilia Frances Di Cocco
Graydon Dorsch
William H. Hermann
Barbara J Lee
Laurence K. Rainsford
Milton H Sisselman
Constance B. Thomas
Donald N. Zehl
1954
Donald R. Cowan
Cavin P Hatcher
Ruth M. Taber
1955
Constance T. Beemer
Lester M, Bornstein
Charline S. Buck
Amy L. Cawley
Morris London
Mary Me C. Mogan
Frances R. Ogasawara
Gerald Rosenblatt
1956
E. St. George Anderson
David D. Boyd
Lois Blatchford Fuller
Kathleen H. Howe
Paul C. Kaufman
John F. Mullett
Julia R. Nole
Mary K. Ochiai
Floyd D Parrish
Alice M. Wagner

1957
Janet Beach
Lee De Cady
William A. Clermont
Gaston Jules Deslouches
Edward R. DeLouise
Sheldon Selig King
Edna May Klutas
William R Metzger
Jerome R Sapolsky
Shirley T. Steidel
Patricia A. Viscosi
1958
Josephine Blanchett
Helen H. Davenport
Thomas T. Flynn
Normand E. Girard
Philip B. Hallen
Edward H. Noroian
Joseph A. Scorpion
Thomas P. Weil
1959
Cesar A. Aleman
Raymond S. Duff
Bennett I. Enowitch
Folly Hofer
Marvin A. Lavenhar
Hugh J. Maher
Lee J. Podolin
Ellwyn D. Spiker
Mattie Lee D. Wade
Kenneth J. Williams
Dorothy M. Wilson
1960
Bruce A. Barron
Thaddeus B Curtz*
Kathryn L. D'Amico
Wouter Ekker
Maxine Geeslin
Rose A. Iannotta
Katharine Anna Keppel
Lowell Stern Levin
Vatividad A. Ngo
R. John C. Pearson
Hannah Clark Russell
1961
Gordon R. Beem
Martin Donabedian
Alfred E. Fletcher
Helen M. O’Connell
Margaret P. Parker
Joseph T. Prekup
William R. Slivka
Harold W. Wicks
1962
Richard B Blakney
James E. Bowes
Thomas R. Mayhugh
1963
Dorothy Weichert Brockway
Raul R Cuadrado
David Dolins
Frank M. Isbell
Edward M. Kenney
Jean M. Maynard
David R. Sheehan
Samuel B. Webb, Jr.
1964
Maria S. Baisier
Bartley H. Calder
Katherine Maria Detre
Carole S. Profant
Theodore Rosenberg
Estelle Siker
Monroe W. Spero
Claudell Sidney Thomas
1965
Robert M. Edwards
Monte Nelson Frazier
H. Patterson Harris Jr.
James F. Jekel
Michael E Kove
Peter J. Levin
Elliot A. Segal
Viola J. Spinelli
David S. Weiner

1966

Allen Cohen
Anne B Collart
Amalia P. Crago
Dorothy Noyes Kane Evans
Diana B. Fischer
Jennifer L. Kelsey
Robert C. Lowrie
1967

Peter T. Elliot-Wotton
Caroline Fong-Cheng
Ann Gomez
Alice Ipsen
Steven Jonas
Joel Kavet
Elisabeth Mueller Mahjoub
Particia D. Mail
James M. Malloy
Brigitte Prusoff
Bruce Steinhardt
Beth M. Whelan
Irma Willner
1968

Richard W. Ashton
Philip D. Cobb
Sonia M. Colon
Joseph L. Dorsey
Robert R Everett
L. Carol Fernow
Carl R. Fischer
Francis J. Greaney
Chester H. Johnson
Susan F. Klein
R. Elizabeth Leif
Jean C. MacCorison
Robert F. Monsse
John M. Patton
Richard L. Petrelli
Arnold R. Saslow
Doreen P. Sharabati
Elizabeth A. Small
Martha F. Steel
Sheila W. Wellington
Elizabeth C. Wright
1969

Susan S. Addiss
Janet A. Albrecht
Victor Crown
James M. Dawson Jr.
Sharon A. Garcia
Gerald R. Harpel
Sylvia N. Holtzberg
Charles C. Jeffrey
Samuel P Korper
Samuel D Rowley
Marva Serotkin
Wanda Vierthaler
Robert L. Young
1970

Frederick G. Adams
Susan W. Balter
Robert T. Beeman
Michael B. Bracken
Hamilton B. Brown Jr.
Shan Cretin
Sabina M. Dunton
Ruth C. Edelson
Walter M. Gawlak
Robert S. Gureasko
C. P. Noel McCarthy
Peter Orris
Charlotte F. Schwartz
Carol B. Von Stein
Donald S. Wilkinson
1971

Evarists Berzine
John Bihldorff
Evelyn J. Bromet
William F. Carey Jr.
William Cates Jr.
Katrina H. Clark
John A. Daeley
Harvey Fernbach
William P Ferretti
Dennis R Hamilton
Sara P Hartman

Wanda J. Hatmaker
Mohamed Ismail Johnson
William P. Koughan
Bernard G. Koval
Catherine S. Lindenberg
Mark J. Magenheim
Joan L. Martinez
Eugene S. Mayer
Joseph S. McManus
Nancy P. Mogielnicki
Lloyd F. Novick
Wan Hin Ooi
David A. Osgood
Carol L. Paul
Jane Silver
Walter O. Spitzer
Dr. Robert E. Steele
David L. Stockton
Claudia J. Svara
1972

David P. Barone
Catherine A. Connolly
Paul Finlayson
Daphne deJ. Gemmill
Dorothy N. Lewis
Sergio Ruschel
Jo Ann K. Silverstein
Laurence A. Tanner
1973

Emily M. Barclay
Edward J. Bernacki
Eva Danielsson Cohen
Ellen B Doft
Helen B. Hubert
Chang S. Lao
Dennis P. May
Dwight N. McNeill
George A. Million
Maijorie E. Nelson
Gary Dean Sax
Janet B. Schoenberg
Alice S. Stark
Thomas J. Stranova
Irene Trowell-Harris
Larry S. Webber
Bonnie C. Yankaskas
Carl J. Zack
1974

Gregory Belok
Thomas A. Benoit
Ian B Berger
Olga M. Brown
Carl A. Cappello
Stanley E. Kilty
Kirby O. Kloter
Roberta Lawrence
Karen K. Lindfors
Nancy F. Meneely
U. Robert Merikangas*
Evelyn B. Mostow
Nils Richardson
Carol T Schreiber
Shelley S. Shanok
Abigail L. Smith
J. Lawrence Tanenbaum
Myrna M. Weissman
1975

Clayton A. Ajello
Edith N. Baum
Ralph E. Binder
Linda K Broker
Ann C. Cunningham
George R Curry
Hillary Demby
Linda K. Demlo
Susan T. Gershman
William J. Grego Jr.
Anne H. Hall
Elizabeth T. Hunter
Susan M. Kaetz
Philip D. Kennedy
James E. Knoben
Kathy S. Kohn
Nancy J. Kreiger
Stewart L. Lefkowich
Laurence F. McMahon Jr.
Lois S. Michaels

Edward J. O’Neill
Mary W. Palshaw
Dale P. Sandler
Edward V. Sargent
Audrey Weiner Solomon
Nancy E. Stroup
Franziska U. Ulrich
Vera B. Walline
1976

France L. dePeyster
Peter B. Aaronson
Elaine P. Anderson
Joanna M. Erikson
Paul H. Etkind
Annette B. Garofalo
Gail lies Genvert
Linda J. Good hart
Karen A. Gordon
Frances Anne Kanach
Robert T. Kauer
Cleve Lee Killingsworth
Janina Levy
Robert C. Marquardt
Lawrence V. Meagher Jr.
Ruth Fitch Quah
James B. Rokos
Robert Risdon Schwarz
Mary Jo Shepard
Gladys A. Williams
Thomas S. Wingardner Jr.
1977

Richard B. Burford
Patrick F. Carone
Bruce D. Cummings
Annette T. Eichenbaum
Gerard J. Foley
Henry C. Gift
Travis K. Hedrick
Ellen D. Jaslow
Rhona Kantor Kershnar
Teri J. Klein
Ronald F. LaPensee
Wendy K. Lefkowich
Polly W. Marvin
Kristin K. O’Connor
Harris Pastides
Linda Mendelsohn Pottern
Dorothy A. Rice
Lynne E. Rosenwald
Abby Rothschild
Anthony V. Sardinas
Carroll Schilling
Barbara G. Smith
Gail M. Sullivan
Thomas H. Ulfelder
Leon F. Vinci
1978

Kathleen M. Berman
Maura Carley
Robert J. Fensterheim
Ann T. Freedman
Janice F. Gold
Cynthia R. Gross
David W. Houck
Margaret Long Karis
Roslyn I. Liss
Christopher M. Maylahn
H. James Myers
Marguerite Nelligan
David W. Osborne
Elizabeth L. Pantelick
Trudee Parenteau
Ellen D. Rothberg
Karen C. Schneider
Michelle D. Schoenberger
Robert E. Schwartz
Robert Jo Shapiro
Gloria Shappy-Meickle
Roberta Nancy Silbert
Alan J. Siniscalchi
Marie Stoeckel
Bernadette S. Vissani
R Bradford Walker
Lucy Ellen Weiger
1979

Virginia P Bainbridge
Gertrud S. Berkowitz

Marianne Berwick
Joann N. Bodurtha
Susan De Renzo
Terry Edelstein
Kathe P. Fox
Judith B. Gancher
Candice C. Haslegrave
Bruce H. Heckman
Shelley Helfer-Amira
Karen Kmetzo
Paul Anthony Kowalski
Benjamin Krevsky
Renee S. Leary
Mary Elisabeth Lorenzi
Osvaldo Marrero
Patricia J. Moore-Pastides
Laure C. Nichols
Catherine Hobbins Norton
Dolores Perteet
Betty J. Reid
Marcia C. Richardson
Lisa K. Rosenfeld
Elisabeth Luttgens Santulli
William E. Schweizer
Audrey P. Silvey
Ilene B Wachs
Louise Wise
1980

Philip R. Aaron
Frederick R. Aronson
Curtis S. Breslin
Richard L. Buck
Anne Morrison Danaher
Alfred E. Fasulo Jr.
Ellen B. Greif
Samuel S. Hamilton
James P. Harisiades
Virginia S. Humphrey
Johanna C. Hunt
Helen E. Kelly
Yee-Lean Lee
Robert V. Levin
Leroy F. Ludwig
James S. Marks
Jane Ungate O’Connor
Ann L. Prestipino
Christie Michele Reed
Jeri Ann Rose
Kathleen M. Scribner
Lydia A. Selling
Jane T. Siegal
Marsha L. Silverman
Judith Stavisky
Thomas A. Tobin
Gary F. Velat
Rhona Weiss
Carolyn K. Wells
1981

Charlotte Abrams
Jean Adnopoz
Nancy R. Angoff
Donna A. Brenn
Rebecca L. Calderon
Patricia J. Checko
Rollin C. Chew
Angelo J. De Vita
Julia Eisenstein
Kristen H. Forrest
Richard T. Forsley
Judy E. Garber
Barbara A. Gaugler
Marie F. Gavula
Louis M. Gonzalez
Joan Urquhart Goodman
Gerlinde B. Hermann
Sondra L. King
Jill L. Lapides
Katherine M. McCormack
Marlee D. Mooney
Howard J. Newman
Mary E. Papke
Gerald W. Robinson Jr.
Elizabeth N. Shapiro
Nancy Schlesinger Weiss
Kathleen R. Yager
John A. Yopp

1982

Jamie L. Amaral
Francis L. Crowley
Cyndie B. Gareleck
Meryl Beth Gold
James L. Hadler
Denise Heinemann
Constance M. Jarowey
Leonard Kalm
Charles A. Klivans
Ann Storms Kloter
Kevin R Lucey
George J. Mandes
Linda F. Me Caig
William F. McKeon
Jean L. Milton
Carolyn Xavier Orcutt
Marie Zullo Rice
Sally R. Rinaldi
Christopher J. Rogers
Dale Allan Rublee
Carol L. Vander Wal
Michele T. Visconti
Sandra Michaelson Warren
Alvin C. White
1983

Gail Alexander
Eileen Conlon
Mark L. Dembert
Robert A. Duncan
D. J. Safiya Edwards
Susan Faris
James N. Gaito
Ellen M. Ginzler
Daniel A. Graybill
Jeffrey B. Hughes
Nancy R. Kellett
Margaret M. Kolb
Allen F. Levy
Cynthia M. Maglaque
Wendy L. McGill
Scott K. Mock
Judith F. Nelson
Suzanne Nutt
Jeannee M. Parker
Nano F. Rush
Marilyn F. Vine
Mara Weiss
1984

Anthony John Alberg
Linda Balzano
Marisa B. Barr
John R Beecher
Georgia K. Berman
Carolyn H. Grantham-Millman
Kim S. Griswold
Penny H. Hausser
Mehrdad Jalai
Robin B. Kupfer
Jean G. Larson
John Andrew Lutz
Julie A. Russem
Gerald L. Springer
1985

Priscilla H. Adams
Theodore W. Bernstein
Anne T. Cadigan
Carl David D’Ruiz
Kathy H. Davidson
Grace P. Erickson
Jerald A. Fagliano
Barbara K. Gottlieb
Denise L. Jacobson
Merian D. Klein
Emily M. McClure
P. Douglas McConatha
Katherine L. Santella
Shirley J. Tirrell

Contributors to the
Public Health Alumni
Fund 1985-86
Friends
Horace Mazzone
John Meigs
Colin White
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Contributors to the
Medical School Alumni
Fund 1985-86
Former House Staff
Jannice Aaron
Robert A. Achtel
Frederick W Ackroyd
N. Erick Albert
John L. Albrigo
Neil S. Alex
Adel H. Ayoub
Robert G Bachand
Ronald J. Bailey
Arnold M. Baskin
Carl Bennet Bean
Gregory Kent Bergey
Larry Berte
Mary C. Bibro
Ralph Daniel Bien
Jacques L. Bonnet-Eymard
William K Boss
Alan L. Breed
David Brigati
Steven A. Brody
Marvin B. Brooks
Thomas N. Byrne
Daniel Cahill
Dennis J Card
Richard S. Casden
J. Richard Casuccio
Joseph B Chandler
Whei C. Chang
Richard Allen Chase
Ryszard Chetkowski
Chang Song Choi
Leo J. Clark
Mark G. Coan
lan M. Cohen
David L. Copen
Robert E. Crootof
F. Mitchell Cummins
Harvey Davis
Muichael Martin Deren
Richard K. Donabedian
William R Drucker
Marlene R. Eckstein
Stephen A. Edelstein
David E. Eibling
Lawrence B Eisenberg
Leslie Elfenbein
Malcolm Mitchell Ellison
Daniel Epstein
Walter Ettinger
Charles Farrow
Alvan R. Feinstein
Robert A. Feldman
Richard Webster Finner
Bruce T. Fletcher
John N. Forrest
Daniel J. Friedenson
Gary E. Friedlaender
Norman H. Gahm
David M. Gershenson
V. Philip Glassman
Barry Goldberg
Nelson H Goldberg
John W. Goldkrand
Isaac Goodrich
Richard Reed Gramse
Willard F. Greenwald
Gordon W Grundy
Joseph Guaraldo
Stephen F. Gunther
Seymour Haber
Hedda Ann Litowitz Haning
Stanley Hersh
Thomas P. Higgins
Douglas P Hobson
Melvin Horwitz.
David Smith Hubbell
Eric A. Hyson
Robert Orville Jensen
Robert M. Johnston
Norman Kaplan
Jill P. Karpcl
David J. Keller
Stephen King
•Deceased
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Samuel C. Klagsbrun
Lawrence E. Klein
Richard Knobelman
Thomas J. Koontz
Jeffrey Kotzen
Eugene Kuchner
Joel C. Labow
Sheri J. Lagin
Emmanuel Landau
Joan L. Lasser
Paul Julius Laube
Douglas M. Levin
Stanley B. Levine
Arthur L. Levy
John D. Lewis
Joseph W. Lewis
John A. Libertino
John Loeffler
Jose Manuel Losada
Genevieve Losonsky
Glenn Lytle
Steve Macht
Mark Maltzer
Abraham Mandel
Stephen Mariam
Frank Masino
Richard J. Maunder
Pamela M. McBogg
John P McGovern
Thalia Mesologites
Lawrence 1. Michel
Patrick E. Moriarty
Dominic J. Nardi
Seymour Cy Nash
George Nichols
Gwedolyn B. Nichols
Richard A. Norton
Joseph Manuel Ortiz
Raymond L. Osborne
Robert L. Paltzik
Elaine Begum Panitz
Gilbert A. Ratcliff
Ranjit Rath
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DEAN: COMMITTED, BULLISH ON
YALE SCHOOL OF MEDICINE
Editor’s note: Shortly after Dr. Leon E. Rosenberg became
Dean of the Yale School of Medicine in July 1984, he addressed
the faculty on the “state of the school.” Now, YALE
MEDICINE has asked Dean Rosenberg to pause and make
some observations on the school today for alumni.

YALE MEDICINE: You have served as Dean of the Yale
School of Medicine for nearly three years. In retrospect, what
have been the greatest “challengesfor change?”

DEAN: The greatest challenges the school has faced during the
past 2Vi years have related to the clinical departments. That is
not to say that the school can take for granted its basic science
departments where we are strong across the board, and second
to none. This strength must be preserved and enhanced, while
we address a number of challenges in the clinical departments.
First and foremost of these is the recruitment of new chair¬
men. In 2Vi years, we have recruited new chairmen in dermatol¬
ogy, neurology, surgery, psychiatry and orthopaedics. We are
currently seeking new chairmen in internal medicine, pediatrics
and diagnostic radiology. Thus, within the five-year term of my
deanship, most of the clinical department chairmanships will
have turned over.
This represents a profound change in the school’s leadership
and a profound challenge to the administration. I have spent
more time on these recruitment efforts than on any other single
item of the school’s agenda; that is as it should be because our
chairmen set the tone, shape the faculty and fashion the
priorities for their respective areas.
But the challenge for change in clinical medicine goes
beyond the recruitment of new chairmen. The entire fabric of
clinical medicine in the United States is undergoing an up¬
heaval, and academic medical centers are certainly not insulated
from the tumult.
Our country has become enormously worried about health
care costs; this has resulted in an increasingly tight embrace of
medicine by laws affecting every phase of clinical practice. For
example, enormous pressures exist to take care of patients as
outpatients rather than in hospitals, yet hospitalized patients
have been the bulwark of clinical teaching programs in the
United States for the last 40 years.
We must find new settings in which to educate third- and
fourth-year students; such settings include health maintenance
organizations (HMOs) in the city of New Haven (such as the
Yale Health Plan and the Community Health Care Plan), private
offices of physicians who have clinical faculty appointments in
the school, and the hospitals in Connecticut with which we have
affiliation agreements.
Another major issue we’ve been addressing concerns the

need to increase the commitment of our full-time faculty to de¬
liver outstanding tertiary care. I wish to see the Yale-New
Haven Medical Center become the pre-eminent medical center
between New York and Boston. Only in this way will we bring
research and teaching in the clinical departments to the high
level currently achieved in our basic science departments.
Finally, we must redouble our efforts to educate humane,
ethical, responsible physicians whose primary commitment will
be to serve the public interest—not their own private interests
or those of organized medicine. Only in this way will we reverse
the national trend to humble physicians.

YALE MEDICINE: We have heard controversial reports
about the national health manpower situation and the “doctor
glut.” Does the School of Medicine have a position on this
issue, and does the school contemplate changes in class size?

DEAN: No medical school can fail to be concerned about the
oversupply of physicians and the decreasing number of young
people who are applying to medical schools. In the past seven
years, we have seen a 20 percent fall in the number of applicants
to the Yale School of Medicine. Therefore, we are experienc¬
ing—just as every other medical school is—the realization that
young people today do not see medicine as attractive a career
as they once did.
The question facing the Yale School of Medicine is whether
this demographic information should push us to decrease our
class size. Even though the total number of applicants has de¬
creased, we still receive more than 2,300 applications for 102
places in our incoming class, and we are still attracting as out¬
standing a group of future physicians as we ever have; that is,
we’ve seen no fall off in the quality of our students. For that
reason, we do not believe that we must reduce class size in order
to maintain quality standards.
Nonetheless, there is some pressure to reduce class size in
order to demonstrate in the only clear way we can that we are
concerned about an oversupply of physicians. For the present,
we have decided not to change class size simply to send a
“signal.”

YALE MEDICINE: Have medical students and their
academic qualifications and career goals changed perceptibly
during the past 25 or 30 years?

DEAN: As I just said, we have not seen less intelligent, humane
or committed people going into medicine, but certainly career
goals have changed.
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More of our students are interested in careers in such special¬
ities as anesthesiology, ophthalmology, radiology and or¬
thopedic surgery; fewer of our graduates are interested in pri¬
mary care fields, such as internal medicine and obstetrics. In
part, career decisions reflect economic opportunities and the
cost of medical education.
Eighty percent of our students graduate with significant
debts—the average debt currently being $39,000. It seems un¬
avoidable that this amount of indebtedness already has affected
career plans of some students; and if indebtedness increases, it
will affect career plans of even more students. That is why we
are working so hard to provide more loan and scholarship assist¬
ance to students.

YALE MEDICINE: Would you please comment on the in¬
creasing number of women and minority group students in the
School of Medicine today and their experience here?

YALE MEDICINE: The senior thesis has been a Yale tradi¬
tion. Is the discipline of research today just as strong in
Yale's training of medical students? If so, could you cite some
examples.

DEAN: The commitment to acquire and disseminate new infor¬
mation remains as central a mission to the School of Medicine
as it has ever been. That commitment is present at every level
of the institution, including the medical students.
We are proud of our tradition of requiring a thesis for every
graduate of the School of Medicine. We are making every effort
to strengthen the thesis requirement. Recently, a thesis subcom¬
mittee of the curriculum committee has been appointed to moni¬
tor and administer the thesis program. This year, for the first
time, student research day will include a large poster session for
all interested students as well as the traditional platform presen¬
tations by prize-winning ones.
We are also trying to identify more funds to support students
KF.NNF-TH ABBOTT

DEAN: The medical school has been attracting more and more
qualified women; and they now comprise 30-40 percent of the
incoming class annually, and this has been the case for the past
five years. In my judgment, it will not be long before 50 percent
of our student body will be women, and then the gender issue
in medical school enrollment will become moot.
Approximately 15 percent of our class is composed of fine

students from minority backgrounds: black, Hispanic and
Oriental. We work hard to find and recruit outstanding members
of minority groups because the national pool is small and com¬
petition is keen. It is very important to our country that an in¬
creasing number of black and Hispanic physicians be trained;
Yale is committed to this effort.
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Speaking at the Magnetic Resonance Center dedication in mid- November, Dean Leon E Rosenberg said the new technology will
be used "to answer fundamental biologic questions, as well as to provide new diagnostic capabilities."
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doing research. In addition to providing summer stipends for an
increasingly large number of students, we recently have ob¬
tained funds which enable 12-14 students annually to take a full
year out of the traditional four-year curriculum in order to do
research with a faculty member in the School of Medicine. We
have also obtained a training grant from the National Institutes
of Health to support student research.

YALE MEDICINE: Many exciting developments in the
biomedical sciences are occurring very rapidly. In what areas
are Yale medical researchers making contributions?

DEAN: If I were to answer that question in detail, it would take
a tome to do so. We have outstanding researchers in many areas
of the basic and clinical sciences.
Perhaps it is more appropriate for us to ask if there are areas
where the Yale School of Medicine is not as strongly rep¬
resented as it would like to be in research. I can think of a few
such areas, and we must do something about them. We are not
as prominent in AIDS research as we should be, nor are we as
strong in molecular oncology or microbiology. These and other
areas will be emphasized in faculty recruitment efforts.

YALE MEDICINE: The medical school has several construc¬
tion projects in various stages. Could you give us a brief update
on them?

DEAN: It’s nice to be able to talk about buildings that are going
up because they signal a sense of growth and vitality.
• We have just dedicated the Magnetic Resonance Center, a
joint undertaking of the School of Medicine and Yale-New
Haven Hospital. I believe it is the finest center of its kind cur¬
rently in the country today.
• We are two-thirds of the way toward completing the Yale
Clinic Building, which will be devoted to the full-time facul¬
ty’s efforts in treating ambulatory patients. Before the end
of this calendar year, that 90,000-square foot building will
be in full operation. Finally, management of ambulatory pa¬
tients by full-time faculty physicians will be coordinated in
a group-practice setting worthy of this institution.
• Demolition is about to begin in preparation for construction
of the new Yale Psychiatric Institute. We hope to have the
YPI back on campus within 24 months, and that will be an
exciting addition to both the clinical care and the educational
components in psychiatry at the school.
• Planning for the new library addition has advanced. We anti¬
cipate that during the next three months ground will be bro¬
ken for this major expansion of the library, thanks to the
magnificent gift from Betsey Cushing Whitney and her
family.
By 1989, the medical school will have a vanguard library
with expanded reading room facilities and significantly in¬
creased amount of computer capability for information re¬
trieval. This will provide us with a library commensurate
with the skill and aspirations of the school’s scholars.
• Finally, and as close to my heart as anything in my deanship,
is the Center for Molecular Medicine, a joint enterprise of
the School of Medicine and the Howard Hughes Medical In¬
stitute. We hope to break ground in November 1987 for that
building, which will be located immediately adjacent to the

Hope Building along Congress Avenue. The building will
consist of four floors of new research laboratories, each or¬
ganized along programmatic themes. One program will be
directed toward molecular genetics, a second toward
molecular neurobiology, a third toward molecular oncology,
and a fourth program has yet to be named. The genetics and
neurobiology programs will be supported by the Howard
Hughes Medical Institute; the other two will be supported by
Yale-acquired funds.

YALE MEDICINE: Along with the Medical School Develop¬
ment Office, you have been working diligently to meet the goals
of the Capital Campaign. What have been some of the greatest
successes during the campaign?

DEAN: Within a 2‘/2-year period, we have come well more than
halfway toward the campaign’s stated goal of raising $125 mil¬
lion for the School of Medicine. At latest count pledges and re¬
ceipts total almost exactly $ 100 million.
Among the largest gifts have been those from Betsey Whit¬
ney, the Howard Hughes Medical Institute, Irving and Neison
Harris and Mr. and Mrs. Adrian C. Israel. It is heartening to
see the number of friends, alumni and organizations that have
contributed to the campaign.
This support makes us feel cautiously optimistic that we can
achieve the goal of raising $125 million. The acquisition of
those funds is vital to the school’s remaining one of the truly
great, research-intensive schools of medicine in the world. I
hope the alumni know how much we need to strengthen the
financial base of the school. The Yale School of Medicine has
the smallest endowment of the top 10 medical schools in the
United States; that must be addressed.
In fact, endowment funds have been the most difficult to raise
thus far. We will almost certainly meet our goals in acquiring
funds for buildings and for research programs, but we are only
about 25 percent of the way toward meeting our goal in identify¬
ing new endowment funds. This must be the major emphasis for
the remainder of the campaign.

YALE MEDICINE: In conclusion, do you have any other
general observations about the state of the Yale University
School of Medicine?

DEAN: When I took this job, I was bullish on the School of
Medicine and on Yale University. I may be a little sadder and
wiser than I was then, but my commitment and my bullishness
have not diminished a bit. I continue to believe that this is a great
school in a great university, and I continue to believe in
medicine, despite the many challenges facing it. We must aspire
to be even greater as we address the enormous opportunities and
equally enormous problems in our field—which, I hope, is still
acalling.
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YALE RESEARCHERS LOOK
BEYOND CLICHES OF AGING

It’s a fact: more of us are getting—and staying—old than ever
before.
Half of all human beings who have ever lived are now alive.
According to the U.S. Bureau of the Census, an estimated 35
million Americans will be over 65 by the year 2000. Between
2000 and 2050, as "baby boomers” enter their mid-60s, the el¬
derly population is expected to nearly double to include more
than 22 percent of the total U.S. population.
Not only has life expectancy increased, but people also are
living healthier as they age. Medical researchers who once
believed chronic illnesses and disabilities to be a normal and
irreversible part of the aging process now know that with pre¬
vention and treatment, people can live rich, active lives well
into their 80s and beyond.
At Yale, gerontology is a multidisciplinary concern.
Throughout the School of Medicine, researchers are challeng¬
ing stereotypes of aging and making profound new discoveries
that hold the promise of improved health care and quality of life
for all. What follows is only a sample of that work.

BASELINE EPIDEMIOLOGY
Although the elder population explosion began in the mid1960s, it didn’t capture the attention of the public—and the
medical establishment—until several years later.
“Most epidemiologic studies, until very recently, have char¬
acteristically looked at people from 18 through 65,” says Dr.
Adrian M. Ostfeld, the Anna M. R. Lauder Professor of
Epidemiology and Public Health at the School of Medicine. Dr.
Ostfeld says interest shifted when the 1970 census data showed
a growing population of elders and a rapid drop in deaths from
heart disease and stroke.
In 1971, Dr. Ostfeld and Stanislav V. Kasl, Ph.D., professor
of epidemiology, received major funding from the National
Institute on Aging to study the health effects of forcing el¬
derly people to move from their homes.
Now, Dr. Ostfeld and LisaF. Berkman, Ph.D., associate pro¬
fessor of epidemiology, are co-principal investigators for the
Yale Health and Aging Project, part of an NIA benchmark study
entitled “Established Populations for Epidemiologic Studies of
the Elderly” (EPESE). NIA published the first phase of the lon¬
gitudinal study, the Resource Data Book, last December.
Under the direction of Dr. Ostfeld and Professor Berkman,
School of Medicine researchers have gathered baseline data

Phyllis Joffe is writer, broadcast specialist for the School of Medicine
Office of Public Information.
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since 1982 on more than 2,800 New Haven residents, ages 65
and older. Similar work has taken place in East Boston. Mass.;
Iowa and Washington Counties, Iowa; and Durham, N.C. The
Yale Health and Aging Project received $2.5 million for the
New Haven research. The entire national project is funded until
1988.
The EPESE project is expected to identify predictors of mor¬
tality, hospitalization and placement in long-term care facili¬
ties, and it will study risk factors for disability and chronic
diseases in the elderly.
“The data book enables us to move from caricature, conjec¬
ture and stereotype to having hard information,” says Dr.
Ostfeld. “It provides us with baseline characteristics of some of
the major economic and social problems of older people....It
will enable us to determine how disability, disease, and social
and economic characteristics interact.”
Dr. Ostfeld believes that the EPESE data also will prove valu¬
able in the development of future public policy and services. “I
anticipate that relatively soon, we'll be developing publications
on what factors cause people to enter nursing homes and how
we might plan wisely for their rate of entry. When we begin to
understand more about how ways of living influence survival,
we will be in a position to develop more rational programs to
help older people prolong their lives.”
Unlike most prior studies on aging, EPESE is communitybased. This distinction is important, says Professor Berkman.
"Most previous studies have been on very selected populabill carte-:r

by Phyllis Joffe

Dr. Adrian M. Ostfeld, the Anna M.R. Lauder Professor of
Epidemiology and Public Health, and Lisa R. Berkman, Ph.D.,
associate professor of epidemiology, are principal co-investigators
on a benchmark NIA study on aging. Since 1982, they have gathered
baseline data on 2,800 elderly New Haven residents. The data
disputes many stereotypes of old age.

tions—people in nursing homes, people who are volunteers or
are highly successful. But until now, we’ve had very little idea
about how most of the people who are over 65 are living.
“When you look at older people who are living in a communi¬
ty, some of the stereotypes change. For instance, most of the
people we interviewed maintained high levels of functioning,
most led independent lives, most were able to take care of them¬
selves, and most were able to be quite physically active and
mentally alert.”
For example, 90 percent of those studied in New Haven were
able to walk and bathe without assistance. Twenty percent re¬
quired help getting from a bed to a chair, getting out of bed or
dressing, whereas only about two percent needed help in toilet¬
ing, grooming and eating.
Even when disabilities exist, they may not be permanent. Ac¬
cording to the Yale team, some people who were function¬
ally disabled when first interviewed at baseline in 1982 had
recovered from their disabilities a year later.
Says Professor Berkman: “This stands in contrast to the kinds
of studies that have been done before where you only look at
people on this kind of inevitable, downward course. So while
people do change, and obviously people do change for the
worse, they also change for the better.”
Whereas nursing home studies have tended to conclude that
“older people are frail and unable to maintain many of their abil¬
ities over a long time,” she says, the NIA data indicates that this
is only true for some large segment of those over 85 in the popu¬
lation. Rather, elders are a far more heterogeneous and produc¬
tive group than stereotypes indicate.
“By and large,” says Dr. Ostfeld, “people in their late 60s,
early and middle 70s, are able to attend all the meetings, do all
the work, stay in touch and be completely responsible in getting
any kind of job done that doesn’t require a great deal of muscle.
From the middle 70s to the middle 80s, people are able to do
a reasonable day’s work at most things, most of the time.”
Professor Berkman and Dr. Ostfeld say they hope the EPESE
data will help health care professionals look beyond accepted
stereotypes of aging. “We need to separate things that are usual
or expected changes of aging from common diseases that can
be treated,” says Dr. Ostfeld.
The EPESE data has become a resource at the School of
Medicine for other research on aging. As one of 15 researchers
on the MacArthur Research Program on Successful Aging, a
national project supported by the John D. and Catherine T. Mac¬
Arthur Foundation, Professor Berkman is using the EPESE co¬
hort to determine the factors that make people age successfully,
both physically and psychologically.

CLINICAL STUDIES
With funding from the Robert Wood Johnson Foundation, Pro¬
fessor Berkman and Dr. Leo M. Cooney Jr., associate professor
of medicine and a 1969 medical school graduate, are conducting
an EPESE substudy on factors that predict recovery from illness
among elders.
Dr. Cooney is director of the Yale Program in Geriatric
Medicine, which has developed an extensive clinical base that
serves as a resource for teaching and collaborative work. The
program includes an inpatient geriatric rehabilitation unit and
the Geriatric Assessment Clinic at Yale-New Haven Hospital;
medical directorship of a nursing home; and a geriatric evalua¬
tion unit, rehabilitation unit and outpatient geriatric clinic at the
West Haven Veterans Administration Medical Center.

Other faculty members in the program are Drs. Mary E.
Tinetti, Ronald L. Miller, Gail M. Sullivan, Sharon K. Inouye
and Margaret A. Drickamer, all assistant professors of
medicine.
In collaboration with Robert Fetter, the Harold E. Hines Jr.
Professor of Health Care Management at the Yale School of Or¬
ganization and Management; and Brant E. Fries, Ph.D., of the
University of Michigan School of Public Health, Dr. Cooney
developed Resource Utilization Groups, a method of classify¬
ing long-term care patients according to their needs. This sys¬
tem now serves as the method for nursing home reimbursement
in New York State and in Veterans Administration facilities
throughout the country.
Dr. Tinetti’s research on the problems of falls among the el¬
derly includes the development of a predictive index that will
assist in fall prevention. The Robert Wood Johnson Foundation
provided funding for this work, which was the basis for a Na¬
tional Institute on Aging Academic Award recently granted to
Dr. Tinetti.
Together with Dr. Ostfeld and Dr. Alvan R. Feinstein, pro¬
fessor of medicine and epidemiology. Dr. Tinetti also has been
studying the effects of falls on participants in the EPESE cohort.
Dr. Miller organized a collaborative effort with the infection
control nurses in 28 nursing homes to study the true complica¬
tion rate in nursing homes of indwelling bladder catheters. This
group also has agreed to work with Drs. Tinetti and Miller to
look at the risks and benefits of using common nursing home
interventions, such as restraints, for patients with multiple
illnesses.
“The differences among nursing home patients, the multiple
reasons for using an intervention, the difficulty in separating the
effects of the intervention from the effects of the patient’s pre¬
existing health status, and the lack of clear-cut outcome mea¬
sures render the usual intervention research techniques inappro¬
priate for nursing home patients,” says Dr. Tinetti.
Drs. Cooney and Feinstein are attempting to identify some
predictors of nursing home care needs for hospitalized elderly
patients. They have developed an index that will predict the
need for care at home and for nursing home placement, with the
particular goal of identifying those patients who would benefit
most from aggressive intervention designed to prevent nursing
home placement.
In the area of basic science research. Dr. Cooney and Nanne
Scholhamer, social worker for the Geriatric Assessment Clinic,
have developed a program with Dr. Elias E. Manuelidis, profes¬
sor of neuropathology(surgery) and neurology, that enables pa¬
tients’ families to have postmortem examinations done on the
brains of Alzheimer’s disease victims. More than 40 examina¬
tions have been conducted thus far.
At the West Haven VAMC nursing home unit. Dr. Drickamer
has been studying the use of functional assessment in setting
goals and planning for care of elderly nursing home patients.
Also at the VAMC, Dr. Sullivan is investigating the problem
of iatrogenic illness in the elderly, and Dr. Sharon Inouye is
looking at the complications of various investigative procedures
in elderly patients.
Says Dr. Cooney: “All of these geriatric program research ef¬
forts are examples of the information that can be obtained from
the close cooperation of clinicians—who are involved in the
day-to-day problems of the frail elderly—and clinical and basic
science investigators.”
In a separate but relevant project, David A. Pearson, Ph D.,
research scientist and associate dean for public health; and Dr.
Walter Hierholzer Jr., professor of medicine and epidemiology
5
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and YNHH epidemiologist, epidemiology and infection con¬
trol, are conducting an 18-month collaborative study on nosoco¬
mial (institutionally induced) infections in nursing homes. The
research is funded through a contract from the Centers for Dis¬
ease Control.
The CDC estimates that nosocomial infections already cause
more than 20,000 deaths and contribute to an additional 60,000
in hospitals each year. Although the annual indirect cost of
treating these infections is thought to be around $2.5 billion for
hospitals alone, little is known about the scope of the infections
in nursing homes.
The Yale researchers plan to define the risks, identify priority
areas and develop guidelines for preventing nosocomial infec¬
tions in the nation’s 18,900 skilled nursing homes. This is the
first study of its kind in the country, according to the CDC. The
findings are expected to be available early in the fall.

SYSTOLIC HYPERTENSION
Octogenarians and their elders make up the fastest-growing
population group in the United States. They also have the high¬
est incidence of isolated systolic hypertension (ISH), a condi¬
tion characterized by systolic pressure elevated to more than
160 mm Hg, while the diastolic remains in the normal range of
less than 90 mm Hg.
In the population at large—excluding the elderly—eleva¬
tions of systolic pressure in the absence of elevated diastolic are
unusual. So, although ISH is now estimated to affect more than
three million Americans over age 60, relatively few studies
have looked seriously at the condition.
“In the past, no American trials of hypertension treatment
studied anybody who was older than 69 years of age when the
study began. Furthermore, no one has ever looked at whether
or not we should treat isolated systolic hypertension, in this or
any population,” says Dr. Henry L. Black, associate professor
of medicine and director of the hypertension service at YaleNew Haven Hospital. “We have many very healthy elderly
people now, who are facing a new kind of problem and really
don’t know what to do about it.”
Dr. Black is principal investigator for the Systolic Hyperten¬
sion in the Elderly Program (SHEP) at the School of Medicine.
This seven-year clinical trial sponsored by the National Heart,
Lung and Blood Institute and NIA has been underway at 17 cen¬
ters nationwide since March 1985. The program is expected to
determine whether standard antihypertensive drug therapy for
ISH will reduce the incidence of strokes in elderly people.
The past 15-20 years have shown that systolic blood pressure
is a better predictor of all hypertension-related complications
than is diastolic pressure. People with systolic elevations of
blood pressure (ISH) have an increased all-cause mortality rate,
twice as many heart attacks, and three times the number of
strokes and angina than do those with normal blood pressure.
Yet, many physicians argue that ISH is a natural consequence
of aging and the increased rigidity of the arterial system. Treat¬
ing ISH, they say, will do nothing to reduce the risk of heart
attack and stroke, because ISH simply marks the presence of
aortic arteriosclerosis.
SHEP is a cooperative study, with all 17 centers using the
same protocol, recruiting patients with the same criteria and
providing medication in the same fashion. A goal of 5,000 vol¬
unteer patients has been set nationwide, with 300 from the Yale
SHEP study.
Because this issue of whether to treat ISH is so important

Dr. Henry L. Black, associate professor of medicine and principal
investigator for the Systolic Hypertension in the Elderly Program
(SHEP), watches as SHEP clinic coordinator Jan Davey, M.S.N.,
measures the blood pressure of Eugenia Zuraski of Branford, Conn
Zuraski has been a patient in the SHEP program since December.

to this population, we’re also looking at things other than
strokes: other cardiovascular diseases and heart attacks, for ex¬
ample,” says Dr. Black. “We’re also looking in a formal way
at whether or not we are causing or preventing dementia and de¬
pression with our medication.”
In this double-blind study, half the group receives antihyper¬
tensive medications and half is given placebos. Participants
have comprehensive cardiovascular monitoring every three
months throughout the program.
The participating centers send weekly data to a coordinating
center in Houston, Tex., where a board of internists, car¬
diologists and neurologists monitors every event. “If it begins
to look as if there is a statistically significant trend toward either
the placebo or the active treatment being better, the study could
be stopped early,” says Dr. Black.
“Since it’s a placebo study, we're very sure that we will get
an answer,” he says. “The answer may well be that we shouldn’t
be treating the population with ISH, which I would consider a
perfectly respectable answer to get. Either way, we'll have a
better idea as to what to do.”
The SHEP team also includes Dr. Charles K. Francis,
associate professor of medicine and diagnostic radiology and
director of the cardiac catheterization laboratory at YNHH;
Dr. Samuel L. Bridgers, assistant professor of neurology; and
Janice Davey, M.S.N., clinic coordinator and a 1976 graduate
of Yale School of Nursing.

SENSORY LOSSES
“About 20 years ago, I read a paper that just made me furious,”
says Linda M. Bartoshuk, Ph.D., professor of epidemiology
(environmental health) and psychology and fellow of the John
B. Pierce Foundation. “It said that elderly patients complained
about food, but that probably didn’t have anything to do with
the real problem with their taste sense. Instead, they just had
a ‘distaste for life’; they were just being cranky.”
To refute the literature that she found so offensive. Professor
Bartoshuk decided “to go out there and measure whatever sen¬
sory disturbances were present and support the complaints that
elderly patients were making.”
But something else happened. “We never found any taste
loss,” she says. “The elderly taste system, at least as far as the
real world perception of foods and beverages, is completely
normal. Aging, per se, does not take a heavy toll on taste. It
devastates smell.”
This loss of ability to smell correctly has a profound effect
on the ability to perceive flavors—an experience that most
people refer to as “taste.”
To explain the distinction: Taste comes from the oral cavity—
the tongue, palate and throat; it comes in four varieties—salt,
sweet, sour and bitter. Smell, from the nasal cavity, contributes
flavor to food as it is eaten. Taste appears to be “hard-wired”
and more primitive, whereas smell is labile, perhaps more
learned.
For example, says Professor Bartoshuk: “There is almost no
real taste to roast beef; it’s all odor. And the odor input is going
all the way from inside your mouth up to your nasal receptors,
stimulating the sense of smell. So if you lose your sense of
smell, you think you can’t taste.”
Professor Bartoshuk and her colleagues discovered that al¬
though taste thresholds (the lowest concentration at which a
taste is noticed) increase with age, the taste of “real world” con¬
centrations, which are far above threshold, appears to remain
intact.

John B. Pierce Foundation fellows Joseph C. Stevens, Ph D. (left),
LindaM. Bartoshuk, PhD., and William S. Cain, Ph.D., demonstrate
a taste test. Cain and Bartoshuk both are professors of epidemiology
and psychology at the School of Medicine, and Stevens is senior
research scientist and lecturer in psychology at Yale University. All
three are investigating the relationship between taste and smell
loss and aging.

Olfaction, however, shows great losses with age. According
to research conducted by two John B. Pierce Foundation fel¬
lows—William S. Cain, Ph.D., professor of epidemiology (en¬
vironmental health) and psychology at the School of Medicine,
and Joseph C. Stevens, senior research scientist and lecturer in
psychology at Yale—this loss begins while people are in their
40s.
Professor Bartoshuk believes that these discoveries may hold
a key to the nutritional well-being of elders. “Properly function¬
ing taste and smell play a very important role in the quality of
life and the way we choose to feed ourselves.
“If olfaction is gone and taste is not, there may be an im¬
mediate remedy,” she says. “At Duke University, Dr. Susan
Schiffman has increased the intensity of odors of foods without
compromising the nutritional status.” Thus, artificial essences
can make food more palatable to the elderly, even if the texture
of the food has been altered to allow for easy swallowing.
But because it is not yet clear whether losses of taste and
smell with aging are functions of the aging process itself or are
the result of other events, such as viral infections and head in¬
juries, that can occur over a lifetime, clinical treatment of taste
loss in the elderly is still at an early stage.
Professor Bartoshuk and her colleagues currently are study¬
ing the effects of viral infections, through evaluation of indi¬
vidual elderly patient histories combined with research on ani¬
mal models. They also are studying the relationship of dental
condition and sensory loss in elders.
“We may need to re-evaluate our clinical norms,” says Pro¬
fessor Bartoshuk. “We don’t want to test someone in the clinic
who is 80, tell them they’ve got a taste loss, and look for clinical
reasons for the loss if this loss is absolutely characteristic of ev¬
eryone who is 80.”
In related research. Dr. Philip M. Sarrel, associate professor
of obstetrics and gynecology and of psychiatry, is chief inves¬
tigator for a $700,000, multidisciplinary study funded by the
National Institute on Aging on the effect of hormones on the
female peripheral nervous system and the peripheral vascular
system. The three-year study will examine the effects of estro¬
gen and progesterone on touch and vibration sense, peripheral
blood flow and skin structure.
Dr. Sarrell says that preliminary findings indicate that a lack
of estrogen affects skin structure, peripheral nervous function¬
ing, cardiovascular functioning and psychiatric functioning and
that estrogen replacement therapy can help correct these
changes.
The mid-life study program research team also includes
Lawrence E. Marks, Ph.D., professor of epidemiology and psy¬
chology; Dr. Irwin M. Braverman, professor of dermatology;
Dr. William M. Glazer, associate professor of psychiatry; Caro¬
lyn Mazure, Ph D., assistant clinical professor of psychi¬
atry (psychology); and Dr. Jean Bolognia, a postdoctoral fellow
in dermatology who graduated from the School of Medicine in
1980. Dr. Hal Morgenstern, former associate professor of
epidemiology and public health and now at UCLA, is the
project consultant epidemiologist.
Dr. Braverman, in addition to his work on this project, has
been investigating the role of elastic fibers and vessels in cutane¬
ous aging.

ALZHEIMER’S DISEASE
Dementias, once referred to by noted biomedical scientist Dr.
Lewis Thomas as “the disease of the century,” are one of the
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Dr. Elias E. Manuelidis, professor of neuropathology and surgery,
believes that Alzheimer's disease may be caused by a virus. In the
late 1970s, he demonstrated that a similar dementia, CreutzfeldtJakob disease(CJD), caused by an unconventional virus, could be
transmitted to laboratory animals.

Patricia S. Goldman-Rakic, PhD., professor of neuroscience
(left), and Amy Arnsten, Ph.D., assistant professor of neuroanatomy,
have used adrenergic agonists to treat memory loss in monkeys.
They currently are testing the alpha-2 adrenergic agonist clonidine
as a potential drug for reversing loss of memory and cognitive
functions in Alzheimer's patients.
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four most common categories of diseases affecting individuals
65 years and older. One of the most prevalent of the dementias
is Alzheimer’s disease.
Alzheimer’s disease now affects an estimated one-to-two
million Americans, and the number is increasing as the elderly
population grows. It is a costly disease, requiring continuous
care over many years for its victims.
Individual convalescent care runs upwards of $30,000 per
year for each Alzheimer’s victim. Federal expenditures for the
disease are projected to be higher than $20 billion by 1990. Al¬
though the causes of Alzheimer’s disease still are unknown, lab¬
oratory researchers at the School of Medicine are finding clues
to its etiology and possible treatment.
Dr. Elias E. Manuelidis, professor of neuropathology
(surgery) and neurology, has been studying virus dementias for
more than 10 years with support from the National Institutes of
Health. In the late 1970s, he was able to transmit CreutzfeldtJakob disease (CJD), a dementia caused by an unconventional
virus, to convenient laboratory animals, such as guinea pigs,
hamsters and mice. He used the animal models to study disease
mechanisms both in CJD and in Alzheimer’s disease, which is
difficult to discriminate on clinical grounds from CJD.
“There are some neurochemical similarities and occasional
overlapping lesions between the two diseases, and the familial
incidence is roughly the same—12 percent of the families of
both CJD and Alzheimer’s have a high incidence,” says Dr.
Manuelidis.
On the hypothesis that Alzheimer’s disease also is caused by
a virus. Dr. Manuelidis and his wife. Dr. Laura M. Manuelidis,
associate professor of neuropathology (surgery), are using ani¬
mal models to study its etiology. They believe that earlier at¬
tempts to transmit the disease to animals failed because the
human victims were in Alzheimer’s end stages, where the virus
may no longer be present.
“We know from other viral diseases that the virus is present
sometimes in the first or second day of the disease,” says Dr.
E. Manuelidis. “For example, with poliomyelitis, when the in¬
dividuals come in for autopsy, the virus is no longer present.
It destroys whatever it can, then is gone.”
The Drs. Manuelidis’ current experiments in this area
involve inoculating animals with blood of humans from highincidence Alzheimer’s families, in hopes of isolating the dis¬
ease in its early, possibly viral, stages.
The symptoms associated with Alzheimer’s disease—begin¬
ning with the loss of learned skills, such as arithmetic, and pro¬
gressing to memory loss and a virtual shutting down of the
mind—result from its disastrous effect on the structure and
function of the cerebral cortex.
Neuropathologists have found that association areas of the
cortex, including the prefrontal cortex, are a major location for
plaques and tangles—the products of degeneration that serve as
diagnostic markers of Alzheimer’s disease.
Aged rhesus monkeys and other non-human primates also
develop these senile plaques and tangles, as well as a decline
in levels of various neurotransmitters. "We discovered that with
aging, there is a sharp fall-off in the content of certain
monoamines—norepinephrine and dopamine—in the cortex of
aged animals. The same neurochemical deficits occur in aged
humans and Alzheimer’s patients,” explains Patricia S.
Goldman-Rakic, Ph.D., professor of neuroscience.
This decline, says Professor Goldman-Rakic, can be traced
to a loss of brainstem neurons, containing norepinephrine, that
have widespread projections throughout the cerebral cortex.

When the neurons die, their axons degenerate, and the cerebral
cortex is deprived of its normal source of norepinephrine.
Earlier experiments conducted at the National Institute of
Mental Health by Professor Goldman-Rakic and colleagues
showed that the depletion of catecholamines, such as
norepinephrine, in the cortex of young adult monkeys resulted
in specific memory and behavioral losses.
But even more important was the discovery that they could
then restore the lost memory and functions with adrenergic
agonists, which replaced the depleted norepinephrine. “This
was the first evidence that ‘replacement therapy’ could be used
for memory loss,” explains Professor Goldman-Rakic.
Professor Goldman-Rakic, Amy Amsten, Ph.D., assistant
professor of neuroanatomy, and their associates believe it may
be possible to treat Alzheimer’s disease similarly. Using aged
monkeys as models, they have been testing the alpha-2 adrener¬
gic receptor agonist clonidine, which already is used to treat
high blood pressure, Gilles de la Tourette’s syndrome and her¬
oin addiction, as a potential drug for reversing loss of memory
and cognitive functions in Alzheimer’s patients.
These researchers found clonidine to be effective in improv¬
ing memory and performance in non-human primates and re¬
ported their findings in the Dec. 13, 1985, issue of SCIENCE.
They have since replicated these findings on 13 monkeys.

Because the positive, cognitive-enhancing effects of the drug
can be blocked by selective alpha-adrenergic antagonists,
clonidine may be working through alpha-2 receptors in the
brain. Studies carried out by Professor Goldman-Rakic and
Dorothy W. Gallager, Ph.D., associate professor of psychiatry
(pharmacology) and neuroanatomy, using the method of in vitro
autoradiography, have revealed that alpha-2 receptors are pre¬
sent in high concentrations in the cortical areas important for the
type of memory that has been examined.
Clonidine is not an ideal drug, however, since it also pro¬
duces sedation in the dose range that would be set for improv¬
ing memory. While looking at ways to solve this problem. Pro¬
fessors Arnsten and Goldman-Rakic discovered alpha-2 recep¬
tor subtypes in the brain. Thus, it may be possible to dissociate
the sedative and cognitive-enhancing properties of selective
alpha adrenergic compounds, says Professor Goldman-Rakic.
Clinical trials based on some of the preliminary findings of
Professors Arnsten and Goldman-Rakic have begun at several
medical centers throughout the country and are expected to
begin soon at Yale under the direction of Dr. Alan P. Siegal,
assistant professor of psych iatry.

A woodcut from Bartholomaeus
Anglicus, Le Proprietaire
deschose, Nicolas Conteau,
Paris, 1510, shows the ages
of man. The book is in the
collection of the Yale School
of Medicine Historical Library.
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CLINIMETRICS: NEW CHALLENGES
IN MEDICAL MEASUREMENT
by Dr. Alvan R. Feinstein

Suppose you have been asked to choose between two baseball
players, one of whom is batting .400 and the other .250. If you
begin comparing the players by using the approach that now
pervades medical literature, you would immediately ask about
“statistical significance.” Thus, if the respective hits per times
at bat were 2/5 vs. 1/4 for the two players, you would dismiss
their batting averages of .400 vs. .250 as non-significant; but
if the same results came from such numbers as 320/800 vs. 200/
800, you would be impressed by the distinction.
If the numerical distinction seems “statistically significant,”
you might next ask some questions that involve a knowledge of
baseball, rather than statistics. Is the .400 hitter an outfielder,
whereas the .250 hitter is a pitcher who wins 30 games a year?
Do the two players have similar fielding averages? What about
other aspects of their performance, such as runs batted in, slug¬
ging average or morale value to the team?
Next, after considering these “clinical" features of the ac¬
tivities, you might want to know if the two players were being
fairly compared. Does one play in the major leagues, for the
New York Mets, whereas the other plays in the seven-sisters
league, for Mount Holyoke College? Finally, you might ask
about the accuracy of the basic, raw data. Have the batting de¬
tails been compiled by scorekeepers who used the same criteria
for deciding how to identify and count walks, hits, errors, outs,
sacrifice hits, fielder’s choices and times at bat?
Aside from the initial question about “statistical signifi¬
cance,” all the other evaluative aspects of the two players' per¬
formances depended on “clinical judgment” about baseball.
You used the judgment in recognizing important features of the
evaluation that were not included in the batting-average statis¬
tics: the additional “clinical” attributes of the players, the fair¬
ness of the comparison, the accuracy of the basic data.
Although the cited judgments might immediately be applied
during a statistical evaluation of baseball players, analogous
types of judgment are regularly neglected today when physi¬
cians do clinical forms of research or read the published reports.
Instead, we tend to rely on a series of mathematical strate¬
gies. We use statistical tests to tell us whether the observed num¬
erical distinctions are “significant.” We use another statistical
technique to assign the treatments compared in randomized
trials of therapy. We apply algebraic formulas, such as Bayes
Theorem, and special graphs, such as receiver-operating-characteristc (ROC) curves, to evaluate the performance of diagnos¬
tic agents. In using the formal technique of “decision analysis”
Dr Alvan R. Feinstein is professor of medicine and
epidemiology and director of the clinical epidemiology unit
d the Robert Wood Johnson Clinical Scholars Program.

for managerial conclusion, we multiply quantitative estimates
of probabilities and “utility values” to get a mathematical score
for each decision.
All of this mathematical activity has become an interesting
paradox in the postgraduate careers of the many physicians who
chose medicine as an occupation because they liked people and
liked science but hated math.

MATHEMATICAL STRATEGIES
The attention to mathematical strategies has many advantages.
By demanding “statistical significance,” we avoid the fallacies
that occurred years ago when major claims about huge differ¬
ences were based on tiny numbers whose distinctions could eas¬
ily have arisen by chance. By using randomized assignment of
therapy, we avoid the type of biased comparisons that occurred
in the days when surgical treatment of the prognostically good
“operable” patients was contrasted with non-surgical treatment
of the prognostically poor “inoperable” patients. By applying
other formal mathematical methods to outline the decisions
made in diagnosis or management, we are forced to give
specific attention to important things that must be identified and
considered during the process of making clinical decisions.
On the other hand, an excessive emphasis on mathematical
procedures has had some major disadvantages for patients, phy¬
sicians and the quality of both humanism and science in modem
clinical practice.
Perhaps the main problem is that many important types of
clinical data and reasoning—the fundamental elements of “clin¬
ical judgment”—are either deliberately rejected or inadver¬
tently ignored during the mathemedical activities.
Aside from the dehumanization that occurs when we pay no
deliberate attention to clinical information about symptoms,
functional status and other human reactions of patients, the
statistical results used in clinical science become non-reproduc¬
ible.
The results are non-reproducible because they lack clinical
* precision: patients with the same disease can have strikingly dif¬
ferent outcomes that depend on unrecorded and unanalyzed
clinical distinctions. Survival in two patients with the same
localized cancer will differ if one of the patients is cachectic and
the other is not. The ability to return to work after coronary
surgery may often depend more on the patient’s pre-operative
occupational status than on the anatomic state of the vascula¬
ture.
If these and other important clinical features of prediagnostic
and pretherapeutic conditions are not suitably identified and
analyzed, the results of statistical studies will be inadequate
for decisions in clinical science and for application in clinical
practice.

Dr. Alvan R. Feinstein's new book discusses strategies and tactics
needed to express clinical, human observations in a manner suitable
for the humanistic science of clinical medicine.

PROBLEMS
A separate set of problems arises in etiologic research intended
to identify causes of disease or risk factors. To test noxious
agents that may cause disease, we cannot apply the type of ran¬
domized trials used for testing therapeutic agents that may pre¬
vent or remedy disease. Consequently, noxious agents or risk
factors are usually evaluated in epidemiologic studies con¬
ducted with “observational designs” that often lack the scientific
precautions routinely employed in experimental plans for ran¬
domized trials.
The epidemiologic research structures often use case-control
and ecologic-association studies that are difficult for clinicians
to understand, and that usually depend more on statistical than
on scientific principles of research. The results of the studies are
often substantially biased because the statistical methods may
not contain suitable provisions for analyzing the human deci¬
sions and clinical data that are a fertile source of distortion in
non-experimental information.
These problems in clinical and epidemiologic science create
a fascinating irony as the 20th century departs—leaving
medicine in an age of molecular biology, magnificent com¬
puters and extraordinarily high-powered technology.
The irony is the existence of a basic need, amid all the splen¬
did molecular and technologic achievements, for better scien¬
tific methods of measuring clinical and human phenomena.

Because these phenomena cannot be expressed in angstroms,
millimoles or other technologic dimensions, we need to im¬
prove the measurements that are done at fundamental human
levels of observation and reasoning.
The basic observational measurements occur when clinicians
(and patients) express and rate the relative magnitude of such
entities as pain, dyspnea, distress, anxiety, depression, fatigue,
insomnia, disability, functional status, joy, grief, satisfaction
and all the other distinctly human clinical features that differen¬
tiate people from films, tracings, fluids, tissues, cells,
molecules or animals. In the informal ratings used for clinical
communication, we may say that a patient has “moderate pain,
severe dyspnea and is 4 -I- sick”.
The ratings are important, often crucial, elements of descrip¬
tive clinical measurement. Yet they do not receive the efforts
of calibration and standardization that are applied for descrip¬
tive measurement in the laboratory tests that are often much less
valuable indications of a patient’s total condition.
We do not develop or teach specific criteria for what is meant
by moderate, severe or 4 + . Consequently, our statistical and
computer colleagues, who justifiably loathe unreliable data,
will usually dismiss the unstandardized clinical observations
and ratings as being too “soft” to receive serious attention. The
result is a computerized collection and statistical analysis of
“hard” scientific data that are often dehumanized, because the
key human information has been omitted.
Even when formal attempts are made to record the human
clinical information, we may not do a very good job. For exam¬
ple, oncologists have now discovered that ratings of a patient’s
“performance status” are often prognostically more precise than
citations of a cancer’s histologic type and anatomic spread. Yet
the ratings of performance status do not distinguish impairments
attributable to the cancer’s pathophysiologic derangements
from disabilities caused by co-morbid associated diseases, de¬
pression or other non-oncologic factors. At the other extreme,
clinicians may use intricate rating scales—for such attributes as
anxiety, depression and health impairment—that have been
deemed “reliable” and “valid” according to the mathematical
strategies of psychosocial scientists.
Despite impressive statistical results for reliability and valid¬
ity, however, the scales may be deficient in clinical “sensibility”
because they contain 200 items, require an hour of time to com¬
plete, and do not focus on the main issues of clinical concern
to the doctor or patient.

CLINJMETR1CS
In a new book called Clinimetrics, (published this year by Yale
University Press), 1 have discussed the strategies and tactics
needed to express clinical, human observations in a manner
suitable for the humanistic science of clinical medicine.
In some instances, we need to make better use of what is al¬
ready available; but many of the improvements will require the
construction or development of new descriptive approaches and
rating scales. For students, practitioners and investigators who
want to observe and think as a humanistic physician, while ex¬
pressing the observations as a precise scientist, Clinimetrics
may offer appealing reading.
The subject of clinimetrics also has another potential attrac¬
tion. For clinicians who seek the immortality of being com¬
memorated with an eponym, abundant opportunities are avail¬
able in the creation of clinimetric indexes and rating scales.
Many of the eponyms we learned in medical school bear the
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names of the pathologists, physiologists, biochemists and
microbiologists who identified diseases or etiologic agents in
the 19th century and first part of the 20th century.
An entirely new set of eponyms today, however, commemo¬
rate the clinimetrically oriented physicians whose names are
cited in the Apgar Score, Jones Diagnostic Criteria, Killip Clas¬
sification, Lansbury Index, Norris Score, and even (dating back
to some work I did many years ago when studying the treatment
of obesity) the Feinstein Reduction Index.
The issues I have just discussed in measurement refer to the
process of observation and expression that produces raw data—
whether the data describe a person’s height, serum cholesterol,
magnitude of pain or severity of disability.
A quite different form of measurement occurs when raw data
that describe individual attributes are collected for groups of
people, when the group information is summarized numerically
with a mean, proportion or other statistical expression, and
when the statistical summaries are contrasted for decisions
about the results in the groups. This is the type of contrast that
was considered in the first paragraph when raw information
about the baseball performance of two players was summarized
into batting averages, and when the averages were compared.
The strategies derived from statistics will provide the means,
proportions and other descriptive expressions that summarize
data quantitatively. Mathematical methods also offer the calcu¬
lations of probability that lead to inferential decisions about
“statistical significance.” What the statistical strategies do not
supply, however, is the judgment that selects important clinical
features to be noted and that uses those features to arrange for
fair comparisons of groups.
The act of randomization is an effective way to avoid bias
when groups are formed in the selection of treatment, but ran¬
domization itself will not avoid bias when the treatments are
carried out and when the outcomes are observed. Randomiza¬
tion also does not affect the suitability with which the research
was originally planned so that the right kinds of treatment are
being compared in the right kinds of patients. When the mea¬
sured results of two (or more) groups are contrasted, all of these
other activities beyond randomization will involve clinical
judgments to which mathematics has little to contribute.
Most importantly, however, we cannot rely on randomized
trials to answer the many questions that will involve quantitative
contrasts in an age of burgeoning technology. Randomized
trials will be too unethical, infeasible or costly for assembling
the groups whose measured comparisons are needed to evaluate
many therapeutic agents, to check most diagnostic agents, and
to appraise almost all etiologic agents or risk factors for disease.

In these circumstances, the measurements will have to come
from groups collected after observation of the events that occur
in ordinary clinical practice, without the statistical and scientific
virtues of the experiments conducted as randomized trials.

SCIENTIFIC CHALLENGES
Accordingly, a major scientific challenge in clinical and
epidemiologic research will be to develop suitable methods for
identifying the cogent factors that produce biased or invalid
comparisons in non-experimental studies, and to remove or ad¬
just those factors appropriately.
Because so much intellectual effort has been devoted in the
past few decades to randomization in studies of therapy and to
other statistical strategies in studies of etiology, relatively little
attention has been given to developing an appropriate set of sci¬
entific principles for identifying the sources of bias or distor¬
tion, and for developing appropriate methods and standards to
deal with the challenges.
Since most of those challenges involve a clinical sophistica¬
tion that has not been used in the conventional public health
orientation of epidemiologic investigation, a new clinical ap¬
proach has been proposed in the past two decades.
In another recent book. Clinical Epidemiology (W.B. Saun¬
ders Co., 1985), I have discussed the scientific challenges of
this new field of research, identified some of its major problems
and proposed some solutions. In addition to this book, four
other books on clinical epidemiology have appeared in the past
few years, reflecting the growing importance of this subject in
modern medicine.
As a research domain, clinical epidemiology deals with the
methods of “measurement” used to form groups, plan compari¬
sons, and express results in a manner that warrants credibility
according to both scientific and clinical standards of judgment.
As a topic of medical education, clinical epidemiology con¬
tains the background that practicing clinicians will need for the
difficult task of evaluating the claims made in conferences, lec¬
tures and publications in the medical literature.
In the advances of modern medicine, we have developed a
“basic science” for understanding and explaining the
mechanisms of disease and biology. For dealing with the di¬
verse measurements that have become prime issues in the cur¬
rent practice of clinical medicine, a different set of scientific
strategies is needed. Clinimetrics and Clinical Epidemiology
offer a complementary, additional “basic science” for this
work.

CORRECTION
A typo in the fall, 1986, issue of YALE MEDICINE, referring
to the anonymous minimum competency examination for medi¬
cal students, may have had some students burning the midnight
oil a little more than necessary. The sentence on page 7 in The
Yale System article. Evaluation of Students—“The examina¬
tion should be written in such a way that each student who has
participated in the coursework should be able to pass with a
score of at least 6590.”—should have read, “...with a score of
at least 65 percent.”

DAVID OTTENSTEIN

YPI PROGRAM BLENDS
THERAPY, SERVICE, RESEARCH
By Alphonsus J. Mitchell

When the Yale Psychiatric Institute moves back to the medical
center in the summer of 1989, it anticipates more than the ad¬
vantages provided by a larger, more flexible space for its pro¬
gram. “A much richer relationship” between the institute and
the various departments of the Yale School of Medicine is fore¬
seen by Dr. Gary L. Tischler, the director.
The links between the institute and such departments as
neurology, internal medicine, adolescent medicine and phar¬
macology have not been lacking during YPI’s 11-year sojourn
on the Albertus Magnus College campus, about 2 Vi miles north
of the medical center.
But the return of YPI to this appropriate setting will generate
more opportunities for consultation, evaluation, research and
training. This can only add to the lustre of an institution which
has earned through half a century a distinctive reputation for
treating mental disorders in a clinical program that incorporates
significant research efforts and the education of mental health
professionals.
YPI had its beginnings in 1935, developing out of the Insti¬
tute of Human Relations, an interdisciplinary program to study
human behavior. YPI is an integral part of the department of
psychiatry, overseen by a nine-member board of directors rep¬
resenting the School of Medicine, Yale-New Haven Hospital
and the university. Although it formerly was exclusively con¬
cerned with mental disorders in older adults, the focus since the
early 1960s has been on adolescents and young adults.
The shift in focus was a logical development in YPI’s work,
according to Dr. Tischler, the Charles B.G. Murphy Professor
of Psychiatry, director of YPI since 1979, and, since July 1986,
chairman of the department of psychiatry. “We know that
adolescence is a time of life when a person is particularly vul¬
nerable to mental illness,” he says. “The most extreme form of
mental illness, schizophrenia, has its usual age of onset during
adolescence. Adolescence is also an age period when a person
is particularly vulnerable to the effects of depressive disorders.
There is growing evidence that the prevalence of these disorders
among adolescents is greater than previously thought and that
the course of early onset of affective disorder is particularly
malignant if not energetically treated.”
The young people admitted to the institute are patients in con¬
siderable peril. All of them previously have been treated in hos¬
pitals or outpatient programs without marked success. Some pa¬
tients—fewer than 10 percent—are destined to spend their lives
in institutions. A small percentage of others will need highly re-

Alphonsus J. Mitchell is the former editor of the Yale Alumni
Magazine.

Dr. Gary L. Tischler has directed the YPI and coordinated its
return to the medical complex.

stricted continuous supervision for most of their lives. “But,”
says Dr. Tischler, “most are able to leave the hospital and lead
fully productive lives, participating in a normal range of social
and vocational activities.”
YPI has a rated capacity of 66 beds, and it is usually filled
or nearly filled with inpatients whose ages range from 14 to 35.
The majority is on the younger end of the scale with the average
age being 18. An additional 75 to 85 men and women are out¬
patients in the institute’s community services division.

INTENSE TREATMENT
YPI is out of the ordinary in that few institutions in the country
are focused on young people with such severe and complicated
cases that require long-term care—up to 18 months. It is even
more unusual, Dr. Tischler believes, in the way its programs are
tailored to the needs of each patient, “a blend of psychological
therapies, medication and social rehabilitation administered
13
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Art therapy is among the adjunctive therapies offered to the YPI
patients. Here. William More, art therapist, (right) is working with
a patient.

Many of the YPI patients are adolescents and young adults who
respond to recreational therapy, including volleyball, swimming
and basketball.

with a high level of intensity.” The aim is to rehabilitate and
educate, “to help them reconstruct elements of their lives,”
he says.
In addition to primary diagnoses of schizophrenia or major
depression, well over half of the patients admitted to the insti¬
tute have a secondary diagnosis of substance abuse or depen¬
dence. The abuse and dependence on drugs or alcohol may re¬
sult in temporary or permanent brain damage, and these prob¬
lems complicate the treatment.
Consequently, a thorough evaluation, including neuropsy¬
chological and neurophysiological tests, is undertaken when the
patient enters YPI to confirm or alter the original diagnosis and
determine if any collateral conditions exist. There are some,
but not many, surprises in the evaluations, according to Dr.
Tischler. “Often the existence of a cognitive impairment has
not been previously identified. Most people (in acute-care
programs) are treated for the basic condition alone.”
After 30 days, the individual patient’s treatment program is
completely reviewed and, if necessary, reformulated. Every pa¬
tient is reviewed subsequently on a monthly basis, and the staff
makes a detailed review quarterly. In addition, weekly rounds
are led by senior medical staff members.
Frequent assessments of patient response and progress are
necessary in an institution where patients are confined for long
periods. The assessments have an additional value in that the
patient's condition and progress can be updated regularly in re¬
ports to parents and medical directors of insurance companies.
The course of treatment at YPI is expensive, ranging up to
$330 per day. Most patients are covered by a pre-paid health
plan or insurance, according to YPI Deputy Director Sheila W.
Wellington. “As with all specialized treatment, it is essential to
make sure that the people here need the treatment they are get¬
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ting. A very active quality assurance and utilization review pro¬
gram reduces the likelihood of unnecessary lengths of stay,” she
explains.
The expense of the program reflects its intensity. The profes¬
sional roster at YPI includes eight psychiatrists, four psycholo¬
gists, 64 nurses and nursing assistants, 16 social workers, four
occupational therapists, nine recreational therapists, eight spe¬
cial education teachers, seven advanced residents in psychiatry,
five postdoctoral fellows in psychology and four social work in¬
terns. In addition, the institute has an administrative and support
staff of 50.

FAMILY PARTICIPATION
YPI has three clinical divisions: admissions and evaluation, the
inpatient clinical program and community services. Dr. Ira
Levine is the clinical director of the institute. The patient and
family have their first encounter, quite naturally, with admis¬
sions and evaluation, headed by Christopher Greene, a clinical
social worker. During the initial phase—while the patient's his¬
tory is being reviewed—members of the family are briefed
on the program, which includes family participation in the
treatment.
“Families are an important resource for the patient, particu¬
larly with adolescents and young adults,” says Leonard Hill,
who heads the family therapy program and the community ser¬
vices division. While some resistance to family therapy might
be expected, he says that this is not the usual case. “Most people
are terribly committed to their children. Many ask to be in¬
volved in the treatment. They may become discouraged and
fearful at times about how long the patient will be disabled.

While impulsivity is often a problem for patients in this
group, the physically secure environment contributes to their
ability to bring it under control.
Intensive treatment with individual and group psycho¬
therapies is provided for each patient, who meets at least three
times a week with the primary therapist and usually once a week
individually with the family therapist. He or she will also meet
three times with a small psychotherapy group consisting of four
to eight patients, a psychiatric resident, postdoctoral fellow and
one or more staff members.
The groups focus on daily activities in an effort to develop
the patients’ understanding of their own behavior and their re¬
lationships with others. Special therapy groups meet once a
week and focus on subjects such as substance abuse, gender and
sexual development, orphans and adoption and sexual abuse.
All patients and staff have a once-a-week community meeting
to discuss social and administrative issues affecting life on the
unit.

PATIENT RESPONSIBILITY

Dr. Charles W. Gardner Jr., clinical professor of psychiatry, (left)
and Dr. Ralph E. Hoffman, associate professor of psychiatry,
discuss the relationship benveen the clinical and educational training
programs.

but it is one of our jobs to help both the patient and family
develop realistic expectations about the course of illness and
the process of recovery
Upon admission, a patient may be confined to one of two
closed units, one for young adolescents up to age 16 and the
other for older adolescents and young adults. Each patient is
provided an individual therapist, family therapist, primary
nurse, primary psychiatric assistant, recreational therapist and
occupational therapist.
For younger patients, a normal range of developmental work
is undertaken while psychopathologies are being addressed.
The severity is indicated by such cases as: a 15-year old girl with
history of drug abuse and several suicide attempts, and a boy
with a history of delinquent behavior, exhibitionism and an air¬
line hijack attempt that led to court-ordered hospitalization.

In all activities, patients steadily are encouraged to take as much
responsibility as they can for decisions affecting their treatment.
The younger adolescents, and other patients who have not
finished high school, attend the Cedarhurst School, a fully
accredited special education high school.
Students from the YPI as well as day students from surround¬
ing school districts attend Cedarhurst. The school is located on
the former Jackson estate, just north of the Albertus Magnus
campus in Hamden. It provides an academic program with a
therapeutic approach for about 50 students. Patients who cannot
leave the inpatient setting for one reason or another are tutored
at YPI. An extensive program of recreational therapy, social
skill development and pre-vocation training is provided for each
patient.
Patients’ families who live within 125 miles of New Haven
meet weekly with the family therapist (sometimes with the pa¬
tient) and are involved in parent groups, which meet weekly or
bi-weekly. The individual family sessions explore relationships
within that particular family; the group sessions focus on the
needs and concerns of all the families who have a child in inten¬
sive treatment. A modified program is available to families liv¬
ing further away.
The immediate safety of the patients is, of course, a major
concern in the closed units. Diagnostic assumptions are re¬
assessed, and both biochemical and psychosocial treatments
are undertaken with these patients. An integral part of the
YPI approach is that patients are brought into communitybased activities, adult education and individual programs that
help them acquire practical living skills.
Patients from either of the closed units may transfer to a 19bed open unit. This unit admits patients directly from other
acute-care hospitals as well. This transition and brief treatment
unit introduces social/vocational rehabilitation and psychoeducational treatments to supplement those treatments already un¬
derway. They are aimed at developing the life skills necessary
for living in the community outside the hospital.
For instance, a critical skill is the ability to recognize impend¬
ing relapse and to know how to seek help. This same skill is em¬
phasized in family therapy sessions. A full-time discharge plan¬
ning coordinator works with the patient and family to assure the
continuity of essential care after the patient leaves YPI. The
transition to the outside world is no light matter for individuals

Dr. Stephen Fleck, professor emeritus of psychiatry and public
health, (left) has fostered much of the blend of research, service
and training that characterizes the YPI, where the patient and his
or her family are the primary focus.

who have had the severe problems manifested in the YPI patient
population. Some of them move into the community services
program or to other outpatient or transitional programs near
where they live.

COMMUNITY SERVICES
The community services division accommodates many more
than the patients at the institute itself. It accepts referrals from
both the inpatient division of YPI and other institutions, both
public and private. The community services division has been
located at the medical center for more than two years and is a
block away from the new YPI site.
All three of the community service programs focus on the ad¬
justment to ordinary life, to dealing with things that most people
take for granted but which may be formidable hurdles for recov¬
ering psychiatric patients. “Some of these people are living in
the community for the first time in years,” says Hill. “They’re
terrified. We spend a lot of time motivating these people, chang¬
ing attitudes, giving them new habits.”
From 20 to 30 people are accommodated in the day hospital
at 350 Congress Ave., which offers intensive psychiatric treat¬
ment, social and vocational rehabilitation and training in com¬
munity living. Patients usually attend full time for six months,
or longer if needed, while they gain confidence and then move
to other YPI or community programs.
The supervised apartment program provides supervised scat¬
ter site housing, including regular home visits by staff and indi¬
vidual and group meetings.
The community work adjustment program provides several
services. In The Workplace, a pre-vocational element of the
program, patients are taught basic work-readiness skills:
mobilizing themselves in the morning, how to dress for work,
how to deal with questions others may ask, how to deal with
. boss and other workers. Patients spend part of the day with

counselors and occupational therapists. They discuss workrelated issues and role play to prepare for various situations.
Then they go to a work site, often a local thrift shop, to serve
as work trainees for a couple of hours, and return for a debrief¬
ing about the experience.
A second phase of the program involves placement in super¬
vised work located by the staff. “Many go out in group place¬
ment,” says Hill, “and they are supervised by a staff member
at the job site. The coordinator spends a lot of time finding these
job sites, and our promise to the employers is that we will pro¬
vide staff support for both patients and employers.”
Usually, this first work experience is part-time, about 15
hours a week, while the patients progress to a greater sense of
independence. “We try to help them compartmentalize their
lives a bit, to get them to think of work as just work,” says Hill.
The program’s final phase involves counseling those who are
ready to enter the marketplace—what jobs they ought to look
for, how they should present themselves, how to use a support
network. “Recovery rates relate strongly to the use of support
networks,” Hill points out. “We encourage patients to use a
group. It can be very important just to know someone to call
when you have a problem. ”
At present, the average YPI patient has a stay of about 12
months. With the development of shorter term (30-90 days) and
intermediate care (90-180 days) programs, the average length
of stay for the entire program has decreased.
Sheila Wellington notes that the number of admissions at YPI
has been rising. Seventy patients were admitted in 1986, com¬
pared to 52 the year before. A good part of that increase may
be attributed to shorter patient stays.
This trend, she says, has developed from greater understand¬
ing throughout the mental health field of how treatment re¬
sources can be mobilized rapidly so that a person with severe
mental illness can be brought back into the appropriate commu¬
nity settings and what it takes to support that person in the com¬
munity. "The number of day hospitals in the state has increased
in response to the increases in resources for community-based
programs and the knowledge of how to use them,” she says.
The merits of YPI may be rightfully measured in terms of its
success in bringing severely ill patients back to better health.
The YPI experience, as disseminated through training mental
health professionals and through research programs closely en¬
twined with clinical programs, form other aspects of the tripar¬
tite mission of training, research and service to the psychiatric
patient. Thus, the YPI commitment of energies and resources
has an impact that goes beyond these patients.
YPI is, as Ms. Wellington says, “a coveted training site” for
advanced psychiatric residents, pre- and post-doctoral fellows
in psychology and students in nursing, social work and
medicine. All those being training are exposed not only to ex¬
pert clinical work but also to fundamental research designed to
improve their understanding of new developments in the field.

RESEARCH
The research, which develops naturally out of institute experi¬
ence is “investigator-driven,” arising on the initiative of indi¬
vidual staff members or units. However, continuity prevails in
these pursuits. For instance, the center for family studies, a
component of YPI now headed by assistant professor of psychi¬
atry Jeri A. Doane, studies family variables in relation to
schizophrenia. “This work has made important contributions to
the understanding of patterns within the family and their effect

on mental illness and the response to it,” says Dr. Tischler.
Dr. Ralph Hoffman, director of the center for biocognitive
studies at YPI, has done important work on the relationship of
language and psychosis; Philip Leaf of Yale’s center for mental
health services, has published papers on patterns of care in the
community and factors in the YPI program which have produc¬
ed tangible benefits.
Dr. Tischler’s own work has dealt with evaluating the quality
of patient care in mental health services and with social psychi¬
atry and psychiatric epidemiology. The move to new facilities
will improve the research aspect of the institute’s work im¬
mediately.

The chief benefits of the YPI move are not only more space
but better space, 20,000 square feet of it. “We can accommodate
more people,” says Dr. Tischler. “We will have room for more
activity, for occupational and recreational therapy, creative
arts therapy. The new facility will be a village that provides op¬
portunity for movement. The open wards are designed speci¬
fically to provide for patients progressing to more and more
autonomy.”
The entire setting is designed to facilitate better care for
patients, better opportunities to educate and train and better
avenues for research that can improve what we know of men¬
tal illness and mental health.

Courtyards are an integral part of the architectural fabric of
Yale University, and the same will be true of the new facilities
for the Yale Psychiatric Institute. The noted California architect
Frank O. Gehry, in collaboration with Allen Dehar Associates
of New Haven, has created a courtyard as part of the YPI
design—a village community complex.
Founded in 1935, the YPI had been located near the school’s
Institute of Human Relations until 1975. Then, the institute
signed a 10-year lease for facilities at Albertus Magnus
College. However, the space proved to be inadequate, and
YPI initiated plans to relocate.
Since the Connecticut Commission on Hospitals and Health
Care approved the certificate of need in May 1985, many
University and school leaders have spent innumerable hours
planning the new facility.
The $9.7 million project has begun with site preparation,
removing existing buildings on the block bounded by Cedar
and Liberty streets and Congress and Washington avenues.
Groundbreaking is scheduled to take place this spring, and
the new facilities are to be completed in 1989.
“At the YPI, the clinical and academic programs interact,
so that patient care reflects the highest standards of
contemporary psychiatric practice,” said Dr. Gary Tischler,
psychiatry department chairman and director of YPI. “The
exceptional knowledge and experience acquired at YPI are
put to work for the benefit of psychiatrically disturbed
individuals throughout the United States.”
Three patient buildings reflect levels of treatment, ranging

from closed units for the most severe cases to open, apartmentstyle living areas.
The building that faces Congress Avenue will accommodate
administrative offices. The street level will provide commercial
space, employing the same concept as the Yale Center for
British Art on Chapel Street, where local merchants operate
businesses on the museum’s first floor.
Architect Gehry is familiar with both Yale and academia.
He was the William F. and Charlotte Shepherd Davenport
Visiting Professor of Architectural Design .at Yale in the fall
of 1985; the following year, he was the focus of a 20-year
retrospective exhibition at the Walker Art Center in
Minneapolis. Among his recent projects are the Loyola Law
School and the California Aerospace Museum and Theater.
Architecture critics have described Gehry as “an artists’
architect,” adding that his houses, office buildings, museums
and furniture possess originality and power. His ideas are
provocative, and his work shows a close relationship to
modem art, especially cubism. This is evident in the YPI
protect.
“In an era characterized by a remarkable proliferation of
knowledge concerning the causes and nature of psychiatric
illnesses, academic centers that span the realms of service
and science have a unique opportunity to broaden our
understanding and improve our ability to treat severe mental
disorders,” said Dr. Tischler. “The move back to the medical
center will allow us to take advantage of this opportunity.”
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RESPONSE TO ALUMNI SURVEY:
A DIALOGUE EMERGES
by Drs. William L. Kissick and Nicholas PR. Spinelli

In April 1986. Dr. Kissick and Dr. Spinelli wrote a paper
evaluating the organization of the Association of Yale Alumni
in Medicine, based on their combined eight years as presidents
of the association (1977-1985). Last May, this paper and a
questionnaire were distributed to all association members,
including medical school graduates, former house staff and
fellows of the Yale School of Medicine. A summary of the
paper and a discussion of the responses to both the paper
and the questionnaire follow.

Traditionally, the major functions of the Association of Yale
Alumni in Medicine have been to provide financial support to
current medical students, to communicate news of the school
via YALE MEDICINE and to organize reunions. But our paper
concluded that these functions are hampered by a weak organi¬
zational structure that is poorly understood by the A YAM mem¬
bership and discourages meaningful participation by members.
We recommended restructuring the association to provide
better communication of personal alumni news; better under¬
standing of the needs of the School of Medicine; better profes¬
sional help to current students; more participation of alumni in
the association; and more awareness and response on the part
of the association to alumni needs and interests.

GENERAL SUMMARY OF RESPONSES
More than 10 percent of the approximately 5,000 association
members returned completed questionnaires, and more than 60
percent of respondents added comments. A recurring theme was
gratitude for a Yale medical education, which time had proven
to be a positive influence on professional careers. Interestingly,
about 20 percent of all respondents are engaged in academic,
rather than practice careers.
Many respondents praised the unique Yale academic experi¬
ence in comparison to that of other academic environments with
which they were familiar.

SCHOOL-ALUMNI COMMUNICATION
Respondents commented on three areas:
1. YALE MEDICINE
Although this publication received almost universally favora-

/ V.v Kissick and Spinelli are past presidents of the Association
oj Yale Alumni in Medicine.

ble comments, respondents requested more news about the
curriculum, academic changes, and student performance and
attitudes.
2. alumni news
The most intense and universal complaint was the dearth of
news concerning classmates. This deficiency is being addressed
by the inclusion of a School of Medicine column in the Yale
Alumni Magazine (note; not YALE MEDICINE). However,
YALE MEDICINE will continue to publish professional news
and class notes about alumni. To be effective, of course, each
alumnus/a must forward personal news, news of classmates and
fellow alums, and address changes to the Office of Medical
Alumni Affairs, Yale University School of Medicine, 333
Cedar St., P.O. Box 3333, New Haven, CT06510.
3. alumni organizations
The Association of Yale Alumni in Medicine is our autono¬
mous alumni organization, with its own bylaws. In the larger,
university sphere, three "umbrella” alumni organizations—the
Yale Alumni Fund, the Association of Yale Alumni (AYA) and
the Yale University Office of Development—integrate all
graduate and professional schools, as well as undergraduate
class activities. The Association of Yale Alumni in Medicine
functions as a component of all three.
Responding alumni were more familiar with the structure and
function of the Yale Medical Alumni Fund—a component of the
Yale Alumni Fund—than with the other alumni organizations.
Annual fund solicitation letters from appointed classmate
agents were acknowledged by medical alumni as the most reli¬
able of all Yale correspondence.
The questionnaire responses indicated that some confusion
exists as to the relationship of Yale medical alumni to the univer¬
sity’s other two umbrella alumni organizations. For clarifica¬
tion, please refer to the short description that accompanies this
article.

SATELLITE REGIONAL PROGRAMS
Although many respondents favored the development of region¬
al alumni satellite organizations by the AYA, some said they
would have difficulty freeing time from busy medical or
academic practices. Thus, the success of such attempted efforts
would depend on the caliber of regional leadership and quality
of programs. Regions of high alumni density may have the most
success. As regions emerge, cooperation from alumni will be
essential. The Hartford, Conn.; San Francisco; Washington,
D.C./Bethesda, Md.; and Durham, N.C. areas already have or¬
ganized leadership and have held informational meetings.
Dean Leon E. Rosenberg and the faculty enthusiastically sup¬
port providing Yale faculty programs for alumni groups. This
initial enthusiasm suggests that these programs be developed
further.

T CHARLES ERICKSON

The House Staff!Fellows-Alumni Status subcommittee is shown at one of its recent meetings. Pictured from left to right are (seated)
Drs. Nina R. Horowitz, E. Maurice Wakeman, Richard Selzer, and (standing) Nicholas PR. Spinelli. Samuel D. Kushlan and
John N. Forrest Jr.

MEDICAL STUDENT WELL-BEING
Perhaps the most touching aspect of the resultant “dialogue”
was the alumni interest in meeting and assisting students. Most
alums want the opportunity to communicate with today’s stu¬
dents, and many have agreed to provide bed and board for outof-town students visiting for residency interviews.
Students, too, are eager for such encounters. Most fre¬
quently, respondents suggested programs in which alumni
provide students with a “tag along” clerkship in practice or
research. While such experiences have so far been difficult to
integrate into the academic curriculum, they may have greater
potential in affiliated Connecticut loci.

“ALUMNI PAPER”—A LEARNING EXPERIENCE
As suspected, most alumni—75 percent—did not know or un¬
derstand the structure of our alumni association or the “barebones” character of its makeup. We hope that our work has
clarified this.
In response to this deficiency, the Office of Medical Alumni
Affairs is planning to inform all Yale medical students about the
alumni association. Future alumni class structure can be greatly

assisted by identifying class leaders while they are still in
school.
Such class organization also can serve as a peer support struc¬
ture for the medical students. Participation by students of the
Class of 1989 in the 25th reunion program of the Class of 1962
in June 1986 exemplifies how mutually nourishing such stu¬
dent-alumni encounters may be. The alumni office will assist
in promoting such future events.

YALE HOUSE OFFICER/FELLOW AS ALUMNUS/A
The commentary that accompanied the “dialogue” responses re¬
vealed a problem the authors had not anticipated: House officers
and fellows who graduated neither from Yale College nor Yale
School of Medicine, but who feel most intensely a Yale identity,
repeatedly expressed feelings ranging from confusion to aliena¬
tion, particularly about their roles at alumni weekend reunions.
Yet as medical students, we all remember house staff in our
clinical rotations who were vital junior faculty and, indeed, role
models for us. They are rightfully important members of our
alumni club and are so identified in our bylaws. Therefore, a
committee of involved and active former house staff alumni will
be convened to study the problems presented, prescribe alterna¬
tive organizational programming and clarify alumni status.
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BYLAWS REVIEW AND REVISION
The bylaws of our association are as simple and as unstructured
as the organization itself. First written in 1880, they last had
minimal attention in 1971. When all committee functions de¬
scribed below are concluded, a bylaws revision subcommittee
may be activated to review and update them.

PROPOSED COMMITTEES TO WORK ON THE
REORGANIZATION OF THE ASSOCIATION OF
YALE ALUMNI IN MEDICINE
A. Ad Hoc Committee for Organization and Bylaws Review
This umbrella committee, chaired by Dr. William L. Kissick
'57 was described in the May '86 paper. Its members include:
William L. Kissick '57, chair
Richard W. Breck '45
Alexander R. Gaudio '63
Carol Goldenthal '44
Attilio V. Granata 'll
Marie-LouiseT. Johnson '56
R. Leonard Kemler'43
Robert A. Kramer '55
Thomas P. Kugelman '60
Samuel D. Kushlan '35
Dwight F. Miller '56
John B. Ogilvie '34
NicholasM. Passarelli '59
Dorothea R. Peck '43
Jerrold M. Post '60
OraK. Smith '53
Muriel D. Wolf'59
B. Proposed Subcommittees
1. Alumni Questionnaire Data Review
This committee is already functioning. Its deliberations will as¬
sist the direction and intensity of future programs.
Richard W. Breck '45
Attilio V. Granata 'll
Samuel D. Kushlan '35
Dwight F. Miller '56, president, AYAM
Dorothea R. Peck '43
Nicholas PR. Spinelli '44
2. Student Well-Being
Attilio V. Granata ’77, chair
Bernard H. Shen '81
John B. Ogilvie '34
Ora K. Smith '53
Amy Lewis (student council president) '89
3. Regional Satellites
Washington, D.C.: Muriel D. Wolf '59, Jerrold M. Post
'60
Hartford, Conn.: R. Leonard Kemler '43, Carol
Goldenthal '44, Alexander R. Gaudio '63
San Francisco: A. John Anlyan '45, Lawrence G. Crowley
'44
4. House Staff/Fellows—Status
Samuel D. Kushlan '35, organizer
Nina R. Horowitz HS '79-84
Richard Selzer HS '53-55, '57-60
John N. Forrest Jr. HS '64-67, 69-70
I Maurice Wakeman HS '60-63

5. Bylaws Review and Revision
Robert A. Kramer '55, co-chair
Nicholas M. Passarelli '59, co-chair
6. Alumni Communication
This committee provides alumni news for YALE
MEDICINE
Richard W. Breck '45, chair
Michael Kashgarian '58
Dorothea R. Peck '43
D. Helaine Patterson, director, YSM Office of Public
Information
Other committees will be formed as needed. Interested
alumni may participate as committee members, even if they live
too far away to attend most meetings. Suggestions from all
alumni are encouraged.

TABLE I
Statistical Summary:
Responses to Questions Enumerated in Questionnaire

A. Alumni Communication
1. Yale Medicine: satisfactory?

yes
no

438
84

total

492

yes
no

205
330

total

535

yes
no
fair

100
63
16

total
(majority didn’t answer or understand
this question—see explanatory paragraphs)

179

2. personal news of classmates and
alumni— satisfactory?

3. news of alumni organizations—
adequate?
(AYA, alumni fund, development)

B. Geographic regional programs: attractive,
yes
reasonable idea?
no
maybe

304
176
26

total

506

yes
no
maybe

364
150
14

total

528

yes
no

153
355

total

508

C. Interest in working with current Yale
medical students?

D. Aware AYAM organization structure
and function before reading paper?

E. Total respondents, as of September 1986

537

CONCLUSIONS
The AYAM paper, circulated in May 1986 to all alumni,
elicited a gratifying response with diverse suggestions for our
association’s future structure and function. These serious deci¬
sions should not be made by only a few association officers or
even the 14-member executive committee. Therefore, numer¬
ous subcommittees are being set up to address each identified
issue. They will be open to all interested alumni.
These alumni will function tentatively as committee mem¬
bers. A word of caution is appropriate, however. Sev¬
eral alumni have commented: “Everything is fine as is;
don’t change a thing; don’t build a nightmare administrative
bureaucracy.”
This sage counsel will be heeded as the dialogue continues.
Meanwhile, the authors and the majority of respondents concur
that the association and its staff can grow to be of even greater
service to our school, its students and ourselves as fellow
alumni. Participation by many and diverse alumni should pre¬
vent the possibilities of unrealistic expectations.
The discussions will be conducted by already busy volunteer
alumni, and the pace of the committees’ work will be slow and,
indeed, deliberate. The counsel of our alumni will be thought¬
fully considered. Change, when recommended, will be to
benefit the school, students and alumni. It will always involve
the simplest administration possible.
Finally, we wish to express our thanks for the abundant colle¬
gial warmth expressed by our alumni correspondents. It was
perhaps best exemplified by an alumna from Monument Valley,
Ariz.(“in the middle of nowhere”), now a physician in the U.S.
Public Health Service. She offered to serve as tourguide to any
YSM alum visiting the American desert, and she extended a
similar invitation from three other Arizona-New Mexico YSM
graduates.

Is the Yale medical alumni mystique alive and well? You’d
better believe it!
Note: Please send personal and professional news, news of
classmates, address changes or other information to:
Director
Office of Medical Alumni Affairs
Yale University School of Medicine
333 Cedar St., P.O. Box 3333
New Haven, CT 06510
To the same office, please send any suggestions for the future
directions of the Association of Yale Alumni in Medicine.

Alumni Glossary
The Association of Yale Alumni in Medicine plans programs
of specific interest to medical alumni. Like its parent organiza¬
tion, the Association of Yale Alumni (AYA), it provides a chan¬
nel of mutual communication between alumni and Yale. Six
medical alumni serve as AYA delegates to report on activities
and concerns of alumni of the School of Medicine.
The Yale Medical School Alumni Fund is part of the Yale
Alumni Fund, which was established in 1890 to raise unre¬
stricted funds for the university. Gifts to the fund by medical
alumni are added to the Student Revolving Loan Fund to pro¬
vide financial aid to medical students.
The Campaign for the Yale School of Medicine was launched
in May, 1985 to raise $125 million for the school’s capital
needs, including endowment, facility construction and renova¬
tion, and program start-up funds.

Reunion 1986
Alumni and guests who attended the 1986 reunion
shared conversation and sustenance. So, plan to
attend the 1987 reunion this June. Center: Dr.
David Raskind '24 and his guest enjoyed the 1986
reunion. Far right: Donald Moore '81 (right) and
guest chat with John D. Thompson, M.S. '50,
professor of public health (hospital administration),
at Yale.
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HERE AND
ABOUT
Dr. Cohen Receives
First Professorship
in Harris Program
Dr. Donald J. Cohen, director of the Child
Study Center and professor in the depart¬
ments of pediatrics, psychiatry and psy¬
chology, has been named as the first Irving
B. Harris Professor of Child Psychiatry.
The Harris professorship is a major com¬
ponent of the Harris Program in Child
Psychiatry, Child Development and Social
Policy created by a $5 million endowment
provided by Irving Harris (Yale ’31) and
Neison Harris (Yale ’36).
The Harris Program consists of the Harris
professorship, four assistant or associate
professorships in child psychiatry, child de¬
velopment, child psychoanalysis and social
policy, and a research fund.
The Harris brothers are leading busi¬
nessmen and philanthropists. Irving Harris
founded the Ounce of Prevention Fund and
is a national advocate for young children
and prevention of mental disorders.
A child psychiatrist and psychoanalyst.
Dr. Cohen joined the School of Medicine
faculty in 1972 and has been the director of
the Child Study Center since 1983.
Dr. Cohen’s clinical and research activ¬
ities have focused on the serious neuropsy¬
chiatric disorders of childhood, including
pervasive developmental disorders, such as
autism, and stereotypic and tic disorders,
such as Tourette’s syndrome. The research
program he has led in the Child Study Cen¬
ter is characterized by the integration of
multiple biological and behavioral perspec¬
tives on psychiatric disorders of childhood,
and the linkage between research and clini¬
cal services.
Dr. Cohen has published more than 200
articles and monographs. Among his
academic activities, he is co-director of the
Yale Mental Health Clinical Research Cen¬
ter; vice president (for North America) of
the International Association of Child and
Adolescent Psychiatry and Allied Profes¬
sions; and a member of various editorial
boards.
He has served on the professional boards
of the National Society for Autistic Chil¬
dren, the Tourette’s Syndrome Association,
and Benhaven, the school and residential
community for autistic individuals affiliated
with the Child Study Center, where he is the
psychiatric director. He also is a trustee of
Brandeis University.
A native of Chicago, Dr. Cohen received
his B.A. degree from Brandeis in 1961 and
an M.D. degree from Yale School of

Medicine in 1966. He took his residency
training at Harvard, Massachusetts Mental
Health Center and Children’s Hospital
Medical Centers, and spent two years at the
National Institute of Mental Health and in
the Office of Child Development in
Washington, D.C.

Dr. Weissman to be
Sterling Professor
Dr. Sherman M. Weissman, professor of
human genetics, medicine and molecular
biophysics and biochemistry, has been
named Sterling Professor of Human Gene¬
tics, Medicine and Molecular Biophysics
and Biochemistry.
In his laboratory. Dr. Weissman is work¬
ing on deriving a molecular map of the
human genome that would be used for gen¬
eral approaches to map genes and different
forms of genes that can effect the likelihood
of having various diseases. Other work fo¬
cuses on the SV 40 virus, an oncogenic
virus; globin genes and genes of the im¬
mune system. He has published more than
170 scholarly articles on his research.
Dr. Weissman was a senior investigator
at the National Cancer Institute metabolism
service from 1960 until 1967, when he
joined the Yale medical faculty as associate
professor of medicine and molecular
biophysics and biochemistry. He was
named professor in 1972.
A member of the National Academy of
Sciences and the Connecticut Academy of
Sciences and Engineering and a fellow of
the American Association for the Advance¬
ment of Science, Dr. Weissman serves on
several editorial boards and has participated
on numerous special national committees
relating to virology and cell biology. At
Yale, he is a member of the University’s
scientific planning committee and was
associate director of the Comprehensive
Cancer Center.
A Chicago native, Dr. Weissman re¬
ceived an M.D. degree magna cum laude in
1955 from Harvard Medical School, an
M.S. degree in 1951 from the University of
Chicago and a B.S. degree in 1950 from
Northwestern University. He took his in¬
ternship at Boston City Hospital, was a clin¬
ical associate at the NIH and completed
residency training at the Illinois Educa¬
tional and Research Hospital in Chicago.

Dr. Farquhar Named
Sterling Professor
Marilyn G. Farquhar, Ph.D., professor of
cell biology and pathology, has been named
Sterling Professor of Cell Biology and
Pathology.
Dr. Farquhar’s current research interests
include the investigation of pathways of
membrane traffic and membrane recycling
in glandular cells. She also is studying
mechanisms of glomerular disease—that
is, diseases that affect the special network
of kidney capillaries that function to filter
the blood.
In 1984, she was elected a member of the
National Academy of Sciences. Earlier, she
was the recipient of a Research Career De¬
velopment Award from the National Insti¬
tute of General Medical Sciences. Her
scholarly publications are among those
most frequently cited.
A past president of the American Society
for Cell Biology, Dr. Farquhar participates
in many professional societies and has
served on the editorial boards of a number
of scientific journals. Within the Univer¬
sity, she has served as director of medical
studies of the department of cell biology and
as chairman of the Basic Sciences Curricu¬
lum Committee. She is currently serving on
the Biological Sciences Advisory and
Senior Appointments Committees.
A native of Tuiare, Calif., Dr. Farquhar
received all three of her degrees: A.B.,
M.A. and Ph.D., from the University of
California at Berkeley. She was a professor
in the faculties of University of California
at San Francisco and the Rockefeller Uni¬
versity before moving to Yale in 1973.

Pediatrics Thanks
Cancer Society
The pediatric oncology division has
thanked the Connecticut Division of the
American Cancer Society for its program
support of research, teaching and patient
services in the School of Medicine.
For the past four years, the Connecticut
Division of the ACS, led by ACS staffer
Jane Bemis, has—through its childhood
cancer committee—brought the needs of
children with cancer into a sharper focus in
both the organization and the state.
Dr. Diane M. Komp, professor of pediat¬
rics and former member of the ACS Na¬
tional Childhood Cancer Advisory Com¬
mittee, recently recognized Mrs. Bemis and
the ACS for the “loving support of our pa¬
tients” in a presentation at the pediatric on¬
cology clinic’s chemotherapy room.

GERI T MANCINI

DRG Costs Must Include
Post-Hospital Care
Some of the money now saved on hospital
costs should be used for home care pro¬
grams for the elderly, says School of
Medicine Professor John D. Thompson,
who helped to develop the DRG cost-con¬
trol system on which the federal govern¬
ment now bases Medicare payments.
Thompson is a professor of public health
(hospital administration) at the medical
school and professor of nursing administra¬
tion at the School of Nursing, and he is a
researcher with the Health Systems Man¬
agement Group at the Yale School of Orga¬
nization and Management.
Since the federal government began
using a DRG-based payment system for
Medicare patients in 1983, hospital admis¬
sions have declined and the average hospital
stay for both Medicare and non-Medicare
inpatients has shortened. Thompson says he
applauds these results.
“Hospitals are unhealthy places for old
folks,” he says. “The longer the hospital
stay, the more chance there is of getting a
nosocomial, or hospital-related, infection.
We wanted to cut down on unnecessary
utilization of hospitals.
“Under the old system,” he says, “no one
asked how long a patient should be in the
hospital. The financial incentives made it
difficult to determine that. Now, with the
DRG system, we can begin to make some
rational decisions.”
But Thompson says he is not pleased with
the overall failure to provide money for
post-hospital care for Medicare patients.
"Shorter terms of hospital care do not
always translate into shorter terms of care
altogether,” he says. “We have seen the
tragedy that resulted from a previous policy
of early discharge and deinstitutionalization
of the mentally ill. There were no support
services provided in the communities to
which these patients were discharged.
“Now we are worried that the same thing
will happen to the Medicare patients: pa¬
tients will be discharged without the support
services, such as home care, convalescent
institutions and nursing homes, that they
will need. Hospitals will be blamed for the
problem, when actually it is just poor public
policy.”
Thompson also is analyzing the use of
DRGs for pricing routine nursing costs in
hospitals. In December, he presented a re¬
port, “DRGs and Nursing,” in London at
the first international conference on “The
Management and Financing of Hospital
Services,” sponsored by the Health Systems
Management Group.

Artist Ann Lehman created this new copper sculpture for the Magnetic Resonance Center.
She's pictured here at the unveiling with Dr. Richard Greenspan (right) and Dr. H. Dirk
Sostman, associate professor of diagnostic radiology.

Copper Sculpture
Created for MR Center
A new sculpture, entitled “Freely Formed,”
welcomes patients, researchers and guests
coming to the Magnetic Resonance Center,
a joint project of the School of Medicine and
Yale-New Haven Hospital.
Ann P. Lehman, an award-winning artist
and teacher who lives in Bethany, Conn.,
created the work that was unveiled in Janu¬
ary by Dr. Richard H. Greenspan, associate
dean for clinical affairs and former chair¬
man of the department of diagnostic radiol¬
ogy. Mrs. Lehman designed the sculpture
specifically for the Magnetic Resonance
Center’s main entrance, and the dramatic
form seems to lean into its comer site.
The hollow sculpture, which measures
6'x4'x5', is made entirely of copper, pos¬
sessing a wonderfully mottled patina that
the artist achieved by combining a variety of
chemicals with heat. The ribbon-like
sculpture is simultaneously strong and deli¬
cate, balanced on a single point. “It is soft,
warm, flowing and non-threatening,” said
Dr. Greenspan, who at the unveiling ex¬
pressed great appreciation for both the work
and Mrs. Lehman’s creativity. He had com¬
missioned the sculpture.
Reaction to the wavy piece has been very
enthusiastic, with viewers noting a resem¬
blance to some MR images.

The piece exemplifies the artist’s philos¬
ophy. Mrs. Lehman says: “Exploring the
extent and variety to which metal can be
manipulated interests me enormously. This
concept has grown out of a fine educational
experience (Smith, Cranbrook and Yale),
combined with sensitivity to technology
and the creative process. Intersecting forms
and the unique abilities of metal are the
methods of my imagery. Some 25 years of
making metal sculpture have given me the
experience to be both practical and erudite.”
Mrs. Lehman has been active in the
Greater New Haven arts community. In
1960, she was one of the founders and first
president of the Creative Arts Workshop,
and she currently serves on the board of di¬
rectors and teaches metal sculpture at the
workshop. She also is president of
Artspace, Inc., an organization that pro¬
vides an exhibition gallery and dance re¬
hearsal performance space for community
artists.
Among her recent commissions include
sculptures for Pepperidge Farm corporate
headquarters, Armstrong Rubber Co., the
New Haven Lawn Club and 100 Whitney
Avenue.
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Book Emphasizes
Doctor-Patient
Relationship, Placebos
Placebos may actually help to relieve pain
and cure illness, says Dr. Howard M. Spiro,
professor of medicine and director of
the school’s program for humanities in
medicine.
“The scientific approach to human
medicine—the molecular model—is not
sufficient by itself to answer all our patients’
needs,” he says. “Disease [the objective
findings of the physician] differs from ill¬
ness [the subjective feelings of the patient],
and placebos help the illness component of
the disease." In his new book. Doctors, Pa¬
tients, and Placebos, published last year by
Yale University Press, Dr. Spiro uses the
placebo as a metaphor for the doctor-patient
relationship and its effect on healing.
“The placebo is a symbol of loyalty of the
doctor to the patient,” he says. “Loyalty in¬
volves knowing what the patient wants,
spending time with the patient, showing
that the doctor cares and doing what is in the
patient’s best interest.”
While placebos alone cannot heal, Dr.
Spiro says their effects on illness cannot be
discounted. He cites evidence that “con¬
trolled clinical trials of healing in peptic
ulcer suggest that more than half the people
getting a placebo benefit from the placebo.”
Their pain is quickly relieved just by being
in the study. “We should look at why that
happens and what placebo relief tells us
about the doctor-patient relationship,” he
urges.
In Doctors, Patients, and Placebos, Dr.
Spiro urges physicians to improve their re¬
lationships with patients, to talk and listen
as much as they look and measure, and to
treat illnesses as well as disease.
He also hopes that medical school
teachers will integrate science and intuition
in teaching medical care, since intuition
gives unique insights that science can test.
“There is increasing emphasis on what
can be seen, on the cellular basis of disease,
and a kind of disdain for the rest,” says
Dr. Spiro. The domination of laboratory
medicine in current medical training “turns
the physician into a scientist studying the
cell and its subcellular processes, tracing its
DNA rather than listening to, or even look¬
ing at, the person who is the patient.
“But there should be no ‘forbidden ques¬
tions,”’ he says. “Medical science, using
scientific criteria, should also examine the
claims of holistic medicine, faith-healers
and folk practitioners.”
Dr. Spiro recommends that physiciansin-training be given more direct experience
with patients who are not in hospitals, since
those are the kinds of patients whom prac¬
ticing physicians are likely to see. “We
should be training doctors not only in the
biomechanical mode,” he says, “but also in

24

seeing outpatients—people who are up and
around—as we used to, 30 years ago.”
Says Dr. Spiro: “Hospitals today are
large intensive-care units. They are not the
best place to train physicians to take care of
patients who may need understanding as
much as science.”
Dr. Spiro received his M.D. from Har¬
vard Medical School in 1947 and has been
a member of the Yale medical faculty since
1955, when he established the gastroen¬
terology section at the Yale School of
Medicine. He is author of a standard
textbook in the field and is the editor of the
Journal ofClincial Gastroenterology.

Dr. Tsien Presented
Javits Award to Study
Calcium Channels
Dr. Richard W. Tsien, professor of physiol¬
ogy, has been given a Javits Neuroscience
Investigator Award for his distinguished
record of contributions in neurological
sciences.
The U.S. Congress established special
Awards to honor the late Sen. Jacob K.
Javits of New York, and the National Ad¬
visory Neurological and Communicative
Disorders and Stroke Council selects the
recipients, whose research is supported for
seven years.
Dr. Tsien, a Rhodes Scholar who joined
the Yale medical faculty in 1970, will focus
his research on developing new approaches
to studying the role of calcium channels in
neuronal function. Specifically, he will
examine the way calcium channels control
the release of neurotransmitters and, in the
long term, the changes in communication
between nerve cells.
His research may be applied in studying
disorders of the nervous system, such as
epilepsy, and in forms of defects in neurotransmitter release.
At Yale, Dr. Tsien and his colleagues
have discovered new types of calcium chan¬
nels in neurons, heart muscle cells and
smooth muscle cells. The new types of
channels seem to be involved in important
cellular functions, such as control of neuro¬
transmitter release and contraction.
Calcium
channels
themselves
are
molecular pores that exist in cell membrane
of all excitable cells. They possess the
unique role of transforming electrical mes¬
sages into chemical messages by allowing
calcium entry into cells.

Unified Language
Sought in Medicine
Computers—those high-tech tools that en¬
gineers and mathematicians have used for
years—have entered medicine, and re¬
searchers at Yale and elsewhere are working
to develop a unified medical language
(UML).
With a two-year, $355,000 grant. Perry
L. Miller, M.D., Ph.D., assistant professor
of anesthesiology, will participate in the
national project sponsored by the National
Library of Medicine.
The goal of the UML project is to develop
a common vocabulary for physicians and
other health professionals when using com¬
puters to retrieve and store bibliographic in¬
formation, abstract clinical records, access
clinical data bases and help in diagnostic
decision-making, according to Dr. Miller.
“If the same language were to be used,
then there would be no need for translation
tables, books and other guides in order to
move easily from one system to another,”
he added. “With a common vocabulary, for
example, clinical computer systems could
gather bibliographic references relevant to a
particular computer-based patient record."
Currently, a variety of vocabularies are
used, including the McSH (Medical Subject
Heading) terms of the National Library of
Medicine and the SNOMED classification
scheme developed for pathology. Computer
programs, such as the INTERNIST/
CADUCEUS diagnosis system, also use
vocabularies to describe symptoms, signs,
test results and diseases.
At Yale, Dr. Miller and his colleagues
will focus on liver disease, using a com¬
puter-based file describing nearly 10,000
liver biopsy specimens meticulously com¬
piled under the direction of the late Dr.
Gerald Klatskin, an internationally known
liver specialist who was the David Paige
Smith Professor Emeritus of Medicine.
“We will see how relationships between
terms may help improve bibliographic re¬
trieval,” Dr. Miller said. "One of our aims
is to facilitate, for example, bibliographic
retrieval of papers relating to a clinical
question in a more focussed, or semanti¬
cally driven, way than the simple keyword
retrieval now available,” he added.
Collaborators include Jon S. Morrow,
M. D., Ph D., and Dr. Kenneth W. Barwick, both associate professors of pathol¬
ogy, and Dr. Caroline A. Riely, associate
professor of medicine. They will work in
conjunction with the Yale Liver Center di¬
rected by Dr. James L. Boyer, professor of
medicine.
Besides Yale, groups at Harvard, the
University of California at San Francisco
and at the University of Pittsburgh and Car¬
negie Mellon University, collaboratively,
are participating in the unified medical lan¬
guage project.

IN PROGRESS
Scientists Quantify
Clothing Comfort
What makes the same shirt feel soft in a dry
climate yet scratchy in the tropics? How do
fabrics affect our perceptions of comfort
and discomfort in different environments?
At the School of Medicine, a team of in¬
vestigators led by Dr. Jan A. J. Stolwijk,
the Susan Dwight Bliss Professor and chair¬
man of the department of epidemiology and
public health, is looking at how the physical
properties of clothing influence human be¬
havior. The work is being conducted in col¬
laboration with researchers at the John B.
Pierce Foundation Laboratory.
“Textile makers say cloth has something
called "hand,’ which is how it feels when
you touch it,” says Dr. Stolwijk. “We tried
to see whether there was another character¬
istic of cloth that would affect how comfort¬

able you would find it—and that would
have to do with how much it pulls on the
skin.”
Their results, reported in a recent issue of
Textile Research Journal, show that when
the human body feels hot and moist, it per¬
ceives clothing texture more keenly; and as
perceptions of clothing texture increase,
physical comfort decreases.
The researchers say these results could
have a significant impact on the design of
cloth and clothing for specific uses—work
uniforms, protective clothing and hospital
bedsheets, for example.
The study marks the first time that re¬
searchers have been able to quantitatively
relate perceptions of fabric texture and
pleasantness to both the friction resulting
from fabric rubbing over the skin surface
and the amount of moisture on the skin.
The research team developed a new tech¬
nique for measuring local skin moisture
(“wettedness”). When this measurement
rose above 30 percent, the measured
coefficient of friction between the skin and
fabric increased significantly, as did subjec¬
tive ratings of clothing discomfort.

The researchers hypothesize that the skin
surface may become more adhesive when it
is wet. “We think the skin softens when we
sweat, allowing fabric fibers to dig into the
skin,’’ says researcher Larry G. Berglund,
Ph D., a visiting lecturer in environmental
technologies at the Yale School of Architec¬
ture. The rougher the fabric, the more it re¬
sists sliding, he says.
The research team also includes Andrea
R. Gwosdow, Ph D., a postdoctoral fellow
in the department of epidemiology and pub¬
lic health; and Joseph C. Stevens, Ph D.,
senior research scientist and lecturer in
psychology.
Of the six fabrics tested in the study (wor¬
sted wool, brushed cotton, cotton, silk,
linen and burlap), silk consistently was
rated by research subjects as feeling most
pleasant and least textured (smooth), no
matter how wet the skin surface. The fric¬
tion of silk against skin was measured to
be less than half of the friction of the other
fabrics under the same environmental
conditions.
But Dr. Stolwijk says the smoothness
that makes a fabric feel pleasant in warm
and humid climates can make the same fab¬
ric uncomfortable in the cold.
“When you get into silk sheets in the win¬
tertime,” he says, “you feel cold; get into
flannel sheets at the same temperature, and
you feel warmer. The only difference is
how the fabric fibers touch your skin." The
nap of flannel keeps a portion of the cloth
fibers away from the skin, says Dr. Stol¬
wijk. Thus, less of the skin surface is cooled
by the fabric. And he says the warmer the
skin surface feels, the warmer the whole
body feels.

NIH Funds Sperm
Physiology Research
on Male Infertility

Andrea R. Gwosdow, Ph D., demonstrates the research apparatus used to measure the
frictional force of fabrics, as she slowly pulls cloth across the forearm of Larry G. Berglund,
Ph D. (behind curtain).

The National Institute of Child Health and
Human Development, a division of the Na¬
tional Institutes of Health, has awarded Dr.
Gabor B. Huszar, director of the sperm
physiology laboratory at the School of
Medicine, a three-year grant of $214,587
for male infertility research. The grant
began in August. Dr. Huszar is a research
scientist in obstetrics and gynecology and
pediatrics.
Dr. Huszar is looking for biochemical
markers that can predict sperm fertility.
This research will concentrate on the activ¬
ity of key enzymes of energy synthesis and
utilization, such as creatine phosphokinase
and dynein ATPase (the principal structural
protein and enzyme in sperm motility), and
the pool of compounds important in energy
transport, such as creatine and creatine
phosphate.
“We are measuring the activity of these
enzymes in sperm specimens of men with
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normal and with low sperm counts, and we
are looking at the correlation among sperm
quality and the activity of these enzymes
and the concentration of the energy transfer
compounds. By a fractionation method
based on sperm motility, we are preparing
the best quality sperm population—those
with the highest linear velocity,” says Dr.
Huszar.
About 40 percent of the 10 to 12 million
infertile couples in the United States have a
male infertility problem. If that infertility is
attributed to oligospermia—a low concen¬
tration of sperm—improved quality sperm
specimens may enhance the chances for
pregnancy by intrauterine insemination and
in vitro fertilization, says Dr. Huszar.
For patients with normal sperm counts
but sluggish sperm motility. Dr. Huszar is
looking at biochemical methods of enhanc¬
ing sperm motility.
Together with Neil J. MacLusky, Ph D.,
associate professor of obstetrics and
gynecology and pharmacology; Dr. Alan
H. DeCherney, the John Slade Ely Profes¬
sor of Obstetrics and Gynecology; Dr.
Hasan Fakih, a former fellow in the depart¬
ment of obstetrics and gynecology, cur¬
rently at Michigan State University; and
Theo Wallimann, Ph D , of the Institute fur
Zellbiologie, Zurich, Switzerland, Dr.
Huszar has published the first major paper
pursuing this line of research, entitled “En¬
hancement of human sperm motility and
velocity in vitro: effects of calcium and
creatine phosphate,” in the November 1986
issue of Fertility and Sterility.

Yale, State Officials
Study Airborne Toxins
The Yale Comprehensive Cancer Center
and the Connecticut Department of En¬
vironmental Protection will collaborate in a
new program to identify and eliminate air¬
borne toxins that contribute to cancer and
birth defects.
In announcing the new program. Gov.
William A. O’Neill said, “This cooperative
program represents an innovative approach
to the protection of our environment and
public health that will tremendously benefit
the citizens of our state.” It is the first pro¬
gram of its kind in the nation.
For this program, Mrinal K. Sanyal,
Ph D., research scientist in obstetrics and
gynecology, has developed analytical tech¬
niques involving biological and human tis¬
sue testing. His new procedures greatly
simplify the search for lethal toxins in air
samples.
The DEP will monitor the biological ef¬
fects of air pollutants on an ongoing basis at
sites across the state and study the toxic ef¬
fects of various air samples.
“The goal of this project is to identify lo¬
cations around the state that have toxic sub¬
stances in the air, to find the sources of those
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substances and to clean them up,” Governor
O’Neill said in late January.
Dr. Alan C. Sartorelli, director of the
Yale Comprehensive Cancer Center, added,
“This collaboration could have a significant
impact on reducing the incidence of cancer
and birth defects in our state. It is our hope
that this important initial study will lead to
further collaborative projects between Yale
and the state Department of Environmental
Protection.”

New Center Focuses
on Pain Management
The Department of Anesthesiology has ex¬
panded its pain management program by es¬
tablishing the Yale Center for Pain Manage¬
ment and naming Dr. Josef K. Wang as its
first full-time faculty director. Dr. Wang,
who left the Mayo Clinic in Rochester,
Minn., to join the Yale medical faculty as
professor of anesthesiology, set up the out¬
patient service to help patients who suffer
from acute and chronic pain syndromes.
The center is located in Hunter 4 at YaleNew Haven Hospital.
“If we can manage pain effectively in the
early stages, then fewer patients will suffer
from chronic pain problems,” says Dr.
Wang. “An aggressive approach, which
combines physical therapy, exercise, re¬
gional pain control and medications, will
help people who have developed such prob¬
lems as shingles or low-back or neck
injuries,” the anesthesiologist says. “By
managing pain earlier,” he contends, “indi¬
viduals may avoid psychological, emo¬
tional and social problems that may result
from delayed treatment.”
The Yale Center for Pain Management,
which is part of the school’s Faculty Prac¬
tice Plan, employs a multidisciplinary ap¬
proach encompassing anesthesiology, psy¬
chology, orthopaedics, neurology and
neurosurgery.
Both outpatients and inpatients are
treated for many types of pain, such as mus¬
cle, joint and cancer pain; headaches and
pain following surgery, nerve injury, ampu¬
tation or spinal cord injury. Nerve blocks,
nerve
stimulation,
medications
and
cryoanalgesia—low-temperature freezing
of nerve fibers—are among the methods
used to relieve pain.
In the mid-1970s. Dr. Wang conducted
basic research that resulted in pioneering
techniques to inject narcotics into human
spinal canals and control cancer pain. After
10 years, he says that the procedure has be¬
come standard practice for treating some
three million patients annually throughout
the world.
Some of this work was based on laborato¬
ry studies using spinal opiates to control
pain that Dr. Luke M. Kitahata, professor
of anesthesiology, conducted at Yale. This
close association between basic science and

clinical work in Yale’s anesthesiology de¬
partment attracted Dr. Wang to the School
of Medicine.
Dr. Wang has expanded his initial re¬
search on cancer pain management to in¬
clude postoperative pain, labor-related pain
and body trauma. Most recently, he’s con¬
centrated on alleviating pain associated
with heart attacks, pulmonary embolisms
and pancreatitis.
Dr. Wang cites several areas where more
pain research is needed: massive bums,
where patients may suffer pain for months
until complete healing occurs; and kidney
stones, where the excruciating pain may last
only two or three days until individuals pass
their stones.
A Kobe, Japan, native who became an
American citizen in 1970, Dr. Wang had
been associated with the Mayo Clinic and
Mayo Medical School since 1974. He
helped establish the Mayo Pain Clinic and
served as its first director from 1980 to
1986, before coming to Yale in May 1986.

New Grant Expands
Brain Cell Studies
Dr. D. Eugene Redmond Jr., associate pro¬
fessor of psychiatry at the School of
Medicine, has been named program direc¬
tor for a three-year, federally funded study
on how brain cell transplants effect a chemi¬
cal model of Parkinson's disease.
For this work extending previous studies,
Yale University will receive $1.8 million
from the National Institute of Neurological
and Communicative Disorders and Stroke.
“Parkinson’s disease is one of the few
brain disorders in which the deficit is under¬
standable and due to the loss of a particular
kind of cell," Dr. Redmond said. “By using
a drug, MPTP, to produce a functional
model by destroying these same cells, we
eventually hope to learn whether we can re¬
store function by replacing the lost cells
through transplantation."
The team’s previous transplant work has
shown that nerve cells will grow and, even
more importantly, organize and establish
themselves like brain cells. The team hopes
to find out whether the transplanted fetal
primate brain cells send and receive mes¬
sages the same way as the original brain
cells did, according to Dr. Redmond.
The research program, which involves
biomedical scientists at Yale and the Uni¬
versity of Rochester, includes four main
projects. John R. Sladek Jr., Ph.D., profes¬
sor and chairman of neurobiology and
anatomy, leads a University of Rochester
team that will study the neuroanatomical
distribution of changes produced by MPTP
and the location and connections estab¬
lished by the transplants.
Robert H. Roth, PhD., professor of psy¬
chiatry and pharmacology, serves as princi¬
pal investigator for project two, in which his

team will use biochemical techniques to
study transmitters and transmitter deficits.
As principal investigator for project
three. Dr. Redmond and his colleagues will
characterize the motor, behavioral and cog¬
nitive changes. Dr. Benjamin S. Bunney,
professor of psychiatry and pharmacology,
will use new electrochemical methods to
study chemical changes in awake behaving
animals for the fourth project.
The transplant work is conducted at the
independent Axion Research Foundation
Primate Facility in St. Kitts, a West Indian
island where the African green monkeys are
studied in a more natural environment. Tis¬
sue samples collected in St. Kitts are
studied in New Haven and Rochester.

FACULTY NEWS
Dr. Bruce M. McDonald, clinical profes¬
sor of pediatrics, has been appointed senior
vice president for medical affairs at
Bridgeport Hospital.
The Yale School of Medicine was well
represented at the National Institute of
Child Health and Human Development
Child Health Day symposium on Oct. 6.
Dr. Ruth Whittemore, clinical professor
of pediatrics, presented a paper on “40
Years in Pediatric Cardiology.” The sym¬
posium, held in conjunction with the begin¬
ning of the NIH centennial year, com¬
memorated 100 years of pediatric research.
Other Yale participants were Dr. Charles
Lowe '45, special assistant to NICHD di¬
rector Dr. John Crawford, and Dr. Harry
H. Gordon '32 of Rye, N Y.
The American College of Epidemiology
presented its Abraham M. Lilienfeld Award
to Dr. Alfred S. Evans, the John Rodman
Paul Professor of Epidemiology and direc¬
tor of the World Health Organization Serum
Reference Bank at Yale’s department of
epidemiology and public health.
The prestigious award was presented at
the ACE annual meeting, held last fall at the
School of Medicine.
Dr. Evans was recognized for his con¬
tributions to the field of epidemiology and
to science and public health, which
“epitomize the high standards of craft and
professionalism demonstrated in the life
and career of Dr. Abraham M. Lilienfeld.”
Dr. Evans came to Yale in 1946 to work
with Dr. Paul, but was recalled into the
Army in 1950. In 1952, he went to the Uni¬
versity of Wisconsin, where he became
chairman of the department of preventive
medicine and director of the state laboratory
of hygiene. When Dr. Paul retired from
Yale in 1966, Dr. Evans was called back to
the School of Medicine to be professor of

epidemiology and director of the WHO
Serum Reference Bank.
Joseph F. Hoffman, Ph D., the Eugene
Higgins Professor of Physiology, received
the first Aser Rothstein Award Nov. 21 in
Toronto. Dr. Hoffman, who gave a lecture
on the occasion of Dr. Rothstcin’s retire¬
ment, was recognized for his contributions
to red cell membrane physiology. This
award was established to honor Dr. Aser
Rothstein, director of the Research Institute
of the Hospital for Sick Children in Toronto.
Dr. Dennis D. Spencer, professor of
surgery (neurosurgery), has been appointed
chief of the neurosurgery section in the de¬
partment of surgery. He has been acting
chief since November 1984.
Dr. Spencer, who completed residency
training at Yale-New Haven Hospital and
was named assistant professor of neuro¬
surgery in 1977, has focused his work on
epilepsy, specifically treating intractable
conditions with surgery. Estimates indicate
that 100,000 patients in the United States
could benefit from such a procedure.
In December, Drs. Dennis and Susan S.
Spencer traveled to Taiwan jointly on the
Lennox Visiting Professorship sponsored
by the Epilepsy Foundation of America.
They presented lectures and began efforts to
assist the department of neurology at Chang
Gung Memorial Hospital in Taipei in set¬
ting up an epilepsy surgery program. Dr.
Susan Spencer is an associate professor of
neurology.
The Camille and Henry Dreyfus Founda¬
tion, Inc. has named William J. McGin¬
nis, Ph.D., assistant professor of molecular
biophysics and biochemistry, a Camille and
Henry Dreyfus Teacher-Scholar. He is one
of 12 young faculty members in the United
States to receive the grants.
As a teacher-scholar, McGinnis will ex¬
pand his work on the molecular genetics of
pattern formation in animal development,
using fruit flies as a model. He joined the
Yale faculty in 1984. In January, the Na¬
tional Science Foundation selected McGin¬
nis as one of 200 engineers and scientists to
receive Presidential Young Investigator
Awards, which are intended to help univer¬
sities attract and retain outstanding young
Ph.D.s who might otherwise pursue non¬
teaching careers.
Frank H. Ruddle, Ph D., professor of
biology and human genetics, and Dr. Leon
E. Rosenberg, dean of the School of
Medicine, have been selected to serve on
the National Research Council Committee
on Mapping and Sequencing the Human
Genome. The committee also includes three
Nobel Prize winners: Walter Gilbert, James
Watson and Daniel Nathans.
Dr. Allen C. Steere Jr., associate pro¬
fessor of medicine, arranged a day-long

symposium at which four physicians from
the Union of Soviet Socialist Republics par¬
ticipated. The December event was the re¬
turn portion of a U.S.-U.S.S.R. exchange
program sponsored by the National Insti¬
tutes of Health and the U.S. Department of
State. In 1985, Dr. Steere traveled to the
U.S.S.R. to speak at the Third Congress of
Rheumatology of the Soviet Union.
The Soviet delegation—two rheumatol¬
ogists, a neurologist and an orthopedic
surgeon—was especially interested in
Lyme disease, a tick-borne infection that
Yale medical researchers identified in 1975
in Connecticut. The disease now occurs in
the Soviet Union.
The Soviet physicians, who spoke at the
department of internal medicine grand
rounds, expressed hope for peace, the dis¬
covery of new drugs to alleviate suffering,
and greater cooperation between the United
States and their own country.
Dr. Anne McB. Curtis, professor of
diagnostic radiology, has been named act¬
ing chairman of the School of Medicine de¬
partment of diagnostic radiology and acting
chief of diagnostic imaging at Yale-New
Haven Hospital. Dr. Curtis, who joined the
Yale medical faculty in 1975, specializes in
thoracic radiology.
A native of New York City, Dr. Curtis re¬
ceived a B.A. degree in 1964 from
Radcliffe College and an M.D. degree cum
laude in 1970 from Yale School of
Medicine. She interned and took one year of
residency training in internal medicine at
Yale-New Haven Hospital, and completed a
three-year residency training program in
diagnostic radiology at Yale-New Haven
Hospital.
She fills an opening created Oct. 1 when
Dr. Richard H. Greenspan was named to the
new position of associate dean for clinical
affairs in the medical school.
Dr. John S. Ebersole, associate profes¬
sor of neurology, began a one-year term as
treasurer of the American Epilepsy Society
at the 40th anniversary meeting last fall in
Seattle. He also presented a paper on the
mechanisms of social epileptogeneis at the
EEG course.
Dr. Pasko Rakic, professor of neurosci¬
ence and chairman of the section of
neuroanatomy, has been presented the Karl
Spencer Lashley Award for his research on
development of the central nervous system.
Established in 1957 by a gift to the Ameri¬
can Philosophical Society, the award is
given periodically to recognize “useful and
significant” work in neurobiology.
Since 1965, Dr. Rakic, the Dorys
McConnell Duberg Professor of Neurosci¬
ence, has been working on the mechanisms
of neuronal proliferation, migration and de¬
velopment of synaptic connections in the
brain.
Among contributions cited at a fall cere-
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mony in Philadelphia were the concept of
membrane surface mediated neuronal-glial
interactions in neuronal migration, discov¬
ery of neuronal abnormalities due to defects
in single genetic loci in neurological mutant
mice, and the role of selective elimination
of supernumerary neurons and axons in for¬
mation of synaptic connections during preand postnatal development.
The American Association of Blood
Banks presented its 1986 Distinguished
Service Award to Dr. Joseph R. Bove, pro¬
fessor of laboratory medicine at the School
of Medicine and associate director of clini¬
cal laboratories at Yale-New Haven Hospi¬
tal, in recognition of his service as chairman
of the association’s committee on trans¬
fusion-transmitted diseases.
Dr. Bove has been instrumental in AABB
efforts to create comprehensive policies on
infectious diseases, especially AIDS. In ad¬
dition to his work as a consultant for the
FDA Blood Products Advisory Committee,
which he chaired from 1981 to 1983, Dr.
Bove is chairman of the Connecticut State
Department of Health Advisory Committee
on Plasmapheresis and Blood Banking. He
was a member of the Food and Drug Ad¬
ministration Panel for Blood and Blood De¬
rivatives and is past president of the New
England Transfusion Society.

Dr. Kashgarian to Edit

YALE MEDICINE
Dr. Michael Kashgarian, professor of pa¬
thology, has been named editor of YALE
MEDICINE, the School of Medicine’s
alumni magazine published three times
a year. He succeeds Dr. Arthur Ebbert Jr.,
deputy dean and professor of medicine,
who has relinquished his editorial duties.
Dr. Kashgarian joined the School of
Medicine faculty in 1964 as assistant pro¬
fessor of pathology, and was named profes¬
sor in 1977. He is vice chairman of the
pathology department, a position he has
held since 1976. He also served as associate
chief pathologist at Yale-New Haven Hos¬
pital from 1976 to 1985.
A New York City native. Dr. Kashgarian
received an A.B. degree in 1954 from New
York University and an M.D. degree in
1958 from Yale School of Medicine. He
took residency training at Barnes Hospital
in St. Louis and Yale-New Haven Hospital.
He also was a research fellow in renal phys¬
iology at the University of Goettingen.
Much of Dr. Kashgarian’s research re¬
lates to the pathobiology of renal disease.
Studies include the morphological corre¬
lates of ionic transport, the role of the

Dr. Provence Named
Professor Emeritus
Dr. Sally Provence retired on Oct. 1, 1987
and was named professor emeritus in the
Child Study Center and pediatrics. Dr.
Provence began her career at Yale in 1949
as instructor in the Child Study Center and
pediatrics.
She created and designed the Child De¬
velopment Unit in the Child Study Center
for the study and treatment of younger chil¬
dren; she served as its director from 1951 to
1978. The wing that houses the unit will be
named the Provence-Harris Wing in honor
of Dr. Provence and Irving B. Harris, a
child and family advocate who generously
supports the Child Study Center.
Dr. Provence is also a founding director
of the National Center for Clinical Infant
Programs; she currently serves as its presi¬
dent.
She has been involved continuously in
teaching, clinical research and clinical ser¬
vice, and has been particularly interested in
applications of research for the improve¬
ment of services to children and parents.
She is the author of many articles and
several books on scientific and clinical as¬
pects of child development.

The wing that houses the Child
Development Unit will be named after
Dr. Sally A. Provence (right) and Irving
B. Harris of Chicago, a 1931 Yale College
graduate and one of the nation’s leading
advocates for children and families. They
and others also founded the National
Center for Clinical Infant Programs.

glomerular
mesangium
in
chronic
glomerularsclerosis and the mechanisms of
recovery from acute renal injury. He has
published more than 160 articles in scholar¬
ly journals.
Active on numerous editorial boards and
professional organizations. Dr. Kashgarian
served as president of the Connecticut Soci¬
ety of Pathologists in 1975 and is a fellow
of the American Society of Clinical
Pathologists and the College of American
Pathologists.
At Yale, Dr. Kashgarian has served as
chairman of the medical school’s commit¬
tee on the well being of students and as a
member of the affirmative action commit¬
tee. He also is a fellow of Jonathan Edwards
College. In 1983-1984, he was president
of the medical staff at Yale-New Haven
Hospital.

Physiologists Win
Top Awards
Two medical faculty members received the
top awards at the 19th annual meeting of the
American Society of Nephrology held Dec.
7-10 in Washington, D.C.
Dr. Emile L. Boulpaep, professor and
chairman of the department of physiology,
received the Homer W. Smith Award given
by the ASN and the New York Heart As¬
sociation for outstanding achievements in
renal physiology.
For his award address. Dr. Boulpaep dis¬
cussed “Biomembranes and Epithelial Path¬
ways in Renal Tubule Transport.”
An electrophysiologist. Dr. Boulpaep
has made fundamental contributions to un¬
derstanding electrical current flow and elec¬
trical potential generation in single renal
tubules. This has significantly contributed
to understanding how the kidney handles
water and ions.
Dr. Boulpaep received an M.D. degree in
1962 from the University of Louvain in Bel¬
gium and an honorary master of arts degree
in 1979 from Yale University. He joined the
Yale medical faculty in 1969 as assistant
professor of physiology, and 10 years later
was named professor and chairman of the
department of physiology.
Walter F. Boron, M.D , Ph D., associate
professor of physiology, was presented the
second annual Young Investigator Award
given by the ASN and the American Heart
Association. The award goes to an indi¬
vidual under age 41 for outstanding nephrologic research.
For two consecutive years, Yale faculty
members have won this award. Last year.
Dr. PeterS. Aronson, associate professor of
medicine and physiology, received the
same award.

ALUMNI NEWS
Dr. Beatrix A. Hamburg ’48, professor of
psychiatry and pediatrics, Mount Sinai
School of Medicine, City University of
New York, has been elected to the Ameri¬
can Association for the Advancement of
Science board of directors. Her four-year
term began Feb. 19.
Dr. Ian C. MacLean 65 HS, associate
professor, department of rehabilitative
medicine, Northwestern University Medi¬
cal School and a member of the attending
staff at the Rehabilitation Institute of
Chicago, was elected to the American
Academy of Physical Medicine and Re¬
habilitation board of governors at its 48th
annual assembly in October. After five
years of service, the post leads to the presi¬
dency of the organization.
Dr. David H. Shapiro ’65 HS, of Clear¬
water, Fla., was elected to the American
College of Surgeons board of governors as
a govemor-at-large from Florida. He began
his three-year term Oct. 23. Dr. Shapiro
practices general and vascular surgery in
Clearwater and is an assistant clinical pro¬
fessor of surgery at the University of South
Florida College of Medicine.
W.W. Norton & Co. recently published
The Crown Prince, a novel by Dr. John
Barchilon ’65, who practices sports
medicine in Los Angeles. The book is based
on the life of the legendary concert pianist
Paul Wittgenstein. Set in Vienna, Paris and
Berlin, it is also the story of Maurice Ravel
and the famous Concerto in D.
Dr. Robert M. Pearl ’72, associate clin¬
ical professor, plastic and reconstructive
surgery, Stanford University, was pre¬
sented the Robert H. Ivy Society Award at
the American Society of Plastic and Recon¬
structive Surgeons (ASPRS) annual scien¬
tific meeting in Los Angeles, Oct. 27. The
award, which recognizes excellence in
preparation, presentation and delivery, is
given to the physician whose presentation
was selected as best during the ASPRS an¬
nual meeting the previous year. Dr. Pearl
received the award for his paper on “Surgi¬
cal Management of Volumetric Changes in
the Bony Orbit.”
Dr. Robert J. DeLorenzo ’74, professor
and chairman, department of neurology.
Medical College of Virginia campus of Vir¬
ginia Commonwealth University, has re¬
ceived a Javits Neuroscience Investigator
Award for research into the role calcium
plays in brain cells, particularly cells dam¬
aged by stroke and epilepsy. The award
honors the late U.S. Sen. Jacob K. Javits of
New York.

Dr. John J. Kao '77 will be promoted to
associate professor of business administra¬
tion at the Harvard University Graduate
School of Business Administration, effec¬
tive June 1987.
In September, Dr. Jean L. McMahon
’44 HS retired as director of rehabilitation
services at the Children’s Hospital at the
University of Colorado School of Medicine
in Denver.
Dr. Bernard Robert Rowen ’43, of
Tacoma, Wash., has retired from his prac¬
tice in internal medicine.
Gov. William A. O’Neill has appointed
Dr. Frederick G. Adams ’70 M.P.H. to
be the commissioner of health services
for Connecticut. A Hartford dentist. Dr.
Adams has served as dean of the University
of Connecticut School of Allied Health Pro¬
fessions and vice president for student
affairs and services at the University of
Connecticut in Storrs. His appointment
was effective March 1.
Dr. John P. McGovern '46 HS, of
Houston, has received the 1986 Distin¬
guished Alumnus Award of Alpha Epsilon
Delta, the national premedical honor soci¬
ety. A past president of the American Col¬
lege of Allergists, Dr. McGovern founded
the McGovern Allergy Clinic in Houston.
He also holds faculty appointments at the
Baylor College of Medicine and all six
degree-granting schools in the University
of Texas Health Science Center at Houston.
Dr. Gary L. Schaer ’79 has been elected
to fellowship in the American College of
Cardiology. He is an assistant professor of
medicine at Georgetown University Hospi¬
tal, Washington.
Dr. William Barry Gault ’64 has been
appointed to the NeWell Health Corporation
Board of Overseers, in Newton, Mass. Dr.
Gault, a practicing psychiatrist, is coordi¬
nator of the psychiatric training program for
Tufts University medical students at New¬
ton-Wellesley Hospital, and he is chief
of intensive treatment at Bournewood
Hospital.

Dr. Shu!man Named
New NIAMS Director
Dr. Lawrence E. Shulman ’45 Ph D. (pub¬
lic health), ’49 M.D. has been appointed
director of the new National Institute of
Arthritis and Musculoskeletal and Skin
Diseases (NIAMS).
As director, Dr. Shulman will oversee
the conduct and support of federal programs
in biomedical research and research training
in arthritis and musculoskeletal and skin
diseases.
He was acting director of NIAMS since
its establishment last April, and previously
was director of the Division of Arthritis,
Musculoskeletal and Skin Diseases at NIH.
An internationally known rheumatolo¬
gist, Dr. Shulman’s research has focused on
rheumatic
diseases,
such
as
lupus
erythematosus and scleroderma. In 1974,
he discovered eosinophilic fasciitis, also
called Shulman’s disease. He has written
more than 100 scientific papers and numer¬
ous sections in major textbooks of
rheumatology and internal medicine.
Dr. Shulman was president of the Ameri¬
can Rheumatism Association in 1974-75,
and in 1979, the Arthritis Foundation gave
him its distinguished service award. For
the past four years, he has been president
of the Pan American League Against
Rheumatism.

NEW BOOKS
Aging Myths: Reversible Causes of Mind
and Memory Loss, by Siegfried J. Kra,
M. D., associate clinical professor of
medicine. McGraw-Hill, Inc., (New York,
N. Y.) 1986.
Ambulatory Surgery and Office Procedures
in Head and Neck Surgery, edited by KeatJin Lee, M.D., assistant clinical professor
of surgery, and Carol Stewart, Southern
New England Telephone Co. Harcourt
Brace Jovanovich Publications, (New
York, N.Y.) 1986.
Bypass Surgery: Who Needs It?, by Sieg¬
fried J. Kra, M.D., associate clinical pro¬
fessor of medicine. W.W. Norton & Co.,
Inc. (New York, N.Y.) 1986.
Doctors, Patients, and Placebos, by How¬
ard M. Spiro, M.D., professor of medicine.
Yale University Press (New Haven, Conn.)
1986.
Ectopic Pregnancy, edited by Alan H. DeChemey, M.D., John Slade Ely Professor
of Obstetrics and Gynecology. Aspen Pub¬
lishers, Inc. (Rockville, Md.) 1986.
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Foundations of In Vitro Fertilization,
edited byC.M. Fredericks, Ph D., Medical
University of South Carolina, Alan H. DeChemey, M.D., John Slade Ely Professor
of Obstetrics and Gynecology, and J.D.
Paulson, M.D., Alexandria Infertility As¬
sociates in Va. Harper & Row Publishers,
Inc. (Washington, D.C.) 1986.
The Nurturing Father, by Kyle D. Pruett,
M.D., associate clinical professor in the
Child Study Center and psychiatry. Warner
Books, Inc. (New York, N Y.) 1986.
Reproductive Failure, edited by Alan H.
DeCherney, M.D., John Slade Ely Profes¬
sor of Obstetrics and Gynecology. Chur¬
chill Livingston, Inc., (New York, N.Y.)
1986.
Reproductive Surgery, edited by Alan H
DeCherney, M.D., John Slade Ely Profes¬
sor of Obstetrics and Gynecology, and
Mary Lake Polan, M.D., associate profes¬
sor of obstetrics and gynecology. Year
Book Medical Publishers, (Chicago, Ill.)
1986.
The Crown Prince, a novel, by John Barchilon, M.D. '65 of Los Angeles, Calif. W.W.
Norton & Co., (New York, N.Y.) 1986.

OBITUARIES
Marguerite Lerner, M.D.
Dr. Marguerite R. Lerner, professor of der¬
matology from 1973 to 1980, died March 3
at her home in Woodbridge, Conn, after a
long illness. She was the wife of Dr. Aaron
B. Lerner, professor of dermatology.
Dr. Lerner was born in Minneapolis on
May 17, 1924. A summa cum laude
graduate of the University of Minnesota in
1945, she attended Johns Hopkins Medical
Institutions, Baltimore, and received her
M.D. degree from Case Western Reserve
University School of Medicine, Cleveland,
in 1950.
Dr. Lerner came to Yale in 1957 as clincal instructor in dermatology, becoming as¬
sistant clinical professor of dematology in
1960, associate clinical professor in 1966
and professor of dermatology in 1973. She
was instrumental in setting up dermatology
services for the Yale Health Plan at Univer¬
sity Health Services and served as chief of
dermatology services from 1971 to 1980.
She wrote 15 children’s books, and in
965 was awarded the Brotherhood Award
tor Red Man, White Man, African Chief, a
book on skin color. She also wrote Medical
School The Interview and the Applicant,
and was co-author, with her husband, of
Dermatologic Medications.
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In 1980, in recognition of her talents as
an author of children’s books, her family es¬
tablished the Marguerite Rush Lerner
Award, which is given annually to a
graduating medical student for outstanding
creative writing.
Besides her husband, she is survived by
four sons. State Rep. Peter Lerner of Woodbridge, Dr. Michael Lerner of Hamden, Dr.
Ethan Lerner of Boston, and Seth Lerner of
New Haven; a brother, Gilbert Rush of Los
Angeles; and a sister, Pamela Smith of San
Diego.

Clarence D. Davis, M.D.
Dr. Clarence D. Davis, professor emeritus
of obstetrics and gynecology, died Jan. 26.
in San Diego, Calif. He was 74.
Dr. Davis began his career at Yale as
associate professor of obstetrics and
gynecology in 1957 and was professor of
obstetrics and gynecology from 1964 until
1978, when he was named professor
emeritus.
While in Connecticut, he was an obstetri¬
cal consultant to the maternal-child health
section of the state Department of Health
Services, lecturing and evaluating services
at state hospitals. He is survived by his
wife, Beatrice McKeller Davis; two sons,
Daniel and Peter Davis, and a daughter,
Susan Davis.

Donald Silverman, M.D.
Dr. Donald R Silverman, assistant clinical
professor of medicine since 1977, died at
his home in Westport, Conn, on Dec. 13.
He was 48.
Dr. Silverman was associated with sev¬
eral area hospitals, and was chief of the sec¬
tion of renology, department of medicine,
at Bridgeport Hospital.
He is survived by his wife, Lynne Nolan
Silverman; his mother, Helen Weinstein
Silverman; a son, Neal Silverman; a daugh¬
ter, Margaret Silverman; and a brother,
Leon Silverman.

Harold G. Higgins, M.D.
Dr. Harold G. Higgins, assistant clinical
professor of medicine from 1955 until
1974, died Sept. 25 in Seattle He was 76.
Dr. Higgins, an internist in New Haven
for many years, was a World War II Army
Medical Corps veteran; he received three
bronze stars while serving as a battalion sur¬
geon in Europe.
Besides his wife, Elizabeth McGuire
Higgins, he is survived by three daughters
and a son.

IN MEMORIAM
Stella Booth, M.D.
(formerly Stella Wood)
June 8, 1986
James Rae Ameill Jr.
September 22, 1986
James C. Hart
December 20, 1986
Jean P. Davis
October 2, 1986
Chester S. Bowers
July 27, 1986
Boy Frame, M.D.
August 1986

’62 M.P.H.

’29 M.D.

’30 M.D.
'39 M.P.H.
’43 M.D.

’48 M.P.H.

’48 HS

Ralph M. Gofstein
August 1986

'51 M.D.

James R. Durham
October 31, 1986

’52 M.D.

William R. Metzger, M.D.
July 28, 1986
Frederick Snyder, M.D.
January 26, 1986

'51 M.P.H.

’57 HS

Gerontology Professorship
Established

New Haven Foundation
Grant to Aid Women

The Department of Internal Medicine has a
newly endowed professorship, thanks to a
grant from The Humana Foundation of
Louisville. The Humana Foundation Pro¬
fessorship will support a senior faculty
member in the field of gerontology.
The strength of the Yale geriatrics pro¬
gram was an important factor in the decision
to award the grant, according to Sue B.
Dorn, associate vice president for develop¬
ment and director of medical school de¬
velopment. One of the aims of the program
is to keep elderly patients as independent as
possible, thus limiting the care burdens on
their families and communities. By retain¬
ing their independence, patients spend their
later years with a greater sense of fulfillment
and dignity.
The Humana Foundation was established
in 1981 by Humana, Inc., which owns and
operates more than 80 hospitals in the
United States and overseas. A Yale Law
School alumnus, David A. Jones ’60, was
a co-founder of Humana, Inc. and serves as
its chairman and chief executive officer.
F. David Rollo, M.D., Ph.D., is senior
vice president for medical affairs of
Humana, Inc. In a letter to Dean Leon E.
Rosenberg, Dr. Rollo expressed the foun¬
dation’s eagerness to work with the school
“in assuring that the Yale geriatric medicine
model is appropriately appreciated and uti¬
lized in community medical centers.”

Yale’s Comprehensive Cancer Center has
received a grant of $144,000 to purchase a
van for a mobile mammography screening
program. The George W. Mixter Fund of
the New Haven Foundation provided funds
for the purchase, and the Connecticut Divi¬
sion of the American Cancer Society
awarded a grant of $75,000 to equip the
unit. Yale-New Haven Hospital is providing
additional support for the project.
The program will provide convenient, in¬
expensive screening for early detection of
breast cancer. At least 6,000 women
throughout Connecticut will be examined
yearly at a cost of no more than $50 each.
It will be the first mobile mammography
unit in the New York-New England area,
and the only mobile facility offering mam¬
mography at no cost to women unable to
pay. Phyllis J. Kornguth, M.D , Ph.D., as¬
sistant professor of diagnostic radiology,
developed the program.
The New Haven Foundation is the
eleventh largest community foundation in
the United States, and awards nearly $4 mil¬
lion in grants annually.

Ogilvie Family
Fund Established
John B. Ogilvie’s wish to honor family
members who have attended Yale has been
fulfilled by his creation of an endowed loan
fund in the School of Medicine. Dr. Ogilvie
is a Sheffield graduate of Yale (B.S. 1931)
and an alumnus of the School of Medicine
(M.D. 1934). Two of his sons, John G.
Ogilvie '64 and Donald Ogilvie ’65, at¬
tended Yale College.
After 53 years in the field of general
surgery, John B. (Jack) Ogilvie retired from
practice this year, which will enable him to
devote more time to The Campaign for the
Yale School of Medicine. He is a member
of the National Volunteer Committee for the
campaign, and previously served as presi¬
dent of the Association of Yale Alumni in
Medicine.

BILL CARTER

THE CAMPAIGN FOR THE
YALE SCHOOL OF MEDICINE

This wrought iron grillwork adorns the
second-floor balcony in the Medical
Historical Library, which will be part of
an expanded medical library funded
through the campaign.

Progress Report Summary
Gifts and Pledges
As of February 15, 1987

PROJECTS
Professorships
Fellowships/Financial Aid
General Endowment
Total Endowment

Center
for Molecular Medicine
Medical Library
Magnetic Resonance Center
Modernization of Labs
Other

11,218,631
3,642,630
6,458,963
$ 21,320,224

20,100,000
8,010,000
3,075,100
3,858,374
1,323,545

Total Facilities
and Equipment

$ 36,367,019

Total Programs
and Research

$ 44,552,227

TOTAL

$102,239,470
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ALUMNI REPORT
Incoming mail to the Office of Alumni
Affairs was abundant last summer and
autumn, largely as a product of alumni
questionnaire responses generated by the
Kissick-Spinelli paper. (The questionnaire
analysis is published in this issue.)
Approximately 50 items of personal
news were received for publication in a col¬
umn that began in the February issue of the
Yale Alumni Magazine. Since magazine
space is limited, some items may be delayed
until subsequent issues. News items of a
professional, rather than personal, nature
will continue to be published in YALE
MEDICINE. All alumni are invited to send
items to the Office of Alumni Affairs. Ad¬
dress changes are especially requested.
Most gratifying were the invitations from
approximately 600 alumni who offered
overnight bed and board to third- and
fourth-year Yale medical students inter¬
viewing for residency training positions
in hospitals in 38 cities. The cities or their
suburbs include: New York, Boston,
Pittsburgh, Miami, Baltimore, San Fran¬
cisco, Durham, N.C.; Torrance, Calif.; San
Diego, Houston, Seattle, Portland, Maine;
Minneapolis, Portland, Ore.; Livingston,
N.J.; Chicago, Providence, Los Angeles,
Burlington, Vt.; Denver, Nashville, St.
Louis, Dallas, Rochester, N.Y.; Ann
Arbor, Montreal, Washington, Irvine,
Calif.; Cleveland, Buffalo, Rochester,
Minn., Cincinnati, Tucson, Bangor, Maine;
Birmingham, Gainesville and Toronto.
Students generally spend an average of
$1,500 during the interviewing process.
The gracious hospitality of Yale alumni ena¬
bles students to save money. At the same
time, communication between graduates
and current students is increased. These
multi-generational exchanges have proven
to be quite stimulating for all participants,
and we hope to expand the program to other
cities.
One of the most successful visits on the
“Dean’s Tour” occurred Nov. 21 in San
Francisco, where Dean Leon E. Rosenberg
presented his “State of the Yale School of
Medicine” address to 83 attendees.
A. John Anlyan, M.D. ’45, of San Fran¬
cisco and LawrenceG. Crowley, M.D. ’44,
of Palo Alto served as chairmen of the ele¬
gant dinner and reception at the Olympic
Club, which preceded Dr. Rosenberg’s pre¬
sentation . The event’s content and social as¬
pects were so well received and appreciated
that the group requested a return visit by a
faculty member this fall.
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Tentatively scheduled to visit the Bay
area group on Nov. 6 is Dr. Stephen
G. Waxman, chairman of the department
of neurology. Dr. Waxman’s research ad¬
dresses the molecular nature of the ner¬
vous system’s response to injury, trauma
and multiple sclerosis.
The Bay area alumni, co-chaired by Drs.
Anlyan and Crowley, are a well-organized
satellite alumni group.
In addition to Drs. Anlyan and Crowley,
the executive committee includes: Drs.
Malcolm Bagshaw ’50, Robert A. Chase
’47, Chandler Dawson ’56, Lee E. Farr ’32,
Roger P. Friedenthal ’62, W. Keith Hadley
’59, Avi J. Hettena '76, Jack Levin '57,
Bennett F. Markel '57, Robert L. Mitchell
’64, William M. Rogoway ’61, Richard A.
Sinnott Jr. ’53 and Joseph F. Walter ’67.
Dr. Stephen Waxman addressed the Yale
Club of Washington, D C. on the topic
“Sparks, Soup and Molecules: How the
Nervous System Copes with Injury.” A
banner number of undergrad and medical
alumni attended March 3 at the City Tavern
Club. After his talk the medical group
hosted an informal supper, with Dr. Waxman as guest. Muriel D. Wolf, M.D. ’59,
of Children’s Hospital in Washington, is
president of the Yale Club of Washington,
DC.
In addition to the student-aid initiatives
previously mentioned, the alumni office has
helped the second-year class achieve
alumni attendance at the class show. A
spring reception is planned for all medical
students, with New Haven and other region¬
al alumni helping to serve as hosts. Efforts
to increase such liaisons will continue.
Identifying leadership potential as alumni at
the student level is an initiative to be pur¬
sued. Student officers to serve alumni class
functions already have been named in the
third- and fourth-year classes this year.
A core group of house staff/fellows has
begun deliberating their special status as
members of the Association of Yale Alumni
in Medicine. Included on this charter house
staff/fellows subcommittee are: Drs. Nina
R. Horowitz HS ’79-84, assistant clinical
professor of surgery; Richard Selzer HS
’53-55, ’57-60, assistant clinical professor
of surgery; John N. Forrest Jr. HS ’64-67,
’69-70, professor of medicine; and E.
Maurice Wakeman HS '60-63, assistant
clinical professorof pediatrics.
The subcommittee, organized by Dr.
Samuel D. Kushlan ’35, clinical professor
of medicine, will seek to define the group’s

role in reunions, evaluate the need for sepa¬
rately structured reunions and update and
correct deficient alumni records.
During the weeks ahead, the reunion of
1987 will occupy the energies of the Alumni
Office. Please note the special events
planned for the June 5-6 reunion weekend:
1. Special senior alumni, including
members of the 65th, 60th and numerous
members of the 55th reunion class, will be
honored at the annual meeting on June 6.
2. The 50th reunion class, as well as
the 55th and 5th reunion group, will be hon¬
ored at the Friends of the 50th Dinner on
Saturday evening at the Graduates Club.
3. A special Friday evening dance,
first held last year, will be moved to Edward
S. Harkness Hall on the medical school
campus. Members of the entire hospitalmedical school family will be invited to
attend. Last year, the ambience of a family
reunion was achieved.
4. The Friday evening dinner, so suc¬
cessful last year, will be repeated, again in
the President's Room at Woolsey Hall. This
is open to all returnees who need dinner
reservations.
See everyone at reunion!

Nicholas P R. Spinelli, M.D. '44
Director of Alumni Affairs

Highlights: Medical Alumni
Reunion Weekend
Friday, June 5
8 a.m.
1:30 p.m.
4 p.m.

5 p.m.
7 p.m.
9 p.m.

8 a.m.

10:30 a.m.
2 p.m.

9:30 a.m.
11 a.m.
1:30 p.m.

2:15 p.m.

Medical alumni registration
Faculty seminars
Yale School of Medicine Special Address
Keynote Speaker: Lowell P. Weicker Jr.
United States Senator
Dean's reception
Medical alumni reunion dinner
Yale School of Medicine reunion dance

Yale School of Nursing annual alumnae college
Keynote Address: Mary Mundinger, dean. School
of Nursing, and associate dean, faculty of medicine,
Columbia University
Panel discussion
Case study and discussion

AYAPH and YUHAAA annual workshops*
Panel discussions
AYAPH and YUHAAA Keynote Address: Robert B. Helms,
Ph.D., assistant secretary for planning and
evaluation, U.S. Department of Health and Human
Services, Washington
AYAPH and YUHAAA combined annual meeting

* Association of Yale Alumni in Public Health (AYAPH)
Yale University Hospital Administration Alumni Association
(YUHAAA)

Saturday, June 6
9:15 a.m.
10 a.m.
11:30 a.m.
12:30 p.m.
2 p.m.
3 p.m.

Greetings and remarks: Benno C. Schmidt Jr.
President, Yale University
Faculty seminars
Annual meeting of the Association of Yale Alumni in
Medicine. Distinguished Service Awards presentation
Sherry and buffet luncheon
Yale School of Medicine Class of 1962 reunion seminar
School of Medicine Alumni Fund class agents meeting
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SPLICING IN THE MD-GENE
by HowardM. Spiro, M.D.
(Delivered at the Yale School of Medicine graduation,
May 25, 1987)

It is always a pleasure to talk to colleagues, and from this morn¬
ing on you are fellow physicians. Congratulations to you all and
the best to those around you. Enjoy this day while you can. Next
month comes internship, residency, the PGY days that rob
house-officership of its glamor. Difficult and responsible times
lie ahead, even if sometime you join the chorus of the blessed
singing praises to the great god Ortho-Ophtho-Oto or pray with
the imagers at their icons in the radiology department. For now,
relax, enjoy yourselves, vacation, don’t study the Washington
University Manual. You’ve earned some good time off. That
“M.D.” you practiced signing a few times over the past months
does belong after your name.

That is really what I want to talk about, the splicing of the
M.D. gene into your genome. Graduate from medical school
and you are like those E. coli, forever making interferon or fer¬
tilizer, working endlessly, your identity forever changed. I was
graduated from medical school 40 years ago this month, and I
have to confess some trepidation at standing here, for I would
have greeted with skepticism bordering on scorn any pro¬
nouncements from a physician who had graduated 40 years be¬
fore me, in “aught seven.” But one of the pleasures of academic
life is the illusion that “students” keep you young in outlook,
even as I bump against a horizon you can hardly glimpse.
Another is the chance to do different things at different times.

SVEN MARTSON

Dean Rosenberg and Dr. Spiro.

to share the ecstasy of laboratory pursuits when you are young,
the joy of the clinic and the bedside in middle life, and finally
to find happiness in the distance that the library lends.

IDENTITY CHANGE
Today marks the greatest change in your identity in your entire
life, even though more of you in this class than in many before
have had other and sometimes distinguished careers. You may
marry or divorce, change companions several times, write
poetry or win research prizes. In academic life you may be
transmogrified into an assistant or associate professor, and ulti¬
mately you may even take on a new name with a named chair.
You may even become a chair. Several of my friends and con¬
temporaries have turned into plaques, lectures, auditoriums,
and one or two have even become buildings. As a gastroen¬
terologist, I hope to become a dining hall, or at least a salad bar,
although some have suggested a sigmoidoscopy suite.
In any case, this morning you were medical students and now
you are physicians and for the rest of your lives you will sign
“M.D.” after your name and answer the phone as “Dr. So and
So.” You may claim, ungrammatically and inaccurately, “My
name is Dr. So and So.” You may cling to the title when you
have retired 40 or 50 years hence. So often, in the warmth of
the winter lecture series in Florida, retired doctors sit in the front
row in clean sport shirts and very quickly fall asleep. They are
retired, but they come to medical lectures not so much, I think,
to keep upon what is new, as to reaffirm theironly identity: “We
are still physicians.” Most keep up their CME credits, to keep
their licenses active. That Fountain of Youth has many fonts in
Florida.
In graduating you run the risk of abandoning your identity as
a person for that of a physician. The wide-eyed enthusiast who
was a dancer or an athlete, a chemist or a writer, or more often
a college student who studied civilization and culture, is funneled into medical school to learn more cellular than human
matters. The still occasionally innocent medical student is
quickly filtered into the “burned out” PGY 3, who turns finally
into a subspecialist. On the tombstone of a friend I fear to find,
“He was born a man. but lived and died a gastroenterologist.”
What you must fear is that gradually the person who is still you
today will become entombed in the personna of the doctor. Like
the ugly toad with yet a precious jewel in its head, we physicians
wrap ourselves in white coats or in green operating gowns, to
fatten, stiffen and forget that we were people once. We grow
pompously so full of ourselves that it is very hard to find that
precious jewel in the head, even by MRI. Make interferon if you
must, but remember that we are all still E. coli.
Several observations over the past few years have
strengthened my conviction that we doctors are still just people
taking care of people. The first is the placebo response; the sec¬
ond, what happens when a doctor thinks he is primarily a Scien¬
tist uncovering The Truth; and the third is what happens when
a doctor falls sick. A brief moment on each.

PLACEBO RESPONSE

a doctor you can give a pill of no discernible pharmacologi1 activity to someone in pain and the patient will feel better,
gardless of whether relief comes from electric changes in the
aologic network, or floats in on the tides of enkephalins
lie opiate league, pain is relieved, in part because the pa¬

tient expects that your pill will help, that you will help. Such
a response celebrates healing, to remind us that physicians treat
more than microsomes. The lens of the placebo shows that pa¬
tients are more than a collection of organs or subcellular parti¬
cles; they respond to symbols, to love. They get better when
someone cares. Someday, all disease will disappear when sci¬
ence wins it final triumph, but until then the goal of medical
practice remains the relief of pain and suffering. Science, by the
way, is a means to that end and not the end in itself. We some¬
times forget that in medical school when doctors are decked out,
disguised as scientists. The goal of medicine is the care of pa¬
tients, always. Only sometimes can we cure, even in CCUs
and ICUs. The relief that a placebo brings should remind you
that physicians are more than conduits of power, pills and
procedures.
Your words and reassurance, the power of your person,
which help to make up the therapeutic alliance of doctor and pa¬
tient, will sometimes be as important as your hands writing out
prescriptions or even transplanting livers and hearts. The split
between science and intuition, between reason and romanti¬
cism, of which you are so uncomfortably aware in medical
school, can be annealed in the care of patients. Diseases, what
the physician finds, are not helped by placebos, and the dualism
may be uncomfortable, but illness, what the patient feels, what
the patient fears, is relieved. Patients are more than their im¬
ages. Cure depends on science, and care on art; but poetry may
sometimes physic your patient better than science and you will
often treat despair along with disease. The relief that comes
from a placebo stands for the promise that you make here today,
to be a doctor, taking care of people.

PHYSICIAN AS SCIENTIST
Since some of you will follow research careers, I will remind
you of Professor Hans Eppinger. A world-famous professor in
Vienna whose papers are still quoted, at the time of the Nazi
occupation of that city, Eppinger kept his position in the First
Clinic even though he was of Jewish descent. He visited the
concentration camps and ignored the evil around him. As the
Second World War progressed, German submarines were being
destroyed so fast that interest turned to whether sea water could
be treated to be made palatable to sailors torpedoed and dying
of thirst on their life rafts. Experiments on volunteers had al¬
ready shown that not to be the case, but the experiments were
not beyond doubt. Eppinger insisted that prisoners in the con¬
centration camps be starved and forced to drink treated sea
water to get what today we would call "statistical validity. ” He
wanted to be sure of the truth. The experiments, duly carried
out on gypsies, learned nothing new.
Summoned after the war to the Nuremberg trials for war crim¬
inals, Professor Dr. Eppinger killed himself. He left no mes¬
sage of remorse, or at least none that his successors in Vienna
will tell about. By the standards of his time Eppinger was not an
evil man, and he was not unique. Even in the 1940s and '50s at
Harvard—and at Yale—my colleages and I carried out experi¬
ments in which our goal was to find the answer to a question and
not necessarily to help the patients. On this happy day, I do not
want to dwell on such unpleasant matters, but I must comment
on the effort to expunge such deeds from memory.
Because I remembered Eppinger’s name from my own medi¬
cal school days, a few years ago I was appalled to find that a
prize in his memory was being given out in Germany. A number
of famous gastroenterologists had rejoiced in that prize, spon-

in a break with tradition, Dean Rosenberg stepped aside and outgoing Deputy Dean Arthur Ebbert Jr. presented members of the Class of
1987 with their diplomas.

sored by a German pharmaceutical company, without appar¬
ently knowing about Eppinger’sdark side. His research was cel¬
ebrated, but his person had been forgotten. Because I had been
much moved as a medical student by Eppinger’s complicity, I
protested, and finally the prize was withdrawn. (Your classmate
Jay Horwitz helped me in that endeavor.) My satisfaction was
diminished by a host of angry letters from academic colleages in
America. They complained that 1 had stirred up what should
have laid buried. Those who protested were all good men (there
were no women), but they had forgotten that we must continue
to talk about the bad things that doctors can do in their search for
the truth, even at Yale, if tomorrow we are not ourselves to do
worse, and grow prouder still.

PHYSICIAN AS PATIENT
Finally, a comment on the paradox of the doctor who has to be¬
come a patient to learn that he is still a person. The trained de¬
tachment of our profession protects us physicians from getting
too involved with our patients, but when too rehearsed and too
repeated, that defending distance becomes our manner and that
manner becomes ourselves. Few of us doctors any longer know
how to deal with emotions in patients or ourselves. We find
it far easier to examine the x-ray or the scan than to listen to
the patient, to get the hard-copy of image or laboratory number
than to heed what our patients would tell us. Sick doctors are
very lonely patients. The first thing that happens when a doctor
is admitted to the hospital is a sign going up on the door:
“No Visitors.”

Sick doctors want to be cared for. Autonomy may be held up
for other patients, held up too high I think, but it is not some¬
thing physicians choose when they are sick. Almost to a man or
woman, sick doctors tell how they want to be taken care of, so
that they can give up their lonely vigil. They want decisions
made for them, in their interest. The stories of doctors as pa¬
tients suggest that one of the goals of medical practice is to learn
the patients’ interests so we can be loyal to those interests and
make right decisions for them. You may be uncomfortably
aware that I am praising paternalism, but it may be too much de¬
meaned these days. I have come away from reading stories of
sick doctors with the conviction that if you are loyal to your pa¬
tient’s cause, even if it must sometimes be what you imagine
that cause to be, you will care for the patient better than doctors
who spread their wares to sick patients forced into unequal
equality. The message from doctors who have been patients
tells us that hope helps as much as truth, and that imagination,
drama, passion, poetry and—yes, even love, will be as impor¬
tant in your medical practice as they should be in the rest of life.
These stories, of the placebo response which tells of the relief
that you can help patients bring to themselves, of the professor
who forgot that people in prison camps were still human beings,
and of the paradox of the doctor become patient, offer the last
lesson for you in medical school: even with your M.D. degree,
you will still be just people caring for other people. But, besides
all this, and most of all, taking care of patients is great fun, the
best way to spend your lives. Congratulations. Go out, take
good care of your patients, and have fun. Bless you all.
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AESCULAPIUS MEETS
THE COMPUTER
by Phyllis Joffe
From administrative record keeping, to storage and retrieval
of clinical and research data, to artificial intelligence sys¬
tems, medical informatics—biomedical computer science—
is changing the face of medicine. And in today’s medical
marketplace, computer-literate physicians increasingly have
an edge.
"There’s a tremendous amount of information relevant to pa¬
tient care, more than any one person can retain,” says Dr. Perry
L. Miller, director of Yale’s medical informatics program. Dr.
Miller, a physician with a Ph.D. in computer science from
M. I.T., is associate professor of anesthesiology at the School
of Medicine.
“Across the board,” explains Dr. Miller, “the computer has
the potential to follow in detail how a physician is practicing
medicine and can alert him to things he may otherwise miss. It
could improve medical care significantly.”
At the School of Medicine, computers are playing a more
central role in patient care, medical education and research. For
example, a grant of $960,000 from the National Library of
Medicine will support research by graduate students and post¬
doctoral fellows for five years as they explore the application
of artificial intelligence techniques in medicine. The school is
one of only eight academic medical centers in the United States
that receive funds for research training in medical informatics.
Dr. Miller’s interest in patient care, “especially where you
have a number of clinical information systems, where clini¬
cal information is on-line and where it can increasingly be
used to help the physician improve medical practice,” has
led to his own research on “critiquing” systems—artificial
intelligence that brings computer-based advice to practicing
physicians.
Dr. Miller believes that the critiquing approach is particularly
suited to fields such as medicine, in which decisions frequently
involve subjective judgment. Working from a physician’s own
treatment plan, the critiquing system discusses the risks and
benefits of the proposed approach and of any other preferred ap¬
proaches. “We are exploring how to design computer-based ad¬
vice so it is not telling the physician what to do, but rather
critiquing his or her own style of practice and way of thinking,”
he explains.
Thus, says Dr. Miller, the computer complements, rather
than substitutes for, a physician’s judgment: “No one is
suggesting that we dispense with the physician and have the pa¬
tient interacting only with a computer. You need an experi¬
enced, intelligent, compassionate person. And most people re-

1is Joffe was writer, broadcast specialist in the
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heal school's public information office.

spect the intuitive judgments that physicians make. But the
computer has the ability to remember masses of information and
the potential to integrate that in a flexible way with what the
physician is doing.”
PROJECTS
In one project, Dr. Miller and Dr. Henry R. Black, associate
professor of internal medicine, are evaluating an expert system,
HT-ATTENDING, which critiques physicians’ plans for phar¬
macologic management of essential hypertension. Expert sys¬
tems are computer systems designed to incorporate human ex¬
pertise in real-world problem-solving domains.
Along with Dr. Henry A. Swett, associate professor of diag¬
nostic radiology and associate director of the medical informa¬
tics program. Dr. Miller is developing expert systems to assist
in radiologic diagnosis. The DxCON system critiques
radiologic workup, and ICON critiques radiologic differential
diagnosis.
Dr. Miller and Dr. Jon Morrow, associate professor of
pathology, have embarked on medical informatics projects that
involve intelligent computer-aided instruction and bibliog¬
raphic retrieval in pathology. One system, PATHMASTER, is
being developed for histologic diagnosis from slides of liver tis¬
sue. This intelligent computer-assisted instruction (ICAI) sys¬
tem is intended especially for use in teaching and consultation
in pathology. Its goal is to help physician-users make correct
diagnoses while it simultaneously teaches how to approach his¬
tologic diagnoses in an organized, criteria-based manner.
Drs. Miller and Morrow also are working with Dr. Seth M.
Powsner, assistant professor of psychiatry; Dr. Kenneth
W. Barwick, associate professor of pathology; and Dr. Caroline
A. Riely, associate professor of medicine, on a major research
project supported by the Unified Medical Language Program
of the National Library of Medicine. The project explores
ways that semantic relationships—the underlying conceptual
relations between terms—can assist in medical bibliographic
retrieval. Drs. Miller and Morrow have chosen liver disease as
their domain for that project, using as a resource an exten¬
sive file of liver cases that are part of Dr. Morrow’s pathology
information system.
Other currently active research projects in medical informat¬
ics include an exploration of novel computer-based diagnostic
strategies in pathology, conducted by Dr. Jerome A. Silbert, as¬
sociate professor of laboratory medicine and pathology, and
Roger Schank, Ph.D., professor of computer science; and vari¬
ous projects to develop expert systems for diagnosis and treat¬
ment in psychiatry, conducted by Dr. Powsner, Dr. Robert
Byck, professor of psychiatry and pharmacology, and David
Gelernter, Ph.D., associate professor of computer science.
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UELCOHE TO THE YALE LIVER CENTER CORE COMPUTER SYSTEM
Your Password:

Good Afternoon, JON.

Liver Option: 20 Ask the Or. Klatskin Bata Base for a Diagnosis
ye leone to 'GIBOC', a consultative progran based on
the Yale experience of the past 30 gears, including
the files of the late Dr. Gerald Klatskin.
The doctor is in, so if you would please just identify
your patient, she will be glad to assist you with a differential
diagnosis, (note, if your patient is not registered in the
Liver Center Conjjmter Systen, you will need to do so before
proceeding. Also please be sure to enter all relevant infomation
on your patient, so the Doctor can help you.

Enter specinen imber, hospital ranter, or part of
Or, enter ? for wore infomation.
BILL CARTER

n:|

A living legacy: When world-renowned liver specialist and Yale professor Gerald Klatskin died in 1986, he left behind over 30 years of welldocumented records on more than 7,000 patients. These data, along with those of other physicians, were organized into a computer database
according to clinical history, biopsy and laboratory results, and diagnosis. So today, thanks to the computer, Dr. Klatskin's experience still
serves Yale physicians and medical students as an aid to diagnosis and teaching.

COMPUTER EDUCATION
As computers assume an increasingly significant role in medical
research, medical education and clinical practice, medical
schools face the formidable task of integrating both the fast¬
changing technology and the resulting explosion of medical
knowledge into the existing curriculum.
To meet this challenge, the School of Medicine has embarked
on a program designed to provide its students with computer lit¬
eracy that incorporates a critical understanding of the strengths
and weaknesses of computers in clinical medicine.
Under the aegis of Project Eli, a program established at Yale
University to distribute $6 million of computer hardware do¬
nated by the International Business Machines Corp., the School
of Medicine is creating a computer teaching laboratory in
Lauder Hall. Project Eli also will allow the department of public
health and epidemiology to upgrade its two existing computer
rooms.

Under Project Eli, networks of microcomputers will com¬
municate with each other throughout the university and with
more powerful computers, such as the mainframes at the Yale
Computing Center. In such networks, the microcomputers
function as workstations, where most of the computing is done.
The higher-level computers function as “servers,” which, upon
demand, perform special functions for the workstations.
The Lauder Hall computer teaching laboratory will house 10
computer workstations. The units will be interconnected and
eventually will be hooked up with the medical school computer
network and the library’s miniMEDLINE database. MiniMEDLINE is a subset of the more than 3,400 journals comprising the
National Library of Medicine MEDLINE database.
Says Dr. Robert H. Gifford, associate dean for education and
student affairs: "We need to network our computers, because
our ability to ‘talk’ with each other through electronic mail and
to access the library from medical school offices will be critical
to our development in the coming decade.”
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Drs. Perry L Miller and Jon Morrow discuss possible ways to
update their PATHMASTER system of histological diagnosis of
liver disease.

Dr. Gifford heads an ad-hoc committee for computers in
medical education, which is developing a plan for the Lauder
Hall laboratory.
The committee has suggested several possible uses for the fa¬
cility, including: formal instructional mini-courses on the uses
of personal computers for medical students, residents and facul¬
ty; mini-courses on using library databases, such as MEDLINE
and miniMEDLINE; practice for students taking computerbased national board exams; student review of on-line examina¬
tion questions that have been prepared by various departments;
access to computer-assisted instructional programs currently
available elsewhere; direct access to MEDLINE and miniMED¬
LINE for bibliographic retrieval; and word processing for medi¬
cal students.
Dr. Gifford cautions that the computers will not be consid¬
ered as substitutes for personal interaction, such as direct connet with patients and instructors. Rather, he says, the technolny will complement existing elements of medical education.
He describes the computer as a non-judgmental resource that
enhance learning; “Medical students, like most students,
mietimes hesitant to ask questions. They don’t want to
their ignorance. Well, there is no way that the computer
to yell back at you to criticize your ignorance. There
is no fear of being exposed.”
s with most new ventures, there are problems still to be

solved. Nonetheless, Dr. Gifford says, “it is important to move
ahead and get the program started. We want to encourage the
use of computers as educational tools as well as database tools. ”
LIBRARY RESOURCES
In the Yale Medical Library, two Project Eli IBM-AT com¬
puters already are in place. With the stimulus of a generous gift
from Mrs. Betsey Cushing Whitney and her family, the future
plans to renovate and expand the library also will prepare it for
the automated future. “We have some catching up to do,” says
medical library director Bella Z. Berson.
“We are using our Project Eli computers to teach courses to
help students organize their own reprint files, to prepare and
manage their own databases and to learn to refine their search
strategies when seeking information.” she says. For example,
by using Boolean logic—combining two search terms with a
conjunction such as ‘and’ or ‘or’—one can acquire more rele¬
vant information. ”
In addition to Project Eli, the medical library offers courses
on National Library of Medicine databases. “One of the
courses, for example, helps people using their own microcom¬
puters to decide which MEDLINE access is best for their pur¬
poses,” says Berson. “A portion of the huge MEDLINE
database, a miniMEDLINE, is mounted on the Biomedical
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Computing Unit’s VAX equipment,” explains Berson. The
unit, located in Sterling Hall of Medicine, houses two com¬
puters and a terminal room from which the computers can be
used for special applications.
ACADEMIC COMPUTING SUPPORT
The Biomedical Computing Unit is the central academic com¬
puting support resource for the medical center. Unit director
David Stagg, Ph.D., is a research scientist in pharmacology
(biomedical computing) at the School of Medicine. In addition
to the library services mounted on its VAX system, the unit pro¬
vides statistical analysis tools and molecular biology databases
that currently are used by more than 100 researchers at the medi¬
cal school.
The unit also installed the network that links the medical
school with a Yale University-wide computer network. Stagg
says this network is growing steadily, providing more and more
access to research and teaching resources, library systems and
world-wide electronic mail.
“This is an exciting time for us, since we have just embarked
on a joint project with the genetic epidemiology research group,
led by Kenneth K. Kidd, to enhance our computing resource to
a VAX 8800, which will be housed at the medical school,” says
Stagg. Kenneth K. Kidd, Ph.D., is professor of human genetics
and psychiatry. This $1 million VAX system, jointly funded by
the National Institutes of Health, the National Science Founda¬
tion and the School of Medicine, represents a major upgrade.
A substantial part of the system will be available to the medical
center community via the Yale computer network, says Stagg.
This new computer system and the expanded network will
provide a state-of-the-art computing resource for the computer
applications mentioned in this article and many other projects
now underway or planned for the medical center.
The medical library’s miniMEDLINE subset contains cita¬
tions from the past three years in 234 medical, nursing and allied
health journals that are in the library’s collection. These include
the 100 journals recommended by members of each school and
department served by the medical library.
The miniMEDLINE database is updated monthly by tapes
purchased from the National Library of Medicine. Two
Lynna Stone-Infeld, user support specialist, explains how each
work station of the IBM network can function independently, allowing
users to access the mainframe computer only when required for the
most involved tasks.

First-year medical student Sarah Davidson uses a personal computer
in the Yale Medical School Library to scan the titles of articles that
are catalogued on a compact disk, or CD. Each CD can hold
600,000 citations, enough information to fill the Encyclopedia
Britannica.

miniMEDLINE terminals currently are available in the library
for access during regular library hours. “We are now exploring
the possibility of adding one more terminal as well as mak¬
ing miniMEDLINE information available in laboratories and
offices in the medical center,” says Berson.
The medical library also is a test site for an Institute for Scien¬
tific Information CD-ROM (compact disk, read-only memory)
project. “The compact disk, which students, staff and faculty
researchers may use, is mounted on a computer in our informa¬
tion room,” says Berson. “It contains subject access to the last
six months of scientific literature. ”
MiniMEDLINE and the ISI CD-ROM are end-user databases
that allow the researcher quick, personal access to information.
For more complex needs, researchers have more than 400
databases available on-line through the library’s professionally
staffed computer search service.
Plans for the library include more space and greater use of
new automation technology. The medical library will be part of
the University library’s integrated computerized system that
will allow readers to know if a book is in the collection, whether
it is on order and whether it is available for circulation. The
major components of this system should be in place by the time
the library construction is completed.
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ON THE CENTENNIAL OF
THE NATIONAL INSTITUTES
OF HEALTH
Throughout the United States, the public joined physicians
and scientists in celebrating the Centennial of the National
Institutes of Health. In Connecticut, Yale and the University
of Connecticut joined to hold two special events honoring
the NIH. First, the universities honored outstanding high
school science students from throughout the state by inviting
them to a seminar where State Health Commissioner Frederick
G. Adams, '70 M.P.H., presented them with certificates.
The students also heard scientists discuss topics ranging
from AIDS to Lyme disease. Then, last September, the uni¬
versities sponsored a professional seminar entitled “Frontiers
of Biomedical Research: The Next 100 Years.” Speakers
included U.S. Sen. Lowell P. Weicker Jr., R-Conn.; Frank
H. Ruddle, Ph.D., professor of biology and human genetics
at Yale University; Sydney H. Croog, Ph.D., professor of
behavioral sciences and community health at the University
of Connecticut School of Dental Medicine and professor of
psychiatry at the University of Connecticut School of Medicine;
and Dr. James B. Wyngaarden, director of the NIH.
To continue the celebration, YALE MEDICINE asked a
distinguished panel of Yale medical alumni, faculty members,
and former faculty and deans to reflect on the National
Institutes of Health. Their comments reveal both NIH's
influence and its diversified approach in fostering bio¬
medical science programs and research.

by William L. Kissick, M.D., Dr.P.H.
In the spring of 1966 the Surgeon General informed me that I
would be responsible for implementing the Planning. Program¬
ing and Budgeting System (PPBS) in the United States Public
Health Service. This analytic technique was developed by
economists at the RAND Corporation in the 1950s to foster for¬
mulation of program options to link budgets with goals and was
brought to the Kennedy Administration by Secretary of Defense
Robert McNamara.
Subsequently, President Johnson mandated the dissemi¬
nation of these cost-effectiveness strategies throughout his ad¬
ministration. At the time, the National Institutes of Health
accounted for the largest expenditures in the Public Health
Service. The Hill-Burton Program had been supporting con¬
struction of hospitals for almost two decades. The Health Pro¬
fessions Education Assistance Act, authorized in 1963 and
amended in 1965, was just beginning to address the physician
shortage. Regional Medical Programs, enacted in 1965, was
mandated to improve the translation of these resources into
medical practice.
PPBS called for orchestration of these and other diverse inter¬
ests and initiatives into a coherent program as a means for the
realization of specified goals. The NIH, under the leadership of
Dr. James A. Shannon, sought to advance undifferentiated
biomedical research. The Office of the Surgeon General
searched for “increased quality life years" as an overarching
goal to measure outcomes from diverse health programs.
Economists in the Office of the Secretary, recruited from the
RAND Corporation, sought a goal of “increased net present
value of future income.”

The Office of the Surgeon General was caught in a bureau¬
cratic battle between the double helix and the Dow Jones. This
was actually fun when one had the privilege of playing in the
same game with James Alyusius Shannon. His charm, intellect,
vision and gall were to be admired. To hear Dr. Shannon testify
to Congress, two-thirds of the NIH expenditures were devoted
to conquering diseases through targeted, applied research. The
next day, before a meeting of biomedical scientists, he extolled
the virtues of investing two-thirds of NIH resources in basic, un¬
differentiated research. The more I listened to him, the more I
realized that it was not duplicity, for he was correct on both
scores. The subtle nuances, I would learn when he told the his¬
tory of the conquest of polio, were best understood by a distin¬
guished physician scientist.
I remember vividly the day I suggested to Dr. Shannon that
we develop a common data base so that the Office of the Sur¬
geon General and NIH could each aggregate budgetary informa¬
tion by our respective definitions of applied and undifferentiated
research. He smiled, patted me on the shoulder and said, “Bill,
you just ask me the questions; I’ll get you the answers.’’ Dr.
Shannon taught me the role of budget busting in search of a goal
higher than “increased net present value of future income.” For
me, the Centenary of the National Institutes of Health recalls
a scientific statesman and consummate bureaucrat, a legend in
his own time, for whom an appropriate Nobel Prize would be
in economics as well as medicine.

laboratory. There also were epidemics of “new” diseases to be
dealt with such as Rocky Mountain Spotted Fever and tula¬
remia. Identifying causative agents and determining modes of
transmission carried risks; investigators not infrequently con¬
tracted diseases under study, and a few died. However, their
pioneering work was rewarded with many successes, leading to
means of prevention of a number of the epidemic diseases of
the period.
In more recent times, vaccines against poliomyelitis and
hepatitis B have been achieved, but the appearance of “new”
diseases apparently is a never-ending problem. In the past de¬
cade, Legionella pneumonia and toxic shock syndrome required
major efforts to unravel their mysteries. Today, AIDS consti¬
tutes a national health crisis. Investigators at NIAID and the
many university laboratories supported by this institute fortu¬
nately have made revolutionary advances in molecular biology
and immunology, and as a result now have highly sensitive tools
for tackling AIDS and other complex diseases. There can be no
doubt that the first 100 years of the National Institutes of Health
constitute a stunning success story. The second century begins
on a high note with prospects or future successes that defy the
imagination.

Dr. Dorothy M. Horstmann is
the John Rodman Paul Professor
of Epidemiology and Pediatrics
emeritus, and senior research
scientist at the Yale School of
Medicine.

by RichardL. Edelson, M.D.

by Dorothy M. Horstmann, M.D.
Having been a longtime worker in the field of infectious dis¬
eases, the early history of the National Institutes of Health par¬
ticularly interests me. This complex organization, which is
made up of 11 diverse institutes located on a 306-acre campus
in Bethesda, Md., began modestly 100 years ago when Dr.
Joseph Kinyoun established the Laboratory of Hygiene at the
Marine Hospital on Staten Island. It consisted of a single room
designated for research on cholera and other infectious diseases.
In subsequent years, the hygienic laboratory underwent succes¬
sive changes in title, mission and location, eventually emerging
as the National Institute of Health in 1930, and in 1955—after
a series of new institutes had been added—as the National Insti¬
tute of Allergy and Infectious Diseases (NIAID).
In 1887 and through the early years of this century, such dis¬
eases as diphtheria, pertussis, typhoid fever, cholera and
botulism were among the most prominent health problems in the
United States and all challenged investigators at the hygienic

The National Institutes of Health has contributed enormously to
the growth of medical academia in many ways. However, it is
not widely appreciated that an extraordinarily high percentage
of our current leaders in medical research and education were
stimulated to enter academia as a result of their “military” ex¬
periences at the NIH during the later stages of the Vietnam war,
a conflict which led so many of us to choose alternative service
at the NIH.
It was my good fortune to spend three very formative years
at the NIH, as an associate in the National Cancer Institute, from
1972 to 1975. During that period of national turmoil, virtually
all male medical school graduates in my Yale medical school
class of 1970 either were drafted, enlisted or made alternative
service arrangements. One of the most desirable possibilities
was to be among the few selected as NIH Associates. Accep¬
tance to that program permitted a two-year deferral of “mili¬
tary” service, thus enabling new physicians to begin specialty
clinical training. The NIH also offered the opportunity of excit¬
ing research experiences in a very pleasant setting in Bethesda,
Md. The fact that we had all performed research at Yale and
could arrive for our interviews with bound theses made us
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particularly attractive candidates for positions at the NIH
and explains the disproportionately high representation of
Yale graduates (approximately 20) among those 150 candidates
finally accepted.
The environment in which we worked was very conducive to
both productive research and personal growth. The associates
were given great responsibility in laboratories basically devoid
of the funding pressures of university life. Clinical responsibili¬
ties largely were limited to the first year and were themselves
quite enriching because of the spectrum of clinical material and
the creative way with which it was dealt. There was an enor¬
mously contagious feeling that we were participating in exciting
adventures and that we were contributing in important ways. 1
am impressed that the NIH experience induced more than half
of the associates to pursue academic careers and that so many
of that cohort group have subsequently done so well. On the
basis of that experience, we are attempting to create a similar
environment for a postdoctoral M.D. fellow in the department
of dermatology at Yale.

associate director of NIH, and then director in 1955. Shortly
thereafter the growth spurt began that made the NIH the source
for the generous and wisely selected support of medical research
that made it the world leader in both quality and quantity. In
1950, the total appropriation for NIH was $52 million. It had
crept up to about $70 million when Jim Shannon took over.
When he retired in 1968, it was approaching $1.5 billion. The
current NIH appropriation is some 100-fold greater than when
I first knew it.
When I joined the NIH in 1950 I was warned that no good
could come from getting the federal government involved as a
major supporter of medical research. As for becoming person¬
ally a part of the federal bureaucracy—horrors! Clearly, time
has shown that at least one federal program can be run in
exemplary fashion, and NIH is one of the few places where
people take pride in being part of the federal government.

Dr. William W.L. Glenn is
Charles W. Ohse Professor
emeritus and senior research
scientist surgery at the Yale
School of Medicine.

Dr Robert W Berliner is dean
emeritus, professor emeritus of
physiology and medicine, and
senior research scientist in
physiology at the Yale School
of Medicine.

by William W.L. Glenn, M.D.

by Robert W. Berliner, M.D.
The National Institutes of Health had a prolonged childhood. It
had not yet achieved its adolescent growth spurt when I arrived
at NIH in 1950, although the NIH was already 63 years old at
that time. 1 joined what was then the National Heart Institute
(other organs have since been added to its title); it was then a
two-year-old infant.
Jim Shannon was organizing the intramural research ac¬
tivities of the Heart Institute. The recruiting job he did at that
time might have led one to expect the phenomenal role that he
would later play as the director of NIH. The initial group of 20
or so people that he brought together included at least 10 who
became members of the National Academy of Sciences and two
who were to win the Nobel Prize.
Before he left the directorship of intramural research, he also
recruited a group of younger people who were to form the Heart
Institute house staff when the Clinical Center opened in 1953.
They included two subsequent directors of the NIH. Thanks to
the effects of the doctor draft, the intramural NIH became the
training ground for an entire generation of leaders in internal
medicine throughout the '50s and '60s. When I was honored by
the Association of American Physicians in 1984, 1 pointed out
it l our of the live councilors of the association and its secrehad spent some part of their careers in the Heart Institute,
i Shannon left the Heart Institute in 1952, first to become

On June 16, 1948, when President Truman signed an act estab¬
lishing the National Heart Institute within the National Institutes
of Health, he did so as the result of a groundswell of enthusiasm
for federal support of research in heart disease, the major cause
of death in America. A specific mandate of the National Heart
Act was “to encourage and support research in cardiovascular
disease.” Thus, 1948 was a propitious year in which to begin
a career in cardiovascular surgery, as it was my good fortune
to do in October of that year at Yale. With the collaboration of
a number of colleagues, fellows, engineers, skilled technicians,
and administrative and nursing staff, we embarked upon an ex¬
tremely active laboratory and clinical program destined to be
carried on for over three decades. The continuous support of our
program by the NIH from 1950 to 1987 enabled us to realize
many of our research objectives.
For the clinical investigator, the approach of the National In¬
stitutes of Health has two major attractions. First is long-term
support for initiation, investigation and resolution of an idea.
A problem presented at the bedside can be carried to the labora¬
tory for study, and the results of the study returned to the bed¬
side for clinical trial and long-term follow-up. Second is the
freedom NIH provides for exploring new ideas that were not
contemplated when the original research proposal was ap¬
proved. This combination of long-term commitment and flexi¬
bility is vital to quality research.

Dr. Paul B. Beeson is professor
of medicine emeritus at the
University of Washington.

by Paul B. Beeson, M.D.
Many extraordinary advances in methods of diagnosis and treat¬
ment can be attributed to the National Institutes of Health, espe¬
cially during the past 40 years. 1 feel fortunate to have been pro¬
fessionally active at a time when so many exciting things were
happening. Nevertheless I shall dwell here on some unantici¬
pated—and untoward—effects of our massive research efforts.
One. The rapid accumulation of factual knowledge, together
with the introduction of complex technologies in diagnosis and
treatment, necessitated narrow specialization in medical prac¬
tice, especially by the clinicians on the faculties of medical
schools, for whom research and acquisition of new information
is an obligation. This trend was quickly followed by doctors in
private practice, and the stampede into specialization has now
brought us to a state where we seem to have too many specialists
and not enough generalists for appropriate service to the Ameri¬
can people.
Two. The complexities of modem diagnosis and treatment,
especially as employed in hospitals, is expensive, and is impos¬
ing a substantial economic burden, to the extent that health care
now amounts to more than 10% of the gross national product.
Inasmuch as health benefits have become major components
of employment contracts, this affects the cost of everything
we buy.
Three. Large charity hospitals which formerly were the prin¬
cipal sites of medical teaching, e.g., Boston City, Philadelphia
General and Cook County, have encountered almost impossible
financial difficulties, and no longer comprise the essential
teaching resource, having been supplanted by private, often
university- operated institutions where few charity patients are
cared for, and where high-cost, tertiary-care medicine is em¬
phasized. In such places, medical students have a somewhat
skewed perspective of the world of health problems.
Four. The hidden costs: a) of operating tertiary-care hospi¬
tals; b) of conducting research; and c) of paying competitive
salaries for clinical faculty members have created financial
problems for our medical schools. Tuition has risen to the point
where the majority of medical graduates now owe large debts.
Five. Young doctors are choosing fields of practice which
make use of technologic procedures in diagnosis or treatment,
partly because these fields provide higher incomes than do those
in which service is largely cognitive in nature.
Six. The high cost of medical care, together with the high
earnings of the medical profession, has contributed to a harmful
increase in litigation and in the cost of malpractice insurance.
All these have tended to change the character of medical prac¬
tice, reducing the popularity of autonomous personal-encounter

careers, and favoring the establishment of group practices, large
private clinics and health maintenance organizations. I under¬
stand that about half of all active clinicians are now working
on a salaried basis, or in some kind of partnership system. It
is astonishing to read that about 50,000 (10 percent) of the
nation’s clinically active physicians are now salaried medical
school faculty members.
Additionally, we must take note of the demographic change
that has come about during this century. When I entered the pro¬
fession a major aspect of our work had to do with acute infecti¬
ous processes. These have diminished in relative importance,
and today’s challenge is to deal with the chronic degenerative
processes that accompany aging. About a third of the national
expenditure for health care now goes to the 11 percent of our
population over age 65.
Looking back over half a century it appears that advances
came along just slowly enough that we failed to foresee the rip¬
ple effects they engendered. Today, no one can deny that a com¬
pelling need exists for reappraisal and for substantial alteration
of our systems of medical education and medical practice.

Dr. Thomas F. Ferris is Nesbitt
Professor and chairman of the
department of medicine at the
University of Minnesota.

ThomasF. Ferris, M.D.
The celebration of the Centennial of the National Institutes of
Health is a celebration of the accomplishments of biomedical
research. NIH has provided the major support for biomedical
research in the United States and the accomplishments of this
effort, particularly in the 40 years since World War II, stand
among mankind’s great achievements. More has been learned
about human biology over the past 40 years than in prior re¬
corded history. Since the public is being reminded constantly
of the cost of medical care and the ethical problems created by
biomedical technology, it is appropriate that we celebrate im¬
provements in understanding disease and the relief of human
suffering that has flowed from these efforts.
As a medical student at Yale in the 1950s I recall learning that
the nucleus of a cell contained desoxyribonucleic acid. Now,
30 years later, the NIH is considering sponsoring a program to
map the human genome.
Fitkin 2 was filled the summer of my junior year with patients
with acute poliomyelitis, many of them in iron lungs. We were
taught that hypertension was part of the aging process; today,
anti-hypertensive therapy has resulted in a striking reduction in
cardiovascular mortality. Strokes that were once so common on
medical wards now are relatively rare. We knew little of the im¬
munologic basis of renal injury and wondered if acute post-

streptococcal nephritis or urinary tract infections caused chronic
renal disease which was invariably fatal. Today transplantation
gives patients with chronic renal failure an 85 percent chance
of normal renal functions five years after the transplant.
We knew from the differences in incubation time that two dif¬
ferent filterable agents caused hepatitis, but today viruses are
cultured almost as routinely as bacteria. Bioassays for crude
measurements of hormones in plasma have been replaced by
accurate immunoassays. Leukemia was invariably fatal
whereas chemotherapy and bone marrow transplantation now
give a normal life to many. As an example of fatal disease, Paul
Beeson presented to our class during our first week of medical
school a young minister with lymphoma; today the patient
would have an excellent chance of cure. In pathology, one of
our most popular teachers humorously derided the possibility
that cigarette smoking caused cancer. Open heart surgery was
in the future, and talk of a heart, lung or liver transplant would
have been considered unscientific fantasy.
It has been a privilege to have lived during the time of these
medical achievements. If NIH flourishes for another 100 years,
my great-grandchildren may see the elimination of disease as
a cause of premature death.

terest in the excitement of research and pushed me toward a
career in academic medicine.
I owe an inestimable debt of gratitude to Yale for nourishing
me intellectually and to the National Institutes of Health for
nourishing me financially.

by Robert G. Petersdorf, M.D.
Dr Gerard N. Burrow is the
Sir John and Lady Eaton
Professor and chairman,
department of medicine,
the University of Toronto.

by GerardN. Burrow, M l).
In several ways the National Institutes of Health has been my
“alma mater” or “bountiful mother” in pursuing a career in
academic medicine. To begin with, a National Health Training
Grant funded my clinical fellowship in endocrinology. As part
of that training I had to spend a period of time in a research labo¬
ratory. Dr. Philip Bondy, my supervisor, had just spent a sab¬
batical learning molecular biology, and my three months work¬
ing with him led to my career interest in bench research. My
research fellowship with Dr. Bondy and subsequent research
support during my first two years as a faculty member also came
under the umbrella of the NIH Training Grant. Later, appoint¬
ment as director of the Clinical Investigation Centre, funded by
the National Institutes of Health, provided financial support
during those early years on the faculty. Eventually, I received
my own national health research grants and a career develop¬
ment research award which provided my salary.
Until I moved to Toronto, my entire academic medical career
had been supported by the National Institutes of Health. Perhaps
more germane is that the time in research spent during the
real fellowship in endocrinology stimulated a permanent in¬

For many of us who established academic medical careers in the
’60s and ’70s, the National Institutes of Health became an inde¬
lible part of our professional lives. I was appointed to my first
assistant professorship in 1958 at the conclusion of my chief re¬
sidency at Yale. For the first year-and-a-half, the sustenance of
my laboratory work came as part of an NIH grant to my mentor.
This research, in turn, helped me gain a position as associate
professor of medicine at the University of Washington and chief
of medicine at the old King County Hospital (now called Harborview Medical Center).
As soon as I began this job, grant writing to the NIH began
in earnest. I applied for—and received—two research grants
and became the principal investigator on a training grant. As a
result of this generous NIH support, I was able to get a rapid
start with my academic career. Within a short period of time,
and with ample NIH support. I started a laboratory and recruited
research fellows. NIH funding continued uninterrupted for the
ensuing 20 years.
This story has been repeated for thousands of young inves¬
tigators who have become beneficiaries of the NIH. I saw this
from a different perspective as chairman of a department; NIH
support was essential to recruit and retain new faculty.
Our small, burgeoning medical service at King County Hos¬
pital received an enormous boost when NIH designated it as a
clinical research center. I cannot overstate the importance of
that modest CRC to the development of a research-oriented
medical service in a county hospital. Several young inves¬
tigators in endocrinology, cardiology, hematology and infecti¬
ous disease used that center to begin their own academic care¬
ers. Although this CRC was eventually merged with a larger one
at the University of Washington, it provided an important start
for a group of young investigators.
The value of the CRC program has been shown many times
since then. As dean of the University of California in San Diego
20 years later, I became principal investigator of the clinical re¬
search center. The presence of that funding instrument enabled
us to complete a major recruitment, not to mention providing

support for some very good clinical investigation.
An important aspect of the NIH in most academics’ lives is
service on NIH committees and site visit teams. I have always
felt that this type of service is a debt academicians owe to the
agency that has made academic life possible. Over the years,
I have served on a training grant committee, an advisory council
and the director’s advisory committee. Each of these assign¬
ments provided the opportunity for addressing challenging
problems and for interacting with a host of outstanding col¬
leagues. Indeed, many of the friendships made in academic
medicine are made around the table of NIH study sections and
committees, and over dinner in a Bethesda watering hole.
In my present position, as president of the Association of
American Medical Colleges, much of the time, effort and re¬
sources of the AAMC and its staff are spent espousing the
causes of the NIH. Some of our key staff are alumni of the NIH
administration. Our constituency—the faculties of medical
schools and teaching hospitals—depend on the continued
health of the NIH. We therefore consider NIH advocacy a vital
part of our agenda. Both the association and I as an individual
feel that the NIH is part of the American academic culture, and
that its support of research and research training is the major
reason that American biomedicine leads the world.
The NIH is a unique institution that we must preserve, nurture
and cherish. More importantly, we must see to it that the role
of the NIH in American biomedicine is strengthened so that
it may do for our successors what it has done for our generation.

Dr. Morton M. Kligerman is the
Henry K. Pancoast Professor of
Research Oncology at the
University of Pennsylvania.

by Morton M. Kligerman, M.D.

author. Consultants included Dr. Harold Johns, radiation phys¬
icist from Toronto, Robert F. Kallman, radiobiologist, and Lin¬
coln Moses, statistician, both of Stanford.
The question posed was whether a collaboration among a
group of academic radiation therapists was necessary to deter¬
mine best methods of treatment, and to agree that input from
physicists, radiobiologists and statisticians was a requirement.
The affirmative answer lead to a meeting at the NCI’s Stone
House when the late Dr. Kenneth Endicott was NCI director and
Dr. Gordon Zubrod was clinical director. The group of radiation
therapists was expanded to 24, and the areas of agreement con¬
cerning the scope of such a collaboration were far greater than
were the disagreements.
This meeting lead to the development of a “white paper”
recommending a program which would support research in ra¬
diation therapy, biology and physics, as well as research train¬
ing in these areas. The report, submitted to the NCI, stressed
the importance of radiotherapy in cancer management and
predicted that the need for radiation therapy, either alone or in
combination with other forms of cancer management, would
increase in the future. It also emphasized that radiobiology
was the basic science of radiation therapy.
This program was accepted, and funds were designated for
its support through the mechanism of competitive grants. In
1961, the division of radiation therapy of the department of
radiology at Yale University received a training grant entitled
“Research Training in Radiation Therapy,” and then in 1962,
a research grant entitled "Radiation Therapy and Biology Re¬
search Program.” Though the author was the principal inves¬
tigator, the contribution of Dr. Paul Howard-Flanders was enor¬
mous. As a result of these grants, Yale became one of the first
six specialized cancer centers. Some of the persons who trained
under this program included Drs. Samuel Heilman, Peter Scibetta, Gustavo Montano, John Chaffee, Stanley Order, James
Fischer and Leonard Prosnitz.
Special tribute must be paid to the NCI for instituting the dou¬
ble review system for grant application review by one’s peers,
which was instrumental in making it possible for all potential
investigators to receive a research award. In my opinion, this
process was of singular importance in establishing American
medical science’s superiority.
Tribute also must be paid to the NCI staff whose effort and
performance were extraordinary. I especially remember the
contributions of Dr. Ralph G. Meader, associate director for
grants and training; Ms. Helen Denson, program director for
postdoctoral and special fellowships; and Dr. Samuel Herman,
executive secretary of the radiation study section at the start of
the radiation program.

Some of the background leading to the establishment of the Na¬
tional Cancer Institute’s radiation program and its importance
to the department of radiation therapy at Yale University should
be recorded.
The need for support for the discipline of radiology by the Na¬
tional Institutes of Health had been stressed by several, includ¬
ing the Drs. Edward W. Chamberlain, Eugene Pendergrass and
Robert Stone, of Temple University, and the Universitites of
Pennsylvania and California at San Francisco, respectively.
One consequence, during the latter half of the 1950s, was a
Chicago conference the NCI sponsored when Dr. J. Rodney
Heller was the director. This meeting of 10 radiation therapists
was chaired by Dr. Henry S. Kaplan of Stanford University.
Some of those attending included Drs. Gilbert Fletcher, Fer¬
nando Bloedom, Richard Chamerlain, Milton Friedman and the
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HERE AND
ABOUT
Sheila Wellington
Appointed University
Secretary
Sheila W. Wellington, M.PH '68, M.U.S.
'68, has succeeded John A. Wilkinson as
secretary of Yale University. Wilkinson,
who had held the secretary's post for 20
years, resigned to become headmaster of
the Germantown Friends School in
Philadelphia. Ms. Wellington, formerly
deputy director of the Yale Psychiatric Insti¬
tute, has been long active in community
affairs.
University President Benno C. Schmidt
Jr. commented, "I am extremely pleased
that Sheila Wellington has accepted this
critically important position at Yale. She
will bring tremendous strength to the Office
of the Secretary. Sheila is an experienced,
skilled and energetic administrator. She has
been a committed citizen of New Haven for
many years, active with the political institu¬
tions and communities of this city. She is
enormously intelligent, open and caring.”
Ms. Wellington, who has taught in¬
troductory and advanced courses in admin¬
istration and mental health policy at Yale
since 1974, has two degrees from the Uni¬
versity, both earned in 1968—a Master of
Public Health degree from the department
of epidemiology and public health and a
Master of Urban Studies from the School of
Art and Architecture. From 1980 to 1986,
she was director of the Greater Bridgeport
Community Mental Health Center.
She joined the Hill-West Haven division
of the Connecticut Mental Health Center in
1968 and was its director from 1977 to
1980. The center is sponsored jointly by
Yale University and state agencies. In her
new post, she became an officer of the Yale
Corporation, the University’s governing
board of trustees.
“I am honored to be asked to serve the
University and the wider community in the
position of Secretary, and 1 look forward to
following in the distinguished tradition of
my predecessors,” Ms. Wellington said.

Health Care Expert
Elected Yale Trustee
William L. Kissick, Yale ’53, '51 M.D.,
'59 M.P.H., '61 D.P.H., has been elected a
trustee of Yale University after a nationwide
balloting of alumni. Dr. Kissick, the
George Seckel Pepper Professor of Public
Health and Medicine at the University of
Pennsylvania, succeeds Frederick B. Dent,
'44. Dr. Kissick will serve a six-year term
as a member of the Yale Corporation.
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When he received his last degree from
Yale in 1961, Dr. Kissick went to
Washington to work on health and science
policy for the Kennedy administration.
During seven years in the nation's capital,
he helped to draft health programs, policies
and legislation for the Kennedy and
Johnson administrations while attached to
the U.S. Public Health Service, the Depart¬
ment of Health, Education and Welfare and
the White House. From 1965 to 1968, he di¬
rected strategic planning for the Surgeon
General until President Johnson appointed
him executive director of the National Ad¬
visory Commission on Health Facilities.
In 1968 he became a member of the facul¬
ty at the University of Pennsylvania, where
he organized research and educational pro¬
grams in health care. His joint professor¬
ships in the School of Medicine and the
Wharton School at Pennsylvania estab¬
lished a national precedent.
Dr. Kissick has served as an advisor,
consultant or trustee of many national and
international groups, including the World
Health Organization, the U.S. Department
of State, the Board of National Missions of
the United Presbyterian Church and several
Fortune 500 corporations.
In the past 25 years, Dr. Kissick has been
intimately involved in the affairs of Yale.
His work on behalf of the University in¬
cludes service on the Alumni Schools Com¬
mittee and on the Board of Directors of the
Yale Club of Washington, D C. In addition,
he has been a director, vice president and
president of the Association of Yale Alumni
in Medicine; a member of the Development
Board and the Alumni Fund for the Medical
School; chairman of the Graduate and Pro¬
fessional Schools Committee; assistant
chairman and vice chairman of the Yale
Alumni Fund; and chairman of the Commit¬
tee on Medical Affairs of the University
Council.

Edwin Cadman Returns
to Lead Department
of Medicine
Dr. Edwin C. Cadman, vice chairman of the
department of medicine at the University of
California at San Francisco and director of
its Cancer Research Institute, became chair¬
man of the School of Medicine department
of internal medicine and chief of medicine
at Yale-New Haven Hospital on Sept. 1. Dr.
Cadman returns to the medical school and
hospital with which he was affiliated from
1974 to 1983.
He succeeds Dr. Samuel O. Thier, who
became president of the Institute of
Medicine in January 1986. During the inter¬
vening months, Dr. Robert M. Donaldson
has served as acting department chairman.
“Ed Cadman is nationally recognized as
a clinician, teacher, researcher and admin¬
istrator. I am personally delighted that he
will lead our school’s large and crucial de-

Dr. Cadman

partment of medicine,” says Dr. Feon E.
Rosenberg, dean of the School of Medicine.
“As a well-recognized leader in medical
oncology, he has made major research
contributions in the field of cancer
chemotherapeutic agents. His work will
strengthen the Yale Comprehensive Cancer
Center,” the dean notes. The Yale Com¬
prehensive Cancer Center is a joint project
of the School of Medicine and Yale-New
Haven Hospital.
During the past decade. Dr. Cadman has
centered his research on the interaction of
cancer drugs and cancer cells. For the last
two years, he has concentrated on studying
the mechanisms by which drug resistance is
transferred among cells. Drug resistance is
the most common cause of treatment failure
in cancer patients.
A native of Oregon, Dr. Cadman re¬
ceived a B. A. degree in 1967 from Stanford
University and an M.D. degree magna cum
laude in 1971 from the University of Ore¬
gon. He completed his internship and resi¬
dency training in medicine at Stanford Uni¬
versity Hospital. Between 1974 and 1976,
Dr. Cadman took a postdoctoral fellowship
in oncology at Yale University School of
Medicine, after which he joined the faculty
as assistant professor of medicine and phar¬
macology. He was named associate profes¬
sor in 1979. He also was an attending physi¬
cian at Yale-New Haven Hospital.
At Yale, Dr. Cadman was noted for
his teaching. In 1978, the department of
medicine named him teacher of the year; in
1982, the School of Medicine presented
him the Francis Gilman Blake Award for
outstanding teaching.
In 1983, Dr. Cadman was named profes¬
sor of medicine and chief of hematology/
oncology at the University of California at
San Francisco. Two years later, he was
named the American Cancer Society Pro¬
fessor of Oncology. In 1986, he became
vice chairman of the department of
medicine and was named the David A.
Wood Professor of Cancer Biology. He held
both endowed professorships concurrently.
In 1985, he served as president of the
American Federation of Clinical Research.

Dr. Feinstein Awarded
International Prize

Yale Model Program
Featured at National
Sickle Cell Conference
A Yale pediatrician who developed the
country’s first successful program for diag¬
nosis and treatment of infants with sickle
cell disease says that early intervention
is the key to saving the lives of children
who have this incurable genetic illness,
which affects as many as one in 500 black
Americans.
“In the last 15 years, we’ve identified
and treated about 45 babies in New Haven
with this potentially life-threatening dis¬
ease,” says Dr. Howard A. Pearson, chair¬
man of the pediatrics department at the
School of Medicine and chief of the pediat¬
ric service at Y-NHH. “Using historical
controls, we would have expected seven to
10deaths in that group. But we had none.”
Dr. Pearson was the introductory speaker
for the National Institutes of Health Con¬
sensus Development Conference on New¬
born Screening for Sickle Cell Disease and
Other Hemoglobinopathies, April 6-8, at
N1H headquarters in Bethesda, Md.

SVEN MARTSON

Dr. Alvan R. Feinstein, professor of
medicine and epidemiology, has received
the prestigious J. Allyn Taylor International
Prize in Medicine for 1987. He shared the
prize with Peter Armitage, professor of
biomathematics at Oxford University, and
David L. Sackett, professor of clinical
epidemiology and biostatistics at McMaster
University.
The Taylor prize, administered by the
Robarts Research Institute in London, On¬
tario, and instituted in 1985, is awarded an¬
nually for “significant contributions to a
field of basic or clinical research.” The sci¬
entific community nominates individuals,
and a peer jury selects the recipients, who
receive gold medals.
The prize this year was given for work in
“the basic principles and discipline of clini¬
cal evaluation.” Drs. Feinstein and Sackett
were being honored for their pivotal work in
establishing and developing the field of
clinical epidemiology as a unique investiga¬
tive discipline for studying problems in
medicine. Professor Armitage was selected
for his work in biostatistics and in the design
of clinical trials.
Dr. Feinstein, who joined the Yale medi¬
cal faculty in 1962, has written four books
as sole author and more than 300 papers on
topics of clinical evaluation, epidemiology
and biostatistics. He directs the clinical
epidemiology unit at Yale, the introduction
to clinical medicine course for medical stu¬
dents and the Robert Wood Johnson Clinical
Scholars Program for post-residency fel¬
lows. He also is co-editor of the Journal of
Chronic Diseases.

Dean Rosenberg presents the Leah Lowenstein Award to Dr. Barbara Kinder.

Sickle cell disease, also known as sickle
cell anemia, is a genetic condition in which
red blood cells change from a normal round
shape to an abnormal sickle, or crescent
shape.
The disease causes unpredictable pain at¬
tacks and other serious health problems.
Says Dr. Pearson: “If you look at the his¬
tory of this disease, you find that as many
as 30-35 percent of affected children die be¬
fore reaching the age of five, and many of
them die of infection. Sudden early death
from catastrophic infection may be the first
manifestation of the disease. ”
Since June 1972, the Yale School of
Medicine department of pediatrics has been
testing all black and Hispanic babies bom at
Y-NHH and the Hospital of St. Raphael, to
identify those with sickle cell disease. Once
an affected baby is identified, he or she is
immediately enrolled in a special clinic for
treatment, follow-up and emergency inter¬
vention.
The Yale neonatal program for sickle cell
anemia has been replicated throughout the
world. The National Heart, Lung and Blood
Institute used it as the model for its
Cooperative Study of Sickle Cell Diseases.
This 10-year national investigation took
place at 21 institutions and enrolled nearly
4,000 patients, beginning in 1977.

Leah Lowenstein
Award Presented
The Office for Women in Medicine pre¬
sented the second annual Leah Lowenstein
Award to Dr. Barbara K. Kinder, associate
professor of surgery at the School of
Medicine and chief of surgery at Yale Uni¬
versity Health Services.

The award recognizes the medical school
faculty member who most clearly provides
positive images of women in the promotion
of humane and egalitarian medical educa¬
tion. The recipient’s teaching style and per¬
sonal example have provided a model for
the principle of equal opportunity espoused
by the late feminist physician, dean and
medical
educator
Leah
Lowenstein
throughout her career, according to Merle
Waxman, director of the Office for Women
in Medicine.
On receiving the award. Dr. Kinder said,
“In an era where the business of medicine
seems all to often to be a major focus of stu¬
dent and practitioner concerns, it is ex¬
tremely important that the humanitarian as¬
pects of our profession not be neglected. An
award such as the Leah Lowenstein Award
honors not only its recipient, but bears wit¬
ness to the importance of a balance between
technological expertise and human compas¬
sion in the practice of our craft.”
Dr. Kinder joined the Yale medical facul¬
ty in 1977 as an assistant professor of
surgery. A native of Washington, DC., she
received a BA. degree magnacum laude in
1967 from Smith College and an M.D. de¬
gree cum laude in 1971 from Yale School of
Medicine. She took her residency training
at Yale-New Haven Hospital, where she
also is an attending surgeon. Dr. Kinder is
president-elect of the Connecticut Society
of American Board Surgeons.
Dr. Kinder’s clinical and teaching inter¬
ests are surgical endocrinology and breast
disease. She concentrates her research on
the second messenger system in secretory
tissues, such as the parathyroid and exo¬
crine pancreas.
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Graduates Select
Residencies; Reflect
Trends in Medicine
Ninety-four students who graduated from
the School of Medicine in June participated
in the national match program on March 18.
They selected residency training programs
mirroring national trends that graduates
have set during the past seven years.
According to Dr. Robert H. Gifford, as¬
sociate dean for education and student
affairs, the most significant change was the
marked decrease in the number of students
choosing internal medicine as a career.
"Only 24 students opted for internal
medicine residencies, a decrease by more
than 50 percent from 1980.

“Even more striking was the fact that no
student applied for an obstetrics and
gynecology residency,” he says. "And
general surgery had the lowest number of
successful applicants in the past seven
years."
In contrast, psychiatry was very popular.
Twice as many students entered the special¬
ty this year as compared with 1986, and five
times as many students as in 1980. A
dramatic increase was also seen in the
number of students entering ophthalmology
programs.
"Emergency medicine, anesthesiology,
therapeutic radiology and otolaryngology
are newly popular specialties,” says Dr.
Gifford, who added “the number of stu¬
dents who entered pediatrics and family
practice has remained relatively constant

during the past seven years.”
Reasons for these trends are not entirely
clear. However, Dr. Gifford says that the
average debt of Yale medical graduates—
now close to $40,000—may play some role
in the selection of career specialties.
Some educators also feel that medical
students’ clinical experiences have become
so heavily identified with highly specialized
in-patient, intensive care that students are
less likely to find role models in general
medicine or surgery.
The country’s litigious climate, the as¬
sociate dean notes, may also be a factor in
residency selection for some graduates.

CLASS OF 1987 Residency Positions
CALIFORNIA
Harbor-UCLA Medical Center, Torrance
Michael Burg, emergency medicine
David Granet, transitional

Kaiser Foundation Hospital, San Francisco
Andres Cortes, general surgery

LA County-USC Medical Center, Los Angeles
Alan Yamada, urology

Martin Luther King Jr.-Drew Med. Ctr., Los Angeles
Cecil Bowen, general surgery

UCLA Neuropsychiatric Institute, Los Angeles
Dan Karasic, psychiatry

UCLA-San Fernando Valley Program, Sepulveda
Rebekah Braslow, medicine

University of California-San Diego Medical Center, San Diego
Harlan Meyer, internal medicine

University of California Hospital, San Francisco
Jerome Chin, internal medicine
Paul Wilson, psychiatry

Yale-New Haven Hospital, New Haven
Lisa Berlin, pediatrics
Cristina Brunet, internal medicine
Richard Diana, orthopedic surgery>
Glenn Healey, therapeutic radioloy
Robert Homer, pathology
Jay Horowitz, surgery
Susan Kruger, psychiatry
Robert Malison, psychiatry
Matthew Miller, internal medicine
Nancy Olson, psychiatry
Lisa Panzini, internal medicine
Tarik Ramahi, internal medicine
Lauri Robertson, psychiatry
Seth Rosenthal, medicine
Patrick Ruwe, orthopedic surgery
Terry Watnick, internal medicine
Mark Widmann, medicine
Nicole Vecchi, internal medicine
Eugenia Vining, surgery

DELAWARE
Medical Center of Delaware, Newark
Steve Gaskin, emergency medicine

Stanford University Hospital, Stanford
Mark vonZastrow, psychiatry

COLORADO
University of Colorado School of Medicine, Denver
Ian Cook, general surgery
Donna Klimowicz, psychiatry

CONNECTICUT
Danbury Hospital, Danbury
Benjamin Chen, medicine

Hospital of St. Raphael, New Haven
Subba Gollamudi, transitional
Hugh Hemmings, medicine

DISTRICT OF COLUMBIA
Children’s Hospital National Medical Center
Robert Englander, pediatrics

ILLINOIS
Illinois Masonic Medical Center, Chicago
Louis Glazer, transitional

University of Chicago Medical Center, Chicago
Mark Block, surgery

IOWA
University of Iowa Hospitals & Clinics, Iowa City
Kenneth Newhouse, orthopedic surgery

St. Vincent’s Medical Center, Bridgeport
Larry Amsel, transitional
Peter Glazer. transitional

F'rancis Scott Key Medical Center, Baltimore

University of Connecticut School of Medicine, Farmington

Johns Hopkins Hospital, Baltimore

Susan Thomas, family practice

VVaterbury Hospital, Waterbury
Michael Cooper, medicine

MARYLAND
William Tse, internal medicine

Cynthia Kapphahn, pediatrics

Has anybody got a letter opener? Where are you going? Oh my gosh, I made it! Such
excited comments echoed through the Sterling Hall mailroom shortly after noon on
March 18—National Resident Match Day.

Lynn Street (right) and Diane Louie
share news of their future assignments.

Photography: T. Charles Erickson

At left, Judy Mayo, medical school registrar, (left) and Beverly Eastty.secretary in the
student affairs office, distribute to graduating students letters about residency training
positions.

MASSACHUSETTS
Boston City Hospital, Boston
Peter Blier, pediatrics
Colleen Collins, internal medicine
Michael Solon, internal medicine
Boston University School of Medicine, Boston
Amita Chaudhary, transitional
Brigham & Women’s Hospital, Boston
John Gaziano, internal medicine
John Keaney, internal medicine
Diane Louie, pathology
Cambridge Hospital, Cambridge
Charles Brackett, internal medicine
Ellen Dolnansky, transitional
Lemuel Shattuck Hospital, Boston
Roxanne Bartel, transitional
Mount Auburn Hospital, Cambridge
Marian Greenburg, medicine

New York Hospital, New York City
Suzanne Conzen, internal medicine
Mindy Schuster, internal medicine
New York University Medical Center, New York City
Judith Green, internal medicine
Lynn Street, internal medicine
Presbyterian Hospital, New York City
William Apfeldorf, psychiatry
Andrew Bazos, orthopedic surgery
Patricia Powell, psychiatry
St. Vincent’s Hospital, New York City
Kristen Mertz, transitional
Winthrop-University Hospital, Mineola
Robert Urban, medicine
NORTH CAROLINA
North Carolina Memorial Hospital, Chapel Hill
Lisa Benaron, medicine/pediatrics
Steven Sieber, internal medicine
David Weingold, pediatrics

New England Medical Center, Boston
Richard Tierney, general surgery

OHIO

University Hospital, Boston
Jeffrey Barkin, internal medicine

CWRU-University Hospital, Cleveland
Linda Lewin, pediatrics

MINNESOTA

PENNSYLVANIA

Mayo Graduate School of Medicine, Rochester
Robert Leggon, orthopedic surgery

Allegheny General Hospital, Pittsburgh
Eugene Fu, medicine

University of Minnesota Hospitals, Minneapolis
Susan Bove, internal medicine
M. Nick Burke, internal medicine

Hospital of the University of Pennsylvania, Philadelphia
David Fujii, general surgery
Rebecca Kadish, anesthesiology
Leslie Vogel, psychiatry
Barry Weinstock, internal medicine

MISSOURI
Barnes Hospital, St. Louis
Elliott Levy, general surgery
NEW JERSEY
UMDNJ-Robert W. Johnson Medical School, Piscataway
Nancy Lee, internal medicine

Medical College of Pennsylvania, Philadelphia
C. Christopher King, emergency medicine
St. Christopher's Hospital, Philadelphia
Douglas Nelson, pediatrics

NEW YORK

Temple University Hospital, Philadelphia
Tammy Olsen, internal medicine

Lenox Hill Hospital, New York City
Jesse Wardlow, surgery

RHODE ISLAND

Long Island Jewish Medical Center, New Hyde Park
Eric Jankelovits, pediatrics

Rhode Island Hospital, Providence
Ross Jenkins, surgery
WASHINGTON

Maimonides Medical Center, Brooklyn
Steven Blumenfrucht, medicine

University of Washington Affiliated Hospitals, Seattle
Patricia Gibbs, family practice
Harley Heath, pediatrics
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IN PROGRESS
Severely Depressed
Patients Respond
to Drug
Fluvoxamine, a drug tested by physicians at
the School of Medicine, has been found
effective in relieving severely depressed
patients who have not responded to other
medication.
Fluvoxamine has been used in clinical
trials since the late 1970s but is not yet
available in this country. The drug has been
marketed in Europe for more than five years
and accounts for about five percent of anti¬
depressants sold by prescription in some
countries, according to Dr. Fawrence H.
Price, assistant professor of psychiatry and
the lead investigator.
Drs. Pedro L. Delgado, a postdoctoral
fellow at Yale; Dennis S. Chamey, as¬
sociate professor of psychiatry; and George
Heninger, professor of psychiatry and di¬
rector of the Abraham Ribicoff Research
Facilities at the Connecticut Mental Health
Center, also participated in the fluvoxamine
studies.
The drug differs from most anti-depres¬
sants in structure and effects, according to
Dr. Price. It is a unicyclic compound, hav¬
ing a one-ring chemical structure instead of
the three-ring structure of a more familiar
generation of anti-depressants. Its main fea¬
ture is its selective effect on the chemistry
of the brain, particularly the serotonin sys¬
tem Serotonin is one of the major neuro¬
transmitters regulating mood, appetite,
sleep, sex, aggression and other physiologi¬
cal functions.
In the depressed state, according to one
theory, serotonin is drained from the sys¬
tem Fluvoxamine blocks the reuptake of
serotonin and increases the amount avail¬
able to other cells, says Dr. Price. Normal
levels of serotonin are attained through
other drug treatments. Dr. Price says, but
only over a long term.
In clinical trials at Yale, more than twothirds of the 28 patients who completed
the study—having previously failed to re¬
spond
to
standard
medication
and
psychotherapy—were judged to have had a
“good response” to the drug in six-week
studies that included time when the patients
received placebos This includes 30 percent
who responded well to fluvoxamine and
lithium, the latter having been in long use
with depressed patients.
The determination of a “good response”
is based on both the judgment of the treating
physician and a significant positive change
measured by standard rating scales for pa¬
tient condition. The trials of fluvoxamine
for approval by the U.S. Food and Drug Ad¬
ministration in (his country are in phase
- of a four-phase procedure, says Dr.

Price. The drug is available now only for
designated investigators to use.
A double-blind study by Dr. Wayne
Goodman, assistant professor of psychi¬
atry, on the use of the drug fluvoxamine for
treating obsessive-compulsive disorders
also is underway. In this study, more than
40 percent of a test group of 20 patients with
the disorder who took the drug showed
“good response.” They were measured by
clinical judgment and changes in such rat¬
ings as the Yale/Brown Obsessive-Compul¬
sive Scale. Dr. Goodman, working with
Drs. Chamey, Heninger and Price, has re¬
ported on this study. The main side effects
from fluvoxamine, says Dr. Price, are
nausea, mild headaches, restlessness and,
in cases of long-term use, sedation.

West Haven VA-Yale
Team Identify
New Hormone
A research team collaborating at the Vet¬
erans Administration Medical Center in
West Haven and School of Medicine has
identified a new hormone that regulates the
amount of calcium in the human skeleton.
In doing so, the Yale-West Haven VA team
solved a puzzle that has eluded scientists
since the 1940s.
This hormone—HHM factor, or humoral
hypercalcemia of malignancy factor—re¬
moves calcium from bones and transfers it
to the bloodstream, sometimes in exces¬
sively high concentrations, which in turn
may lead to kidney failure, coma and death
The process also can lead to bone calcium
loss similar to osteoporosis. “We hope the
information about this new hormone will
provide a useful tool for figuring out the
amount of calcium in bones and what os¬
teoporosis is about," says Dr. Andrew F.
Stewart, associate professor of medicine at
the School of Medicine and chief of endo¬
crinology at the VA Medical Center.
To study HHM factor, the team examined
cancerous tumors from 20 patients, ex¬
tracted the hormone, and purified it.
“Healthy tissues make only small amounts
of HHM factor; but, for unknown reasons,
cancerous tumors produce large amounts of
the hormone,” Dr. Stewart says.
Abnormally high calcium concentrations
in blood may occur in many patients with
lung cancer, breast cancer, leukemias,
gynecologic cancers and other tumors.
“This new hormone, which transfers cal¬
cium from bones to the bloodstream, may
help explain why tumors grow in some
cancer patients,” Dr. Stewart says. “We
don't know whether this HHM factor is ac¬
cidentally made by the tumors or whether
the factor may be responsible for the
tumors.... That’s another question we are
going to work on.”
Dr. Stewart envisions that physicians
eventually may use the hormone as a means
to diagnose the cause of hypercalcemia—

abnormally high calcium concentrations in
human blood—and as a test to screen for
cancer. For cancer patients with elevated
calcium, physicians may be able to follow
HHM factor levels to determine the pa¬
tients’ responses to therapy.
Dr. Stewart says that identification of this
hormone implies that a gene exists to code
for HHM factor. “The next step is to iden¬
tify that gene and to study what turns it on
and off. We also want to look more closely
at the relationship between the gene and
cancer. This work is being conducted by
Dr. Arthur E. Broadus, associate professor
of medicine (endocrinology) and chief of
the endocrine division at the School of
Medicine; and Marguerite S. Mangin,
Ph.D., associate research scientist in
medicine at Yale.
“Now that we have identified the hor¬
mone, we can work to clone it and readily
produce more of it in order to conduct
further studies. For instance, we’d like to
know what body activities this hormone
regulates, where it is made and what sub¬
stances or systems it ‘talks’ to," the endoc¬
rine researcher says.
Dr. Stewart’s group published its
findings in a May issue of the Journal of
Biological Chemistry’ and presented the
work at the American Society for Bone and
Mineral Research annual meeting.
Grants from the National Institute on
Diabetes and Digestive and Kidney Dis¬
eases and the VA Medical Center in West
Haven have supported this research.
Dr. Stewart started work on the newly
identified hormone in 1978 as a postdoc¬
toral fellow at Yale medical school in Dr.
Broadus’ laboratory. Drs. Stewart, Broadus
and their colleagues have continued the
work at the endocrine research laboratory at
Yale and the VA Medical Center in West
Haven.
Besides Drs. Stewart, Broadus and Mangin, the team includes; Dr. William Burtis,
assistant professor of medicine (endocrinol¬
ogy) at Yale and research associate at the
VA Medical Center; and Dr. Karl F.
Insogna, research associate at the VA and
assistant professor of medicine at Yale.

Major Federal Grant
Supports New AIDS
Research
A team of Yale University biomedical sci¬
entists has begun a major research project
which they hope will lead to a new drug
treatment for AIDS.
The research project, supported by a fiveyear grant that the National Institutes of
Health has awarded Yale University, will
center on subcellular research to understand
the chemical structure of AIDS virus pro¬
teins in order to design new drugs or im¬
prove existing drugs. For the first year, the
NIH has awarded $1 million to Yale.
“This project represents a new direction

in biomedical science’s fight to combat the
deadly AIDS virus.... We will approach the
HIV virus, which causes AIDS—acquired
immune deficiency syndrome—through the
framework of structural biology, a relative¬
ly new field which seeks to understand
the chemistry of complex biological
molecules,” says Donald M. Engelman,
Ph. D., the project’s principal investigator.
He also is professor and chairman of the
Yale department of molecular biophysics
and biochemistry and professor of biology.
“With five years of federal support for
our research, we see an opportunity for our
basic scientific skills to be useful in helping
to solve an important problem: how to keep
millions of people from dying from this
relentless disease,” Professor Engelman
says.
According to Halvor G. Aaslestad,
Ph. D., assistant dean for research adminis¬
tration in the School of Medicine, this pro¬
gram project grant is the largest that the NIH
has awarded Yale for basic AIDS research.
The Yale group that Engelman leads is
one of six funded by the NIH and managed
by the National Institute of General Medical
Sciences. Three other groups are based at
universities: the University of California at
San Francisco and at Los Angeles and
Harvard University. Two laboratories are
located at companies, including Agouron
Pharmaceuticals Inc., La Jolla, Calif.; and
SmithKline & French Laboratories, Inc.,
Swedeland, Pa.
In conducting the research to determine
the structure of protein molecules—which
the virus uses to infect a cell and to make
more virus—the Yale scientists plan to use
the sophisticated technology of protein
crystallography, which involves growing
crystals of certain proteins and studying
their structures by x-ray scattering. In doing
so, the researchers will use techniques
which omit human subjects or animals.
According to Engelman, the Yale re¬
searchers want to map where each atom is
located among the thousands of atoms that
determine the protein’s chemical structure.
“We will design new drugs that will fit
chemically and stick to the protein we are
studying, and perhaps successfully block
the protein’s function,” says Engelman, a
biophysicist who was named chairman of
the molecular biophysics and biochemistry
department in July. The department in¬
cludes faculty in Arts and Sciences and in
the School of Medicine.
A newly designed drug could possibly
work in several ways, Engelman explains.
“A drug either could stop the HIV virus
from getting into cells, or it could block key
steps necessary for the virus to grow within
cells. The latter approach may be more use¬
ful for people with advanced cases of
AIDS.”
Engelman cautions that the progress of
this basic scientific research may take many
years, but he points out that AIDS has a long
time-course. “AIDS often appears 10 to 15
years after a person has been infected, so

Human Genetics Opens
DNA Diagnostic Lab

Dr. Donald Engelman

even a solution which may take five or more
years to develop still could be very useful,”
he says.
Yale scientists will pursue four main
areas of laboratory research. Dr. William
C. Summers, M.D., Ph.D., professor of
therapeutic radiology, human genetics and
molecular biophysics and biochemistry,
and his colleagues will clone or copy indi¬
vidual HIV proteins and produce them in
large quantities, either in E. coli or in cell
culture systems.
Then, they will purify the cloned protein
and give it to Thomas A. Steitz, Ph D.,
professor of molecular biophysics and
biochemistry, and his laboratory col¬
leagues, who plan to study the protein by
using x-ray diffraction.
Frederic M. Richards, Ph D., Henry
Ford II Professor of Molecular Biophysics
and Biochemistry, will conduct theoretical
studies leading to drug designs. His work
will be based on the previous structural
studies. Finally, Engelman and his group
will study the proteins responsible for get¬
ting the virus into cells.
The four principal scientists will direct
research in their own laboratories. In addi¬
tion, they will use the protein chemistry lab¬
oratory that Kenneth R. Williams, Ph.D.,
senior research scientist in molecular
biophysics and biochemistry, heads in the
Sterling Hall of Medicine and the Center for
Structural Biology in Kline Biology Tower.
HIV virus falls within a family of viruses
called retroviruses. These RNA-containing tumor viruses include herpes and such
cancers as sarcomas, leukemias and lym¬
phomas.
“If we learn how to deal with the HIV
virus, then there may be other applications
for our findings,” says Engelman. "Be¬
cause this work is fundamental, it poten¬
tially opens an entirely new direction in
thinking about viral problems.”

The department of human genetics has
opened a new DNA Diagnostic Laboratory
that uses sophisticated recombinant DNA
technology to test for three severe genetic
disorders.
The disorders are fragile X associated
mental retardation, the most common cause
of inherited mental retardation; X-linked
muscular dystrophy and an enzyme defi¬
ciency of ornithine transcarbamylase,
(OTCase).
“In establishing this new laboratory, we
will widen the coverage of available genetic
services in the New England area,” says
Carolyn W. Slay man, Ph. D., professor and
chairman of human genetics and professor
of physiology.
The new laboratory expands the com¬
prehensive genetic services that physicians
and other health professionals in human
genetics offer at the Yale School of
Medicine. Two other laboratories provide
biochemical and cytogenetic chromosome
analysis. Counseling services also are avail¬
able.
Until recently, prenatal detection and
diagnosis of single gene disorders have
been limited. In less than 200 of approxi¬
mately 2,000 known genetic diseases, the
defect has been identified. However, for
more than 20 years, microscopic techniques
to detect abnormal chromosomes in chil¬
dren with physical or mental abnormalities
or in unborn fetuses have been available.
“The genetic diseases for which the Yale
lab will test and other genetic diseases make
a significant impact on health care facilities
and medical support,” Dr. Slayman notes.
“In many cases, retarded or handicapped
individuals with these genetic diseases re¬
quire considerable care. ”
“The DNA Diagnostic Laboratory will
apply newly developed techniques to detect
inherited changes in DNA directly or to use
naturally occurring variations in human
DNA—called RFLPs, restriction fragment
length polymorphisms—to track the sec¬
tion of the chromosome carrying the mutant
gene from generation to generation within
families,” explains Maurice J. Mahoney,
M D., professor of human genetics, pediat¬
rics and obstetrics and gynecology. He also
is acting director of the new laboratory.
“This laboratory will allow both carrier de¬
tection and prenatal diagnosis to be possible
in those families where it is appropriate to
apply the tests,” Dr. Mahoney adds.
The genes that cause the three inherited
diseases for which the new laboratory will
test are located on the larger of the two sex
chromosomes, the “X," according to Pat¬
ricia D. Murphy, Ph D., assistant director
of the laboratory.
Consequently, males, who have sex
chromosome constitution XY, have the mu¬
tation on their only X chromosome. They
are seriously affected by the disruption the
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disease gene causes. Females, who have
sex chromosome constitution XX, can be
carriers of the mutant gene on one X, but be¬
cause they have a normal copy of the gene
on the other X, they are rarely and only
mildly affected. Dr. Murphy explains.
Located on the third floor of the William
Wirt Winchester Building, the new labora¬
tory has been partially supported by a
$150,000 grant from the Johnson &
Johnson Co. of New Brunswick, N.J. The
three-year grant comes from the corpora¬
tion’s focused giving program.
In the future, the laboratory staff antici¬
pates adding tests for other disorders, such
as cystic fibrosis, adult polycystic kidney
disease, myotonic dystrophy and neurofi¬
bromatosis, according to Dr. Murphy, who
holds a doctorate in human genetics.
The laboratory also will serve as a site to
test improved and new diagnostic proce¬
dures that members of the human genetics
department develop, she adds.
National health statistics show that one in
1,500 to 2,000 men has marker X or fragile
X syndrome. Mental deficit (IQ of 50 to
60), hyperactivity, large and often protrud¬
ing ears and enlarged testicles characterize
this syndrome.
Females who carry the gene are relatively
frequent, one in 700 to 1,000. These carrier
women—whether or not they express the
marker—are at increased risk of having
some degree of mental retardation or learn¬
ing disability themselves.
The gene that causes the two major forms
of muscular dystrophy—Duchenne and
Becker types—resides in another region of
the X chromosome. These diseases occur in
approximately one in 3,300 children.
Women may be carriers of the gene. The
disorder usually is first noticed when the
child is learning to walk. The child may ex¬
perience progressive muscle weakness,
until he is confined to a wheelchair.
This confinement occurs about age 10 in
the more severe form of muscular dys¬
trophy—Duchenne type—and later in the
Becker type Boys with the Duchenne form
have significantly shortened lifespans.
Women who carry the gene rarely show any
physical signs of the disorder, but half of
theirsons will have muscular dystrophy.
OTCase deficiency is less common. Male
children born with the mutation die of am¬
monia poisoning within hours or days of
birth. Girls who carry the gene occasionally
can show somewhat milder symptoms.
They require careful monitoring to prevent
permanent brain damage due to high am¬
monia levels in their blood.

Psychiatric Patients
Rehabilitated
Through Work
Adults disabled by psychiatric illness are
learning to become productive workers in
their communities, thanks to a transitional
program available through the Yale Psychi¬
atric Institute.
The Community Work Adjustment Pro¬
gram, part of the YPI Community Services
Division, is designed for people who have
been out of work for a long time or for those
who have attempted jobs without success.
“Our typical client has been in and out of
psychiatric hospitals for 10 or more years,
with psychiatric diagnoses that include
schizophrenia, major affective disorders
and personality disorders,” says Dr. Ira R.
Levine, associate clinical professor of psy¬
chiatry at the medical school and senior
clinical consultant to the Community Ser¬
vices Division.
Community Services Division director
W. Leonard Hill Jr., M.Div., M.S.W., ex¬
plains: “When clients come to us, they are
relatively stable but are often still struggling
with residual symptoms of prolonged men¬
tal illness. We have found that helping pa¬
tients re-enter the working world not only
moves them closer to the goal of making
them contributing members of society, but
has the added benefit of considerably en¬
hancing their self-esteem
Hill also is assistant clinical professor of
psychiatry (social work) at the School of
Medicine, and director of social work and
coordinator of the family therapy program
at YPI
The work adjustment program teaches
basic employment skills, such as getting up
on time; calling employers to report lateness
or absences; getting along with co-workers;
accepting supervision; problem-solving on
the job; learning to manage stress in the
workplace; improving speed and stamina;
and developing good grooming habits.
The program offers a continuum of ser¬
vices. Initially, the “Workplace,” a voca¬
tionally oriented day treatment program,
combines a protected work environment
with group and individual counseling.
From the “Workplace,” clients can move
to unpaid, transitional employment in New
Haven worksites—including the Salvation
Army Thrift Shop and the Jewish Home for
the Aged—that provide training oppor¬
tunities for the program’s clients. An addi¬
tional network of 60 agencies, including
hospitals, museums, libraries, animal shel¬
ters and other social service organizations,
supervise client-volunteers.
Clients who go on to paid employment
may fine-tune their work skills through a job
maintenance program that includes indi¬
vidual counseling and job groups. For some
patients, the work adjustment program co¬
ordinates services with the state Division of
Rehabilitative Services, providing evalua¬

tion, placements and follow-up vocational
services.
“Counseling is the key to the success of
this program,” says Hill. “Instead of feel¬
ing like mental patients, participants learn
to identify themselves as workers.
“By tailoring the program to individu¬
als," he adds, “we help the clients to find
the niches where they function best. One of
the program’s strengths is its diverse clien¬
tele—the Community Work Adjustment
Program serves patients from all socio¬
economic backgrounds. ”
In addition to its program for adults, the
work adjustment program provides work¬
readiness services for adolescents through
a joint venture with Yale’s Cedarhurst
School, a special education secondary
school in Hamden.
A year ago, the Community Work Ad¬
justment Program received a grant from the
State Department of Mental Health for work
services through the Consortium of Com¬
munity Support Providers—a network of
New Haven area agencies that provide as¬
sistance to people with disabilities. Funding
for individual clients also comes from
the Division of Rehabilitative Services,
the Veterans Administration and private
sources.
Of the 20 clients referred by the consor¬
tium to the program, five have already
moved on to competitive employment,
where they are receiving a regular
paycheck. “Others are moving in a similar
direction,” says YPI Community Services
Division director Hill.

FACULTY NEWS
Adrian M. Ostfeld, M.D., and Alan C.
Sartorelli, Ph D., have been elected mem¬
bers of the Institute of Medicine, chartered
in 1970 by the National Academy of Sci¬
ences to enlist distinguished members of the
medical profession to examine policy mat¬
ters pertaining to the public’s health.
Dr. Ostfeld is Anna M.R. Lauder Profes¬
sor of Epidemiology and Public Health,
while Sartorelli is professor of pharmacol¬
ogy and director of the Yale Comprehensive
Cancer Center.
Dr. Michele Barry, associate professor
of medicine at the School of Medicine and
an attending physician at Yale-New Haven
Hospital, has been selected to receive a
W.K. Kellogg Foundation National Fellow¬
ship Award.
Dr. Barry is one of 45 outstanding Amer¬
ican professionals who will pursue learning
outside their area of expertise. Each Kel¬
logg fellow receives a three-year grant of
$30,000 to fund his or her plan of study.
Dr. Barry set up exchange programs for
Yale physicians-in-training in Haiti and
Tahzgania. In January she will return to Af¬
rica on a six-month sabbatical at the Univer¬
sity of Zimbabwe, where she will be visit¬
ing professor of medicine.
At Yale, Dr. Barry serves as co-director
of the International Travelers Clinic and the
tropical medicine program, which she
helped develop within the department of in¬
ternal medicine. She is founder and director
of the Southeast Asian Refugee Health Care
Clinic at Yale-New Haven Hospital.
At commencement in May, Bank Street
College of Education presented an honorary
Doctor of Humane Letters degree to Dr.
James P. Comer for his “exceptional ser¬
vice to children outside formal educational
settings.” Dr. Comer, the Maurice Falk
Professor in the Child Study Center and
Psychiatry and associate dean for students,
has worked with and written extensively
about children, especially black children.
He strongly advocates more humane set¬
tings for growth and learning.
Dr. Kerry Cooper ’79, assistant clinical
professor of medicine, was selected by first
year assistant residents to receive the Be¬
nedict R. Harris Award, an award given an¬
nually to the physician who has contributed
the most to teaching of house staff at YaleNew Haven Hospital.
Dr. Ralph A. DeFronzo, associate pro¬
fessor of medicine, has received the 1987
American Diabetes Association Award for
Outstanding Scientific Achievement by a
Young Investigator. The award, sponsored
by Eli Lilly and Company, was presented at

the association’s 47th annual meeting on
June 6 in Indianapolis. Dr. DeFronzo has
concentrated his efforts in the pathogenesis
and treatment of non-insulin dependent
(Type II) diabetes.
Nigel D.F. Grindley, Ph D., professor
of molecular biophysics and biochemistry,
was one of 273 artists, scientists and schol¬
ars selected as a Guggenheim Fellow
for 1987. Guggenheim fellowships are
awarded for distinguished achievement and
exceptional promise for future accomplish¬
ment. Grindley’s research will focus on
protein-DNA complexes active in recombi¬
nation.
Dr. Bernard Lytton, professor of
surgery (urology), was named master of
Jonathan Edwards College, oneof Yale’s 12
residential colleges for undergraduates. His
appointment was effective July 1. Dr. Lyt¬
ton is chief of the section of urology at YaleNew Haven Hospital and the Veterans Ad¬
ministration Medical Center in West Haven.
In 1985, he received the American Urologi¬
cal Association’s Hugh Hampton Young
Award for his contributions to urology.
Donald M. Quinlan, Ph D., professor
of psychiatry (psychology), was appointed
master of Morse College, an undergraduate
residential college at Yale, on July 1. Quin¬
lan, whose research focuses on psychologi¬
cal diagnostic testing, is chief psychologist
at Yale-New Haven Hospital. He and Sid¬
ney J. Blatt, Ph.D., professor of psychiatry
and psychology, are editing a book on
depression.

Robert Donaldson
Named Deputy Dean
Dr. Robert M. Donaldson Jr., acting chair¬
man of the School of Medicine’s depart¬
ment of internal medicine, became the
school’s deputy dean on Sept. I.
In announcing the appointment. Dr.
Leon E. Rosenberg, dean of the School of
Medicine, says "Bob Donaldson possesses
lengthy experiences in medical administra¬
tion, both at Yale-New Haven Medical Cen¬
ter and the Veterans Administration Medi¬
cal Center in West Haven. He has been a
creative laboratory scientist, a devoted
teacher of students and residents and an
excellent clinical chief. He leads by
exemplary personal behavior, and he is
committed to the highest standards of pa¬
tient care, research and education. ”
Dr. Donaldson succeeds Dr. Arthur Ebbert Jr., who has relinquished the dean’s
office position to take a sabbatical leave of
absence. Dr. Ebbert, professor of medicine,
was the school’s first deputy dean, holding
the position from 1974 through Aug. 31,
1987. He also has been assistant and as¬
sociate dean, serving for 34 years in the
dean’s office at Yale. “His contributions

Dr. Robert Donaldson

are extraordinary, and his unparalleled
record of service and leadership will never
be surpassed," says Dr. Rosenberg.
Dr. Donaldson, the David Paige Smith
Professor of Medicine, joined the Yale med¬
ical faculty in 1973 as professor and vice
chairman of the department of internal
medicine. Between 1973 and 1982, he was
chief of the medical service at the Veterans
Administration Medical Center in West
Haven. For 20 months, he was acting chair¬
man of Yale's department of internal
medicine.
In his research and patient care activities,
Dr. Donaldson has focused on the sub¬
specialty of gastroenterology. He has con¬
ducted basic research concerned with gas¬
tric function, vitamin B12 transport and
intestinal bacteria. He also has performed
clinical studies related to peptic ulcer dis¬
ease, liver disease and the diagnosis of gas¬
trointestinal disorders.
Active in many professional societies.
Dr. Donaldson served as president of the
American Gastroenterological Association
in 1979-80. He also has served on several
advisory committees of the National Insti¬
tutes of Health. From 1970 to 1977, he
served as editor of the scientific publication
Gastroenterology and is now chairman of
the journal’s editorial board.
A native of Wellesley, Mass., Dr.
Donaldson received a B.S. degree with high
orations in 1949 from Yale University and
an M.D. degree cum laude in 1952 from
Boston University. After medical school,
he interned at Montreal General Hospital
and completed residency training at the Vet¬
erans Administration Hospital in Boston.
He was a postdoctoral fellow in gastroen¬
terology at Peter Bent Brigham Hospital.
He also served on the faculty at Boston Uni¬
versity, where he directed the gastroenterol¬
ogy division from 1967 to 1973.
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ders. Dr. Leckman also serves as associate
program director of the Children’s Clinical
Research Center, a five-bed research unit
funded by the National Institutes of Health.
Dr. Volkmar’s work stresses the impor¬
tance of basic child development research
on understanding clinical disorders. His re¬
search centers on investigations of develop¬
mental psychopathology in infants and chil¬
dren under age five, and studies of severe
developmental disorders. He also is con¬
cerned with custody issues, developmental
assessment and psychiatric diagnosis.

Two Become
Emeritus

Dr. Bernard Forget

Forget Named
New Associate Dean
Dr. Bernard G. Forget, professor of
medicine and of human genetics at Yale, has
been appointed to the newly created posi¬
tion of associate dean for research affairs at
the medical school, effective Nov. 1.
“Bernard Forget is a distinguished
molecular hematologist, a longstanding in¬
stitutional leader and a man of broad vision
and principle. He will combine his new ad¬
ministrative responsibilities with his re¬
search efforts,” says Dr. Leon E. Rosen¬
berg, dean, in announcing the appointment
Dr. Forget came to New Haven in 1976
as associate professor of medicine and of
human genetics and as chief of the hematol¬
ogy section in the department of internal
medicine in the School of Medicine and at
Yale-New Haven Hospital. He was named
professor in 1978.
During this time, he has centered his re¬
search on the molecular genetics of globin
gene expression and genes for the red cell
membrane protein called spectrin.
Since 1985, he also has directed the phy¬
sician scientist research training program in
the School of Medicine. He also serves as
a member of the NIH’s Heart, Lung and
Blood Research Review Committee.
The author of more than 150 scientific
publications, Dr Forget co-authored, with
Dr. H. Franklin Bunn, professor of
medicine at Harvard Medical School, the
textbook Hemoglobin Molecular, Genetic
and Clinical Aspects, published last year.
I Ic also serves as an editorial board member
lora number of journals.
Dr Forget has been elected a member of
American Society for Clinical Investi¬

gation and the Association of American
Physicians. Before joining the Yale faculty.
Dr. Forget taught at Harvard Medical
School and was an attending physician at
the Children’s Hospital Medical Center in
Boston.
A native of Rhode Island, Dr. Forget re¬
ceived an A.B degree in 1959 from the
University of Montreal and an M.D. degree
in 1963 from McGill University. He com¬
pleted residency training at the Massa¬
chusetts General Hospital in Boston, and
between 1968 and 1971 conducted research
as a fellow at the National Institutes of
Health and the Children’s Hospital Medical
Center.

Two Designated
As Harris Professors
Dr James Leckman and Dr. Fred R. Volkmar were named to endowed professor¬
ships. Dr Leckman is the Neison Harris
Associate Professor of Child Psychiatry and
Pediatrics, and Dr. Fred R Volkmar is the
Harris Assistant Professor of Child Psychi¬
atry, Pediatrics and Psychology.
The Harris professorships are part of the
new ly created Harris Program in Child Psy¬
chiatry, Child Development and Social Pol¬
icy, established last year at the Child Study
Center with a $5 million gift from Yale
alumni Irving B Harris and his brother
Neison Harris, both of the Chicago area.
Dr. Leckman is the research coordinator
at the Child Study Center. His research in¬
volves children with severe developmental
disorders and the relationship between
genetic and environmental factors in the
transmission and expression of those disor¬

Dr. Nicholas M. Greene, professor of
anesthesiology
and
attending
anes¬
thesiologist at Yale-New Haven Hospital
since 1955, was named professor emeritus
of anesthesiology July I. Dr. Greene had
been chairman of the department of anes¬
thesiology from 1955 to 1973. He also
served as a consultant in anesthesiology to
the Veterans Administration Medical Cen¬
ter in West Haven, Stamford Hospital and
Waterbury Hospital. Dr. Greene has been
editor-in-chief of the journal Anesthesia &
Analgesia since 1977. From 1975 to 1978
and from 1980 to 1982, he served on the
School of Medicine admissions committee.
Dr. Greene is an honorary fellow of the
Faculty of Anaesthetists of the Royal Col¬
lege of Surgeons and an honorary member
of the Japan Society of Anesthesia.
Dr. David Seligson, a member of the
School of Medicine faculty for 29 years,
was named professor emeritus July I. Dr.
Seligson was chairman of the department of
laboratory medicine from 1971 to 1984. He
also was director of clinical laboratories at
Yale-New Haven Hospital from 1958 to
1984.
Dr. Seligson is a member and past presi¬
dent of the Academy of Clinical Laboratory
Physicians and Scientists and the American
Association of Clinical Chemists, and has
been honored by both organizations for out¬
standing contributions to his field.

Noted Pediatrician
Assumes Chairmanship
Dr. Joseph B. Warshaw has been appointed
professor of pediatrics and chairman of the
department of pediatrics at the School of
Medicine, and chief of pediatrics at YaleNew Haven Hospital. His appointment was
effective Aug. 1.
He succeeds Dr. Howard A. Pearson,
professor of pediatrics, who stepped down
as chairman to rejoin the pediatric hematol¬
ogy division and continue his research on
sickle cell disease and thalassemia.
Dr. Warshaw was an associate professor,
then a professor of pediatrics and obstetrics
and gynecology at the medical school from
1973 to 1982. He also was director of the di¬
vision of perinatal medicine at Yale-New
Haven Medical Center and director of the
newborn special care unit at the hospital
during the same period.
“We are pleased to have Dr. Warshaw
back at Yale,” says Dr. Leon E. Rosenberg,
dean of the School of Medicine. “He is a
distinguished clinician, teacher, adminis¬
trator and investigator who has made major
contributions to care of the newborn. ”
Dr. Warshaw is returning to Yale from
Texas, where he has been the George L.
MacGregor Professor of the pediatrics de¬
partment at the University of Texas Health
Science Center at Dallas, Southwestern
Medical School, since 1984. He has been in
Texas since 1982 as chairman of the Univer¬
sity of Texas pediatrics department, chief
of staff at Children's Medical Center of
Dallas, and chief of pediatrics at Parkland
Memorial Hospital.
“Dr. Warshaw is recognized internation¬
ally for his research on metabolic influences
on fetal growth and development. There is
no doubt that he is an outstanding leader in
academic pediatrics and especially in the
field of perinatal medicine. He was the
unanimous choice of our search commit¬
tee," says Dean Rosenberg.
In December 1986, Dr. Warshaw was ap¬
pointed to a four-year term on the National
Advisory Child Health and Human De¬
velopment Council of the National Insti¬
tutes of Health. He is a member of the re¬
search advisory committee of the National
March of Dimes Foundation; the committee
on research of the American Academy of
Pediatrics; the scientific advisory commit¬
tee of The Hospital for Sick Children in To¬
ronto, Canada; and the scientific advisory
board of the St. Jude Children’s Research
Hospital in Memphis, Tenn.
Dr. Warshaw received his M.D. degree
in 1961 from Duke University Medical
School. He is a native of Miami, Fla.

GALLERY

Mr. O’Brien the Irish Giant the Tallest Man in the
Known World Being Near Nine Feet High
by John Kay (Scottish, 1742-1826)
Patrick O’Brien, bom Patrick Cotter in 1760, is thought to have stood 8 feet 1 inch,
somewhat less than the “near nine feet” which he claimed. Nevertheless, Cotter’s
genuine stature, together with his personality and keen business sense, contributed to
his becoming a celebrity. Adopting the name O’Brien, he advertised, as did other tall
Irishmen, lineal descent from “the old and puissant king Bryan Boreau,” a hero of the
11th century. In an age when many who suffered pituitary abnormalities were exploited
by entrepreneurial showmen. Cotter assumed control of his own fortune. He acquired
significant means by appearing at fairgrounds and in private showrooms where he
collected one to two shillings for admission. When he visited Edinburgh in 1803 and
was fitted for a greatcoat by a diminutive tailor, the event aroused great public curiosity
which was duly addressed by the most popular printmaker of the city with the etching
shown here. Shortly thereafter, symptoms resulting from Cotter’s acromegaly became
debilitating and he retired from public life. He died in 1806.
John Kay, the artist, apprenticed as a barber and was a member of Edinburgh’s
Society of Surgeon-Barbers until he closed his prosperous shop to devote his full
energies to portraiture and printmaking. His print is one of many representing the
range of human dimensions to be found in the Clements C. Fry Collection of the Yale
Medical Library.— Susan Wheeler
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ALUMNI NEWS
Dr. Myron E. Wegman '32, dean emeritus
of the University of Michigan School of
Public Health, received the 1986 National
Sanitation Foundation’s Spes Hominum
Award for his work as an environmentalist.
Helen M. Tepperman ’42 PhD., and
her husband. Dr. Jay Tepperman, received
honorary Doctor of Science degrees at com¬
mencement at the State University of New
York, Health Science Center at Syracuse.
The Teppermans are professors emeriti of
pharmacology at the SUNY Health Science
Center Dr. Jay Tepperman was associated
with the Yale medical school from 1940 to
1944.
Dr. Walter J. Burdette '42 presented a
paper on “The Role of the Surgeon in the
Management of Immune Deficiency Syn¬
drome” at the first Beijing Conference on
General Surgery in the People’s Republic of
China. Dr. Burdette, a general and thoracic
surgeon in Houston, previously was chair¬
man of the departments of surgery at the
Universities of Missouri and Utah and as¬
sociate director (research) at the University
of Texas M.D. Anderson Hospital and
Tumor Institute.
Dr. R. Leonard Kemler ’43, associate
clinical professor of surgery at the Univer¬
sity of Connectcut School of Medicine since
Oct. 1, 1986, is president-elect of the
Hartford County Medical Association. He
will assume the presidency on April 20,
1988.
The Association of Community Cancer
Centers presented its annual award for out¬
standing contribution to community cancer
care to Dr. Robert Frelick '44. Frelick, a
former ACCC president and one of its foun¬
ders, retired in July as National Cancer In¬
stitute program director of the Community
Clinical Oncology Program.
Dr. Robert E. Cooke ’44, professor and
chairman of the department of pediatrics at
the State University of New York at Buffalo
School of Medicine, gave the keynote ad¬
dress at the National Institute of Child
Health and Human Development 25th an¬
niversary program on Sept. 21 in Bethesda.
Dr. Cooke, who was instrumental in creat¬
ing the institute—one of the 12 National In¬
stitutes of Health—presented his recollec¬
tions of the conceptualization and founding
of the NICHD Dr Cooke also is chairman
of the Scientific Advisory Committee of the
Joseph P. Kennedy, Jr. Foundation. Dr.
( ooke was a member of the Yale medical
faculty from 1950 until 1956, serving as as¬
sociate professor of pediatrics and physiol¬
ogy when he resigned in 1956.

The American College of Allergists, at
its 42nd annual congress in March, created
the John P. McGovern Society to honor Dr.
John P. McGovern 46 HS, a past presi¬
dent of the ACA. In May, Pan American
University, Edinburg, Texas, awarded its
first honorary doctorate to Dr. McGovern,
founder and chief consultant to the
McGovern Allergy Clinic in Houston.
Dr. Paul Talalay ’48, the John Jacob
Abel Distinguished Service Professor in the
department of pharmacology and molecular
science at Johns Hopkins University School
of Medicine, was elected to the National
Academy of Sciences in April.
Dr. David B. Skinner ’59 was named to
the newly created position of president and
chief executive officer of New York Hospi¬
tal, effective Oct. 1. The hospital, founded
in 1771, has a total of 1,460 beds at its Man¬
hattan and Westchester locations.
Col. William H. Heydorn ’ 59 is com¬
mander of the Letterman Army Medical
Center at the Presidio of San Francisco.
Col. Heydorn previously was chief of
surgery at the hospital, one of eight U.S.
Army medical centers.
Dr. Muriel D. Wolf ’59, associate pro¬
fessor of pediatric cardiology at George
Washington University School of Medicine
in Washington, D C., has completed a term
as the first woman president of the
Washington Yale Club.
At the annual meeting in San Diego, on
Sept. 29, the American College of Radiol¬
ogy Board of Chancellors awarded Dr.
Royal C. Hudson Jr. ’61, of Lincoln, R.I.,
a fellowship for his outstanding contribu¬
tions to the field of radiology.
Dr. Robert I. Levy ’61, senior associate
vice president for health sciences at Colum¬
bia University College of Physicians and
Surgeons, has been named vice president
for biomedical research for the Association
of American Medical Colleges. His ap¬
pointment is effective Jan. 1,1988.
In January 1987, New Jersey Gov.
Thomas Kean awarded Dr. Leon Smith ’62
HS, of Essex Fells, N.J., the first annual
Clara Barton Medical Service Award for
“outstanding effort and contributions to the
welfare of human life.” Dr. Smith is direc¬
tor of medicine and chief of infectious dis¬
ease at Saint Michael’s Medical Center in
Newark.
Dr. Charles B. Anderson '62 serves as
professor and chief of the division of gen¬
eral surgery at the Washington University
School of Medicine and general surgeon-in¬
chief at Barnes Hospital, both in St. Louis.
Dr. John T. Harrington ’62. professor
of medicine at Tufts University School of
Medicine, was appointed chief of medicine

at Newton-Wellesley Hospital, a teaching
affiliate of Tufts University School of
Medicine, June 1, 1986.
In an April 26 feature story. The New
York Times asked prominent New Yorkers
to predict which people, in their respective
fields, will make a difference in the future
of New York. For medicine. Dr. Mathilde
Krimm, the founding co-chairwoman of the
American Foundation for AIDS Research
and an associate research scientist at St.
Luke’s-Roosevelt Hospital Center and at
Columbia University College of Physicians
and Surgeons, selected Dr. Stephen C.
Joseph ’63, New York City Commissioner
of Health. Says Dr. Krim, "He's a humane
person. He has an appropriate view of the
relations of AIDS to socioeconomic prob¬
lems, such as the prevalence of AIDS in
poverty.”
Dr. Helen L. Smits ’67, of Essex,
Conn ., has been appointed director of John
Dempsey Hospital at the University of Con¬
necticut Health Center in Farmington. Dr.
Smits, who was interim director since May
1, 1986, is the fourth person and first physi¬
cian to direct the 232-bed hospital, which
opened in 1979. It is the university's teach¬
ing hospital.
Dr. John D. Baxter ’66, chief of the di¬
vision of endocrinology at the University of
California at San Francisco, received the
Medical Society of the State of New York's
Albion O. Bernstein, M.D Award for
pioneering work applying molecular and
cell biology to the field of endocrinology.
Elizabeth H. Avery ’68 M.P.H. of
Gwynedd Valley, Pa., has become presi¬
dent and chief executive officer of The Lankenau Hospital and The Lankenau Hospital
Foundation in Philadelphia. Her appoint¬
ment was effective June 22.
Dr. Robert H. Posteraro '73, of Lub¬
bock, Texas, an associate professor in the
department of radiology at Texas Tech Uni¬
versity Health Sciences Center School of
Medicine, was elected to Sigma Xi and pro¬
moted to lieutenant colonel in the U.S.
Army Reserve.
Dr. Alvin H. Strelnick ’75, deputy
chairman of the department of family
medicine at Montefiore Medical Center in
the Bronx and assistant professor in the de¬
partment of epidemiology and social
medicine at the Albert Einstein College of
Medicine, recieved a W. K. Kellogg Foun¬
dation fellowship. Dr. Strelnick will study
urban communities to identify factors that
contribute to their deterioration or vitality.
Dr. Jeffrey L. Sklar ’77, assistant pro¬
fessor of pathology at Stanford University
School of Medicine and director of the
Molecular Diagnosis Service at Stanford
Medical Center, and Dr. Abul K. Abbas, a

pathologist at Harvard Medical School,
shared the American Association of
Pathologists 1987 Warner-Lambert/ParkeDavis Award, presented annually to an indi¬
vidual under 40 for meritorious research in
experimental pathology.

lecturer in surgery (otolaryngology); Clar¬
ence T. Sasaki, M.D. ’66, professor of
surgery (otolaryngology); and Katherine S.
Harris, Ph.D., City University of New
York. Little, Brown and Co., (Boston,
Mass.) 1987.

At a Sept. 28 convocation ceremony.
Mount Sinai School of Medicine named Dr.
Jon W. Gordon ’80 the G. Harold and Leila
Y. Mathers Research Professor in Geriatrics
and Adult Development. Dr. Gordon, as¬
sociate professor of molecular biology of
geriatrics and adult development, and of
obstetrics, gynecology and reproductive
science at Mount Sinai, received the honor
which recognizes his outstanding research
in mammalian development.

Melancholia and Depression: From Hip¬
pocratic Times to Modern Times, by Stan¬
ley W. Jackson, M.D., professorof psychi¬
atry and history of medicine. Yale Univer¬
sity Press, 1986.

William Sabella ’83 M.P.H. was ap¬
pointed AIDS education coordinator and
counselor at Yale-New Haven Hospital on
Sept. 9. Sabella, a former state of Connect¬
icut AIDS coordinator, will develop risk-re¬
duction programs, provide AIDS education
for the hospital staff and assist with counsel¬
ing individuals who test positive for HIV
antibodies.
Wichit Srisuphan ’83 Dr. PH. has been
appointed dean of the faculty of nursing at
Chian Mai University in Thailand.

NEW BOOKS
America's Family Support Programs,
edited by Sharon L. Kagan, Ed.D., assis¬
tant professor in the Yale Child Study Cen¬
ter and psychiatry; Douglas R. Powell, Pur¬
due University; Bernice T. Weissbourd,
Family Focus, Inc.; and Edward F. Zigler,
Ph.D., Sterling Professor in the Yale Child
Study Center and Psychiatry. Yale Univer¬
sity Press, 1987.
Clinimetrics, by Alvan R. Feinstein, M.D.
'54 HS, professor of medicine and
epidemiology. Yale University Press, 1987.
Healing AIDS Naturally, first edition, by
Laurence Badgley, M.D. ’68, of San
Bruno, Calif. Human Energy Press, (San
Bruno, Calif.) 1986.
Hospitals, Health, and People, by Albert
W. Snoke, M.D., lecturer in public health
and former director of Yale-New Haven
Hospital. Yale University Press, 1987.
The Human Vocal Tract, Anatomy, Func¬
tion, Development, and Evolution, by Ed¬
mund S. Crelin, Ph.D., D.Sc., professorof
anatomy (surgery). Vantage Press, Inc.,
(New York, N.Y.) 1987.
Laryngeal Function in Phonation and Re¬
spiration, edited by Thomas Baer, Ph.D.,

Parents' Book for Raising a Healthy Child,
by Morris A. Wessel, M.D. ’43, clinical
professor of pediatrics. Ballantine Books,
(New York, N.Y.) 1987.
The Smoker's Book of Health: How to Keep
Yourself Healthier and Reduce Your Smok¬
ing Risks, by Tom Ferguson, M.D. ’78, of
Austin, Texas. G.P. Putnam’s Sons, (New
York, N.Y.) 1987.
Sports Fitness and Training, by Richard J.
Mangi, M.D. ’68 HS, associate clinical
professor of medicine; Peter Jokl, M.D.
’68, professor of orthopaedics and rehabili¬
tation; and William Dayton, lecturer in or¬
thopaedics and rehabilitation.
The Structure of Individual Psychotherapy,
by Bernard D. Beitman, M.D. ’68, Univer¬
sity of Missouri-Columbia. Guilford Publi¬
cations, Inc. (New York, N.Y) 1986.
Textbook of General Medicine and Primary
Care, psychiatry section, by John Pearce,
M.D. ’61, of Cambridge, Mass. Little
Brown and Co., (Boston, Mass.) 1987.
To Do No Harm, A Journey Through Medi¬
cal School, by Philip R. Reilly, M.D., ’81,
Eunice Kennedy Shriver Center for Mental
Retardation. Auburn House Publishing
Co., (Dover, Mass.) 1987.
Evidence, a novel, by Neil Ravin, M.D. ’81
HS, Georgetown University School of
Medicine. Charles Scribner’s Sons, (New
York, N.Y) 1987.
Second Seed, a novel, by Mary Lake Polan,
M.D. ’75, Ph D., associate professor of
obstetrics
and
gynecology.
Charles
Scribner’s Sons, (New York, N.Y.) 1987.

OBITUARIES
Max Alpert, M.D.
Dr. Max Alpert ’28, of Bridgeport, Conn.,
died Aug. 3 after a brief illness. He was82.
Bom in Russia, Dr. Alpert was educated
at Yale and had practiced medicine in
Bridgeport for 50 years. He is survived by
his wife, Claire; a daughter, Rita Steinberger; two brothers, Samuel and Herbert
Alpert; and two grandsons.

Thaddeus S. Danowski, M.D.
Dr. Thaddeus S. Danowski ’40 died Sept.
12 in Miami. He was a magna cum laude
graduate of the Class of 1940 and a faculty
member at Yale School of Medicine from
1942 until 1947, when he resigned to
become the Renziehausen Professor of
Research Medicine and chairman of the
department of research medicine at the
University of Pittsburgh.

Hugh L. Dwyer, M.D.
Dr. Hugh L. Dwyer Jr. of Woodbridge,
Conn., associate clinical professor of
medicine, died Sept. 10 after a brief illness.
He was the husband of Dr. Dorothea R.
Peck ’43, associate clinical professor of
diagnostic radiology.
Bom in New Orleans on Aug. 21, 1917,
Dr. Dwyer spent his childhood in Kansas
City, Mo., and was a 1939 graduate of the
University of Kansas. He attended the Uni¬
versity of Kansas Medical School and was
graduated from Northwestern University
Medical School in 1943.
He trained as an intern and resident at
Grace-New Haven Community Hospital,
now Yale-New Haven Hospital, from 1943
to 1948. During 1945 and 1946, he served
as an Army Medical Corps physician with
the Manhattan Project. He was a full-time
faculty member at the Yale School of
Medicine from 1948 until 1951, when he
began his private practice. He continued his
association with the medical school, be¬
coming associate clinical professor of
medicine in 1952.
He was president of the medical staff of
Yale-New Haven Hospital from 1965 to
1967 and a member of the hospital’s board
of trustees from 1978 until 1984. As one of
the first two physicians and the first commu¬
nity physician to serve as a trustee, he was
instrumental in creating a stronger liaison
between community physicians and full¬
time University physicians.
In addition to his wife, he is survived by
a daughter, Martha M. Dwyer; two sons,
Hugh E. and Thomas Duane Dwyer; one
brother, Frank Dwyer; and four sisters.
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Martha Phillips, Joan O’Connor, Barbara
O’Brien and Jeanne Lonergan.
Memorial contributions may be made to
the Hugh L Dwyer Memorial Fund at YaleNew Haven Hospital, or to the Hugh L.
Dwyer Memorial Fund at the Yale Golf
Course.

ArthurS. Griswold, M.D.
Dr. Arthur S. Griswold ’21, retired chief of
orthopedic surgery at Bridgeport Hospital,
died at his home in Bridgeport, Conn., on
April 20.
Bom of missionary parents in India, he
came to the United States at age 12. He re¬
ceived his undergraduate degree from Yale
College in 1918, and after graduating from
the medical school in 1921, completed his
internship at Bridgeport Hospital. In 1930,
he became chief of orthopedic surgery.
He is survived by his wife, Edith; two
sons, Gordon and Robert Griswold; and five
grandchildren.

Rockefeller University. He remained there
for 31 years, serving as dean of graduate
studies from 1972 to 1980. In 1981, he
became president of the Josiah Macy Jr.
Foundation.
As president of the Macy foundation, he
helped develop medical education pro¬
grams for minorities and initiated a program
to encourage doctoral candidates in the be¬
havioral sciences to pursue research on
human disease.

Nathan Levy, M.D.
Dr. Nathan Levy ’27, of Branford. Conn.,
died April 12 after a brief illness. He was
85. Educated at Yale, he practiced medicine
in Branford for 58 years. He is survived by
his wife, Bertha; a son. Dr. Harold D. Levy;
a daughter, Elaine Kaplan; a sister, Bertha
Rosenberg; and six grandchildren. He was
predeceased by his first wife, Sadye Bren¬
ner Levy.

Garner L. Lewis, M.D.
Seymour L. Handler, M.D.
Dr Seymour L. Handler, associate clinical
professor in the Yale Child Study Center
and psychiatry since 1974, died at his home
in Woodbndge, Conn., on May 31 after a
long illness. He was 63.
Dr Handler received his M.D. degree
from the University of Louisville School of
Medicine in 1950, and came to Yale in 1959
as a resident in psychiatry. Dr. Handler also
was a faculty member and former president
of The Western New England Institute for
Psychoanalysis.
He is survived by his wife, Estelle; three
sons, Michael, Robert and Thomas Hand¬
ler; a daughter, Margaret; and four grand¬
children

James G. Hirsch, M.D.
Dr. James G. Hirsch of New York City, cochairman of the Campaign for the Yale
School of Medicine, a successor trustee of
the Yale Corporation and a member of the
Yale Development Board, died May 25 at
Memorial Sloan-Kettering Cancer Center in
New York. He was 64.
A biological scientist and medical
educator, Dr. Hirsch was best known for his
research in cell biology, particularly his
studies of the relationship between white
cells in the blood and immune reactions.
Bom in St. Louis, Mo., in 1922, Dr.
Hirsch was a 1942 magna cum laude
graduate of Yale’s Sheffield Scientific
School and a 1946 graduate of Columbia
College of Physicians and Surgeons. After
a two--year internship at Barnes Hospital in
it. I ouis and two years as chief of medicine
id pediatrics at Warren Air Force Base in
rung, he joined the staff of the Rocke¬
feller Institute for Medical Research, now

Dr. Garner L. Lewis ’45, a radiologist in
Simsbury, Conn., died Aug. 24. He was
67. Educated at Yale, Dr. Lewis was a U.S.
Navy physician until he retired in 1964 and
entered private practice. Surviving are his
wife, Grace Virginia "Jean” Lewis; two
sons, Garner R. and Gregory P. Lewis; two
daughters, Ruth Ann Coleman and Patricia
Stoecker; a brother, Orville N. Lewis Jr.;
a sister, Catherine Smith; and 11 grandchil¬
dren.

Richard H. Mann, M.D.
Dr. Richard H. Mann '46, retired chief of
cardiology at Lancaster General Hospital in
Pennsylvania, died May 25 at his home
after a 17-month illness. He was 64.
Two months before his death, Lancaster
General Hospital honored him by establish¬
ing the Richard H. Mann, M.D., Endow¬
ment for the Advancement of Cardiology,
and renaming its cardiology division the
Richard H. Mann, M.D.. Division of Car¬
diology. Considered a Lancaster medical
pioneer. Dr. Mann, who joined the medical
staff at Lancaster General Hospital in 1954,
was the first LGH physician to receive such
an honor.
Born in Lancaster, Dr. Mann received a
bachelor’s degree from Yale’s Sheffield
Scientific School in 1944 and his medical
degree from the School of Medicine in
1946.
Surviving are his wife, Mary Jane; his
mother, Anna Hess Mann; two daughters,
Dana T. Hutchinson and Lisa H. Gemill; a
son, Gregory S. Mann; four grandchildren;
andabrother, William H Mann.

Bruce S. Schoenberg, M.D.
Dr. Bruce S. Schoenberg ’68, chief of the
neuroepidemiology branch of the National
Institute of Neurological and Communica¬
ble Disorders and Stroke, died July 14 of
cancer. He was 44.
A native of New Jersey, Dr. Schoenberg
received a B. A. degree from the University
of Pennsylvania in 1964 and his M.D. de¬
gree from Yale in 1968. He also received
M. P H. and Dr. P. H. degrees from the Johns
Hopkins University School of Hygiene
and Public Health, and an M S. degree
in neurology from the University of
Minnesota.
After graduating from the School of
Medicine, Dr. Schoenberg continued his
association with Yale as a part-time lecturer
in public health (biometry) until 1981. He
also was associated with the Georgetown
University School of Medicine and the
Mayo Clinic, and was a visiting professor in
the neurology departments of universities in
Mexico City, Llorence, Madrid, Beijing
and Lima.
Dr. Schoenberg was the founding editorin-chief of the journal Neuroepidemiology
and the author of the textbook Advances in
Neurology: Neurological Epidemiology
(Principles and Clinical Applications).
Dr. Schoenberg joined the NINCDS in
1975 as chief of the institute’s neuro¬
epidemiology section, and became chief of
the neuroepidemiology branch in 1984. Dr.
Schoenberg was widely respected for his
contributions to the methodology of neuroepidemiologic investigations. He helped
establish centers for the study of neuro¬
logical disorders in more than a dozen
countries in Asia, Africa, Europe and South
America.
On June 23, Dr. C. Everett Koop pre¬
sented Dr. Schoenberg with the Surgeon
General’s Medallion—the Public Health
Service’s highest honor—for his "unique
contributions in the field of epidemiology
and the neurosciences.” Dr. Schoenberg is
only the seventh person to receive this
honor.
He is survived by his wife, Devera;
his son, Ian Charles; his daughter, Claire
Jennifer; and his parents, Mr. and Mrs.
Mitchell Schoenberg.

Virginia Lee Swanson, M.D.
Dr. Virginia Lee Swanson '52, of Montecito, Calif., died May 20 of cancer. Dr.
Swanson was born in Sioux City, Iowa, on
June 15, 1922, but she spent her childhood
in Los Angeles. As a child she suffered
from osteomyelitis Her experiences with
hospitals and surgical procedures led to her
decision to pursue a medical career.
Dr. Swanson received a B.A. degree
from the University of Southern California
in 1947 and her M.D. degree from Yale in
1952. After an internship in pathology, she
spent two years in Copenhagen on a U.S.
Public Health Service fellowship and re-

turned to Yale in 1955 as chief resident and
later assistant pathologist at Grace-New
Haven Community Hospital, now YaleNew Haven Hospital.
From 1959 to 1962, she worked as a civi¬
lian pathologist with the U.S. Army Com¬
mand in Japan and New Guinea, and from
1962 to 1965 was chief of the pathology di¬
vision for the Tropical Medical Research
Laboratory in San Juan, Puerto Rico. For
her work, the University of Puerto Rico
Medical School awarded her an honorary
doctorate in 1965.
After a year at the Walter Reed Army In¬
stitute of Pathology, Dr. Swanson was ap¬
pointed associate professor of pathology at
the University of Southern California Medi¬
cal School and staff pathologist at the Chil¬
dren’s Hospital of Los Angeles.
Although Dr. Swanson retired in 1982,
she continued research in immunopathology and held appointments at the University
of San Diego and the Scripps Institute of
Oceanography. Most recently, she was a
visiting fellow at the department of neuro¬
anatomy at Oxford University in England.
She is survived by her husband. Dr. Mar¬
tin Kamen; a brother, Robert Swanson; and
two sisters, Carole Swanson and Beverly
Hill.

William B. Terhune, M.D.
Dr. William B. Terhune died June 26 in An¬
niston, Ala., of natural causes. He was 93.
He had been a Yale School of Medicine fac¬
ulty member twice during his career. He
was a clinical instructor in psychiatry from
1920 to 1922 and a lecturer in psychiatry
from 1922 to 1927. He returned in 1941,
and was associate clinical professor of psy¬
chiatry from 1950 until he retired in 1960.

Reuben Zucker, M.D.
Dr. Reuben Zucker '44 died June 9 at the
University Medical Center of Southern
Nevada, where he had been a staff member
since 1961. Dr. Zucker was 68.
Bom May 24, 1919, in Waterbury,
Conn., Dr. Zucker earned both his under¬
graduate and medical degrees from Yale
University. Dr. Zucker was responsible for
the first medical residency program at
Southern Nevada Memorial Hospital, now
University Medical Center of Southern
Nevada. From 1963 to 1986, Dr. Zucker
was chairman of Memorial Hospital’s Max
C. Fleischman Library Committee, which
in 1963 established the first medical library
in Las Vegas. In appreciation of his work
supporting academic programs and the Uni¬
versity library, Nevada Gov. Richard Bryan
named April 9 as Reuben Zucker Day in
Nevada.
Surviving are his wife, Blanche; two
sons, Jeffrey and David Zucker; a daughter,
Ellen Frank; a stepdaughter, Kay Green; a
stepson, Gary Marsh; and eight grandchil¬
dren. He is also survived by a sister. Belle
Gruber, and a brother, Zal Zucker.

IN MEMORIAM
William J. Norris, M.D.
March 27, 1987
ArthurS. Griswold
April 20, 1987

ex med’18

Reuben Zucker
June9, 1987

’44 M.D.

ex pbh '44

Edith L. Glasgow
August 6, 1987
Gamer L. Lewis
August 24, 1987

’45 M.D.

Charles S. Judd Jr.
July 23, 1987

’46 M.D.

Richard H. Mann
May 15, 1987

’46 M.D.

21 M.D

Reginald T. Lombard
September 18, 1986

’22 M.D.

Elizabeth H. Heinson
July 20, 1986

ex med’23

Gregory K. Dwyer,

Henry M. Glaubman
March 29, 1987

’27 M.D.

Nathan Levy
April 12, 1987

'27 M.D.

Max Alpert
August 3, 1987

D

’47 HS

Henry W. Baird III
April 7, 1987

’49 M.D.

Robert W. Lusk

’51 M.D.

’28 M.D.

Virginia Lee Swanson
May 20, 1987

'52 M.D.

LouisM. D’Esopo
September 6, 1987

’28 M.D.

Herman L. Kamenetz, M.D.
June 2, 1987

Fumiko Yamaguchi-Amano
January 8, 1987

’29 M.D.

Lloyd W. Miner
February 3, 1987

’32 M.D.

Gilbert E. Moore
December 22, 1987

’34 M.D.

Samuel J. Goldberg Jr., M.D.
January 30, 1987
Philip A. Bearg
May 5, 1986’43 D.PH.
Willard Emrich Buckley, M.D.

’37 HS

’37 M.D.

’39 HS

Stuart S. Stevenson
September 1987

’39 M.D.

Thaddeus S. Danowski
September 12, 1987

'40 M.D.

Frank Payne, M.D.
September 22, 1986

’41 HS

John Edward Hughes, M.D
September 10, 1987

’41 HS

Hugh Dwyer, M.D.
September 10, 1987

’43 HS

Ira A. Rashkoff
September8, 1987

’43 M.D.

John V. Munro Jr.

’43 M.D.

Roland N. Tessier
January 19,1987

’43 M.D.

Russell A. Morissette, Sr.
February 9, 1987

’43 M.D.

'57 HS

Robert D. Osborn

’57 M.D

Bruce S. Schoenberg
July 14, 1987

'68 M.D.

Henry R Fenhager
June 30,1986

’72M .P.H.

Bernard R. Swan, M.D.
June 17,1987

ex pbh’72

David Evan Sears
October 29,1982

exmed’82

John H . Winfrey Jr.
July 31,1987

’83M.P.H.

Julia Foley
January 12, 1987

’85M .P.H.

Erratum
Dr. Boy Frame, who died on Aug. 17,
1986, was incorrectly listed in the spring
1986 In Memoriam as a member of the 1948
house staff. Dr. Frame was a 1948 graduate
of the Yale School of Medicine. He com¬
pleted his internship and residency training
at Massachusetts General Hospital. Dr.
Frame was chairman of the department of
medicine at the Henry Ford Hospital in De¬
troit, and clinical professor of internal
medicine at the University of Michigan
Medical School.
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REUNION 1987
The sun shone on June 5 and 6, and one of
the most meterologically perfect alumni
weekends in recent memory unfolded to a
record attendance of the past graduates of
the Schools of Medicine, Nursing and Pub¬
lic Health.
Highlights of the weekend included
superb scientific presentations on both Fri¬
day and Saturday by faculty members of
eight clinical and basic science depart¬
ments. The programs were indeed of such
excellence that strategies must be gener¬
ated to achieve wider audiences at future
reunions.
U.S. Sen. Lowell P. Wcicker Jr. pre¬
sented a rousing and uplifting keynote ad¬
dress Friday afternoon. Ignoring his pre¬
pared speech, he conducted a forum and
dialogue with his audience, generating a
spirited exchange on health care issues
which ranged from AIDS to the funding
of basic science research. He concluded,
"There is no group in our society which en¬
joys greater credibility with the general
public than the medical profession.” He
emphasized that there has never been a time
when health care issues were generating
more questions of national concern. He em¬
phasized that the health professions should
be heard. Greeted by Dean Leon E. Rosen¬
berg, the event concluded when Dean
Judith Krauss of the School of Nursing pre¬
sented Senator Weicker a plaque making
him an honorary member of the Yale Uni¬
versity School of Nursing Alumnae/i As¬

Alan Sartorelli, PhD., professor of pharmacology (left), and Dr. Myron Genet, associate
dean for government and community affairs, present U.S. Senator Lowed Weicker (R-Conn.)
with the first annuaI Distinguished Service Award of the Yale Comprehensive Cancer
Center for his long-term support of cancer research.

sociation for his support of research funds
by Congress.
The remainder of Friday was devoted to
social pleasures of the dean's reception and
a special alumni dinner and dance. Saturday
reunion day began with a warm address of

z

o
C/3

welcome by Sheila Wellington, secretary of
Yale University. Mrs. Wellington, a
graduate from our School of Public Health,
was deputy director of the Yale Psychiatric
Institute. She conveyed greetings from
President BennoC. Schmidt.
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and including
the Class of 1983.

“Surgical House Staff
of the ’ 40 s” Reunion
A reunion dinner of surgical house staff of
early and mid-1940s took place June 5 at the
New Haven Lawn Club. This reunion was
the inspiration of John Frazer, HS ENT ’41’44 recently retired chairman of otolaryn¬
gology at the University of Rochester. With
the help of Charles Cheney ’41, HS ’46’49, John organized a truly memorable
gathering.
Many of the attendees had had their resi¬
dency training interrupted by military ser¬
vice in World War II. After the war, several
returned to complete their training. They
were members of the house staff at the old
New Haven Hospital, where all except the
few married ones lived as well as worked.
Salaries ranged from 0 to $100 monthly
(chief resident).
Nineteen former surgical house officers
attended, including Frazer and Cheney,
Ralph Alley, Lloyd Brown, Guido De
Blasio, Mai Ellison, Harvey Kausel, Nat
Kenigsberg, Ed Krementz, Frank Lepreau,
Jack Parella, Nick Stahl, Bill Kenny (or¬
thopedics), Charlie Petrillo (ENT); Dee
Peck and Arnold Janzen (both switched
from surgery to radiology). Sid Cramer and
A1 Kummer (radiology house staff) and
Hugh Dwyer and Jim Twyman (internal
medicine) were also included. Fifteen
wives attended. Elaine Bemeike, widow of
Bob (urology) and Pat Fiorito, widow of Joe
(ob-gyn), were welcomed. Joe Milici, the
Yale-New Haven Hospital barber, was
guest of honor and was awarded the title of
professor of depilatory surgery.
Reminiscences were endless, and con¬
viviality unsurpassed. Each gave a resume
of his academic or practice career—sev¬
eral still being in practice—though few
doing surgery.
The late Samuel C. Harvey chaired the
department in the ’40s with Gustaf E.
Lindskog following (1948-1966). Dr.
Lindskog sent his greetings.
It was a memorable event, and many ex¬
pressed their hope that it would be repeated
with even more surgical house staff of the
'40s attending.
D. Peck, M.D. '43

REUNION
REPORTS
1927
60th Reunion
by Harry M. Zimmerman
The alumni records of this class, which
originally numbered 45 members in 1927,
indicated that in February 1987, 15 mem¬
bers remained. Letters to them in early
March announcing plans for a 60th reunion
in New Haven failed to elicit a single re¬
sponse. Accordingly, I tried to reach as
many classmates as possible by phone; this
report is a summary of the results.
I learned that Milton Berman, whose
last address was Miami, died on July 11,
1986. Henry Fineberg’s son, Coleman, in¬
formed us that several years ago his father
had a severe stroke that completely in¬
capacitated him. He is confined to a nursing
facility on Long Island. Coleman requested
that we not attempt to communicate with his
father in the future, because it creates a
stressful situation for his mother.
Meyer Friedenson, whose last known
address was in New Rochelle, N.Y., failed
to respond to repeated calls, and I finally
was informed that his telephone had been
disconnected.
After speaking with Donald Gibson in
West Redding, Conn., I received a note
from him and a generous gift for the Medi¬
cal School Alumni Fund. He informed me
that he was in good shape, but that his
wife’s illness prevented him from attending
ourreunion.
I learned that Henry Glaubman of
Hartford had passed away on March 29. For
many years, Ernesto Icaza of Mexico City
failed to respond to letters, and attempts to
reach him by telephone have been equally
unsuccessful. He is unknown at the Mexico
address we have for him.
I spoke with Albert Jablonsky on May
27. He retired from practice about five years
ago; he has not been well in recent years and
has been hospitalized several times. He
spends four months each year near Miami,
and the remainder of the year at his home in
Jeannette, Pa. Both he and Mrs. Jablonsky
were not well enough to attend the reunion.
It was a pleasure to speak with Lewis
James in his home in Rocky Hill, Conn. He
is generally in good shape, but two weeks
previously had undergone a successful ab¬
dominal aortic aneurysm resection, which
prevented his trip to New Haven on June 5.
The news about Nathan Levy of Branford,
which I learned from his son, also a physi¬
cian in Branford, was that Nate died in
Florida of congestive heart failure on April
12. His grandson, also a physician in Bran¬
ford, spoke at his memorial service.
Attempts to reach William Meredith at
his latest address in Stratford, Conn., were

to no avail, both by letter and telephone.
Equally disappointing were all attempts to
reach Eugene Pfanner, for whom no cur¬
rent address is available.
Moses Rothberg of Palm Harbor, Fla.,
supplied the information that his health and
his wife’s health would not permit them to
travel to New Haven. He gave up his prac¬
tice several years ago.
Alfred Seibert, who now lives in Nor¬
wich, Vt., and is on his third cardiac
pacemaker, was unable to attend because of
recent cataract surgery. He still drives his
car, but only for short distances.
I reached Theodore Sills at his home in
Columbus, Ohio. He, too, has had prob¬
lems with cataracts, which limit his abil¬
ity to travel, and so he had to forego the
reunion.
The news from Dawson Tyson was more
encouraging, as far as travel to New Haven
was concerned. In spite of coronary artery
bypass surgery, Dawson was able to get
around fairly well, and looked forward to
seeing his classmates.
We have lost contact with, and have no
address for, our classmate, Cora Wong,
who left the medical school after her first
year to return to China.
Thus, my wife Miriam and I, and Daw¬
son Tyson were the only representatives of
the Class of ’27 who attended the reunion
festivities. The program sparkled with sci¬
entific interest and good fellowship from the
returning reunion classes.

1932
55th Reunion
by Clement C. Clarke
Seven classmates and four wives attended,
as guests of the University, the Saturday
night dinner now known as the “Friends of
the 50th” dinner at the Graduates Club.
They were Frank Carroll and Shirley,
Rye, N. Y.; Clement C. Clarke (Clare was
not well), Woodbridge; Robert Cushing
and Robin, Long Island, N.Y.; Lee Farr
and Miriam, Walnut Creek, Calif.; Conrad
Lam and Marian, Farmington Hills, Mich.;
Rudolph Vandeveer (his wife died in
1986), Rome, N.Y.; and Myron Wegman
(his wife was visiting friends), Ann Arbor,
Mich.
Nostalgic letters came from Edward
Holland in Maine and Francis Wisner in
California. Ned is not well. Francis, who
lost his wife, is climbing California moun¬
tains and looking forward to walking the
Chinese wall.
Medical school Distinguished Service
Awards were given to four honorees, two of
whom—Conrad Lam and Myron Weg¬
man—were from ourclass.
A unique feature of the “Friends of the
50th” is that representatives of several
classes are included. There were varying
reactions to this feature. Some felt this cut
short the intra-class visitation.
Now that our class is over the “50” hill.
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at Saint Joseph’s Hospital Medical Center.
Dennie Pratt and his wife are enjoying re¬
tirement in Bass Harbor, Maine. He is still
best remembered by his ancestors’ activities
in writing the Ballad of Chambers Street. A1
Rosen, except for four years in the army,
has practiced general medicine in New
Haven and claims four children and seven
grandchildren as his reasons for not retiring.
Morgan Sargent retired in 1986, and is
now living in Hingham, Mass. He still
keeps his hand in at weekly hospital meet¬
ings, and spends many days on the golf
course. He practiced for 40 years as a gen¬
eral surgeon and surgeon-in-chief at Quincy
City Hospital. Al Spicer journeyed from
Weepapaugh, R.I. where he is retired. Al
continued his studies after graduation, re¬
ceived a dental degree and practiced dentis¬
try with his father. He and his wife have
traveled extensively, recently in China.
Wilbur Johnston retired after practicing
orthodontics in New Haven for 49 years, al¬
though he is still active as a consultant at
Yale-New Haven Hospital and clinical pro¬
fessor of surgery (dental) at Yale School of
Medicine.
We were the guests of honor at a sumptu¬
ous banquet at the Graduates Club; we
asked Dr. Dawson Tyson, Class of 1927 to

we can welcome every year. If you find
yourself eastward bound at the time of the
next reunion, let us know and we can have
a special class reunion.

1937
50th Reunion
by Wilbur D. Johnston
Six members of the class attended the twoday alumni meeting. All were accompanied
by their wives, except Wilbur Johnston,
whose wife Betty died in 1982. Nature out¬
did herself in providing two fine June days.
It enabled the alumni to enjoy a delightful
luncheon, served in Harkness dining room
and on the patio under a large tent for those
who wished to chat and eat outdoors. Our
class was particularly interested in the
award presented to Dr. Harry Zimmer¬
man, and in the continuing educational pro¬
gram, which consisted of four excellent
seminars, climaxed by an address by U.S.
Sen. Lowell P. WeickerJr. of Connecticut.
Jim Morrill and his wife Barbara have
been enjoying retirement since 1978 at
Heritage Village in Southbury, Conn. He
had a private practice in pediatrics in New
Jersey, and had been director of pediatrics
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join us. Several members of the Class of
1932 and many members of the Class of
1982 also attended. The five-year alumni
added youth to this festive occasion; we
hope this joint meeting will encourage their
return in future years. We were greeted
warmly by Dr. Nicholas Spinelli, director
for alumni affairs and Dean Leon E.
Rosenberg. Also present was Dr. Dwight
Miller, president of the alumni association.
Several members who were unable to return
sent warm greetings. These included David
Dolowitz,
our
class
agent;
James
DuShane, Jean Wells Hollingshead, Al
King, John Thomas, Dunham Kirham
and Bill Cooper.

UW'VEMitt school
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(1) A pause for posterity. (2) Will Melton, director of medical school development
(left), explains Yale's ambitious plans for expanding the medical center complex.
(3) Dr. Richard Swett, '67, contemplates the joys of lunch — and fatherhood.
(4) Dr Dwight Miller, '56, president of the Association of Yale Alumni in
Medicine (left) with Dean Rosenberg and Dr. Spinelli.

1942
45th Reunion
by Michael A. Puzak
We met in the upper room at Mory’s, a place
that has changed a little less than we have,
and for that matter, a lot less than the outer
aspects of New Haven and the medical com¬
plex. The present medical students looked
like teenagers, and we wondered if we
looked that young when we first met. There
were 24 of us, classmates, wives and
friends. Although we had been concerned
that we might not recognize each other, it
was clear that even with changes in girth
and hair patterns, we would have known
each other if we met in the middle of Man¬
hattan. Each classmate and wife/guest was
given a chance to speak on whatever they
chose. The prevailing sentiments were not
so much on past achievements but on newly
found avocations, joys and enthusiasms in
life. Fish and Wolfson are into art, some
classmates are into music—the things we
never had a moment for in training and prac¬
tice days.
Returning classmates were Sam Budd,
Jim Bunce, Walter Burdette, Ludmil
Chotkowski, Nick Fish, Bill Harrison,

Leo Kellerman, Mike Puzak, Sam Ritvo,
Carter Stilson, Maurice Tulin, Edgar
Taft,
Irvin
Wolfson
and
Charley
Scholhamer. The food was fine, but feel¬
ings of mutual love, sympathy, empathy
and support permeated the room. The phi¬
losophy of Maurice Tulin summed it up:
“We were fortunate to be taught by giants
at one of the only truly graduate schools in
the country. I’ve never forgotten the values
learned, they are constant. Only the facts
change.”
Telephone calls were successfully com¬
pleted with the following: Eugene de Hostos. Bill Bloomer, Vincent Collins, David
Decker,
Hendrik
Dekruif,
Allan
Goodyer, Bill Fleeson, Elihu Friedmann,
Steve Mullins, Randolph Page, Joseph
Seronde and Philip Viscidi. Letters were
received from: Davitt Felder, Elihu Fried¬
mann, Allan Goodyer, William Fleeson,
Randolph Page and Philip Viscidi. Gene
de Hostos suggests more frequent reunions.
That thought brought on ideas for a winter
reunion in the islands in a few years. Sug¬
gestions about this possibility would be
welcomed. A more detailed letter is planned
to be mailed to each member of the class.
Please keep in touch.

(5) Connie Tolliver, assistant to the director of alumni
affairs at the School of Medicine (left), reminisces
with Dr. Harold Bornstein,'53, and his wife Maureen.
(6) As Dr. Arthur Ebbert (left) shares a laugh with
Drs. William Kissick, Leon Rosenberg and Nicholas
Spinelli, Sheila Wellington, MPH '68, chats with Dr.
Helen Langner, '22. (7) Merle Waxman, director of
the Office for Women in Medicine, with Dr. Helen
Langner, '22. At age 90, Dr. Langner maintains an
active psychiatric practice. In the background are
second-year medical students Tom Christopher and
Vicky Barber.
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1947
40th Reunion
by Philip H. Phi I bin
The Class of 1947 was well represented for
the 40th. We congratulate the Yale Alumni
in Medicine for the interesting professional
program and update on the current state of
the school. The dean’s reception and the
YAM reunion dance were delightful, great
sources of fun and relaxation. The latter
was particularly enjoyable; ask Somberg,
Lynch and Newton.
The buffet luncheon on Saturday saw
many of '47 continuing to refresh each other
on current activities and plans. Then the
class picture has to be interesting. Saturday
night, thanks to Bill Maniatis’ labors, was
outstanding. We met at the New Haven
Medical Society building for cocktails and
dinner, where Bill had for each, a beautiful
pewter dish with the YAM logo. During
cocktails and dinner, strolling musicians
provided the right background. After din¬
ner, class members gave a short resume of
their current activities and further plans.
Brock Lynch is working full time for the
VA in Massachusetts. Bill McClelland and
Betty are still in Greenfield, Mass. Jack and

Doris Cannon are outside Hartford, where
he has sold his practice and his services to
the hospital. He’s very happy with the deal.
Igor Tamm was present, but Olive Pitkin
could not make it. Root Ziegra and Marie
are in the Philadelphia area and into houses.
He works for a large pharmaceutical con¬
cern. Vic and Barbara Machcinski, and Pat
Tddbury have retired to Cape Cod Hank
and Lorraine Blansfield are about to test the
waters of retirement. Ed Foord and Archie
Dean still are laboring in the fields in New
Jersey. Bob Kerin is still going strong,
fixing bones in Connecticut. Coming great
distances were the Friedlanders from San
Francisco, the Youngs from Arizona, and
Dick and Betty Carlin from Missouri. All
are in active practice, except Betty who has
decided to let Dick handle all professional
problems. Down from Maine came Dick
and Marion Britton, and from the Big
Apple, Ellis Van Slyke. The Maches,
Charles and Mary Ann, still love upper
New York and their boat. Frank Epstein
was down from the Boston area, and the
Darrows from Vermont. George and Elbe
Barnes came all the way from Tucson,
where he heads the radiology program.
From the New Haven area were Bob New¬
ton, Frank Horton, Brad Colwell, Roy
Breg and Bill Collins. Bill Maniatis is in
active surgical practice.
Henry Williams and Larry Perry
seemed very fit, both still in the harness.
Alvin Somberg and his wife Claude, a
Parisienne, made the dance, but couldn't
get to the dinner. Rudman, Cavanaugh,
Chernoff, Gehrs, Golbranson and Kimmerling signed up but never appeared,
which was quite disappointing.
There is much we could tell you of each
of those attending, but space does not per¬
mit. You will have to make the 45th to ex¬
perience the fantastic emotions of reminisc¬
ing with friends from so long ago.

1952
35th Reunion
by Harvey L. Young
Thirteen class members attended the reun¬
ion dinner, which Bob Gerety arranged. As
he has done at each reunion. Mo Bogdonoff
presented a timely summary of medical
education and health care as viewed by our
35 years of experience. It was superb, but
not recorded for our posterity.
Our group included: Mo Bogdonoff and
Diana; Frank and Barbara Coughlin; Bob
and Maggie Gerety; Bill and Jean
Klatchko; Milnor Morrison; Bob and
Janice Nolan; Sid and Beth Paly; Jack and
Peggy Roberts; Don Schultz; Doris and
Garvall Booker; and Harvey and Hilda
Young. Bob Gerety read two letters; one an
invitation from Phil Deane to visit him in
retirement on Shaw Island in the San Juan
Islands of Puget Sound, and a letter from
John Filley who has retired to Agoura,
Calif. Several visited with Ray Duff at his
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Woodbridge home and reported on his re¬
covery from a severe and debilitating stroke
last November.
The evening’s sad note was the an¬
nouncement that our classmate Virginia
Lee Swanson of California died May 20 of
carcinoma of the lung.
The reunion was memorable, and all
present agreed that a greater effort should
be made to have everyone attend the 40th
reunion

1957
30th Reunion
by Jack Levin
The Class of 1957 held a successful 30th
reunion, maintaining its tradition of well-at¬
tended reunions. Attending were Vince and
Daria Andriole; Jack Blechner; Albert
and Myrna Chun-Hoon; Lou and Madeline
Cooper; Tom and Nancy Danaher; Joe
Demis and his wife; Jim and Colleen Dorr;
Ed Eyerman; Hal, Jo Ann and Mike Fal¬
lon; Ron and Estelle Fishbein; Tony and
Mary Fons; Liz Forsyth; Gil, Carol, Greg
and Cameron Hogan; Bob and Margaret
Kaiser; Stan and Carole Kilty; Bill and
Priscilla Kissick; Howie, Gretchen and
Brad Minners; Bob and Jill Modlin; Herb
and Anne Newman; Cliff and Barbara
Reifler; Mel and Marianne Roberts; Leo
MacCallum and his wife; Don Stahl; and
Bill and Barbara Waskowitz.
Continuing the pattern of our 25th reun¬
ion, our class assembled after the Saturday
luncheon to hear presentations, organized
by Ron Fishbein, by their classmates and to
share experiences. Speakers were Bill Kiss¬
ick on “Managing the Medical Industrial
Complex’’ and Hal Fallon on "Current and
Future Trends in Internal Medicine”.
Our Saturday evening class dinner was
held again at the Pine Orchard home of Gil
and Carol Hogan. However, this year we
had sun rather than the torrential rains of
1982, allowing those who attended to enjoy
the lovely environment of Long Island
Sound. Howie Minners assembled a collec¬
tion of biographic information from the ap¬
proximately three dozen class members
who responded to his questionnaire.

1962
25th Reunion
by Michael H. Alderman
Members of the Class of 1962 assembled
for their 25th reunion to discover that the
passing years had neither muted the en¬
thusiasm that marked their undergraduate
days nor dulled the sense of the adventure
in medicine that had been so firmly estab¬
lished during their years at Yale. At one
time or another during the weekend Drs.
Alderman, Anderson, Bull, Cantor,
Dann, Eisenfeld, German, Godley, Har¬
rington, Karney, Kosto, Marshall, Mar¬
tin, Matyszewshi, Miller, Psehirrer, Seil,

Spencer and Stoutland appeared and par¬
ticipated in what proved to be a marvelous
opportunity to see where we have been, get
a sense of where we were, and least reli¬
ably, to take a stab at where we might be
going. The sample tested—more than onefourth of the class—although inadequate by
rigorous epidemiological standards, was
sufficiently large and representative to sup¬
port at least a few observations and tentative
conclusions.
The heterogeneous group that first came
to the Yale School of Medicine more than a
quarter century ago
has
not been
homogenized either by that undergraduate
experience or by what subsequently hap¬
pened. Our reunion program included a
class meeting on Saturday afternoon in the
Day Amphitheater, where each classmate
had the chance to speak about anything he
or she wished. Most chose to describe their
post-graduation experience; many offered
some general observations, and a few spoke
more impersonally about the state of the
world and medicine in broader terms.
We were a spectrum of individuals that
included solo clinicians or practitioners
serving in structured private or public
groups, academicians, including depart¬
ment chairpersons, directors of medical ser¬
vices, hospital administratiors, several lab¬
oratory bench scientists, a public advocate
for AIDS patients, as well as a rural prac¬
titioner recently turned international foun¬
dation executive.
Although it is always hazardous to char¬
acterize such a diverse group of robust indi¬
vidualists, I think it fair to conclude that
those whose primary role was in medical
practice were somewhat distressed by an
unanticipated changing work environment.
In contrast, those employed either academi¬
cally or in other structured positions (the
two polar groups about equal in size)
seemed, on the whole, more content with
the present and optimistic about the future.
The weekend of catching up and ex¬
changing among nearly 40 classmates and
spouses produced a sense of good fellow¬
ship and a glow of warming nostalgia. We
dined lavishly Saturday night at the New
Haven Lawn Club, and, after a toast to all—
both those present and in absentia—a thor¬
oughly successful 25th dissolved with the
universally shared wish that we meet again
soon, but no laterthan our 30th.

1967
20th Reunion
bv Bob Kirkwood
On Friday night Jim Dowaliby hosted an
informal get-together at his home in New
Haven. We sipped wine, enjoyed a deli¬
cious
buffet
dinner
and
renewed
friendships. On Saturday night we had din¬
ner at Leon’s, the Italian restaurant just
southeast of the campus, where many of us
ate on Sunday nights during our time in
medical school.

We had a good turnout. Those who came
the greatest distance were Bill Perkins,
Alex Dora, John Drews and Cindy Rapp
Curry, all from California. Ken Crumley
came from Albuquerque, N.M.; Gary
Burget and Dennis Egnatz from Chicago;
Ihor Zachary from Ohio; Bob Young and
Dick Hart from Washington, D.C.; Karen
Harkevey Toker and Joe Morris from
Maryland. From the Northeast came Mar¬
tin Wand, Peter Herbert, Tony Lovell,
Brian Rigney, Dick Swett, Dave Tilson,
Jim Dowaliby and Laura Kirchman
Manuelidis.
Although some talk centered on our con¬
cerns about fundamental changes in
medicine, our conversations quickly turned
to our personal lives and accomplishments.
We enjoyed two wonderfully warm and
happy evenings together I sensed a strong
feeling of friendship among us, the same
supportive feeling that we had as a class
throughout our four years in medical
school. We toasted ourselves for having
made it this far while still keeping our en¬
thusiasm for medicine, and we wished our¬
selves luck for the future.

1972
15th Reunion
by Bruce B. Haak
The 15th reunion of the Class of 1972 was
as anticipated a memorable occasion. The
class dinner was held at Reilly's Restaurant,
and at the excellent suggestion of Jerry
Meyer, and with some lead time, our 20th
reunion will be scheduled for the New
Haven Lawn Club.
Mike Charney was voted as youngest
looking among those in attendance. Tom
Converse is practicing psychiatry in Provi¬
dence, R.I. Felix Freshwater was voted as
having best memory of class events after
quoting verbatim, Larry Temkin’s speech
in his role as Byron Waxman from the class
show of 1970. By the way, although Larry
and his wife could not make it, he did send
a nice letter indicating that he is practicing
cardiology in Tuscon. His wife, Barbara, is
practicing psychology, and they have two
children, Joshua, 11, and Deborah, who
was two in August. Frank Kahr and his
wife Kathy have returned from Texas and
now are in the Providence area. Frank, now
known as the “Canoe Man,” has in his
spare time handcrafted six small boats and
canoes. Mike Kaufmann has turned the
other cheek, so to speak, and now is practic¬
ing law in Boston. Donald and Ellen Kent
brought their two lovely children to the din¬
ner. Phil Leibowtiz and Jerry Meyer held
down one end of the table and reminisced
about many of the events of the Class of ’72.
Richard “Dickey” Robins and Helen are
living in Columbus, Ga., where he prac¬
tices as a gastroenterologist. They live on
the same street as his mother, says Helen.
Phil Rothfeld, who lives in Woodbridge, is
a practicing radiologist in the Connecticut

Valley area. Gary Strauss is practicing on¬
cology in the Wooster area. Sherry and I are
looking forward to a gala celebration for our
20th reunion. Hope to see you all then!

1977
10th Reunion
byAttilio V. Granata
Amidst a sunny, pleasant New England
weekend, 14 members of the Class of 1977
gathered for two days of tours, conferences
and nostalgia, climaxed by a reunion dinner
on Saturday evening at the Graduates Club
on Elm Street across from the New Haven
green. Fortuitously, a photographer arrived
at just the right moment to take a class pic¬
ture on the front steps.
Along with 10 spouses or guests, the 14
included: Marcia Arem, George Bolen,
Jerry Brody, Harriet Comite, Sybil
Duchin, Julia Frank, Attilio Granata,
Bob Hand, Bob Mitchell, Mike Owens,
Alan Penziner, Ricky Schneider, Gail
Sullivan and Didi Wasserman. Julia
Frank kindly provided us with her carefully
cherished album of our second-year show,
“Mephistofollies,” which had its preBroadway run at Harkness auditorium in
December 1974. We all agreed that the
show truly launched many of our future
careers.
After dinner. Dean Leon E. Rosenberg
answered questions and helped us rekindle
some memories. The alumni then updated
each other on the whereabouts of most of
the rest of the class. Attilio Granata shared
letters he had received from those who
could not attend, including John Witcomb,
director, emergency services, St. Luke’s
Hospital, Milwaukee; Vaughn Kirchoff as¬
sistant professor of internal medicine (in¬
fectious diseases) at the University of Iowa;
and Tom Ferguson, widely known writer
and speaker on self-care and the future of
health, Austin, Texas.
We felt that being together after 10 years
provided a more realistic taste of past foun¬
dations, and gave us a bit of perspective.
Members of the Class of 1977 toast our
school, our teachers and each other, and
look ahead to the 15th, 20th, 25th and
beyond.

1982
5th Reunion
by Stephanie Wolf-Rosenblum
Paula Braverman
None of the Class of 1982 could believe that
five years had passed since that pouring,
muddy day in May. Not only did the New
Haven crowd come, including Lynn
Tanoue, Stephanie Wolf-Rosenblum and
Carrie Redlich, but Patty Kellner and
Paula Braverman came from as far as
Ohio; Joyce O’Shaughnessy from Balti¬
more; and Jeff Tepler and Daphne Hsu
from New York. The largest city rep¬

resented was Boston with Bill Sikov, Jes¬
sica Herzstein, David August, Brian
D’Angora, Michele Masi and Jed Gorlin.
There was plenty of time for reminiscing at
the dinner hosted by the 50th reunion class.
The festivities continued on Sunday at an
all-day brunch at Lynn’s house.
Many of our classmates are still in train¬
ing. Bill, Jed and Jeff are doing heme-onc
fellowships. Joyce is going into the NCI’s
therapy evaluation program. Stephanie and
Lynn are pulmonary fellows. Carrie is mov¬
ing to Seattle to follow suit after finishing
occupational medicine in New Haven.
David is paying back the NHSC by doing
nutrition research at MIT and working part
time with "a funky collection of ’60s radi¬
cals
practicing
internal
medicine.”
Michelle will be a neuro attending at the
Brigham. Daphne is in pediatric cardiology
at Columbia, and Patty is doing family prac¬
tice and urgent care at Case Western. Paula
is moving from Cincinnati to do adolescent
medicine at St. Christopher’s in Philadel¬
phia. Brian is leaving surgery to pursue
radiology in Boston.
We also heard about many others includ¬
ing Lew Rubin, a neonatologist at Boston
Children’s, and three budding car¬
diologists, including Mary Vandervelde,
pediatric, in Boston; Colin Lee in Vermont
and Phil Sager in New Haven. The sur¬
geons in the group include Jose Guillem in
New York and Bob Rizzo, who is going to
Chicago to do CT. Radiology has proven
popular, attracting Pat Toth and Henry
Stein in New York from surgery and Paul
Sylvan from medicine in New Haven.
Henry will join Mike Katz to do radiology
in Michigan.
Ed Dohring will do ortho after his NHSC
payback at an Indian reservation in New
Mexico, and Muriel Cyrus will do ER
medicine in Texas after finishing her
payback in Alabama. Gus Simpson-Roth
will begin ob-gyn in Arizona, while Ron
Voit is in an ob-gyn practice on Maui. Dave
Fassler and Bob Pierritini have a private
psychiatric practice in Vermont. Dave has
just finished an award-winning film on
epilepsy. Other psychiatrists include Bob
Rohrbaugh in New Haven and Rich Doan,
pediatrics, in Pittsburgh.
Finishing training are Laurie Katz,
pathology in Philadelphia; Terry Massagli,
rehabilitation in Seattle; Larry Ttirka,
renal in Boston; Fred Drennan, GI in Seat¬
tle; Bert Ungricht, ophthalmology in Bos¬
ton; Don Stromquist, rheumatology in
New York; and Kate Albert, Ph.D. at
Rockefeller. Hugh Hemmings is taking
his Ph D. degree to an anesthesia residency
in Boston, while Jay Kranzler took his
into business.
On a final note we have started the Class
of 20??: Mara Redlich-Revkin; Joshua
Turka; Aaron and Debbie (Koenreich) Katz;
Everett and Gavin Stem; Ariel and Raissa
Wolf-Rosenblum; Sarah Tepler; Andrew
Ungricht; Angie and Clarice Simpson-Roth
and Conner Cyrus.
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discussed at the annual class agents meeting
Saturday afternoon. The changing needs of
student aid were discussed at length In¬
creasing scholarship awards are becoming
necessary for some students in the light of
the unrealistically high loan debt with
which some students graduate.
The evening concluded with the tradi¬
tional reunion class dinners held at many
sites. Again, the fourth annual “Friends of
the 50th'' dinner at the Graduates Club was
a heartwarming event, with approximately

70 guests saluting the Class of 1937. Also
feted was the Class of 1932, with 15 pre¬
sent, and the Class of 1982, celebrating its
first reunion with 17 members attending.
Dr. Stephanie Wolf-Rosenblum moderated
the commentary of this young group, which
included two well-behaved “1982" infants.
Dr. Nicholas P R Spinelli
Director of A lumni Affairs

Bil l. CARTER

At the annual meeting of the Association of
Yale Alumni in Medicine, President Dwight
F. Miller introduced Dean Rosenberg, who
outlined several ambitious building pro¬
jects, faculty appointments and honors. The
dean also described the highly successful
Student Research Day.
Chairman R Leonard Kemler ’43, of the
Yale School of Medicine reported receipts
of $540,217 by the Medical School Alumni
Fund as of May 27, exceeding our goal for
the year of $500,000. A similar achieve¬
ment was reported by Mrs. Kay Flowe from
the Public Health Alumni Fund, with a
record $67,016 received, surpassing a goal
of$50,000.
The Distinguished Service awards for
1987 were presented to four alumni: Dr.
Myron E Wegman and Dr. Conrad R. Lam
of the Class of 1932; Dr Arthur Ebbert,
deputy dean of the Yale School of Medicine
for the past 34 years; and Dr. Nicholas P R.
Spinelli, director of Alumni Affairs and
past president of the Association of Yale
Alumni in Medicine. Dr. Ebbert, a graduate
of the University of Virginia School of
Medicine, was made an honorary and
lifetime member of the Association of Yale
Alumni in Medicine for his extraordinary
service to alumni/ae, students and the
school for so many years.
President Dwight Miller also presented
special citations to Dr. Helen P. Langner,
Class of 1922, on the occasion of her 65th
reunion and to Dr. Harry M. Zimmerman,
Class of 1926, a distinguished teacher of
neuropathology, on the occasion of his 60th
reunion Dr. Miller also presented citations
to each member of the 50th reunion to
the respective class secretaries; Wilbur
Johnston, ’37 and Dr. Michael H. Aiderman, ’62.
Saturday afternoon provided special
class seminars conducted by the 25th-year
reunion group of 1962 and the 30th reunion
Class of 1957. With the planning efforts of
Drs. Michael Alderman, Dr. Fred Cantor
and Dr A. Richard Pschirrcr, “Reflections
of the Class of 1962 at 25’’ took place in
103. The Class of 1957 presented Dr.
William L. Kissick, “Managing the Medi¬
cal-Industrial Complex;’’ and Dr. Harold J.
i allon Jr., "Current and Future Friends in
Internal Medicine." The record perforlance achieved by Dr. R. Leonard Kemler,
■1 ’ as chairman of the Alumni Fund, was

At the 1987 A YA in Medicine Annual Meeting, (from left) Drs. Arthur Ebbert Jr., Nicholas
Spinelli. Conrad Lamm and Myron Wegman were given Distinguished Service Awards for
their years of extraordinary’ service to the Yale School of Medicine. (Please see opposite
page.)

DISTINGUISHED SERVICE AWARDS

Arthur Ebbert, Jr., M.D.

Nicholas P.R. Spinelli, M.D.

Your extraordinary and unique service to Yale School of Medicine
began in 1953 when Dean Vernon Lippard appointed you assistant
dean of the School of Medicine and has been unparalleled in the
history of the school. Your skills in this crucial executive role were
to establish your remarkable record as deputy dean for the five
succeeding deans, during your 34 years of service. Your sensitive
concern and knowledge of all members of the school—faculty,
student, administration, alumni—is now legend. Your personal
knowledge of medical students, from the graduating Class of 1953,
when you arrived, to the present, has rendered you the true archivist
for our school and for our alumni association. You are an irreplaceable
resource. Your ability to communicate with all of us has been a
model of finesse, informed judgment and grace.
We are fortunate today to have inducted you as permanent member
of the Association of Yale Alumni in Medicine. We are blessed to
look forward to your coming years in New Haven, and our ability
to count upon your continued and unmatchable support. We thank
you for your past assistance. It is with affection that the alumni
association salutes you today.

Your service, devotion and dedication to Yale spans 50 years, since
you entered as a Yale freshman in 1937.
Your Yale training after military service brought you home to
practice as a general internist. You taught Yale medical students,
and your service never strayed far from your academic source.
When personal circumstances required that you leave practice in
1968, you became director of medical education at Bridgeport
Hospital. In this role, you assisted the Yale medical school to
achieve formal affiliation with the teaching community hospitals of
the region. The circle of your continued activity at our medical
school thus grew in its linkages through the years. Since 1950, you
have been Alumni Fund agent for your Class of 1944. You were
chosen to be chairman of the Medical School Alumni Fund in the
early '70s and have assisted in forming the board of directors of
the fund, an effort which has energized annual giving.
You have helped raise the consciousness of our medical graduates
and house staff trainees to help meet the needs of our financially
stressed students.
You were honored to serve as president of the Association of
Yale Alumni in Medicine from 1981 to 1985. In 1985, you were
appointed director of medical alumni affairs. You have accelerated
communication among our membership, without which our associ¬
ation cannot thrive.
Your alma mater is grateful for your help and applauds you
today.

Conrad Ramsey Lam, M.D.
Your distinguished career as a pioneer thoracic and cardiac surgeon,
anchored in Henry Ford Hospital in Detroit, has brought you
international awards and recognition.
As the eldest of 11 children from central Texas, your Yale School
of Medicine education was funded, in part, by your merchandising
of musical instruments. The trumpet and music, as well as the
study of medicine, occupied your youth and young adulthood.
Although Detroit remained your academic home, you responded
whenever our medical school sought your help as an alumnus. You
served as chairman of the Yale Medical School Alumni Fund from
1963 to 1966. You served as medical school representative to the
Alumni Board during those years.
In your long illustrious career, you remained a teacher and role
model to many of our graduates. Despite your busy schedule, you
devoted attention to your medical school when she sought your
counsel or help. Your presence at and assistance with your class
reunions has been as constant and unwavering as your love of
music. One of a large number of distinguished and accomplished
classmates of the Class of 1932, the Yale School of Medicine salutes
you and thanks you today.

Myron E. Wegman, M.D.
Fifty-five years ago, upon your graduation from the Yale School of
Medicine, you began a medical career in academic pediatrics and
public health. It was to take you through the byways of the world
into top administrative positions in the World Health Organization
and as secretary general of the Pan American Sanitary Bureau. In
a life dedicated to medical education and international health, with
teaching assignments at Columbia, Johns Hopkins, Cornell,
Louisiana State University and extensively in Latin America, your
path repeatedly brought you back to New Haven for service at
Yale. From 1969 to 1972, your duties as chairman of the Yale
Medical School Alumni Fund contributed to the process of growth
which now renders the fund a major source of support to our
students. Your energy, enthusiasm and support of our school and
the remarkable Class of 1932 is acknowledged today by your alumni
peers who have watched your career with pride, your service with
gratitude. Although you are dean emeritus at the University’ of
Michigan School of Public Health, you continue your journeys
across the globe today with the youthful vigor which has marked
your distinguished career.
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1986-1987 ALUMNI FUND REPORT
A Message from the Dean
Our students express enormous anxieties
and concern about the high costs of medical
education today, and it is a poignant plea
that they make. Many will graduate in June
with an average indebtedness of $55,000.
This burden threatens our ability to accept
and educate the brightest young people re¬
gardless of their economic backgrounds.
So as dean, finding additional financial
aid for our medical students is one of the
major issues which faces me, other admin¬
istrators and faculty in the School of
Medicine and, of course, the students.
The generous past support of medical
school alumni/ae has been tremendously
helpful in our efforts to address this pressing
need. Your support in the form of unre¬
stricted gifts totaled more than $600,000 in
1986-87, and I as dean greatly appreciate
these gifts. Once again I have directed that
your contributions be used to assist stu¬
dents, primarily through financial aid.
It is gratifying to note that your total giv¬
ing has more than doubled during the past
three academic years. Nonetheless, 1 re¬
main deeply concerned about the gap be¬
tween the funds that alumni/ae provide and
the needs that medical students have. To as¬
sist our students and to ensure that tomor¬
row’s medical care and scientific research
will remain at the high level of excellence
we now enjoy, we must generate additional
funds and develop new ways to finance
medical education for the young people
who feel the effects of the high costs of

medical education and who may have their
career choices influenced by these costs and
subsequent indebtedness.
As we work together to increase the
amount of funds available for student finan¬
cial aid, we must explore new forms of
financial aid to supplement our traditional
loan awards. Your Alumni Association and
its leaders—from President Dwight Miller
to Medical School Alumni Fund Chairman
Leonard Kemler—will play a significant
role in helping the school set this course for
our outstanding students.
Dwight, Leonard, along with Sam
Kushlan and Roswell Gallagher in their ef¬
forts as bequest and endowment co-chair¬
men, have worked ably to generate gifts to
enlarge the Medical School Alumni Fund,
and future leaders will be challenged to
surpass iheir fund-raising successes. Dr.
Nicholas Spinelli’s diligence, both as an
alumnus and medical alumni association
director, is appreciated, and Ms. Claire
Lauterback’s consistent administrative con¬
tributions are noted too.
During 1987, the many members and
leaders of the Medical School Alumni
Association have strongly supported the
school and its students. I greatly value your
important and generous contributions,
which I hope you will sustain and surpass.
Thank you.
LeonE. Rosenberg, M.D.
Dean
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Message from the Medical
School Alumni Fund
Chairman
Hooray! Hooray! You've done it again. As
you will note in the accompanying report,
the Yale Medical School Alumni Fund has
again set a new record—$615,000 dollars.
It must be satisfying to realize how many
students you will be able to help with these
monies. Mother Yale, the students and I are
very grateful for your interest, efforts and
success. The only cloud to darken this pic¬
ture is that participation remained at the
same level. We must try to increase our per¬
centage of participation in future cam¬
paigns.
To all of you who responded to the call,
again, our heartfelt thanks.
To those of you who have not partici¬
pated, please reconsider this year, and make
a contribution to enable more students to
participate in our loan and scholarship pro¬
gram and ease the financial burden on these
deserving young men and women.
Let's keep our momentum going with
another record in giving and participation
for the academic year 1987-88.
R. Leonard Kemler, M.D. '43

The Medical School Alumni Fund last year established the Sterling Association, a new
gift club. Donors may join the Sterling Association by making contributions in any of
the following six categories:
Lifetime Benefactor

$50,000 and above

Patron

$5,000-49,999

Sponsor

$2,000-4,999

Fellow

$ 1,000 - 1,999

Associate

$ 500 - 999

Member

$ 200 - 499

First-year medical students pitch in and solicit alumni support for alma mater. (From
left) Narisse Daye, Victoria Barber, Mindy Schuster and Matthew Miller.

Kemler Increases Fundgiving
R. Leonard Kemler, M.D. '43, has com¬
pleted his first year as chairman of the Yale
Medical School Alumni Fund. In pursuing
his goal of increasing the percentage of
alumni who participate in fund giving. Dr.
Kemler has attempted to speak with each of
the approximately 100 class agents. Such
personal communication has reaped many
benefits. Some class agents of long stand¬
ing, weary after many years of service, have
been replaced at their request. Other class¬
mates have been added to the roster to share
the work load.
In addition, leaders among current medi¬
cal students have been identified, and
alumni have shared insights with them
about the importance of laying the ground¬
work for class organization while they are
still in school

Memorial Established
Dr. Kemler notes, “Not only does such
organization serve a class in its alumni ac¬
tivities after graduation; it is an important
psychological support system while they
are still students. Bonds are forged which
endure for a lifetime.” The Alumni Associ¬
ation has planned social events with Yale
medical students and hopes to broaden such
activities.
As a result of these efforts, the Class of
1988 already has selected two of its Alumni
Fund class agents, and the Class of 1987
graduated with its four agents well oriented
to their tasks. This group includes: Subba
Gollumudi,
Mindy
Schuster,
Barry
Weinstock and Mark Widmann. The associ¬
ation will assist the Classes of 1989 and
1990 in similarefforts.

Messages to Graduates and Friends of Epidemiology
and Public Health
The department’s faculty, students and staff
are very appreciative of the contributions
made to this year’s Yale Public Health
Alumni Fund drive. We congratulate the
alumni who reached new records both in
participation and contributions. This clearly
is the result of great effort on the part of
alumni leadership combined with the deep
gratitude and respect so many of our alumni
feel toward Professor John D. Thompson,
who influenced so many students. The
department of epidemiology and public
health is proud to share in the expression of
this recognition of a dedicated teacher and
respected researcher.
JanA.J. Stolwijk, Ph D.
Chairman and Susan Dwight Bliss
Professor of Epidemiology
and Public Health

The Public Health Alumni Fund for 198687 and 1987-88, designated the John D.
Thompson Scholarship Fund, surpassed its
first- year goal by 50 percent! The early re¬
sponse was so good that the original
$50,000 goal was raised to an unofficial
$75,000, which was reached by the end of
the fiscal year.
Credit and many thanks for this extraor¬
dinary effort, honoring a teacher par excel¬
lence and mentor to several generations of
hospital and health services administration
students, go to many people: to Edward
Noroian, MPH '58, who made a special and
effective appeal to the graduates in health
services administration; to Stephen Skorcz,
MPH '70, president of the Yale University
Hospital Administration Alumni, who
wrote many personal follow-up solicita¬
tions; to the enthusiastic group of local
alumni/ae who participated in a highly suc¬
cessful phonathon; and of course to all the
dedicated class agents who assisted in the
record-breaking event.
We look forward to the continuing sup¬
port of all EPH alumni/ae and department
friends in next year’s campaign, when the
official goal will be $75,000, thus enabling
the department to award three John D.
Thompson Scholarships each year.
Kathleen H. Howe, M.P.H. '56
Chairman
Public Health Alumni Fund

Mrs. Berthold R. Comeau of Delray Beach,
Fla., has established a memorial fund at the
School of Medicine in memory of her late
husband, Berthold R. Comeau, who re¬
ceived his medical degree from Yale in 1928
and practiced medicine in New York
throughout his long career. The gift will be
used to support scholarships for students in
the School of Medicine, and will be known
as the Berthold R. Comeau Memorial Stu¬
dent Financial Aid Fund.
When he learned of the gift. Dean Leon
E. Rosenberg expressed his appreciation to
Mrs. Comeau. “Assisting our students with
adequate financial aid is a major concern of
mine,” he said. "Our school is proud of our
tradition of educating and training the very
best students without regard to their finan¬
cial qualifications. We, therefore, are grate¬
ful to you for your much-needed help. With
such kindness, we are encouraged that we
will be able to continue in the tradition of
excellence that has been the hallmark of our
school.”

Memorials
Deceased medical alumni and friends may
be memorialized by a gift at any time to the
Medical School Alumni Fund Endowment
in the name and class of the person so hon¬
ored. The next-of-kin of a deceased medi¬
cal alumnus/a is advised about this In
Memoriam Program by a mailing from New
Haven some weeks after the School of
Medicine receives notification of the death.
The letter of information includes a copy of
The Testament of Remembrance in which
the names of all persons so memorialized
are listed in the medical section by class,
thus establishing a lasting memorial. Do¬
nors receive a personal penned note of ap¬
preciation from me. Your inquiries and in¬
terest are welcome at any time.
Deceased alumni and friends so honored
for the first time in 1986-87 were: Berthold
R. Comeau '28, Lewis Dickar '30, Edward
T. O'Donnell '34, Boy Frame '48, 1942 de¬
ceased classmates, 1950 deceased class¬
mates, Bernhard H. Lisker '75, Anthony
DeLuca and Thomas M Tierney.
RichardG. Jordan
Director. In Memoriam Program

ALUMNI REPORT

Drs. Richard Breck, '45 (left), and Nicholas
Spinelli, '44.

The Alumni Association gave an informal
reception May 1 for medical students of all
four classes. Approximately 100 students,
alumns, faculty and administration assem¬
bled in Harkness Lounge. In an informal at¬
mosphere, refreshments were served, and
good feeling and warmth prevailed.
Students relaxed and discussed questions
about the curriculum, future practice or
teaching careers. Drs. Bernard Shen ’81
and Attilio Granata 'll chair the associa¬
tion's Student Well-Being Committee.
Plans to consult with officers of the Student
Council to discuss possible future social
events and opportunities to meet with
alumni/ae informally were announced.
The universally expressed request in
1985 for more news of fellow alumni/ae has
resulted in the publication of several col¬
umns entitled MEDICAL SCHOOL in the
YALE ALUMNI MAGAZINE. After an in¬
itial flood of notes sent to the Medical
Alumni Affairs office, the receipt of news
items has tapered off. News is urgently
requested of all, and a tear-out card is
enclosed in this issue. Class columns,
published in YALE MEDICINE, will high¬
light alumni news of professional honors
or status changes; the YALE ALUMNI
MAGAZINE will feature items of persona!
and social interests.

The response to the request for volunteers
to provide overnight bed and board to Yale
medical students visiting 40 cities for resi¬
dency interviews last year was most en¬
thusiastic. An early letter requesting such
volunteers was mailed this summer for
1987. This opportunity should provide an
excellent means for students and alumni to
exchange information and insights.
Preparations for Alumni 1987 Reunions
occupied most of the springtime. An
Alumni Weekend event undergoing inter¬
esting changes each year is the “Friends of
the 50th Dinner,” held on Saturday reunion
night. It was begun four years ago as a spe¬
cial effort to honor the returning classmates
of the 50th reunion class. Members of the
older classes, faculty and school officers as¬
semble as guests of the association to share
the 50th reunion class dinner and salute
them as individuals. In 1986, the first reun¬
ion class (five years out) were added as
guests or "friends.” The latter group histor¬
ically had poor attendance at their first reun¬
ion, usually for financial reasons. Gratifyingly, nearly 20 percent of the fifth-year
classes has appeared for two years, and
most heartening has been the communica¬
tion and conviviality between the younger
and the older grads.
Since our last report, the subcommittee
of House Staff Alumni has appointed Dr.
John N. Forrest, Jr. as its chairman. Added
to the committee have been Dr. Michael R.
Berman, HS '73-’76, assistant clinical pro¬
fessor of obstetrics and gynecology; and Dr.
G.J. Walker Smith, HS ’69-’73, professor
of pathology.
Alumni Records over the years has ex¬
perienced major deficiencies in the citation
of former House Staff and Fellows,
amounting to nearly 60 percent of them.
Old records currently are being researched.
When identified and located, these alumni/
ae will be polled as to their desire for active
membership in the Association of Yale
Alumni in Medicine. An intense identifi¬
cation with Yale medicine has been articu¬
lated by those “lost alumni/ae” who have
phoned us.
In 1988, this committee will attempt to
define this group’s role in annual reunions,
or perhaps more appropriately, reunions of
their own groups. Subspecialty organiza¬
tions already exist and regularly provide

their own continuing medical education
seminars. Dr. Dorothea Peck’s description
of the reunion of surgical house staff of the
1940s, concurrently with the annual reun¬
ion, is typical of such events. Representa¬
tion of current medical house staff in pre¬
sent association activities seems desirable
to underscore early on their membership
in the alumni family and future network
potential.
This fall Yale medical faculty continued
to make regional visits. Dr. Alvan R. Feinstein, professor of medicine and epidemiol¬
ogy, spoke in Hartford on “Muddles in the
Model”, discussing clinical decision-mak¬
ing. Dr. Robert Gifford, professor of
medicine and associate dean for medical
education and student affairs, spoke to the
San Francisco and Bay area group on the
current Yale medical school scene.
Mr. Gail Ferris, director of alumni rec¬
ords, has announced that the Yale Univer¬
sity Directory will be kept current. It is
available to all medical school graduates
from the Rose Alumni House, Association
of Yale Alumni, 232 York St., New Haven
Conn.06520.
It is hoped that our efforts of the past year
have improved communication among
alumni/ae, faculty and students. To transmit
information, you must forward it to the
Office of Alumni Affairs. With your coop¬
eration, the challenge and potential for
alumni to assist ourselves is great.
The director wishes to acknowledge the
remarkable service and sage counsel proved
by four local alumni/ae: Dr. Samuel
Kushlan, ’35, Dr. Dorothea Peck, '43, Dr.
Richard Breck, ’45, and Dr. John Ogilvie,
’34. They provide assistance in fund raising
(the Medical School Capital Campaign),
editorial work, hospitality, social function
planning and communications. Alumni/ae
in the New Haven area with free time and
specific interests are invited to volunteer for
membership in this remarkable “kitchen
cabinet.” Many thanks.
Dr. Nicholas P R. Spinelli
Director of Alumni Affairs
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Medical School Alumni Fund Class Participation
1985-86
AGENT
1922 and prior
1923
1924
1925
1926
1927
1928
1929
1930
1931
1932
1933
1934
1935
1936
1937
1938
1939
1940
1941
1942
1943A
1943B
1944
1945
1946
1947
1948
1949
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
I960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973

1974

William Cohen
David M. Raskind
Alice Whittier
Maxwell Bogin
Harry Zimmerman
Max Alpert
Paul McAlenney
J. Edward Flynn
Michael D'Amico
Henry Brill
Franklin Foote
John Ogilvie
James Haralambie
Frederick Post
David Dolowitz
Nelson Ordway
Rebecca Solomon
James Ferguson
Charles Cheney
Walter Burdette
Dorothea Peck
S Brownlee Brinkley
Nicholas Spinelli
Richard Breck
Chales Judd
Thomas Whelan
William Roy Breg
Paul Koehler
Daniel Elliott
David Frucht
Lowell Goodman
Harvey Young
Vincent Gott
John Rose
Robert Kramer
John Gardner
Ronald Fishbein
Howard Minners
Andrew McGowan
Paul Rudnick
Asa Barnes
Muriel Wolf
Victor Altshul
Thomas Kugelman
Earl Baker
Annoush Miridjanian
A. Richard Pschirrer
Frank Hartman
Craig Llewellyn
William Houghton
William Pratt
David Hill
Mary Alice Houghton
Gary Townsend
James Dowaliby
Anthony Lovell
Frank Lucente
Donald Lyman
Lee Jampol
James Missett
John Cieply
Barbara Kinder
Paul Lucky
Lee Goldman
John McQuade
Jerrold Rosenbaum
Amy Schecter
Robert Schecter
Daniel Passeri
Mary Jane Minkin
A William Levy
Robert Taylor

1986-87

TOTAL
2,180
553
1,873
755
2,927
1,025
3,569
1,341
6,072
2,923
2,066
1,944
3,898
12,837
108,906*
1,540
1,065
18.441
8,453
3,692*
2,519
2,908
2,171
6,014
4,025
58,100*

%PART
—
67
67
70
83
60
77
67
70
79
54
73
50
57
53
53
53
67
54
69
53
70
55
76
60
75

TOTAL
1,519
540
2,226
825
486
1,995
53,765
1,296
16,262
1,274
14,039
1,600
4,210
17,020
4,239
6,013*
1,036
2,976
9,503
17,008
56,144*
5,406
2,815
13,235
3,520
69,323

4,925
6,067
3,970
4.486
6,884*
8,432
3,665
5,088
6,370
15,300*
8,121

59
62
55
76
52
57
52
68
60
57
64

12,700*
6,461
4,034
16,272
8,778
11,320*
2,925
5,273
5.294
8,267
16,043*

69
55
55
70
58
65
44
63
55
51
73

6,795

62

9,300

73

13,898

65

9,769

67

8,819

58

8,101

57

13,000*

51

8,875

54

4,100

40

16,820*

54

7,395
9,130

58
72

7,577
10,520

54
66

5,455
5,445*

47
59

13,412
5,725

55
58

6,877

70

15,644*

75

5,567

47

7,304

57

6,516
3,526
10,411*

60
45
61

8,011
4,104
8,495

60
56
48

4,983
2,988

41
38

11,178*
4,047

58
42

2,370

37

3,385

38

1,715

23

1,825

24

3,370*

39

3,085

29

%PART
—

100
100
60
60
89
69
81
71
71
60
71
71
59
29
67
63
58
69
75
69
72
69
71
57
52

1,350

31

2,380*

35

1,520

29

1,935

25

Jeffrey Kaine
Cynthia Sherman

881

23

1,551

33

1980

Eduardo Alfonso

870

26

1,220

27

1981

Cesar Molina
Anthony Urbano

1,310*

24

965

19

680

21

649*

23

535

16

425

14

325

11

620

23

2,299

94

725

26

1977

Attilio Granata
Ronald Vender

1978

Duke Cameron
Seth Powsner
Thomas Smith

1979

1982

Muriel Cyrus
Jed Gorlin
Stephanie Wolf-Rosenbaum

1983

Michael Tom
David Schwartz

1984

Hingge Hsu
Jay Kostman

1985

Robert Higgins
Fred Santoro
Javier Vizoso

1986

15

Eric Bernstein

755

Clifton Lindo
Eric Suan
*Reunion

48

Alumni

467,234

577,069

22
22

Former house staff

11,821

50

19,675

Parents/friends
Interest/misc. gifts

8,558
14,532

18

10,396

TOTAL

18

41

11,309

502,145

615,449
41

Medical School Alumni Fund
1985-86

Alumni

1986-87

NUMBER
SOLICITED

NUMBER
CONTRIBUTED

PERCENT
PARTICIPATION

3,583

1,773

1,002

TOTAL

NUMBER
SOLICITED

NUMBER
CONTRIBUTED

PERCENT
PARTICIPATION

TOTAL

50

467,234

3,624

1,753

48

574,069

181

18

11,821

1,002

222

22

19,675

432

79

18

8,558

432

93

22

10,396

5,017

2,032

41

502,145

5,058

2,068

41

615,449

Former
House Staff
Parents/Friends
Int/Misc.
TOTAL

14,532

11,309

Public Health Alumni Fund
1985-86
NUMBER
SOLICITED
Alumni
Int/Misc.

1,938
-

1986-87

NUMBER
CONTRIBUTORS
618
-

PERCENT
PARTICIPATION

TOTAL

NUMBER
SOLICITED

32

35,201

2,044

_

2,339

_

NUMBER
CONTRIBUTORS
669
_

PERCENT
PARTICIPATION

TOTAL

33

72,455

—

2,685

41

Public Health Alumni Fund Class Participation
1985-86
AGENT

1986-87

TOTAL

%PART

TOTAL

—

10,458

—

60

425

60

%PART

1942

Eric Mood

2,159
420

1943
1944

Eric Mood

90

27

395

36

Eric Mood

275

22

250

22

1945
1946

135

50

80

29

75
330

100
140

29

1947

29
48
44

1941 and prior

1948
1949
1950
1951
1952
1953
1954
1955
1956

Samuel Herman
Edgar Geibel

750

35
41

465

33

595

42

Eric Mood
Norton Chaucer
Elizabeth Throm

685

43

1,150

43

600

50

455

33

Yolande Lyon
Milton Sisselman

695

41

1,075

40

810

52

950

38

85

21
44

100

21
44

Eric Mood
Frances Ogasawara

1957

David Boyd
Edward DeLouise

1958

Philip Halien

1959

Dorothy Wilson

1960

R. John C. Pearson
William Slivka

1961

675

485
672

50

345

705

52

373
1.010

1,175
430

29

3,760

35
36

38

835

46

1,159

43

1,075

40

195
580

32

Joseph Prekup

40

22

400

1962

Thomas R. Mayhugh

175

30

1,750

50

1963
1964

David Dolins

785
640

38

1,620
2,225

48

600

1,370
2,125

45
37

1965

Estelle Siker
H. Patterson Harris

1966
1967

280

31
27

James Malloy

1,185

32

1,825

34

1968

Arnold Saslow

1,705

51

1,645

41

1969

Samuel Korper

955

32

Allen Cohen

33

52

36

Robert Young
1970

Susan Balter

1,533

31

5,205

37

1971

John Bihldorff

1,803

2,855

39

1972

Dorothy Lewis

830

1973

Judith Beatrice

385
1,160

53
17
31

5,185

33
34

765

33

1,190

30

1,602

35
30

4,142
1,240

32
27

29
29

3,015

30

1,123

30

995

31

2,988
1,215

1,050

27

1,825

40

1,235

29

855

29

750

23

1,700

34

Gary Sax
1974

Thomas Benoit
Karen Lindfors

1975
1976
1977

Linda Broker
Elaine Anderson
Dorothy Rice

1978

Ann Freedman

1979

Catherine H. Norton

1,140
918

33

Ralph Tartaglione
1980
1981

Christina Quinn
Angelo DeVita
Barbara Gaugler

1982

Constance M Jarowey
Jean L. Milton

1983

Jeffrey Hughes
Mary Beth McNemey

505

23

1,639

31

1984

Anthony Alberg

265

15

365

12

448

15

500

19

—

—

720

19

—

—

Leslie A. Balch
1985

Joan M. Cleary
Katherine Fitzpatrick

1986

Indue Ahluwalla
Aric Wilt

Alumni gifts

35,201

Intercst/misc. gift;s
TOTAL

2,339
37,540

72,455
32

2,685
75,140

33

Contributors to the Medical School Alumni Fund
Edward P J Kearney

Alumni

1903
Robert L. Rowley*

Ralph E. Knutti

Benjamin N. Tager
Rudolph E. Vandeveer

Charles W. Neuhardt
T. Dennie Pratt

William A. Carey
Joseph P Carson, Jr.

R. Harold Lockhart
Edward W. Ludwig*

Myron E. Wegman
Roland J. Wehger*

Alan A. Rozen

Charles B. Cheney
Herbert W. Diefendorf
Robert Dine*

Nathan E. Ross

1906
Charles R

Mitchell*

1908

Morgan Sargent

Robert I. Rubinstein

1933

Edward J. Shaw
Albert D. Spicer

John M. Russell*
Alvin A. Schaye*

Myron John Adams*

John M. Thomas

Lloyd D Flint

Fred W. Buse

Jean Wells
Lorande M Woodruff

John Franklin

John E. Fenton

Lewis A. Scheuer

Warren P Cordes
Franklin M. Foote

1929

Jack Greenberg

1938

William Edmund Kenney

Daniel F. Harvey*

Roy N. Barnett
Henry L. Carideo

Sidney L. Lasell
Bjom Lih

Michael A. Parlato*

Robert L. Gilbert
Frederick P. Glike

1912

James R

Walter C. Tilden*

John W. Cass, Jr

George K. Hirst

Frank H

F. Eugene Martin

Charles J. Epstein
Robert A. Frisch

John G. Martin
Raymond E. Miller

S. Charles Kasdon

1913

Benjamin E. Lyons

Willys M. Monroe

Ralph E. Taylor*

1916
Ernest Russell*

Arneill Jr.*
D'Andrea

Ashley Pond III*

John J. McGillicuddy

Malcolm C Murfitt

Olive Gates

Paul L. Saffo

George S. Goldman
Alexander O. Haff*

Sidney Stringer*

Edward Nichols
Nelson K. Ordway

Edward B O'Connell
Robert W. Ollayos

John J. Wolfe

Edward W. Pinkham, Jr.

Gioacchino S

John A. Hangen

Francis M. Woods

James Radcliffe, Jr
George E. Roberge
Lester J. Wallman

David V. Pecora
Edwin D. Rogers

Parrella

1919

Harold J. Harris

Willys M. Monroe*

Paul F. McAlenney

1934
Leona Baumgartner
Frederick Beck

J. Richard Zahn

1920

Tony L. Rakieten*
William F. Roth*

Oscar Brenner*

Russell B. Scobie

James F. Blades

1939

Robert Tennant

Joseph Budnitz

Harold H. Coppersmith

1942

1922

Francis P Guida*

Norman L. Cressy

William E Bloomer

Maurice Grozin*

Newell Raymond Washburn*
Julius G. Weiner*

Derick A. January

William H. Druckemiller

James M. Bunce

Chester E. Hurwitz*
Helen P. Langner

Mabel Wilson
Herman Yannet

Knowles B. Lawrence

Robert G. Ernst*

Walter J. Burdette

Herbert C. Miller
Edward Thomas O’Donnell

John P Ferguson, Jr.
Joseph B. Forman

Robert E. Carroll

1923

1930

S. Jerome Greenfield

William Cohen

Daniel N. Beers*

John B Ogilvie
Lucien M. Pascucci

Julius A. Olean*

Frederick Fitzherbert Boyce
Charles A. Breck*

Harry Sherman
George Zalkan*

Hyman W. Weinstein*

Lewis Dickar*

1924
John J

Batchelor

Vincent A. Doroszka
Knox H. Finley

1935
George A. Carden, Jr.

Leslie Simmonds
Janet H. Van Orden
Irving Waltman

Nathaniel Kenigsberg
Arthur E. Laidlaw
Ward J. McFarland
James Peter Murphy
Russell Nahigian
Douglas S. Riggs

Donald S. Childs, Jr.
Ludmil A. Chotkowski
Vincent J. Collins
David G. Decker
Hendrik DeKruif
Davitt Felder
William Fleeson
Elihu Friedmann
Allan V.N. Goodyer

D. Anthony D'Espo
David M. Raskind

J. Edward Flynn
J. Roswell Gallagher

Sawnie R. Gaston
H Hoffman Groskloss

James C. Hart*

James Quintin Haralambie

Bradford Simmons
Rebecca Z. Solomon

William Harrison, Jr

Myron A. Sallick
Harold T Vogel

Amy H. Hunter-Wilson
Edmund L. Kitzmeyer

W. Howard Horner

John D. Tobin

John R Lincoln

Mildred Hartshorn January

Patrick S

1925

Moses D Lischner

Dorence S. Cowles
Waldo F. Desmond
William E. Hall

James M. Lynch*
John W. Maroney

Samuel D. Kushlan
Donald Peter Morris*

Douglass W. Walker
John H. Wentworth

Samuel Reback

Class of 1935
John D Preece

Eli H. Rubin*

Charles L. Wood

Norman P. Rindge

Alice A. S. Whittier

1931

Milton Rose*
Clark P Searle

1926
Stanton T. Allison*

Henry H. Briggs, Jr.
Benjamin Castelman*
Michael D’Amico

Maxwell Bogin
William H. Hahn*

Helen R Gilmore
Paul A. Harper

Joseph L. Hetzel*

Harold E. Harrison

Ben Klotz
Milton Malev

Morris Freund Heller*
Thomas C. Jaleski
Rhoda M. Mickey

George Hahn*

Nelson Newmark
Abraham J. Schechter

Louise G. Hutchins
Philip M. LeCompte

John M. Freiheit*
Donald F. Gibson

James A. Stringham

Albert Jablonsky
Nathan Levy*

1932

1927
Wallace R. Bostwick*

Samuel Zelman

Thaddeus S. Danowski

Irving Norman Wolfson
Class of 1942 In Memoriam Fund

1936

Wynant Dean
Richard E. Dormont

Daniel Bergsma
Lester W. Burket
Albert W. Diddle
Margaret C. L. Gildea

1943 March

James F. Ferguson, Jr.
Eugene J. Fitzpatrick, Jr.

Ralph D Alley
John R. Brobeck
Donal L. Dunphy

H. Stuart Irons, Jr.
Donald G. Johnson

Gerard Fountain
Stuart L. Joslin

Frederick A. Post

Ira D. LeFevre, Jr.
Paul D. Mac Lean

R Leonard Kemler
Joseph P. Kriss

Margaret Sommers
Morris Tager

Edward Martin
William R. Oakes

Jonathan T Lanman

1937

Maurice Ross
W. Norman Sears*
Joseph E. Sokal

David A. Dolowitz

M Dawson Tyson
Harry M. Zimmerman

Clement C. Clarke
Joseph P Donnelly

1928

Lee E. Farr
Thomas E. Farthing*

D. Crosby Greene
Joseph B Hollinshead
Benjamin F. Hoopes

* deceased

Robert M. Dunlap

Henry D. Humphrey

Frank Carroll

Elizabeth M. Ramsey

Edgar B. Taft,

Walter A.L. Thompson

John T.B. Carmody

Sheldon A. Jacobson

Theodore E. Allen
Joseph V. Baldwin

Charles F. Scholhamer
Richmond W. Smith, Jr.
Maurice Tulin

Theodore H Sills

Lewis F. Foster
Conrad R. Lam
Arthur J. Present

Samuel Ritvo

1940

Francis P Voss*
Arthur A. Ward, Jr.

Edmund R. Blower
William G. Cooper, Jr.

Berthold M. Comeau*
Louis M D’Espo

Mullins

Dean Nichols*
Michael A. Puzak

Jack S. Blaisdell
Philip S. Brezina

William C. Meredith
Moses Rothberg
Alfred F. Seibert

Max Alpert

Leo Kellerman

Ronald S. Beckett

Louis K. Alpert
Reginald V. Berry
Henry Brill

Malvin F. White

Norman E. Peatfield

John C. Mendillo
Paul Watson*

Welles A. Standish

Ernest L. Sarason

Wilbur D. Johnston
Alfred E. King
Dunham Kirkham
Julia Mehlman
James P. Morrill

J. Champneys Taylor
Patricia E. Wanning
John B. Wells

Douglas Lindsey
J. Philip Loge
Henry E. Markley
Walter J. J. Nero
Dorothea R. Peck
Earl J, Rhoades

Helen H. Woods

Henry A. Riedel
Bernard R Rowen

1941

Marcus E. Sanford
Robert A. Sears

Robert H. AI way
Robert H. Areson

Edward Hersey Soule
Hilliard Spitz

W. Randal Bell
Knute E. Berger

Nicholas M. Stahl
Sophie Trent Stevens

43

William K. McClelland

Sylvia L. Axelrod
John E. Borowy

Raymond A. Gagliardi

Robert F. Newton
Myron K. Nobil

Philip S. Good
Gove Hambidge, Jr.

Lawrence C. Perry
Philip H Philbin

1943 December

Herbert S. Hamed, Jr.

John R. Almklov

Paul W Hoffert
O Roger Hollan

Olive E. Pitkin
Irving Rudman

Frederick A. Waldron

Robert S. Easton
Alice Dershimer Friedman

John J. Weber
Robert H. Wyatt

Oliver G. Stonington

David G. Borden
Robert F. Bradley

Alvin Somberg

Leland W. Jones

Igor Tamm
Patricia B. Tudbury

Raymond E. Lesser
Gamer L Lewis

Ellis J. Van Slyck
M Henry Williams, Jr.

Jane B. Cadbury

Mark McD Lindsey

Sumner Root Ziegra

Philip B Chase

James R Mason
George W. Naumburg. Jr

S. Brownlee Brinkley
Henry B. Bruyn, Jr.
Thomas L. Bucky

Hans R

Huessy

William H. Bucher
Alvin Davis
Claude W. Delia
Kent Ellis
Thomas J. Ferraro, Jr.
Daniel Fine
David A. Frucht
Carl A. Gagliardi
Melvin H. Kaplan

Leonard Rush
Elizabeth M Rush
Mary Wheatland Schley
Donald H. Schultz
Robert B. Schultz
Virginia Lee Swanson*
John H Wagner, Jr.
Doris L. Wethers
John L. Wolff
Harvey L. Young
Robert Zeppa

Sidney S. Lee
Janus C. Lindner
Margaret S. Lyman

1953
Claude Bloch

1948

Harold March

Russell J Barmett
George F. Batten

Harry L. McClelland
John H. Meyers

Edith M. Beck

Orlando J

Joseph I. Epstein

Charles E. Sherwood
Joseph R Stanton

Allyn G. Bridge

Robert T. Sceery

Robert H. Furman

Kenneth C. Steele

Richard Steele Buker, Jr.
Ruth E. Cortell

Cynia B. Shimm

Donnell Dencil Etzwiler

Jane B. Shumway

Vincent Lynn Gott

Hunter H. Comly
Norman I. Condit
Thomas D. Cook
Ronald W. Cooke

Fitzhugh C. Pannill
Richard M Peters

Victor C. Hackney

Miller

Harold D Bomstein, Jr.
William R. Chaffee
Allen Chetrick
Rex B Conn
James P Dunn

Fred M Haddad
Paul W Hughes

1946

Richard H. Cote

Martin E. Smith*

Robert Emanuel Hamlisch

Margaret J. Albrink

G. Robert Downie

Frank R Hurlbutt. Jr.
Henry II Jones

William G Banfield, Jr
Aaron T. Beck

Victor A. Drill
Elizabeth Fuller Eisner

John S. Strauss
Robert H. Sturman

A. Daniel Hauser
George L. Hoffmann

Joseph F Kell
Sawyer E. Medbury

Franklin C. Behrle
Linus W Cave

Boy Frame*
Emil Frei, 3d

Hoyt B. Miles, Jr.

Thomas J. Coleman
Robert R Cooper, Jr.

Julian Frieden

1951

Robert L. Nolan

Allan Green*

W. Robert Adams
Frank R. Allen

Warwick Potter, Jr.

Sylvia Preston Griffiths
Richard M. Hannah

Thomas T. Amatruda, Jr.
Stanley D. Ardell

Jose Ramirez-Rivera
Barbara F Rosenberg

Ross R. Harcus
Paul B Koehler

Eleanor Clay Bigley

Irwin K. Rosenberg

Charles S Judd, Jr.

Daniel X. Freedman

Benjamin F. Kitchen, Jr
James A Kleeman

Robert E. Lempke
John P Morris

Sidney S. Furst
Joseph M. Garland

Virginia C. Saft
Ora K. Smith

Vincent J. Longo

John B. Morrison

Lowell I. Goodman

Lynn Cortland Stoker
William Junior Vandervort

Richard H

Mann*

William August Wilson

Mathieu

Lewis P Rowland
Benjamin F. Rush, Jr

John T. Groel

Thomas J

Ira A. Rashkoff
Benjamin R Robinson, Jr.
Donald W. Seldin

Thomas A. Doe
Edward F. Edinger

Francis A Spellman

Gregory E Flynn

C. Wesley Watson

1944
Carl E. Andrews
John C. Coolidge
George B. Corcoran, Jr
Frank W. Countryman

Martin E. Gordon

McLane
Morton

B

Herold Griffith

Myra D. Tyler

David Purdy Holman

Class of 1950 In Memorial Fund

Richard Robert Knowles, 3d
Robert N. Melnick

Paul G. Quie

Gabriel A. Saviano*

Robert N. Hamburger
John V. Haxo

1954

Jerome H. Shapiro

Carrold K. Iverson

Frank P Berg

Lawrence G Crowley
John H. Doherty
Robert W. Frelick

Hugh J
John H

Laura W. Neville

Jessie Parkinson Spear

Robert D. King

Richard J. Bouchard

Carol Goldenthal
Charles A Hall

John F. Neville, Jr.

Anne G. St. Goar

Jocelyn S. Malkin

Francis G

Francis L. Merritt

Robert I. Hinkley
Donald W Holden

David H. Riege
Julian A. Sachs

Paul Talalay
Wallace W. Turner

George N. Bowers, Jr.
Ralph K. Campbell

Paul D Millikin

John R. Cole

Paul Woodbury Weld

Arthur C. Crovatto

W Raymond James
Ward S. Jenkins
Edith M. Jurka

Donald P. Shedd

Walter S. Morgan
Albert R Mowlem

Richard G. Sisson

1949

Richard S

Robert R. Wagner

John Weaver King

Thomas J. Whelan, Jr.

William G. Anlyan
Henry W Baird, III*

Reilly*

Frederick F. Krauskopf

Munford

Ismail Nik Nevin

John A. Gariepy
Frank L. Gruskay

DeWitt C. Baldwin, Jr.

Charles A. Nugent. Jr.
Gerard B Odell

Ronald E. Losee

1947

William D. Bevis

Arthur A. Pava

Ellen P. MacKenzie
Elias J Marsh

George R. Barnes, Jr.
Albert W Bostrom, Jr.

Jonathan S. Bishop
Phillip G. Couchman

Majic S. Potsaid
William F. Stephenson

Katharine Hawley Martin
Joseph Massaro

John E. Bowers
W. Roy Breg, Jr.

Mary Pucci Couchman
N Joel Ehrenkranz

John L. Sullivan
William Taylor*

A Reese Matteson
Paul E. Molumphy

Richard G. Britton
M Richard Carlin

Daniel W. Elliott
Gunnar O Eng

James Walker
Andrew S. Wong

Lawrence K. Pickett
Laurence G Roth

Charles R Cavanagh, Jr

Albert A. Fisk

Roland G. Chambers
Amoz I. Chemoff

Eleanora C. Gordon
Frederic W Gray
Jackson Harris

Haynes W Sheppard
Sarah P. Sherwood
Eugene Smith

Maurice L Bogdonoff
Frank A. Carone

Benjamin A. Johnson
Timothy F. Nolan, Jr.

Willard R. Centerwall
Siegried A Centerwall

Richard D. Otis
Julian I. Pichel

Frank R Coughlin, Jr.

Archie L. Dean, Jr.
Jean H. Dougherty
Owen W, Doyle

Reuben Zucker*

Franklin Harold Epstein
Edward Foord

Charles L Rennell, Jr.

1945

Richard K. Friedlander
Stephen W. Gehrs
Frank H Horton

Murray Z Rosenberg
Daniel Rudman
William H Sewell

Robert J. Kerin

Lawrence E. Shulman

Thomas S Kelly
William W. Klatchko

Don F. Kimmerling
Anton N. Lethin, Jr.
Richard P. Levy
Brock Lynch

R David Sudarsky
Martha Vaughan

N. Karle Mottet
Robert F Owen

Victor A. Machcinski
Charles L. Mache, Jr.

Russell N. Anderson
Lyal D. Asay

Thomas P. Cotter
Ldwa. t M. Daniels

1950

Robert J T. Joy
Donald S. Komfeld
Richard Lamb
Harry C. Miller. Jr.
Paul N. Neufeld

Priscilla Dienes Taft
Anthony Varjabedian
Calvin W. Woodruff

Louise H. Burr
Alice Shepard Cary

Heap, Jr

Eva H. Henriksen
Herbert S. Hurwitz

James J Nora
Lowell E. Olson

Nicholas PR. Spinelli

Frederic M. Blodgett
Richard W. Brcck

Walker R

1952

Gordon D Jensen

Edmund L Piper

Nicholas A Halasz
Robert P. Hatch

John W Arnold

William F Collins, Jr.
Bradford S. Colwell
Robert P Darrow

George Howard Allison
Albert S. Atwood

Donald D Davis
Walter J Freeman

William J. Paule
Anthony V. Piccirillo
Richard D Pullen

Richard N. deNiord, Jr.
John P Filley

Jacques M. Quen
Earl D. Rees
John Keith Rose

Richard D Floyd
Robert P Gerety

Elihu M. Schimmel
Leonard M Silverman

William Joseph Johnson

Robert L. Stein
Martin B. Vita

Sidney Nathan Paly
Robert G. Petersdorf
Leon A. Phillips
John Macklin Roberts

John W. Vosskuhler

1955
John B

Atwater

John C. Bailar, III
George E. Becker
E. Edward Bittar
* deceased

Richard I. Breuer

Theodore W. Lieberman

1960

Harry C. Briggs
Carl A. Brinkman
John P. Carey

Myron Lotz
Thomas J. Mauro, Jr.

Victor Altshul
Jack D. Barchas

Michael J. McCabe

Ormond V. Brody

Albert K. Chun-Hoon
Louis Z. Cooper

Leo T. McCallum
Andrew Joseph McGowan, Jr.

Donald P. Buebendorf
Thomas E. Carson

Edward D. Coppola*

Harold Dick Cross

John A. Merritt, Jr.

Stanley M. K. Chung

Milton Corn
Pasquale James Costa

John D’Agostino, Jr.
Thomas H. Danaher

Richard Charles Miller
Albert Muggia

Francis D. Cogliano

Michael H. Alderman
Charles B. Anderson

Robert G. Crounse

James R. Dorr

Robert S. Neuwirth

Jon E. Courtney
John M. Davis

Frederic P. Anderson
Fredric K. Cantor

John G. Daley

Edward Louis Eyerman, Jr.

David W. O'Keeffe

David Paul Dunn*

Ray Allen Carlsen

Fred Wendell Doyle
Leroy Engel

Salvatore Falbo
Harold J. Fallon, Jr.

Carol F. Phillips

Caldwell B. Esselstyn, Jr.

F. Robert Fekety, Jr.
Edwin G. Fernand

Ronald H. Fishbein
Robert E. Fishbein

David M. Pugh
William B. Radcliffe

Warren H. Fisher
Paul Jay Friedman

Thomas Newell Chase
Oliver Townsend Dann

Paul A. Rudnick

James I. Gilman

Mahlon V.R. Freeman
James Conway Garlington
Barbara W. Gibson

James R. Fitzgerald
Anthony L. Fons, 3d
Elizabeth H. Forsyth

Thomas R. Shea
Bruce H. Sklarew

Paul Gonick
Ion Gresser
John H. Hodge
D Franklin Johnson, Jr.

Douglas G. Boyden
Irwin M. Braverman
Edward Noel Brennan
Padraic Bums
Leo R. Cardillo
Nicholas A. Coassin

David E. Weaver
Warren D. Widmann
John R. Woodward

1962
Paul H. Ackerman

Arnold Joel Eisenfeld

Maxwell E. Gottesman

I. Bruce Elfenbein
John W. Foreman

Edward Lloyd Socolow

Roland H. Ingram, Jr.
Daniel M. Jones

Leroy A. Forstrom
Stephen John Flicker

Edward O. Fox

Raymond W. Tbmer

William S. Kaden

Anthony V. Furano

Gary A. Fry

Margaret Smith Wenzel

John N. German

Robert H. Glass

Joseph P. Wierzbinski, 3d
John Patrick Wood

Eric P. Kindwall
Susan T. Kleeman

Harry O. Kendall

Anne H. Good
Jack Peter Green

David R. Kessler
Robert A. Kramer

Gilbert F. Hogan
Warren R. Johnson

James Lum

Richard Lee Kahler

Joseph S. McGuire, Jr.

Pauline B. Wood

Thomas P. Kugelman
Edward R. Lang

John T. Harrington
Frank R. Hartman

Edward Longo

Patricia C. Hassakis
J. Dale Howe
Gary Jacobson

1959

Eugene G. McCarthy, Jr.

Scott Ingram Allen
Carol J. Amick

Donald L. Miller

Walter Watson Kamey

Richard G. Morrill

Robert M. Amick

Robert C. Nodine

Stanley E. Kilty
William L. Kissick

Allan W. Newcomb

Glenn L. Kelly
David E. Knoop

Gloria C. Onque

Willard A. Krehl

Asa Barnes, Jr.

Buford L. Nichols, Jr.

John P. Lynch

John C. Pace, Jr.
Robert H. Peters, Jr.

Jack Levin

Francis A. Beer
Jack F. Bowers

J. Thomas Okin
Jerrold M. Post

Carter L. Marshall

Gregory Peterson, Jr.

Mark D. Marshall
Howard A. Minners

William C. Butterfield

Nancy Rolick Powell

David J. McConnell

Charles H. Robinson, Jr.

William A. Miller
Malcolm S. Mitchell

Robert A. Reich
Paul J. Robinson

Bennett F. Markel

Stanley E. Matyszewski

Robert K. Modlin

Med. Class Of 1959
Edwin M. Clayton

F. Brantley Scott, Jr.

Hugh Lamson Moffet

Sidney M. Cohen

Albert Matthew Ross
Daniel J. Rubin

Clement B. Sledge
Phillip W. Smith

Herbert A. Newman

Martin Colodzin
Lyall S. Crary, Jr.

John J. Schrogie
Ross L. Snyder, Jr.

Ronald C. De Conti

Fred Stargardter

James A E Spencer

Gerald Fenichel
Robert L. Fisher

Robert C. Wallach
May Yung-Fun Woo Wang

Nancy Ann Staley

Paul Jay Friedman

Ronald A. Yankee

Larry Lee Stewart
H. Oliver Stoutland
Seth Thaler

Joseph S. Pagano
Raymond E. Phillips

1956

Clifford B. Reifler

Levon Z. Boyajian

Arnold Schoolman
Kenneth A. Simon

Rosalie A. Burns

David D. Nicholas
A. Richard Pschirrer
David Seil

Joseph C. Cerny
Edwin L. Child

Charles A. Slanetz, Jr.

Robert J. Gonyea
Gerald B. Gordon

Class of I960

Gilbert B. Solitare

Chandler Dawson

Robert W. Southworth

W. Keith Hadley

1961

S. Evans Downing

Donald C. Stahl
Arthur Taub

H. Rodney Hartmann

Kenneth A. Arndt

William H. Heydom Me, Usa

Frank H. Baker

1963

Romeo Vidone
William J. Waskowitz

C. Richard Hinckley
Leonard Inker

Albert A. Bechtoldt, Jr.

Arthur Howard Ackerman

Herbert Winston
James G. Zimmer

John J. Jasaitis

Arne G. Haavik

1958

Armen Charles Haig
John Herd Hart

George K. Aghajanian
Don P. Amren

David W. Kingsbury
Myron S.S. Lee

Robert L. Hill

John C. Marsh
Brian J. McGrath

T. Wayne Downey

William H. Hindle

Joseph E. Angelo
John P. Amot

John E. Fenn

Dudley Seth Danoff
Andrew Edin

Marie-Louise T. Johnson
George T. Kammerer

Peter Alfred Benson
Gerard N. Burrow

James A. O’
Robert H. Ostberg

Edward C. Gilbert
Robert Sterling Gillcash

David H. Fram

Jerome O. Klein
William V. Lewit

Benjamin Bursten
David A. Carlson

Nicholas M. Passarelli

David D. Griffith

William T. Friedewald

Charles A. Phillips

Preston C. Manning
Robert McDivitt
Dwight F. Miller

John A. Carlston

Lincoln T. Potter
James D. Prokop

Walter J. Hierholzer, Jr.
Richard L. Keefe

David H. Fulmer
Alexander R. Gaudio

Robert Isaac Levy

Vincent F. Geremia, Jr.

Norman F. Moon
Donald J. Nalebuff

Robert J. Donohue, Jr.
Lawrence Dubin
Donald A. Duncan

Hugh James Lurie
Joseph Richard Lusby

Lee D. Goldberg
Peter B. Gregory

Sally Lockwood Marchesi
Vincent T. Marchesi

Brian C. Judd
Harold P. Kaplan

David B. Matloff

Constantine D. Kyropoulos

Sanford P. Solomon

Anoush Miridjanian
Richard Allen Moore

Edward C. Larkin
William B. Lehmann

Gene W. Spector
James J. Stagnone

Norman I. Moss
Roland D. Paegle

Lisa A. Steiner
Lois Withrow Tice*

John Curtis Parker

Marcia Kraft Goin

Daniel R. Silbert

James Greenwald
Charles A. Hall, Jr.

Leo H. Von Euler
Muriel D. Wolf

Roy E. Ronke, Jr.
Shaun J. Ruddy

1957

Stanley Harris

Class of 1959

Donald Agostinelli
Joseph S. Amenta
Jack Norman Blechner

Michael Kashgarian
Haskins K. Kashima
Jay Ward Kislak

Stanley G. Schade
Robert N. Taub

Mitchell Edson
Gilbert M. Eisner
Thomas F. Ferris
John H. Gardner, III
Sumner Gochberg
George E. Green

William M. Narva
A. Frederick North, Jr.

Joseph James Cillo
Robert V. Diserens

Joel C. Eberlin

David A. Page
George W. Paulson

Philip R. Fazzone
Michael E. Fishman

Robert Lee Scheig

Peter A. Flynn

James Scheuer

Raymond A. Gaito
John C. Gallagher

Edward C. Senay
Benjamin A. Shaver, Jr.

* deceased

Edvardas Kaminskas
Herbert J. Kaufmann, Jr.

Kathryn Huxtable Lewis

James R. Ralph
David Pardee Reed
Joseph D. Saccio
Constantine J. Sakles
Marc D. Schwartz
Owen A. Shteir

Sherwood Waldron, Jr.
Stewart R. Wright

Robert S. Briggs

Miguel R. Alonso

David William Brook
Orson R. Dee

V. Richard Back
Charles W. Carl, Jr.

Paul David Deiter

Theodore J. Chu

Ralph J. DePonte

Gordon S. Cohen
John E. Conte, Jr.

Ronald A. Dierwechter
Jon Dudley Dorman

William M. Rogoway

Hugh C. Thompson, III
Franklin H. Top, Jr.

James S. Dalsimer

B. Allen Flaxman

Peter B. Livingston*
Craig H. Llewellyn
Edward G. Lund, Jr.
Robert H. Margulis
Herbert Meltzer
Robert E. Mueller
Sheldon R. Pinnell
Jay M. Pomerantz
Lee Bland Talner
Thomas W. Tillack

45

Walter W. Noll

Peter N. Herbert

1969

Robert M. Rosa

A. Lawrence Ossias
John A. Parrish
Robert L. Pickens

George P Herr
David L. Ingram
Mary Jurbala

Charles S. Angell

Joel F. Rubinstein
Dennis E. Shield
Stuart S. Shorr

Alfred J. Wise

Alan N. Rachleff
Gene A Robinson

J. Robert Kirkwood
Melvyn Korobkin

Robert E. Belliveau
David A. Berkowitz

1964

John F. Schilke
Margretta Ann Reed Seashore

Anthony P Lovell

N. Roger Cooke

Ralph G. Maurer
Stephen W. Miller

Leo M. Cooney, Jr
Richard J Daly

Joseph L. Morris

Charles A. Dinarello

Leland S. Berger

Charles J. Semonsky
David M. Shames

Jennifer Robinson Niebyl

Ralph J. Falkenstein

Philip Blume

David P. Simmons

Gary S. Farnham

Anthony J. Bravo
Robert M. Briggs

Harlan Spitz
Alan William Stone

John O. Pastore
William E. Perkins

Thomas A. Cardella
Joseph F J Curi
Mary V. Digangi

Robert G. Weiner
Bert Yuan-Shu Wong

Robert I Roy
Jonathan L. Saveli

Peter V. Tishler
Lawrence Tremonti
Peter G. Weiner
Jerome Allen Winer

William A. Alonso
Berton W. Ashman
Sidney M. Baker

John H. Seashore

Brian F. Rigney

David G. Ansel
David W. Barry

Lesley Forman Fishelman
Steven A. Frankel
William H. Frazier

Don H. Smith
Richard Jay Solomon
Richard A. St Onge
Daniel A. Symonds
Ray W. Tripp, III
Brian Weiss
C. Bruce Wenger
Joellen Weme
Daniel Wuensch
Karl O. Wustrack

Anna S. Gail
Royal J. Gay

Judith L. Bader

Sander G. Genser

Gregory W. Bartha

1971

Beverly Ann Dudek

1966

Alfred Q Scheuer
Stephen C. Schimpff

Alfonso Esguerra
Norman C. Fost

Benjamin F. Balme

Sidney C. Smith, Jr.

Robert O. Gordon

Michael J

John D. Baxter

Helen L. Smits

Thomas C. Howard

Peter A. Gross
John FB Haney

Patricia Bazemore
Robert P Bazemore

Lewis S. Solomon

Lee M. Jampol
Joel Mark Kaufman

Laurie J Bleicher
Marian H Block

Gene 1 Higashi

Frank C. Bell

Lawrence Horwitz
William E. Knight

Philip Bernstein

Robert S. Steinberg
Richard B Swett
M. David Tilson, III
Karen H. Toker

Lewis Landsberg

James Edward Brown
Eugene Patrick Cassidy

Richard V. Lee

Joseph A. Donadio

Robert A. Vogel
Robert A. Vollero

Thomas L. Lentz

Robert E. Dragon

Joseph F. Walter

Paul H Kelker
John J

Kelly, Jr.

Rowena Korobkin
Stephen Krant

Beierle

Bruce Block
Willard Cates, Jr.
John L. Cieply
Frederick L. Cohn
Andrew D. Cook

Lynn G. Lagerquist, Jr.

Michael Cynamon
John S. Ebersole

David B Leof

Marvin A. Eisengart

Martin Wand

Michael R Liebowitz
Robert L. Marier

James S. Levine
Paul R. Lightfoot, Jr.

Jared M. Emery
Robert N. Frank

Redford B Williams, Jr.

Paul A. Markey

Robert J. Winer

Arnold F. Mazur

Fred Finkelman

Richard Murray Linburg
Robert W. Lyons

Peter D Gibbons

Robert S. K. Young

Thomas F. Minehan

John W. Foster, Jr.

Jeffrey B Gluckman
Stanley I Greenspan

Ihor George Zachary
Peter M Zeman

Bruce K. Nagle

Allan W. Graham

William F Matched

Lionel M. Nelson

Robert L. Mitchell
Alan H. Morris

J. McLeod Griffiss
Robert A. Gunn

Michael J. Hart
William W. Hay, Jr.

1968

James J. Murphy

Stuart T. Hauser

Philip L. Barry

Donald A. O'Kieffe
William B. Pratt

Jay G. Hayden

Grace Jordison Boxer

Mary Alice Houghton

Joseph M. Rochford

Jack S. Rice, Jr

Dennis J. Rudzinski

William J

Stanley J. Rosenberg

Richard J Howard
Bruce W. Jackson

Donald R. Coustan
John Demarchi

William L. Krinsky
David H Lippman

David J. Sahn

Samuel S. Masters

Jonathan J

Gordon R. Kelly

Edward M. Druy
Barbara Mayer Egbert

Adrian M. Schnall

Alan G

David J. Schulak

John C. Mills
Patrick T. Minihan

Russ

Nancy Olmsted
Deborah A. Putnam

Norman Seher
Robert L Shelton

Stuart M Kotler
Wilbur L. Kukes

William F. Flynn

Diane Shrier

Henry B Mann

Richard A. Getnick

Donald G. Skinner

John Stephens Melish

Mark Gilbert Grand

A Thomas Snoke

Marian Matheke Melish

Lyall C. Stilp, II
Signd L Tishler

Harold Mellin

Leonard Grauer
Ralph S. Greco

Charles Vogel
Stephen Waltman
Oscar Wand

Finesilver

Robert J Walat
Stephen R Webb

Harry S Holcomb, III

1970

Thomas R. Johnson

Elissa B. Arons
William Romney Burke

1965

Mark Snider
Gary L Townsend
Jon S. Way land
Joan T. Wayland

Marc E Lippman
Frank E. Lucente

Arne S. Youngberg

Mangione

Richard Albert Moggio
Robert Park
John A. Patti
Barry Bruce Perlman
Michael C. Piercey
Anthony V. Proto

Hill, II

Thomas T. Aoki
Susan A. Aoki

Barbara K. Kinder

Stuart B

William D

Peterson

N. Timothy Jette

Steven C. White

John R

Daniel E. Keim
Jeffrey S. Lee

Paul Balter
Victor J Burner

Gerald J. Smallberg
Michael S. Toren

Eli H. Newberger
Edward J O'Keefe
Joel Singer
James D. Slavin, Jr.

John H.M. Austin

N. Burgess Record, Jr.
Joseph D. Robinson

Leonard I. Eisenfeld
Harvey Fern bach

Henry Chessin
Michael J. Chusid

Phillips

Barry S. Rand
David M. Rinzler
James P. Southwick
Jonathan W. Stewart

Donald O Lyman

C Norman Coleman
James E. De Lano, Jr.

Richard D. Travers
Yvonne E. Vaucher

Stephen I

Marglin

Margaret W DeLano

Robert B. Vranian

Rodrigo Martinez
Harmon Michelson

W Montague Downs

Albert Carl Weihl

Thomas B Caldwell. Ill
Grant L. Christian
Robert M. Cohn

1967

David P Millet!

Jonathan Ecker
Robert Alan Epstein

Daniel L. Arons
Arthur L. Beaudet

Richard P. Mills
Richard M. Morehead, Jr.

Bruce A. Fabric
Thomas H. Gouge

Robert D. Arbeit

Gregory A. Culley

Daniel J. Booser

John A. Ogden

Marcus W Hedgcock, Jr.

Michael J. Cummings
David S. Fedson

Gary C. Burget
William T Cave, Jr.

James W. Ogilvie
Margot Onek

Paul C. Hessler
Jay H Hoofnagle

Michael A. Catalano
Alan J Clark

Robert I. Finkel
Frank J. Grady

Mary Williams Clark

Henry F. Panek

Cynthia Rapp Curry

Jackson B E Pickett, III
Charles T. Post, Jr.

Robert E. Humphreys
Jonathan D Katz

Robert Andre Gryboski
James K. Gude
Reid R Heffner, Jr.
David A. Hill
Carl E. Hunt
Virginia Burnham Johnson
Ronald J. Karpick
Mohandas M. Kini
Richard J. Kozera
David B. Leof
Sandra Chook Levine
Philip D Manfrcdi

Marian C. Davidson
James Lucius Davis, III
James J Dineen
Alexander F. Dora
James M. Dowaliby, II
John A. Drews
Peter R. Egbert
Dennis Grant Egnatz
Herbert W, Fclscnfeld
Melvin Victor Goldblat
Richard J. Hart, Jr.
Richard L. Hcppner

1972
R. Michael Buckley, Jr.

Philip L. Cohen
Leonard H. Cohen

Gerard T Kennealey

Gloria Cummings*
Robert F. Deblasi

Joseph L. Renda
Gordon H Sasaki

William G. Koehne
Mark A. Korsten

Norman M. Dinerman
William H Druckemiller, Jr.

Jacob J. Schlesinger
Frederick C. Sherman
Elizabeth M. Short

Thomas L. Lewis
Robert B. Litman

William F. Duke
M Felix Freshwater

Howard W Siegel

Anne W. Lucky
Roger A. Mason

John P Fulkerson
Robert B Geehr

David A. Soskis
Gerald L. Springer
Lee H Strohl

Leonard M. Milstone
James R Missett
William K Mueller

Dorothy M. Gohdes
Andrew E. Hoover

Edmund C. Tortolani. Jr
Per Henrik Wickstrom

John J. O’Brien
W. Scott Peterson

Thomas L. Horn
Vernon H Humbert, Jr.
Fred Hyde

* deceased

Anthony H. Jackson
Jesse B. Jupiter

Irl L. Extein

Richard D Bucholz

Pamela E. Smith

1983

Reginald K. Franklin

Stuart Brian Dubin

John Taylor Adams*

Frank M. Kahr
Roy A. Kaplan

Allan B. Friedland

James A Fox
Julia B. Frank

Thomas Trumble
John T. Woo
Jeffrey Work

Elena Citkowitz
Dianne Edgar

1980

David C. Helfgott
William Kadish

Donald L. Kent

Michael A. Gerber
Harvey Gerhard

David L. Kneapler
Philip W. Lebowitz

David Grant
Robert F. Hempton

Jeffrey Neal Hausfeld
Bruce L. Inms

Theodore M. Levin
Stephen A. Liebhaber

Ancil A. Jones

Karen G. Kelly
Howard K. Koh

Paul A. Lucky

Robert M. Kolodner
Leon F. Kraft

Harry L. Malech
Jeffrey S. Menkes
Jerome H. Meyer
Jorge A. Motta
James A. Nathanson
Thomas H. Ogden

Robert W. Hand
David E. Adelberg
Eduardo Alfonso
Seth Leo Alper

Robert E. Bookstein

Ana Maria Lamas

Frederick R. Aronson

Laurie Margolies
John H. Neal

Saul Lande

David J. Kreis, Jr
Margaret S. McKenna

David Allen August

Dan A. Oren

Olusegun O. Lawoyin

Robert J. Mitchell

Richard C. Pasternak
Andrew L. Ries

Alan S. Penziner

Jay M. Baraban
Patricia Church Brown

Augusta S. Roth
Moshe Rubin, M.D.

Michael W. Champeau

Daniel Paul Sabbeth

Ricky M. Schneider

Michael M. Chang
Thomas F. Deering

David E. Schwartz
Philip M. Spiro

David Z. Ritvo
Amy S. Schechter
Robert J. Schechter

Theodore M. Pitts
Steven J. Scheinman

Edward J. Olinger
Peter J. Panzarino, Jr.

James A. Strom

Susan Bromberg Schneider
Simeon A. Schwartz

Jeffrey Neil Dornbusch
Forrest John Doud

1984

Louis Reik, Jr.

George H. Talbot

Mark S. Smith

William L. Risser

Carol C. Teitz

Gail M. Sullivan

Todd J. Garvin
Marc F. Glickstein

Charles S. Abrams
Martha Ray Arden

Richard S. Robbins
David H. Romond
Philip M. Rothfeld

John Jones Thompson

Phyllis A. Taufield

David Jay Goldberg
Nancy S. Goldman

David I. Astrachan
John F. Babich

1975

Ronald J. Vender
Steven L. Warsof

Maria White Greenwald

Leonard Bell

Charles F. Scholhamer, Jr.

Ralph E. Binder

John S. Smolowe

Gary I. Greenwald

Barbara Ann Coda

William S. Bush

John E. Whitcomb
J. Douglas White

Barry M. Kacinski

Joseph G. DeSantis

Frederick D. Stock well

Chau V. Dang

Daniel Wohlgelemter

Lawrence P. Temkin
Philip J. Weyman

Stanley W. Gale

Theodore W. Marcy
Cesar R. Molina

Conrad Jeffrey Duncan
David A. Frank
Kim A. Gutner

Michael W. Yogman
Steven M. Zeldis

1973
David A. Adler
Marvin M. Chassin

James P. Grabman
Carol L. Kandall

1978

Steven Ira Rosenfeld

Michael J. Anderson

Jane G. Schweitzer

Bruce G. Haffty

Kevin Kane

Richard J. Baron

Leslie W. Sojka

Jeffrey N. Katz

Richard J. Loewenstein
Bruce B. McLucas

Joann N. Bodurtha

Marcia R. Taylor

Michel Kliot

Hyman J

Duke E. Cameron
Howard M. Chase

1981

Daniel M. Kolansky
Jay R Kostman

Cynthia B. Aten

Richard L. Leff

Louann Brizendine
Sherri L. Brown

Lynn B. Mehlman

Milstein

Booker T. Bush, Jr.

Joseph M. Connors

Mary Jane Minkin
Edwin G. Olson

David L. Coulter

George J. Pardos

Eugene Glenn Fong
Stuart M. Forman

Christopher M. Doran

Daniel J Passeri
Vivian Reznik

Arthur M. Gershkoff
Linda J. Hall

Stephen Wilson Burgos

William A

Patricia A. Burke

Philip J. Rich

Robert Hershfield
Robert L. Kraft

Paul B. Rothman
Mark Stein

Jane H. Ferguson
Richard J. Fingeroth

Steven A. Porcelli
Rios

Robert A. Florin

Salvatore V. Romano, Jr.

Lee Goldman
Gary V. Gordon

Fred P Rosenfelt
Richard L. Roth

Michael R Lemer

Christine M. Duranceau, PhD
Paula M. Fracasso
Judy E. Garber

Kenneth L. Marek

Robert S. Goldman

Gary T. Grimes

Robert S. Sandler
Steven A. Schwartz

Jose Luis Martinez
Seth M. Powsner

Laurie J. Gordon

1985

Scott A. Hundahl

Michael Behrman

Barbara J. Stoll

Donald C. Simonson
Thomas Joseph Smith

Elliot Lach
Mary Romig McKinstry

Barry D. Bergquist
Stafford R. Broumand

Douglas R Zusman

Rafael J. Tavares

Robert M. Milstein

Bryan DeSouza

Richard L. Mogerman

Harold R. Mancusi-Ungaro, Jr.

1976

Caroline R. Taylor
Marcia J. Wade

Barbara Guillette
Robert S.D. Higgins

Mark G F McCormick
John F. McQuade, III
Claes M. Nilsson

Sarah S. Auchincloss

Sharon R. Weinstein

Peter B. Bitterman
Sharon L. Bonney

David L. Wessel
Susan Wong

David E. Peach

Roger A

David Pickar
John W. Popp, Jr.

Randall D. Cebul
Helen Y. Y. Chang

Neal Handel
Wanda D. Huff
David C. Johnson
Andrew G. Kadar

Henry S. Willner

Michael S. Kramer

Boshes

Charles F. Reynolds, III

Pauline Y. Chao

James S. Robertson
Thomas J Romano

John D. Clemens

Harry S. Romanowitz
Jerrold F. Rosenbaum
Joseph F. Simeone
Robert A. Sirota
John R. Stratton
James F. Sullivan
Thomas F. Sweeney
Robert J. Ursano
Christine A. Walsh
Richard S.K. Young

* deceased

Nancy Berliner
David A. Brenner

David August
Sylvia R. Beck

Shirley J. Lee
Ted W. Love
Anthony Marks

Jon Nakamoto
Robert D. Needlman

Glenn A. Gorlitsky
Joel Kabak

Joel I. Franck

Daphne Hsu
Rise Maura Jampel

Leslye C Pennypacker
Samuel Richard Pesin

Norman V. Kohn

John Jay Gargus, PhD
David E. Golan

Henry Jampel

Ellen C. Rieur

Patricia Kellner
Kathleen Anne Nolan

Richard A. Ruiz
Greg A. Sachs

Rose Hannah Goldman

William J. Lederer
William K. Levy
Paul R. Ramirez

J. Kenneth Burkus
Stuart L. Bursten

1982

Susan Korrick

Muriel Cyrus

Lloyd Friedman

Bruce Halperin
Edward C. Halperin
Marc Hellerstein
Jeffrey L. Kaine

Joyce A. O’Shaughnessy
Dan B Odenheimer

Michael K. Lindsay

Class of 1985

Shirley McCarthy
Thomas R. Moore

Robert J. Rizzo
Lewis P. Rubin
William M. Sikov

David E. Ness

Lynn T. Tanoue

Catharine Ann Arnold

Peter M. Ting

Barbara Ann Peters

John C. Wiles
Jerome B. Zeldis

Jean Rosenthal
Lynn K. Rudich
Gary L. Schaer

Jeffrey Tepler
Albert L. Ungricht

Eric F. Bernstein
Samir M. Bhatt

David A. White
Stephanie Wolf-Rosenblum

Gerard M. Doherty

Mark C. Ruchman
Lawrence E. Samelson
Bonita F. Stanton
Jacob E. Tauber
Robert F. Taylor

Vincent A. Di Maria

1979

Stuart Neal Isaacs
Michael A. Johnson

Jed B. Gorlin
Jessica Herzstein

Stephen B. Arnold
Irving M. Asher

Bert D. Collier, Jr.
Paul David

Dovelet Shashou
Martin H. Teicher

Marie Hobart

Isabel Cunningham
John A. Fox

Geoffrey Etherington
Ira H. Gewolb

Charles R. Swenson

Neil Blumberg
Peter J. Buchin

Barbara A. Roach
Susan C. Schachner

Zacks

John Jerome Merendino
Elizabeth G. Moy

1974

Leonard I. Banco
Douglas A. Berv

Robert B. Portney

Fong Wang
Charles M

1977

Eric A. Schwartz

Michael G. Adelberg
John J. Boronow

Cynthia Anne Sherman
Alfred Windsor Sloan

Carrie A. Redlich

Charles D Wright

Fred Santoro
Joshua D. Schor
Louis J. Tesoro

1986

Amanda B. Dill
Jay Gates
Michael Grossbard
Gary Hirshfield

47

Morris A. Flaum

Pradip M. Pathare

Parents and Friends

Gregory J. Orloff
D. Bradford Reich
Gary L. Shapira
Andrew W. Steele

Bruce T. Fletcher
John N. Forrest, Jr

Gordon K. Phillips
Emanuel T. Phillips

Mr. Irving Abelow

Daniel J. Friedenson
Gary E. Friedlaender

Jerold J. Principato
Erwin R. Rabin

Mr Myles H. Adelman

Dr. Joseph Schlesinger
Arthur A. Shachner

Kurt I Altmann

Mohan N. Shrestha

Eric P. Suan
Steven Waisbren

Norman H. Gahm

Edward L. Racek

George O. Gelinas, Jr.
David M. Gershenson

Gilbert A. Ratcliff

Nancy Andreoni
Stanley August

Mr. Stanley M. Silverberg
Mr. & Mrs. Philip Soskis

Mr. Robert August

Mr. Barry S. Spector

Former House Officers

V. Philip Glassman

N

Leonard Gold
Barry Goldberg

Manuel B

Litchman

Erick Albert

Neil S. Alex
Michael Francis Angel

Nelson H. Goldberg
John W. Goldkrand

Ranjit Rath
Stephen Rawe

Mr. Jacques Scharoun

Peter A. Rice

Drs. John and Marie Babich
Stuart M. Berkman

Jeffrey P. Robbins

Malcolm Brochin

Claude Roge
Jean F. Rogier

Mr. Hormoz K. Broumand
Harriet Farnsworth Brown*
Mr. Harold Burg

Prof. & Mr. Lubert Stryer

Thomas M. Tierney
T. Beers Townsend*
Mr. Zaccheans O. Ukomadu
Mrs. Albina K. Vazquez

Peter A. Goodhue
Isaac Goodrich

Leon E. Rosenberg
Stephen A. Ross

John M. A versa

Richard Reed Gramse
Willard F. Greenwald

Ms. Minnie R. Cartwright
Mr. & Mrs. Abe Cazen

Allen Rossman, III

Ms. Betty Chelmow

Adel H

Gordon W. Grundy

David R Rubinow

Abel A. Applebaum
Alan Milford Aron
Harold Lewis Atkins
Ayoub

Henry S. Sanematsu

Fred M

Rosenbloom

Mrs. Gertrude Spinelli*
Kenneth Alan Stein
Argyle Stoute
Mr. Malcolm H. Stull
Mrs. Leo Teitz

Robert G. Bachand

Joseph Guaraldo

Mary Sanders

Mr. & Mrs. Richard S. Childs
Mr. Howard Chin

Ronald J Bailey
Arnold M. Baskin

Hedda Ann Litowitz Haning
Donald H. Harter

Michael Saruk

Mr. Henry A. Christopher

Sheldon K. Schiff

Mrs. Susi Chung

Mr. & Mrs. Milton Weinberg
Jack Weingold

Richard Bass
Carl Bennett Bean

Mary M Herman

Lowell E. Schnipper

Stanley Hersh

Robert Schnurr

Mr. & Mrs. Sidney J. Cohen
Mr. Fred C. Colin

James Wells*
Marion W. West

Gerald A. Belkin

A

Carl I. Schoenberger

Mrs. Yvonne M. Conrad

Mr. & Mrs. Herman H. Zusman

Gregory Kent Bergey

Judith Hochstadt

Willibald H. Conzen

Larry Berte
Kenneth R Berv

Clifford L. Hoyle
David Smith Hubbell

Marianne Ida Schuelein
Louis N. Scotti
James Thomas Sehn

Mrs. Judy Coppola
Anthony Deluca*

Mary C Bibro
Ralph Daniel Bien

Eric A. Hyson

Richard Alan Selzer

Mr. Edward J. Dilisio

Henry G. Jarecki

Howard Senter

Mr. Arthur E. Dolnansky

Richard A. Blasband
William K Boss, Jr.

Rollin M

Edwin C. Sevennghaus
Carlton C. Sexton

Mr. & Mrs. Kenneth T Doran
William G. Dyess

Douglas Heymann

Robert M

Johnson
Johnston

Laurence A Boxer
James L. Boyer
Hubert B Bradbum, Jr

Clifford Joseph

Ezra A. Sharp

Gerald Wilfred Friedland
Mr. Yuan C. Fu

Alan L Breed

Lee D Katz

Gary R. Siegel

Mrs. Ana M. Garcia

Steven A. Brody
Thomas M. Brown, Jr

Bernard L. Kaye

Joel Silidker

David J. Keller

Dr. Jose M. Garcia-Madrid
William J. German*

Robert A. Buccino

David M Kessner
Stephen King

Frederic N. Silverman
Robert E. Silverman

Daniel J. Buchalter

Juliana Haeng-Cha Kang
Jill P Karpel

Thomas E. Shaffer
Daniel W. Shapiro

Mr. Max Finkelman

Mrs. June Girard

Thomas N. Byrne
William J. Callahan

Samuel C. Klagsbrun

Paul I. Silverstein
Earl J. Simburg

Lawrence E. Klein

Domenick Sisto

Mrs. Harold Grant

Dennis J. Card

E. Larry Knight

Richard I. Staiman

Dr. Myron Greengold

Victor Carpiniello

Richard Knobelman
Thomas J. Koontz

Sally K. Stansfield

Richard S. Casden

Mrs. Barbara J. Guillette
Mr. Kenneth H. Gutner

J Richard Casuccio
John C. Cate, IV

Joel C. Labow

Eugene Kuchner

Joseph B Chandler

Randi Leavitt

Whei C. Chang
Girard A. Chapnick

Samuel M. Lemer
Stanley B Levine

Richard Allen Chase

Arthur L. Levy

Martin S. Chattman
Chang Song Choi

Joseph W. Lewis, Jr.
Steven Macht
Abraham Mandel

Michael Chun
Leo J. Clark
Lawrence S. Cohen
Ian M. Cohen
David L. Copen
Sidney L. Cramer

Edward J

Man well

Kim Margolin
Stephen Mariani
Joan L. Martinez

Don Starr
John G. Steciw

Dr Herbert I. Goldman
William & Isabel Goodrich

Frederick W. Heilman

Sturla Stefansson
Elsa L. Stone

Carl Hirshfield
Mr. Norman J. Hobbin

Fred Leslie Strieker
Craig Summers
Herbert Tabor

Jacques Hussussian

Mrs. Gloria F. Holmes

I mad F. Tabry

Dr. & Mrs. Robert Karol
John F. Keaney

Troy L. Thompson, II
Daniel W. VanHeeckeren

Kenneth P Kinney

Martyn A. Vickers, Jr.
Milton Virshup
E Maurice Wakeman
Thomas A Warthin

Mrs. Juanita Kessler
Mr. Boris Kliot
Mr. T. D. Lee, Jr.
Mrs. Amy G. Lloyd
Leighmin James Lu

James E. Watson

Mrs. Virginia G. Mannick

Robert E. Crootof

Frank Masino
Richard J Maunder

Alan Weinberg

F. Mitchell Cummins

Pamela M

Mr. James C. Marsters
Mr Shizuo Matsui

Martin Thomas Davis
Daniel M. Divack

John P McGovern

Lionelle Wells
Ssu I. Weng

Donald S. Dock
Richard K. Donabedian
John W Drake
Alan Dror
William R Drucker
Patrick R. Duffy, Jr.
Frank H. Duffy
Tom W. Duke
Israel Dvorctzky
Marlene R. Eckstein
Stephen A. Edelstein
Lawrence B. Eisenberg
Malcolm Mitchell Ellison
Walter Ettinger
Charles Farrow
Alvan R. Feinstein
I chard Webster Finner

McBogg

Thalia Mesologites
Gerald L. Meyers
John H Monroe
Patrick E. Moriarty
Lloyd A. Moriber
Lewis B Morrow
John Moses
Michael H Moses
Hans C. Muechler
Seymour Cy Nash
George Nichols
Gwendolyn B. Nichols
Richard A. Norton
William L. Nyhan
Joseph Manuel Ortiz
Raymond L. Osborne, Jr
Robert L. Paltzik
Gary R. Pasternack

Mr Earl M. McChesney

Herbert Allan Wenner

Harry Meisels

George Wharton

Myron Roy Melamed
Mr Arthur P Miller
Pedro Miro

Robert R White, 3d
Robert J. Williamson
Suna Woods

Mr. Harold Weinberg

Mr. & Mrs. Victor M. Newman
Mr. Marshall D. Newton

Eiji Yanagisawa
Michael Yaros
Robert C. Young

Dr William G. O
Jon Ogland

Richard Walter Zimmerman

Mr. & Mrs. Louis Parent

Marvin Paul Zimmerman
Lawrence H Zingesser

Mr. Samuel Perlman
Mr Morris Price

Louis Zinterhofer

Mr. Edward A. Quattrocki
R. Donald Reich
Mrs. Yolanda Rivero
Mrs. Yolanda Rivero
Mr. Joel G. Roth
Dr. & Mrs. Carl E. Rothschild
Harold & Frances Sampson

* deceased

Contributors to the Public Health Alumni Fund 1986-1987
1921
Ira V. Hiscock*
1926
John J. Batchelor
1929
Gertrude S. Boyle
1930
Ruth E. Grout
1933
Miriam M. Campbell
Elizabeth Murphy
Eunice Nickerson Tyler
1934
Amy H. Hunter-Wilson
Iwao M. Moriyama
1935
Franklin M. Foote
Almeda King
1936
M. Allen Pond
1937
Lidie V. Dyer
Howard West
William R. Willard
1938
Willard H. Boynton
Richard K C Lee
Katharine Hawley Martin
Jean H. Nelbach
1939
Carl I. Cohen
James C. Hart*
1940
Elizabeth H. Pitney
1940
Meyer J. Plishner*
1941
Roslyn L. MacNish
Marion Redmond
Alexander Witkow
1942
Leonard Parente
Arthur B. Robins
Charles D. Spangler
1943
Carolyn S. Koffler
Eric W. Mood
Miriam H. Rohde
Jane L. White
Muriel Bliss Wilbur*
1944
Jean F. Heston
Jane Y. Parker
1945
Roslyn R. Bilford
Naomi Barer Golden
Joe Bales Graber
Lois M. Jund

deceased

1946
Dorothy B. Hamilton
D. Patricia Nelson
1947
Anne E. Fulton
Lillian L. Konick
Raymond W. Leonard
Edna Miller
Paul A. Pamplona
Oscar Sussman
Samuel Zibit
1948
John B. Dibeler
Mary L. Ellis
Mary Margaret Fitzgerald
Samuel S. Herman
Richard E. Johnson
Dorothea S. LaBelle
Hiram Sibley
1949
Paul Anton
Edgar L. Geibel
Eleanor P. Kostant
Hilda H. Kroeger
Edmund R. Mattos
William B. Parsons
Elizabeth D. Robinton
Mary C. Springer
1950
Henry G. Brickman
Hilda B. Carr
Helen P. Cleary
Austin J. Evans
Jerome M. Glassman
Dorothy R. Granoff
Martha P. Jayne
Frances K. Reynolds
Nathan M. Simon
1951
Clarissa E. Boyd
Robert L. Johnson
Leonard F. Menczer
Emi T. Rausch
Jessie Parkinson Spear
Angelica Z. Syseskey
Elizabeth Ulrich Throm
Walter Wenkert
John J. Zugich
1952
Cahit H. Corbacioglu
Mary M. Del Piero
Howard Dunphy
Joanna Adele Henry
Malcolm C. Hope
Charles Holway Lawrance
Sidney S. Lee
Helen Kardys Loria
Yolande F. Lyon
Richard B. Ogrean
Anne Barlow Ramsay
BrenaB Wolff
1953
Jeanette Averill
Harold Robert Bemshock
Graydon Dorsch
William H. Hermann
Fraser M. Mooney
Laurence K. Rainsford
Milton H. Sisselman
Constance B. Thomas

1954
Donald R. Cowan
Calvin P. Hatcher
Ruth M. Taber
1955
Constance T. Beemer
Amy L. Cawley
Evelyn S. Farnsworth
Morris London
Mary Me C. Mogan
Frances R. Ogasawara
Gerald Rosenblatt
Daniel E. Ross
1956
David D. Boyd
Marvin H. Burton
Kathleen H. Howe
Paul C. Kaufman
John F. Mullett
Julia R. Nole
Mary K. Ochiai
Alice M. Wagner
1957
William A. Clermont
Edward R. DeLouise
Sheldon Selig King
Jerome R. Sapolsky
Shirley T. Steidel
Sylvia R. Talbot
Patricia A. Viscosi
1958
Eduardo Anzola
Helen H. Davenport
Thomas T. Flynn
Normand E. Girard
Philip B Hallen
Edward H. Noroian
Joseph A. Scorpion
Mary K. Spiker
Thomas P. Weil, PhD
Robert Kenneth Wood
1959
Rita Dingman
John T. Foster
Folly Hofer
Erica J. Koehler
Marvin A. Lavenhar, PhD
Hugh J. Maher
John F. O’Connor
Lee J. Podolin
John S. Pullman
Ellwyn D. Spiker
Mattie Lee D. Wade
Kenneth J. Williams
Dorothy M. Wilson
1960
Gyla E. Brooks
Thaddeus B. Curtz*
Kathryn L. D'Amico
Wouter Ekker
R John C Pearson
Hannah Clark Russell
1961
Gordon R. Beem
Alfred E. Fletcher
Helen M. O’Connell
Joseph T. Prekup
William R. Slivka
Harold W. Wicks

1962
Richard B. Blakney
Thomas A. Blumenthal
John R. Galbraith
Charles A. Macintosh
Thomas R. Mayhugh
1963
Hamp Coley
David Dolins
Frank M. Isbell
Edward M. Kenney
Cecilio O. Maningas
Jean M. Maynard
George Eddy Parker
David R. Sheehan
Rosemary W. Stevens
Samuel B. Webb, Jr.
1964
Maria S. Baisier
Elizabeth C. Beilis
Bartley H. Calder
Katherine Maria Detre
John S. T. Gallagher
Linda F. George
Carter L. Marshall
Neal L. Maslan
Carole S. Profant
Theodore Rosenberg
Estelle Siker
Monroe W. Spero
1965
Robert M. Edwards
H. Patterson Harris, Jr.
William C. Harvey
James F. Jekel
Warren C. Kessler
Michael E. Kove
Peter J. Levin
Norman R. Penner
Elliot A. Segal
Viola J. Spinelli
Matagiese G. Tunoa
Sarah L. Thmer
David S. Weiner
1966
Richard W. Benfer
Barbara L. Brody
Allen Cohen
Amalia P. Crago
Dorothy Noyes Kane Evans
Diana B. Fischer
Robert C. Lowrie, Jr.
Nancy Alfred Persily
Gary J. Robinson
Arthur J. Schreier
1967
Carlos E. Alvarez Herrera
Peter T. Elliot-Wotton
Ann Gomez
Alice Ipsen
Steven Jonas
Joel Kavet, SCD
Joseph F. Kukla
Dennis J. Magid
Patricia D. Mail
James M. Malloy
Nancy Ruth Phillips
Brigitte Prusoff
Bruce J. Steinhardt
Robert L. Woodward

1968
Sonia M. Colon
Joseph L. Dorsey
Robert R. Everett
Carl R Fischer
Michael J. Geaney, Jr.
Francis J. Greaney
Susan F. Klein
R. Elizabeth Leif
Harold C. Lovely
Jean C. MacCorison
Robert F. Morisse
John M. Patton
Richard L. Petrelli
Arnold R. Saslow
Cornell Scott
Elizabeth A. Small
Elizabeth C. Wright
1969
Susan S. Addiss
Janet A. Albrecht
Victor Crown
James M. Dawson, Jr.
Gerald R. Harpel
Charles T. Heaney
Sylvia N. Holtzberg
Charles C. Jeffrey
Samuel P. Korper
Judith B. Nichipor
Phyllis J. Pallett
Marva Serotkin
Wanda Vierthaler
Robert L. Young
Chester W. Zamoch, Jr.
1970
Susan W. Balter
Robert T. Beeman*
Arthur A. Berarducci
Michael B. Bracken, PhD
Shan Cretin
Forrest G. Dressier, Jr.
Walter M. Gawlak
Robert S. Gureasko
C. P. Noel McCarthy
Saro Palmeri
David A. Pearson
Nancy Norton Reitz
Charlotte F. Schwartz
Stephen Skorcz
Brian D. Sullivan
Carol B. Von Stein
Donald S. Wilkinson
Joseph A. Zaccagnino
1971
John Bihldorff
Evelyn J. Bromet
William F. Carey, Jr.
Katrina H. Clark
John A. Daeley
Harvey Fembach
William P. Ferretti
Billie S. Hamblin
Sara P. Hartman
Wanda J. Hatmaker
Mohamed Ismail Johnson
William P. Koughan
Bernard G. Koval
Mark J. Magenheim
Eugene S. Mayer
Joseph S. McManus
Nancy P. Mogielnicki
Wan Hin Ooi
Carol L. Paul
Jane Silver

49

Robert E. Steele
David L. Stockton
1972
David P. Barone
Steven H. Beloff
Frances L. Bushnell
Catherine A. Connolly
Daphne deJ. Gemmill
Jean T. Harrison
Dorothy N. Lewis
Steven M. Lipsius
Jorge A. Motta
Sergio Ruschel
Jo Ann K. Silverstein
Gerald A. Starr
Laurence A Tanner
Joyce R. Waksman
1973

Emily M. Barclay
Eva Danielsson Cohen
Ellen B. Doft
Bruce Goldman
Marilyn S. Halper
Hans V. Holt
Helen B Hubert
Chang S. Lao
Dennis P May
Dwight N. McNeill
Charles D. Mross
Marjorie E. Nelson
Jacqueline M. Rosenthal
Gary Dean Sax
Janet B. Schoenberg
Alice S. Stark
Thomas J. Stranova
Irene Trowell-Harris
Bonnie C. Yankaskas
Carl J. Zack
1974

Rose Salisbury Beer
Thomas A. Benoit
Ian B Berger
Carl A. Cappello
Beth G. Crocker
J. Breckenridge Eagle
Elizabeth M. Helming
Kirby O. Kloter
Roberta Lawrence
Karen K. Lindfors
Evelyn B. Mostow
Edward J. Mullen
Deborah Rose
Shelley S. Shanok
Abigail L. Smith
Bienvenido G. Yangco
1975

Edith N. Baum
Ralph E. Binder
Gerald E. Bisbee, Jr
Linda K. Broker
Linda K. Demlo
Gerard R Goulet
William J. Grego, Jr.
Anne H. Hall
Edward J. Halloran
Donald L. Harris
Kenneth G. Hill
Rosemary M. Johnson
Barbara R Untcrman Jones
Philip D. Kennedy
Amy P. Kentera
Kathy S. Keuning
James E. Knoben
Stuart I Lcfkowich
John T Lynch

Laurence F. McMahon, Jr.
Eileen M. O’Gara
Edward J. O'Neill
Mary W. Palshaw
William P. Quinn
Audrey Weiner Solomon
Nancy E. Stroup
Raymond Chiu-Ping Tang
John H. Tobin
Maura M. Tobin
Thomas J. Trudell
Franziska U. Ulrich
Pat Boylston Whitt

Marguerite Nelligan
David W. Osborne
Michael H. Owens
Elizabeth L Pantelick
Ellen D. Rothberg
Karen C. Schneider
Roberta Jo Shapiro
Gloria Shappy-Meickle
Karen Wolchuck Sher
Marie Stoeckel
Sydney S. Tang
Bernadette S. Vissani
Lucy Ellen Weiger

1976

1979

Elaine P. Anderson
William F. Appicelli
Kathleen Keenan Bucholz
Cynthia D. Butler
Helen Y. Y. Chang
Frances L. de Peyster
Paul H Etkind
Robert H. Frazier
Annette B Garofalo
Gail lies Genvert
Cleve Lee Killingsworth
Robert A Knauf
Janina Levy
Lawrence V. Meagher, Jr
Gino A. Nalli
James B. Rokos
Robert Risdon Schwarz
Mary Jo Shepard
Thomas S. Wingardner, Jr.

Virginia P. Bainbridge
Joann N. Bodurtha
Jonathan Brenn
Elizabeth S. Carter
Richard T. D’Aquila
Susan De Renzo
Frances D. Dwyer
Kathe P. Fox
Judith B, Gancher
Debra Haffner
Bruce H. Heckman
Shelley Helfer-Amira
Loren R. Kantor
Phillip S. Katz
Karen Kmetzo
Paul Anthony Kowalski
Renee S. Leary
Bennett Myles Locke
Mary Elisabeth Lorenzi
Osvaldo Marrero
Laure C. Nichols
Catherine Norton
Dolores Perteet
Marcia C Richardson
Lisa K. Rosenfeld
Elisabeth Luttgens Santulli
William E. Schweizer
Audrey P. Silvey
Ralph Tartaglione, Jr.
Ilene B. Wachs
Louise Wise

1977

Richard B. Burford, Jr.
Steven R. Cohen
Chantal C. Dotoli
Marsha E. Dunn
Gerard J. Foley
Paula Yaney Gambill
Rhona Kantor Kershnar
Teri J Klein
Ronald F. LaPensee
Polly W Marvin
James M O’Connor
Kristin K. O'Connor
Veronica C. Oestreicher
Harris Pastides
Linda Mendelsohn Pottern
Dorothy A. Rice
William T. Richards
Abby Rothschild
Anthony V. Sardinas
Carroll Schilling
Young S. Shin
Gail M. Sullivan
Rose M. Truax
Thomas H. Ulfelder
Leon F. Vinci
John Stephen Zil
1978

David S. Abernethy
Kathleen M Berman
Bradford A. Buxton
Maura Carley
Ann T. Freedman
Janice F. Gold
Cynthia R. Gross
Olympia Hadjimichael
Patricia S. Harfst
Stephen W. Hildreth
Jane E. Hill
David W. Houck
Margaret Long Karis
Christopher M. Maylahn
H. James Myers

1980

Phillip R Aaron
Diane Denis Aye
Curtis S. Breslin
Antoinette M. Brooke
Richard L. Buck
Sheila Conneen
Martha G. Dale
Anne Morrison Danaher
Phyllis F. Dower
Alfred E. Fasulo, Jr.
Audrey L. Fetter
Barbara H. Granger
Ellen B. Greif
Irwin J Halperin
Samuel S. Hamilton
James P. Harisiades
Virginia S. Humphrey
Johanna C. Hunt
Helen E. Kelly
Yee-Lean Lee
Robert V. Levine
Kathleen A. Lewis
Leroy F. Ludwig
James S. Marks
Linda L. Moraga
Steven Morrow
Jane Ungate O'Connor
Ann L. Prestipino
Christina P. Quinn
Nancy Maguire Rhodes
Jeri Ann Rose

Kathleen M. Scribner
Lydia A. Selling
Marsha L. Silverman
Richard Gerard Stracqualursi
Gary F. Velat
Carolyn K. Wells
Philip A. Witman
Marie L. Zanotti
Barbara A. Zappas
1981

Jean Adnopoz
Christopher J. Bevan
Rebecca L. Calderon
Kimberly J. Chauncey
Rollin C. Chew
Ann M. Dunbar
Julia Eisenstein
Brian J. Foley
Kristen H. Forrest
Ellen M. Gallagher
Judy E. Garber
Barbara A. Gaugler
Louis M. Gonzalez
Joan Urquhart Goodman
Gerlinde B. Hermann
Susan E. Jennings
Jill L. Lapides
Charles R. Lawson
Blackford Middleton
Howard J. Newman
Mary E. Papke
Gerald W. Robinson, Jr.
Idalia Sanchez
Elizabeth N. Shapiro
Karin Swanson
Keith D. Tait
Nancy Schlesinger Weiss
1982

Margarita Acosta
Jamie L. Amaral
Jenny I. Andrus
Janet M. Bedney
Francis L. Crowley
Barbara L. DeCesare
Kathleen K. Devine
Cyndie B. Gareleck
Meryl Beth Gold
James L. Hadler
Nancy Conlee Hart
Denise Heinemann
Karla A Hitchcock
Constance M. Jarowey
Charles A. Klivans
Ann Storms Kloter
Kevin R Lucey
Linda F. Me Caig
William F. McKeon
Jean L. Milton
Tsuneki Mizuta
David L. Mork
Carolyn Xavier Oreutt
Erica Pifer
Susan G. Poland
Mercedes H. Primer
Marie Zullo Rice
Sally R Rinaldi
Christopher J Rogers
Dale Allan Rublee
Lisa E. Stone
Carol L. Vander Wal
Michele T. Visconti
Sandra Michaelson Warren
Alvin C. White
Amy B Wilson
Jill Okrent Zaheer

1983

Barbara W. Abraham
Joseph A. Amatruda, Jr.
Dean S. Archibald
Eileen Conlon
Robert A. Duncan
D J Safiya Edwards
Susan Faris
Rosanne G. Flaks
James N. Gaito
Ellen M. Ginzler
Halesteen Graham
Virginia C. Hiland
Jeffrey B. Hughes
Nancy R. Kellett
Sandra Knight
Margaret M. Kolb
Linda S. Leo
Allen F. Levy
Peter W. Lyden
Wendy L McGill
Scott K. Mock
Judith F. Nelson
Suzanne Nutt
Nano G. Rush
William Sabella
Marilyn F. Vine
Rita E. Watson
Patricia C. Weber
Vicki L Wilson
Timothy B. Young
1984

Leslie A. Balch
Jean L. Freeman
Carolyn H. Grantham-Millman
Penny H. Hausser
Sarah M. Horwitz
Robin B. Kupfer
Jean G. Larson
James H. Reich
Julie A Russem
Dennis G. Shrauger
Gerald L. Springer
Marie Ann Tobin
1985

Christine D. Berman
John L. Binder
Sally J Erdman
Grace P. Erickson
Katherine Santella Fitzpatrick
Barbara K. Gottlieb-Ware
Suzanne S. Huang
Kathryn L. Keller
Unhee Kim
Merian D. Klein
P. Douglas McConatha
Susan M. Moore
Heather Oliver
Adrian J. Pinsince
Marie V. Roberto
Heidi Roberta Sulis
Shirley J. Tirrell
Terry Martin Zingman
1986

Andrea Lee Boissevain
Lewis P Bower, Jr.
Marie Irene Ciacco
Lori Ann Cohen
Robert S. Dobkin
Joe Tom Easley
Michelle F. Getches
Michael S. Huncharek
Wendy Lee
Monica Ann O’Neill
Tracey M Orloff
Joseph M. Pajor
*

deceased

Elizabeth G. Pelz
Philip O. Renzullo
Denise Amy Riedel
Allen Arthur Ries
Norman C. Schipke
Carrie Shepard
Eric Triffin
Lynn D. Wilson
Friends
Capital Area
Health Consortium
Bruce P. Ameill
Anthony J. DeLuca*
Lorraine V. Klerman*
U. Robert Merikangas*
John L. Quigley
George A. Silver
C. Thomas Smith
Nicholas PR Spinelli
Virginia R. Towle
Terrie Wetle

* deceased

Sterling Association 1986-1987
Parents and Friends
Anne G. St. Goar ’48
Willibald H. Conzen
N. Joel Ehrenkranz ’49
Gerald Wilfred Friedland
William H Bucher ’50
R. Donald Reich
Janus C. Lindner ’50
Arthur A. Shachner
Orlando J. Miller ’50
Myra D. Tyler ’50
Member
Thomas T. Amatruda, Jr. ’51
Gerard B. Odell ’51
Michael A. Parlato ’08*
Donald H. Schultz '52
Helen P. Langner ’22
Arthur C. Crovatto ’54
William Cohen ’23
Lowell E. Olson ’54
Julius A. Olean ’23*
Robert L. Stein ’54
D. Anthony D’Esopo ’24
James Conway Garlington 55
Myron A. Sallick ’24
Mitchell Edson ’56
Harold T. Vogel ’24
John Herd Hart ’56
Marie-Louise T. Johnson ’56
Waldo F. Desmond ’25
Donald J. Nalebuff ’56
Alice A. S. Whittier ’25
Harry C. Briggs ’57
Maxwell Bogin ’26
John M. Freiheit ’27*
Ronald H. Fishbein '51
Max Alpert ’28
Robert J. Donohue, Jr. ’58
Andrew Joseph McGowan, Jr. ’58 Sheldon A. Jacobson ’28
Richard Charles Miller '58
Ralph E. Knutti ’28
Raymond W. Turner ’58
Tony L. Rakieten ’29*
Carol J. Amick ’59
Robert Tennant ’29
Robert M. Amick ’59
Paul A. Harper ’31
Paul Jay Friedman ’59
Nelson Newmark ’31
H. Rodney Hartmann ’59
Lee E. Farr ’32
James A. O’Neill, Jr. ’59
Conrad R. Lam ’32
James R Ralph ’59
Arthur J. Present ’32
Paul Jay Friedman ’60
Benjamin N. Tager ’32
Roland H. Ingram, Jr. ’60
Myron E. Wegman ’32
Albert A. Bechtoldt, Jr. ’61
Jack Greenberg ’33
Robert S. Briggs ’61
Ashley Pond III '33*
Jon Dudley Dorman ’61
Sidney Stringer ’33*
Charles B. Anderson ’62
George A. Carden, Jr. ’35
Former House Officers
Ray Allen Carlsen ’62
Parents and Friends
Samuel D. Kushlan ’35
Richard Allen Chase
Frederick W. Heilman
I Bruce Elfenbein ’62
Daniel Bergsma ’36
John N. German '62
Lester W. Burket ’36
Parents and Friends
Associate
Carter L. Marshall ’62
Albert W. Diddle ’36
Argyle Stoute
William A. Miller ’62
Margaret C. L. Gildea ’36
A. Richard Pschirrer ’62
Robert L. Rowley ’03*
Louise G. Hutchins ’36
Fellow
David Seil ’62
Walter C. Tilden ’12*
Philip M. LeCompte ’36
Nathan E. Ross ’28
Nancy Ann Staley ’62
Morris Tager '36
David M. Raskind ’24
Knox H. Finley ’30
H. Oliver Stoutland ’62
William G. Cooper, Jr. ’37
Donald F. Gibson ’27
Seth Thaler ’62
Charles L. Wood ’30
T. Dennie F*ratt '31
Louis M. D’Esopo ’28
Stewart R. Wright ’62
Norman E. Peatfield ’35
Albert D. Spicer ’37
Lewis A. Scheuer ’28
David A. Dolowitz ’37
Arthur Howard Ackerman ’63
Jean Wells '31
Vincent A. Doroszka ’30
Benjamin F. Hoopes ’37
Alexander R. Gaudio ’63
Benjamin E. Lyons ’38
John T.B. Carmody ’32
Wilbur D. Johnston, DDSM ’37 Lawrence Tremonti ’63
J. Richard Zahn ’38
Joseph P. Donnelly ’32
Julia Mehlman ’37
Peter A. Gross ’64
John P. Ferguson, Jr. ’39
Harry Sherman ’34
Charles W. Neuhardt ’37
Richard Murray Linburg ’64
S. Jerome Greenfield ’39
Donald Peter Morris '35*
Alan A. Rozen ’37
A. Thomas Snoke ’64
Nathaniel Kenigsberg ’39
George Hahn ’36*
Morgan Sargent ’37
Oscar Wand ’64
Malvin F. White ’39
Frederick A. Post ’36
Paul Balter ’65
William H. Druckemiller '39
Wynant Dean ’40
Alfred E. King ’37
Rebecca Z. Solomon ’39
David A. Hill '65
Richard E. Dormont ’40
Willys M. Monroe ’41
Thaddeus S. Danowski ’40
Gene A. Robinson ’65
Henry D. Humphrey ’40
Michael A. Puzak ’42
Robert H. Areson ’41
John A. Drews ’67
Edward Martin ’40
Class of 1942 In Memoriam Fund Robert W. Ollayos ’41
John O. Pastore ’67
Joseph E. Sokal '40
Ralph D. Alley ’43 March
Leo Kellerman ’42
Joseph F. Walter ’67
Patricia E. Wanning ’40
Carl E. Andrews '44
Edgar B Taft, MD ’42
Redford B. Williams, Jr. ’67
John B. Wells '40
Lawrence G. Crowley ’44
Maurice Tulin ’42
Daniel E. Keim ’68
Helen H Woods ’40
Nicholas PR. Spinelli ’44
R. Leonard Kemler ’43 March
Charles T. Post, Jr. ’68
Herbert W. Diefendorf ’41
Thomas J. Coleman ’46
Ralph J. Falkenstein ’69
Bernard R. Rowen ’43 March
Robert L. Gilbert ’41
Martin E. Gordon ’46
Paul A. Markey '69
Henry H. Jones ’43 December
William Edmund Kenney ’41
George R Barnes, Jr. ’47
Frederick F. Krauskopf ’44
Joseph M. Rochford ’69
William E. Bloomer ‘42
W. Roy Breg, Jr. ’47
A. Reese Matteson ’44
Dennis J. Rudzinski ’69
James M. Bunce ’42
Owen W. Doyle ’47
Eugene Smith ’44
Adrian M. Schnall ’69
Walter J. Burdette ’42
Brock Lynch '47
Thomas H. Gouge '70
Franklin C. Behrle ’46
Ludmil A. Chotkowski ’42
Paul B. Koehler ’48
John A. Patti ’71
William F. Collins, Jr. ’47
Vincent J. Collins '42
Russell N. Anderson ’50
William K. McClelland ’47
Jerome H. Meyer ’72
William Fleeson ’42
Lyal D. Asay ’50
Myron K. Nobil ’47
Gary T. Grimes ’73
Elihu Friedmann ’42
John E. Borowy ’50
Leon F. Kraft ’74
Irving Rudman ’47
Samuel Ritvo ’42
Claude W. Delia ’50
Mark C. Ruchman ’76
Sumner Root Ziegra ’47
Charles F. Scholhamer ’42
Kent Ellis ’50
Allyn G. Bridge ’48
Irving Norman Wolfson ’42
Daniel Fine '50
Richard Steele Buker, Jr. ’48
Former House Officers
Jonathan T. Lanman ’43 March
Harry L McClelland ’50
Sylvia Preston Griffiths ’48
Samuel C. Klagsbrun
Douglas Lindsey ’43 March
Robert F. Owen ’52
Jerome H. Shapiro ’48
J. Philip Loge ’43 March

Robert B. Schultz ’52
William H. Hindle ’56
Berthold M. Comeau ’28*
Albert K. Chun-Hoon '51
Jack Levin ’57
Robert R Wagner ’46
Clifford B. Reifler ’57
Sponsor
Donald C. Stahl ’57
Philip R. Fazzone ’58
J. Roswell Gallagher '30
Paul A. Rudnick ’58
Reginald V. Berry ’32
Ralph J. DePonte ’61
Anoush Miridjanian ’61
James Quintin Haralambie ’35
Warren D. Widmann '61
Theodore E. Allen ’40
W. Randal Bell ’41
James A E Spencer ’62
Robert E. Carroll ’42
Robert E. Mueller ’63
William Harrison, Jr. ’42
Peter G. Weiner ’63
John C. Coolidge ’44
Leland S. Berger ’64
Oliver Townsend Dann ’62
Robert W. Lyons ’64
Michael J. Cummings ’65
Donald G. Skinner ’64
M Felix Freshwater '72
Mohandas M. Kini ’65
Class of 1950 In Memoriam Fund Jay G. Hayden ’66
Gary L. Townsend ’66
Patron
Richard J Hart, Jr. ’67
George P. Herr ’67
Amy H. Hunter-Wilson ’30
Robert I Roy ’67
John B. Ogilvie ’34
Jeffrey S. Lee ’68
Sidney L. Lasell ’41
James W. Ogilvie ’68
Sidney S. Lee ’50
Laurie J. Bleicher ’71
Lowell I. Goodman ’51
John W. Foster, Jr. ’71
Sidney Nathan Paly ’52
Richard Albert Moggio ’71
Mary Wheatland Schley ’52
Robert F. Deblasi ’72
John D’Agostino, Jr. ’57
Edward O. Fox ’57
Former House Officers
Leo H. Von Euler ’59
Samuel M. Lemer
J. Thomas Okin 60
John P. McGovern
Dennis Grant Egnatz ’67
Jerold J. Principato
Life-time Benefactor

51

Henry A. Riedel '43 March
John J. Weber '43 March
Robert H Wyatt '43 March
Jane B. Cadbury '43 December
Hunter H. Comly '43 December
Robert H. Furman
'43 December
Hoyt B Miles, Jr.
'43 December
Francis A. Spellman
'43 December
Carol Goldenthal '44
Charles A. Hall '44
Donald W. Holden '44
W. Raymond James '44
Elias J. Marsh '44
Paul E. Molumphy '44
Laurence G Roth '44
George Howard Allison '45
Alice Shepard Cary '45
Edward M. Daniels '45
Robert S. Easton '45
Alice Dershimer Friedman 45
O. Roger Hollan '45
George W. Naumburg, Jr. '45
Richard M. Peters '45
Aaron T. Beck '46
Gregory E. Flynn '46
Charles S Judd, Jr. '46*
James A. Kleeman '46
Thomas J. Mathieu '46
Francis G. Reilly '46*
Thomas J Whelan, Jr. '46
Richard G. Britton '47
Charles R. Cavanagh, Jr. '47
Roland G. Chambers '47
Archie L. Dean, Jr. ‘47
Franklin Harold Epstein '47
Richard K. Friedlander '47
Stephen W. Gehrs ’47
Robert J. Kerin '47
Don F. Kimmerling '47
Richard P. Levy '47
Charles L. Mache, Jr. '47
Olive E. Pitkin '47
Igor Tamm '47
Patricia B. Tudbury '47
Ellis J. Van Slyck '47
Russell J Barrnett '48
Ruth E. Cortell '48
G. Robert Downie '48
Boy Frame '48*
Ross R. Harcus '48
William G. Anlyan '49
Jonathan S. Bishop '49
Jackson Harris '49
Benjamin A. Johnson '49
Timothy F. Nolan, Jr. '49
Julian I. Pichel '49
Charles L Rennell, Jr. ’49
Daniel Rudman '49
Martha Vaughan '49
Sylvia L. Axelrod '50
Carl A. Gagliardi '50
Margaret S. Lyman '50
Jane B. Shumway '50
Eleanor Clay Bigley '51
Daniel X. Freedman '51
Sidney S. Furst '51
Joseph M. Garland '51
Robert N. Hamburger '51
John V Haxo '51
Carrold K. Iverson ’51
Jocelyn S. Malkin ’51
Francis L. Merritt ’51
Albert R Mowlem '51
Arthur A. Pava '51
Majic S. Potsaid '51
Andrew S Wong '51

Maurice L. Bogdonoff '52
Frank A. Carone '52
Thomas S. Kelly '52
Robert G. Petersdorf '52
Leon A Phillips '52
John Macklin Roberts '52
John H. Wagner, Jr. '52
John L. Wolff '52
Harvey L. Young '52
Robert Zeppa '52
Harold D. Bomstein. Jr. '53
James P. Dunn '53
A. Daniel Hauser ’53
David Purdy Holman ’53
Richard Robert Knowles, 3d
'53
Paul G. Quie '53
Richard J. Bouchard ’54
Herbert S. Hurwitz ’54
Robert J. T. Joy ’54
Harry C. Miller, Jr. ’54
Paul N. Neufeld '54
Anthony V. Piccirillo '54
Jacques M. Quen '54
Leonard M. Silverman '54
John W. Vosskuhler '54
George E. Becker '55
Padraic Bums '55
Pasquale James Costa '55
Leroy Engel '55
F. Robert Fekety, Jr. '55
Mahlon V.R Freeman '55
Paul Gonick '55
John H. Hodge ’55
David R Kessler '55
Robert A. Kramer '55
James Lum '55
Joseph S McGuire, Jr. '55
Phillip W. Smith '55
Levon Z. Boyajian ’56
Rosalie A. Bums ’56
Chandler Dawson ’56
Thomas F. Ferris '56
Sumner Gochberg '56
George E. Green '56
Arne G. Haavik '56
George T. Kammerer '56
Jerome O. Klein '56
William V. Lewit '56
Preston C. Manning '56
Dwight F. Miller '56
A. Frederick North, Jr. '56
George W. Paulson '56
Robert Lee Scheig '56
James Scheuer '56
Donald Agostinelli '57
Richard I. Breuer ’57
Carl A. Brinkman '51
John P. Carey '57
Louis Z. Cooper ’57
Thomas H. Danaher '57
James R. Dorr ’57
Edward Louis Eyerman, Jr.
’57
Harold J. Fallon, Jr. ’57
Anthony L. Fons, 3d '51
Anne H. Good '51
Richard Lee Kahler '51
William L. Kissick '51
Bennett F. Markel '57
Mark D. Marshall '51
Robert K. Modlin '51
Hugh Lamson Moffet '57
Herbert A. Newman '57
Charles A. Slanctz, Jr. '57
Joseph E. Angelo '58
Gerard N. Burrow '58
David A. Carlson ’58
Lawrence Dubin ’58

James Greenwald '58
Stanley Harris '58
Michael Kashgarian '58
Theodore W. Lieberman '58
Thomas J. Mauro, Jr. '58
Leo T. McCallum '58
Thomas R. Shea '58
Margaret Smith Wenzel '58
Asa Barnes, Jr. '59
William C. Butterfield '59
Martin Colodzin '59
Robert L. Fisher '59
William H. Heydom Me,
Usa '59
C. Richard Hinckley '59
John J. Jasaitis '59
Sanford P. Solomon '59
Muriel D. Wolf '59
Victor Altshul '60
Jack D. Barchas '60
Ormond V. Brody '60
Donald P. Buebendorf '60
Francis D. Cogliano '60
Daniel M. Jones '60
Thomas P. Kugelman '60
Edward R. Lang '60
Donald L. Miller '60
Daniel J. Rubin '60
Fred Stargardter '60
May Yung-Fun Woo Wang
'60
Ronald A. Yankee '60
Orson R Dee '61
Paul David Deiter '61
Ronald A. Dierwechter '61
John E. Fenn '61
Richard L. Keefe '61
Norman I. Moss ’61
Roland D. Paegle '61
John Curtis Parker '61
Shaun J Ruddy '61
Hugh C. Thompson, III 61
Michael H. Alderman '62
Fredric K. Cantor '62
John W. Foreman '62
Stephen John Flicker '62
John T. Harrington '62
Frank R Hartman '62
David E. Knoop '62
John P. Lynch '62
Stanley E. Matyszewski '62
Larry Lee Stewart '62
Sherwood Waldron, Jr. '62
Miguel R. Alonso '63
Charles W. Carl, Jr. '63
Dudley Seth Danoff '63
Peter B Gregory '63
Harold P. Kaplan '63
Edward G. Lund, Jr. '63
Peter V. Tishler '63
William A. Alonso '64
Thomas A. Cardella '64
Mary V. Digangi '64
Beverly Ann Dudek '64
Alfonso Esguerra '64
Lewis Landsberg '64
David B Leof '64
James S. Levine '64
William F. Matched '64
Robert L. Mitchell '64
William B. Pratt '64
Stanley J Rosenberg '64
Robert L. Shelton '64
Diane Shrier '64
Sigrid L. Tishler '64
Stephen Waltman '64
Robert M. Cohn ’65
Gregory A. Culley '65
Robert Andre Gryboski '65

Carl E. Hunt '65
Virginia Burnham Johnson '65
Ronald J. Karpick '65
David B Leof '65
Sandra Chook Levine '65
Philip D Manfredi '65
A. Lawrence Ossias '65
Robert L. Pickens '65
Margretta Ann Reed Seashore
'65
John H Seashore '65
Frank C. Bell '66
Eugene Patrick Cassidy '66
Robert N. Frank '66
J McLeod Griffiss '66
Robert A. Gunn '66
Stuart T. Hauser '66
Wilbur L. Kukes '66
Daniel L. Arons '61
Arthur L Beaudet '67
Gary C. Burget '61
Mary Williams Clark '67
James Lucius Davis, ITT '61
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TO BREAK THE CYCLE OF POVERTY
by Irving Harris
Editor’s note: Many Yale medical alumni have had experience
with one of this nation's most serious public health problems:
a cycle of poverty in which teenagers bear children who—if
they survive—grow up socially and economically disadvan¬
taged. All too often these children bear the added burden of a
physical or mental handicap that results from inadequate
health care. And many go on to become the next generation of
too-young parents as the cycle of poverty winds on.
Is there any hope of breaking this pattern, especially in an
era of federal cutbacks?
One Yale College alumnus, Irving Harris, '31, a Chicago
businessman, felt that there must be an alternative to simply
turning our backs on the problem. He got involved in his com¬
munity and achieved remarkable results.
Last year, Mr. Harris was invited to chronicle his success
in the annual Clifford Beers Lecture at the Yale Child Study
Center. YALE MEDICINE presents an excerpt from this
lecture.

As a businessman, I am frequently asked why I am concerned
about child development and the cycle of poverty. My answer
is simple: Because of the awesome effects of poverty on chil¬
dren and families, we cannot afford to go blithely about our
lives thinking the problem will solve itself.
In 1975, my friend Bernice Weissbourd began talking to
me about her idea for organizing a family support system in
Evanston, Ill. In 1965 and 1966, Bernice and Joan Costello,
formerly of Yale, had operated a Head Start program in one of
the housing projects in the inner city of Chicago. When
she looked back at that experience, Bernice told me that the
project had been both exhilarating and disappointing.
She classified the children they worked with into three
groups: A third were well-nurtured at home and would prob¬
ably make it in life even without a Head Start program; the
second third needed, and really benefitted from. Head Start,
but required good teaching to stay on track; the final third
were so badly damaged by the time they arrived in Head Start
that they could not be helped.

THE CRITICAL THIRD
Irving Harris

Bernice believed that the only way to address the problem of
this last group was primary prevention —to work with the
mothers of those children from the time the babies were born
or even earlier —during the first months of pregnancy.
As a result, in 1976, Bernice Weissbourd created Family
Focus, a non-profit social service organization whose clients
are families with children under age three. The mission of the
program is to help parents improve their knowledge of healthy
child development and so enhance their parenting skills. Her
husband and I shared the principal part of the cost.
Family Focus began with a very good drop-in center in
Evanston, Ill., a community of 100,000 which ranges from
affluent to poor, about 77 percent white and 23 percent black.
We expected that 50 families would use the center in its first
year. To our surprise, 250 mothers and their children piled in.
But we failed to attract the teenagers we had hoped would
use the program. So four years later we opened a second cen¬
ter, located across from the high school. This did attract lowincome youths, who named the center “Our Place.” Here we
counseled many teenagers, including those who were preg¬
nant or parenting, and those who were not.
The center was very successful. The health of those who
were young mothers was clearly improved. The number of low
birth weight babies was low. (In Chicago’s inner city, low
birth weight affects 21 percent of all newborns; in our sample
the percentage was six.) One of our goals was to encourage
these young mothers to wait before having a second baby.
In most cases we were successful, but there was still room
for improvement. In a study of multiple births four years later,
much to our surprise we found that all of the second and third
children born to these young mothers were progeny of only six
families. Those families —siblings and cousins —represented
the hard core of Evanston's social problems and proved to be
the most difficult to reach through our program.

A mother and her six-month-old play games with a mirror at Christopher House, a Chicago Ounce of 1
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FUNDING STRATEGIES
We knew all along that the costs for Family Focus would not
be cheap. We also knew that those costs would have to be jus¬
tified on one of two bases: humanitarian considerations or
cost effectiveness. If the concern was purely humanitarian,
the cynics would be sure to say, “Don't look to us for money.
Tap the bleeding hearts.” To prove cost effectiveness, we
would have to measure the damage —and determine the
cost —of what happens when society does nothing.
This is not an easy process. My own estimate suggested
that $10,000 a year would not be a bad guess for what it costs
if a child becomes a failure. Prison alone costs over $20,000
a year. Retardation and other handicapping conditions, wel¬
fare, unemployability and teenage parenting are all
expensive.
Experts have said that my estimate is low, and the figures
bear them out. A study of the 24,348 births to Illinois teen¬
agers in 1983 estimated annual costs at $35,000 per birth dur¬
ing the first five years of the children’s lives. That adds up to
an annual cost of $853 million.
Yet even at the conservative figure of $10,000 a year, the av¬
erage cost to society for a failed individual with a life ex¬
pectancy of only 30 years would come to $300,000. I have
also estimated that at least 600,000 children are born each
year at high risk of societal failure, and without intervention
half will in fact fail. Again, my estimates are conservative.
Despite such grim figures, and the fact that our preventive
approach costs $1,000 per child, funding for Family Focus
has been difficult to come by from the start. Early on, I
thought our fund-raising prospects might improve if we ap¬
pealed to the self-interest of corporations and could place a
center near a factory site.
CLOSE TO HOME
A logical corporation to initiate such an experiment was the
Pittway Corp. of which I was chairman. Pittway manufac¬
tures smoke detectors in Aurora, III., which has a large pocket
of poor Hispanic families who work for the company.
Pittway supplied a substantial part of the funds needed to
finance a Family Focus drop-in center in Aurora. This was to
a three-yearexperiment, with the intent of interesting other
\urora employers in joining as financial supporters.

We asked the Illinois department of children and family
services for $25,000 a year towards our estimated $100,000
budget, believing that the Aurora center would be a model
primary prevention program and could potentially reduce
child abuse and neglect.
We were pleasantly surprised when department Director
Greg Coler volunteered to commit $400,000 if Pittway would
match it. His goal was to establish six experimental sites that
would test the concept of primary prevention. The Pittway
board agreed to match the grant. Greg Coler invited me to
think up a name for our public-private partnership, and that is
how The Ounce of Prevention Fund was created.
Without question, the state could not have established a
radical experiment such as Ounce of Prevention using state
funds alone. The matching grant greatly reduced the diffi¬
culty of gaining legislative approval.
Greg Coler asked for a $400,000 grant from Pittway for one
year only. He promised that once underway, the project would
be funded in its second and third years by the state: After all,
it would take only $800,000 a year from his department’s
$260 million budget.
From the corporate side, despite the fact that this was by far
the largest grant the Pittway Corp. Charitable Foundation had
ever considered, our board believed it was worthwhile, par¬
ticularly since that we were leveraging our $400,000 against
$2 million from the state over three years.
Pittway directors recognized that the long-term success of
the corporation is dependent upon the economic and social
health of the community, not only in Aurora but in all of the
communities where the company operates a factory or offers
its products for sale. The board felt that the issues related to
early childhood development are of concern to the nation as
a whole and that Pittway’s effort might have national
significance.
AN IDEA TAKES HOLD
A public announcement of the new program was made in Jan¬
uary 1982. We requested proposals, insisting on a strong com¬
munity base. In the first year, with $800,000, we funded six
programs. In the second year, the state increased its contri¬
bution to $2 million and in the third year to $4.5 million. This
enabled us to add 22 programs. And in the fourth year, with
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modest additional funding, we added 13 small experimental
prevention programs.
Ounce of Prevention sites usually offer home visiting, par¬
ent training, pregnancy prevention, support mechanisms to
promote healthy family functioning and prevent child abuse
and neglect, and in many instances, developmental infant and
toddler day care. Ounce of Prevention also now manages 10
federally funded Head Start programs for some 700 children.
Pittway, incidentally, has continued its support at $250,000
a year. This pot of flexible funding has been important to the
growth and dynamism of Ounce of Prevention programs,
which today include training for paraprofessionals in infant
and toddler assessment, new programs to prevent sexual
abuse, job training programs and other projects that collabo¬
rate with schools and churches to reach children put at risk
by poverty.
Despite our success, there is much more to be done. For
instance, it was always clear that The Ounce of Prevention
Fund and Family Focus were not helping the most difficultto-reach, highest-risk families —including the "hard core,"
estimated at 6 percent of families who account for 50 to 70
percent of the social problems that we are trying to counter.
THE ELUSIVE PURSUIT
We also became aware that Family Focus and Ounce of Pre¬
vention were not achieving our goal of promoting primary pre¬
vention. We were working mostly with adolescent mothers
who already were pregnant or had had a baby. At best, we were
trying to improve parenting skills and encourage young people
not to have a second or third child while they were still of
school age.
Realizing that primary prevention meant trying to keep chil¬
dren from having their own first child, I hired a man named
Bill Young to scout around the nation and see what was being
done to successfully prevent first births.
Regular home visits are key to the Ounce of Prevention Fund
approach to supporting young parents.
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He discovered that the Comprehensive School-Based Med¬
ical Clinic in St. Paul, which offered medical care and family
planning services, had managed to cut births to teenagers in
one high-risk high school by 59 percent. While nationally,
some 33 percent of adolescents have a second baby within two
years after delivering their first child, St. Paul had been able
to reduce this percentage to 1.4.
With this information I returned to the state director of pub¬
lic aid. He agreed to fund one-half the cost of two such clinics
if I could find private funding for the other half.
To match the state’s funding, we would have to raise $1 mil¬
lion. This would provide $1 million for each clinic, to be spent
over eight years. The Pittway Corporation Charitable Foun¬
dation agreed to give $75,000 a year for several years; and The
Robert Wood Johnson Foundation agreed to provide additional
funds. Since then, 10 more Chicago foundations, including
the Chicago Community Trust, have joined the effort.
THE STRUGGLE CONTINUES
Surprising as it may seem, not everyone in the community has
welcomed our efforts. Take, for example, the Moral Majority.
Thanks to the efforts of Bill Young and Ruth Belzer, exec¬
utive director of the Harris Foundation, the city administra¬
tion and the Chicago board of education agreed to permit
comprehensive clinics to be established at two Chicago high
schools, DuSable and Orr. The vote of the board was 10 to one
and reported in The Chicago Sun-Times and The Chicago
Tribune, both of which noted that contraceptives would be dis¬
pensed to students.
It should be mentioned that to use any of the clinics’ ser¬
vices, including birth-control counseling, students need writ¬
ten permission from their parents. Three months after the first
clinic opened, a black minister, the head of the Illinois Moral
Majority, wrote a letter of complaint to the governor and sent
copies to 50 well-placed individuals, including the editor of
the Sun-Times.
The story ran under a banner headline: "The Pill Goes to
School." The fact that 85 percent of the visits were for med¬
ical problems was not newsworthy. Only sex is news.
Interestingly, all of the excitement generated by the news¬
paper, the pickets and the television cameras was of little con¬
cern to the families of DuSable students. Not a single call
from a parent was received by the principal. The parents, the
principal and the faculty wanted the clinic there.
Nevertheless, the picketers did convince the president of the
school board and two other board members to welch on their
votes. We found ourselves in a new battle for approval of the
second clinic, despite the approval granted six months earlier.
We won that critical second vote six to five, but on the con¬
dition that before opening the second clinic at Orr High
School, we were to survey the community and the students.
We found that 85 percent of those responding favored opening
a clinic that would dispense contraceptives.
Since that episode, the state of Illinois has appropriated
funds to fully support two more clinics.
Our experience with these programs has led me to believe
that by working together, perhaps we can use our education
and insights to understand the causes of social failure and
weed them out. Human motivation and social organization
should not be insoluble mysteries. Nor should it be beyond our
talents to eradicate the conditions that create a permanent
underclass.
Poverty is not preordained in heaven. It is a problem created
by people. If we really want to, we can solve it.
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AT THE INFINITESIMAL
FRONTIER OF PHYSIOLOGY
by Doris Falk and Gregory R. Hath
bringing together many of the brightest researchers in the field
of membrane physiology.”
At first glance, such a research focus might appear to be
limiting. However, Dr. Boulpaep explains that in fact, mem¬
brane physiology is so basic that its study has applications to
an extremely wide range of organs and systems.
For example, departmental projects are throwing light on
the mysteries of membrane transport in red blood cells, epi¬
thelial cells of the digestive tract, cardiac and skeletal-muscle
cells and neurons. Such research is helping to explain the
workings of such varied mechanisms as muscle contraction,
color vision processing and electrolyte transport in the
kidneys.
From a teaching standpoint. Dr. Boulpaep explains that
medical students in advanced courses gain from this approach
in three ways:
First, it allows students to learn about organ and system
function in the most up-to-date fashion.
Second, it orients them to an approach that is becoming in¬
creasingly important in other aspects of medicine. Dr. Boul¬
paep observes, “If students go into internal medicine, for
JAMES ANDERSON

When the “department of physiology” became the “depart¬
ment of cellular and molecular physiology” in July 1987, the
name change formally affirmed the path the department has
been following for a decade, a path that has led it to become
one of the top graduate physiology departments in the country.
“There was some concern when we first asked for the name
change that we were departing from our educational mis¬
sion,” observes Professor Emile L. Boulpaep, M.D., chair¬
man of the department since 1979. “But our mission has not
changed. We are simply adjusting the name to reflect our re¬
search activities.” Professor Walter F. Boron, M.D., Ph.D.,
acknowledges that those activities play a vital role —as re¬
flected by the department’s annual research budget of $4.5
million.
However, as the department’s director of medical studies.
Dr. Boron is quick to add that research and educational efforts
must complement each other. “We take our teaching respon¬
sibilities very seriously,” he concludes.
Historically, physiology has dealt with the function of sys¬
tems and organs. This has remained the thrust of two major
courses given by the department: basic physiology, taken by
first-year medical students, and clinical correlations, where
second-year students learn to apply basic physiology to patient
care.
Advanced graduate courses, however, which are elected by
medical and graduate students as well as by M.D., Ph.D. can¬
didates, have come to reflect the sophisticated new techniques
that have made it possible to study physiology at the cellular
and even molecular levels.
With such techniques gaining importance, adding the
words ‘cellular and molecular' to the physiology department’s
name reflects its position at the cutting edge of research.
Thus, Dr. Boulpaep points out, the name change “should be
useful in attracting new grants as well as the best young fac¬
ulty and graduate students.”
A SINGULAR FOCUS
Dr. Boulpaep believes that his department also has been
strengthened by recruiting researchers who specialize in cel¬
lular functions related to membranes. While several faculty
members carry on important studies at the supracellular
level —into the organization of many cells —others specialize
in the surface of single cells, and in some cases even the in¬
dividual molecules of the cell membrane.
This contrasts with many physiology faculties that include
a wide range of researchers who each specialize in a different
an or system, and thus who may have little or no common
research interests.
“There’s truth to the old adage ‘Two heads are better than
u Dr. Boulpaep suggests. “In our case, we have been for■naugh to add depth to an already strong faculty by

Dr. Emile Boulpaep, a native of Belgium, adds a dash of
Flemish flair as chairman of the department.
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example, they will discover the same trend to a cellular and
molecular focus at the research level in the study of abnormal
function.”
Finally, students who undertake a senior thesis in cell and
membrane transport will find that they gain knowledge that
will make them highly marketable —and all the more so for
having some of the leading researchers in the field as their
advisors.
The department’s 15 full-time faculty members divide their
medical school teaching responsibilities between large lecture
classes of 100 or more students and seminars where 10 to 12
students can study specialized research in depth. A minority
confine their attention solely to the department’s 15 graduate
students.
PURSUING THE INFINITESIMAL

YALE MEDICINE Spring 1988

Technicians pursue their vital work—producing much of the
highly specialized equipment required by researchers—in the
obscurity of the instrument shop. Widely respected, these
craftsmen have filled requests for custom designed equipment
from places as far away as East Germany and China. Here
Brian Cullen, an electrical technician, looks on as Senior
Electrial Technician Jo Wonowski tests a circuit board.
JAMES ANDERSON

What are Yale medical students learning about the micro¬
scopic and even submicroscoic workings of cell membranes?
In simple terms, Dr. Boulpaep explains that scientists have
come to view cell membranes as a two-molecule deep “ocean
of lipid, in which are floating many proteins.” These proteins
can be divided into four basic groups —channels, transport¬
ers, pumps and receptors —according to the way they move
materials in and out of the cell, thus regulating the intracell¬
ular environment.
Dr. Boulpaep and several of his departmental colleagues
specialize in channels, the molecules that regulate ionic flux
through the surface of the cell. In this system, channel pro¬
teins can be seen as the “locks” that respond to electric sig¬
nals in the cell membrane. Channels cause an opening in the
membrane, allowing calcium, sodium, potassium or other
kinds of ions through, or they close the cell surface and stop
all such movement.
Channels have gained much prominence during the past few
years because of the effectiveness of calcium channel-block¬
ing drugs in treating cardiac arrhythmias. Yet, as with so
many modern medications, it was discovered that calciumchannel blockers were safe and effective before it was discov¬
ered why.
Professor Richard W. Tsien, Ph.D., is leading a group that
is trying to understand how these drugs work. “By under¬
standing how calcium channels function at the molecular
level, we hope to throw some light on how calcium affects
heart muscle contraction,” he explains.
The human heart is not Professor Tsien’s only research in¬
terest. In 1986 the National Institute of Neurological and
Communicative Disorders granted him a Javits Award that as¬
sures the university seven years of support for the Tsien
team’s research into the role of calcium channels in neuronal
function. This endeavor may have implications for the treat¬
ment of epilepsy and other disorders of the nervous system.
Dr. Boron and others are investigating the second major cat¬
egory of cell membrane proteins: transporters. Transporters
act as “barges” in the cell membrane’s lipid ocean, binding
to ions or solutes, and then translocating these substances into
or out of the cell. These proteins are essential for regulating
intracellular ion composition, including the concentration of
hydrogen. Dr. Boron’s lectures include discussion of a tech¬
nique he helped pioneer that uses hydrogen-sensitive microe¬
lectrodes and minute amounts of dyes to monitor rapid pH
changes in single nerve, muscle and renal-tubule cells.
One of Dr. Boron’s colleagues. Professor Peter S. Aronson,
M.D., takes a different, but no less innovative tack to inves¬
tigate how transporters function. He employs radio-labeled

Henry Paulson, a fifth-year M.D., Ph.D. student, consults
with Assistant Professor Toni Claudio, Ph.D., about the data
from a patch clamping experiment.
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tracers and fluorescent probes in various epithelial cells to ob¬
serve the transport properties of cell membrane fragments.
AGAINST THE GRADIENT
Associate Professor Bliss Forbush III, Ph D., works with oth¬
ers at looking into the third major category of membrane pro¬
teins: pumps. Pumps —enzymes such as sodium-potassium
ATPase —come to the fore when a cell needs to move an ion
into or out of its interior, but neither its “locks,” the channels,
nor its “barges,” the transporters, can do the job.
For unlike these two proteins, which use an ion’s own elec¬
trochemical gradient to move it passively, a pump actively
transports an ion or solute against its gradient, analogous to a
water pump working against the force of gravity.
Professor Forbush’s research may one day help in the treat¬
ment of blood cell disorders, and gastrointestinal and kidney
diseases. Other Yale research into pumps may reveal the pos¬
sible tie between hypertension and the metabolism of sodium.
It could also one day throw light on the workings of cardiac
glycocides, medications whose effectiveness in preventing
heart failure has remained a mystery since the physicians of
ancient Greece began employing digitalis, the oldest and most
famous of this drug group.
Receptors round out the major categories of cell membrane
proteins. These proteins are able to “recognize” and bind to
specific compounds in the blood, such as hormones and neu¬
rotransmitters. Receptors also serve as “home ports” for an¬
tibodies and drugs as they combat disease within the cell.

Because of receptors’ relationship to the therapeutic action
of many drugs, much research into these proteins, at Yale as
well as other institutions, takes place under the aegis of phar¬
macology. Nevertheless, the key role of receptors in mem¬
brane physiology has led the department to consider if some
receptor researchers might not be logical additions to the
physiology faculty.
A COMMON DENOMINATOR
The wide application of the research undertaken at the depart¬
ment of cellular and molecular physiology is reflected in the
diverse sources from which the department receives outside
funds.
The National Institutes of Health sponsors the largest pro¬
portion of research. A majority of NIH institutes, ranging
from “Heart, Lung and Blood” to “Cancer,” support depart¬
mental studies. Other grants come from such organizations as
the American Heart Association, the Kidney Foundation and
the National Multiple Sclerosis Society. The department does
not engage in any contract work.
Another sign of the research's extensive practical implica¬
tions comes from the diverse makeup of the department's fac¬
ulty. In addition to its 15 full-time primary appointments, 12
hold joint appointments in physiology and other departments,
ranging from epidemiology and public health to human ge¬
netics, internal medicine and pharmacology.
In fact, as the applications of cellular and molecular re¬
search become more and more basic, they increasingly blur
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Hold the Arm & Hammer, Please

or Lawrence Cohen pauses during a brain storming

si on.

To an uninformed observer, using government money to test
the palates of lowly sea slugs might leave a scientific in¬
vestigator open to a congressional Golden Fleece Award.
But in fact, the research of Professor Lawrence B. Cohen,
Ph D., whose funding comes from the National Institute of
Neurological and Communicable Diseases and Stroke, il¬
lustrates some of the important work being done at the supracellular level within the department of cellular and
molecular physiology. Professor Cohen points out that the
brains of even primitive animals, such as sea slugs, are dif¬
ficult to study because the millions of neurons in their
brains are constantly active, while conventional techniques
allow for only a few of these cells to be monitored at a time.
However, Professor Cohen and his group have developed
optical methods for studying more than 100 sea slug neu¬
rons simultaneously. First, the scientists apply dye or flu¬
orescent material to certain brain cell membranes of the
animals. Then the researchers record by means of comput¬
erized photodetectors the changes that occur when the sea
slugs learn a simple task, such as which of two paths lead
to food not flavored with bicarbonate, a substance which
the creatures find unpalatable. Such methods may one day
lead to more effective methods to study the brains of higher
animals, including humans.
Professor Charles R. Michael, Ph.D., is investigating
individual nerve cells in much higher animals. Old World
monkeys. In research funded by the National Eye Institute,
Professor Michael has surgically implanted electrodes in
the cortex of the primates in an effort to discover which
cells are responsible for color vision and what role each in¬
dividual cell might play in this type of perception.
YALE MEDICINE Spring 1988

the distinction between medical disciplines. As this trend con¬
tinues, departments are finding it advantageous to combine
their strengths and apply jointly for grant funding.
During the past few years, for example, the department has
received program project grants to investigate transporters
and pumps in conjunction with the departments of human ge¬
netics, medicine and pathology. And last year, the department
earned five-year funding to work with the department of phar¬
macology in studying channels.
This overlap of disciplines has encouraged interdepartmen¬
tal cooperation in other areas as well. Notes Dr. Boulpaep,

“The more basic our research gets, the more we use the same
instruments as other medical areas. This has led cellular and
molecular physiology to share tissue culture and electron mi¬
croscopy labs with the departments of pathology and
medicine.’’
What sort of future does Dr. Boulpaep predict for the his
department?
“The trend toward more shared research between depart¬
ments will continue. 1 also foresee increasing numbers of
graduate students as the importance of our field —and our de¬
partment’s reputation for excellence —continue to grow.’’

Recording the Song of
A Single Molecule
Investigation of cell structure and function has received a
major boost in recent years by improvements in the tech¬
nique known as “patch clamping.” Frederick J. Sigworth,
Ph.D. (’79), assistant professor of physiology, is one of the
pioneers in this field. He explains how he can use patch
clamping to measure the electrical changes that occur when
a single channel protein molecule opens its “lock” of
atomic dimensions.
The technique involves pressing against the cell wall a
tiny glass pipette with an opening about half-a-micron
wide. The tube is filled with a saline solution into which
is placed a silver wire electrode that can measure the picoampere currents that flow in milliseconds through the
cell surface.

The pipette’s seal against the cell is so tight that a piece
of the membrane —a patch —can be excised and placed
in an experimental medium designed by the investigator.
By monitoring the patch in its new, carefully controlled
environment, the scientist can determine how even a
single molecule reacts when exposed to various ions and
electrical charges.
Among its many applications, patch clamping is being
used to study the movement of water and ions across the ep¬
ithelium of kidney tubules, neuromuscular transmission,
and the mechanisms of the sense of smell.
Fred Sigworth, Ph.D., displays a pipette he uses in patch
clamping, a technique that he helped develop.

JAMES ANDERSON

Diary of a patch clamp. (1) A pipette with a tip half-a-micron wide is placed against the
membrane of a cell. The junction is sealed with a charge from an electrode inside the pi¬
pette. (2) As suction is applied, a section of the membrane is drawn into the pipette. (3)
The pipette is pulled away, excising a patch of the membrane along with some of the cell's
cytoplasm.
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7

WHEN DOCTORS GET SICK
by Howard Spiro, M.D.
Doctors make poor patients, everyone knows. They usually
keep quiet about being sick, either as practitioners afraid that
patients want a doctor who can be counted on, or as academics
worried that their colleagues discount the future of someone
wounded. But then we do get sick, just like anyone else, even
if no one knows because most of us tend to keep on working
unless the complaints put us to bed.
Few physicians stay home with the flu and fewer of us are
as careful of our own health as we tell our patients to be.
Sometimes we think that we are less neurotic than they be¬
cause the hypochondriasis of medical school and residency
has purged us of acting on our fears and led us to conclude that
we are almost immortal. Most doctors know about sickness
from their patients, not from their own experiences.
Harvey Mandell, a clinical associate professor and medical
director of the Backus Hospital, and 1 were discussing such
matters one day after a lecture by Bob Byck in the Program for
Humanities in Medicine recounting his own heart operation.
Harvey and 1 have had lunch together on Fridays for over 30
years, and yet as old friends aging together we had never really
talked about doctors who had been sick. It was all the more
surprising because Harvey himself had had a melanoma many
years before.
But Bob Byck's lecture gave us an idea. Recalling a book
by Pinner and Miller, When Doctors are Patients, a collection
of essays which had appeared in the 1950s, it seemed like the
opportune time to put together a new collection.
THE SILENT PHYSICIAN
Indeed, the fruit of our efforts, When Doctors Get Sick,
(Plenum 1987), has just appeared —and the job proved far
harder than we had anticipated. Only a few doctors who have
been patients have written about what they learned from the
experience. Oliver Sacks comes first to mind because he has
been the most prominent to do so recently. A small number of
other physicians have described their travails in the pages of
the Lancet and British Medical Journal, and even fewer have
done so in our American journals.
These individuals are exceptions because we physicians are
always doing something, not writing about it. Our lives are far
less contemplative than they could be because of the demands
for action we face —and love —everyday. We have been trained
to measure and not to reflect, and our fast-paced lives leave
very little time for introspection.
Though even Bob Byck was too busy —or too wary —to put
his moving and humorous account down on paper for us, sev¬
eral other colleagues did agree to write about their own encounters with illness. Of these, Kenneth Barwick, Charles
Kleinman, Hastings Wright, and Barry Zaret, along with the
i.
Hugh Dwyer, are among the best known of our recent Yale
lty. A few physicians who had been residents or teachers
us ago at Yale also contributed.
Y iy contributors have told me what a catharsis it was to
"n their illness while writing their story. Reliving their

frustrations and anxieties gave those physicians a chance to
reorder their experience, to reframe it with the tranquility that
comes from knowing how it all came out. They found new
meanings in retrospect that at the time of their frenzy they
could not have seen.
But for many physicians the opportunity to tell the story of
their illness was not an attractive one. For a few, those with
emotional or drug problems, recounting their illness was just
too painful. Though I cannot blame them, for some are very
prominent individuals, we nevertheless could have learned
so much from them about the contrasting worlds of doctor
and patient.
A YOUTHFUL PERSPECTIVE
Some Yale medical students have already benefitted from
When Doctors Get Sick. Last year a class of first-year stu¬
dents read some of these stories and their reactions were quite
different from mine and some other physicians. “Heaven lies
about us in our infancy," and first-year students have not yet
been so acculturated into medical tradition that they see sick¬
ness with our blinders. They especially found fault with the
implicit concern of the physicians’ doctors with the disease
rather than the patient, a fault that I was too “trained" to
recognize.
Still, the students’ emotional reaction offers me hope that
when physicians read these stories, they will not only reflect
about them in the quiet of the evening, but also discuss and
criticize them.
Larry Cohen, the eminent cardiologist, tells me that he read
one chapter of our book every morning while bicycling. (I was
relieved to learn that Larry uses a stationary bicycle.) I like to
think that when he read the story of Bob Seaver, a former Yale
GI fellow who had to give up his practice in his 40s because
of angina, Larry learned something new about the anxiety and
frustrations of his own patients.
PHYSICIAN HEAL THYSELF
It is of course a paradox to be a patient and a doctor at the same
time. As a doctor-patient you know a lot —or think you do —
and your doctor gives you credit for knowing even more. For
that reason the doctor-patient gets treated differently from
most other people, sometimes better and sometimes worse,
but rarely the same.
Doctors generally deny their symptoms as long as they can
and look for help only when the tension grows too great. They
usually prefer to settle for a corridor consultation along the
lines of, “What would you do about this little pain I've got?"
Once physicians do reluctantly turn themselves over to be
“worked up," they must then deal with conflicting impulses
that result from their paradoxical patient-doctor role. Try as
they might to be a good patient, someone who never com¬
plains, some physician-patients cannot overcome the urge to
remain in charge.
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on a hot day. The radiologist subsequently was scheduled
for immediate bypass surgery —to which he agreed only
when he was promised that he would never have to undergo
another angiogram.
His doctor’s good-hearted insistence on seeing what was
going on and, once he found a lesion, doing something about
it, sounds familiar to me. Such stories make me wonder how
much the increasing visual qualities of medicine make for ac¬
tions that are correct and even appropriate, but on occasion
possibly not required.
Since I know more about gallstones than hearts, I rest with
the observation that the wonderful perspectives of ultra¬
sonography and computed tomography uncover gallstones
which many times deserve to rest in peace. Yet once physi¬
cians see gallstones —even if the patient has no complaints —
the doctors are tempted to do more than just look at them.
Lithotripsy anyone?
LESSONS IN ISOLATION

Dr. Spiro

This is certainly understandable, for every physician knows
what mishaps may —and do —happen in a hospital or in an of¬
fice. So most doctors remain vigilant throughout their own
treatment: Even as they're being watched, they are watching
others. Our book tells of doctors who became monitors of IV
drips to the extent of keeping a flashlight in the bed table
drawer to check on patency of lines in the middle of the night.
Others reacted to the doctor-patient paradox in a different
way. These physicians wrote that they spent a lot of time look¬
ing for the “right’' doctor, and once they found one, let the
physician take over.
They wanted someone else to make decisions for them in
their interest, and as I interpret it, did not want to spend a lot
of time discussing what was to happen. In this regard, too, I
have been impressed by how much many physician-patients
want comfort and optimism, even at the expense of hard truth.
This implicit trust may occur partially because doctors
know that their physicians will be loyal to them as members of
the same profession. Nevertheless, the approach of these phy¬
sicians to being a patient throws new light on the issue of pa¬
tient autonomy— making the patient equal to the doctor in
decision making —that has been so widely discussed over the
last decade.
OUT OF SIGHT. . .
Another observation. I was struck by the complete reliance of
many physician-patients on technology, on seeing their illness
on “hard copy” as quickly as possible. And I was likewise
impressed by the reaction of the attending physicians to find¬
ing a structural defect: Once a doctor can see something
wrong, he or she has to do something about it.
One such doctor insisted that his patient, a reknowned
radiologist, undergo angiography for extrasystoles which
occurred only after strenuous tennis following a heavy meal
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The physician’s doctor must contend with his or her own set
of problems, as well. For example, an immediate empathy, a
merging of identity with the patient-physician does not always
make it easy for the doctor to act as objectively as our credo
tells us we should.
I think this is one of the reasons why that “No Visitor’’ sign
appears on the door of the doctor-patient’s room in the hos¬
pital. We say that it is to keep the patient from being bothered
by visitors. But I suspect that the sign actually protects us
while still vertical from having to confront our own vulnera¬
bility as reflected in our horizontal colleagues. Keeping this in
mind, I hope that these stories will “open the door’’ to the
sick physician, to give us the chance to see ourselves and our
patients more as persons.
I wish I could state that the physicians in our book changed
their character after living the role of patient for a while. Not
many claimed that they became better people for the experi¬
ence. Although a few boasted more tolerance, for some, the
opposite reaction set in: “I was sick, I suffered and got better,
and my patients can do the same.’’
How has putting this book together affected me? I do feel
that I have learned something from every story. For instance,
I have learned that you don’t have to be a physician 24 hours
a day, and that human problems don’t always yield to medical
solutions.
Reading the manuscripts in this book has also convinced me
more than ever that medical education must aim at ensuring
that physicians do not become simply scientists or technicians
taking care of disease. Doctors must remain caregivers to fel¬
low human beings.
But probably the most profound way in which I hope I have
changed is the way I deal with sick colleagues and those who
have recently recovered from illness. Now I try not to turn
away when a physician who has been sick passes by. I have
learned to overcome my embarrassment in asking how he or
she is doing. And when I stop to talk, it turns out not to be as
difficult as I had feared.
Coincidentally, my co-editor Harvey Mandell had a coro¬
nary artery bypass scheduled just about the time our book
came out. Before our experience of working on this book,
upon his return we might have first joked briefly about his ill¬
ness and then gone on forever to easier topics. Instead we
talked often and intimately about the whole affair.
Fortunately, he did very well and is back to having lunch,
less lucullan than before, with me on Fridays.
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CAREER CHOICE VERSUS
STUDENT DEBT:
TIPPING THE BALANCE?
by Gregory R. Huth

BILL CARTER

Throughout the early 1990s, the champagne corks will be
popping for members of the Class of '81 who will be toasting
the payoff of their medical school loans. They will have good
cause to revel. Along with their diplomas, these graduates
left Yale with an average debt of just over $20,000.
For the Class of '88, however, the mean debt (the pun ap¬
plies) will have doubled —to over $40,000 —for the majority
of students who borrowed to help finance their education. Dr.
Robert H. Gifford, associate dean for education and student
affairs, points out that 55 percent of 130 medical school se¬
niors have borrowed to pay for their professional education,
with individual debts ranging from $3,000 to a whopping
$80,660.
In most cases, the more medical students owe, the more
baffling the array of loans they face, and with more expensive
terms. Even some federally insured loans feature rates that
can reach 19 percent, with interest accruing from the moment
a student signs on the dotted line.
A NATIONAL I88UE
The problem is not Yale's alone. More than 80 percent of med¬
ical students nationally borrow to finance their professional ed¬
ucation, and across the country tuitions are rising, especially at
private institutions.
For example, the Association of American Medical Colleges
(AAMC) reports that fees for a first-year student entering a pri¬
vate medical school in 1980 totalled $7,910. By 1986 that figure
had grown to $15,023. Correspondingly, debt burdens for med¬
ical students, which averaged $19,700 in 1981, have soared to

$35,600 today.
Moreover, there is no relief in sight from burgeoning debt bur¬
dens as rising costs are matched by federal policies that are mak¬
ing financial aid more expensive —and more difficult—to come
by. Nationally, scholarships and grants to students are on the
wane as well.
Escalating medical student debt harbors disturbing ramifica¬
tions for the students, their schools and the nation's health care
system. The AAMC. for instance, is conducting a study to dis¬
cover if increasing debt burdens are encouraging students to pur¬
sue lucrative subspecialties, where there is a glut of
practitioners, while driving students away from primary care
and research, where there are mounting shortages.
Conversations with Yale students indicate that such a study
is warranted. Confesses one second-year student: "I entered
Yale assuming that I could do whatever I wanted with my
medical education. I thought I might practice in a rural area,
but now I feel that's not realistic. The pressure to pay off my
loans is making me take a close look at surgery or some other
well-paying specialty.”
Another legacy of the debt dilemma may be the fourteen-year
nationwide decline in the total number of applicants to medical
schools and, according to a recent article in the Journal of the
American Medical Association, a decreasing proportion of mi¬
nority student applicants.
In coping with medical school debt, Yale has been able to
maintain its competitive position among leading medical
schools. Despite a 1987-88 tuition of $13,770 —which is more
than double the figure of seven years ago —record contributions
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HISTORICAL TRENDS
For many schools, a major part of the problem dates back to the
early 1970s. As the Vietnam war wound down, the nation began
to focus more on domestic concerns. Among the federal gov¬
ernment’s top priorities: heading off a projected doctor
shortage.
In response to this perceived threat, the U.S. Department of
Health and Human Services worked with Congress to encourage
medical schools to admit more students. This federal encour¬
agement came in the form of a capitation system which allotted
money for every student enrolled.
Financial aid to students also flowed. If a medical student
wanted a low-interest federally insured loan, by and large it was
there for the asking, regardless of financial need. Scholarships
were not as pressing an issue because interest rates for loans
ranged between 3 and 7 percent, and were relatively inexpensive
to pay back.
This flood of federal money had its intended effect —the
national medical student population almost doubled, to 15,269,
within 10 years. Faculties and facilities were expanded
accordingly.
By the 1980s, however, the political climate had changed.
Even as President Ronald Reagan and Congress blamed each
other for a record-smashing federal deficit, the government be¬
gan predicting a doctor glut for the 1990s. Inflation in health
costs helped erode public support for the medical establishment,
and student loan defaults became a major issue.
The deficit and the doctor glut helped the administration and
Congress eliminate capitation payments in 1980, a source of as¬
sistance that was never replaced.

The Reagan years also marked the end of the era when a ma¬
jority of medical students could finance most of their education
with loans under 8 percent. In fact, some students found them¬
selves saddled with federally insured loans with variable rates
that reached 19 percent.
The result of this mercurial national policy? Today, many
schools of medicine find themselves with much expanded staff
and facilities, yet faced with substantial cutbacks of the federal
support that had nurtured this growth.
Yale's budget also was affected by the abrupt elimination of
capitation payments, which totaled $324,000 during 1980, the
last full fiscal year they were provided. Fortunately, however, the
capitation program had not induced the School of Medicine to
increase its student population markedly—between 1970 and
1982, enrollment increased by only 10, to 102.
Though not faced with the consequences of overexpansion,
Yale still has had contend with the rising costs that are part of
operating a leading medical school. Most of these costs come
under the categories of maintaining a top faculty and updating
facilities and equipment to keep current with sophisticated med¬
ical technology.
Higher tuitions have been able to ease only a small part of the
resulting financial squeeze. Tuitions pay for only between 6 and
8 percent of a student's medical education.
Thus, Yale and other medical schools, saddled with increas¬
ing costs, and their students, confronted with rising tuitions, are
approaching the 1990s with a wary eye on their finances.
Director of Financial Aid Pamela Nyiri sums up how difficult
the situation has gotten for the average Yale medical student.
“Since I came to this job in 1980, the financial aid scenario has
gotten worse every year. Tuitions keep going up, and the federal
government keeps making loan money less available and more
difficult to apply for, especially for middle-income families. Un¬
less we can come up with creative alternatives to finance med¬
ical education, our population of students will consist only of
the very rich and the very poor.' ’
INTO THE LABYRINTH

E3 living expenses for single students
□ tuition

Tuition at the medical school has more than doubled—to $13,770—
between the years 1980-81 and 1987-88. Toted living costs for a
single student increased during this time from $12,900 to $22,490.
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To best understand how the debt dilemma affects Yale medical
students, one should follow the process of how they apply and
are considered for financial aid.
First, applicants must comply with a federal requirement that
the financial need of students and their parents be documented.
To assist in this “needs analysis,’ ‘ the financial aid office enlists
the Graduate and Professional Financial Aid Service (GAPS-

BILL CARTER

to the Medical School Alumni Fund for fiscal years 1986 and
1987 have kept Yale medical students unencumbered by the
loans with the most onerous terms. Furthermore, the propor¬
tions of minority applications and admissions to the school have
not decreased, as has been the national trend.
Nevertheless, some Yale medical students have not been able
to avoid higher interest loans. And school officials fear that this
may develop into a trend as the economic and political pressures
intensify which have led to higher indebtedness among medical
students nationwide.

FAS) one of several national firms that specializes in needs
assessment.
GAPSFAS provides students with a comprehensive financial
questionnaire that they and their parents fill out along with sup¬
porting documentation, such as federal and state income tax re¬
turns. A GAPSFAS form must be resubmitted by students and
their families every year that financial help is requested.
Once a prospective freshman is accepted, the financial aid of¬
fice uses the GAPSFAS information to implement a new method
mandated by Congress to determine how much financial aid, if
any, medical students should receive.
This involves a series of calculations that determines how
much in loans and scholarships the student will be offered —

each applicant’s needs are analyzed using one of 14 formulas.
Yale offers the student the financial aid package that provides
the most favorable terms.
Pamela Nyiri points out that Yale, Harvard and other leading
private medical schools use a “unit loan” in their standard fi¬
nancial aid packages. For a student whose family agrees to pro¬
vide the “family contribution,” the unit loan is the maximum
amount that the student should have to borrow to finance his or
her education for the school year. Additional financial aid is
provided in the form of scholarships.
For example, during the current academic year, the unit loan
comes to $12,500. If the financial aid office calculates that a
student requires an additional $8,500 to pay for annual ex-

Medical Student Loans—
An Overview
Federally Insured Loans
Perkins Loans

while student is in school; no
grace period for repayment.

RATE: 5 percent, deferred while
Health Education

in school
MAXIMUM: $18,000, includ¬

Assistance Loan

ing undergraduate studies

MAXIMUM: $80,000

TERMS: Must provide needs

TERMS: Same as Supplemental
Loan for .Students, except one-

analysis. In addition to a oneyear forbearance, deferment for

year grace period, and maximum
four-year deferment without gov¬

as long as it takes to obtain a li¬
cense. Deferments also for full¬
time students, or while in the
Armed Forces, VISTA or Peace
Corps. Ten years to pay, mini¬
mum $50/month plus interest.
Guaranteed
Student Loan

ernment service

Uninsured Loans
Yale Revolving
Loan Fund

RATE: 8 percent, deferred while

MAXIMUM: Depends on funds

TERMS: Same as Supplemental
Loan for Students

TERMS: Same as Perkins

NOTE: Rates are set to cover the

Health Profession

RATE: 9 percent, deferred while

Student Loan

in school
MAXIMUM: Tuition

RATE: 12 percent

available

in school
MAXIMUM: $54,750

costs of administration and losses
through borrower death, disabil¬
ity and default.

plus

$2,500
TERMS: Same as above, except
for maximum four-year defer¬

Supplemental Loan
For Students

RATE: Variable, 33/4 percent
above treasury bill rate

SHARE or FELP,
AAMC MEDLOAN

RATE: Market rate
MAXIMUM: Varies among pro¬
grams, with a range of $40,000

ment without government service

to $120,000

RATE: Variable, 33/4 percent
above U.S. Treasury bill rate

TERMS: High service charges.
Student must pass credit check.
Except for MEDLOAN, student

MAXIMUM: $20,000
TERMS: Same as GSL, except
interest accrues and capitalizes

repays loan while still enrolled,
with deferred loans available only
at higher rates.
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penses, then this amount is provided in scholarships.
Notably, the amount of the unit loan depends on how much
scholarship money there is available: The more scholarship
money there is to go around, the lower the unit loan.
The financial aid package assumes a different look, however,
when a student’s family does not contribute what is required ac¬
cording to the needs analysis. To make up for the missing family
contribution, the student must take out other loans, at higher in¬
terest rates than those the unit loan comprises. |See “Medical
Student Loans —An Overview.”J
The parental support provision is not a flawless criterion to
insure that finite loan resources are distributed fairly. Though it
does succeed in keeping the children of wealthy families from
borrowing needlessly for their education, the provision also can
cause some truly needy students to “fall through the cracks”
and end up deeply in debt.
Many students in their 30s or even older—who have been liv¬
ing independently for years —do not feel it fair to prevail on their
parents for support, especially if the parents are at or near re¬
tirement. In other cases parents refuse to support the student.
Such refusal is not always hostile or even voluntary. In many
cases parents prove to be “assets-rich and cash-poor”: Despite
their “paper wealth,” they have no money to contribute to their
offspring’s education. [See “A Tale of Two Students.”]

A Tale of Two Students

O unit loan total for four years
♦ unit loan

The unit loan of $12,500 for the 1987-88 academic year actually
represents a decrease from the $13,250 level reached during 19851986. Lower unit loans have been made possible because all gifts to
the Yale Medical School Alumni Fund that are available for current
use have been designated for scholarships.

John takes out a government-insured loan at a 12 percent interest
rate. John estimates that when he graduates from medical
school, he will face an $80,000 debt.

Editor's note: In an attempt to distribute limited loan funds eq¬
uitably, the federal government requires every medical student
who applies for financial aid to undergo a needs analysis. While
this approach does keep children from wealthy families from un¬
necessary borrowing, it also forces some truly needy students to
accept higher interest loans.
A major shortcoming of needs analysis: The formula for cal¬
culating how much parents should contribute to their children's
education fails to take into account how long a student has been
financially independent. Neither does it make allowances for
parents who may be ‘ 'assets-rich and cash-poor,'' as illustrated
by the following accounts of two second-year Yale medical stu¬
dents. (Names have been changed for the sake of privacy.)
John was a teenager when his parents divorced. He went to
live with his mother, and his father stopped support when John
turned 18. The young man was able to put himself through col¬
lege by a combination of scholarships, loans and odd jobs.
After he entered medical school, however, John's needs anal¬
ysis took into account his father’s assets as well as his mother’s.
Indeed, the parental obligation to help pay for John's education
also extended to his father’s second wife, whom John barely
knows.
The father’s new wife owns a farm where the couple now
lives. Because of this asset —though John’s father brings home
only $22,000 a year—he and his second wife are supposed to
contribute $10,000 a year toward John’s education. To make up
for this sum —an obligation that John’s father will never pay —
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Andrea, who is in her mid-30s, finds herself facing another
“catch-22.” Her parents, elderly and retired, live on a fixed in¬
come of just over $20,000. They have virtually no savings.
Years ago, however, in the era before steep housing inflation,
they had bought a small home in an affluent suburb.
Because of this asset, the needs analysis stipulates that An¬
drea’s parents should be contributing $17,000 per year to her ed¬
ucation. In fact, they can provide nothing. This high parental
obligation —impossible to meet without her parents selling their
home —means that Andrea receives no scholarship aid.
During her first two years of medical school, Andrea has
been spending her recess and vacation working overtime to min¬
imize the amount of higher interest loans she will have to bear
in lieu of the parental contribution. Thus far she has managed to
keep her total loans down to $30,000, although she knows that
her third-year academic obligations will keep her from contin¬
uing any outside work.
As a result, upon graduation in 1990, Andrea expects to have
accrued between $70,000 to $80,000 in debt. She wonders if
this will keep her from pursuing her goal of working in aca¬
demic medicine, where she hopes to be an advocate for the poor
and underserved.
“A medical education, especially at Yale, is so rewarding,”
Andrea muses. “It’s just a shame that I’m so often distracted,
worrying about money.”
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The shrinking number of medical school applicants nationally
adds the dimension of interschool competition to the financial
aid problem. Yale must compete not only with independent in¬
stitutions but also with prestigious state schools that offer low
tuitions.
Compare Yale's tuition of $13,770 with the $3,600 residents
of Texas pay at the University of Texas at Houston. California
residents can attend the University of California at San Fran¬
cisco for an annual tuition of $1,600.
Even in the face of such figures, though, many factors argue
in favor of Yale. Among them:
• Prospective students know that they will receive the highest
quality preparation in either clinical or research medicine.
• Many will be attracted by the Yale System, which offers flex¬
ibility in choosing courses and deemphasizes competition and
testing.
• The school's reputation for excellence insures that Yale grad¬
uates have a broad range of career choices.
Soaring medical student debts could threaten this third ad¬
vantage, however, especially for students who wish to pursue
lower-paying careers in research or in practices among the un¬
derserved. Again, federal cutbacks have exacerbated the
problem.
Observes Dr. Myron Genel, associate dean for government
and community affairs. "The National Health Service Corps of¬
fers loan forgiveness of up to $25,000 annually to new M.D.s
who serve certain underserved populations. But this year only
40 to 50 doctors will be able to join the program because of an
inadequate appropriation of $2 million.''
Dr. Genel adds that Armed Forces scholarships have survived
with their otter of free tuition and a stipend for military service,
but the program is more difficult than ever to enter because of
great demand.
1 en Yale's policy of admitting students without regard to fimcial need —another competitive advantage —faces the danot being rendered moot. This will happen if many
Gukites from middle-income backgrounds decide against en’ because of the debt burdens they and their families will
have to bear.
innately, the Yale medical school administration and the
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STAYING COMPETITIVE

alumni are working together to keep this from happening.
In 1986, Dean Leon E. Rosenberg began a policy of ear¬
marking for scholarships all gifts to the Medical School Alumni
Fund that are available for current use. Such alumni support is
augmented by scholarship endowments and funds that the dean
earmarks from his discretionary budget.
This academic year, the dean designated $317,000 for
scholarships, which was complemented by $245,000 in
endowment income and $235,000 in alumni contributions. A
significant increase in alumni giving from the previous year
made it necessary to raise the unit loan only 2 percent —from
$12,250 to $12,500.
Though not faced with the consequences of overexpansion,
Yale still has had to contend with the rising costs that are a part
of operating a leading medical school. Most of these costs come
under the categories of maintaining a top faculty and updating
facilities and equipment to keep current with sophisticated med¬
ical technology.
This, in turn, allowed financial aid director Nyiri to keep stu¬
dent loans —aside from those given in lieu of the family contri¬
bution—at or below a 9 percent interest rate. This development
will have a profound, positive effect on the finances of schol¬
arship students. Observes Ms. Nyiri, "Last year's generous out¬
pouring of support from the alumni saved Yale medical students
who are on financial aid thousands of dollars in interest
payments.”
She also points out that from a recruitment standpoint, this
has helped Yale stay competitive. For instance, the debt burdens
of 1987 Yale and University of Connecticut medical graduates
were comparable, although the state school's tuition is about
half, according to a recent New York Times article.
Dean Rosenberg underscores the importance of continued
alumni support. "In this era of federal stringency and rising
costs, we rely on the financial support of our alumni more than
ever. Educating tomorrow's Yale physicians —this school's
heirs —must always be a cooperative effort between Yale and its
alumni.”
At a recent executive committee meeting of the Association
of Yale Alumni in Medicine, however, members expressed con¬
cern that donations for the current fiscal year were running
$200,000 behind last year's record pace.
"Should the alumni decrease their giving.” the dean points
out. "scholarships will decrease, and many Yale medical stu-
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The Class of 1988
A profile of those who borrow
to finance their medical education
Estimated Mean Debt
Medicine
Physician Associate
Epidemiology and Public Health

$40,000
23,000
25,600

Estimated Maximum Debt
Medicine
Physician Associate
Epidemiology and Public Health

$80,600
30,100
40,100

The debts of physician associate and epidemiology and public health
students tend not to be as high as those of medical students, who, on
average, take more years to complete their degree. Nevertheless, in¬
debtedness also affects PA and EPH students seriously, because they
receive lower salaries than do most new doctors.

dents will literally be the poorer for it. We must get the word out
to the alumni about the great degree to which our students ben¬
efit directly from their gifts.”
LOOKING TO THE FUTURE
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engender complaints of others who do not receive extra schol¬
arship aid despite similar needs and interests.
As the dialogue over long-term strategy continues, however,
a specter looms over the immediate future: The cost of attending
medical school will keep escalating even as the prospects for
low-interest student loans continue to dim.
For the Yale University School of Medicine to continue her
legacy of attracting the best students from all walks of life, sup¬
port from her alumni must continue to grow.
BILL CARTER

Given the current economic and political climate, medical ed¬
ucation administrators and their allies are trying to make the
best out of a difficult situation.
One of the few promising developments is a loan administra¬
tion program called MEDLOANS which was recently unveiled
by the Association of American Medical Colleges. Among
other features, the program offers a simplified application pro¬
cess for applying for government loans.
MEDLOANS also makes higher interest non-government
loans somewhat less expensive by requiring no payments while
the recipient is in school or in the early part of the residency pe¬
riod. The program also offers a graduated payment plan so that
physicians can make lower payments during the first, less lu¬
crative years of practice.
Meanwhile, at Yale, administrators and alumni leaders are
discussing contingencies that could ease the pressure of mount¬
ing student debts.
Associate Dean Gifford is considering an income-contingent
plan whereby borrowers who receive financial aid would pay a
percentage of their salary until the debt incurred by their grad¬
uating class is paid off. Because those who earn smaller salaries
would pay less, students could choose research or other lower
paying areas of medicine without fear of how they could support
their medical school debts.
Another approach calls for alumni classes to sponsor individ¬
ual students with scholarships or low-interest loans. Such
awards would go to students who stated a career preference for
a lower paying or underserved area of medicine.
Neither approach, however, would be without its problems.
The first invokes the memory of the Tuition Postponement Op¬
tion, a percentage-payback plan that was instituted at Yale Col¬
lege in the early 1970s. It was discontinued after only a few
years because low-interest government loans became available
and not enough students chose to enlist.
The second plan would require a fundamental change in the
school's philosophy of providing financial aid. Through the
current unit loan system, scholarships are provided in a uniform
fashion and on a needs-basis only. Scholarships based on career
interest, while easing the debt burden of some students, would

15

HERE AND
ABOUT
Team Evaluates
Curriculum
Just as physicians diagnose their patients'
condition, a new School of Medicine task
force will examine the medical curriculum
and diagnose the four-year educational
program.
“The best aspects of the Yale curricu¬
lum are its flexibility and diversity," says
Dr. Edward J. Benz Jr., professor of med¬
icine and human genetics and chairman of
the task force on curriculum evaluation.
“While we would like to know that every
Yale graduate comes out well educated,
all of our students don't necessarily have
to take the same courses."
Hallmarks of the Yale System are the
minimum number of required lectures and
the thesis requirement. “We will not rec¬
ommend any changes in these areas; we
will not tamper with things sacred to the
curriculum, and we will preserve its flex¬
ibility," Dr. Benz says.
The task force, which includes depart¬
ment chairmen, members of the curricu¬
lum committee, faculty and medical
students, is not empowered to write a new
curriculum, Dr. Benz emphasizes. "We
are simply going to study it." At the same
time, the school's curriculum committee,
a separate group which he also chairs, will
continue to monitor ongoing course
offerings.
Basically, the task force will:
- Define the goals of a Yale medical
education which trains both professors
and practitioners.
- Hold the curriculum up against cer¬
tain educational standards to see whether
such essential aspects as nutrition and out¬
patient practice are being taught and to see
whether such basic science courses as
physiology and pharmacology are com¬
plementing clinical experiences.
- Recommend, in a broad way, the
scope of any curriculum revisions. This
process may range from revising some
areas to writing a new curriculum. The
task force then will provide guidelines
about which areas need to be preserved or
strengthened.
Among specific questions that the task
force will address are: What are the best
ways to teach students the clinical skills
the\ need'1 How do educators relate vast
amounts of basic science information to
the complexities of clinical care? Should
basic sciences be reintroduced in the
fourth year? Is teaching an activity that is
sufficiently recognized and rewarded at
Yale?
I he risk force has invited faculty, stuand recent graduates to present their
the curriculum. In addition. Dr.

Benz has written to peer institutions, such
as Stanford and Johns Hopkins, to learn
about their educational programs. “While
we are looking for ideas and insights from
others, we don’t want to repeat someone
else’s mistakes,” he notes.
The work is expected to be completed
by the end of May, Dr. Benz projects, add¬
ing "We are not predicting answers or so¬
lutions until we get the data."
Why did Dean Leon E. Rosenberg ap¬
point the curriculum task force?
Several factors indicated the merit of
such a move. Recently, the faculty agreed
to introduce a new course, "Professional
Responsibility." during the second year,
but it was difficult to find a place in the
curriculum. This pointed up the need to
look at the curriculum in anticipation of
future course additions that will adapt
physician education to new challenges.
There also is a need to take a closer look
at the fourth-year program, where stu¬
dents may benefit from a more structured
approach. Now, Dr. Benz says, these stu¬
dents spend considerable time interview¬
ing for residency positions and writing
their theses.
Among suggestions the task force will
consider is reintroducing basic sciences in
the fourth year, after students have had
some clinical experience. "Basic science
and clinical experience are two universes
that students have to master. Integrating
these areas is very important if physicians
wish to stay current and help their pa¬
tients,” notes Dr. Benz.
The current approach, which divides
the curriculum into two distinct parts, may
not allow students to appreciate how the
basic sciences and clinical experiences are
intertwined. Dr. Benz explains. “One
needs to think of these four years of med¬
ical school as the first stage of on¬
going education, not just as single-shot
training. . . . Physicians should always
use basic science to try to understand what
happens to patients.”
Members of the Task Force for Curric¬
ulum Evaluation include:
Walter F. Boron. M.D., Ph.D., professor
of cellular and molecular physiology
Dr. Ann M. Curtis, professor of
diagnostic radiology
Dr. Richard L. Edelson, professor and
chairman of the department of
dermatology
Sonya S. Erickson, third-year medical
student
Dr. Robert H. Gifford, associate dean for
education and student affairs
Dr. Richard J. Gusberg, associate
professor of surgery
Ethan A. Halm, second-year medical
student
Dr. Barbara Kinder, associate professor
of surgery
Vincent T. Marchesi. M.D., Ph.D.,
chairman of the department of
pathology and the Anthony N. Brady
Professor of Pathology. Cell Biology

and Biology
Dr. Dwight F. Miller, associate clinical
professor of pathology and president
of the Association of Yale Alumni in
Medicine
Gordon M. Shepherd, M.D., D.Phil.,
professor of neuroscience
Walter M. Stadler, fourth-year medical
student
Arthur J. Viseltear, Ph.D., associate
professor of the history of medicine
and public health
Dr. Joseph B. Warshaw, professor and
chairman of the department of
pediatrics

Novel Mentorship System
Stimulates Networking
The Office for Women in Medicine has ini¬
tiated a novel system whereby spouses of
School of Medicine faculty will be paired
as mentors for partners of postdoctoral fel¬
lows. residents and interns.
“The mentorship system will provide
both professional and social networks,"
says Merle Waxman, the director of the
Office for Women in Medicine, who has
established the program.
"We expect the mentors to be important
role models during this period of intense
training when the spouses of postdoctoral
fellows, residents and interns have to cope
with a variety of issues, and often feel
stressed, anxious or socially isolated,"
says Ms. Waxman.
“We expect that mentors will provide
an introduction to Yale University, YaleNew Haven Hospital and the Greater New
Haven area, to the intricacies of being a
medical partner, and to the ways in which
couples can effectively balance busy
careers with family responsibilities,"
she adds.
The mentorship program is an out¬
growth of recommendations made by the
housestaff support group, called Support
Plus. The group was organized last year by
two psychotherapists who are in private
practice and are medical spouses.

Yale-New Haven
Board Elections
Dr. Leon Rosenberg, dean of the School of
Medicine, and Sheila Wellington, ’68
M.P.H., M.U.S., secretary of Yale Uni¬
versity, were elected to Yale-New Haven
Hospital's 28-member board of trustees in
December, 1987. Also elected was George
W. Edwards, Jr., chairman of the board
and chief executive officer of United
Illuminating.
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Yale Physicians Building Enhances Patient Care

atrium
In early March, the School of Medicine
opened the Yale Physicians Building, a
four-story, $13 million facility located
at 800 Howard Ave.
“The building represents a major
step for the school to operate more ef¬
ficiently its specialty ambulatory care
programs which are essential compo¬
nents of our mission,” explains Dean
Leon E. Rosenberg.
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dean for clinical affairs, notes that the
new building consolidates and central¬
izes many of the specialty ambulatory
patient care services that full-time fac¬
ulty physicians provide patients who
are referred from throughout the North¬
east and around the world. In the past,
these services have been at sites scat¬
tered throughout Yale-New Haven
Medical Center.
A number of outpatient specialty
services have not moved, including in¬
ternal medicine, which remains in the
Dana Clinic Building. It is easily ac¬
cessible to the Yale Physicians Build¬
ing via a second-floor pedestrian bridge
over Howard Avenue. The Yale Eye
Center also remains in its newly reno¬
vated space in the Boardman Building.
For the convenience of patients, the
Yale Physicians Building also houses
satellites of a number of Yale-New Ha¬
ven Hospital services, including diag¬
nostic imaging, electrocardiography,
clinical laboratories and physical ther¬
apy. A Medical Center Pharmacy sat¬
ellite is located on the first floor.
The building is fully accessible to
the handicapped; it includes handi¬
capped parking immediately adjacent
to the building, ramps and a revolving
entrance door which accommodates
wheelchairs. Additional patient park¬
ing adjoins the facility.
“This summer, we will have a com¬
puterized patient appointment sched¬
uling system installed,” Dr. Greenspan
explains. “The system will simplify
the scheduling of appointments for re¬
ferring physicians and their patients and
also will provide patients with preregis¬
tration information.”
Faculty offices for four medical school
departments or sections are now housed
in the new building. These include ear,
nose and throat; orthopaedics and reha¬
bilitation; plastic surgery and urology.
Ellerbe Associates, Inc., an architec¬
tural and engineering firm based in Min¬
neapolis, Minn., designed the new
building, while Morganti Inc. of Ridge¬
field, Conn., served as the primary
contractor.
The Yale Physicians Building: exterior view
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The 95,000 square-foot building in¬
cludes specialty care services in der¬
matology, ear, nose and throat;
neurology, obstetrics and gynecology,
medical oncology, orthopaedics and re¬
habilitation, pediatrics, surgery and
urology. In addition, the genetic coun¬
seling service has moved into the new
facility.
Dr. Richard H. Greenspan, associate
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EPH Receives $311,000
Recruitment Grant
The department of epidemiology and
public health has received a threeyear federal grant to encourage minor¬
ity and economically disadvantaged
students to obtain graduate education
leading to careers in public health.
The new Health Careers Opportu¬
nity Program (HCOP) is funded by a
S311,000 grant from the U.S. Depart¬
ment of Health and Human Services.
EPH is one of the few graduate and
professional schools to receive the
award. Most grants go to undergrad¬
uate colleges to recruit high school
students into he a 1th- oriented
programs.
The new HCOP grant encourages
students to seek graduate education in
order to enter the health field where
their views and talents are needed.
“We are very pleased to receive
this grant,” says Professor Stolwijk,
the principal investigator. “In this
time of tight money, the federal gov¬
ernment has recognized our commit¬
ment to promoting educational
opportunities for minorities and the
economically disadvantaged.”
Professor Stolwijk notes that while
the HCOP grant will complement the
comprehensive teaching program al¬
ready in place, it will be administered
in the student Resource Center, which
counsels students about careers and

practicum opportunities.
Comments Matthew Lopes, assis¬
tant director of the center, “HHS
awarded this grant because we argued
successfully that the field of public
health needs these professionals. It is
a field where students can choose
from among a wide variety of vital,
fulfilling careers.”
He adds that while EPH minority
enrollments have not followed the
downward national trend, the HCOP
grant should allow the department —
which is an accredited school of pub¬
lic health —and other health schools
to increase their numbers of minority
students as these students become
aware of career opportunities in the
health field.
The EPH Resource Center will recuit students, provide academic sup¬
port if it is needed, and assist them in
obtaining health experience. Students
in their junior college year are helped
with their senior course selections.
Mr. Lopes has already visited col¬
leges in Connecticut, Rhode Island,
Virginia, Massachusetts and Georgia.
Career advisors at some of these
schools will also visit Yale to see the
program in action. A committee of
students, faculty and health profes¬
sionals will advise and monitor the
program.
As part of the HCOP grant, Yale in¬
vestigators will study why some stu¬
dents elect to go to graduate school
and why some choose health careers
but others do not.

The Class of 1991: Who's Who
Nina J. Abramson, Brooklyn, N.Y.
B.A. (chemistry) City University of New York, Brooklyn. 1987
Jeanne Bari Acknian, Chappaqua. N.Y.
B.S. (biology) Harvard University, 1987
Marc Edward Agronin, Appleton, Wis.
B.A. (philosophy/psychology) Harvard University’, 1987
Cargill Herley Alleyne, Washington. D.C.
B.S. (chemistry/mathematics) George Washington University, 1986
Jorge Guillermo Arroyo II, Tampa, Fla.
B . A. (engineering/neurobiology) Amherst College, 1987
Stephen Michael Bell, Milton, Mass.
B.A. (biology) Harvard University, 1986
Stacy Ann Beller, Bowie, Md.
B. A. (biology) Wellesley College, 1985
Ulrienne Louise Bennett, New York City
B \. (biology) Vassar College, 1981

Sports Medicine Center
Opens at Long Wharf
The Sports Medicine Center, a joint effort
of the department of orthopaedics and
rehabilitation at the School of Medicine
and Yale-New Haven Hospital, opened in
January.
Physicians at the center, located adja¬
cent to the Gaylord/YNHH Rehabilita¬
tion Center at Long Wharf, will diagnose
and treat sports medicine problems and
injuries.
‘ ‘The Sports Medicine Center brings to¬
gether outstanding expertise and facilities.
It provides state-of-the-art patient care,
including diagnosis, treatment and reha¬
bilitation. At the same time, it serves a
worthwhile teaching function,” states Dr.
Gary E. Friedlaender, chief and chairman
of orthopaedics and rehabilitation at the
hospital and medical school.
Dr. Peter Jokl, professor of orthopaed¬
ics and rehabilitation, will direct the cen¬
ter, along with Dr. J. Kevin Lynch,
assistant clinical professor.

Peter Samuel Bernstein, Setauket, N.Y.
B.A. (English) Yale University, 1986
Mark Steven Bianchi, Brooklyn, N.Y.
B.A. (biology) New York University, 1986
Michael Jason Borodkin, New York City
B.A. (history) University of Pennsylvania, 1987
Elizabeth Ann Bower, Woodside, Calif.
B.A. (biology) Stanford University, 1984
Marcus Otho Butler, Houston, Texas
B.S. (biology) Rice University, 1987
Michael Anthony Capozza, Houston, Texas
B.A. (biochemistry/biology) University of California, San Diego
1987
Steven Brooks Care, Oberlin, Ohio
B.A. (philosophy) Yale University. 1986
Jeffrey Donald Carter, St. Louis, Mo.
B.A. (African and Afro-American studies/biology) Washington
University, 1987
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Jonathan Theodore Chai, Syracuse. N Y.
B.S. (biology) Stanford University, 1985
Ada Cheung, Alberta, Canada
B.S. (medical microbiology) Stanford University, 1987
Christopher John Cohen, Swarthmore, Pa.
B.A. (biology) Swarthmore University, 1986
Daryl Keith Daniels, West Newton, Mass.
B.A. (biology) Washington University, 1986
Sarah Ann Davidson, Larchmont, N.Y.
B.A. (English) Columbia University, 1987
Frederic White-Brown Deleyiannis, Alexandria, Va.
B.A. (history) University of Pennsylvania, 1987
David Jeffrey Eisenman, Teaneck. N.Y.
B.A. (classical studies) Columbia University, 1987

Class of 1991 Profile
The Class of 1991, comprised of 66 men and 38 women, was se¬
lected from 1,935 applicants representing more than 40 colleges.
The class includes four students accepted through the early decision
plan, 10 students enrolled in the M.D., Ph.D program, three chil¬
dren of Yale University faculty and seven children of alumni, two of
whom are children of medical school alumni. Three of the first-year
students hold Ph.D. degrees and six have master’s degrees.
Black Americans and other minority students comprise 24 percent
of the Class of 1991. Four of the students are foreign nationals. Stu¬
dents in the Class of 1991 range in age from 19 to 35. with a mean
age of 23.
As in previous classes, the majority of the Class of 1991 were sci¬
ence majors as undergraduates, but one third of the students had ma¬
jors in the humanities and social sciences, 6 percent more than the
Class of 1990.
Twelve of the first-year students are Yale alumni, 10 are Harvard
graduates and seven graduated from the University of Pennsylvania.

Elizabeth Denise Elguera, Elmhurst, N.Y.
B.A. (biology) Johns Hopkins University, 1986

Lawrence James Hirsch, Holmdel. N.J.
B.A. (computer science) University of Pennsylvania, 1987

Mark Alan Epstein, Dallas, Texas
B.A. (biology) Stanford University, 1986

John Sheda Ho, Killeen, Texas
B.S. (biology) Johns Hopkins University, 1987

Amin Fazeli, Berverly Hills, Calif.
(biology) University of California, Los Angeles, 1987

Elizabeth Hopkins Holt, New Haven. Conn.
B.S. (biology) Columbia University, 1986

Daniel William Fitzgerald, Sudbury, Mass.
B.A. (philosophy) University of Notre Dame, 1986

Larry Horesh, Atlanta, Ga. (physics) Georgia Institute of
Technology, 1986

Douglas Theodore Fleming, Princeton. N.J.
B.A. (religious studies) Yale University, 1984

Karen Mei Hsieh, Towson, Md.
B.A. (biochemistry) Harvard University, 1986

Colleen Daun Foy, Madison. Wis.
B.A. (anthropology) University of Wisconsin, 1982

Doris Monica larovici, Forest Hills, N.Y.
B.S. (biology) Yale University, 1987

Gaetane Caroljean Francis, Cambridge, Mass.
B.S. (biology/engineering) Massachusetts Institute of Technology,
1986

Richard George Ihnat, Nishanic, N.J.
B.A. (biology) Rutgers University, 1987

David Frankfurter, Jamesville. N.Y.
B.S. (psychology) Syracuse University, 1986

Richard Geoffrey Ingber, Cambridge, Mass.
B.A. (English) Harvard University, 1973
M.A., Ph.D. (comparative literature) Harvard University, 1983

Jean Louise Fraser, Atlanta, Ga.
B.A. (biology) University of Chicago, 1987

Paul Allen Isenbarger, Whittier, Calif.
B.A. (chemistry) Whittier College, 1987

Gwendolyn Grant, New York City
B.A. (art) Amherst College. 1981

Alan Bruce Jotowitz, Teaneck. N. J
B.S. (pre-health sciences) Yeshiva College, 1986

Leacroft Fitz-Henley Green, Bronx, N.Y.
B.A. (theology) Atlantic Union College, 1978

John Edmund Kilty, Hillsborough. Calif.
B.A. (physiology) University of California, San Diego, 1987

Michele Yolanda Griffith .Teaneck, N.J.
B.A. (biology) University of Pennsylvania, 1987

Hi mi Tina Kim, Menands, N.Y.
B.S. (economics) Harvard University, 1986

James Akio Hartleroad, Indianapolis, Ind.
B.S. (biochemistry) Indiana University, 1986

Kurt Treider Kubicka, Yardley, Penn.
B.A. (biology/economics) Cornell University, 1987

Irene Marion Hegeman, Eastport, N.Y.
B.S. (biology) Cornell University, 1987

Helena Akua Kwakwa, Accra-North. Ghana
B.A. (chemistry) Bryn Mawr College, 1987

Carl Thomas Henningson, Hazlet. N.J.
B.S. (chemistry) Seton Hall University, 1987

Kenneth Allen Laughinghouse, Mantoloking, N.J.
B.A. (chemistry) Dartmouth College, 1987

James Whitney Hicks, New Haven, Conn.
B.A. (classical civilization) Yale University, 1987

James Scott Levine, St. Louis Park, Minn.
B.A. (biology) Harvard University, 1986
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David Bruce Lim, Livermore, Calif.
B.A. (physiology) University of California, Davis, 1987

Kathryn Marie Ryder, Lexington, Mass.
B.S. (biology/psychology) Yale University, 1987

Doris Da May Lin, Ephrata, Penn.
B.A. (chemistry) University of Pennsylvania, 1986

Daniel Benjamin Saal, West Orange, N.J.
B.S. (biology) Massachusetts Institute of Technology, 1987

Thomas Samuel Lin, Texas City, Texas
B.A. (chemistry) Harvard University, 1987

Jeffrey Scott Schechner, Brookline, Mass.
B.A. (biology) Boston University, 1987

Francis Matthew Lobo, Scranton, Penn.
B.A. (biology) University of Pennsylvania, 1985

Marc Seltzer, New York City
B.S. (meteorology science) McGill University, 1983
M.S. (meteorology science) Massachusetts Institute of Technology
1984

Monica Lee McDonald, Blaine, Minn.
B.S. (biology/genetics) University of Utah, 1987
Edward Leonard McNellis, Nanuet. N Y.
B.S. (pharmacy) Duquesne University, 1984
Peter Sebastian Marcus, Anaheim, Calif.
B.A. (history) Tulane University, 1987
Ellen Ann Markstein, Springfield, N.J.
B.A. (biology) Williams College, 1986
Funda Meric, Lawrenceville, N.J.
Hacettepe University {Turkey)
David Bernard Miklos, White Oak, Penn.
B.S. (pre-professional studies) University of Notre Dame. 1987
Kent K. Min, Woodcliff Lake, N.J.
B.A. (biology) Brown University, 1987
Jane Elizabeth Minturn, Torrance, Calif.
B.S. (biology) University of Southern California, 1986
Quoc Ai Nguyen, Huntington Beach, Calif.
B.S. (biochemistry) University of California, Irvine, 1987

Grant Harper Shumaker, Fairfax Station, Va.
B.A. (biology) Harvard University, 1987
Ann Marion Smith, Essex Fells, N.J.
B.S. (psychology) Duke University, 1987
Robin Lisa Smith, New York City
B.A. (psychology) Yale University, 1986
Gina Michelle Solomon, New York City
B.A. (comparative literature) Brown University, 1986
Robert Matheson Spillane, Woodland Hills, Calif.
B.A. (chemistry) California State University. Northridge, 1987
James Edward Stanislaw, Warren. Ohio
B.S. (pre-professional studies) University of Notre Dame, 1987
Christopher Charles Steevens, Claremont, Calif.
B.A. (psychology) Stanford University, 1986
Margaret Reba Stevens, New Haven, Conn.
B.A. (psychology) Harvard University, 1986

John McIntosh Ninos, Fayetteville, N Y.
B.A. (biology) Dartmouth College, 1985

Jivin Gerard Tantisira, Glendale, Calif
B.S. (psychology) University of Southern California, 1982
M.S. (biology) California State University, 1985

Gonzalo Javier Paz-Soldan, Weston, Mass.
B.A. (biology) Boston Universitty, 1987

Chloe Lynne Thio, Marietta, Ga.
B.A. (biochemistry) University of Pennsylvania, 1987

Andrew Fisher Phillips, Princeton. N.J.
B.A. (chemistry) Amherst College, 1987

Margaret Maria Toth, Lakewood, Ohio
B.A. (anthropology) Case Western Reserve University, 1987

John Luther Phillips, Tarrytown, N Y.
B.S. (biology) Wesleyan University, 1987

Anthony Yu-Ning Tse, Gaithersburg. Md.
B.A. (biochemistry) Dartmouth College, 1987

Eleanor Susan Poliak, South Bend, Ind.
B.A. (biochemistry) Harvard University, 1985

Steven Jay Ugent, Milwaukee, Wis.
B.A. (biology/Spanish) Washington University, 1987

Marc Nicholas Potenza, Highland Park, N.J.
B.S.. M.S. (molecular biophysics & biochemistry)
Yale University, 1987

David Andrew Utzschneider, Cantonsville. Md.
B.A. (physics) Bowdoin College, 1985

Pablo Alejandro Quintela, Jr., Hialeah. Fla.
B.A. (chemistry) University of Miami, 1987

Marco Verga, Dix Hills, N.Y.
B.S. (biochemistry) State University of New York, Stony Brook.
1987

Eric Alan Richard, Warwick, R.I.
BSE. (engineering) University of Pennsylvania, 1987
Lauren Renee Rodgers, Yardley, Penn.
B.A. (chemistry) Princeton University, 1984
\I ichael Fedele Romanelli, Saint James, N Y.
B.A. (philosophy) Princeton University, 1987
Elizabeth Rubin Roth, New Haven. Conn.
B V (history) Yale University, 1985
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Ellis Lorenzo Webster, Anguilla, West Indies
B.S. (biology) University of the Virgin Islands, West Indies, 1986
Symphorosa Magdaleine Williams, Silver Spring, Md.
B.S. (zoology) Howard University, 1987

Mindy Ellen Wiser. Freehold, N.J.
B.A. (economics) Brown University, 1987

YALE MEDICINE Spring 1988

Waichi Wong, Jamaica, N.Y.
B.S. (molecular biophysics & biochemistry) Yale University, 1986

IN PROGRESS

James Su-Min Yeh, Bethesda, Md.
B.S. (chemistry) Yale University, 1987

Researchers Earn
Javits Awards

Sang-Wook Tim Yoon, Eastman, Ga.
B.S. (engineering) Massachusetts Institute of Technology, 1987

Two scientists from the Yale School of
Medicine —one an expert on secretory
cells and another on how our senses per¬
ceive the world —have received Javits
Neuroscience Investigator Awards from
the National Institutes of Health.
William Douglas, M.D., F.R.S., pro¬
fessor of pharmacology, will use his sevenyear, $1.1 million award to continue his
longstanding investigation into how cal¬
cium and other mediators allow cells to
“understand” an outside stimulus as a
message to begin secretory activity. His
research may have implications for dis¬
eases such as cystic fibrosis and diabetes,
in which patients’ secretory cells behave
pathologically.
Lawrence E. Marks, Ph.D., professor
of epidemiology and psychology, and fel¬
low and associate director of the John B.
Pierce Foundation Laboratory, received
his award to support research on percep¬
tual processes in the senses of touch, hear¬
ing, vision and taste. It extends a current
five-year NIH grant for two years, and
brings his total funding from the federal
agency to $789,000.
The Javits Award is granted through the
National Institute of Neurological and Communicative Disorders and Stroke, and is
named in honor of the late U.S. Sen. Jacob
Javits of New York. It is given to research
scientists “who have a distinguished re¬
cord of contributions in some field of neu¬
rological or communicative sciences and
who can be expected to be highly produc¬
tive over the next seven years.”

EPH Class of 1989 Profile
In the department of epidemiology and public health , 71 women and 43 men are enrolled
in the first-year class. One student is enrolled in a combined M.D., M.P.H. program, and
five are seeking a combined master’s degree in nursing and public health.
The Class of 1989, which includes 16 foreign nationals and 27 black and other minority
students, comes from 19 states and 14 countries. Fifteen first-year students are nurses; 16
hold M.D. degrees; one student has a D.V.M. degree and one has a J.D. degree. The re¬
mainder earned undergraduate degrees in the sciences and liberal arts.
The department of epidemiology and public health, in addition to being a department of
the medical school, is an accredited school of public health.

GALLERY
The Anatomist Overtaken by the Watch . . .
by William Austin (British, 1721-1820)
In the 18th century, anatomists and surgeons were not viewed kindly by the public.
This was due, in part, to the practice of dissection and the illegal means of procuring
subjects —resurrection —literally raising the dead. William Austin's print, published
in 1773, implicates William Hunter, one of England's most prominent anatomists, in a
grave robbing incident. Hunter flees to the right as the watchman, hired to protect the
sanctity of the cemetery, sounds his rattle in a call for help. The watchman holds unto
a burly resurrectionist, typical of the professionals who supplied the dissecting rooms
of London hospitals and private schools, such as Hunter's at Great Windmill Street.
The body of Miss Watts, in a hamper for its removal, has fallen to the ground. It is un¬
likely that a physician of Hunter’s stature would have ventured into the cemetery him¬
self, but that he employed others to do so is certain. That fact that the subject, Miss
Watts, is named, implies that the print is based on a real incident. —Susan Wheeler

$1.25 Million Grant
Funds Spinal Study
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The National Institute of Neurological and
Communicative Disorders and Stroke has
awarded Yale a five-year $1.25 million
grant to study a new approach to spinal an¬
algesia. Principal investigator Dr. Luke
M. Kitahata, professor of anesthesiology
at the School of Medicine, will test
whether newly developed experimental op¬
iate-derivatives are feasible for spinal an¬
algesia. These drugs promise effective and
long-lasting analgesia without the side ef¬
fects that accompany the opioid analgesics
now in use.
Dr. Kitahata’s pioneering studies on the
effects of anesthetics and opioid analge¬
sics on spinal cord function have involved
a sophisticated technique that records the
functioning of single neurons, the cells
that play a key role in transmitting nerve
impulses.

21

Major Research Project
on Dyslexia Begins

Dr. Kashgarian Leads
Kidney Study

Researchers at the School of Medicine, in
cooperation with the Haskins Laborato¬
ries, have initiated a major new research
project combining powerful new technol¬
ogies and innovative approaches to better
understand dyslexia.
Dr. Bennett A. Shaywitz. associate pro¬
fessor of pediatrics, neurology, and at the
Child Study Center, is the principal inves¬
tigator for the five-year project funded last
fall by the National Institute of Child
Health and Human Disorders. The $4 mil¬
lion grant to Yale University will enable
Dr. Shaywitz and his colleagues to extend
their work on learning and attention dis¬
orders in children.
"This comprehensive project represents
a major step forward in understanding dys¬
lexia. It offers, for the first time, the po¬
tential of using magnetic resonance
imaging (MRl) data to provide detailed
pictures of the anatomy, as well as inno¬
vative electrophysiologic measures to ex¬
amine the brains of school children with
dyslexia,” says Dr. Shaywitz.
The MRI information will be combined
with state-of-the-art linguistic testing to
focus on the precise anatomic areas related
to language and reading and to relate ana¬
tomic patterns found in the brains of dys¬
lexic children to specific reading patterns.
Dyslexics, according to Dr. Shaywitz,
"have difficulty learning, even though
they may have conventional instruction,
adequate intelligence and educational op¬
portunities. . . . From both its prevalence
and its impact on children and families,
the disorder presents a major concern to
educators, physicians and families.
"Our new research project will allow us
to approach this important disorder in the
same serious fashion that we use to inves¬
tigate other disorders, such as diabetes.”
the pediatric neurologist says. “The study
also will have broad implications for pub¬
lic policy on education of individuals with
dyslexia.”
The project has four components:

An interdisciplinary team in the School of
Medicine has started a new research proj¬
ect to define the way cells respond in ini¬
tiating and perpetuating the disease
processes that lead to chronic kidney
failure.
Dr. Michael Kashgarian. professor of
pathology and vice chairman of the pa¬
thology department, is directing the pro¬
gram project for which the National
Institutes of Health has granted $1.5 mil¬
lion to Yale University. The research will
focus on the kidney.
“Chronic renal disease is one of the ma¬
jor medical expenditures in the United
States," says Dr. Kashgarian, who esti¬
mates that more than $4 billion per year
is spent on dialysis and kidney
transplantation.
”We plan to use molecular biological
techniques to examine the cellular proc¬
esses which lead to chronic renal disease,''
explains Dr. Kashgarian, “and we have
initiated three main studies.” Specificially. the team will look at:
— endothelial cells and supporting
molecules in chronic renal disease of
diabetes
— kidney filter cells and supporting
molecules in progressive renal diseases,
ranging from early kidney scarring to loss
of kidney function
— cells of the kidney tubules which
transport salt and water and their reaction
to injury and recovery.
The three-year research project brings
together basic scientists who are collabo¬
rating to examine practical problems re¬
lated to various aspects of chronic renal
disease. In this innovative approach, they
are applying fundamental scientific infor¬
mation and new techniques to the study of
kidney disease.
"We now have molecular probes to look
at the interaction of cells, w'hat they pro¬
duce and how these products are regulated
in cells, what stimulates synthesis and
how cells respond to injury. With new
techniques, we can look at the cellular
events that control the disease response,"
Dr. Kashgarian explains.
For instance, the researchers hope to
learn more about the factors that cause kid¬
ney disease to progress even after a kidney
injury has been treated. This often results
in the loss of kidney function, the treat¬
ment of which drains the patient's finan¬
cial resources.
In addition, the researchers are looking
at the cellular and molecular aspects of
how a cell organizes its own structure and
how' this relates to the way salt and water
are transported in the kidney.
Coinvestigators with Dr. Kashgarian
are: Dr. Heinz Furthmayr. professor of pa¬
thology; Joseph A. Madri, M.D., Ph.D..
associate professor of pathology; Dr. Ed-

• learning about the relationship be¬
tween language and reading in chil¬
dren between ages l'l2 and 9'U
years. This will involve magnetic
resonance imaging and even newer
electroencephalographic tech¬
niques to examine dyslexic chil¬
dren’s brains;
• studying the genetic patterns of
reading disability in children, their
siblings and parents;
• studying the relationship of atten¬
tion disorders to reading disorders;
• relating the kinds of reading disa¬
bilities found in the children stud¬
ied to learning disabilities in a more
general population.
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ward J. Benz Jr., professor of medicine
and human genetics; Dr. Bemd Sterzel. as¬
sociate professor of medicine; Harald
Foellmer. Ph.D., assistant professor of
medicine; Mark S. Mooseker. Ph.D., as¬
sociate professor of biology and cell biol¬
ogy, and Jon S. Morrow. M.D.. Ph.D.,
associate professor of pathology.

Frozen Brain Cells
Transplanted in Monkeys
Researchers at Yale University and the
University of Rochester have successfully
frozen and preserved monkey brain cells,
and these cells have survived transplanta¬
tion in three monkeys.
The brain cells, called dopamine neu¬
rons. use the chemical substance dopa¬
mine to control subtle motor movements,
among other central nervous system func¬
tions. If primates or humans lose nearly all
of their dopamine neurons, they show' the
signs of Parkinson's disease.
In May 1986. the Yale-Rochester team
w'as the first to publish a scientific report
on the survival of transplanted brain cells
in primates. In these animal studies, the
reseachers reversed the symptoms of Par¬
kinson's disease in monkeys by transplant
ing fresh fetal dopamine neurons.
In the new studies, the team has devel¬
oped cryopreservation—freezing and stor¬
ing-techniques which will move physicians
and biomedical scientists a step closer toward
clinical applications to treat Parkinson's dis¬
ease in humans, according to Dr. D. Eugene
Redmond Jr., professor of psychiatry and di¬
rector of the neurobehavior laboratory in
the School of Medicine. He also is director
of the Yale-Rochester primate neural trans¬
plant program.
These animal studies, completed last year,
were reported in the current issue of Brain Re¬
search. an international journal published in
.Amsterdam. Timothy J. Collier. Ph.D., as¬
sistant professor of neurobiology and anatomy
at the University of Rochester, is the first au¬
thor of the report.
In conducting the federally funded re¬
search. the Yale-Rochester team found that it
could grow the same dopamine cells in tissue
culture after the cells were frozen and stored
in liquid nitrogen. Cells stored for as long as
28 days remained viable.
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Investigators Win
MERIT Awards
Of 13 Yale scientists who earned MERIT
research awards in 1987 from the National
Institutes of Health, 11 are faculty mem¬
bers of the School of Medicine. MERIT
(Method to Extend Research in Time) is an
NIH program that provides from seven to
10 years of support for medical research to
principal investigators with a longstand¬
ing record of excellence.
Investigators may not apply for MERIT
awards. The NIH National Advisory
Boards which evaluate proposals for
standard five-year research grants recom¬
mend the awards for only the most prom¬
ising research. This reduces the paper
work award winners must put into raising
money for long-term projects, thus freeing
time that the scientists can dedicate to
their research. Last year, the NIH made
187 MERIT awards in the United States
for a total of more than $40 million. Av¬
erage annual payments to Yale researchers
for the awards are in the range of $130,000
to $150,000.
Observes H.G. Aaslestad, director of
grants and contract administration for the
School of Medicine, "The Merit Awards
illustrate the excellence of the medical
school’s scientific faculty, as determined
by their peers and by high level NIH offi¬
cials." He points out that Yale had the sec¬
ond highest number of MERIT awards
among the nation's medical schools, be¬
hind the University of California at San
Francisco, which had 18 winners.
The following summary highlights the
research projects of MERIT award recipi¬
ents who are faculty members of the Yale
School of Medicine:
• Dr. Philip W. Askenase, professor
of medicine and pathology. Dr. Askenase’s work focuses on the role of
certain T cells in skin hypersensi¬
tivity. His research may have a bearing on understanding allergic
diseases and on the functioning of
body’s immune system.
• Ari H. Helenius, Ph.D., professor
of cell biology, is attempting to
learn more about how viruses in¬
vade cells and then use the host
cells’ genetic material to multiply.
His study is focusing on both the
cellular and the molecular levels
and may help in understanding the
flu virus.
• James D. Jamieson, M.D., Ph.D.,
professor of cell biology and chair¬
man of the cell biology department,
is studying how the pancreas sorts
and targets secretory proteins
within the organ's individual cells.
His research has implications for
diseases such as cystic fibrosis and
pancreatic cancer, in which cell po¬
larity is lost.
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• Kenneth K. Kidd, Ph.D., professor
of human genetics and psychiatry,
is attempting to locate within
strands of human DNA the genes
that may cause schizophrenia,
Tourette's syndrome and other
mental disorders.
• Dr. I. George Miller, the John F.
Enders Professor of Pediatric Infec¬
tious Disease, Epidemiology, and
Molecular Biophysics and Bio¬
chemistry, is studying on a molec¬
ular level the Epstein-Barr virus,
associated with mononucleosis,
herpes and other diseases. His team
is trying to discover how the virus
multiplies in immunodeficient in¬
dividuals, such as AIDS victims
and organ transplant patients.
• Dr. George E. Palade, Sterling Pro¬
fessor Emeritus of Cell Biology and
senior research scientist in cell bi¬
ology, will continue his molecular
research into the workings of the
vascular endothelium, the cells that
line blood vessels. His research is
shedding light on how cardiovas¬
cular diseases develop.
• Howard Rasmussen, M.D., Ph.D.,
professor of medicine, physiology
and cell biology, is investigating
various aspects of cell physiology,
including how information is com¬
municated from a cell’s exterior to
its interior via calcium channels.
• John Kenneth Rose, Ph.D., profes¬
sor of pathology and cell biology, is
leading a molecular investigation

into how some viruses target them¬
selves to particular membranes
within the body, and then reproduce
once they reach those membranes.
His study will help in the fight
against such virus infections.
• Dr. Leon E. Rosenberg, the C.N.H.
Long Professor of Human Genetics,
Medicine and Pediatrics, and dean
of the School of Medicine, is at¬
tempting to illuminate how inborn
errors in metabolizing certain
amino acids may be related to such
conditions as Down’s syndrome.
His research could lead to more ef¬
fective prenatal diagnosis of inher¬
ited diseases.
• Dr. Kay Tanaka, professor of hu¬
man genetics, is spearheading re¬
search about the genetic evolution
of certain inherited metabolic dis¬
orders such as isovaleric acidemia
and glutaric aciduria. Understand¬
ing the history of such diseases on a
molecular level may reveal clues to
possible cures.
• Dr. Robert B. Tesh, associate pro¬
fessor of epidemiology, is studying
insect-borne viruses such as yellow
fever, dengue and Japanese enceph¬
alitis, that are submitted to the
World Health Organization’s Ref¬
erence Center for Arboviruses, part
of the Yale Arbovirus Research
Unit. The unit also trains research¬
ers from around the globe to iden¬
tify such viruses.

FACULTY NEWS
Dr. Shope Presented
Arbovirology Award
Dr. Robert E. Shope, professor of epide¬
miology and director of the Yale Arbovirus
Research Unit, was the co-recipient of the
Richard Moreland Taylor Award for 1987
of the American Committee on Arthropodborne Viruses. He was recognized for
his outstanding achievement in the field of
arbovirology during the annual meeting
of the American Society of Tropical
Medicine and Hygiene last December in
Los Angeles.
Established in 1966 and presented every
three years, the award honors the late Dr.
Taylor, who was a Rockefeller Foundation
staff member before teaching in Yale’s
department of epidemiology and public
health. Dr. Taylor died in 1981.
Both men have centered much of their
research on arthropod-borne viruses, or
arboviruses —pathogens that are transmit¬
ted by the bite of infected arthropods, such
as ticks, mosquitoes and sandflies, and
usually involve a reservoir host.
Dr. Shope’s contributions to the knowl¬
edge of arboviruses and certain other vi¬
ruses linked to them have been described
as “exceptional, original and pioneer¬
ing.” Among his outstanding achieve¬
ments are his work on rabies. Rift Valley
fever and the reassortment of genetic ma¬
terial among virus serotypes.
One of Dr. Shope's colleagues. Dr. Jordi
Casals, professor emeritus of epidemiol¬
ogy and now professorial lecturer at Mount
Sinai School of Medicine, recently de¬
scribed the work of this “complete arbovirologist.” He wrote:
“From the time of Pasteur, until Dr.
Shope proved otherwise, rabies virus had
been considered to be an agent totally dis¬
tinct; the only one of its type with no an¬
tigenic relatives or variants.
"As a result of Dr. Shope’s work and its
influence on other investigators, rabies
lost its aloofness, became identified as part
of a family of viruses mostly arthropodborne. Even more importantly, antigenic
differences between isolates became ap¬
parent, a fact which had a great impact on
diagnosis, strain selection for vaccination
and on the epidemiology of the disease.
“A similar situation developed with
Rift Valley fever, a disease of considerable
veterinary and medical importance. The
virus causing it had been known for about
50 years. But Dr. Shope's investigations
on the serological properties of the phlehotomus fever antigenic group of viruses
lted in the unexpected finding that Rift
Valley fever virus was a member of this
.'roup, subsequently named the genus
nhlebovirus. This finding came shortly
alter the devastating 1977 epidemic in
I \ pt m which Dr. Shope contributed with

distinction. It also resulted in new guide¬
lines for specific diagnosis and epidemiol¬
ogical investigations.
“A third important contribution by Dr.
Shope concerns his work on reassortment
of genetic material between arboviruses.
Investigators who first defined the anti¬
genic group C had noticed that strains of
Caraparu virus, identified as such by hem¬
agglutination-inhibition and neutraliza¬
tion tests, reacted in one of two different
ways in the complement-fixation test: Cer¬
tain strains cross-reacted by CF with the
other group C viruses, certain other strains
did not. In fact, the latter strains of Cara¬
paru failed to react with the former; it
seemed as through some strains of virus
were deficient in the group C common
antigen.
“Dr. Shope came up with a brilliant
concept: the rapid turnover of group C vi¬
ruses in the Belem area of Brazil made it
conceivable that an occasional strain
might by chance, in nature, acquire pieces
of genetic material from another group C
virus yielding a recombinant with altered
antigenic properties.
“Today, exchange of genetic material
between viruses is almost a daily routine
laboratory procedure, but this was not so
in the mid-1960s. At a later date and in as¬
sociation with other colleagues. Dr. Shope
studied genomic reassortment in the Cali¬
fornia group and showed changes in the resi stance of mice to experimental
inoculation correlating to the presence or
absence of a given RNA piece.”

Drs. Rosenberg, Ruddle
Endorse Federal Gene
Mapping Project
Dean Leon E. Rosenberg and his col¬
league Frank Ruddle, Ph.D., professor of
biology and human genetics, served on a
National Research Council committee that
unanimously endorsed a $3 billion na¬
tional effort to map the human genome.
The massive project, which would pin¬
point the location of all human genes and
establish how their chemical building
blocks are sequenced, would cost $200
million annually for the next 15 years.
Yale would play a major role in any such
project by virtue of the Human Gene Map¬
ping Library, located at Science Park in
New Haven. With Professor Ruddle as its
co-founder and director, the library offers
the largest gene data base in the country.
The committee concluded that gene
mapping offers the best hope of identify¬
ing the genes responsible for 3,000 inher¬
ited diseases, including cystic fibrosis,
Huntington’s disease and certain kinds of
Alzheimer’s disease.
Included on the distinguished 15-member panel was James D. Watson, who dis¬
covered the double helix structure of DNA.

Dr. Baldwin to Head
Cardiothoracic Surgery
Dr. John C. Baldwin, an internationally
renowned heart and lung transplant sur¬
geon, has been appointed professor and
chief of cardiothoracic surgery at the Yale
School of Medicine and Yale-New Haven
Hospital.
He comes to New Haven from the Stan¬
ford University Medical Center, where
among his many responsibilities, he was
an assistant professor of cardiovascular
surgery and head of the heart-lung trans¬
plantation program.
For his joint hospital-medical school ap¬
pointment, Dr. Baldwin will be responsi¬
ble for program and educational
development in the cardiothoracic section
of the department of surgery. He will teach
at the medical school and serve as an at¬
tending surgeon at the hospital.
“Dr. Baldwin comes to this position
with a reputation for being an exceptional
surgeon, as well as a committed academi¬
cian,” commented Dr. William F. Collins
Jr., chairman and the Harvey and Kate
Cushing Professor of Surgery. “He is a pi¬
oneer in the field of heart and lung trans¬
plants among children with cystic fibrosis.
This novel surgery is a potentially crucial
treatment for this common and lethal dis¬
ease which usually kills by causing pul¬
monary failure.”
The new chief of cardiothoracic surgery
said he was attracted to the position be¬
cause of the hospital's reputation as a
leading clinical center and the strength of
the medical school's basic scientific
research.
“The beauty of basic cardiothoracic re¬
search is that it can be so readily applied to
clinical practice. This is particularly true
in the area of lung preservation where
basic research has quickly led to success in
the distant procurement for heart-lung
grafts,” Dr. Baldwin noted.
While the distant transport of hearts for
transplantation has been common practice
for years, even short-term preservation of
donor lungs had proven difficult, thus pre¬
cluding the possibility for such transplants
to patients in faraway locations. Tech¬
niques developed by Dr. Baldwin and
other Stanford researchers have led to
longer viability for donor lungs, thus al¬
lowing for the transport of these life-sav¬
ing organs across city, state and even
international borders.
Dr. Baldwin said that among his top
priorities were to strengthen the laboratory
for clinical practice at the cardiothoracic
section, and expand the clinical program
for training residents.
His international awards include a 1985
designation as Medalist of the Gothenburg
Thoracic Society in Sweden. In 1987 Dr.
Baldwin was awarded the Madaile de la
Ville de Bordeaux from the French Tho¬
racic Society.
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Students gather in the Arthur Ebbert Lounge.

Arthur Ebbert Lounge
“Ask Art Ebbert.”
For 34 years, that refrain has echoed
throughout Sterling Hall of Medicine as
legions of medical students, faculty and
staff have sought Dr. Arthur Ebbert’s wise
counsel and advice during his tenure as as¬
sistant dean, associate dean and the
school’s first deputy dean.
People still seek him out, and Dean
Leon E. Rosenberg and others have tapped
him for several special projects requiring
his quiet diplomacy even though Dr. Eb¬
bert relinquished his position as deuty
dean in August and began a long-overdue
sabbatical year.
Last June, the dean hosted an afternoon
reception honoring Dr. Ebbert. More than
600 faculty. University administrators,
medical alumni, hospital colleagues and
friends attended the Yale-blue event in the
Edward S. Harkness Courtyard.
The outdoor celebration for the gentle¬
man who has been the soul of the medical
school for 34 years marked the end of an
era: the Ebbert era, according to Dean Ro¬
senberg, one of the five deans with whom
Dr. Ebbert has worked.
Under sunny skies, words of praise
were spoken in animated conversations
and in the special remarks offered by
Deans Rosenberg and Robert Berliner,
who also read comments from former
deans Fritz Redlich and Lewis Thomas
and from Peg Lippard, the widow of Dr.
Lippard. Dr. Dorothy M. Horstmann, the
John Rodman Paul Professor Emeritus of
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Epidemiology and Pediatrics, spoke on
behalf of the faculty.
To recognize his extraordinary contri¬
butions and service to Yale, the third-floor
lounge in the Jane Ellen Hope Building
has been named the Arthur Ebbert
Lounge, Dr. Rosenberg announced at the
reception. Since then. Dr. Ebbert’s por¬
trait, painted by William F. Draper of New
York City, has been hung in the lounge,
along with a gray slate plaque citing his
service to the school. And the deputy
dean’s responsibilities have been handed
on to Dr. Robert M. Donaldson, also a
professor of medicine.
A native of Wheeling, W. Va., Dr. Eb¬
bert received his B.A. and M.D. degrees
from the University of Virginia, where he
also completed residency training in inter¬
nal medicine. In 1953, he joined the Yale
faculty as an instructor in medicine and
was asked by Dean Lippard to serve also
as assistant dean of postgraduate medical
education. Although Dr. Ebbert intended
to stay only a year or two, he remained as
a member of the faculty in internal medi¬
cine and rose through the deanery ranks.
During his service in the dean’s office,
he has seen many changes in the School
for Medicine. For instance, the size of the
entering class of M.D. candidates rose
from 80 to 102 students; the number of
M.P.H. students increased from 29 to
more than 200, and the physician associ¬
ate program was established.
The faculty increased from approxi¬

mately 150 to more than 700. New depart¬
ments have been established, including
anesthesiology, cell biology, dermatol¬
ogy, human genetics, laboratory medi¬
cine, neurology, ophthalmology and visual
science,
and
orthopaedics
and
rehabilitation.
The buildings constructed during Dr. Eb¬
bert’s tenure have changed the face of the
school, beginning with the Edward S.
Harkness Hall in 1955 and extending to the
recently completed Yale Physicians Build¬
ing. The growth of the medical center has
been tremendous, he noted, and the sur¬
rounding neighborhood has completely
changed.
Dr. Ebbert recently observed, “One thing
which has not changed in the past 34 years
is the quality of our students; they are still
the best to be found anywhere.”
During his sabbatical year. Dr. Ebbert has
been reading, writing, thinking and travel¬
ing, as well as skiing and sailing.

Yale Ranks Third
In NIH Funding
For the second consecutive year, during FY
1987 Yale ranked third among 124 medical
schools receiving support from the National
Institutes of Health. Including both direct
and indirect costs, the school received over
$89.7 million from the NIH. Ranking above
Yale were the University of California at
San Francisco ($102 million), and Johns
Hopkins ($93.5 million).

25

h

Dr. White

Dr. Robert White to Lead
Diagnostic Radiology
Dr. Robert I. White Jr., formerly professor
of radiology and of medicine at Johns Hop¬
kins University, has been named chairman
of the Yale University School of Medicine
department of diagnostic radiology and
chief of this service at Yale-New Haven
Hospital.
Dr. White succeeds Dr. Richard H.
Greenspan, who earlier was named to the
newly created position of associate dean
for clinical affairs.
"We are delighted that Dr. White will
lead our diagnostic radiology department.
He is an internationally recognized leader
in the field of cardiovascular and interven¬
tional radiology, and he has a well-earned
reputation as an outstanding teacher, re¬
searcher and physician,” says Dean Leon
E. Rosenberg.
Comments Dr. White, “Radiologists
often have been referred to as the cartog¬
raphers of the human body. We now are de¬
veloping a new breed of radiologists who
do more than use x-rays to ‘map’ the body.
Instead we use imaging technology to
study disease and make an impact on
treatment.”
Dr. White has concentrated his profes¬
sional work on interventional radiology, a
medical specialty that employs radiologically guided wires, catheters, stone bas¬
kets. balloons and drug infusions.
One of Dr. White’s many clinical inno¬
vations is a treatment for varicocele, a type
of male infertility. Also, in 1980, he and
his colleagues performed the first balloon
valve surgery to open heart valves blocked
by congenital heart disease. Dr. White has
done pioneering work in treating lung mal¬
formations as well.
\ native of Los Angeles, Dr. White re¬
ceived a B.A. degree in 1959 from Po¬

mona College and an M.D. degree magna
cum laude in 1963 from the Baylor Uni¬
versity College of Medicine. He was an
Osier intern in medicine at Johns Hopkins
Hospital. In 1969. he completed residency
training in radiology and medicine at
Johns Hopkins Hospital and then joined
the university faculty as an instructor in
radiology.
At Johns Hopkins University, Dr. White
directed seven cardiovascular diagnostic
laboratories from 1971 until 1988. He was
named assistant professor of radiology in
1971 and was appointed professor of ra¬
diology in 1977. He also holds joint ap¬
pointments in medicine, pediatrics and
surgery.
A fellow of the American College of Ra¬
diology, Dr. White served as secretary,
vice president and president of the Ameri¬
can Society of Cardiovascular and Inter¬
ventional Radiology from 1982 to 1985.
He also was a scholar in radiological re¬
search of the James Picker Foundation.
A prolific author. Dr. White has pub¬
lished more than 170 articles in scientific
journals.

Dr. Bunney Awarded
First Lieber Prize
Dr. Benjamin S. Bunney, acting chairman
of the department of psychiatry, has been
awarded the $50,000 Lieber Prize by the
National Alliance for Research on Schiz¬
ophrenia and Depression (NARSAD).
Dr Bunney, also professor of psychiatry
and of pharmacology, is the first recipient
of the award, which recognizes outstand¬
ing achievement in research on mental ill¬
ness. The prize was established this year
with a gift by Constance and Stephen Lie¬
ber of Mamaroneck, N.Y. Dr. Bunney will
use the prize to replace outdated labora¬
tory equipment.
Dr. Bunney's research has focused on
the brain's dopamine system, which has
been implicated in the major neuronal dys¬
function of schizophrenia. He has also pi¬
oneered research on the effects of
antipsychotic drugs on the brain, and how
they effect transmissions in the dopamine
system.
“This is a particularly exciting time to
be working in the area of brain function,”
says Dr. Bunney. “There has been an ex¬
plosive growth in both the fields of neuros¬
cience and population and molecular
genetics. Because of this, the tools are
now becoming available which allow us to
answer questions that we couldn’t answer
before.”

Dr. Evans Wins
Military Award
Alfred S. Evans, M.D., M.P.H., the John
Rodman Paul Professor of Epidemiology,
has been awarded the John R. Seal Award
for his contributions to military medicine.
The annual award, given by the Society of

Medical Consultants to the Armed Forces,
cites Dr. Evans’ long history of contribu¬
tions to the U.S. military, beginning with
his service as an active duty medical offi¬
cer in Japan in 1944. Over the years Dr.
Evans has also served as a preventive med¬
icine consultant to several U.S. Surgeons
General, and has advised the Navy Sub¬
marine Service, NASA's Manned Space
and Space Shuttle Programs and the World
Health Organization’s Tropical Medicine
Program.

NEW BOOKS
The American Disease: Origins of Nar¬
cotic Control, an expanded edition, by Dr.
David F. Musto, professor in the Child
Study Center, psychiatry, and the history
of medicine. Oxford University Press,
(New York) 1988.
Early Schooling: The National Debate,
edited by Sharon L. Kagan Ed.D., asso¬
ciate research scientist in the Child Study
Center, and Edward F. Zigler, Ph.D., Ster¬
ling Professor of Psychology and professor
in the Child Study Center. Yale University
Press. 1988.
Manual of Cardiac Arrhythmias: A Prac¬
tical Guide to Clinical Management, ed¬
ited by Dr. Stephen C. Vlay ’75, State
University of New York at Stony Brook.
Little, Brown and Co., (Boston, Mass.)
1987.
Medicine on Trial, by Charles Inlander of
Emmaus, Penn., Lowell S. Levin. Ed.D.,
M.P.H., professor of public health, and Ed
Weiner of Philadelphia. Prentice-Hall
Inc., (New York) 1988.
The Parental Leave Crisis: Toward a Na¬
tional Policy, edited by Edward F. Zigler,
Ph.D., Sterling Professor of Psychology
and professor in the Child Study Center,
and Meryl Frank, director of the infant
care leave project at The Busch Center in
Child Development and Social Policy, Yale
University. Yale University Press, 1988.
When Doctors Get Sick, edited by Dr.
Harvey Mandell, associate clinical profes¬
sor of medicine, and Dr. Howard Spiro,
professor of medicine. Plenum Publishing
Corp., (New York) 1988.

Dr. Pruett Earns
Book Award
Dr. Kyle D. Pruett, associate clinical pro¬
fessor in the Child Study Center and psychiatry, has won American Health
Magazine's Book Award for The Nurtur¬
ing Father: Journey Toward the Complete
Man. Dr. Pruett’s book tells of 17 families
in which the father stays home to provide
childcare.
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ALUMNI NEWS
The University Foundation at the State
University of New York at Albany named
I)r. Ralph I). Alley 43, '51 HS as 1987
Citizen Laureate, the foundation’s highest
award for civic and academic community
representatives. Dr. Alley, a thoracic sur¬
geon who introduced open heart surgery to
northern New York in 1958, was honored
for his contributions to medical science
and education. A past president of the So¬
ciety of Thoracic Surgeons, Dr. Allen is a
member of the board of governors of the
American College of Surgeons and direc¬
tor of the American Board of Thoracic
Surgery.
Dr. Henry Jones '43, '46 HS, a radiol¬
ogist at Stanford University for nearly 40
years, has received the Association of
University Radiologists Gold Medal
Award for distinguished service.
Dr. Donald W. Seldin 43, 46 HS re¬
signed Feb. 1, after 35 years as chairman
of the department of internal medicine at
Southwestern Medical School at the Uni¬
versity of Texas Health Science Center at
Dallas.
His accomplishments in shaping the ac¬
ademic program at Southwestern Medical
School were described in a major feature
story in The New York Times, published
Feb. 13. Dr. Seldin, a former instructor
and assistant professor of medicine at
Yale, began his career at Southwestern in
1951. At that time the school consisted of
a series of abandoned army barracks with
no funding for permanent buildings. In
1952, as Dr. Seldin planned a return to
Yale, a new dean. Dr. George Aagard, per¬
suaded him to become chairman of the de¬
partment of internal medicine, a
department of one —Dr. Seldin. Today the
department has 150 faculty members.
Dr. Seldin developed Southwestern's
basic sciences and research faculty by per¬
suading many of his brightest students to
make their careers in academic medicine at
Southwestern. Among them are Nobel lau¬
reate Dr. Joseph L. Goldstein, and South¬
western's current president. Dr. Kern
Wildenthal. His successor is another for¬
mer student. Dr. Daniel W. Foster, an in¬
ternationally known diabetes specialist.
Dr. John P. McGovern 46 HS, founder
and chief consultant to the McGovern Al¬
lergy Clinic in Houston, has been ap¬
pointed to a four-year term on the National
Advisory Council on Alcohol Abuse and
Alcoholism.
Dr. William G. Anlyan '49 has been
appointed chancellor of Duke University
effective July 1. Dr. Anlyan, chancellor for
health affairs at Duke since 1983, and ex¬
ecutive vice president since 1987, began
his career at Duke in 1949 as a resident in
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general and thoracic surgery. He was pro¬
moted to professor of surgery in 1961. He
was named dean of the School of Medicine
in 1964, and in 1969, after having served
one year as dean and associate provost,
was appointed vice president for health af¬
fairs, a position he held until 1983, when
he was appointed chancellor for health
affairs.
As chancellor. Dr. Anlyan will serve on
the university’s committee of chief exec¬
utive officers and will oversee major as¬
pects of Duke’s external affairs. He also
will take an important role in alumni rela¬
tions and selected aspects of fund raising.
At Yale, President Benno C. Schmidt Jr.
has appointed Dr. Anlyan chairman of the
University Council Committee on Medical
Affairs, the presidential advisory commit¬
tee that studies major scientific and medi¬
cal issues. He will serve a five-year term.
In an editorial in the Panamerican Fed¬
eration of Associated Medical Faculties
newsletter, federation chief Dr. Jose Felix
Patino '52, '58 HS. of Bogota, Columbia,
urged faculties at Latin American medical
schools to emphasize recent progress in
molecular biology and scientific medicine.
Dr. Robert G. Petersdorf '52, presi¬
dent of the Association of American Med¬
ical Colleges, received the American
Society of Internal Medicine "Distin¬
guished Internist of 1987" award at its an¬
nual meeting Oct. 15 in Washington, D.C.
The award is presented annually to an in¬
ternist who has made outstanding contri¬
butions to the social and economic aspects
of medicine and has helped to promote
cost-effective, high-quality care.
Dr. Thomas F. Ferris 57, '63 HS, Nes¬
bitt Professor and chairman of the depart¬
ment of medicine at the University of
Minnesota, has been elected president of
the American Society of Nephrology. His
one-year term began Jan. 1.
Dr. Gerard N. Burrow '58, '65 HS,
formerly chairman of the department of
medicine and the Sir John and Lady Eaton
Professor at the University of Toronto and
physician-in-chief of Toronto General
Hospital, became vice chancellor for
health sciences and dean of the University
of California, San Diego, School of Med¬
icine on March 1. He succeeds Dr. Robert
G. Petersdorf '52.
After completing his education and
training at Yale, Dr. Burrow joined the fac¬
ulty and was professor of medicine, when
he left Yale in 1976 to become director of
the division of endocrinology metabolism
at Toronto General Hospital, and professor
in the Banting and Best Department of
Medicine Research at the University of To¬
ronto. A member of numerous profes¬
sional organizations. Dr. Burrow has
recently completed terms as president of
both the American Thyroid Association

and the Canadian Association of Profes¬
sors of Medicine. He also has served as
director of the American Thyroid
Association.
At the Connecticut Division's 1987
leadership conference and annual dinner
Oct. 24, the American Cancer Society
awarded Dr. John C. Marsh '59, profes¬
sor of medicine and lecturer in pharmacol¬
ogy, a bronze medal, the highest national
award given to ACS volunteers. Dr.
Marsh, an oncologist and an immediate
past president of the Connecticut Division,
became an ACS volunteer in 1971. Since
that time he has served the society in sev¬
eral capacities on the national, state and
local levels.
Dr. Robert I. Levy '61, '63 HS became
president of the Sandoz Research Institute
in East Hanover, N.J. on Jan. 1. He will
not be joining the Association of American
Medical Colleges staff as was previously
announced.
Dr. H. Steven Moffic 71, associate
professor of psychiatry at Baylor College
of Medicine in Houston, published his
thoughts on the changes in medicine in a
fictional account of his 15th reunion in The
Pharos of Alpha Omega Alpha, Summer
1987, Vol. 50, No. 3.
Dr. Peter S. Kennedy '71 HS, an on¬
cologist at St. Vincent Medical Center in
Los Angeles and assistant clinical profes¬
sor of medicine at the University of South¬
ern California School of Medicine, was
named associate principal investigator for
the Community Oncology Program, a pro¬
gram established by the National Cancer
Institute to make innovative cancer treat¬
ment programs available to patients in
community hospitals. As director of clin¬
ical practices for the Los Angeles Oncol¬
ogic Institute, an affiliate of St. Vincent
Medical Center, Dr. Kennedy is director of
the oncology unit and chairman of both the
department of medicine and the depart¬
ment of hematology-oncology.
Dr. Stephen C. Vlay '75 was promoted
to associate professor of medicine at the
State University of New York at Stony
Brook. Dr. Vlay, a cardiologist, is director
of the Stony Brook Arrhythmia Study and
Sudden Death Prevention Center and direc¬
tor of the Coronary Care Unit at University
Hospital.
Dr. Anne Flitcraft '77. assistant profes¬
sor of medicine at the University of Con¬
necticut School of Medicine and her
husband, sociologist Evan Stark, in co-op¬
eration with the Office for Women in Medicine, presented a state-wide training
conference at Yale on Jan. 21 on the identi¬
fication and treatment of victims of domestic
violence. Dr. Flitcraft is director of the Do¬
mestic Violence Training Project: A Pro¬
gram for Health Professionals, developed in
accordance with Connecticut’s new Family
Violence Prevention and Response Act.
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OBITUARIES
Massimo E. Calabresi,
M. D., Dr. P.H.
Dr. Massimo E. Calabresi, Dr. P.H. '44,
clinical professor emeritus of medicine,
died Feb. 28 at his home in New Haven. He
wras 84.
A native of Italy and former chief car¬
diologist at the University of Milan, Dr.
Calabresi was an early opponent of the fas¬
cist movement. His activities in helping to
circulate an underground anti-fascist
newspaper forced him to leave Italy in
1939. He came to Yale in 1940 as a re¬
search fellow and was named assistant
clinical professor of medicine in 1941, as¬
sociate clinical professor in 1959, and
clinical professor emeritus in 1971.
Dr. Calabresi worked as a cardiac phys¬
iologist for the Connecticut Department of
Health from 1950 to 1952, when he be¬
came chief of the cardiovascular section at
the Veterans Administration Medical Cen¬
ter in West Haven. His work in cardiology led
to innovative treatments for hypertension.
Dean Leon E. Rosenberg, who met Dr.
Calabresi during his residency training in
internal medicine at the Veteran’s hospi¬
tal, remembers Dr. Calabresi “as one of
the most compassionate and devoted phy¬
sicians I’ve ever known. Moreover, I found
his commitment to the education of stu¬
dents and house officers as total as his
devotion to patients. Over the years my
admiration for this modest, noble man was
continually reinforced, and like so many of
those he taught, I shall miss him greatly.”
His wife. Bianca, who for many years
was a professor and chairman of the Italian
department at Albertus Magnus College in
New Haven, died in 1982. Surviving are
his sons, Guido Calabresi, dean of the
Yale Law School, and Dr. Paul Calabresi,
chairman of the department of medicine at
Brown University; a sister, Renata Cala¬
bresi; and six grandchildren.

Henry I. Fineberg, M.D.
Dr. Henry I. Fineberg ’27 died in New
York Oct. 4, 1987. He^was 83. Dr. Fine¬
berg served as president of the Medical So¬
ciety of New York from 1959 to 1960, and
its executive vice president from 1961 until
his retirement in 1982. A New York dele¬
gate to the AMA House of Delegates from
1959 to 1978. he was chairman of the del¬
egation from 1961 to 1969. Dr. Fineberg
specialized in communicable diseases,
and from 1939 to 1940, he was physicianin-charge at Kingston Avenue Hospital for
Communicable Diseases in Brooklyn,
N. Y., and in 1942 was named medical su¬
perintendent of Queens Hospital Center.
Dr Fineberg was 1927 class agent for
the Medical School Alumni Fund and a
lit president of the Yale Alumni Associ11ion ol Queens, N.Y. He is survived by

his wife, Grace; a daughter, Karen; and a
son, Coleman.

Hugh R. Williams, M.D.

William U. Gardner,
Ph.D.

Dr. Hugh R. Williams ’46 died Dec. 9,
1987 of prostatic cancer at his home in
Royal Oak, Md. He was 65. Dr. Williams
was director of the Talbot County Mental
Health Clinic in Easton, Md., from 1977
to 1985 and the in-patient psychiatrist at
Franklin Square Hospital in Baltimore
from 1985 until early 1987.
Dr. Williams had been an assistant pro¬
fessor of psychiatry at the State University
of New York at Buffalo and at the Univer¬
sity of Colorado Medical Center. He also
was associated with Mary Imogene Bas¬
sett Hospital in Cooperstown, N.Y., and
the Geisinger Medical Center in Danville,
Penn., and had a private practice in High¬
land Park. N.J.
Surviving are his wife, Irene; four sons,
Hugh Jr., David, Mark and Paul; a daugh¬
ter, Margaret Karl; a sister, Anne Sullivan
and four grandchildren.

William U. Gardner, Ebenezer K. Hunt
Professor Emeritus of Anatomy and chair¬
man of the anatomy department from 1943
to 1967, died Feb. 14 in Yale-New Haven
Hospital of Parkinson’s disease. He was
80.
Professor Gardner began his career
at Yale in 1933 as a National Council
Research fellow. He was appointed to the
faculty in 1935, and in 1943 was named
Ebenezer K. Hunt Professor of Anatomy
and department chairman. He was a strong
supporter of the Yale System of medical
education, and in the early 1940s devel¬
oped a method of teaching anatomy called
prosection, which was adopted nation¬
wide. Professor Gardner's research fo¬
cused on reproductive endocrinology and
the intluence of hormones on abnormal and
malignant growths.
An internationally recognized scientist.
Professor Gardner received several honor¬
ary degrees, including one from the Uni¬
versity of Perugia in Italy. He was a former
president of the International Union
Against Cancer, the American Association
for Cancer Research and the American As¬
sociation of Anatomists. An associate ed¬
itor of several scientific journals, he also
served on numerous advisory boards, in¬
cluding those of the National Research
Council, U.S. Public Health Service, Na¬
tional Cancer Institute, American Cancer
Society, and National Board of Medical
Examiners.
Mr. Gardner was named Ebenezer K.
Hunt Professor Emeritus at his retirement
in 1974. He served as scientific director of
the Council of Tobacco Research from
1974 to 1984.
He is survived by his wife, Catherine.
Memorial contributions may be made to
the William U. Gardner Loan Fund, estab¬
lished in 1973 to provide financial aid to
medical students.

Patrick S. Mullins, M.D.
Dr. Patrick S. Mullins ’42 of Morehead
City. N.C. died December 18, 1987. He
was 73. Surviving are his wife, Margaret;
a daughter Patricia Ann Dyk; two sons,
Terrence Thomas and Kevin Michael; and
one grandchild.

Paul J. Myerson, M.D.
Dr. Paul Joseph Myerson, assistant profes¬
sor of radiology from 1975 to 1980, died
Jan. 2 at Ormond Memorial Hospital in
Florida. Dr. Myerson, 48, had lived in Or¬
mond Beach, Fla. since 1981. He leaves
his wife, Sandra; two sons, Terry and Neal;
two brothers. Dr. Daniel A. Myerson, with
whom he practiced, and Dr. Manny
Myerson.

Robert P. Zanes Jr.,
M.D.
Dr. Robert P. Zanes, associate clinical pro¬
fessor of medicine since 1978, died Jan. 13
after a brief illness. Dr. Zanes was a mem¬
ber of the executive committee of the Yale
Comprehensive Cancer Center and was as¬
sociated with several New Haven area hos¬
pitals. He had been chief of the oncology
section and director of the oncology unit at
the Hospital of St. Raphael from 1975 to
1982, when he became medical director of
Connecticut Hospice in Branford. From
1985 to 1987, he was vice president for
medical affairs. He remained at hospice in
1987 as a staff physician.
He is survived by his wife. Carmela;
two sons. Robert and Richard; a step-son,
Clifford John Dudley, and a step-daughter,
Clotilde Dudley; a sister, Priscilla Buckley;
and one grandchild.

Memorials
Contributions made in memory of de¬
ceased alumni are put into the Medical
School Alumni Fund endowment in the de¬
cedent’s name. Classmates receive fund
credit in the year the gift is made. Income
from these gifts is added, in perpetuity, to
the Medical School Alumni Fund and
credited to the deceased and his or her
class.
Names of all alumni remembered
through this program are listed in the
fund’s Testament of Remembrance, and
the memorialized alumni are considered
contributors to the fund forever.
The next of kin is informed of contri¬
butions made to this person's memory.
Yale Medical School
In Memoriam Program
P.O. Box 1890
New Haven, CT 06508
(203)432-5844
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IN MEMORIAM
Waldo F. Desmond
September 7, 1987
William H. Holden, M.D.
August 13, 1984

’25 M.D.

’26 HS

Henry Irwin Fineberg
October 4, 1987

’27 M.D.

Vincent A. Doroszka
September 6, 1987

’30 M.D.

Donald G. Barton
October 20, 1986

’33 M.D.

Merriwell T. Shelton, M.D.
October 3, 1987
Derick A. January
June 27, 1987

’33 HS

’34 M.D.

Russell C. Norton, M.D.
February 25. 1987

ex med ’39

Ruth G. Taylor
January 17, 1988

ex pbh ’40

Patrick S. Mullins
December 18, 1987
MassimoE. Calabresi, M.D.
February 28, 1988
Hugh R. Williams
December 9, 1987
Blackburn S. Joslin, M.D.
February 26, 1986

’42 M.D.
’44 Dr. P.H.
’46 M.D.
ex HS ’48

H. Lester Medlinsky, M.D.
March 21, 1987

’60 HS

Martin R. Krigman, M.D.
October 27, 1986

’61 HS

Amalia P. Crago
November 13, 1987
Alan M. Gutman, M.D.
June 5, 1987
John F. Neil
Harry I. Kaminsky
December 29, 1987

’66 M.P.H.
’67 HS

’73 M.D.
’86 PA

Real Estate Bequest
Establishes Fund
An alumna of the Class of 1952 of the
School of Medicine has endowed a fund to
support untenured faculty members in the
department of pathology. The will of Vir¬
ginia Swanson Kamen, M.D., who died
on May 20, 1987, directed that Yale re¬
ceive a one-half interest in a 122-unit
apartment complex in Modesto, Califor¬
nia. The proceeds from the sale of the
property by Yale will establish the Vir¬
ginia L. Swanson Sustaining Fund for
Junior Faculty.
By helping to launch careers of prom¬
ising young scientists. Dr. Swanson's be¬
quest meets a crucial need. Much research
funding is awarded on the basis of an in¬
vestigator's prior results rather than his or
her future promise. This makes it ex¬
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tremely difficult for underendowed depart¬
ments to attract the most talented young
men and women to academic careers.
Dr. Swanson enrolled at Yale in 1948
thanks to the encouragement of famed Yale
physiologist. Dr. John Fulton. Her interest
in research was kindled when she served as
a laboratory helper in the renowned pri¬
mate laboratory directed by Dr. Gertrude
Van Wagenen. Through Dr. Van Wagenen
she met the virologist and faculty member
Dr. Dorothy Horstmann, the first woman
to achieve full professorial status in the
School of Medicine. The two became life¬
long friends of Dr. Swanson.
After completing a USPHS Fellowship,
Dr. Swanson returned to serve as chief res¬
ident and later assistant pathologist at
Grace-New Haven Community Hospital.
From there her career led her to hospital
pathology work overseas and eventually to
distinguished service as staff pathologist
and professor at Children’s Hospital, the
pediatric division of the University of
Southern California Medical School.
In 1982 she chose to concentrate on her
research interests, studying human tumor
transplants in nude mice at the University
of California San Diego, changes during
aging in spawning salmon through Scripps
Institute of Oceanography, and temporal
lobe induced epilepsy in children during a
visiting fellowship at the Department of
Neuroanatomy at Oxford University. She
maintained close contact with her friends
at Yale, even during her final illness.
In a moving eulogy of Dr. Swanson, her
husband Dr. Martin D. Kamen, himself an
internationally known biochemist, wrote,
“In searching through her desk I found a
clipping she had saved of a remark attrib¬
uted to Winston Churchill which is apt:
‘You make a living by what you get, but
you make a life by what you give.’

Gilman Professorship
Established
A challenge grant from The Burroughs
Wellcome Fund proved to be the catalyst
for the establishment of the first endowed
professorship in the department of phar¬
macology at Yale. The chair will honor the
late Alfred Gilman ’28S, Ph.D. ’31, who
was a member of the National Academy of
Sciences, a Yale faculty member, and one
of the most important pharmacologists of
his generation.
Dr. Gilman’s book. The Pharmacolog¬
ical Basis of Therapeutics, coauthored with
Louis S. Goodman, M.D., is now in its sev¬
enth printing.
Dr. Gilman served for more than 20
years as an advisor to the Burroughs Well¬
come Fund. The foundation was estab¬
lished in 1955 to provide financial aid for
the advancement of medical knowledge by
research and is financially supported by
the pharmaceutical firms, Burroughs Well¬
come Co.

The Burroughs Wellcome Fund Chal¬
lenge was met through memorial gifts
from family and friends of Dr. Gilman and
by corporate contributions from Hoffmann-La Roche and Macmillan, Inc., Dr.
Gilman’s publisher. A major anonymous
gift completed funding of the Alfred Gil¬
man Professorship of Pharmacology.
The Yale Corporation appointed Alan
C. Sartorelli, Ph.D., as the first Gilman
Professor. A member of the pharmacology
faculty since 1961, Dr. Sartorelli served as
chairman of the department from 1977 un¬
til he was named director of the Yale Com¬
prehensive Cancer Center. He edits two
pharmacology journals and serves as pres¬
ident of the American Association for
Cancer Research and the Association of
American Cancer Institutes. In June 1987,
he was elected to the Institute of Medicine
of the National Academy of Sciences.

Why The “Double Ask”?
As part of the Yale School of Medicine’s
first capital campaign, volunteers will be
contacting you, our alumni, to ask for
your support.
Gifts from alumni and friends enhance
the school’s academic programs and over
the years have sustained the quality of
medical teaching and research at Yale.
Most alumni gifts come in response to so¬
licitations by the Yale Medical School Al¬
umni Fund. These unrestricted gifts are
applied by the dean for current use in fi¬
nancial aid for medical students.
A major impediment to the school’s
progress is its limited endowment re¬
sources. The Campaign for Yale School of
Medicine was launched in 1985 to address
this problem and to meet other immediate
capital needs of the school.
The alumni fund remains a leading
priority of the school, and campaign so¬
licitations are intended to build upon an¬
nual alumni giving, not to replace it. The
“Double Ask’’ means that alumni are
being asked to continue their level of giv¬
ing to the Yale Medical School Alumni
Fund and to contribute toward strength¬
ening of the school’s endowment through
the Campaign for Yale School of
Medicine.
This is an important opportunity for al¬
umni to help to insure that your alma ma¬
ter will continue to be a leader in medical
discovery and clinical treatment, and in
preparing young people for the new era in
medicine.
Office of Development
Yale School of Medicine
350 Congress Avenue, Wing C-3
P.O. Box 3761 Yale Station
New' Haven, Connecticut 06520
(203) 785-4420
Yale Medical School Alumni Fund
P.O. Box 1890
New1 Haven, Connecticut, 06508
(203) 432-6075
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DEVELOPMENT REPORT
Campaign Update

Artist's rendering of the Center for Molecular Medicine

Markey Trust Grants
$12.1 Million
One of the largest foundation grants the
University has ever received will establish
a new research program in the soon-to-beconstructed Center for Molecular Medi¬
cine. The Lucille P. Markey Charitable
Trust of Miami, Fla., will provide $12.1
million over five years to fund the center's
program in molecular oncology and de¬
velopment, which will be directed by Dr.
Sherman M. Weissman, Sterling Profes¬
sor of Human Genetics, Medicine and
Molecular Biophysics and Biochemistry.
An acknowledged leader in studies of
gene structure and function. Dr. Weiss¬
man will lead a team of approximately
eight faculty members and their staffs who
will study cells whose regulatory mecha¬
nisms influence cell growth and replica¬
tion and the development of the organism.
In announcing this significant gift.
Dean Leon E. Rosenberg said, “Much has

PVA Supports
Neuroscience Center
The Paralyzed Veterans of America, a
congressionally chartered organization
with a longstanding interest in spinal cord
injury, has pledged $1.5 million to the
School of Medicine for support of spinal
cord injury research and laboratory facili¬
ties. The research will be conducted in a
new facility constructed at the Veterans
Administration Medical Center in West
Haven. The facility will be dedicated
May 14 as the PVA/EPVA Center for Neuro¬
science and Regeneration Research of
Yale University.
Yale's chairman of neurology, Stephen
G. Waxman, M.D.. Ph.D., will direct the
new center. Dr. Waxman is an internation¬
ally known expert in spinal cord injury and
disease. The center’s research will focus
on ways in which the nervous system re¬
sponds to injury, as well as the growth and

already been learned about the structure,
function and location of cancer-causing
genes called oncogenes. However, we still
understand very little about how these
genes act during normal development and
differentiation. The Markey Trust’s cru¬
cial gift will enable Yale to mount a major
new program in molecular oncology and
development at an unusually opportune
time for progress and understanding of hu¬
man biology and disease."
The will of the late Lucille P. Markey
established the trust in 1983, and directed
that its assets be used exclusively for sup¬
porting and encouraging basic medical re¬
search. Mrs. Markey was the owner of
Calumet Farm, a thoroughbred breeding
and racing stable in Lexington, Ky.
Since 1984, Yale also has benefited
through the trusts's Markey Predoctoral
Fellowship Program which provides three
years of financial aid for Ph.D. candidates
in the departments of physiology and hu¬
man genetics.

As the following summary shows, gifts
and pledges to The Campaign for Yale
School of Medicine totalled $140,235,500
as of December 31, 1987. This represents
nearly four years of intensive activity on
the part of the dean, faculty members and
a corps of volunteers across the country led
by Campaign Chairman Frank A. Sprole.
Plans are now underway to bring the
campaign to a successful conclusion by
July 1, 1988, through a nationwide effort
to reach all graduates of the School of
Medicine to ask for their participation in
this, the first major capital campaign
mounted by the school. The alumni solic¬
itation will be directed toward completing
the campaign objectives which have not
yet been fully met. Foremost among these
is the need for endowment funds. Thus far,
$25 million in endowment gifts have been
received toward the original goal of $59
million. John B. Ogilvie '31S, M.D. '34
is Chairman of the Alumni Division of
the campaign.

Progress Report
December 31, 1987

GIFTS BY PURPOSE
Endowment
General Endowment
Professorships
Fellowships
SUBTOTAL

regeneration of nerve cells, their interac¬
tion with glial or supporting cells, and
ways in which they develop the capacity to
conduct nerve impulses.
PVA represents more than 12,500 mem¬
bers who participate through 40 chapters
around the nation. Its largest chapter.
Eastern Paralyzed Veterans Association
(EPVA), is based in New York. R. Jack
Powell, executive director of PVA, an¬
nounced the grant in a letter to Dean Leon
E. Rosenberg. “For PVA. our major finan¬
cial commitment to this center and the un¬
qualified support clearly evident from PVA
chapters and friends nationwide under¬
scores our solemn and continuing commit¬
ment to dedicate our best efforts, energy,
time and resources, not only to improve
the lives of those with spinal cord injury or
disease, but also to provide aggressive
leadership in the crucial quest for a cure
for all mankind,” Powell said.

$

7.349.910
11,872,654
5.895.523
25,118,087

Facilities
Molecular Medicine
Magnetic Resonance
Medical Library
Labs and Equipment

$20,100,000
3.077,000
8,015,000
5.971.888

SUBTOTAL

37,163,888

Programs and Research

77,953.525

TOTAL

$140,235,500

GIFTS BY SOURCE
Corporations
Foundations
Individuals
Research and
Other Organizations
TOTAL

$28,723,535
24.682,716
56.524,047
30.305.202

$140,235,500
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ALUMNI REPORT
Admissions.

Dr. Robert Gifford, asso¬
ciate dean for student affairs, is continuing
to provide personal interviews to all appli¬
cants to the school who are children of alunrni. In other admissions news, this
winter. Dean of Admissions Thomas Lentz
has begun to solicit the help of the alumni
in interviewing medical student candi¬
dates. Such help is particularly needed for
students from faraway places, who often
cannot afford the trip to New Haven for an
interview. Alumni who would like to con¬
duct such interviews should contact the
alumni office.

Building “Class Consciousness.”
For the first time, student class agents and
officers have been appointed for each of
the four medical classes. Dinner was
shared with the class agents by Dr. Leon¬
ard Kemler, chairman of the fund, and Ms.
Claire Lauterback, its director. We hope
such social events will reinforce the stu¬
dents’ continued participation in the asso¬
ciation after they graduate.
The association plans to sponsor one of
the school's monthly student teas this
spring. We also hope that medical students
will participate in the reunion weekend of
June 10. 11. Students will be invited to
conduct tours of the ever-changing medi¬
cal campus, as well as to enjoy the social
activities of the reunion weekend.
The alumni office participated in fresh¬
man orientation last September. We hope
an expanded group of alumni will attend
the freshman welcome party scheduled for
September 1988.

Career Counseling.

Students —espe¬
cially women students —often query the
alumni office to see if they can receive
counseling regarding career choices. They
sometimes ask if they could speak with al¬
umni who practice in a particular specialty
that the students are interested in.
Such encounters, however desirable, are
difficult to schedule due to time con¬
straints for both students and alum practi¬
tioners. To make this process easier, a
committee is being organized which will
include students and alums, with an em¬
phasis on younger graduates. This group
will suggest possible initiatives for the
coming year.

Financial Aid.

The issue commanding
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most concern in our most recent alumni
survey was the economic and emotional
well-being of the current medical student.
Reflecting an increasing concern over stu¬
dent need. Dean Rosenberg has earmarked
for scholarships all unencumbered gifts to
the Yale Medical School Alumni Fund that
are available for current use.
For the year ended July 1, 1987, donations
to the fund totalled a record $615,000, of
which $235,000 went to scholarships.
Gifts to the Medical School Alumni Fund
have risen approximately $100,000 an¬
nually during the past two years, and must
continue to increase if Yale is to stay com¬
petitive with other leading medical schools
in providing financial aid.
An article highlighting the increasing
stress provoked by current student indebt¬
edness is featured in this issue of YALE
MEDICINE. Though it should be empha¬
sized that loan defaults are less than 1 per¬
cent at Yale Medical School, many
students fear that at current rates of inter¬
est, loan indebtedness is becoming
insupportable.
Because of the current federal deficit,
there is only a slim hope that programs for
loan forgiveness will be developed at this
level. Thus, our association may find its
primary and most compelling mission as
that of student advocacy in the financial
arena: We should develop new mecha¬
nisms for scholarship support, with coun¬
sel and assistance from the office of
student affairs. For example, a class re¬
union gift might be dedicated to "adopting
a needy student,” or selecting the "Class
of 19xx Scholar.”

House Staff/Fellows —Alumni Sta¬
tus in AYAM. The 1985 survey pro¬
duced many inquiries concerning the
alumni status of residents and fellows who
had not received Yale degrees. While not
considered alumni by the University, they
are members of the Association of Yale
Alumni in Medicine according to its by¬
laws. As such, former house staff and fel¬
lows are entitled to receive YALE
MEDICINE and AYAM literature and cor¬
respondence. My office receives several
calls every year from such members con¬
cerning this issue. Many display an intense
loyalty for, and a close identity with, Yale
for the specialty training they received
here.
Alumni records have long been deficient
in recording past house staff and fellows
because department directors regularly

fail to register these physicians at the com¬
pletion of their training. A subcommittee
chaired by Dr. John Forrest of the depart¬
ment of medicine met with representatives
from each of the major clinical depart¬
ments to discuss this problem.
As a result of this effort, communica¬
tion was reestablished with 471 former
house staff and fellows, who were ex¬
tended an invitation to join the associa¬
tion. The committee will now consider
scheduling departmental reunions, which
are often arranged informally at specialty
society meetings distant from New Haven.
Perhaps such reunions could be set up
on a regular basis to coincide with the
spring medical school reunion, as cur¬
rently occurs with surgery, orthopaedics
and opthalmology. As members of AYAM,
all house staff and fellows should be
warmly greeted upon their initial arrival
on campus, and their rights and privileges
in the organization made clear.
The appointment of many new depart¬
ment chairmen should provide the oppor¬
tunity for departmental fund raising efforts
to aid defined projects relevant to the
chairman’s needs. This could be done with
the help of the development office, with
both the resident/fellow and department
receiving credit. The constant need by
both the school and chairmen for unre¬
stricted funds is ever present, and should
be directed through the efforts of the Yale
Medical School Alumni Fund, for many
years supervised and assisted by Samuel
Kushlan, M.D., ’35.
The opportunities described present
"unfinished business” of this subcommit¬
tee and under the leadership of Dr. Forrest
should be further addressed in 1988.
A final note in closing. We are receiving
a good response from alumni who are re¬
turning their tear-out cards from YALE
MEDICINE, complete with news of their
whereabouts and activities. Items of per¬
sonal news will be listed in the medical
school column in the Yale alumni maga¬
zine, while professional news will appear
in YALE MEDICINE.
Keep those cards and letters coming.
Nicholas P.R. Spinelli, M.D. '44
Director of Alumni Affairs
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ALUMNI FUND NOTES
The J. Roswell Gallagher
Endowment Fund

Recent Gifts
Each year, thousands of School of Medi¬
cine alumni and friends give to the alumni
fund to provide support essential to the
school's educational strength. Each gift
is important, helping to underwrite oper¬
ating costs while expressing the generos¬
ity of the many individuals who believe in
the school’s mission. Each has been
gratefully received. The following exam¬
ples represent the commitment and gen¬
erosity of those who continue to offer that
support.

The Robert and Jane
Frelick Charitable Trust
Dr. Robert Frelick and his wife, Mrs. Jane
Frelick, received their degrees from Yale
in 1944: Dr. Frelick from the medical
school and Mrs. Frelick from the nursing
school. To support both schools and to
make gifts to their grandchildren, the Frelicks recently established a charitable
trust. This trust will pay incomes to their
grandchildren for the next 15 years. At the
end of that time, the assets of the trust will
be equally divided between the Class of
1944 alumni fund endowments of both the
medical and nursing Schools. This gift ar¬
rangement will entitle the Frelicks to a
substantial income tax charitable deduc¬
tion and other tax benefits, and it will en¬
able them to achieve two goals with the
same asset: a substantial gift to their
grandchildren and a generous contribution
to the medical and nursing Schools.

The Thomas H. Drews
And Mary Jones Drews
Scholarship Fund
John A. Drews, a member of the Class of
1967, recently established a scholarship
fund in honor of his parents. Fie did so by
purchasing a life insurance policy that will
deliver substantial proceeds to the school.
In making his gift. Dr. Drews commented:
“My parents have provided me with enor¬
mous financial and emotional support
throughout my educational career, and
this gift seeks to acknowledge this support
and to express my gratitude for it."

Income For Life
You can make a gift and in return receive
a lifetime income and an income tax de¬
duction as well as other tax benefits.
• An 80-year-old can contribute
$10,000 and receive a guaranteed life
time income of $900 a year, as well
as an income tax deduction of nearly
$6,000.
• A 70-year-old can contribute $10,000
and receive about $600 in income in
the first year, with income increases
of approximately 5 percent in each
succeeding year as well as a tax de¬
duction of $4,800.

Dr. J. Roswell Gallagher, ’25, ’30 M.D.,
is a long-standing chairman of the medical
school alumni fund endowment program,
and he has provided important support to
both his Yale College and medical school
classes with a series of life-income gifts,
beginning in 1976. Each gift has entitled
him to significant tax benefits, as well as
to a life-income for both himself and Mrs.
Gallagher. These gifts will be combined at
a future date to establish the J. Roswell
Gallagher Scholarship.
About the life-income gift option. Dr.
Gallagher has commented: “I have been
very pleased with the results of my gift ar¬
rangements with Yale. The tax and in¬
come benefits from a life-income plan are
considerable, and they offer alumni the
opportunity to make significant contribu¬
tions at a very reduced cost. I heartily en¬
dorse this program and urge all alumni to
participate.”

W hy Send a Small Gift?
Some alumni of the School of Medicine
are reluctant to send along small gifts to
the alumni fund, because such donations
might appear inconsequential next to the
gifts of thousands or even millions of dol¬
lars that the school receives. What these
alumni may not know is that even a modest
gift helps the School of Medicine solicit
large contributions from sources that look
to the percentage of alumni giving in de¬
ciding whether or not to support the
school.
Hence, no matter how large or small,
your gift to the Yale Medical School Alum¬
ni Fund goes to work for your alma mater.
The Yale Medical School Alumni Fund
P.O. Box 1890
New Haven, CT 06508
(203)432-2810

• A 60-year-old can contribute $10,000
this year, receive an immediate in¬
come tax deduction of $7,750 and,
starting in 10 years at his 70th birth¬
day, receive $1,160 a year for life.
Please call (203) 432-5855 collect for
further information.
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Highlights: Medical Alumni
Reunion Weekend
Friday, June 10
8 a.m.
1:30 p.m.
4 p.m.
5 p.m.
7 p.m.

8 a.m.
9 a.m.

Noon
2:45 p.m.
6:30 p.m.

8 a.m.
9 a.m.
Noon
1 p.m.

Medical alumni/ae registration
Class reunion seminars
Special address: Robert G. Petersdorf, M.D. '52,
President, Association of American Medical Colleges
Dean's reception
Medical alumni/ae reunion dinner

Nursing alumni/ae registration
Keynote address: Ada Sue Hinshaw, M.S.N. '63, Ph.D.,
R.N., F.A.A.N., Director, National Center for Nursing
Research
Luncheon and special address
Faculty presentation
Social hour and dinner

Hospital administration alumni association (YUHAAA)
and EPH alumni/ae registration
Alumni/ae workshops
YUHAAA business meeting
Alumni/ae workshops

Saturday, June 11
9:15
10:30
11:45

Medical faculty seminars
Medical alumni/ae reunion seminar
AY A in Medicine annual meeting

All medical graduates are welcome to attend reunion weekend. Reunion
festivities will be held for classes ending in the years “3” or “8".
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Confronting Armageddon
Yale Neurology: Expanding Hope’s Horizon
Doctors: A Poem
Looking Back at Tomorrow
Gallery: Metallic-Tractors
Here and About
In Progress
Faculty News
Alumni News
New Books
In Memoriam
Obituaries
Alumni Report

YALE MEDICINE is distributed to members of the
Association of Yale Alumni in Medicine, and students and
friends of the School of Medicine. Communication may be
addressed to Dr. Michael Kashgarian, editor; c/o the Office of
Public Information, 350 Congress Ave., New Haven, Conn.
06510.

Dr. Michael Kashgarian, professor of pathology, is editor of
YALE MEDICINE. The magazine is produced by him and the
Office of Public Information: Helaine Patterson, director;
Gregory Huth, publications editor; and Leah D'Eugenio,
senior administrative assistant. The tri-annual magazine is
prepared in cooperation with the Alumni and Development
offices at the School of Medicine, with assistance from
Victoria Chave, layout and production.

The cover features Joel Black, PhD., assistant professor of
neurology, preparing a “freeze-fracture” slide for electron
microscopy. The technique is helping Yale medical scientists
further their quest to understand nerve function. Photo

credit: James Anderson.
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CONFRONTING ARMAGEDDON
“Nuclear war cannot be won and must never be fought.” President Ronald Reagan, in a letter
to the International Physicians for the Prevention of Nuclear War (IPPNW), Spring 1983
“The physicians have really done a great thing; you have convinced the Soviet military that
they cannot win a nuclear war” State Department official, Washington, 1984
“// we all agree, and all these heads of state and the Pope say we are correct—/ mean, if
everything's so good, why is everything so bad?” Georgii Arbatov, leading Soviet expert on the
United States, addressing an IPPNW Congress, 1983
IPPNW

IPPNW co-presidents Lown, an American, and Chazov, a Soviet, conduct a press conference before the Nobel Prize ceremonies in Oslo in
December 1985. The author. Dr. John Pastore, is at the far right.

by Dr. John O. Pastore '67
Academician Arbatov’s melancholy observation, an echo of
sentiments from the American side, captures the essence of
the physicians' movement against the nuclear arms race.
The United States and the Soviet Union have recently
concluded, and their leaders have signed, the first treaty that
will result in dismantling a whole class of nuclear weapons.
Before the treaty’s ink was dry, it was assumed that the
Intermediate Nuclear Force (INF) accord would be ratified in
the U.S. Senate without effective opposition and its stringent
verification measures would render the treaty virtually
impossible to violate without detection.
From the American standpoint, and particularly for
President Ronald Reagan, the asymmetry of the treaty—with
YALE MEDICINE Summer 1988

four times as many Soviet as U.S. missiles being
dismantled—represents a great triumph. The INF treaty will
probably ensure that the Republican Party will emerge from
its convention in New Orleans this summer claiming effective
management of the Russians and their dynamic leader
Mikhail Gorbachev. In fact, so impressive is the President’s

Dr. John Pastore, a cardiologist at St. Elizabeth's
Hospital of Boston and associate professor of medicine at
Tufts University School of Medicine, graduated from the Yale
School of Medicine in 1967. Since 1984 he has been the
secretary of International Physicians for the Prevention of
Nuclear War.

achievement in purely political terms that as of this spring.
Democratic contenders for the presidential nomination had
barely mentioned the nuclear arms race.
Yet. no matter how exciting or politically effective, the INF
agreement is little more than a symbolic first step on the road
to nuclear disarmament. Consider that less than 4 percent of
the world’s nuclear weapons will be removed as a result of the
agreement. No nuclear weapons capable of reaching the
United States will be dismantled. And the agreement leaves in
place the system of nuclear blackmail we euphemistically call
"deterrence.” Maybe that’s what Arbatov meant: Though we
have attended to a single symptom, the disease festers at a
much deeper level.
It’s possible that before the end of the Reagan presidency a
major arms control achievement—a 50 percent reduction in
superpower stockpiles—will become a reality. Conventional
wisdom has it that the Soviets want the reductions just as
much as those Americans who care for Reagan's place in
history. It seems that only the intransigence of the American
right (sensing betrayal by a lame duck president once their
stalwart) or the impenetrable vagaries of Soviet domestic
politics could forestall a 50 percent reduction.
Certainly, you say, such a reduction would satisfy, at least
temporarily, the “peaceniks,” including the physicians
internationally clamoring for nuclear disarmament. But the
answer is an emphatic no, as anyone familiar with the history
of International Physicians for the Prevention of Nuclear War
(IPPNW) would surmise. Perhaps I can explain.
WHERE WE HAVE BEEN
In the early 1960s, a small band of physicians played a key
role in the passage of the Limited Test Ban Treaty that ended
atmospheric nuclear test explosions by the United States and
the Soviet Union. Concerned mothers in the American
Midwest and the doctors demonstrated that Strontium 90, a
radioactive isotope liberated into the atmosphere during
nuclear testing, behaved biologically like calcium—collecting
in the deciduous teeth of babies because it was in the milk
from cows that grazed on grasses containing the isotope.
The resulting public outrage helped the Kennedy
administration achieve the atmospheric test ban, signed in
1963. With this success. Physicians for Social Responsibility
(PSR) was off and running. Movement leaders published
articles in prestigious medical journals extrapolating about the
effects of nuclear explosions over major American cities, and
proclaimed in churches, universities and town meeting halls
that nuclear war could not be survived.
Thus was born the so-called “bombing run,” a one-hour
lecture on the effects of a megaton blast over Boston, New
York or San Francisco. People listened, and some were
energized to act, but an escalating war in Southeast Asia,
along with the civil rights issue, soon dominated the agenda
of social concern. Husbands, sons and brothers were dying in
Vietnam, even as “freedom riders” perished here at home.
PSR members continued to publish in scholarly medical
periodicals, but the most important outlets—the mass media
in the United States—were focusing on other issues.
Meanwhile, underground nuclear test explosions continued
at the annual rate of approximately 30 in the United States
and 20 in the Soviet Union. But the principle of “out of sight,
iu o! mind” held true; few noticed what was happening. The
led test ban had created the illusion that the nuclear arms
had been slowed, if not stopped, and public outrage was
ed because the atmosphere was no longer being
animated. A new generation took office in the U.S.

Congress—people who had never witnessed the frightening
power of a nuclear blast.
In a tit-for-tat “policy,” the nuclear superpowers engaged
in an open-ended arms race, with atomic weapons on each
side soon reaching the tens of thousands. Many missiles
packed the firepower of 80 or 100 Hiroshimas. Deadly
accuracy was “improved,” and the possibility of a disabling
first strike by one’s enemy became the defense planner’s
nightmare.
A TURNING POINT
In 1978, shortly after the Three Mile Island nuclear reactor
accident in Pennsylvania, a small group of Boston doctors,
including Helen Caldicott, Eric Chivian and Ira Helfand,
revived the dormant Physicians for Social Responsibility. At
first the organization was concerned with both nuclear power
and weapons, but its leaders soon decided to focus solely on
nuclear weapons—an approach that has continued in the
succeeding 10 years.
In late 1979 and early 1980, another group of Boston
doctors, members of the rejuvenated PSR, joined with
prominent leaders in Soviet medicine to found an
international organization against the nuclear arms race. Six
of them—three Soviets and three Americans—met in the
restaurant of a Geneva hotel and, during a dramatic and
sometimes tumultuous weekend, hammered out the principles
that would guide this risky new endeavor.
The Americans—Bernard Lown, James Muller and Eric
Chivian—and the Soviets—Evgueni Chazov, Leonid Ilyin
and Mikhail Kuzin—agreed that heading off a nuclear conflict
would be the single agenda item of the International
Physicians for the Prevention of Nuclear War. Through
IPPNW, physicians from around the world would demonstrate
their professional commitment to protect life and preserve
health. Moreover, the organization would be neutral and
disseminate the same information about nuclear war to all
nations.
On the American side, many prominent physicians played
an important role in the formative months, including Herbert
Abrams, Helen Caldicott, David Greer and Howard Hiatt.
Bernard Lown’s living room in Newton, Mass., was the scene
for many lively evenings as IPPNW went through a neonatal
period in the early 1980s.
The wisdom of focusing on the nuclear arms race became
apparent as disparate political philosophies and attitudes
toward the Soviet Union surfaced within the group. But to
paraphrase Samuel Johnson, "There is nothing like the threat
of nuclear annihilation to concentrate the mind,” and there
were no substantive disagreements on that score.
A MEETING OF MINDS
Perhaps more importantly, the Soviet physicians agreed with
us not only on general principles, but also on details and
strategy. Many times a plan would be hatched in the Lown
living room, completely American in formulation, and we
would telex or phone the details to Dr. Chazov in Moscow. If
the matter were especially important, the next day the
Russians often would notify us simply that they agreed! For
those of us nurtured on cold war platitudes about the Soviets,
it took a while to get used to this challenge to our
preconceptions.
It bears emphasizing that this international unanimity was
manifest only on our single-issue official agenda. Many of us
continued to engage our new Soviet colleagues (and yes,
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friends) in heated private discussions on other matters,
reflecting the differences between our two social and political
systems.
Some in the West felt that we should “go public” with
these disagreements—especially on human rights. My own
experience has been that our effectiveness has come through
quiet diplomacy rather than attempts to embarrass our Soviet
colleagues. Several Soviet emigres now living in the West
bear witness to the success of that approach.
Beginning in 1981, the main event on the 1PPNW annual
calendar has been its international congress. The first, held
near Washington, D.C., attracted 70 doctors from 12
countries.
1PPNW growth has been dramatic since that first
international meeting. The seventh congress, which took place
in Moscow in June 1987, attracted more than 2,600 delegates
representing more than 60 countries. Fifty-five of those
nations are now official affiliates of IPPNW.
Physicians for Social Responsibility, the U.S. affiliate of
IPPNW, has enrolled more than 40,000 physicians and
medical students, and another 10,000 health care workers,
including nurses, who also have their own autonomous
Nurses Alliance.

EYES ON THE PRIZE
The greatest boon to the international physicians movement
undoubtedly came in 1985, when IPPNW was awarded the
Nobel Peace Prize. The Nobel Committee cited the
federation’s “considerable service to mankind by spreading
authoritative information and by creating an awareness of the
catastrophic consequences of atomic warfare.”
Perhaps for the first time, IPPNW came to be regarded as a
threat by those espousing a contrary view of the nuclear arms
race, whose rationale spans a spectrum from “Nuclear
weapons have guaranteed the peace” to “Why not spend the
Russians into submission.” Thus, controversy attended the
peace prize.
Its nominal focus was the human rights orientation of the
Soviet Dr. Chazov, who by then had served alongside Dr.
Lown as a co-president of the federation for five years. Dr.
Chazov held that office without any aspersions on his
character. In fact, among the emigre community in the Boston
area. Dr. Chazov was highly regarded as a cardiologist,
although one with close ties to the Soviet leadership. He was
reputed to be the private cardiologist of Leonid Brezhnev and
his successors.
Almost as soon as the IPPNW’s Nobel Peace Prize was
announced, however, the media in the Federal Republic of
Germany brandished a letter co-signed by Dr. Chazov and
about 20 other scientists in the early 1970s. The letter
criticized Andrei Sakharov, the dissident Soviet physicist who
was later exiled to Gorky. Those opposed to Soviet-American
rapprochement seized upon the incident with glee.
Regardless of one's attitude toward the Russians, Dr.
Chazov or Sakharov, the controversy was a source of pain for
those of us who struggled through it. My own view is that the
Nobel Prize was awarded to a worldwide federation in more
than 50 countries, and not to any individual. Dr. Chazov had
to speak for himself on the Sakharov affair, that predated his
work with us by nearly 10 years. The work itself was not only
beyond reproach but a service to humanity.
In December 1985, the media’s attention was abruptly
redirected by a propitious development. At the Nobel Prize
press conference in Oslo, a Soviet journalist collapsed in view
of the world as these contentious issues were being hurled at
us by the assembled reporters.
That evening millions of television viewers worldwide saw
on the news an international group of physicians, including
Soviet and American cardiologists, leap to the aid of Lev
Novikov, who had just become a victim of sudden cardiac
death. As an example of international cooperation, the
moment was poetic; a few skeptics even suggested that
IPPNW had staged the rescue. Happily, Novikov survived and
now speaks occasionally on behalf of IPPNW.
PEACEFUL PROLIFERATION
The incident catapulted the physicians movement into the
spotlight. It did not stifle our critics, of course, but it certainly
reinforced our credentials as doctors. The dramatic and
successful resuscitation of Mr. Novikov did not hurt
recruiting, either.

WIDE WORLD
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(At left) Drs. Chazov (white shirt) and Lown (in vest) use closed
chest massage to revive a Soviet journalist at the 1985 Nobel press
conference. Dr. Pastore, in the foreground, monitors the patient's
pulse.
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IPPNW now represents 175,000 physicians in 55 countries.

It i the fastest growing medical organization in the world and
the only one with a co-presidency shared by an American and
a Soviet. Our current vice presidents are from Sweden,
Hungary, Argentina, Australia and Canada.
The International Council, the governing body for the
federation, is comprised of councilors from each of our 55
affiliates. The People’s Republic of China is the only nuclear
weapons state not officially represented on the council, but
prominent Chinese physicians have attended as active
observers at each of the last three world congresses. The
future of our organization is limited only by finances;
imagination and daring have never been a problem.
For instance, IPPNW played an important role in getting
the Soviet Union to institute a unilateral 18-month
moratorium on nuclear test explosions from August 1985 to
January 1987. The Soviets initially resisted our arguments
that they stop nuclear testing. They felt that the United States
would not halt its own test explosion program and that few in
the West would be made aware that the Soviet side had indeed
done so.

YEAR
Nuclear test explosions by the superpowers continue. (Courtesy:
Union of Concerned Scientists.)

The Soviets were partially right. The United States did not
join the nuclear explosions moratorium, despite the active
advocacy of the Western anti-nuclear movement. On the other
hand, the Soviets’ willingness to stop test explosions was
highlighted and the comprehensive test issue ban was
rejuvenated before a wide Western audience.
IPPNW has launched CEASE FIRE ’88, a concerted effort
to gain worldwide support for a comprehensive test ban treaty.
Our affiliates around the world are protesting each U.S. or
Soviet nuclear test explosion—not only with letters and
telegrams, but also by seeking meetings with the ambassadors
from the offending superpower resident in the affiliate
country. We are giving it our best shot.
Together with our American affiliate, PSR, we shall
continue to bring Soviet physicians to the United States and
send our doctors to the Soviet Union. The anti-nuclear
message is the same on both sides.
An independent corporation, SatelLife, has been formed to
inch, with the cooperation of Soviet space scientists, a
lunications satellite for medical purposes. SatelLife will
mate health information to developing countries, and
educational and communication needs of their
health-care deliverers.

IPPNW has long maintained that the heavens should be
used to lift humanity’s spirits and improve health worldwide.
We are not simply against weapons in space. We advocate
using space to elevate humanity to a new plane of inter¬
national cooperation.
WHERE WE ARE GOING
Since Hiroshima and Nagasaki, physicians have realized that
upwards of 80 percent of all medical personnel would be
killed outright in the event of a nuclear war—and the
survivors would function more as patients than doctors. Once
the Nagasaki weapon demolished that city’s Medical
University—immediately killing 90 percent of those inside
and destroying all supplies—we had all the evidence we
needed about the physicians’ role regarding nuclear war. The
only cure is prevention.
There are still pockets of hard core nuclear war strategists
in the militaries of the United States and the Soviet Union.
But thanks in large part to the physicians, it is no longer
considered intelligent to speak of nuclear war as ‘'winnable.”
So in large measure, our first battle has been won.
But much more needs to be done. The world still bristles
with 55,000 nuclear weapons—more than 95 percent of which
are in the hands of the United States and the Soviet Union.
Even after dismantling medium and some short-range missiles
in Europe following ratification of the INF accord, there will
still be more than 50,000 instruments of genocide on our
small planet, with a combined firepower of one million
Hiroshimas.
Beginning last year, the International Physicians for the
Prevention of Nuclear War has espoused the goal of eliminat¬
ing all nuclear weapons. Our physicians are not arms con¬
trollers.The career arms controller objects to abolition on the
grounds that nuclear weapons cannot be “disinvented.” We
agree that knowledge, scientific or general, cannot be
eradicated; but the use of that knowledge is controllable. The
real problem is that nuclear weapons have become an integral
part of the defense postures of the United States and the
Soviet Union.
However, it is naive and delusional to believe that
humanity and nuclear weapons can coexist indefinitely. We
must learn to defend ourselves without nuclear weapons,
because their use would terminate civilization as we know it.
We also are continuing our grassroots educational efforts.
At the urging of the World Health Organization, IPPNW is
preparing a curriculum on the medical effects of nuclear war
and the nuclear arms race that medical schools around the
world can use. It is distressing that few medical schools teach
about what many experts have called humanity's most
important public health problem.
Considering the many Yale medical academicians who
provided leadership to the Atomic Bomb Casualty
Commission in Hiroshima and Nagasaki, it would be
appropriate that our own medical school play a larger role in
developing and using this important curriculum.
Anyone interested in attending the 1989 IPPNW congress
in Hiroshima—and all are invited—should contact a local
chapter of Physicians for Social Responsibility.
When that next congress meets, the Albert Einstein quote
on the IPPNW letterhead will seem even more immediate;
“We shall require a substantially new manner of thinking if
mankind is to survive.” But it will take more than thinking; it
will take all the optimism and work physicians and their
patients can muster.
We think the future is worth it. YM
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YALE NEUROLOGY:
EXPANDING HOPE’S HORIZON

Dr. Stephen Waxman in his new laboratory.

by Nancy Pappas
Few injuries or diseases are more devastating than those that
affect the central nervous system. Some 300,000 Americans
have been left quadriplegic or paraplegic by spinal cord
injuries. Their numbers increase by some 14,000 each year.
Another 250,000 suffer from multiple sclerosis, with its
unpredictable course of neurologic disability caused by the
demyelination of nerve fibers.
Moreover, these conditions disproportionately affect young
people in the prime of their family- and career-building years.
This enormous human toll has stimulated considerable
scientific research—but frustratingly little progress toward
effective treatments or cures.
Stephen G. Waxman, M.D., Ph.D., professor of neurology
and chairman of the School of Medicine’s neurology
department since 1986, is determined to change all that.
Observes Dr. Waxman, who is also chief of neurology at YaleNew Haven Hospital and a staff physician in neurology at the
VA Medical Center in West Haven, “The traditional picture is
that if something happens to the central nervous system,
there’s no recovery. Recently, it's become clear that the picture
may not have to be so pessimistic.”
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Dr. Waxman and his colleagues are collaborating on a
series of research efforts designed to illuminate the basic
mechanisms of central nervous system development, function,
injury and recovery. Working in a new, custom-designed
research facility built by Yale on the grounds of the Veterans
Administration Medical Center, the group is attacking these
problems with a combination of state-of-the-art research
techniques.
“We’re doing basic science,” emphasizes Jeffery Kocsis,
Ph.D., associate professor of neurology. “We can’t promise to
make wheelchair patients walk. But that’s in the back of our
minds.”
NEW RESEARCH CENTER
An intense, confident man. Dr. Waxman describes the
evolution of this new research center. It all began, he explains,
when Dr. Leon E. Rosenberg, dean of the medical school,
recruited him from Stanford University School of Medicine to

Nancy Pappas is a free-lance medical writer.
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lead Yale’s neurology department.
Dr. Waxman had already earned widespread recognition
for his work on neural regeneration and on the molecular
neurobiology of myelinated nerve fibers. He had assembled a
first-rate group of collaborators, several of whom have since
joined the Yale faculty.
In the process of moving his research operations from
Stanford to Yale, Dr. Waxman recalls, he began to dream
aloud about the ideal research facility. It would, he said, be
designed to embrace the kind of intellectual and practical
collaboration that had already developed within the group.

schools,” Kocsis notes. “People get scattered all over the
place, and it's hard to get together. Here, we're right across
the hall from each other.”
The center currently houses Drs. Waxman, Kocsis and two
other senior members of the research team, Beth Friedman,
Ph.D., and Joel A. Black, Ph.D., both assistant professors of
neurology. Each collaborator leads one of the center's four
primary laboratories, where research is carried out by teams
comprising graduate students, postdoctoral fellows and
laboratory assistants.
At least once a week, the four investigators meet formally

Dr. Waxman encourages informal
meetings among his team’s members.
Here he shares a lighter moment with
Jeffery Kocsis (left). Beth Friedman
and Joel Black.

“Finally, I said to Lee Rosenberg, ‘Why don’t you build us a
research center?' And he did it!" Waxman recalls.
Open since early 1988 and dedicated in May, the center is
housed in a single-story brick building on the campus of the
VA Medical Center. In keeping with its close ties with the
medical school, the VA made the land available to Yale on a
long-term lease.
"We're happy to be at the VA because they have a
longstanding interest in diseases of the CNS,” Dr. Waxman
says, speaking as the center’s director.
A major source of funds for the new building and
program—$1.5 million—came from the Paralyzed Veterans
of America and one of its chapters, the Eastern Paralyzed
Veterans Association. In recognition of the groups’ support,
the center has been named the PVA/EPVA Center for
Neuroscience and Regeneration Research of Yale University.
Showing visitors around the new, H-shaped building,
Jeffery Kocsis, the center’s associate director, talks of the rare
privilege of being able to design a scientific research facility
from scratch. Every principal investigator has been given
plenty of room for equipment and staff, and the floor plan has
been laid out to encourage easy contact between the various
research teams housed there.
This is not as common as one might imagine in medical

to discuss the progress of their work and search for ways to
enhance each other's efforts. Dr. Waxman likes his
researchers to collaborate informally, as well. Blackboards
hang in the hallways to encourage spur-of-the-moment
discussions.
The center’s research activities flow in many directions,
but all. Dr. Waxman says, with a common goal: "Our projects
are variations on the theme of functional recovery after
damage to the central nervous system. What are the
mechanisms surrounding it? How can we encourage it? We
hope our basic research will throw some light on these
issues.”
PURSUING THE DREAM
To the public, recovery from neurological disease or injury
seems synonymous with regeneration of nervous tissue. But
Dr. Waxman points out that in many such disorders "though
there's not a reconstitution of structure, we get recovery of
function.” Limbs paralyzed or eyes blinded by multiple
sclerosis can start working again, even though the myelin
insulation is still stripped from the nerves. Stroke victims may
regain their speech or powers of movement, even though their
brain tissue remains damaged.
continued on page 9
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The Platinum Portraits of Freeze-Fracture

Critical to Yale’s research into spinal cord injury and multiple
sclerosis is the ability to inspect the membranes of nerve
fibers in the finest possible detail—down to individual ion
channels and protein receptors.
That is where Joel Black, Ph.D., comes in. An assistant
professor of neurology, he is a specialist in an esoteric—but
extremely useful—electron microscopy technique called
freeze-fracture. This technique produces detailed platinum
castings of split membranes that produce minutely detailed
electron micrographs.
“Joel is one of the people at the forefront of applying this
technique to the central nervous system,” notes Dr. Stephen
G. Waxman, professor and chairman of the department of
neurology.
Black demonstrates the technique in his new laboratory at
the PVA/EPVA Center for Neuroscience and Regeneration
Research of Yale University, which features a $120,000
freeze-fracture machine.
Freeze-fracture, he explains, is like hitting a block of ice
with a hard, sharp object, only on a minute scale. The
researcher begins by putting tiny bits of nerve tissue—in this
instance, from the optic nerves of laboratory rats—on
confetti-sized gold-and-copper mounts, then flash-freezing
these in a vat of liquid nitrogen.
Then he sets the frozen mounts on a bottle cap-sized
“table,” and inserts the whole assembly into the supercooled
vacuum chamber of his freeze-fracture machine.
Here a sharp blade slashes forward, breaking the nerve
tissue apart. “The fracture follows the pathway of least
resistance,” Black explains. In most cases, the tissue fractures
between the two layers of lipid molecules that make up the
cell membrane. When the fracture plane reaches a protein
penetrating this double layer, it tends to go over or under the
protein—leaving it intact for study—rather than splitting it.
“I have no control over the fracture plane. It’s just a
random event,” Black explains. Nevertheless, about 90
percent of the fractures produce usable images.
Next, Black directs a fine platinum vapor at the exposed
membrane face, in effect spray-painting it with a thin layer of
metal only several molecules thick. Then he layers carbon
over the platinum to stabilize it (the carbon, transparent to
electrons, will not show up on the electron micrograph).
Finally, he uses chemicals to digest away the nerve tissue
itself.
What’s left is a perfectly detailed casting of the nerve
membrane that is totally impervious to electrons, and
therefore completely visible to the electron microscope.
Next comes an even greater challenge. “The difficult part
of the technique is interpreting the micrographs, because the
image you get is so different than conventional thin-section
microscopy,” Black says. “You’re looking at vast amounts of
membrane instead of the customary thin cross-section.”
Black points out that by using freeze-fracture to look at
large areas of membrane, he can see the spatial organization
of proteins within the membrane.
Having mastered this demanding technique. Black is now
trying to extend its utility. “The drawback of conventional
freeze-fracture is that if you look at a particle, you can’t tell
anything about its composition. Is it a glycoprotein, a
lipoprotein? We don’t know.”
Black is working with a colleague, Beth Friedman, Ph.D.,
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A freeze-fracture electron micrograph taken by Joel Black shows a
myelinated axon magnified 50,000 times. (A) The node of Ranvier,
site of action potential propagation, is bounded top and bottom by
paranodal axon membranes (B), which have a scalloped
appearance due to constriction by overlying oligodendrocyte
processes. Numerous intramembranous proteins are apparent
within the nodal membrane.

assistant professor of neurology, who specializes in the use of
antibodies in research, to combine their two disciplines to
overcome this problem. They hope to find an antibody that
will stick to specific membrane proteins, and in turn tag this
signal antibody with yet another antibody whose tail sports a
trace of electron-dense colloidal gold. Under the electron
microscope, these tagged proteins should stand out like so
many push-pins, giving the researchers valuable information
about the identity and distribution of various proteins.
Notes Black:
“Once we work out this technique, it will have
wide-ranging possibilities for other investigations,
since we will be able to tag specific molecules for study
in the electron microscope.”
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The Emerging Option of Epilepsy Surgery

One of the traditional strengths of the neurology department is
the treatment of epilepsy. “Epilepsy treatment and research
are among the ‘jewels in the crown’ of this department. They
are a major factor in our claim to leadership in the field of
neurology,” notes Dr. Stephen G. Waxman, chairman.
Surgery is beginning to play a more prominent role in
relieving epileptic symptoms, for in spite of steady
improvement in drug therapy, an estimated 30 percent of
people with focal seizures—seizures that originate in a
localized part of the brain—can't be helped by drugs.
For some of these individuals, a Yale neurologyneurosurgery team can offer a new lease on life through the
removal of seizure-generating portions of the brain. The Yale
team, one of just a handful around the country with expertise
in this demanding treatment, receives referrals from all over
the world.
"It's one of the most rewarding things 1 can think of in
medicine—to be able to help people who have been
devastated their whole lives,” says Susan S. Spencer, M.D.,
associate professor of neurology. “Among ideal candidates,
carefully selected, over 90 percent are able to have the surgery
with minimal neurological deficit and with cure or near-cure.”

years, is only just coming into its own as an established
treatment for drug-resistant seizures. Dr. Susan Spencer
estimates that as a result, as many as 300,000 people in the
United States may need the surgery but are not getting it.
“It is becoming more popular because it really works,” she
observes. “It’s gratifying to be able to treat a chronic disease
and in many instances to cure it.”
In the 15 years since the surgery program began, demand
has increased to the point where the team is performing an
average of two operations a week. “We have grown so busy it
takes close to two years from the start of pre-operative
evaluation to the finish of the surgery," Dr. Spencer says.
Many of the team’s patients have been so disabled by
seizures that they have been confined to their homes, unable
to work or go to school. Successful surgery enables them to
lead essentially normal lives.
The key to successful surgery. Dr. Spencer explains, is a
careful pre-operative evaluation of patients.
“First we must establish that seizures are all arising from a
small part of the brain, and that this tissue can be removed
without causing a lot of neurological problems in the
individual,” she points out. “Those are a lot of ‘ifs’.
“Sometimes the localization of the spot requires dangerous
procedures such as placing electrodes deep in the brain. This
carries a 2 percent risk of hemorrhage or infection,” she notes.
“There are not that many centers capable of doing these
kinds of evaluations,” Dr. Spencer observes. “It really
requires a team approach involving neurologists, neuro-

Dr. Susan Spencer tests the
periferal vision of a young
patient whose epilepsy has
been successfully managed
with brain surgery.

Epilepsy research was begun at Yale in the 1950s by
Gilbert H. Glaser, M.D., Sc.D., professor of neurology and
former chairman of the department. In addition to Dr.
Spencer, the team’s neurologists include Dr. Richard H.
Mattson, professor of neurology and director of medical
tidies in the neurology department, and Dr. Peter D.
amson, associate professor of neurology. The team's
surgeon is Dr. Dennis D. Spencer, professor of
neur airgery, and Susan Spencer’s husband.
surgery, although done occasionally for many

psychologists and neurosurgeons.”
Precise localization of the epileptic focus enables the
surgeon to remove only that part of the brain and no other, she
explains, thus sparing as much normal tissue as possible.
In recent years, the team has been moving toward doing the
surgery on younger and younger patients. “Most of our
patients are young adults," Dr. Spencer points out. “But we are
seeing more and more children. With any removal of brain
tissue, if you do the surgery early in life the brain recovers and
compensates better.”
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continued from page 6
“We want to get at the principles of how nerve cells
reorganize after injury—the whole issue of plasticity," Dr.
Waxman explains.
Already Dr. Waxman and his colleagues have begun
illuminating the question of remissions in multiple sclerosis.
They expect that this work, which they began at Stanford,
will be greatly enhanced by their move to Yale.
That is because the Yale faculty includes people like J.
Murdoch Ritchie, Ph.D., Sc.D., Eugene Higgins Professor of
Pharmacology and one of the world’s experts on the
physiology of the myelinated nerve fibers damaged in
multiple sclerosis. In fact. Professor Ritchie and Dr. Waxman
co-authored research reports before the latter moved to Yale.
Thanks to their newly combined forces, Dr. Waxman says,
“in terms of understanding the physiology of multiple
sclerosis, Yale is the best place in the world.”
Dr. Waxman explains that normally, many fibers in the
central nervous system are covered by a sheath of myelin, a
lipid that acts as an electrical insulator. But the myelin does
not coat the fiber continuously as electrical insulation covers
a copper wire. At microscopic intervals the myelin sheath is
absent, exposing the nerve surface underneath.
These unmyelinated segments, known as “nodes of
Ranvier,” make possible an extremely efficient means of
electrical transmission known as saltatory—literally, jumping
or leaping—conduction. In saltatory conduction, the electrical
impulse generated at the nerve body does not move steadily
down the fiber. Instead, the impulse builds at one node until it
is strong enough to jump to the next.
This type of conduction is controlled by sodium and
potassium channels, specialized protein molecules that
penetrate the fiber membrane. Professors Ritchie and
Waxman have demonstrated that the sodium channels on
nerve fibers are densely clustered at each node of Ranvier.
When stimulated by the arrival of an electrical pulse, the
channels open to flood the fiber with positively charged
sodium ions.
When the charge at the node builds to a critical point, the
current begins “searching” for a place to go. It cannot simply
travel continuously along the fiber because between the
nodes, underneath the myelin sheath, there are few sodium
channels. Moreover, the fiber is coated under the myelin with
current-resisting potassium channels.
Nor can the current leak into the surrounding extracellular
space; the insulating myelin blocks that route. That leaves the
current only one means of progression: to leap to the next
node, micrometers down the fiber.
When multiple sclerosis attacks and destroys myelin
(presumably through some autoimmune process), this
electrical system is disrupted. Instead of leaping from one
node to another, the impulse travels into the area between the
nodes, where the potassium channels dissipate it uselessly.
This dissipation of nerve impulses is responsible for the
paralysis, loss of sensation and blindness that occur after
damage to the myelin.
MEDICAL DETECTIVES
While Ritchie, Kocsis and Waxman all have made major
contributions to the understanding of this means of
conduction, Kocsis works most directly on the
electrophysiological aspects of demyelinating disease. His
research involves pulsing minuscule electrical currents
through individual rodent axons in various states of
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In his specially shielded lah, Jeffery Kocsis prepares an experiment
in which he will place a microelectrode within a single rodent nerve
fiber.

myelination and demyelination. He then records their
electrical behavior by placing tiny, specially fabricated
micro-electrodes within single nerve fibers that are less than
one hundredth of a millimeter in diameter.
The researcher works from a room within a room, a large
metal mesh cage designed to keep out stray electromagnetic
signals that could disrupt his delicate measurements.
“The mandate is to gain a better understanding of how
axons work, and develop pharmacological means to make
them perform better after they have been injured,” Kocsis
notes.
One phenomenon being studied intensely is in the area of
multiple sclerosis. In some cases nerves renew their ability to
transmit electrical impulses effectively—even though they
have not regained their myelin coatings.
Assistant Professor Joel Black has contributed importantly
to this question with a specialized technique called freezefracture electron microscopy, which produces incredibly
detailed pictures of the molecules within membrane surfaces
of nerve fibers. “The technique allows us to look at large
areas of membranes and to see the spatial organization of
molecules within the membranes,” he explains. (See “The
Platinum Portraits of Freeze-Fracture.”)
Using Black’s freeze-fracture pictures and Kocsis’
electrophysiological findings, the team has established that
the demyelinated region begins to acquire conduction¬
enhancing sodium channels—enough, it seems, to keep the
current flowing across the unmyelinated wasteland of nerve
fiber damaged by multiple sclerosis. One line of research. Dr.
Waxman says, is to see whether drugs can speed this process,
or perhaps neutralize the conduction-dampening potassium
channels.
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To this end, the group has begun in vitro experiments with
4-uminopyridine, a potassium channel blocker. "We have been
able to induce reliable conduction in demyelinated nerve
l ibers. Dr. Waxman reports. “But we still have to understand
more about this drug before we test it clinically. The potential
side effects are very significant.”
Dr. Waxman is also interested in the possibility of inducing
remyelination of central nervous system tissue. If
demyelination occurs in the peripheral nervous system—as it
does in the Guillain-Barre syndrome, for example—Schwann
cells simply extrude new myelin and recovery eventually
occurs. Dr. Waxman notes. But in the central nervous system,
oligodendrocytes, not Schwann cells, make myelin and they
do not switch on so readily.
"We would like to be able to turn this cell on so that
remyelination will occur in demyelinating diseases,” Dr.
Waxman says. "We are searching for the instructional
molecules on the axon that tell the oligodendrocyte,
‘myelinate me.'”
Using freeze-fracture technology. Black has detected what
he takes to be just such molecules. He made this finding by
examining fibers taken from the optic nerves of rats at a point
in development characterized by rapid myelination. At just
the time when they instruct oligodendrocytes to form myelin,
the axons exhibit a new population of protein molecules on
their surfaces.
Chemically prevented from being myelinated, the fibers
nevertheless displayed numerous protein particles on the areas
of fiber that ordinarily would have received coats of myelin.
The particles were conspicuously absent on the areas destined
to become unmyelinated nodes of Ranvier. “It seems the
signal is programmed into the neuron,” Black concludes.
Now the problem has been handed to Beth Friedman, who
will
attack
it
with
her
research
specialty:
immunocytochemistry. Using monoclonal antibody probes
that stick to specific molecules and show up on electron
micrographs, she is able to track changes that occur in
specific molecules on nerve cells undergoing development,
myelination or demyelination. To investigate the mysterious
myelination-signal proteins, she is attempting to locate
antibodies that attach to those particular molecules. This
approach, if successful, will provide the group with a handle
on the molecules that turn on myelination, and that hopefully
can be used to turn on remyelination.
BIEL CARTER

SPINAL CORD INJURY
At
first
glance,
multiple
sclerosis—a
chronic
disease—-wouldn't seem to have much in common with the
acute disability caused by spinal cord injury. But there is an
important connection.
Jeffery Kocsis points out that many cases of paraplegia and
quadriplegia occur not because the spinal cord is completely
severed, but because of demyelination that occurs in reaction
to contusion and edema at the injury site.
“You can have a person with functional total paraplegia,
who has a number of intact, though demyelinated, fibers
coursing through the area of contusion,” he notes.
An important goal is to get these demyelinated axons to
conduct impulses. Thus, an effective treatment for the
demyelination of multiple sclerosis may also apply to spinal
injury.
The investigators also plan to pursue the traditional goal of
spinal injury research: the regeneration of damaged central
nervous system fibers.
Drs. Waxman and Kocsis both observe that research on
nerve regeneration acquired an unsavory reputation a decade
or so ago, when several investigators at other centers
promised breakthroughs within specified time periods, then
failed to deliver.
This image has improved in recent years. Dr. Waxman
adds. One reason for the change is the steady progress of
careful research into neural development and regrowth being
conducted by his own group and others like it. Dr. Waxman
says he is pleased that the Paralyzed Veterans of America has
supported this approach with its grant. Other grants have
followed, like a recent $60,000 gift from the Daniel Heumann
Fund for Spinal Cord Research, named for a young New
Yorker who was paralyzed in a 1985 auto accident.
This research. Dr. Waxman emphasizes, involves a
painstaking inquiry into the most basic cellular and molecular
processes that could take years, even decades, to evolve into
clinically useful findings.
“What causes axons to initiate growth and develop the
machinery to generate electrical impulses? How can we
induce regenerating axons to traverse scar tissue barriers in
the central nervous system? What guides a growing or
regenerating axon to the right target?” Dr. Waxman asks.
“Every one of these problems needs work.”
Asked if it will ever be possible to heal severed or
functionally damaged spinal cords. Dr. Waxman answers
carefully: “What I think is a minimal goal is to get some
subset of fibers to cross the injured region.” He points out that
even if a mere 10 percent of fibers in the cord survive and
function, it is enough to enable a person to walk.
Waxman leaves no doubt that he considers his department
up to the challenge. “We have the best people. And everyone
is passionately committed to it,” he concludes. YM

(At left) Dr. Waxman converses with two veterans at the May
dedication of the PVA/EPVA Center for Neuroscience and
Regeneration Research of Yale University.

YALE MEDICINE Summer 1988

by Dr. Adrian M. Ostfeld

BILL CARTER

1 felt so honored when, in cap and gown.
They shook my hand and gave me my degree.
You’re Medicinae Doctor now, I thought,
A new successor to Hippocrates.
On graduation afternoon, I bought a model T
And started practice in my parents’ home.
My patients all came from the neighborhood.
Most of them kids and pregnant women.
Some women at the change of life, but damn few men.
I always listened hard to patients’ talk
And tried to give them peace of mind if nothing else.
It was pathetic how they trusted me.
How glad they were when my old model T
Pulled up in front of where the patient lived.
How often there was nothing I could do
Except to sit and fret and look concerned.
I always said—and some thought it a joke—
That hospitals were no place for sick people.
It’s where you went to die, was what I thought
When I first put my shingle on the door.
And I had many a patient die at home.
It’s not like now when death is sanitized.
We quarantine our dead and dying well.

Dr. Adrian M. Ostfeld

I
I finished medical school in 1915.
War in the background.
But I had no part of it.
I can see me now.
Lanky fellow I always was.
Night time studying in the kitchen.
I had my feet in ice cold water.
Drinking black coffee by the quart.
Jabbing my leg with an ice pick
To stay awake and learn.
Medical school was very tough.
So much anatomy. So many names
Of bumps on bones I had to learn.
All that materia medica.
Hundreds of plants and drugs I read about.
Sometimes I felt so stuffed with facts that I
Could see me pop and spew those facts for miles
The way a seed pod does in early fall.
Prescription writing was so difficult.
Infusions, decoctions, sublimates and all.
How many drops or parts of this and that?
How did I ever keep those matters straight!
Sometimes they showed us patients in the pit.
That’s what we called the amphitheatre.
They’d take their clothes and point to parts diseased.
And talk as if the patient wasn’t there.
I felt embarrassed at the time.
But we were all discerning gentlemen
And it did seem a dandy way to learn.
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We went so much by custom than by fact.
The journals then were full of anecdotes
And quaint reports but not a lot of science.
For a while it was autointoxication
That was the root of all disease.
High colonics were the order of the day.
I never put much faith in all that stuff.
But many top men took the view
That every bit of poison in the gut
Must be removed.
We took real risks in my day too.
Many a time a TB patient coughed into my face,
Or a skin rash I palpated without gloves
Turned out to be contagious syphilis.
Lues was what we used to call it then
So we could name it in polite society.
But I was lucky, too, I guess.
I never caught anything from my patients
Except sometimes their pain and helplessness.
Some patients really made me mad.
They said I didn’t help them. Sometimes true.
But when they claimed I didn’t care about them
Or that I charged too much, that really angered me.
I knew what all my families earned.
I always knew just what my fee should be.
And if they couldn’t pay it right away.
Why, I could always wait a month or two.

Dr. Adrian M. Ostfeld is the Anna MR. Lauder Professor of
Epidemiology and Public Health. Last year he was elected
to the Institute of Medicine.

In the late thirties when sulfoamides
Came in and started widely to be used,
1 saw a whole new ball game coming up.
For each disease a treatment was my hope.
(I even remember that old radio joke
About the brand new sulfa drug, so new.
They didn't even have a disease for it yet.)
But by the time I quit the game in fifty-one
We'd only made a little progress in that way.
Surgery was much safer, that was true.
And penicillin changed things for all time.
Infections started on a downward trend.
But heart disease and cancer got all out of hand.
I’m glad I quit just when I did.
I’d never have been able to keep up.
All those new tests and x-rays, EKGs,
Were starting to puzzle me.
Seemed biochemistry was taking over medicine.
And that was good for medicine but not for me.
Got way out of sight in growth and in complexity
Blood clotting, and the new hormones, microbial sensitivities.
Biopsies, frozen sections and surgical pathology
All left this poor old doctor way behind.
For about 10 years or so, ’til sixty-one,
I still looked at my journals as they came.
But more and more I was not reading them.
So me and my old woman went to Florida.
We used to swim a little, play some golf.
But gave that up. It got to be too much.
We have our bridge game every Thursday night.
I read the newspapers although
The print is getting much too fine for me.
I garden some but most of what I do
Is watch TV and walk around the block.
Now all that's left of my degree
And thirty-six years of practice
Is that the neighbors call me "doc".

Thank God for the G.I. Bill of Rights.
Before the war, I was a poor old country boy.
I always felt like I was smart.
And now I had the med school funds in hand.
Just call me Vector. All my classmates did.
That's a force with magnitude and direction.
I'm aimed at life like an arrow.
And I’ve always picked out the right target.
One thing really got to me in school.
I he faculty was in a civil war
B tv .vn the basic scientists and the clinicians.
1 he basic scientists taught us
But all they really cared about
A as their research and their graduate students.
I tell like they looked down on us
\nd on the part-time doctors on the staff.
I he clinical men were hard to find sometimes,
for lectures, sometimes missing rounds.

The house staff were the ones who taught us most.
1 figured they're the ones who graded us
So I tried the old brown nose technique on them.
I told the surgery residents I was going into surgery.
And the medicine house staff I had medicine in mind.
The pediatricians that I loved to work with kids.
I didn't lie to the psychiatrists.
Near the end of my senior year
1 saw how things stacked up in clinical academia.
Surgeons made the money. Internists pulled the strings.
I decided my talent lay in medicine.
I ended up board certified.
At first I thought of going home to practice.
I'd halfway promised folks there that I would.
But my wife had seen the bright lights
And I certainly did not want to be
file only specialist in Idabel, Oklahoma,
Right down the road from De Queen, Arkansas.
So I stayed in the big city with the big hospital.
Old Vector, I stayed aimed and pointed.
I joined a group of very smart men.
1 kept my mouth shut, started rounds at seven
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Then came the fight for Medicare.
We couldn't make the politicians see
That none of us ever turned down
An older patient who really couldn’t pay.
Nor did our standards ever fall
When we took care of poor but honest folks.
Most of us came into medicine to help people
And we needed independence to do that,
Not stacks of government regulations.
Politicians don’t know how to practice medicine
But they sure knew how to beat us.
Three words are not in my vocabulary, though—
“Surrender” and "Medicare assignment.”
By 1970 I was pretty well fixed.
I devoted a little more time to fun.
I went to all my medical alumni meetings.
We’d learn some cardiology the easy way.
On soft deck chairs in warm tropical waters.
It wasn’t too much later, though.
That I saw danger signals all around.
Internal medicine fragmented.
And, drowning in subspecialies,
I didn’t feel secure in what I knew.
Then an orthopedic surgeon, tenant of mine.
Got sued for a cool million and lost.
The message came home loud and clear:
Practice defensive medicine! Cover your ass!
Send ’em to the superspecialist—
And get a CATSCAN to be sure.
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And was very, very nice to the house staff.
They weren't making any more than I did
When I was a resident, about a hundred a month.
Bourbon for house staff parties was my gift
And something special when they took extra good care
Of one of my very sick or puzzling patients.
It took me three whole years to realize
That I was seeing as many patients
As both my partners put together. I hushed my mouth.
For two years I nursed every nickel.
And was very nice to the other men’s patients.
Then I pulled out. Leased a big office in the new suburb
And took most of the group’s patients with me.
I bought suburban land, held it four years.
Resold the land and tripled my investment.
When central city looked like it was moribund,
I bought out a medical lab
And moved it lock, stock and barrel
To the suburb of my choice.
I worked those years as hard as I could work.
But I never sacrificed my standards for care
Just to make an extra buck.
YALE MEDICINE Summer 1988

Then along comes the HMO,
Based on the muddled principle
That if you brought together
The bottom third of the graduating class.
They’d make fewer mistakes than practicing alone.
That made as much sense to me
As fancy public housing in the slums.
Everyone’s amazed how fast those buildings run down
But what the heck could you expect
When you pile a lot of losers under one roof?
Old Vector started thinking to himself
There’s trouble coming sure if you don’t switch.
And then in 1983,1 got a break.
There’s a small college near my summer home
Just about sixteen hundred students. Real nice place.
We'd go there sometimes for plays and such.
Their health service doc suddenly ups and dies.
The dean asked me if I was interested.
The salary they offered me per year
Was more than any of the faculty
But less than half what my investments made.
1 took their job, and feeling mighty good,
I felt like I shucked a sack of cement.
Now I work only three or four hours a day.
See nothing but colds and ankle sprains.
And give advice, sometimes, on safer sex.
But what the heck! I’m doing what I like
And looking out for good old number one.
13

Ill
In 1968 I was a flower child.
And campaigned hard for Gene McCarthy's run.
So I had seen a little bit of life
Before my own bright college years.
I went to Carleton. majoring in history.
Then spent two dry and lonely, humbling years
In the Peace Corps in Northern Africa.
Nutrition was the greatest need I saw
For all those bloated-bellied kids
And mothers smiling while they slowly starved.
The cry of a really hungry baby
Will stay with me until the day I die
Or lose my mind to Alzheimer’s disease.
It makes you feel that you must feed that kid
And steal or murder just to get the food
To quiet that awful, awful cry.
A farmer or a doctor was the way for me
But I thought medicine more challenging.
I breezed through college science and some math.
Then took the MCATs and did well on them,
Sent out my application to the schools I liked
And got accepted at my second choice.
I borrowed from my dad and from the bank.
To pay tuition and to house and feed myself
Took nineteen thousand dollars my first year.
My freshman year was really culture shock.
The facts of science hit me like a swarm of bees.
Cell biology, biophysics, biochemistry.
The threads of neuroscience, immunology
And the marvelous checks and balances maintained
By molecules complex beyond belief.
I was lost in wonder at the miracles
Of human reproduction, growth and life.
In that same year, I met a classmate
Whose views on life and human needs were much like mine,
And we were married in our second year.
The clinical years posed a problem I have not resolved:
How to put that wonderful science I had learned
In service to the people of the world.
I saw that pharmacology
Had placed a mighty arsenal of drugs
In service to us, even though some side effects
Must keep the patient and the doctor ever watchful.
But how did my knowledge of glucose metabolism
Provide calories to starving Africans?
How did my knowledge of the hypothalamus
Keep teenagers away from drugs and cigarettes?
I still don't have the answers.
\n- ither thing I really didn’t like
\h< ut the growing reliance on technology
Was that it even further cut

Communication of patient with the doc.
The patients sometimes went
From complaint to CATSCAN
Without a history or examination in between.
Graduation was remarkable for me.
But in my cap and gown no one could see
That I was six months pregnant, full of joy.
1 don't know how we made it through our first parental year.
My husband and my baby and myself.
Bottles, diapers, au pairs and an endless need to sleep
Are things that stay the strongest on my mind.
And then, most marvelous of days, first laugh.
First crawl, first word and then first walk.
In Africa and in my infant son
Were linked the greatest human needs I could perceive.
I couldn't feed the hungry of the world,
But if I practiced pediatrics well.
I'd maximize life chances for a lot of kids.
Well, maybe that’s a little grandiose.
I'll do the best I can.
By the time we'd finished residencies
My husband and I owed eighty-five thousand dollars.
We had to start in earning right away.
We joined an HMO and liked it there.
The need was great. There was so much to do.
Each of us saw about two dozen kids per day
Both sick and well, with problems great and small.
To me the most wonderful thing in the world
Is a really happy baby.
To hear the contented babbling of a child
Is as close to heaven as I expect to get.
Today’s my birthday. I am thirty-five
And full of questions still:
Do we want another child?
To send another child into the world,
A world encased in filth.
Is not a choice that I can lightly make.
We spend our billions on nuclear bombs
When for a tiny fraction of the cost
We could make hunger disappear.
But what can I do about this insanity?
Shall I go to work for WHO?
Write letters to my congressman
And add them to the ocean of his mail.
Or take, perhaps, the plunge.
And challenge him for office?
What can 1 do to bring the wisdom
Of our science to serve the people of a world
Beset by war and hunger, blind leaders,
Old men with money in their eyes,
Preoccupied with looking tough and resolute
And carefully avoiding all the time
The screams of hungry babies, broken lives?

YM
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LOOKING BACK AT TOMORROW
by Gregory R. Huth
In an era of laser surgery and submicroscopic research, some
may view the history of medicine as anachronistic. Those who
do, however, ought to glimpse at the calendar of Dr. David
Musto, a professor who shares an appointment between the
Child Study Center and the history of medicine.
When The New York Times needed an authority to
comment on waning drug use among the middle class, they
called on Dr. Musto, author of the landmark book The
American Disease. A short time later, nationally syndicated
journalist William Raspberry interviewed him and dedicated
an entire column to Dr. Musto’s research into cocaine use in
tum-of-the-century Washington, D.C.
About the same time ABC’s “Nightline” and CBS’s
“Sunday Morning” approached the physician/historian to lend
some perspective to the debate over providing clean needles
to addicts, and comment on proposals to legalize street drugs.
More recently. Dr. Musto was appointed as historical
consultant to the presidential AIDS commission.
Although Dr. Musto’s area of interest makes him one the
most publicly visible faculty members at the School of
Medicine, he is but one of several scholars affiliated with the
history of medicine section who are producing volumes of
fascinating, useful—and sometimes disturbing—research.
These scholars also teach some of the most popular courses at
the School of Medicine.
“It is both fitting and necessary that as a leader in scientific
and medical research, Yale should also teach the background
from which these disciplines have sprung,” observes Joseph
S. Fruton, Ph.D. Fruton, the Eugene Higgins Professor
Emeritus of Biochemistry, is the author of Molecules and
Life. This history of biochemistry earned him the coveted

Pfizer Prize of the History of Science Society in 1973.
The scholarship of section chairman Frederic L. Holmes,
Ph.D, the Avalon Professor of the History of Medicine and
Biology, illustrates the respect the section has earned in both
the history of science and of medicine. Holmes' book Claude
Bernard and Animal Chemistry earned him the Pfizer Prize in
1975. Then, three years later, the same book won the William
H. Welch Medal of the American Association for the History
of Medicine.
Professor Holmes sees the section’s dual emphasis on
science and medicine as characteristic of the School of
Medicine: “Although the history of science emerged as a
distinct subspecialty about 25 years ago, at Yale you can't
draw a line where this discipline leaves off and the history of
medicine begins. This reflects the character of a medical
school where basic research goes hand-in-hand with clinical
care.”
Students from the medical school and throughout the
university have affirmed the quality of the section’s
scholarship by their enthusiastic response to its classes.
Moreover, as many as 20 students carry this enthusiasm
outside the classroom by joining the Nathan Smith Club,
where they deliver papers in the history of medicine at
monthly meetings. And every year several students turn to the
section for advisors when they pursue an M.D. thesis in the
field of medical history.

Gregory R. Huth is publications editor at the School of
Medicine’s Office of Public Informtion.
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Frederic Holmes, history of medicine chairman, flanked by the section's other primary faculty members, Arthur Viseltear (left) and John Warner.
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This year, the Class of 1988 paid one of its highest honors
to Arthur Viseltear, Ph.D.,
associate professor of the
history of medicine and public health, by voting him co¬
recipient of the Francis Gilman Blake Award for
distinguished teaching. Viseltear’s courses range from the
introductory “History of Medicine” to "The Physician in
Modem Society" and "Government and Health Policy."
Arthur Viseltear and Thomas R. Forbes, Ph.D., the
Ebenezer K. Hunt Professor Emeritus of Anatomy and an
expert in the history of forensic medicine, are traditionally
invited to offer their reflections on the Hippocratic Oath and
Prayer of Maimonides that are delivered to fourth-year
students on graduation day at a private ceremony.
Phis early morning ritual evokes Viseltear’s 1981 medical
school commencement address, “Looking Back at
Tomorrow,” in which he challenged his audience to pursue
history "to see if we can determine what we might choose to
remember, what we might wish to preserve, and what needs
to be reevaluated.”
A DELICATE BALANCE
The contrasting styles Dr. Musto and the other section
members—the one appealing to a wide, general audience, the
other to the academy—illustrate a duality in the section that
its chairman strives to keep in balance. Observes Professor
Holmes, "We always walk a tightrope between the practical
and the academic. The work of Dr. Musto has a high public
profile because it shows how the history of medicine provides
a broader perspective on one of today’s most serious public
health problems. At the same time, section members also
pursue important historical issues that may be of less interest
to the public.”

Professor Holmes sees a parallel with this situation in
research medicine. “Scientists are pleased, of course, when
their research turns out to have a clinical application. At the
same time, this does not discourage them from carrying out
the basic research that adds to our general body of
knowledge.”
The duality between the practical and the academic even
shows itself in the careers of individual section faculty
members. Arthur Viseltear, for example, spent two years in
the late 1970s in Washington, D.C., as a Robert Wood
Johnson Health Policy Fellow assigned to the Institute of
Medicine and to Senator Edward M. Kennedy’s health
subcommittee.
While he still teaches courses in national health policy,
Viseltear has focused his latest research efforts on 20thcentury history. He has established at Yale a major archive,
“The Contemporary Medical Care and Health Policy
Collection," that contains the papers of more than 40 health
policy statesmen and institutions.
One of those statesmen is C.-E.A. Winslow. Associate
Professor Viseltear is currently preparing a biography of this
20th-century Yale legend, who is widely regarded as the
"father of modern public health.”
Another recent Viseltear study documents the rise and fall
of a bold educational experiment that the School of Medicine
began in 1928, the Institute of Human Relations (IHR). This
program, designed to make the school “civically
constructive," brought under one roof varied resources made
available by the divinity, law and nursing schools and the
departments of economics, political science and sociology.
IHR was discontinued in the early 1950s, the victim of a
philosophical shift at the school in which medicine was
viewed as a discipline distinct from the social sciences.
Why Viseltear’s focus on Yale?
Replies the historian, "By examining the particular, in this
case Yale, I hope to reveal the universal with respect to
contemporary medicine and medical education.”
THE SWEAT OF GENIUS

II hues interviews Sir Hans Adolph Krebs in 1978. The
ixsician died in 1981.

Section chairman Frederic L. Holmes throws light on the
universal in another historical field—the development of
research. His work documents the methods of leading
scientists whose research spans three centuries, beginning in
the late 1700s. Professor Holmes’ scholarship helps us
appreciate how much hard work medical researchers over the
centuries have put into pursuing answers to the human body’s
most difficult puzzles.
"There’s a stereotyped view of creative scientists, where
discovery occurs due to a kind of ‘eureka effect'
characterized by a flash of insight,” Professor Holmes
observes. While he does not downplay the importance of such
experiences. Holmes points out that they almost always
culminate years of difficult, frustrating research.
Professor Holmes’ 1985 book. Lavoisier and the
Chemistry of Life: An Exploration of Scientific Creativity,
highlights the career of one of the late 18th century’s greatest
medical researchers. Antoine Lavoisier not only discovered
oxygen but also suggested its role in releasing energy in the
human body.
Professor Holmes award-winning work, Claude Bernard
and Animal Chemistry, chronicles the career of the scientist
who was first to explain the glycogen function of the liver
and other important organ processes. The French physician’s
continued on page 18
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A Brief History of the Section
Although the section of the history of medicine was
established only in 1979, it has deep roots in School of
Medicine tradition. Since the 1920s, for example, the
Beaumont Medical Club, established by medical school
faculty members, has served as a focal point for the study and
appreciation of medical history.
Moreover, for the last 30 years, beginning with Dr. Samuel
Clarke Harvey, members of the department of surgery have
sponsored annual lectures in the history of medicine. And
medical students have long expressed their interest in the
subject through the Nathan Smith Club, where they present
historical papers at monthly meetings.
A distinguished neurophysiologist during the 1930s, ’40s
and ’50s, Dr. John F. Fulton was a major influence in
promoting interest in the history of medicine at Yale. One of
the driving forces behind the Medical Historical Library and
its outstanding collection of old and rare medical works, in
1951 Fulton also worked with the School of Medicine to
establish a department of the history of medicine, and served
as its first chairman until his death in 1960.
That same year, with the addition of Professor Derek Price,
the department was expanded—to encompass the history of
science and medicine—and was jointly administered by the
medical school and the faculty of arts and sciences. During
this decade, the department grew to a peak of seven members,
and developed a highly successful Ph.D. program. Among the
graduate students who obtained their degrees in those years
are leading scholars and teachers of history of science and
medicine today.
During the financially pressured years of the early 1970s,
however, the university disbanded the department. A number
of medical school faculty members, concerned to preserve the
long tradition of teaching and scholarship in the discipline,
persuaded then Dean Robert W. Berliner to establish an
autonomous Section of the History of Medicine with two
tenured faculty positions.
In 1979, Frederic L. Holmes, Ph.D., was appointed
professor of the history of medicine, and Arthur J. Viseltear,
Ph.D., M.P.H., associate professor of the history of medicine
and public health. Together they constituted the new section
of history of medicine, housed in John Fulton's old offices in
the historical library.
In 1984 the section obtained approval from the Graduate
School of Arts and Sciences to initiate a Ph.D. program in the
history of medicine and life sciences, and Dean Leon E.
Rosenberg supported the creation of a third, non-tenured,
faculty position to help carry out this expanded activity. In
1986 John Harley Warner, Ph.D., was appointed assistant
professor of the history of medicine.
Currently, two Ph.D. students are pursuing their degrees at
the section, with another two first-year Ph.D students and a
transfer student arriving in the fall.
In addition to its medical and graduate school
responsibilities, the section offers Yale College courses in the
history of medicine and of the life sciences.
Frederic L. Holmes, Ph.D.
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A Beaumont Medical Club Member's Coup
Though most of the 50 or so members of the Beaumont
Medical Club content themselves to attend monthly lectures
that keep them abreast of the latest issues and controversies
in the field, others engage history as an avocation. Some, in
fact, pursue their interest by writing scholarly articles and
books.
One such devotee is former club president Dr. Sherwin B.
Nuland, '55, an associate clinical professor in surgery and
full-time private surgeon in New Haven. His recently
published book. Doctors, has been selected as a Book-of-theMonth Club alternate and Paperback Book Club main
selection. The book traces the history of physicians who
changed the course of medicine from the time of Hippocrates
to the present.
Dr. Nuland, a 20-year member of the Beaumont Club,
credits the group with nurturing his interest in the history of
medicine. “The fellowship and intellectual camaraderie of the
Beaumont Club has been one of the major influences in my
historical studies.” He adds with a smile, “Participating in the
club is something like playing baseball in the old semi-pro
leagues. It brings professionals and talented amateurs
together to produce a top-quality product.”

Yale Student's History Paper
Wins National Recognition

Francis M. Lobo:
Osier Medal
winner

Yale medical students as well as faculty have won distinction
in the history of medicine. Francis M. Lobo, ’91, was
awarded the 1988 William Osier Medal from the American
Association for the History of Medicine for his essay, "John
Haygarth, Smallpox and Religious Dissent in 18th-Century
England.” The award is given for the best unpublished essay
written by a medical student in the history of medicine.
Mr. Lobo, a 1985 graduate of the University of
Pennsylvania, wrote the paper while attending the Wellcome
Unit of the History of Medicine at the University of
Cambridge. In conjunction with the prize, he was flown to
New Orleans in May to present his essay at the association’s
annual meeting. His paper will be considered for publication
in the Bulletin of the History of Medicine.
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continued from page 16
ntific approach to the human body allowed him to
establish physiology as an experimental field in the mid-18th
century.
In recent months, Professor Holmes has completed a book
about the pioneering work of Nobel laureate Sir Hans Adolph
Krebs. During the early part of this century, Krebs, a German
physician who emigrated to England, identified some of the
processes of intermediary metabolism. The metabolic cycles
he discovered, one of which is generally known as the "Krebs
cycle,” explain such important mechanisms as the pathway
through which the body oxidizes food and synthesizes urea.
Is there any common thread running through the careers of
these great scientists? Professor Holmes believes so: a
carefully reasoned, logical inquiry into the human organism.
"We tend to think of medicine as ascending out of an age ot
ignorance over the last three centuries. But in fact, at a
fundamental level modern medical research has more in
common with its forebears than we might think," the historian
concludes.
Dr. Stanley W. Jackson says that his historical studies have
led him to a similar view. A section member and professor of
psychiatry, he also serves as acting executive director of the
Yale Psychiatric Institute. His most recent book is
Melancholia and Depression: From Hippocratic Times to
Modern Times.
To illustrate the sophistication of some medical
investigators from the past. Dr. Jackson cites a monograph
published by Dr. John Haygarth in the 1790s. Haygarth
wanted to test the efficacy of instruments called metallic
tractors. Doctors of the period routinely used these devices to
"draw out” pain and inflammation by running them above the
affected area.
"Haygarth devised a classic controlled study,” notes Dr.
Jackson. “For half his patients, the experimental group, he
used metallic tractors for therapy. For the other half, the
controls, he used wooden tractors painted to look like metal.
The results of the groups were identical.” This experiment
disproved the effectiveness of metallic tractors.

Why this peculiar pattern in Cincinnati? Warner discovered
that the city had become a stronghold of alternative medicine,
with practitioners of eclectic, homeopathic and physiobotanic
healing winning away many patients from orthodox
physicians. Complained one doctor to a lay friend in an 1851
letter, “even the longest established and most estimable
physicians have yielded large and lucrative portions of their
practice to homeopathy, & etc....”
Warner’s interpretation of these developments: “The
revival of heroic depletion...was one device that regular
physicians used to cope with an erosion of their professional
power and control that could, they feared, lead to collapse."
In other words, the historian suggests that the Commercial
Hospital doctors used dramatic, highly visible depleting
“therapies” as a kind of symbol of orthodoxy that affirmed
their identity as the only bona fide healers in the community.
Lest the modern observer shrug off the doctors’ behavior as
that of an isolated group of hysterical practitioners, the
historian raises the disturbing possibility of a parallel with the
present.
Warner thinks that today’s physicians should consider
whether the increasing use of some heroic, high-technology
procedures—such as heart transplants—might not represent
another symbolic crusade of a profession that finds itself
challenged on many fronts. Taking the traditional historian’s
stance, he does not presume to answer this question, but rather
raises an important issue for examination and debate.
John Warner’s scholarship affirms what Dr. Stanley
Jackson terms a “central lesson” of the history of medicine.
“Historical scholarship does more than give us respect for the
past. It humbles us. It makes us realize that we had better not
be too certain or overconfident.”
Dr. Jackson concludes, “Many of today’s medical findings
will hold up, but we need to be reminded that some will
change.” YM
BILL CARTER

DISQUIETING LESSONS
John H. Warner, Ph.D., an assistant professor in the section,
studies the role that medical practice plays in 19th-century
culture. He believes that the mirror of history also reminds
today's practitioners to keep their own theories and practices
in perspective. Warner’s research into the treatments delivered
by hospital physicians in the mid-1800s shows that theraputic
practices can take on special significance when the profession
finds itself under attack and threatened economically, as it
does today.
A Warner study entitled "Power and Identity in American
Medicine” focuses on doctors practicing at Commercial
Hospital in Cincinnati. The scholar’s review of hospital
records show that the once standard use of “heroic depletive
therapeutics"—bleeding patients heavily, or purging them with
powerful laxatives or emetics—was in steady decline among
American doctors during the mid-1800s. Curiously, however,
i 10-year period these practices enjoyed a marked
’
ice among Commercial Hospital’s physicians.

.

The Yule Medical Historical Library, opened in 1941,
r 90.000 books and manuscripts dating back to the
one of the most important resources of its kind in the
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GALLERY
Metallic-Tractors
by James Gillray (British, 1757-1815)
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In James Gillray’s “Metallic-Tractors,” the patient
recoils from the tractors being applied by a
disinterested operator. The popular print does not
appear to be an advertisement for this form of therapy.
It was secretly commissioned, however, by Benjamin
Perkins, proprietor of the tractors in London, who
apparently considered a print by London’s foremost
caricaturist to be a powerful advertising medium.
Perkins commissioned the print at a time when the
efficacy of the tractors was being questioned and when
his business was being threatened by adverse publicity.
Metallic tractors, invented by Dr. Elisha Perkins, a
prominent Connecticut surgeon, were a popular
therapy at the turn of the 19th century. In published
testimonials, the metal rods were claimed to effect
cures of epilepsy, gout, rheumatism, bums, and more.
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when drawn across the afflicted area. The tractors were
introduced in London by the inventor’s son, Benjamin
Perkins, in 1795, shortly after his graduation from
Yale. The claims for the tractors and their popularity
prompted John Haygarth, a physician at Bath, to
conduct a controlled therapeutic trial. A pair of
wooden tractors, painted to look like the metallic
tractors, were applied alternately with those of Perkins
in five cases of rheumatism and found to have equal
effects. The results were published in 1800 in a
pamphlet “Of the Imagination, as a Cause and as a
Cure of Disorders of the Body; Exemplified by
Fictitious Tractors and Epidemical Convulsions.” The
pamphlet was reprinted in 1801, the date of Gillray's
print.
—Susan Wheeler
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HERE AND ABOUT
Two Appointed to
National Commission
Dr. Donald J. Cohen, director of the Yale
Child Study Center, and Irving B. Harris,
a Chicago businessman and child advo¬
cate who is an associate of the Child
Study Center, have been selected to serve
on the newly created National Commis¬
sion on Children.
The 36-member commission includes
individuals who provide services, activi¬
ties or research for children, public offi¬
cials, and parents or representatives of
parent organizations.
The President. U.S. House of Repre¬
sentatives and the U.S. Senate each
appoint 12 members. Dr. Cohen, also the
Irving B. Harris Professor of Child Psy¬
chiatry and professor of pediatrics, psychi¬
atry and psychology, was appointed by the
House, while Harris, a 1931 Yale College
graduate and benefactor of the endowed
professorship that bears his name, was
named by the Senate.
The commission will serve as a forum
on behalf of children, conducting public
hearings on their status and on ways to
safeguard and enhance their physical,
mental and emotional well-being. It also
will make recommendations on child
health, and social and support services for
children and their parents. The commis¬
sion is scheduled to report next March.
Among the issues the commission will
address: reducing infant mortality and the
number
of
low-birth-weight
babies,
improving child nutrition, preventing and
treating child neglect and abuse, encour¬
aging academic excellence among chil¬
dren and reducing poverty.
The commission also has been charged
to identify how the public and private sec¬
tors can work together to identify defi¬
ciencies in local family support services
and to develop recommendations for
meeting the needs of families and children
in a coordinated way.

Postage Stamp Honors
Dr. Harvey Cushing
The U.S. Postal Service released a 45-cent
stamp honoring Dr. Harvey W. Cushing,
the lather of neurosurgery. The stamp, one
of the Great Americans series, was issued
June 17 in Cleveland, Ohio, Dr. Cushing’s
birthplace.
Noted artist Bradbury Thompson based
e design for the stamp on a charcoal por¬
trait ol Dr. Cushing by John Singer Sar¬
gent. which hangs in the Yale University
Art Gallery.

Dr. Cushing was an American surgeon,
author and artist who laid the foundation
for the field of brain surgery. Bom in
Cleveland in 1869, he received his B.A.
degree at Yale in 1891 and M.D. degree at
Harvard in 1895. He studied under noted
American surgeon W.S. Halsted for four
years at Johns Hopkins, followed by a
year in Europe under Swiss surgeon
Theodor Kocher.
Dr. Cushing returned to Johns Hopkins
in 1901. He remained there until he
became surgeon-in-chief at Peter Brent
Brigham Hospital in Boston in 1912 and
Mosely Professor of Surgery at Harvard
Medical School. After retiring in 1932, he
served as neurologist and medical histori¬
an at Yale. Before his death in 1939, he
and two colleagues established the Yale
Medical Library.

As an innovator who had a command¬
ing influence on the progress of medicine
and surgery throughout the world, Dr.
Cushing was one of the first in the United
States to use x-rays and the first to rou¬
tinely take blood pressure readings during
operations and in general practice. He also
developed the use of electric cautery in
brain surgery.
Dr. Cushing was among the first to
operate on the pituitary gland, describing
a condition which now is know as “Cush¬
ing’s syndrome," and contributing to the
overall understanding of the gland. He
also made many laboratory studies of the
nervous system.
However, his most notable achieve¬
ments were in the development of many
of the techniques and procedures for
surgery of the brain and spinal cord that
still are fundamental to the field of neuro¬
surgery. His work has been credited with
reducing the mortality rate in brain opera¬
tions from nearly 100 percent to less than
10 percent.
In addition to his surgical skills, he
won a Pulitzer Prize for his book. Life of
Sir William Osier, in 1926. His talent as
an artist is evident in his illustrations that
describe his medical work and enhance his
travel diaries. Dr. Cushing also took
strong positions on better hospital and
classroom training for medical students.

Paul Newman Receives
Honorary Degree
Actor, director and philanthropist Paul
Newman was among the nine individuals
who received honorary degrees at the Yale
University commencement on May 30.
Mr. Newman was awarded the degree of
Doctor of Humane Letters for his service
to others.
Paul Newman's Hole in the Wall Gang
Camp for children with life-threatening
diseases opened June 26. The camp ses¬
sions, which will run through Aug. 18,
will offer seriously ill boys and girls, age
seven to 17, a camping experience as
close as possible to that which is available
to healthy youngsters. The 300-acre camp,
built on the town boundaries of Ashford
and Eastford, Conn., was designed to
resemble the Old West, with log cabins, a
corral filled with animals and an old-fash¬
ioned music hall.
Children will attend the camp free of
charge. Half of the budget supporting the
camp comes from Mr. Newman's food
companies. The Internal Revenue Service
required that the other half be from private
and corporate donors.
Yale-New Haven Hospital is providing
administrative direction, medical and
nursing staff support and other services.
Dr. Howard A. Pearson, former chairman
of the department of pediatrics in the med¬
ical school and former chief of pediatrics
for the hospital, provides medical supervi¬
sion at the new camp. At the camp’s June
dedication, it was announced that the
camp pond was being named Pearson
Pond, in honor of Dr. Pearson.
Also providing services to the camp
will be specialists in pediatric hematology
from the University of Connecticut,
Brown University School of Medicine,
Baystate Medical Center in Springfield.
Mass., and the University of Mas¬
sachusetts School of Medicine.
MICHAEL MARSLANI)

Paul Newman
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Class of 1988 Residency Placements

CALIFORNIA

FLORIDA

Cedars-Sinai Medical Center, Los Angeles
Lisa Matzer, internal medicine

Jackson Memorial Hospital, Miami
Gregory Brown, internal medicine
Odett Stanley-Brown, pediatrics

Harbor-LCLA Medical Center, Torrance
Martin Chenevert, emergency medicine
Mercy Hospital, San Diego
Mitchell Sklar, transitional
Stanford University Hospital, Palo Alto
Dean Kedes, internal medicine
Mitchell Sklar, diagnostic radiology
Hedayatollah Zaghi, internal medicine
UCLA Medical Center, Los Angeles
E. Ted Parks, orthopaedic surgery
UCLA Neuropsychiatric Institute, Los Angeles
Steven Dobscha, psychiatry
Joshua Freedman, psychiatry
University of California, San Francisco
John Belzer, orthopaedic surgery
Allen Bowling, internal medicine!neurology
David Chelmow, obstetrics and gynecology
Jonathan Friedes, obstetrics and gynecology
Linda Hudak, psychiatry
Richard Jenkins, medicine-primary

ILLINOIS
Children's Memorial Hospital, Chicago
Cristina Bengoa, pediatrics
Irene Freeman, pediatrics
Illinois Masonic Medical Center, Chicago
Michael Mockovak, transitional
Michael Reese Hospital, Chicago
Walter Stadler, internal medicine
University of Chicago Medical Center, Chicago
Stephen Bowers, emergency medicine
Lisa Conrad, internal medicine
Robin Komegay, pediatrics
Andres Rodriguez, internal medicine
University of Illinois, Chicago
Michael Mockovak, ophthalmology
LOUISIANA
Tulane University School of Medicine, New Orleans
Elizabeth Mannick, pediatrics

CONNECTICUT
Hospital of St. Raphael, New Haven
Cynthia DeAngelis, transitional
Thomas Handler, transitional
Peggy Liao, medicine-preliminary
Pedro Miro, medicine-preliminary
Susanna Park, medicine-preliminary
Norwalk Hospital, Norwalk
Frederick Long, medicine-preliminary
Waterbury Hospital Health Center, Waterbury
Francis Cutruzzola, medicine-preliminary
Geraldine Ruffa, medicine-preliminary
Yale-New Haven Hospital, New Haven
Sibel Akyol, psychiatry
Stephen Bowers, medicine-preliminary
Martha Brochin, pediatrics
Robert Brown, orthopaedic surgery
Cynthia DeAngelis, ophthalmology
Charisse Deutch, medicine-preliminary
Kenneth Easterling, orthopaedic surgery
Thomas Handler, diagnostic radiology
Carla Jones, obstetrics and gynecology
Rhonda Karol, medicine-preliminary
Robert Kim, internal medicine
David Klimstra, pathology
Peggy Liao, ophthalmology
Elizabeth Murphy, general surgery
Autry Parker, transitional
Michael Rigsby, internal medicine
Geraldine Ruffa, neurology
Susan Valley, medicine-preliminarylanesthesiology
Leslie Weinstein, surgery-preliminary/otolaryngology
Terry Yee, surgery-preliminary/urology
DISTRICT OF COLUMBIA
Children's Hospital National Medical Center
Carol Miller, pediatrics
Washington Hospital Center
Daniel Schwarz, surgery-preliminary
YALE MEDICINE Summer 1988

MARYLAND
Francis Scott Key Medical Center, Baltimore
M. Kathleen Carney, internal medicine
Johns Hopkins Hospital, Baltimore
Kenneth Andreoni, general surgery
Geraldine Mogavero, diagnostic radiology
Eva Simmons, internal medicine
MASSACHUSETTS
Beth Israel Hospital, Boston
David Ives, internal medicine
Ellen Weinstein, medicine-preliminary

1988 National Match Results
The results of the 1988 National Resident Matching Program were
announced March 23. Of 19,513 positions offered this year, 16,119
were filled. U.S. graduates were matched into 13,496 of these; the
balance were filled by foreign medical graduates, U.S. physicians
who had graduated in previous years and osteopathic physicians.
Within the primary care specialities, fewer U.S. students matched
into family practice programs than in any previous year of this
decade. Only 1,494 positions were filled, a 16 percent decrease in
U.S. graduates entering family practice as compared to 1987. There
were 3 percent fewer U.S. graduates entering categorical programs in
internal medicine than in 1987, but the percentage in primary care
internal medicine programs increased by 17 percent, from 173 to
209. Pediatric positions filled by U.S. graduates decreased by only
53. The number of U.S. graduates entering Ob/Gyn programs
increased from 828 to 903.
—The Association of American Medical Colleges
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Boston University School of Medicine, Boston
Carlton Bamswell, general surgery
Donna Richman, internal medicine
Brigham and Women's Hospital, Boston
Lenore Soodak, obstetrics and gynecology
Pradeep Varma, diagnostic radiology
Massachusetts Eve and Ear Hospital, Boston
Susanna Park, ophthalmology
McLean Hospital, McLean
Leslie Jacobsen, psychiatry
New England Deaconess Hospital, Boston
Michael Mahig, internal medicine
Tufts/New England Medical Center, Boston
Jonathan Borden, general surgery!neurosurgery
MISSOURI
Barnes Hospital, St. Louis
Kelle Moley, obstetrics and gynecology
NEW YORK

PENNSYLVANIA
Abington Memorial Hospital, Abington
Geraldine Mogavero, medicine-preliminary
Hospital of the University of Pennsylvania, Philadelphia
Laura Dember, internal medicine
Robert Dorns, pathology
Amy Justice, internal medicine
Joseph King, neurosurgery
Peter Merkel, internal medicine
Temple University, Philadelphia
Joi Barrett, internal medicine
WASHINGTON
Group Health Cooperative of Puget Sound, Seattle
David Cowan, family practice
University of Washington Affiliated Hospital, Seattle
David Galbraith, surgery-preliminary
Janice Janas, otolaryngology
John Nienow, medicine-primary
Henry Rice, general surgery

Beth Israel Medical Center, New York City
Pradeep Varma, medicine-preliminary

WISCONSIN

Cornell University/New York Hospital, New York City
Charisse Deutch, neurology

Medical College of Wisconsin, Milwaukee
Pedro Miro, diagnostic radiology
Frederick Long, medicine-preliminary

Mary Imogene Bassett Hospital, Cooperstown
Laura Kuckes, transitional
Montefiore/Einstein Affiliated Hospitals, Bronx
Leslie Jacobsen, pediatrics
Mount Sinai Hospital, New York City
Larry Amsel, psychiatry
Vivian Orey, pediatrics
Michael Rothschild, surgery-preliminary!otolaryngology
The New York Hospital, New York City
Amy Bloch, psychiatry
Nicole Davis, obstetrics and gynecology
Jose Dizon, internal medicine
Laura Kuckes, psychiatry
Robert Root, psychiatry
Lisa Straus, general surgery
New York University Medical Center, New York City
Leigh Hutchinson, internal medicine
Frederick Lang, surgery-preliminary! neurosurgery
Presbyterian Hospital, New York City
Francis Cutruzzola, diagnostic radiology
Lance Markbreiter, orthopaedic surgery
Steven Slovic, general surgery
Linda Washington, internal medicine
Strong Memorial Hospital, Rochester
Edgar Blair, internal medicine
Brent Tatum, internal medicine
NEW HAMPSHIRE
Dartmouth-Hitchcock Medical Center, Hanover
Timothy James, general surgery
NEW JERSEY
UMDNJ-New Jersey Medical School, Newark
Khristine Lindo, general surgery
NORTH CAROLINA
Duke University Medical Center, Durham
K. Lisa Cairns, medicine-preliminary
1 rederick Long, diagnostic radiology

rth Carolina Memorial Hospital, Chapel Hill
F I Miclau, orthopaedic surgery

Yale School of Medicine
Residency Applications 1983-1988
Total No. in Class

1983
98

Medicine (total)
Medicine (3 year)
Medicine (1 year)
Surgery (total)
Surgery (categorical)
Surgery (1 year)
Obstetrics/gynecology
Pediatrics
Pediatrics (1 year)
Psychiatry
Orthopaedic surgery
Diagnostic radiology
Ophthalmology
ER medicine
Ear, nose & throat
Family practice
Primary care
Neurology
Anesthesiology
Neurosurgery
Urology
Pediatrics/medicine
Occupational medicine
Pediatric neurology
Dermatology
Transitional/flexible
Radiation therapy
Pathology
Rehabilitation medicine
Research, teaching

45
39
6
15
10
5
3
8
0
14
5
4
3
1
2
5
0
1
1
1
0
0
0
0
0
5
0
0
0
0

1984 1985
108
101
47
33
8
19
10
9
9
8
0
7
4
6
3
1
2
2
0
1
1
2
2
0
0
0
0
2
1
3
0
5

43
31
12
19
13
9
11
10
1
6
2
6
5
1
2
1
0
1
0
2
0
1
1
1
1
4
1
0
0
3

1986
104

1987
96

1988
99

50
37
13
21
15
6
4
7
2
9
1
3
5
0
1
2
0
3
3
2
0
0
0
0
0
4
1
2
0
4

50
24
16
11
7
4
0
8
1
15
5
2
7
3
3
2
1
1
4
1
1
1
0
0
0
3
3
2
1
5

40
23
17
15
8
6
6
8
1
9
7
7
4
2
3
1
2
3
1
3
1
0
0
0
3
6
1
2
0
1
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President Schmidt Visits
Medical School Council
Yale President Benno C. Schmidt Jr. pre¬
sented remarks to the Medical School
Council on March 17. He outlined four
trends that he saw as key to the School of
Medicine's role in the University.
• Inter-departmental and inter-school bar¬
riers are coming down. Students and
researchers from various disciplines are
working together more closely. The
president said that the Center for Molec¬
ular Medicine will further encourage
such collaboration.
• The University is entering a period of
extensive
physical
expansion
and
rebuilding. “I am entirely devoted to the
tremendous building and renovation
efforts that are ongoing at the School of
Medicine,” President Schmidt com¬
mented.
• Yale is involving itself more deeply in
the cultural and economic development
of New Haven. The University and the
medical school have a keen interest in
redevelopment projects such as Down¬
town South in the Hill neighborhood,
and a possible biomedical research park
along the Route 34 extension.

• The University is increasingly stressing
the historical roots and ethical responsi¬
bilities of the professional disciplines
that it teaches. President Schmidt noted
that the School of Medicine has a long
tradition of emphasizing the social
responsibility of medicine.

led The Yale Journal of Biology and
Medicine to initiate a new section of soft¬
ware reviews. Programs may be submitted
for review to The Yale Journal of Biology
and Medicine, 333 Cedar St., New Haven,
CT 06510. Reviewers are recruited from
medical students and faculty, and they are
entitled to keep the software after it has
been reviewed.

Yale Journal Seeks
Editors, Software
The Yale Journal of Biology and
Medicine has instituted a new category of
member for its editorial board. In addition
to student and faculty editors, the journal
is now appointing a limited number of
editors-at-large from among its former
student editors. To qualify, candidates
must apply to the editorial board and must
recruit at least one paper per year that is
accepted for publication in the journal.
Appointments
as
editor-at-large
are
renewed
annually.
Reappointment
depends on continuing activity by the can¬
didate. Suzanne Lande, managing editor
of the journal, welcomes inquiries from
alumni of the journal’s board.
The increasing importance of comput¬
ers for scholarly and medical purposes has

BILL CARTER

Yale President Benno C. Schmidt Jr. flanked by Dr. John H. Seashore, president of the Medical School Council, and Dean Leon E Rosenberg
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IN PROGRESS
Dr. Black Promotes
Heart Disease Prevention
Dr. Henry R. Black, associate professor of
medicine, has received a Preventive Car¬
diology Academic Award from the
National Heart, Lung and Blood Institute
of the National Institutes of Health.
With the award, a five-year grant that
began July 1, Dr. Black will develop a
preventive cardiology program designed
to focus medical school curriculum on
emphasizing prevention of cardiovascular
disease.
According to Dr. Black, “cardiovascu¬
lar disease is the biggest killer in the Unit¬
ed States, and up to now most of our
attention has been directed at treating peo¬
ple who already have cardiovascular dis¬
ease.
"The success of treating hypertension
has made it clear that preventive efforts
pay off. If we have similar success in
treating lipid disorders and getting people
to stop or never to start smoking, we hope
to reduce significantly the impact of car¬
diovascular disease.”
Dr. Black says the National Heart,
Lung and Blood Institute is committed to
preventive cardiology education, and is
providing awards to insure that medical
students and house staff are familiar with
developments in this rapidly expanding
field. In addition to supplementing the
current curriculum, which is directed
toward treating in-patients with cardiovas¬
cular disease, the preventive cardiology
program will foster interdisciplinary col¬
laboration among faculty and broaden
training and research opportunities for
medical students and house staff.
Dr. Black has assembled a team of fac¬
ulty
representing
internal
medicine,
surgery, epidemiology and public health,
psychology and psychiatry to work with
him in designing and implementing the
program. A nine-member preventive car¬
diology program advisory committee also
has been established to review program
materials
and
proposed
curriculum
changes.
"The essence of the program is to pro¬
vide students with an expert's view on
what they should know in preventive car¬
diology," says Dr. Black. The faculty will
provide material in their area of expertise
to students and house staff. Senior internal
medicine house staff in their role as teach¬
ing residents will impart that knowledge
to medical students during the students’
internal medicine clerkship. In this way,
the program will also insure that internal
medicine house staff are aware of current
concepts in preventive cardiology.
faculty will serve as advisers to stu¬
dents provide articles for a preventive
ardioli>y\ newsletter to be edited by Dr.

Dr. Henry R Black
Black, help run a student journal club and
suggest topics for theses. In collaboration
with Dr. Perry Miller, associate professor
of anesthesiology, computer-based expert
systems for managing hypertension and
lipid disorders will be further developed
and improved.
The preventive cardiology program
faculty and their areas of expertise are:
behavior modification and stress man¬
agement. Gary E. Schwartz, Ph.D.,
professor of psychology and psychia¬
try, and Lynda H. Powell, Ph.D., assis¬
tant professor of epidemiology;
biostatistics and preventive medicine, Dr.
James F. Jekel, the Charles E-A.
Winslow Professor of Public Health;
cardiovascular epidemiology, Dr. Adrian
M. Ostfeld, the Anna M.R. Lauder
Professor of Epidemiology and Public
Health;
diabetes and obesity. Dr. Robert S. Sherwin, professor of medicine;
exercise, Dr. Frans Wackers, professor of
diagnostic radiology and medicine;
hypertension, Dr. Marvin Moser, clinical
professor of medicine;
lipids, Dr. Kenneth L. Cohen, associate
professor of medicine;
peripheral vascular disease and surgical
aspects of preventive cardiology, Dr.
Richard J. Gusberg, associate professor
of surgery;
smoking, Dr. Richard A. Matthay, profes¬
sor of medicine.

Grant Furthers Research
On Psychotropic Drugs
A multidisciplinary team headed by Dr.
George K. Aghajanian, professor of psy¬
chiatry and pharmacology, will expand its
research into the neurophysiological and
neurochemical factors in mental illness.
The group hopes to develop more effec¬
tive and safer drugs to use in treating peo¬
ple with mental illness and in helping drug
addicts cope with withdrawal.

The research is being supported in part
by a $500,000 unrestricted grant that the
Bristol-Myers Company has awarded Yale
University. The grant is one of five that
the pharmaceutical company has made to
universities this year.
Dr. Aghajanian and his colleagues con¬
duct their research in the Abraham Ribicoff Research Facilities at the Connecticut
Mental Health Center, a collaborative
effort of the University and the Connecti¬
cut Department of Mental Health. Their
laboratory adjoins a clinical research unit,
an arrangement that enables biomedical
scientists and physicians to quickly apply
basic scientific discovery to the clinical
arena.
Dr. Aghajanian, director of the biologi¬
cal research training program in psychia¬
try, describes his team’s research focus as
"the possible biological bases of disorders
from depression and schizophrenia to drug
abuse."
The research concentrates in three
areas—the mechanisms of action of hallu¬
cinogenic drugs, opiate withdrawal and
anti-depressant drugs. These processes
involve the three major neurotransmittersdopamine,
norepinephrine
and
sero¬
tonin—that are believed to be involved in
psychiatric disorders. Imbalances in these
substances have been linked to such major
psychiatric illnesses as anxiety, depression
and schizophrenia.
"The drugs we now have to use for the
treatment of major psychiatric disorders
were almost all discovered serendipitously," Dr. Aghajanian says. "But we can use
these drugs to identify the brain processes
involved in the disorder. Then our
research on the processes may reveal the
mechanisms of the disease, and lead to the
development of more specific drugs with
fewer side effects."
Researchers hope one day that bio¬
chemical testing techniques will be avail¬
able to use in the diagnosis or early
detection of psychiatric illness.
The Yale findings could lead to ways
to make drugs more efficacious for some
10 to 15 percent of Americans who at
some time in their lives will suffer from
serious depressive illnesses.
Researchers are investigating new anti¬
psychotic agents which react to the serotonin-2 receptor—the same receptor site
that hallucinogens interact with. Most
anti-psychotic agents interact with the
dopamine receptor and, with continued
long-term use, can cause irreversible neu¬
rological dysfunction.
Researchers also hope that studies of
the way hallucinogens interact with the
serotonin-2 receptor will lead to the devel¬
opment of anti-psychotic drugs with fewer
toxic side effects. In addition, Dr. Aghajanian’s basic research on opiate receptors
provides information from which clinical
researchers hope to develop drugs to assist
opiate
and
heroin
addicts
through
withdrawal.
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Yale Prof Fuels Pilot
Of Daedelus Flight

Medical Library Expands

On April 23, when Kanellos Kanellopoulos plunged into the Aegean Sea 30 feet off
Santorini island, he had MIT to thank for
the Daedelus, the ultralight aircraft that
allowed him to pedal there from Crete.
And he had a Yale professor to thank for
the drink that fueled him—and cooled
him—in his record setting human-powered
tlight.
Ethan R. Nadel, Ph.D., professor of
epidemiology (environmental health) and

physiology, and a fellow at the John B.
Pierce Foundation Laboratory, developed a
drink for the four-hour, 74-mile Daedelus
Bight that provided both cooling and calo¬
ries by employing a glucose molecule that
passes through the stomach lining to the
blood stream without digestion.
Kannelopoulos, the Greek national
bicycling champion, sipped the liquid dur¬
ing the course of his flight, that more than
tripled the distance record for straight-line
human-powered flight set by Bryan Allen
on June 12, 1979. On that date, Allen
piloted the Gossamer Albatross across the
English Channel.

A $10.2 million construction project has
begun that will increase the size of the
medical library by nearly half. The 58,000
square foot expansion, which includes
room for offices and stacks, is scheduled
to be completed by 1990.
The library will be renamed the Harvey
Cushing/John
Hay
Whitney
Medical
Library.

Yale-Harvard Study
Suggests Shyness Inborn
A joint study by researchers at Yale and
Harvard bolsters earlier evidence that
some children are bom to be shy and that
the tendency persists as they grow older.
According to the study, between 10 and 15
percent of all children are extremely shy,
and many of them may be shy because
their nervous systems react more vigor¬
ously to new situations and strangers.
Shy children in the study responded to
new situations with higher than average
heart rates, blood pressure and muscle ten¬
sion as well as greater pupil dilation and
higher levels of norepinephrine, a brain
chemical produced during stress. Further¬
more, they tended to have higher heart
rates even when sleeping, suggesting pos¬
sible inborn differences.
The study, which is the first to link
physiological factors to shy behavior in
children, followed Boston-area children
between the ages of 1 1/2 and 7 1/2 and
compared them to children who were
extremely outgoing. Although a few of the
older children appeared to outgrow their
shyness, most still hesitated before joining
in play sessions with unfamiliar children.
About 400 children were evaluated for the
study published April 8 in the journal
Science.
"We would tell parents who want to
change their shy child’s behavior that their
efforts are perhaps better spent helping the
child adapt to shyness,” says T Steven
Reznick, assistant professor of psychology
at Yale, who was joined in the research by
Harvard psychologists Jerome Kagan and
Nancy Snidman. "While shy children may
never become the life of the party, with
their parents’ help they can learn to enjoy
the party."

YALE MEDICINE Summer 1988

The flight of the Daedelus—35 centuries after its mythical namesake.

Bristol-Myers Increases
Cancer Center Support
A $3 million, five-year research agree¬
ment to develop anticancer drugs has been
announced between Bristol-Myers Co.
and the Yale Comprehensive Cancer Cen¬
ter (YCCC).
The collaboration will continue a suc¬
cessful
partnership
between
BristolMyers, the world’s largest researcher and
developer of anticancer drugs, and YCCC,
one of the few institutions where scientists
involved in researching such drugs work
together from the first laboratory experi¬
ments through clinical trials among
patients.
Previous agreements between BristolMyers and the center date back to 1977.
when the company granted $500,000 over
five years. A subsequent six-year grant
provided $3 million for six years. These
funds helped the center play a leading role
in developing several important anticancer

drugs, notes Alan C. Sartorelli, Ph.D.,
Alfred Gilman Professor of Pharmacology
and center director.
"The cooperative research agreement
has provided an excellent opportunity for
Yale and Bristol-Myers scientists to com¬
bine our skills in areas of mutual research
interests and apply them to the solution of
some of the most perplexing areas of can¬
cer chemotherapy," comments Professor
Sartorelli. "These areas include the devel¬
opment of promising new anticancer
antibiotics as well as methods to search
for new drugs capable of converting
malignant cells to benign cells.”
Professor Sartorelli adds that while
Yale researchers have the resources to
identify new drugs with the potential for
treating cancer, the resources of industry
are necessary to conduct toxicology tests
for safety.
Bristol-Myers has the option to license
anticancer drugs developed by participat¬
ing Yale faculty during the the agreement.
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Student Research Day
On Tuesday, May 10, 40 students from all
four c lasses of the School of Medicine
presented at the second annual poster
session of Student Research Day. Stu¬
dents represented each of the school’s 17
departments, and made up the largest
research day to date.
Dr. Arnold S. Reiman, editor of The
New England Journal of Medicine, deliv¬
ered the first Lee E. Farr, M D. Lecture ,
"Communicating the Results of Medical
Research: Ethics, Economics and the
Media."
The following includes an excerpt
from the opening remarks of Dr. John N.
Forrest, Jr. director of the office of stu¬
dent research, and abstracts of the award
winning theses of five students, who made
oral presentations.

Opening Remarks
Student research and the required thesis
have been a part of Yale School of
Medicine since 1839, when graduating
students presented their thesis work to the
Connecticut Board of Medical Examiners.
It would not be an exaggeration to say that
the student research presented here today
surpasses that of the past 149 years in its
substance and diversity of biological sci¬
ences. The students presenting and listen¬
ing today may be interested to know the
tradition of student research:
Vesalius published his anatomy text on
the day after graduation (obviously in the
days before the match) and that the best
work of many investigators including
Charles Best’s discovery of insulin and
Jay MacLean’s discovery of heparin was
accomplished as medical students. It is
notable that two of our distinguished
departmental chairmen who are members
of the National Academy of Sciences,
Chuck Stevens of the section of molecular
neurobiology and Vince Marchesi of the
department of pathology, began their
research careers as Yale medical students.
Today’s activities demonstrate that this
tradition is intact.
Dr. John N. Forrest Jr..

tion results in loss of the ladder pattern on
SDS gels, and amino acid analysis of the
purified proteoglycan reveals it to be a
proline-rich protein with an amino acid
composition almost identical to that previ¬
ously reported for a well characterized
acidic proline-rich protein from rat parotid
(50). The proteoglycan also incorporates
radiolabel when isolated granules form
chronically stimulated rats are incubated
in vitro with the activated sulfate donor
35S-phosphadenosine
phosphosulfate
([35-S]PAPS). 35S incorporation is sensi¬
tive to known inhibitors of PAPS transport
and is associated in large part with intact
granules, based on sedimentation and
autoradiographic analyses. Incorporation
into secretory granules appears to be
lower in magnitude than that occurring in
a Golgi-containing fraction. Thus granuleassociated
sulfation
may
reflect
“spillover” of an activity that is more
proximally focused in the intracellular
transport pathway.
A hypothesis is
advanced that Golgi- and granule-level
sulfation facilitates secretory packaging
and is amplified in the chronically stimu¬
lated parotid in order to reduce the fixed
positive charge contributed by the large
amount of basic secretory protein.
An Effective New Prognostic Staging
System for Acquired Immunodeficiency
Syndrome (AIDS).
Amy Caroline Justice, 1988
To evaluate promising new treatments for
acquired
immunodeficiency
syndrome

(AIDS), without the ethical dilemma of
concurrent placebo controls, an effective
system is needed for prognostic staging.
Such a system has not been developed,
because investigators have either concen¬
trated on the prognostic transition from
HIV-positivity to overt AIDS, or have
staged the overt syndrome mainly accord¬
ing to morphologic evidence. In 76 con¬
secutive patients with AIDS treated at
Yale-New Haven Hospital during 198186, 3 major functional deficits were found
to be important predictors of death. They
were: substantial neurologic deficit (e.g.
seizures, severe lethargy, aphasia); severe
hypoxemia (arterial pO2<50); or any 1 of
3 cytopenias (Hematocrit <30, WBC
<2,500, or platelets <140,000). Stage III
was assigned to patients with “bone mar¬
row" failure, classified as any 2 of the 3
cytopenias; Stage II was assigned for any
of the neural, respiratory, or single hema¬
tologic deficits; and Stage I had none of
the deficits. For the “development set” of
76 patients, 4-month survival rates in the
three stages were I, 25/28 (89%); II, 19/38
(50%); and III, 3/10 (30%). The corre¬
sponding median months of survival were
10.8, 3.85, and 2.3. The next 42 consecu¬
tive patients during 1986-87 were used as
a “challenge set." The corresponding sur¬
vival rates for 16, 19, and 7 persons in
each stage were I, 69%; II, 42%; and III.
29% at 4 months, with median survival
times of 7.2, 1.6. and 0.7 months. The
challenge set results thus confirmed the
prognostic gradient.
This prognostic staging system, based
on functional deficits, is simple to use,
noninvasive, and inexpensive. It offers an
effective way to predict prognosis for
individual patients, and to improve
evaluations when treatments are compared
with or without use of randomized trials.

Abstracts
Sulfation of Proteoglycan w ithin
Exocrine Storage Granules: A Possible
Role in Secretory Packaging.
Edgar Allen Blair. 1988
A proteoglycan is amplified in parotid
secretion granules of rats chronically stim¬
ulated with isoproterenol which can be
radiolabeled by injecting the animal with
35S-inorganic sulfate and which, upon
SDS-polyacrylamide gel electro-phoresis,
appears as a closely spaced ladder of
bands. Chondroitinase AC or ABC diges¬

Five members of the Class of 1988 made oral presentations at Student Research Day. (From
left) seated: Peter Merkel, Edgar Blair and Amy Justice. Standing: David Klimstra and Kelle
Moley.

PHOTOS BY BILL carter
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Insulin Resistance and Hyperinsulinemia Precede Insulin Deficiency in
Hypertransfused Patients with Tha¬
lassemia Major.
Peter Alexander Merkel, 1988
Diabetes mellitus in patients receiving
hypertransfusion therapy for thalassemia
major is usually attributed to damage to p
cells. To examine whether iron overload
might lead to insulin resistance even
before the development of impaired
insulin secretion, 12 children with tha¬
lassemia major (4 prepubertal, 8 pubertal)
with normal or only modestly impaired
glucose tolerance on chelation therapy
were studied. Each patient received intra¬
venous insulin (40 m|i/m~ min) to raise
plasma insulin to =80 pU/ml for 2 hours
while plasma glucose was maintained at
90 ± 5 mg/dl by a variable rate glucose
infusion (euglycemic insulin clamp tech¬
nique). Under these conditions of euglycemia and hyperinsulinemia, the glucose
infusion rate reflects total body glucose
metabolism (M) and is an index of insulin
sensitivity. In prepubertal patients with
thalassemia major, M values (319 ± 23
mg/m~ min) were similar to those in pre¬
pubertal normal controls (315+41 mg/m~
min, P=not significant). In contrast,
insulin sensitivity was markedly reduced
in pubertal thalassemics (151 ± 17 vs. 224
± 15 mg/m- min in normal pubertal con¬
trols, p<0.01). The reduction in insulin
sensitivity in patients with thalassemia
major was correlated with iron load (r=0.77, p<0.01). The pubertal, but not the
prepubertal thalassemics, had an excessive
rise in plasma insulin levels after oral glu¬
cose (p<0.001). Furthermore, in response
to a standard 125 mg/dl (6.9 mmol/1)
hyperglycemic stimulus (hyperglycemic
clamp technique), 2-3 fold greater than
normal early and late insulin and C-peptide responses were demonstrated in the
pubertal patients. These data suggest that
insulin sensitivity is reduced in children
with thalassemia major when they reach
puberty due, in part, to chronic iron over¬
load. Compensatory increases in insulin
secretion may help maintain normal glu¬
cose tolerance in the face of insulin resis¬
tance at this stage of the disease. Increased
insulin secretion due to insulin resistance
may contribute to [3-cell exhaustion in tha¬
lassemia major.
Manifestation of Diabetes Mellitus on
Mouse Follicular and Pre-Implantation
Embryo Development: An In Vitro and
In Vivo Investigation.
Kelle Harbert Moley, 1988
This thesis examines the manifestations of
a chemically induced, in vivo diabetic
state on follicular and pre-embryo devel¬
opment. In addition, the influence of indi¬
vidual metabolic derangements existing in
the uncontrolled diabetic state on in vitro
pre-embryo development was examined.
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Dr. John N. Forrest, director of the office of student research, reviews the poster of Ken
Andrioni '88 (right), while Ole Aassar '90 looks on.

The poster of Frederick Lang '88 (right), grabs the attention of Dr. Bennett A. Shaywitz, asso¬
ciate professor of pediatrics, neurology, and the Child Study Center.

An in vivo diabetic state was created in
mice by intraperitoneal injection of streptozotocin (S, 300 mg/kg) or alloxan (A,
330mg/kg). Ovarian follicular develop¬
ment was assessed by germinal vesicle
breakdown (GVBD) in oocytes recovered
from follicles 8 hours after hCG adminis¬
tration. GVBD was noted in 57% of
oocytes from control animals, but was sig¬
nificantly less in oocytes recovered from
streptozotocin (24%) and alloxan (42%)
diabetic groups (p<0.001). This delay in
oocyte maturation was reversed by in vivo
insulin administration to the diabetic mice
(GVBD controls, 60%; S, 60%; A, 57%).
Additionally, an early in vivo delay in pre¬
embryo development was evident at
recovery of pre-embryos 48 hours. This
developmental delay was also seen in the
72 hours in vitro culture of the two-cell

embryos recovered from diabetic animals.
Compared to controls, pre-embryos from
alloxan or streptozotocin diabetic mice
exhibited markedly impaired growth as
assessed by both 1) distribution of devel¬
opmental stages at each 24 hour observa¬
tion period for up to 72 hours in culture;
and 2) overall rate of development.
With in vivo insulin administration, the
early in vivo pre-embryo growth delay,
was reversed and was not significantly
different from control. To examine the
effects of individual metabolic distur¬
bances in a diabetic state on pre-embryo
development, pre-embryos from non-dia¬
betic mice were cultured in vitro in elevat¬
ed
concentrations
of
d-glucose,
acetoacetate, lactate, amino acids or lipids.
Compared to controls, pre-embryos cul¬
tured
in
elevated
glucose
levels
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Neuroscience Center
Dedicated in May

Dr. Robert H. Gifford, associate dean of medical education and student affairs, chats with Dr.
and Mrs. Lee E. Farr. Dr. Farr 32. HS '33-'34, endowed the annual lecture that premiered at
this year's Student Research Day.
(950mg/dl) exhibited markedly retarded
overall growth rates (p<0.005). No signifi¬
cant difference in overall growth rate or
distribution of developmental stages was
seen in elevated concentrations of lactate
(5mM) or elevated concentrations of
lipids (250 mg/dl). Pre-embryos cultured
in both concentrations of amino acids
(7mM) demonstrated an overall retarda¬
tion in growth rate (p=0.001).
Pre-embryos incubated in elevated
concentrations of acetoacetate (lOmM)
demonstrated the most marked growth
retardation. By 72 hours, only 8% of the
total number of pre-embryos cultured in
acetoacetate were at a 4-call developmen¬
tal stage or above versus 97% of total con¬
trol pre-embryos.
In conclusion, diabetes mellitus has the
potential to deleteriously affect oocyte
maturation as well as pre-implantation
embryo development, and that these dia¬
betic manifestations are partially reversed
by insulin administration and improve¬
ment in metabolic control. Culturing pre¬
embryos in vitro in elevated concentra¬
tions of glucose or ketones recreates the in
vivo diabetic state.
MIH'K Cells Synthesize Increased
Basement Membrane Heparin Sulfate
Proteoglycans Upon Polarization.
David S. Klimstra, 19X8
Preconfluent and confluent (polarized)
MDCK cell cultures grown on plastic
were labeled (16 h) with '^SC>4 and pro¬
teoglycans were isolated from the cell lay¬
ers and medium. In both preconfluent and
(influent cultures, most of the proteoglyans (>60%) were found in the cell layer.
With confluence the ratio of HSPG to CSDSPCi in the cell layer increased four fold

due to an 80% decrease in CS-DSPG pro¬
duction. The amount of total HSPGs pro¬
duced per cell did not change. The
HSPG/CS-DSPG ratio in the medium
remained constant with polarization.
When HSPGs from the cell layers were
analyzed by hydrophobic chromatography,
only a small fraction (<10%) bound to
octyl-Sepharose
columns
(potentially
membrane-intercalated HSPGs) at both
stages of growth. In preconfluent cell lay¬
ers, 35% of the total HSPGs could be pre¬
cipitated with an antibody to basement
membrane
HSPG,
and
the
amount
increased to 65% after polarization. By
immunoelectron microscopy, basement
membrane HSPGs were seen concentrated
along lateral cell surfaces with occasional
basal staining in preconfluent cells,
whereas after polarization large amounts
were deposited in a loosely-organized
matrix exclusively along the basal cell
surfaces. No morphologically recogniz¬
able basement membrane was seen at
either stage of growth. When confluent
monolayers were grown on permeable fil¬
ters, most of the proteoglycans were
secreted into the medium (basal = 63%,
apical = 29%). Most (82%) of the base¬
ment membrane HSPGs were found in the
basal medium, while only 11% were in the
apical medium.
The main conclusions that can be
drawn from this work are: 1) confluent
MDCK cell layers synthesize twice as
much as basement membrane HSPG as
preconfluent cell layers: 2) basement
membrane HSPGs are localized exclusive¬
ly basally only after polarization; and 3)
MDCK cells grown on filters deliver base¬
ment member HSPGs predominantly to
the basal cell surface for secretion into the
basal medium.

On a beautiful spring day the School of
Medicine, the Paralyzed Veterans of
America (PVA) and the Eastern Paralyzed
Veterans Association (EPVA) joined the
Veterans Administration to celebrate the
fruits of a remarkable collaboration.
May 14 marked the dedication of the
PVA/EPVA Center for Neuroscience and
Regeneration Research of Yale University.
The single story, 4,500-square-foot facility
on the grounds of the Veterans Adminis¬
tration Medical Center in West Haven will
enable scientists to study how the nervous
system, especially the spinal cord, adapts
to injury. The researchers also will investi¬
gate such diseases as multiple sclerosis.
A remarkable example of civic, gov¬
ernmental and scientific cooperation, the
Veterans Administration made the land
available to Yale through a long-term leas¬
ing arrangement. The PVA provided $1.5
million to help support the center’s con¬
struction and research. And the School of
Medicine brought together a renowned
research team of physicians and scientists,
headed by Stephen G. Waxman, M.D.,
Ph D., professor and chairman of neurolo¬
gy. (See “Yale Neurology: Expanding
Hope’s Horizon.”)
Observed Dean Leon E. Rosenberg:
“With the combined forces of our various
resources, I feel confident that we will
continue to make steady progress which
will benefit those with spinal cord dys¬
function and disease. Dr. Waxman and his
colleagues will strive for innovation and
discovery; as important, they will see that
their students go forth from Yale with the
same depth of compassion and determina¬
tion they clearly have.”
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FACULTY NEWS
Dr. Philip K. Bondy, associate dean for
veterans administration medical center
and professor of medicine, was among the
speakers at Columbia College's May 14
reunion for the Class of 1938. He present¬
ed an update on osteoporosis. Dr. Bondy
received a B.A. degree in biology from
Columbia in 1938.
Marilyn G. Farquhar, Ph D.. Sterling
Professor of Cell Biology and Pathology,
delivered the 31st annual Maude Abbott
Lecture on March 1 at the 77th annual
meeting of the U.S. and Canadian Acade¬
my of Pathology. Professor Farquhar, the
first woman chosen to deliver the lecture,
discussed “A Cell Biologist’s View of
Glomerular Permeability and Pathology.”
The kidney, and in particular the
glomerus, the kidney’s filtering apparatus,
has been one of Professor Farquhar’s
major research interests. She has also
studied and characterized a variety of cell
components and their functions. Her
research on the enzymes known as perioxidases led to automated blood cell count¬
ing, and she was the first to make detailed
studies of the fine structure of kidney
biopsies.
During the 65th annual graduation cer¬
emony on June 5, the University of New
Haven awarded a doctor of humane letters
to Dr. John E. Fenn, clinical professor of
surgery at the School of Medicine and
chief of staff at Yale-New Haven Hospital.
Dr. Fenn was recognized for his more
than 30 years of research and patient care
in the field of cardiovascular surgery. As a
surgeon, teacher, administrator and mem¬

ber of many advisory and decision-mak¬
ing committees at YNHH and the medical
school, he has helped shape and foster the
technological advances that have revolu¬
tionized in the practice of medicine and
surgery. He also has been involved in such
social concerns as problems of the aged,
status of women and bioethics and has
encouraged young people to enter the
medical profession.
Dr. Myron Genel, professor of pedi¬
atrics and associate dean for government
and community affairs, addressed the May
1988 reunion meeting of the Children’s
Hospital of Philadelphia Alumni Organi¬
zation on “The Gender Verification Con¬
troversy: Athletic Sex in International
Competition.”
Dr.
Genel
has
been
engaged in an international campaign to
eliminate the use of sex chromatin for
gender verification of female athletes in
international athletic competition.
The Behavioral and Social Sciences
Section of the Gerontological Society of
America has awarded Judith Rodin,
Ph.D., professor of psychology, psychiatry
and medicine, and Philip R. Allen, Ph D.,
professor of psychology, the 1987 Distin¬
guished Creative Contribution to Geron¬
tology Award for their paper “Aging and
Health: Effects of the Sense of Control.”
The article, which was published in the
September 1986 edition of Science, exam¬
ined the linking mechanisms interrelating
aging and health.
The American College of Physicians
has presented its William C. Menninger
Memorial Award to Dr. Morton F.
Reiser, the Albert E. Kent Professor of
Psychiatry, for “his distinguished contri¬
butions to our understanding of the inter¬
actions of the mind and body, and in
recognition of his major achievements in
the field of psychiatric education.”
Dr. George E. Palade, Sterling Pro¬
fessor of Cell Biology, special adviser to
the dean and senior research scientist in
cell biology, was a Lee Kuan Yew Distin¬
guished Visitor at the National University
of Singapore (NUS) from Feb. 22 to Feb.
29.
He also visited the New Institute for
Molecular Biology and the Science Park
associated with NUS. One of the Science
Park companies produces AIDS test kits
for the American market.

million check from PVA leaders.
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Eight members of the Yale Compre¬
hensive Cancer Center have received the
New Haven Foundation's Argali L. and
Ann G. Hull fund Cancer Research
Awrds. The awards, up to $20,000 and
granted for one year, are given to support
innovative research in the fields of cancer
cause, therapy and prevention. Recipients
include: Marianne Berwick, Ph.D., asso¬
ciate research scientists in epidemiology
and public health; Neal C. Birnberg,

Ph.D., assistant professor of pharmaco¬
logy; Dr. Robert Dubrow, assistant pro¬
fessor of epidemiology and public health;
Maureen Gilmore-Herbert, Ph.D.,
associate research scientists in internal
medicine; Dr. Ben Z. Katz, assistant pro¬
fessor of pediatrics and epidemiology and
public health: I).Y. Anendra Kumar,
Ph.D., associate research scientists, human
genetics; Dr. Thomas F. Patterson, post¬
doctoral fellow in medicine; and Eliot M.
Rosen, M.D., Ph.D., assistant professor of
therapeutic radiology.
Elaine E. Grant, P.A., director of the
medical school’s physician associate pro¬
gram, has been selected to receive a
Twentieth
Anniversary
Appreciation
Award from the American Academy of
Physician Assistants. Twenty such awards
were presented during a May 20 dinner at
the Los Angeles Biltmore to P.A.s who
have made a significant contribution to the
profession.
Barry M. Kacinski, M.D., Ph D.,
assistant professor of therapeutic radiolo¬
gy and a lecturer in molecular biophysics
and biochemistry, has been awarded
$100,000 a year for five years by the Bris¬
tol-Myers Company. The company has
committed $16 million nationally in
research grants to investigators studying
how tumors develop resistence to anti¬
cancer drugs. Dr. Kacinski will apply the
grant to research into the role of the fms
oncogene in ovarian and endometrial can¬
cer.
Dr. Norman J. Siegel, professor of
pediatrics and medicine and vice chairman
of the department of pediatrics, was
installed as president of the American
Society of Pediatric Nephrology during its
annual meeting in Washington, D.C., May
2. His one-year term began June 1.
Dr. Vincent T. Marchesi, chairman of the
department of pathology, was elected to
the National Academy of Sciences. Dr.
Marchesi, also the Anthony N. Brady Pro¬
fessor of Pathology, Cell Biology and
Biology, is one of 61 new members elect¬
ed during the academy's 125th annual
meeting in Washington, D.C. He is the
15th medical faculty member selected for
membership.

Dr. Vincent T. Marchesi
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Professor Ruddle Named
To Sterling Chair

John Thompson Feted
At Retirement Gala

Emeriti Professors
Announced

President Benno C. Schmidt Jr. has
appointed Frank H. Ruddle, Ph.D., to an
endowed professorship. Professor Ruddle,
the Ross Granville Harrison Professor of
Biology and Human Genetics, has been
appointed Sterling Professor of Biology.
Professor Ruddle’s primary concern is
mammalian genetics, cell biology and
development. His laboratory maps gene
locations, determines structural organiza¬
tion at the chromosome and molecular
levels and examines patterns of gene
expression and mechanisms of regulation.
Professor Ruddle, who specializes in
exploring how hereditary traits are passed
from one generation to another, also is the
co-founder and director of the Human
Gene Mapping Library, located in Science
Park in New Haven. The library houses
the largest gene data base in the country,
containing information about more than
1,500 identified human genes.
Professor Ruddle’s experiments estab¬
lished that fruit flies and mice share simi¬
lar genetic patterns. Some of these
patterns appear to be so basic that they
have survived intact in different species
through more than a billion years of evo¬
lution. His current research focuses on
"controller genes,” which appear to con¬
trol how similar gene sequences are
expressed differently in flies and mice.
The recipient of numerous honors. Pro¬
fessor Ruddle was recently awarded the
1988 Katherine Berkan Judd Award by the
Memorial Sloan-Kettering Cancer Center.

The Yale University Hospital Administra¬
tion Alumni Association honored John D.
Thompson, professor of public health
(hospital administration) and nursing
administration, at a retirement gala March
29 at the Museum of Fine Arts in Boston.
The Whiffenpoofs entertained during
the reception and dinner, which was
attended by Professor Thompson’s family
and more than 300 alumni and friends of
the hospital administration program.
An alumnus representing each decade
from the 1950s to the 1980s spoke during
the program, which was entitled “JDT His Life at Yale by Decades.” In addition,
representatives of the Class of 1988 pre¬
sented him with a Memory Book contain¬
ing approximately 75 commemorative
letters from faculty, alumni and friends of
the hospital administration program. Pres¬
ident Ronald Reagan and Mrs. Reagan
also sent a letter commending Professor
Thompson on his accomplishments in the
health-care field and wishing him well in
his retirement. Highlighting the evening
was the presentation of a retirement trip to
Vienna, Austria, during the 1988 opera
season.
Thirteen
contributors,
donating
between $400 and $1,500 each, assisted in
defraying the costs of the party, consid¬
ered to be the largest gathering of gradu¬
ates in the history of the department of
public health.

Seven members of the Yale medical facul¬
ty retired July 1, and the Yale Corporation
has named them emeriti professors.
Dr. Philip K. Bondy, professor of
medicine, associate dean for veterans
affairs and a member of the medical
school faculty since 1952, was named pro¬
fessor emeritus of medicine and consul¬
tant to the medical school on veterans
administration affairs. He will continue as
chief of staff for the Veterans Administra¬
tion Medical Center in West Haven.
Alfred S. Evans, M.D., M.P.H., the
John Rodman Paul Professor of Epidemi¬
ology, is a leading infectious disease clini¬
cian. His main interests are Epstein-Barr
virus, viruses and cancer, epidemiology
and the law, and medieval history. An
assistant professor of medicine from 1949
to 1951, Dr. Evans returned to Yale in
1966 as professor of epidemiology, chief
of the section of international epidemiolo¬
gy and director of the World Health Orga¬
nization Serum Reference Bank. In 1982,
he was named the John Rodman Paul Pro¬
fessor of Epidemiology.
Dr. Evans also served as editor-in-chief
of The Yale Journal of Biology and
Medicine from 1972 to 1973 and from
1974 to 1976.
Paul Howard-Flanders, Ph.D, professor
of therapeutic radiology (radiobiology)
and molecular biophysics, joined the Yale
faculty in 1959. Director of the radiobiol¬
ogy laboratory since 1963, his research
interests involve enzyme purification for

YALE MEDICINE Summer 1988

genetic recombination and repair; biochemi¬
cal mechanisms of mutagenesis by carcino¬
genic agents and radiation; and enzymatic
repair of DNA recombinants.
Each year
since
1963, Dr.
Howard-Flanders has
received a Research Career Award from the
U.S. Public Health Service.
Chief of the Veterans Administration
Medical Center laboratory service from 1974
to 1987, Dr. Leonard S. Kaplow, professor of
pathology and laboratory medicine, has been
a member of the Yale faculty for 24 years. A
pioneer in the fields of hematologic cyto¬
chemistry and How cytometry, he is best
known for his methods for staining and eval¬
uating leukocyte enzymes, which have
become standard procedures throughout the
world. He is a fellow of the American Soci¬
ety of Clinical Pathologists and a past presi¬
dent of the Histochemical Society.
George F. Mahl, Ph.D., who joined the
Yale faculty in 1947, was named assistant
professor of psychiatry and psychology in
1950, and was promoted to professor of psy¬
chiatry and psychology in 1964.
His
research interests include psychophysiology,
psychoanalysis, the dynamics of personality,
and nonverbal and speech behaviors. Sever¬
al of Professor Mahl's publications have
been translated and published in Japanese,
German and Italian.
Sofia Simmonds, Ph.D., professor of
molecular biophysics and biochemistry, has
been a Yale faculty member since 1945. Her
research has encompassed microbiology,
genetics and biochemistry. She received the
Garvan Medal in 1969, an award that recog¬
nizes outstanding women scientists. A fel¬
low of Calhoun College, she served as
associate dean of Yale College and dean of
undergraduate studies during the spring
semester.
John D. Thompson, M.S., professor of
public health (hospital administration) and
professor of nursing administration at the
School of Nursing, is a leader in health care
administration. His major research under¬
takings include the economics of maternity
service, studies in hospital function and
design, and the use of diagnosis-based clini¬
cal and financial information systems for
reimbursement, management, planning and
quality evaluation in hospitals. The Diagno¬
sis-Related Group (DRG) concept was
developed by Professor Thompson and Pro¬
fessor Robert B. Fetter of the Yale School of
Organization and Management. Director of
the program in hospital administration since
1961, Professor Thompson joined the Yale
faculty in 1956.
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Judith Rodin to Lead Minority Recruitment Study
Yale President Benno C. Schmidt Jr. has
appointed Judith Rodin, Ph.D., the Phillip
R. Allen Professor of Psychology and pro¬
fessor of medicine and psychiatry, to chair
a faculty committee that will study the
University’s policies regarding recruit¬
ment and retention of minority-group fac¬
ulty.
The 13-member committee, compris¬
ing faculty from throughout the Universi-

ty, will recommend how to attract minori¬
ty-group scholars to Yale. Dwight T.
Janerich, D.D.S., M.P.H., another medical
school faculty member, will join Professor
Rodin on the panel. He is professor of epi¬
demiology,
associate
director
of
control/prevention of the Cancer Control
Research Center and director of the Can¬
cer Control Research Unit.

Dr. Ment Presented Leah Lowenstein Award
BILL CARTER

Dr. Laura Ment receives the Leah Lowenstein Award from Dean Leon E. Rosenberg.

The Office for Women in Medicine has
presented the third annual Leah Lowenstein Award to Dr. Laura R. Ment, associ¬
ate professor of pediatrics and neurology.
The award recognizes the medical
school faculty member who most clearly
provides positive images of women in
promoting humane and egalitarian medi¬
cal education. The recipient’s teaching
style and personal example provide a
model for the principle of equal opportu¬
nity espoused by the late feminist physi¬
cian, dean and medical educator Leah
Lowenstein, according to Merle Waxman,
director of the Office for Women in
Medicine.
Leah Lowenstein Award recipients are
selected from nominations that students
submit. Wrote one student: “She is smart,
competent and has a terrific sense of
humor! She is great with patients. It has
been wonderful to really be aware of her

presence during my pediatrics rotation.
There are truly so few women role models
for us....I am grateful for the presence of
this very nice and intelligent woman who
does clearly provide a positive image of
women in medicine.”
Dr. Ment joined the Yale medical fac¬
ulty in 1979 as an assistant professor of
pediatrics and neurology. She received
B.A. and M.MSc. degrees in 1970 and
1972, respectively, from Brown Universi¬
ty and an M.D. degree in 1973 from Tufts
University. She completed residency train¬
ing at Massachusetts General Hospital and
also was a visiting fellow in pediatric neu¬
rology at Hammersmith Hospital in Lon¬
don.
Dr. Ment, a mother of three who has
published more than 60 scientific articles,
has focused her research on neonatal neu¬
rologic disorders, such as cerebral hemor¬
rhages and stroke.
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EPH Researcher
Wins CDC Honor
Rebeca Rico-Hesse, Ph.D., assistant pro¬
fessor of epidemiology, has won the 1988
Charles C. Shepard Science Award, the
Centers for Disease Control’s preeminent
science award.
Ms. Rico-Hesse’s scientific publica¬
tion, titled "Geographic Distribution of
Wild Poliovirus Type 1 Genotypes” and
published in the journal Virology, was
judged the outstanding scientific paper
from among 1,117 manuscripts published
in peer-reviewed journals by CDC authors
in 1987. The papers were evaluated on
their scientific merit and the significance
of the work’s impact on the CDC’s mis¬
sion.
She conducted the research for this
paper while she was a National Research
Council postdoctoral fellow at the CDC in
Atlanta.
The
award-winning
publication
explains a laboratory method for deter¬
mining the geographic origin of polio
virus strains that cause epidemics. Basi¬
cally, the method calls for studying the
evolution or lineage of viruses by deter¬
mining their genetic content. With this
information, health professionals may
eradicate epidemic viruses in countries
where epidemics may occur.
Although public health efforts have
virtually eliminated poliomyelitis in the
United States, the viruses annually cause
approximately 400,000 new cases of the
paralytic disease in developing countries.
Ms. Rico-Hesse, who received a Ph.D.
degree in 1985 in microbiology from Cor¬
nell University and joined the Yale faculty
last fall, is concentrating her research on
the evolution and epidemiology of
mosquito-borne viruses occurring in the
tropics.

Dr. Strauss Receives
Van Amerigen Award
Dr. John S. Strauss, professor of psychia¬
try at the Yale School of Medicine, has
been presented the van Amerigen Award
in Psychiatric Rehabilitation by the Amer¬
ican Psychiatric Association (APA).
The award is given annually to an indi¬
vidual, institution or organization that has
made an outstanding contribution to the
field of psychiatric rehabilitation and care
for the chronically mentally ill. The award
was established in memory of Mr. Arnold
I van Amerigen, who made many contri¬
butions to the psychiatric rehabilitation of
the mentally ill.
Dr. Strauss has made outstanding con¬
tributions to the field through his research
and involvement with psychiatric rehabili¬
tation programs at international, national
and local levels.
Nationally, he, along with Dr. Morton
Silverman and Courtenay M. Harding,

Ph.D., assistant professor of psychiatry
(psychology), organized a National Insti¬
tute of Mental Health-sponsored confer¬
ence on work as treatment for psychiatric
disorders. Dr. Strauss also has served as a
consultant to the APA on the joint project
with the Social Security Administration to
develop more effective assessments of
psychiatric disability. He serves on the
board of the Boston University Center for
Rehabilitation Research and Training in
Mental Health and as a consultant to the
Veterans Administration for developing a
national rehabilitation research agenda.
Locally, Dr. Strauss chaired the Con¬
sortium for Community Support Pro¬
grams,
an
agency
that
provides
coordinated management of rehabilitation,
resocialization and supported living set¬
tings in the New Haven area.
He helped found the Consortium for
Rehabilitation Services of Greater New
Haven, an organization that brings togeth¬
er staff of many agencies providing psy¬
chiatric rehabilitation. And he leads an
effort to organize a consumer support
group for persons with mental illness.
In his research. Dr. Strauss has concen¬
trated on various aspects of social func¬
tioning and how they relate to the course
and outcome of severe mental disorders.
His early work established the importance
of work and social relationships in pre¬
dicting and reflecting outcomes of disor¬
der. He and his colleagues were the first to
suggest that social relations, work and
symptoms represented open-linked sys¬
tems of functioning, central to the theory
and treatment of severe psychiatric disor¬
ders. This work led Dr. Strauss to generate
innovative methods for research in psychi¬
atric rehabilitation.

E. Kirstin Dahl Named
To Harris Professorship
The Yale Corporation has named E.
Kirsten Dahl, Ph.D., assistant clinical pro¬
fessor in the Child Study Center, to be the
first Harris Assistant Professor of Child
Psychoanalysis. Her appointment was
effective July 1.
The professorship, as well as several
others, was established with funds from a
$5 million gift from Irving and Neison
Harris, two Chicago area brothers and
businessmen who graduated from Yale
College.
Professor Dahl graduated from Anti¬
och College in 1963. Her early work as a
nursery' school teacher lead her into her
chosen field, and she earned an M.S.
degree in child development in 1971 from
the Bank Street College of Education. She
completed a Ph.D. degree in 1978 at Yale,
where she trained under Dr. Sally A.
Provence, now professor emeritus in the
Child Study Center (child development)
and pediatrics and senior research scientist
in the Child Study Center.

Since 1971 Professor Dahl has been
associated with the Yale Child Study Cen¬
ter, first as a research associate and also as
director of the early childhood educational
and therapeutic programs from 1978 to
1983.
In her clinical work. Professor Dahl
treats children who experience a variety of
psychological problems, including depres¬
sion, anxiety and phobias, including fear
of thunderstorms or clowns.
A child psychoanalyst, Professor Dahl
has centered her research on the meaning
of children’s play. The Harris professor¬
ship will allow her to continue research on
the play of normal children, aged 4 to 6
years, during clinical interviews with psy¬
choanalysts. As she and her colleagues
learn about the ways in which normal
children communicate their imaginative
world through play, they will develop sys¬
tematic methodologies to study the com¬
munication of emotionally disturbed
children in clinical settings.

Two Win Javits Awards
In the Neurosciences
Two School of Medicine faculty members
have been selected to receive Javits Neu¬
roscience Investigator Awards which pro¬
vide grant support for up to seven years.
The recipients are lisa R. Schwartz,
Ph.D., associate professor of surgery (oto¬
laryngology) and neuroanatomy, and Car¬
ole C. LaMotte, Ph.D.. associate professor
of research in surgery (neurosurgery) and
anesthesiology.
According to the National Advisory
Neurological and Communicative Disor¬
ders and Stroke Council, these Yale
researchers have demonstrated scientific
excellence and exceptional productivity,
are pursuing research of significant scien¬
tific importance and have proposed work
of the highest scientific merit.
Professor Schwartz’ research is aimed
at identifying the structure, connections
and chemical properties of neurons in the
inner ear and lower brainstem which pro¬
cess information about sound. This basic
research will help physicians understand
how neurons in the auditory system con¬
tact one another, and the nature of chemi¬
cal signals used to send information
between them, going from ear to ear.
"Ultimately, if we understand how the
system works in normal hearing adult ani¬
mals, we may be able to identify what
goes wrong in aging or genetically con¬
trolled diseases which effect hearing,” she
explains.
Professor LaMotte’s research will con¬
centrate on identifying and analyzing neu¬
ral
elements
of
spinal
pain
and
temperature pathways in primates. She
will compare the organization and func¬
tional physiology of the three major areas
of the spinal grey in order to gain a better
understanding of the areas.
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Medicine at Urbana-Champaign, has
authored several books (see New Books)
and is interested in reviewing scholarly
works of Yale colleagues for publication.

ALUMNI NEWS
I)r. Byron C. Smith ’34-’38 HS continues
to practice ophthalmic plastic surgery in
New York City.
Dr. Robert L. Gilbert ’41 has retired
to Naples, Fla., and serves as medical
director/physician in residence at Bentley
Village Life Care Community.
The University of Missouri-Columbia
Medical Alumni Organization has named
Dr. Samuel P.W. Black ’44-’50 HS an
honorary alumnus. The award was pre¬
sented to Dr. Black for his commitment to
the school and the alumni organization at
the Missouri State Medical Association’s
annual meeting in April. Dr. Black, pro¬
fessor emeritus of surgery at the Universi¬
ty of Missouri-Columbia School of
Medicine,
directs
the
Intracranial
Aneurysm Study with the department of
pathology and serves as a consulting neu¬
rosurgeon for several Missouri hospitals.
Dr. Karel B. Absolon
’52,
Rockville, Md., an emeritus professor
surgery and former academic chairman
the University of Illinois College

of
of
at
of

Dr. Eva Henriksen MacLean ’54
retired from her position with the Los
Angeles County/University of Southern
California Medical Center effective Oct.
31, 1987; she is now a full-time associate
professor of anesthesiology at the Univer¬
sity of Southern California School of
Medicine.
Dr. William H. Hindle ’56 has joined
the department of obstetrics and gynecolo¬
gy of the University of Southern Califor¬
nia School of Medicine as director of the
Breast Diagnostic Center, Women’s Hos¬
pital, Los Angeles County/University of
Southern California Medical Center.
Dr. George Miz.ner ’56-’58 HS prac¬
tices psychiatry and psychoanalysis in
Denver, Colo., and is associate clinical
professor of psychiatry at the University
of Colorado Health Sciences Center
School of Medicine. A former past presi¬
dent of the Colorado Psychiatric Society,
he serves as a representative to the Ameri¬
can Psychiatric Association Assembly.

Dr. David W. Kingsbury ’59 joined
the Howard Hughes Medical Institute in
July as a senior scientific officer.
Dr.
Kingsbury, a virologist who has worked
extensively with paramyxoviruses, has
been a member at St. Jude Children’s
Research Hospital and professor at the
University of Tennessee, Memphis, Col¬
lege of Medicine since 1969.
Retired U.S. Air Force Col. Richard
C. Yeomans ’67 M.P.H. began a one-year
chemical dependency counselor training
program at the Hazelden Foundation in
Center City, Minn., on March 1.
Dr. David H. Shapiro ’67 ’71 HS, of
Clearwater, Fla., a governor of the Ameri¬
can College of Surgeons and a recent
appointee to the Florida Cancer Control
and Research Advisory Board, testified
for the National Cancer Advisory Board
on the need for cooperation between the
National Cancer Institute and community
hospitals. He expressed concern that com¬
munity hospitals designated as Cancer
Treatment Centers by the American Col¬
lege of Surgeons were not included in
patient referrals by NCI’s Cancer Informa¬
tion Service telephone hotline.
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Yale President Benno C. Schmidt Jr., Dr. Robert Petersdorf '52 and Dean Leon E Rosenberg spoke at Alumni Weekend 1988. Full Alumni Week¬
end coverage will follow in the fall edition of YALE MEDICINE.
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Dr. Marc Estes Lippman ’68, senior
investigator and head ot the medical
breast cancer section, medicine branch at
the National Cancer Institute since 1976,
has been named director of the George¬
town University Vincent T. Lombardi
Cancer Center effective July 1. Dr. Lipp¬
man was among the first to work on estro¬
gen
and
progesterone
receptors
as
important predictors for the use of
endocrine therapy for breast cancer. As
director, he hopes to establish state-of-theart research and treatment programs in
breast, colon and prostate cancers.
I)r. Gerald R. Harpel 69 M.P.H., of
Acadia, Calif., is chairman, department of
obstetrics/gynecology, Methodist Hospital
of Southern California and associate pro¬
fessor, clinical obstetrics/gynecology at
the University of Southern California
School of Medicine.
In February, Dr. Paul Hessler III ’70,
of Barrington, R.I., was appointed director
of the combined departments of radiology
of Woonsocket and Fogarty Hospitals in
Rhode Island. He recently completed his
second
term
as
president
of
the
Woonsocket District Medical Society.
Dr. Raymond L. Sphar 72 M.P.H.
manages the U.S. Department of Defense
biomedical research program for the
Office of the Secretary of Defense. He
previously commanded the Naval Medical
Research Institute in Bethesda, Md.
Dr. Caroline Deegan '72, a Maryknoll
missionary nun since 1983, recently com¬
pleted three years as head of internal
medicine in a government hospital in Ocotal, Nicaragua, 20 miles south of the Hon¬
duran border. She was the only internist
for 150,000 people and the only cardiolo¬
gist for 500,000 people. Dr. Deegan
expects to return to Nicaragua in 1989 and
will probably teach in the medical school
in Leon.
Dr. Harold R. Mancusi-Ungaro Jr.
’73, formerly assistant professor of
surgery and director, University Hospital
Bum Unit at the University of Colorado
Health Sciences Center, became associate
professor, chief of the division of plastic
surgery', and director of the Bum Center at
the University of New Mexico on June 1.
Dr.
Ronald
Neumann
’74,
of
Potomac, Md., was named chief of the
nuclear medicine department at the
National Institutes of Health on Feb. 1.
Dr. Kwaku Ohene-Frempong ’75, of
F.lkins Park, Pa., has been assistant profes>r of pediatrics at the University of PennIvania and pediatric hematologist and
ccior of the sickle cell program at the
Children’s Hospital of Philadelphia since

The American Association of Patholo¬
gists presented its 1988 Wamer-Lambert/Parke Davis Award to Dr. Jordan S.
Pober ’77, associate professor of patholo¬
gy at Harvard Medical School and Brig¬
ham and Women’s Hospital in Boston.
The award, given annually to an individu¬
al under age 40, recognizes meritorious
research in experimental pathology.

doned army barracks with no funding for
permanent buildings. Today the depart¬
ment has 150 faculty members, and the
medical school is a sprawling, modem
medical complex.

Dr. Steven M. Shoum ’78, of Massapequa, N.Y., serves as director of the
department of anesthesiology at South
Nassau Communities Hospital and presi¬
dent of district VIII of the New York State
Society of Anesthesiologists.
After
completing
residency
in
orthopaedic surgery and a fellowship in
sports medicine, Dr. David S. Weiss ’81
is in private practice specializing in sports
and dance medicine in New York City. He
also serves as attending surgeon at the
Hospital for Joint Diseases Orthopaedic
Institute.
Michael S. Huncharek ’86 M.P.H., a
first-year medical student at Boston Uni¬
versity School of Medicine, was recently
named a J.M. Scholar by the J.M. Founda¬
tion for training in alcohol and drug abuse.
Catherine McQuilkin, J.D., M.P.H.
’86 joined the law firm of Sills, Cummis
m Newark, N.J., as an associate in the
products liability department on March 1.
The firm recently filed the first fetal alco¬
hol syndrome cases.

Dr. Donald W. Seldin '43, '46 HS was
awarded an honorary Doctor of Laws
degree at the University commencement.
Until his recent retirement, he ser\’ed for
35 years as the chairman of the depart ment of internal medicine at Southwest¬
ern Medical School.

NEW BOOKS
Dr. Seldin Awarded
Honorary Degree
Dr. Donald W. Seldin ’43, ’46 HS, the
William Buchanan Professor of Internal
Medicine, University of Texas Southwest¬
ern Medical School, was awarded an hon¬
orary Doctor of Laws degree at the Yale
University commencement on May 30.
Yale President Benno C. Schmidt Jr. cited
Dr. Seldin as a distinguished leader in
American medicine and principal intellec¬
tual architect of a new medical school,
whose blend of “academic rigor, poetic ele¬
gance and inspired teaching forged a
generation of great medical scientists and
scholars.”
Dr. Seldin, who retired Feb. 1 after 35
years as chairman of the department of
internal medicine at Southwestern Medical
School, developed Southwestern’s basic
sciences and research faculty by persuading
many of his brightest students to make their
careers in academic medicine at Southwest¬
ern.
When Dr. Seldin became chairman of
the department of internal medicine in
1951, it was a department of one—Dr.
Seldin. The school was a series of aban¬

Changing Families, A Guide for Kids and
Grown-ups, by Dr. David Fassler ’82,
Michele Lash, M.Ed., A.T.R. and Sally B.
Ives, Ph.D. Waterfront Books (Burlington,
Vt.) 1988.
Dance Medicine: A
Comprehensive
Guide, edited by Dr. Allan J. Ryan ’36 and
Robert E. Stephens, Ph.D. Pluribus Press
(Chicago) 1987.
Divorce Workbook: A Guide For Kids
and Families, by Sally Ives, Ph.D., Dr.
David Fassler ’82 and Michele Lash,
M.Ed., A.T.R. Waterfront Books (Burling¬
ton, Vt.) 1988.
Doctors: The Biography of Medicine, by
Dr. Sherwin B. Nuland ’55, associate clin¬
ical professor of medicine. Alfred A.
Knopf (New York) 1988.
From G. Prochaska to J.E. Purkinje, by
Dr. K.B. Absolon ’52. Kabel Publications
(Rockville, Md.) 1987.
Physical Diagnosis, by Dr. Siegfried J.
Kra, associate clinical professor of
medicine. Norton (New York) 1987.
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OBITUARIES
Albert W. Snoke, M.D.
Dr. Albert W. Snoke, lecturer in public
health and a consultant in health adminis¬
tration, died April 18 of a heart attack at
his home in Hamden, Conn. He was 80.
Dr. Snoke had been professor of hospi¬
tal administration and director of Grace-

Russell V. Nahigian, M.D.
Dr. Russell Nahigian ’39, died Jan. 6 of a
ruptured aneurysm of the abdominal aorta
at his home in Birmingham, Mich. An
internist. Dr. Nahigian had practiced in the
Detroit area until his retirement in 1987.
He is survived by his wife, Mary; two
sons, Lawrence and Kenneth; two daugh¬
ters, Nancy Cipparone and Carol Jeffrey;
one sister, Mrs. Nuvarite Gullan, and sev¬
eral grandchildren.

Jonathan T. Lanman, M.D.

IN MEMORIAM
Thomas J. Walz
January 3, 1988
Meyer Friedenson
January 19, 1987

'22 HS

’27 M.D.

Mamie F. Hulsman
November 1987

’28 M.P.H.

Harold J. Harris
November 22, 1987

.ex med ’29

Moses D. Lischner
March 8, 1988

’30 M.D.

Theodore P. Merrick
February 15, 1987

’34 M.D.

Teresa F. Rhoads
May 12, 1987

’34 HS

Edward R. Mountain
March 12, 1988

’37 M.D.

Russell Nahigian
January 6, 1988

’39 M.D.

William R. Oakes

’40 M.D.

John R. McDermott
February 22, 1988

’41 M.D.

Jonathan T. Lanman
July 13, 1987

’43 M.D.

Robert A. Sears
January 20, 1988

’43 M.D.

Richard G. Britton
January 20, 1988

’47 M.D.

Gilbert Lee Gordon
May 1988

Dr. Jonathan T. Lanman ’43, of Bethesda,
Md., died of a lung ailment Feb. 22 at his
home. He was 70.
A former chainnan of the department
of pediatrics at the Downstate Medical
Center in Brooklyn, N.Y., and a professor
of pediatrics at New York University, Dr.
Lanman directed the Center for Research
for Mothers and Children at the National
Institute of Child Health and Human
Development,
National
Institutes
of
Health, from 1976 to 1978. Prior to his
appointment with the NIH, he was associ¬
ate director of the biomedical division of
the Population Council.
Surviving are his wife, the former
Janet Edgerton; a daughter, Jacqueline
Sheehan; a son, Jonathan Jr.; a sister, Har¬
riet L. Fulton, and two brothers, William
and Henry.

’50 HS

Jonathan Barry
February 2, 1988

’53 M.D.

Gilbert M.P. Leiv
April 28, 1987

’55 M.D.

Mark Snider
September 8, 1987

’66 M.D.
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Dr Albert W. Snoke was director of
Grace-New Haven Community Hospital
in 1965 when it revised its affiliation
agreement with the University and was
renamed Yale-New Haven Hospital.
New Haven Community Hospital and
Yale-New Haven Hospital from 1946 to
1968. Dr. Snoke was director of the hospi¬
tal when in 1965 it revised its affiliation
agreement with the University and
changed its name to Yale-New Haven
Hospital.
He served as coordinator of health ser¬
vices for the state of Illinois from 1968 to
1973.
A past president of the American Hos¬
pital Association and the Connecticut
Hospital Association, he supported the
creation of the Medicare system and the
development of health maintenance orga¬
nizations. In his book Hospitals, Health
and People, published last year, he
reproved hospitals for appearing to be pre¬
occupied with the “bottom line,” rather
than with patient care, and offered admin¬
istrators advice on many facets of hospital
administration, including reimbursement
and cost containment.
Dr. Snoke's wife. Dr. Pamie Hamilton
Snoke, died in 1981. He is survived by
two sons. Dr. A. Thomas Snoke and Dr. J.
Arthur Snoke.

Memorial Gifts
Deceased medical alumni and friends may
be memorialized by a gift at any time to
the Medical School Alumni Fund Endow¬
ment in the name and class of the person
so honored. The next-of-kin of a deceased
medical alumnus/a is advised about this In
Memoriam Program by a mailing from
New Haven some weeks after the School
of Medicine receives notification of the
death. The letter of information includes a
copy of The Testament of Remembrance in
which the names of all persons so memori¬
alized are listed in the medical section by
class, thus establishing a lasting memorial.
Donors receive a personal penned note of
appreciation from me. Your inquiries and
interest are welcome at any time.
Richard G. Jordan
Director, In Memoriam Program
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ALUMNI REPORT
Since our last report, the alumni office has
increased communication with medical
students and the financial aid office con¬
cerning scholarship student needs. Ms.
Pamela Nyiri presented detailed data to
Yale Medical School Alumni Fund board
members about changing regulations gov¬
erning student assistance. Fund Chairman
Dr. Leonard Kemler, Director Claire Lauterback and the board have thereby been
oriented as to directions of further fund
efforts.
Meetings with student volunteers have
provided agents for all four classes, with
eight self-appointed agents for the fresh¬
man class of 1991! We plan continued
communication to emphasize our mission
with this group, which represents the four
classes. The objective of alumni efforts to
aid the school and its future students will
be identified early. We hope that support
activities, such as alumni networking, will
be addressed with increased benefit for
ourselves as alumni as reward for partici¬
pation in association affairs, initiatives
never previously emphasized.
Another positive development this
spring regarding student aid is the eligibil¬
ity of graduate students for Yale Club
scholarships. Previously these scholar¬
ships had been restricted to Yale College
students. This achievement was the result
of a major effort on the part of John W.
Foster '72, of the Eastern Connecticut

Yale Club. The inherent message here is
that as alumni/ae we should seek member¬
ship in our local Yale Clubs. The net¬
working potential in our communities for
such participation is again suggested. The
issue of alumni networking underlines the
need for updating the medical school
alumni directory last published in 1984. It
is hoped that this can be accomplished in
1989. The committee addressing the
alumni status of former house staff at
Yale-New Haven Hospital also has been
active. Alumni Records has added more
than 1,000 names not previously record¬
ed, and further corrections in this list are
planned this summer.
With the arrival of several new depart¬
ment chairmen in the past year, interest in
soliciting fellow/house staff members for
targeted projects is anticipated. Contribu¬
tions for unrestricted funds from this
source occur regularly, currently under the
supervision of Dr. Samuel Kushlan ’35,
and will continue to be requested by the
alumni fund. With the assistance of fund
facilities and personnel, a small percent¬
age of such needed unrestricted endow¬
ment may be assigned by the dean.
Our major office effort this winter was
the planning and promotion of the reunion
held on June 10 and 11. Of special interest
was the address by Dr. Robert Petersdorf
'52, president of the Association of Amer¬
ican Medical Colleges, who discussed the
BILL CARTER

decreasing pool of applicants to medical
schools nationally; curriculum reform; the
changing environment of medical educa¬
tion; and a summary of current threats and
challenges to medicine. President Dwight
Miller represents our association on the
curriculum review committee.
On June 11, seminars were held updat¬
ing alumni about developments in the neu¬
rosciences; explaining advances in genetic
mapping and diagnosis; and outlining the
Yale experience with AIDS. In addition, a
seminar moderated by Dr. William
Kissiek '57, entitled "Managing the Medi¬
cal Industrial Complex," featured several
noted panelists. They anticipated changes
in systems of health care delivery and the
need to provide specialized professional
management by physicians (Dr. Helen L.
Smits, '67); by nurses (Professor John D.
Thompson, department of epidemiology
and public health) and by the health care
manager (David R. Baily M.P.H. '67).
Dr. Robert H. Gifford, associate dean
for education and student affairs, contin¬
ues to interview applicants who are chil¬
dren of alumni/ae, with 11 interviews
personally held by Dr. Gifford to date this
year. Three such applicants were accepted
in 1986-87. Because the applicant pool to
Yale remains superior in quality, disap¬
pointments were inevitable despite the
fact that alumni children with equivalent
records are given preference. The grade
point average (on a scale of 4.0) was 3.72
in the present freshman group. A profile
of the freshman student may be obtained
in the Facts booklet obtainable on request
at the alumni office.
News for our medical school column
in the Yale Alumni Magazine has been
erratic in arriving. Please use the tear-out
card in YALE MEDICINE, or write to us
directly. The University publication is
printed nine times annually, but the col¬
umn appears only when we have enough
news.
We are grateful for the assistance of
our alumni in (a) interviewing students for
the school when travel to New Haven was
not possible; (b) providing bed-board
assistance to Yale seniors seeking residen¬
cy; and (c) serving as consultants to senior
students seeking critiques of residency
programs.
Our
communications
are
improving. Please let the alumni office
know how it can be more helpful to you.
Dr. Nicholas PR. Spinelli '44
Director of Alumni Affairs

Bail) Vt.P.H '67 and Dr Helen L Smils '67 join Professor Emeritus John D.
on an Alumni Weekend panel entitled "Managing the Medieal Industrial Com<derator Dr. William Kissiek '57 is not pictured.
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If You Did Not Receive the Spring Edition...
We have received a number of inquiries from readers in the
New Haven area about their not receiving the spring edition of
YALE MEDICINE, which was mailed in early May.

After

following this up with our mailing contractor and the U.S.
Postal Service, we have determined that some copies of the
spring issue got lost in the mail.

This is a matter of serious

concern to us, because the spring edition featured an article on
the medical student financial aid crisis and other important
information.
We would be happy to mail the spring YALE MEDICINE
to anyone on our distribution list who did not receive a copy.
To have this issue mailed to you, simply return one of the
postcards included with this edition, state your request and
include your name and address.
We apologize for any inconvenience this may have caused
our readers.
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